PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Behrenfeld, MJ; Randerson, JT; McClain, CR; Feldman, GC; Los, SO; Tucker, CJ; Falkowski, PG; Field, CB; Frouin, R; Esaias, WE; Kolber, DD; Pollack, NH				Behrenfeld, MJ; Randerson, JT; McClain, CR; Feldman, GC; Los, SO; Tucker, CJ; Falkowski, PG; Field, CB; Frouin, R; Esaias, WE; Kolber, DD; Pollack, NH			Biospheric primary production during an ENSO transition	SCIENCE			English	Article							1997-98 EL-NINO; SOUTHERN-OCEAN; INTERANNUAL VARIATIONS; EQUATORIAL PACIFIC; SATELLITE; SURFACE; MODEL; SEAWIFS; PHOTOSYNTHESIS; LIGHT	The Sea-viewing Wide Field-of-view Sensor (SeaWiFS) provides global monthly measurements of both oceanic phytoplankton chlorophyll biomass and light harvesting by land plants. These measurements allowed the comparison of simultaneous ocean and land net primary production (NPP) responses to a major El Nino to La Nina transition. Between September 1997 and August 2000, biospheric NPP varied by 6 petagrams of carbon per year (from 111 to 117 petagrams of carbon per year). Increases in ocean NPP were pronounced in tropical regions where EL Nino-Southern Oscillation (ENSO) impacts on upwelling and nutrient availability were greatest. Globally, land NPP did not exhibit a clear ENSO response, although regional changes were substantial.	NASA, Goddard Space Flight Ctr, Sci Syst & Applicat Inc, Greenbelt, MD 20771 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Wales, Dept Geog, Swansea SA2 8PP, W Glam, Wales; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Scripps Inst Oceanog, La Jolla, CA 92037 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Science Systems and Applications Inc; California Institute of Technology; California Institute of Technology; Rutgers State University New Brunswick; Carnegie Institution for Science; University of California System; University of California San Diego; Scripps Institution of Oceanography	Behrenfeld, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Sci Syst & Applicat Inc, Greenbelt, MD 20771 USA.		Los, Sietse/G-8985-2012; Los, Sietse/Q-6261-2019; Randerson, James/Y-2550-2019	Los, Sietse/0000-0002-1325-3555; Randerson, James/0000-0001-6559-7387				Barnes RA, 1999, APPL OPTICS, V38, P4649, DOI 10.1364/AO.38.004649; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Chen JM, 1996, IEEE T GEOSCI REMOTE, V34, P1353, DOI 10.1109/36.544559; Dierssen HM, 2000, J GEOPHYS RES-OCEANS, V105, P26301, DOI 10.1029/1999JC000296; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; FROUIN R, 1992, J APPL METEOROL, V31, P1056, DOI 10.1175/1520-0450(1992)031<1056:ATFGMO>2.0.CO;2; Hooker S.B., 1993, EOS T AM GEOPHYS UN, V74, P241, DOI [10.1029/93EO00945, DOI 10.1029/93EO00945]; Los SO, 2000, J HYDROMETEOROL, V1, P183, DOI 10.1175/1525-7541(2000)001<0183:AGYBLS>2.0.CO;2; MAISONGRANDE P, 1995, TELLUS B, V47, P178, DOI 10.1034/j.1600-0889.47.issue1.15.x; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Meinen CS, 2000, J CLIMATE, V13, P3551, DOI 10.1175/1520-0442(2000)013<3551:OOWWVC>2.0.CO;2; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Moore JK, 1999, GEOPHYS RES LETT, V26, P1465, DOI 10.1029/1999GL900242; MOREL A, 1991, PROG OCEANOGR, V26, P263, DOI 10.1016/0079-6611(91)90004-6; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; Myneni RB, 1996, GEOPHYS RES LETT, V23, P729, DOI 10.1029/96GL00266; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; *NASA, 2000, NASA TECHN MEM SER, V9; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Tucker CJ, 1999, AMBIO, V28, P587	28	408	427	8	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2594	2597		10.1126/science.1055071	http://dx.doi.org/10.1126/science.1055071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283369	Green Submitted			2022-12-01	WOS:000167861000039
J	Esplin, MS; Fausett, MB; Fraser, A; Kerber, R; Mineau, G; Carrillo, J; Varner, MW				Esplin, MS; Fausett, MB; Fraser, A; Kerber, R; Mineau, G; Carrillo, J; Varner, MW			Paternal and maternal components of the predisposition to preeclampsia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH FACTOR-II; GENE; BIRTH; ANGIOTENSINOGEN; POPULATION; ECLAMPSIA; MICE; IGF2; RISK	Background: There is an inherited maternal predisposition to preeclampsia. Whether there is a paternal component, however, is not known. Methods: We used records of the Utah Population Database to identify 298 men and 237 women born in Utah between 1947 and 1957 whose mothers had had preeclampsia during their pregnancy. For each man and woman in the study group, we identified two matched, unrelated control subjects who were not the products of pregnancies complicated by preeclampsia. We then identified 947 children of the 298 male study subjects and 830 children of the 237 female study subjects who had been born between 1970 and 1992. These children were matched to offspring of the control subjects (1973 offspring of the male control group and 1658 offspring of the female control group). Factors associated with preeclampsia were identified, and odds ratios were calculated with the use of stepwise logistic-regression analysis. Results: In the group of men whose mothers had had preeclampsia (the male study group), 2.7 percent of the offspring (26 of 947) were born of pregnancies complicated by preeclampsia, as compared with 1.3 percent of the offspring (26 of 1973) in the male control group. In the female study group, 4.7 percent of the pregnancies (39 of 830) were complicated by preeclampsia, as compared with 1.9 percent (32 of 1658) in the female control group. After adjustment for the offspring's year of birth, maternal parity, and the offspring's gestational age at delivery, the odds ratio for an adult whose mother had had preeclampsia having a child who was the product of a pregnancy complicated by preeclampsia was 2.1 (95 percent confidence interval, 1.0 to 4.3; P=0.04) in the male study group and 3.3 (95 percent confidence interval, 1.5 to 7.5; P=0.004) in the female study group. Conclusions: Both men and women who were the product of a pregnancy complicated by preeclampsia were significantly more likely than control men and women to have a child who was the product of a pregnancy complicated by preeclampsia. (N Engl J Med 2001;344:867-72.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Oncol Serv, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Esplin, MS (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, Rm 2B200,50 N Med Dr, Salt Lake City, UT 84132 USA.		Kerber, Richard/B-8038-2009; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973				Adams MM, 1997, PAEDIATR PERINAT EP, V11, P78, DOI 10.1111/j.1365-3016.1997.tb00799.x; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; Cincotta RB, 1998, INT J GYNECOL OBSTET, V60, P23, DOI 10.1016/S0020-7292(97)00241-5; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; LITSON WA, 1991, BRIT J OBSTET GYNAEC, V98, P1079; McDermott J, 1997, PAEDIATR PERINAT EP, V11, P105, DOI 10.1046/j.1365-3016.1997.d01-4.x; Mogren I, 1999, EPIDEMIOLOGY, V10, P518, DOI 10.1097/00001648-199909000-00009; O'Shaughnessy KM, 1999, HYPERTENSION, V33, P1338, DOI 10.1161/01.HYP.33.6.1338; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; SNELL LM, 1992, AM J PERINAT, V9, P219, DOI 10.1055/s-2007-999325; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Varner MW, 1996, OBSTET GYNECOL, V87, P905, DOI 10.1016/0029-7844(96)00064-6; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59	21	300	319	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2001	344	12					867	872		10.1056/NEJM200103223441201	http://dx.doi.org/10.1056/NEJM200103223441201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412PN	11259719				2022-12-01	WOS:000167563700001
J	Friis, EM; Pedersen, KR; Crane, PR				Friis, EM; Pedersen, KR; Crane, PR			Fossil evidence of water lilies (Nymphaeales) in the Early Cretaceous	NATURE			English	Article							ANGIOSPERM PHYLOGENY	Phylogenetic analyses have identified the water lilies (Nymphaeales: Cabombaceae and Nymphaeaceae), together with four other small groups of flowering plants (the 'ANITA clades': Amborellaceae, Illiciales, Trimeniaceae, Austrobaileyaceae), as the first diverging lineages from the main branch of the angiosperm phylogenetic tree(1-4), but evidence of these groups in the earliest phases of the angiosperm fossil record has remained elusive. Here we report the earliest unequivocal evidence, based on fossil floral structures and associated pollen, of fossil plants related to members of the ANITA clades. This extends the history of the water lilies (Nymphaeales) back to the Early Cretaceous (125-115 million years) and into the oldest fossil assemblages that contain unequivocal angiosperm stamens and carpels. This discovery adds to the growing congruence between results from molecular-based analyses of relationships among angiosperms and the palaeobotanical record. It is also consistent with previous observations that the flowers of early angiosperms were generally very small(5) compared with those of their living relatives.	Swedish Museum Nat Hist, Dept Palaeobot, SE-10405 Stockholm, Sweden; Aarhus Univ, Dept Geol, DK-8000 Aarhus C, Denmark; Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Swedish Museum of Natural History; Aarhus University; Royal Botanic Gardens, Kew	Friis, EM (corresponding author), Swedish Museum Nat Hist, Dept Palaeobot, Box 50007, SE-10405 Stockholm, Sweden.		Pedersen, Kaj Raunsgaard/L-4105-2013	Crane, Peter/0000-0003-4331-6948; Friis, Else Marie/0000-0001-7587-9687				BESSEY CE, 1915, ANN MISSOURI BOT GAR, V2, P109; Brenner Gilbert J., 1992, Palynology, V16, P137; Doyle J.A., 1976, ORIGIN EARLY EVOLUTI, P139; DOYLE JA, 1992, CRETACEOUS RES, V13, P337, DOI 10.1016/0195-6671(92)90039-S; DOYLE JA, 1977, PALYNOLOGY, V1, P43, DOI DOI 10.1080/01916122.1977.9989150; DRINNAN AN, 1994, PL SYST EVOL S, V8, P93; Endress PK, 2000, INT J PLANT SCI, V161, pS211, DOI 10.1086/317572; Friis EM, 1999, ANN MO BOT GARD, V86, P259, DOI 10.2307/2666179; Friis EM, 2000, INT J PLANT SCI, V161, pS169, DOI 10.1086/317570; Friis EM, 1997, EVOLUTION DIVERSIFIC, P121; FRIIS EM, 1994, PL SYST EVOL S, V8, P31; Frumin S, 1999, PLANT SYST EVOL, V216, P265, DOI 10.1007/BF01084403; Gandolfo M. A., 2000, MONOCOTS SYSTEMATICS, P44; HUGHES NF, 1990, REV PALAEOBOT PALYNO, V65, P145, DOI 10.1016/0034-6667(90)90065-Q; HUGHES NF, 1994, ENIGMA ANGIOSPERM OR; Kuzoff RK, 2000, TRENDS PLANT SCI, V5, P330, DOI 10.1016/S1360-1385(00)01685-X; Les DH, 1999, SYST BOT, V24, P28, DOI 10.2307/2419384; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Penny, 1986, SPEC PAP PALAEONTOL, V35, P121; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Qiu YL, 2000, INT J PLANT SCI, V161, pS3, DOI 10.1086/317584; REY J, 1972, SERVICOS GEOLOGICOS, V21, P1; Saporta GD., 1894, ACAD ROY SCI LISBONN, P112; Schneider E.L., 1993, FAMILIES GENERA VASC, P486, DOI DOI 10.1007/978-3-662-02899-5_57; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Takhtajan A, 1969, FLOWERING PLANTS ORI; Williamson PS, 1993, FAMILIES GENERA VASC, V2, P157, DOI DOI 10.1007/978-3-662-02899-5_16	28	173	179	3	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					357	360		10.1038/35066557	http://dx.doi.org/10.1038/35066557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268209				2022-12-01	WOS:000167464100047
J	Huang, YH; Park, YC; Rich, RL; Segal, D; Myszka, DG; Wu, H				Huang, YH; Park, YC; Rich, RL; Segal, D; Myszka, DG; Wu, H			Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain	CELL			English	Article							APOPTOSIS PROTEIN XIAP; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BACULOVIRAL-INHIBITOR; SURVIVIN REVEALS; NMR STRUCTURE; CELL-DEATH; IAP; COMPLEX; FAMILY	The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors and are characterized by the presence of baculoviral IAP repeats (BIRs). Here, we report the crystal structure of the complex between human caspase-7 and XIAP (BIR2 and the proceeding linker). The structure surprisingly reveals that the linker is the only contacting element for the caspase, while the BIR2 domain is invisible in the crystal. The linker interacts with and blocks the substrate groove of the caspase in a backward fashion, distinct from substrate recognition. Structural analyses suggest that the linker is the energetic and specificity determinant of the interaction. Further biochemical characterizations clearly establish that the linker harbors the major energetic determinant, while the BIR2 domain serves as a regulatory element for caspase binding and Smac neutralization.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Program Physiol Biophys & Mol Med, New York, NY 10021 USA; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Cornell University; Cornell University; Utah System of Higher Education; University of Utah	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Blanchard H, 2000, J MOL BIOL, V302, P9, DOI 10.1006/jmbi.2000.4041; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LaLonde JM, 1998, J MED CHEM, V41, P4567, DOI 10.1021/jm980249f; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 1999, MOL RECOGNIT, V12, P1; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2	53	402	433	2	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					781	790		10.1016/S0092-8674(01)00273-2	http://dx.doi.org/10.1016/S0092-8674(01)00273-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257231	Bronze			2022-12-01	WOS:000167531100017
J	Marsh, AG; Maxson, RE; Manahan, DT				Marsh, AG; Maxson, RE; Manahan, DT			High macromolecular synthesis with low metabolic cost in Antarctic sea urchin embryos	SCIENCE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; PROTEIN-METABOLISM; ENERGY-METABOLISM; GROWTH; LARVAE; GASTROPODA; RATES	Assessing the energy costs of development in extreme environments is important for understanding how organisms can exist at the margins of the biosphere. Macromolecular turnover rates of RNA and protein were measured at -1.5 degreesC during early development of an Antarctic sea urchin. Contrary to expectations of tow synthesis with tow metabolism at low temperatures, protein and RNA synthesis rates exhibited temperature compensation and were equivalent to rates in temperate sea urchin embryos. High protein metabolism with a tow metabolic rate is energetically possible in this Antarctic sea urchin because the energy cost of protein turnover, 0.45 joules per milligram of protein, is 1/25th the values reported for other animals.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, USC Norris Hosp Inst, Dept Biochem & Mol Biol, Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Manahan, DT (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.							BERG WE, 1970, EXP CELL RES, V60, P218, DOI 10.1016/0014-4827(70)90508-2; CLARKE A, 1983, OCEANOGR MAR BIOL, V21, P341; Davidson E. H., 1986, GENE ACTIVITY EARLY; FRY BJ, 1970, DEV BIOL, V21, P125, DOI 10.1016/0012-1606(70)90065-5; GOUSTIN AS, 1981, DEV BIOL, V82, P32, DOI 10.1016/0012-1606(81)90426-7; HAWKINS AJS, 1989, PHYSIOL ZOOL, V62, P745, DOI 10.1086/physzool.62.3.30157925; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Houlihan D.F., 1991, Advances in Comparative and Environmental Physiology, V7, P1; ITO M, 1988, DEV BIOL, V129, P147, DOI 10.1016/0012-1606(88)90169-8; Leong PKK, 1999, J EXP BIOL, V202, P2051; LYNDON AR, 1989, ARCH INT PHYSL BIOCH, V97, pC31; Marsh AG, 1999, MAR ECOL PROG SER, V184, P1, DOI 10.3354/meps184001; Marsh AG, 1999, J EXP BIOL, V202, P2041; MARSH AJ, UNPUB; REEDS PJ, 1987, ANIM PROD, V45, P149, DOI 10.1017/S0003356100018754; REIGER JC, 1977, DEV BIOL, V57, P270; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; SIEMS WG, 1992, CELL BIOCHEM FUNCT, V10, P61, DOI 10.1002/cbf.290100110; Thieringer HA, 1998, BIOESSAYS, V20, P49; Vavra J, 1999, BIOL BULL, V196, P177, DOI 10.2307/1542563; Weiser W., 1994, BIOL REV, V68, P1; WELBORN JR, 1995, J EXP BIOL, V198, P1791; WU RS, 1974, DEV BIOL, V41, P352, DOI 10.1016/0012-1606(74)90312-1	23	84	86	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1950	1952		10.1126/science.1056341	http://dx.doi.org/10.1126/science.1056341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239152				2022-12-01	WOS:000167401600042
J	Schwetz, BA				Schwetz, BA			New measures to manage risks associated with Accutane	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-01	WOS:000167194700005
J	Sanz, JL; Chiappe, LM; Fernandez-Jalvo, Y; Ortega, F; Sanchez-Chillon, B; Poyato-Ariza, FJ; Perez-Moreno, BP				Sanz, JL; Chiappe, LM; Fernandez-Jalvo, Y; Ortega, F; Sanchez-Chillon, B; Poyato-Ariza, FJ; Perez-Moreno, BP			Palaeontology - An Early Cretaceous pellet	NATURE			English	Article							BIRD BONES		Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain; Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Sanz, JL (corresponding author), Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain.		Ortega, Francisco/B-5760-2009; Sanz, Jose Luis/O-1421-2019; Chillón, Begoña Sánchez/AAB-6021-2019; Sánchez, Begoña/K-2257-2014; Ortega, Francisco/K-3255-2015	Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; SANCHEZ, BEGONA/0000-0002-1839-4453; Sanz, Jose Luis/0000-0002-5214-5725; Chiappe, Luis/0000-0001-9661-0601				Andrews P, 1998, NATURE, V393, P629, DOI 10.1038/31356; Andrews P. O, 1990, CAVES FOSSILS; Behrensmeyer A.K., 1991, TAPHONOMY RELEASING, P291, DOI DOI 10.1007/978-1-4899-5034-5; Bochenski ZM, 1998, J ARCHAEOL SCI, V25, P425, DOI 10.1006/jasc.1997.0213; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Davis PG, 1997, INT J OSTEOARCHAEOL, V7, P388, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<388::AID-OA357>3.0.CO;2-H; FISHER DC, 1981, PALEOBIOLOGY, V7, P262, DOI 10.1017/S0094837300004048; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Poyato-Ariza FJ, 1998, PALAEOGEOGR PALAEOCL, V144, P65, DOI 10.1016/S0031-0182(98)00085-6; SANZ JL, IN PRESS PALAEOBIOLO, V2	10	31	32	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					998	1000		10.1038/35059172	http://dx.doi.org/10.1038/35059172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405FT	11234054				2022-12-01	WOS:000167148800032
J	Hamprecht, K; Maschmann, J; Vochem, M; Dietz, K; Speer, CP; Jahn, G				Hamprecht, K; Maschmann, J; Vochem, M; Dietz, K; Speer, CP; Jahn, G			Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding	LANCET			English	Article							BREAST-MILK; VIRUS INFECTION; PREMATURE-INFANTS; NESTED PCR; DNA; SEQUELAE; WHEY	Background Breastfeeding practices strongly influence the epidemiology of human cytomegalovirus infection. By contrast with term neonates. few data are available on transmission of infection from mothers to preterm infants during breastfeeding. Methods 151 mothers and their 176 preterm infants (gestational age at birth <32 weeks or birthweight <1500 g) were prospectively screened for cytomegalovirus infection by serology. virus culture, and PCR. The roles of cell-free and cell-associated cytomegalovirus excretion during lactation were analysed longitudinally in relation to transmission, by maximum-likelihood estimates. Findings Of the 69 seronegative breastfeeding control mothers, none had detectable cytomegalovirus DNA in breastmilk and none of their 80 infants shed the virus in urine. The proportion of cytomegalovirus reactivation in seropositive breastfeeding mothers was 96% (73 of 76). The early appearance of viral DNA in milk whey (median 3.5 days post partum in transmitters; 8 days in non-transmitters: p=0.025) and infectious virus in milk whey (10 days and 16 days, respectively: p=0.005) were risk factors for transmission. The cumulative rate of transmission was 37% (27 of 73 mothers; 33 infants). The infection of the neonates had a mean incubation time of 42 days (95% CI 28-69). About 50% of the infected infants had no symptoms, but four had sepsis-like the symptoms. Interpretation The proportion of cytomegalovirus reactivation during lactation almost equals maternal seroprevalence. Breastfeeding as a source of postnatal cytomegalovirus infection in preterm infants has been underestimated and may be associated with a symptomatic infection.	Univ Tubingen Hosp, Inst Med Virol & Epidemiol Viral Dis, D-72076 Tubingen, Germany; Childrens Univ Hosp Tubingen, Dept Neonatol, Tubingen, Germany; Univ Wurzburg, Childrens Hosp, D-97070 Wurzburg, Germany; Univ Tubingen Hosp, Dept Med Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hamprecht, K (corresponding author), Univ Tubingen Hosp, Inst Med Virol & Epidemiol Viral Dis, Calwerstr 7-6, D-72076 Tubingen, Germany.		Dietz, Klaus/R-9268-2016	Dietz, Klaus/0000-0001-8503-9737				ADLER SP, 1986, CRIT REV CL LAB SCI, V23, P1; Asanuma H, 1996, MICROBIOL IMMUNOL, V40, P201, DOI 10.1111/j.1348-0421.1996.tb03335.x; BALLARD RA, 1979, AM J DIS CHILD, V133, P482, DOI 10.1001/archpedi.1979.02130050026005; DIOSI P, 1967, LANCET, V2, P1063, DOI 10.1016/S0140-6736(67)90338-8; DWORSKY M, 1983, PEDIATRICS, V72, P295; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; GILBERT GL, 1989, LANCET, V1, P1228, DOI 10.1016/S0140-6736(89)92330-1; HAMIRECHT K, 1998, J CLIN VIROL, V11, P125; Hamprecht K, 1998, J VIROL METHODS, V70, P167, DOI 10.1016/S0166-0934(97)00179-1; Hamprecht K, 1997, J VIROL METHODS, V69, P125, DOI 10.1016/S0166-0934(97)00148-1; Hamprecht K, 2000, ADV EXP MED BIOL, V478, P231; HAYES K, 1972, NEW ENGL J MED, V287, P177, DOI 10.1056/NEJM197207272870407; HOTSUBO T, 1994, MICROBIOL IMMUNOL, V38, P809, DOI 10.1111/j.1348-0421.1994.tb01862.x; KUMAR ML, 1984, J PEDIATR-US, V104, P669, DOI 10.1016/S0022-3476(84)80941-5; LANG DJ, 1969, NEW ENGL J MED, V280, P1145, DOI 10.1056/NEJM196905222802103; PARYANI SG, 1985, J PEDIATR-US, V107, P451, DOI 10.1016/S0022-3476(85)80533-3; Prix L, 1998, EUR J CLIN MICROBIOL, V17, P525, DOI 10.1007/BF01691140; REYNOLDS DW, 1973, NEW ENGL J MED, V289, P1, DOI 10.1056/NEJM197307052890101; Schanler RJ, 1999, CLIN PERINATOL, V26, P379, DOI 10.1016/S0095-5108(18)30058-7; Sinzger C, 1996, INTERVIROLOGY, V39, P302, DOI 10.1159/000150502; STAGNO S, 1994, P NATL ACAD SCI USA, V91, P2384, DOI 10.1073/pnas.91.7.2384; STAGNO S, 1980, NEW ENGL J MED, V302, P1073, DOI 10.1056/NEJM198005083021908; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012; YEAGER AS, 1983, J PEDIATR-US, V102, P918, DOI 10.1016/S0022-3476(83)80025-0; 2000, STAT BUNDESAMT	27	291	305	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					513	518		10.1016/S0140-6736(00)04043-5	http://dx.doi.org/10.1016/S0140-6736(00)04043-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229670				2022-12-01	WOS:000167011700011
J	Lander, ES; Int Human Genome Sequencing Consortium; Linton, LM; Birren, B; Nusbaum, C; Zody, MC; Baldwin, J; Devon, K; Dewar, K; Doyle, M; FitzHugh, W; Funke, R; Gage, D; Harris, K; Heaford, A; Howland, J; Kann, L; Lehoczky, J; LeVine, R; McEwan, P; McKernan, K; Meldrim, J; Mesirov, JP; Miranda, C; Morris, W; Naylor, J; Raymond, C; Rosetti, M; Santos, R; Sheridan, A; Sougnez, C; Stange-Thomann, N; Stojanovic, N; Subramanian, A; Wyman, D; Rogers, J; Sulston, J; Ainscough, R; Beck, S; Bentley, D; Burton, J; Clee, C; Carter, N; Coulson, A; Deadman, R; Deloukas, P; Dunham, A; Dunham, I; Durbin, R; French, L; Grafham, D; Gregory, S; Hubbard, T; Humphray, S; Hunt, A; Jones, M; Lloyd, C; McMurray, A; Matthews, L; Mercer, S; Milne, S; Mullikin, JC; Mungall, A; Plumb, R; Ross, M; Shownkeen, R; Sims, S; Waterston, RH; Wilson, RK; Hillier, LW; McPherson, JD; Marra, MA; Mardis, ER; Fulton, LA; Chinwalla, AT; Pepin, KH; Gish, WR; Chissoe, SL; Wendl, MC; Delehaunty, KD; Miner, TL; Delehaunty, A; Kramer, JB; Cook, LL; Fulton, RS; Johnson, DL; Minx, PJ; Clifton, SW; Hawkins, T; Branscomb, E; Predki, P; Richardson, P; Wenning, S; Slezak, T; Doggett, N; Cheng, JF; Olsen, A; Lucas, S; Elkin, C; Uberbacher, E; Frazier, M; Gibbs, RA; Muzny, DM; Scherer, SE; Bouck, JB; Sodergren, EJ; Worley, KC; Rives, CM; Gorrell, JH; Metzker, ML; Naylor, SL; Kucherlapati, RS; Nelson, DL; Weinstock, GM; Sakaki, Y; Fujiyama, A; Hattori, M; Yada, T; Toyoda, A; Itoh, T; Kawagoe, C; Watanabe, H; Totoki, Y; Taylor, T; Weissenbach, J; Heilig, R; Saurin, W; Artiguenave, F; Brottier, P; Bruls, T; Pelletier, E; Robert, C; Wincker, P; Rosenthal, A; Platzer, M; Nyakatura, G; Taudien, S; Rump, A; Yang, HM; Yu, J; Wang, J; Huang, GY; Gu, J; Hood, L; Rowen, L; Madan, A; Qin, SZ; Davis, RW; Federspiel, NA; Abola, AP; Proctor, MJ; Myers, RM; Schmutz, J; Dickson, M; Grimwood, J; Cox, DR; Olson, MV; Kaul, R; Raymond, C; Shimizu, N; Kawasaki, K; Minoshima, S; Evans, GA; Athanasiou, M; Schultz, R; Roe, BA; Chen, F; Pan, HQ; Ramser, J; Lehrach, H; Reinhardt, R; McCombie, WR; de la Bastide, M; Dedhia, N; Blocker, H; Hornischer, K; Nordsiek, G; Agarwala, R; Aravind, L; Bailey, JA; Bateman, A; Batzoglou, S; Birney, E; Bork, P; Brown, DG; Burge, CB; Cerutti, L; Chen, HC; Church, D; Clamp, M; Copley, RR; Doerks, T; Eddy, SR; Eichler, EE; Furey, TS; Galagan, J; Gilbert, JGR; Harmon, C; Hayashizaki, Y; Haussler, D; Hermjakob, H; Hokamp, K; Jang, WH; Johnson, LS; Jones, TA; Kasif, S; Kaspryzk, A; Kennedy, S; Kent, WJ; Kitts, P; Koonin, EV; Korf, I; Kulp, D; Lancet, D; Lowe, TM; McLysaght, A; Mikkelsen, T; Moran, JV; Mulder, N; Pollara, VJ; Ponting, CP; Schuler, G; Schultz, JR; Slater, G; Smit, AFA; Stupka, E; Szustakowki, J; Thierry-Mieg, D; Thierry-Mieg, J; Wagner, L; Wallis, J; Wheeler, R; Williams, A; Wolf, YI; Wolfe, KH; Yang, SP; Yeh, RF; Collins, F; Guyer, MS; Peterson, J; Felsenfeld, A; Wetterstrand, KA; Patrinos, A; Morgan, MJ				Lander, ES; Int Human Genome Sequencing Consortium; Linton, LM; Birren, B; Nusbaum, C; Zody, MC; Baldwin, J; Devon, K; Dewar, K; Doyle, M; FitzHugh, W; Funke, R; Gage, D; Harris, K; Heaford, A; Howland, J; Kann, L; Lehoczky, J; LeVine, R; McEwan, P; McKernan, K; Meldrim, J; Mesirov, JP; Miranda, C; Morris, W; Naylor, J; Raymond, C; Rosetti, M; Santos, R; Sheridan, A; Sougnez, C; Stange-Thomann, N; Stojanovic, N; Subramanian, A; Wyman, D; Rogers, J; Sulston, J; Ainscough, R; Beck, S; Bentley, D; Burton, J; Clee, C; Carter, N; Coulson, A; Deadman, R; Deloukas, P; Dunham, A; Dunham, I; Durbin, R; French, L; Grafham, D; Gregory, S; Hubbard, T; Humphray, S; Hunt, A; Jones, M; Lloyd, C; McMurray, A; Matthews, L; Mercer, S; Milne, S; Mullikin, JC; Mungall, A; Plumb, R; Ross, M; Shownkeen, R; Sims, S; Waterston, RH; Wilson, RK; Hillier, LW; McPherson, JD; Marra, MA; Mardis, ER; Fulton, LA; Chinwalla, AT; Pepin, KH; Gish, WR; Chissoe, SL; Wendl, MC; Delehaunty, KD; Miner, TL; Delehaunty, A; Kramer, JB; Cook, LL; Fulton, RS; Johnson, DL; Minx, PJ; Clifton, SW; Hawkins, T; Branscomb, E; Predki, P; Richardson, P; Wenning, S; Slezak, T; Doggett, N; Cheng, JF; Olsen, A; Lucas, S; Elkin, C; Uberbacher, E; Frazier, M; Gibbs, RA; Muzny, DM; Scherer, SE; Bouck, JB; Sodergren, EJ; Worley, KC; Rives, CM; Gorrell, JH; Metzker, ML; Naylor, SL; Kucherlapati, RS; Nelson, DL; Weinstock, GM; Sakaki, Y; Fujiyama, A; Hattori, M; Yada, T; Toyoda, A; Itoh, T; Kawagoe, C; Watanabe, H; Totoki, Y; Taylor, T; Weissenbach, J; Heilig, R; Saurin, W; Artiguenave, F; Brottier, P; Bruls, T; Pelletier, E; Robert, C; Wincker, P; Rosenthal, A; Platzer, M; Nyakatura, G; Taudien, S; Rump, A; Yang, HM; Yu, J; Wang, J; Huang, GY; Gu, J; Hood, L; Rowen, L; Madan, A; Qin, SZ; Davis, RW; Federspiel, NA; Abola, AP; Proctor, MJ; Myers, RM; Schmutz, J; Dickson, M; Grimwood, J; Cox, DR; Olson, MV; Kaul, R; Raymond, C; Shimizu, N; Kawasaki, K; Minoshima, S; Evans, GA; Athanasiou, M; Schultz, R; Roe, BA; Chen, F; Pan, HQ; Ramser, J; Lehrach, H; Reinhardt, R; McCombie, WR; de la Bastide, M; Dedhia, N; Blocker, H; Hornischer, K; Nordsiek, G; Agarwala, R; Aravind, L; Bailey, JA; Bateman, A; Batzoglou, S; Birney, E; Bork, P; Brown, DG; Burge, CB; Cerutti, L; Chen, HC; Church, D; Clamp, M; Copley, RR; Doerks, T; Eddy, SR; Eichler, EE; Furey, TS; Galagan, J; Gilbert, JGR; Harmon, C; Hayashizaki, Y; Haussler, D; Hermjakob, H; Hokamp, K; Jang, WH; Johnson, LS; Jones, TA; Kasif, S; Kaspryzk, A; Kennedy, S; Kent, WJ; Kitts, P; Koonin, EV; Korf, I; Kulp, D; Lancet, D; Lowe, TM; McLysaght, A; Mikkelsen, T; Moran, JV; Mulder, N; Pollara, VJ; Ponting, CP; Schuler, G; Schultz, JR; Slater, G; Smit, AFA; Stupka, E; Szustakowki, J; Thierry-Mieg, D; Thierry-Mieg, J; Wagner, L; Wallis, J; Wheeler, R; Williams, A; Wolf, YI; Wolfe, KH; Yang, SP; Yeh, RF; Collins, F; Guyer, MS; Peterson, J; Felsenfeld, A; Wetterstrand, KA; Patrinos, A; Morgan, MJ		Int Human Genome Sequencing Conso	Initial sequencing and analysis of the human genome	NATURE			English	Review							OLFACTORY RECEPTOR GENES; HIGH-FREQUENCY RETROTRANSPOSITION; COMPLETE NUCLEOTIDE-SEQUENCE; WILLIAMS-BEUREN-SYNDROME; DNA REGULATORY MOTIFS; SMALL NUCLEAR-RNA; LOW-COPY REPEATS; PHYSICAL MAP; CODON USAGE; LINKAGE DISEQUILIBRIUM	The human genome holds an extraordinary trove of information about human development, physiology, medicine and evolution. Here we report the results of an international collaboration to produce and make freely available a draft sequence of the human genome. We also present an initial analysis of the data, describing some of the insights that can be gleaned from the sequence.	Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02142 USA; Sanger Ctr, Hinxton CB10 1RQ, Cambs, England; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77225 USA; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Genome Therapeut Corp, GTC Sequencing Ctr, Waltham, MA 02453 USA; Inst Mol Biotechnol, Dept Genome Anal, D-07745 Jena, Germany; Chinese Acad Sci, Inst Genet, Ctr Human Genome, Beijing Genom Inst, Beijing 100101, Peoples R China; So China Natl Human Genome Res Ctr, Shanghai 201203, Peoples R China; No China Natl Human Genome Res Ctr, Beijing 100176, Peoples R China; Inst Syst Biol, Multimegabase Sequencing Ctr, Seattle, WA 98105 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Stanford Human Genome Ctrr, Sch Med, Stanford, CA 94305 USA; Univ Washington, Genome Ctr, Seattle, WA 98195 USA; Keio Univ, Sch Med, Dept Biol Mol, Shinjuku Ku, Tokyo 1608582, Japan; Univ Texas, SW Med Ctr, Dallas, TX 75235 USA; Univ Oklahoma, Adv Ctr Genome Technol, Dept Chem & Biochem, Norman, OK 73019 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Cold Spring Harbor Lab, Lita Annenberg Hazen Genome Ctr, Cold Spring Harbor, NY 11724 USA; GBF, German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; MIT, Dept Biol, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; Affymetrix Inc, Berkeley, CA 94710 USA; RIKEN, Yokoham Inst, Genom Sci Ctr, Genom Explorat Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; Univ Calif Santa Cruz, Dept Comp Sci, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Dublin Trinity Coll, Dept Genet, Smurfit Inst, Dublin 2, Ireland; Compaq Comp Corp, Cambridge Res Lab, Cambridge, MA 02142 USA; MIT, Genome Ctr, Cambridge, MA 02142 USA; Univ Calif Santa Cruz, Dept Math, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Weizmann Inst Sci, Crown Human Genet Ctr, IL-71600 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-71600 Rehovot, Israel; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Inst Syst Biol, Seattle, WA 98105 USA; NHGRI, NIH, Bethesda, MD 20892 USA; US DOE, Off Sci, Germantown, MD 20874 USA; Wellcome Trust Res Labs, London NW1 2BE, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Wellcome Trust Sanger Institute; Washington University (WUSTL); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute for Systems Biology (ISB); Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Keio University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman; Max Planck Society; Cold Spring Harbor Laboratory; Helmholtz Association; Helmholtz-Center for Infection Research; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Case Western Reserve University; University Hospitals of Cleveland; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of California System; University of California Santa Cruz; Affymetrix; RIKEN; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Trinity College Dublin; Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Weizmann Institute of Science; Weizmann Institute of Science; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oxford; Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE)	Lander, ES (corresponding author), Whitehead Inst Biomed Res, Ctr Genome Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lander@genome.wi.mit.edu; jes@sanger.ac.uk; bwaterst@watson.wustl.edu; fc23a@nih.gov	Duan, Yanwu/A-5786-2015; Smith, Andy/A-7512-2011; Seaman, Steven/A-2755-2013; Hokamp, Karsten/C-5534-2009; Li, Shuangding/C-1455-2011; Bateman, Alex/H-2861-2019; Ponting, Chris/AAV-2621-2021; Baum, Dana A./B-3720-2008; McPherson, John D/D-2633-2017; Stupka, Elia/J-6279-2012; Marra, Marco A/B-5987-2008; Glöckner, Gernot/A-7800-2010; Hubbard, Tim J.P./AAT-4571-2020; Li, Wei/A-8544-2009; Hermjakob, Henning/AFM-3497-2022; Grimwood, Jane/ABD-5737-2021; Mungall, Andrew J./U-7067-2018; Hattori, Masahira/C-6958-2016; Mardis, Elaine/W-2202-2019; Bork, Peer/F-1813-2013; 郑, 征/C-8514-2011; Bateman, Alex/E-6518-2011; Santoyo-Lopez, Javier/C-9714-2012; Deschamps, Stephane/R-3806-2019; Gish, Warren/C-8123-2012; Deloukas, Panos/B-2922-2013; Kucherlapati, Raju/ABC-8807-2021; Schultz, Joerg/B-9346-2008; Durbin, Richard/AAE-7178-2019; Wilson, Richard K./AAF-4139-2019; Lowe, Todd Michael/ABJ-5261-2022; Maggi, Leonard/L-5217-2019; Weinstock, George M/C-6314-2013; Itoh, Takehiko/E-8873-2014; Fukami, Kaoru/N-7896-2015; Szustakowski, Joseph/HGB-2712-2022; THIERRY-MIEG, Jean/F-1975-2017; Hubbard, Tim J/C-2567-2008; Ganesh, Dunna Sai/AGX-5170-2022; Mesirov, Jill/AGF-7626-2022; Wendl, Michael C/A-2741-2008; Taylor, Todd/A-7121-2009; Wolfe, Kenneth H/B-4653-2009; Hattori, Masahira/AAD-3785-2019; Schmutz, Jeremy/N-3173-2013; Burge, Christopher B./AAH-2177-2020; Mikkelsen, Tarjei S/A-1306-2007; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Duan, Yanwu/0000-0002-6000-0534; Smith, Andy/0000-0001-8580-278X; Seaman, Steven/0000-0003-3349-3334; Bateman, Alex/0000-0002-6982-4660; Baum, Dana A./0000-0002-2777-1708; McPherson, John D/0000-0001-8049-9347; Stupka, Elia/0000-0003-3154-4011; Marra, Marco A/0000-0001-7146-7175; Glöckner, Gernot/0000-0002-9061-1061; Hubbard, Tim J.P./0000-0002-1767-9318; Hermjakob, Henning/0000-0001-8479-0262; Mungall, Andrew J./0000-0002-0905-2742; Hattori, Masahira/0000-0001-9467-0344; Bork, Peer/0000-0002-2627-833X; Santoyo-Lopez, Javier/0000-0003-1988-5059; Deloukas, Panos/0000-0001-9251-070X; Durbin, Richard/0000-0002-9130-1006; Wilson, Richard K./0000-0002-1992-1358; Maggi, Leonard/0000-0003-0138-0984; Weinstock, George M/0000-0002-2997-4592; Itoh, Takehiko/0000-0002-6113-557X; THIERRY-MIEG, Jean/0000-0002-0396-6789; Hubbard, Tim J/0000-0002-1767-9318; Taylor, Todd/0000-0003-4247-6253; Schmutz, Jeremy/0000-0001-8062-9172; Mikkelsen, Tarjei S/0000-0002-8133-3135; Wang, Jun/0000-0002-2113-5874; Brown, Dan/0000-0002-5205-5762; Pelletier, Eric/0000-0003-4228-1712; Dunham, Ian/0000-0003-2525-5598; Steward, Charles/0000-0001-8829-5349; Wolfe, Kenneth/0000-0003-4992-4979; Gilbert, James/0000-0001-8079-3159; Birney, Ewan/0000-0001-8314-8497; Galagan, James/0000-0003-0542-3291; Slater, Guy/0000-0002-4202-8285; Koculi, Eda/0000-0001-9477-555X; Szustakowski, Joseph/0000-0001-7900-3973; Schultz, Brian/0000-0003-4964-976X; Gregory, Simon/0000-0002-7805-1743; Hunt, Adrienne/0000-0002-1227-0310; Furey, Terry/0000-0001-5546-9672; McLysaght, Aoife/0000-0003-2552-6220; Thierry-Mieg, Danielle/0000-0001-9568-4211; McKernan, Kevin/0000-0002-3908-1122; Eddy, Sean/0000-0001-6676-4706; Aravind, L/0000-0003-0771-253X; Ponting, Chris/0000-0003-0202-7816; Hokamp, Karsten/0000-0001-7464-2370; Qureshi, Matloob/0000-0003-2208-4236; Martin, Sancha/0000-0001-6213-5259; Cheng, Jan-Fang/0000-0001-7315-7613; Pan, Huaqin/0000-0002-7166-108X; Glusman, Gustavo/0000-0001-8060-5955; Wang, Jun/0000-0002-8540-8931; Worley, Kim/0000-0002-0282-1000; Chinwalla, Asif/0000-0001-7831-3996; Kaul, Rajinder/0000-0002-7895-9284; Reinhardt, Richard/0000-0001-9376-2132; Mulder, Nicola J/0000-0003-4905-0941; Rubin, Irit/0000-0003-2377-3498; Sai Ganesh, Dunna/0000-0002-3570-7466; Rump, Andreas/0000-0001-7116-6364; McCombie, W. Richard/0000-0003-1899-0682; Kulp, David/0000-0001-6540-0222	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aravind L, 1999, CURR OPIN GENET DEV, V9, P688, DOI 10.1016/S0959-437X(99)00028-3; Arcot SS, 1998, J MOL BIOL, V281, P843, DOI 10.1006/jmbi.1998.1984; ARNOLD N, 1995, GENOMICS, V26, P147, DOI 10.1016/0888-7543(95)80095-4; Attwood TK, 2000, NUCLEIC ACIDS RES, V28, P225, DOI 10.1093/nar/28.1.225; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Bachellerie J. P., 1998, MODIFICATION EDITING, P255; Bailey LC, 1998, GENOME RES, V8, P362, DOI 10.1101/gr.8.4.362; BAINS W, 1992, MUTAT RES, V267, P43, DOI 10.1016/0027-5107(92)90109-F; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bateman A, 2000, ADV PROTEIN CHEM, V54, P137, DOI 10.1016/S0065-3233(00)54005-4; Bateman A, 1996, PROTEIN SCI, V5, P1939, DOI 10.1002/pro.5560050923; Beck S, 1999, NAT BIOTECHNOL, V17, P1144, DOI 10.1038/70651; Bentley DR, 1996, SCIENCE, V274, P533, DOI 10.1126/science.274.5287.533; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERRY R, 1995, NAT GENET, V10, P415, DOI 10.1038/ng0895-415; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730; Bishop J. ., 1990, GENOME; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bouck J, 1998, GENOME RES, V8, P1074, DOI 10.1101/gr.8.10.1074; Bouck JB, 2000, NAT GENET, V25, P31, DOI 10.1038/75563; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Buckley L. J., 1992, Smart Materials and Structures, V1, P1, DOI 10.1088/0964-1726/1/1/001; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Carlo T, 1996, RNA, V2, P342; Casavant NC, 2000, GENETICS, V154, P1809; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chan MF, 2000, CURR TOP MICROBIOL, V249, P75; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; CHENG Y, 2000, ISMB, V8, P93; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; CHURCHILL GA, 1989, B MATH BIOL, V51, P79; Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Cook-Deegan Robert M., 1994, GENE WARS SCI POLITI; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CORDONNIER A, 1995, J VIROL, V69, P5890, DOI 10.1128/JVI.69.9.5890-5897.1995; Correns C., 1899, BERICHTE DTSCH BOT G, V17, P410; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COX D, IN PRESS SCIENCE; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DEVFRIES H, 1900, ACAD SCI PARIS, V130, P845; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETRICH W, 1992, GENETICS, V131, P423; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Drews J, 1999, NAT BIOTECHNOL, V17, P406, DOI 10.1038/8531; Dunham I, 2000, YEAST, V17, P218, DOI 10.1002/1097-0061(20000930)17:3<218::AID-YEA37>3.0.CO;2-X; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Eliot T.S., 1936, TS ELIOT COLLECTED P; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyre-Walker A, 1999, GENETICS, V152, P675; Fahrer AM, 2001, NATURE, V409, P836, DOI 10.1038/35057020; FAN W, 1999, SCIENCE, V286, pA1255; Feil R, 1999, TRENDS GENET, V15, P431, DOI 10.1016/S0168-9525(99)01822-3; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FICKETT JW, 1992, GENOMICS, V13, P1056, DOI 10.1016/0888-7543(92)90019-O; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; FILIPSKI J, 1987, FEBS LETT, V217, P184, DOI 10.1016/0014-5793(87)80660-9; Firestein S, 2000, NATURE, V404, P552, DOI 10.1038/35007167; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRASER JRE, 1996, EXTRACELLULAR MATRIX, V2, P141; Fuchs T, 2001, HUM GENET, V108, P1, DOI 10.1007/s004390000436; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; Gardiner K, 1996, TRENDS GENET, V12, P519, DOI 10.1016/S0168-9525(97)81400-X; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871; GEARHART J, 1997, CELLS EMBRYOS EVOLUT; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gelfand MS, 1996, P NATL ACAD SCI USA, V93, P9061, DOI 10.1073/pnas.93.17.9061; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; GONOS ES, 1990, FEBS LETT, V276, P138, DOI 10.1016/0014-5793(90)80527-P; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Gregory TR, 1999, GENOME RES, V9, P317; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Guthrie C., 1982, MOL BIOL YEAST SACCH, P487; GUTTMAN A, 1990, ANAL CHEM, V62, P137, DOI 10.1021/ac00201a010; Guy J, 2000, HUM MOL GENET, V9, P2029, DOI 10.1093/hmg/9.13.2029; Guyer M, 1998, GENOME RES, V8, P413; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hagmann M, 2000, SCIENCE, V288, P945; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Haring E, 2000, J MOL EVOL, V51, P577, DOI 10.1007/s002390010121; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HATLEN L, 1971, J MOL BIOL, V56, P535, DOI 10.1016/0022-2836(71)90400-1; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; HOLMQUIST GP, 1994, TRENDS ECOL EVOL, V9, P65, DOI 10.1016/0169-5347(94)90277-1; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; HOULGATTE R, 1995, GENOME RES, V5, P272, DOI 10.1101/gr.5.3.272; Hubbard T, 2000, NATURE, V403, P825, DOI 10.1038/35002770; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hurst LD, 2000, BIOESSAYS, V22, P105, DOI 10.1002/(SICI)1521-1878(200002)22:2<105::AID-BIES1>3.0.CO;2-S; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; *INT SNP MAP WORK, 2000, NATURE, V407, P513; JANIN J, 1985, METHOD ENZYMOL, V115, P420; Jenczewski E, 1999, MOL ECOL, V8, P1317, DOI 10.1046/j.1365-294X.1999.00697.x; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347; Jurka J, 1999, GENETICA, V107, P239, DOI 10.1023/A:1003989620068; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; KENT WJ, 2001, UCSCCRL0017; KEVLES DJ, 1992, CODE COPDES SCI SOCI; Kickhoefer VA, 1996, TRENDS CELL BIOL, V6, P174, DOI 10.1016/0962-8924(96)10014-3; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Koga A, 2000, GENETICS, V155, P273; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; KULP D, 1996, ISMB, V4, P134; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; LANDER E S, 1988, Genomics, V2, P231; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Lee LG, 1997, NUCLEIC ACIDS RES, V25, P2816, DOI 10.1093/nar/25.14.2816; LEWIN B, 1990, GENES, V4, P466; LEWIS B, 1980, GENE EXPRESSION; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; LI WH, 1998, MOL EVOLUTION; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; LINDGREN V, 1985, NATURE, V314, P115, DOI 10.1038/314115a0; LITTLE RD, 1989, GENOMICS, V4, P376, DOI 10.1016/0888-7543(89)90345-5; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; LUCKEY JA, 1990, NUCLEIC ACIDS RES, V18, P4417, DOI 10.1093/nar/18.15.4417; LUNDGREN R, 1991, CANCER GENET CYTOGEN, V51, P57, DOI 10.1016/0165-4608(91)90008-I; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Mahairas GG, 1999, P NATL ACAD SCI USA, V96, P9739, DOI 10.1073/pnas.96.17.9739; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Malik HS, 2000, GENETICS, V154, P193; MANUELIDIS L, 1984, CHROMOSOMA, V91, P28, DOI 10.1007/BF00286482; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Marshall E, 1998, SCIENCE, V281, P1774, DOI 10.1126/science.281.5384.1774; Marshall E, 2000, SCIENCE, V290, P242; Marshall E, 1998, SCIENCE, V281, P1121; MARSHALL E, 1995, SCIENCE, V267, P783, DOI 10.1126/science.7846520; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; Mateu E, 2001, AM J HUM GENET, V68, P103, DOI 10.1086/316940; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; McLysaght A, 2000, YEAST, V17, P22, DOI 10.1002/(SICI)1097-0061(200004)17:1<22::AID-YEA5>3.0.CO;2-S; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Meldrum D, 2000, GENOME RES, V10, P1288, DOI 10.1101/gr.157400; Metzker ML, 1996, SCIENCE, V271, P1420, DOI 10.1126/science.271.5254.1420; MEUNIERROTIVAL M, 1982, P NATL ACAD SCI-BIOL, V79, P355, DOI 10.1073/pnas.79.2.355; MIKI Y, 1992, CANCER RES, V52, P643; MILNER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497, DOI 10.1093/nar/11.16.5497; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Moran JV, 1999, GENETICA, V107, P39, DOI 10.1023/A:1004035023356; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Mott R, 1999, J COMPUT BIOL, V6, P91, DOI 10.1089/cmb.1999.6.91; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Murray AW, 2001, NATURE, V409, P844, DOI 10.1038/35057033; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nadeau JH, 1998, MAMM GENOME, V9, P491, DOI 10.1007/s003359900806; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Ohno S., 1970, P1; Okada N, 1997, GENE, V205, P229, DOI 10.1016/S0378-1119(97)00409-5; OKEEFE C, 2000, COMP GENOMICS, P29; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Olivieri NF, 1998, HUM MOL GENET, V7, P1655, DOI 10.1093/hmg/7.10.1655; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; Osoegawa K, 2000, GENOME RES, V10, P116; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; PALCA J, 1986, NATURE, V321, P371; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Pavelitz T, 1999, EMBO J, V18, P3783, DOI 10.1093/emboj/18.13.3783; Pennisi E, 1999, SCIENCE, V283, P1822, DOI 10.1126/science.283.5409.1822; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Pletcher MT, 2000, GENOME RES, V10, P1463, DOI 10.1101/gr.146600; PODUGOLNIKOVA OA, 1983, HUM GENET, V63, P183, DOI 10.1007/BF00291542; Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029; Ponting CP, 2000, ADV PROTEIN CHEM, V54, P185, DOI 10.1016/S0065-3233(00)54007-8; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Porter TL, 1997, RRD POLYM SCI, V1, P1; Potier MC, 1998, GENOMICS, V51, P417, DOI 10.1006/geno.1998.5389; Prak ETL, 2000, NAT REV GENET, V1, P134; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; PUTNEY SD, 1983, NATURE, V302, P718, DOI 10.1038/302718a0; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; REEVE MA, 1995, NATURE, V376, P796, DOI 10.1038/376796a0; Regnier V, 1997, HUM MOL GENET, V6, P9, DOI 10.1093/hmg/6.1.9; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; RILES L, 1993, GENETICS, V134, P81; Ritchie RJ, 1998, HUM MOL GENET, V7, P1253, DOI 10.1093/hmg/7.8.1253; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Romer AS, 1966, VERTEBRATE PALEONTOL; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sacksteder KA, 2000, AM J HUM GENET, V66, P1736, DOI 10.1086/302919; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SARICH VM, 1973, SCIENCE, V179, P1144, DOI 10.1126/science.179.4078.1144; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saunders AJ, 1999, SCIENCE, V286; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Seri M, 2000, NAT GENET, V26, P103; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; SHASHOUA VE, 1991, ANN NY ACAD SCI, V627, P94; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; Sidow A, 1991, CURR OPIN GENET DEV, V1, P451, DOI 10.1016/S0959-437X(05)80191-1; SIMMONS GM, 1992, MOL BIOL EVOL, V9, P1050; SINSHEIMER RL, 1989, GENOMICS, V5, P954, DOI 10.1016/0888-7543(89)90142-0; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Smaglik P, 2000, NATURE, V405, P264, DOI 10.1038/35012771; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Solovyev V, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P294; SORENSEN PD, 1991, NUCLEIC ACIDS RES, V19, P4147, DOI 10.1093/nar/19.15.4147; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Su┬ll D., 1995, TRNA STRUCTURE BIOSY; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; SWERDLOW H, 1990, J CHROMATOGR, V516, P61, DOI 10.1016/S0021-9673(01)90204-3; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; TABOR S, 1990, J BIOL CHEM, V265, P8322; TABOR S, 1989, J BIOL CHEM, V264, P6447; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Thomas JW, 2000, GENOME RES, V10, P624, DOI 10.1101/gr.10.5.624; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Timofeeva M. Ya., 1993, Molekulyarnaya Biologiya (Moscow), V27, P861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trachtulec Z, 1997, GENOMICS, V44, P1, DOI 10.1006/geno.1997.4839; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Tschermak-Seysenegg Ev, 1900, BERICHTE DTSCH BOTAN, V18, P232; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; Van Laer L, 1998, NAT GENET, V20, P194; VANARSDELL SW, 1984, MOL CELL BIOL, V4, P492, DOI 10.1128/MCB.4.3.492; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf YI, 2000, TRENDS GENET, V16, P333, DOI 10.1016/S0168-9525(00)02059-X; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wolfsberg TG, 2001, NATURE, V409, P824, DOI 10.1038/35057000; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; ZACHAU HG, 1993, GENE, V135, P167, DOI 10.1016/0378-1119(93)90062-8; Zhang J, 1999, GENETICS, V153, P1403; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082; Zimonjic DB, 1997, P NATL ACAD SCI USA, V94, P11461, DOI 10.1073/pnas.94.21.11461; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9; 1995, NATURE, V375, P93	449	15686	16429	59	3059	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					860	921		10.1038/35057062	http://dx.doi.org/10.1038/35057062			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237011	Green Published, hybrid			2022-12-01	WOS:000166938800058
J	Pollard, TD				Pollard, TD			Genomics, the cytoskeleton and motility	NATURE			English	Article							BETA-ACTIN; PSEUDOGENES; PROTEINS	The draft human genome sequence is an important step in cataloguing the molecular hardware that supports the processes of life. Here I look at what we have learned from the draft sequence about our cytoskeletal and motility systems. Most cytoskeletal and motility proteins were discovered previously by biochemical isolation, traditional cloning methods or random sequences of complementary DNAs. The ongoing challenges of assembling and annotating genes for motor proteins with long, fragmented coding sequences emphasize the importance of expert knowledge of related proteins and confirmatory evidence from cDNA sequences.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Pollard, TD (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							BERG JS, IN PRESS MOL BIOL CE; Brinkman FSL, 2000, NATURE, V406, P933, DOI 10.1038/35023188; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; Schafer DA, 1999, ANNU REV CELL DEV BI, V15, P341, DOI 10.1146/annurev.cellbio.15.1.341; SCHROER TA, 1994, J CELL BIOL, V127, P1777, DOI 10.1083/jcb.127.6.1777; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Ueyama H, 1996, CYTOGENET CELL GENET, V74, P221, DOI 10.1159/000134420	10	42	45	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					842	843		10.1038/35057029	http://dx.doi.org/10.1038/35057029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237005	Bronze			2022-12-01	WOS:000166938800052
J	Demetriou, M; Granovsky, M; Quaggin, S; Dennis, JW				Demetriou, M; Granovsky, M; Quaggin, S; Dennis, JW			Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation	NATURE			English	Article							MEMBRANE MICRODOMAINS; RECEPTOR; BINDING; LECTIN; ENCEPHALOMYELITIS; COSTIMULATION; GALECTIN-1; APOPTOSIS; BIOSYNTHESIS; SEGREGATION	T-cell activation requires clustering of a threshold number of T-cell receptors (TCRs) at the site of antigen presentation, a number that is reduced by CD28 co-receptor recruitment of signalling proteins to TCRs(1-5). Here we demonstrate that a deficiency in beta1,6 N-acetylglucosaminyltransferase V (Mgat5), an enzyme in the N-glycosylation pathway, lowers T-cell activation thresholds by directly enhancing TCR clustering. Mgat5-deficient mice showed kidney autoimmune disease, enhanced delayed-type hypersensitivity, and increased susceptibility to experimental autoimmune encephalomyelitis. Recruitment of TCRs to agonist-coated beads, TCR signalling, actin microfilament re-organization, and agonist-induced proliferation were all enhanced in Mgat5(-/-) T cells. Mgat5 initiates GlcNAc beta1,6 branching on N-glycans, thereby increasing N-acetyllactosamine(6), the ligand for galectins(7,8), which are proteins known to modulate T-cell proliferation and apoptosis(9,10). Indeed, galectin-3 was associated with the TCR complex at the cell surface, an interaction dependent on Mgat5. Pre-treatment of wild-type T cells with lactose to compete for galectin binding produced a phenocopy of Mgat5(-/-) TCR clustering. These data indicate that a galectin-glycoprotein lattice strengthened by Mgat5-modified glycans restricts TCR recruitment to the site of antigen presentation. Dysregulation of Mgat5 in humans may increase susceptibility to autoimmune diseases, such as multiple sclerosis.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,R988, Toronto, ON M5G 1X5, Canada.		Dennis, James/E-7268-2013					Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Granovsky M, 2000, NAT MED, V6, P306; HUBBARD SC, 1986, P NATL ACAD SCI USA, V83, P1852, DOI 10.1073/pnas.83.6.1852; Karsan A, 1998, J CLIN INVEST, V101, P2438, DOI 10.1172/JCI905; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; Oliveira-dos-Santos AJ, 1999, J IMMUNOL, V162, P4490; Pace KE, 1999, J IMMUNOL, V163, P3801; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reif K, 1998, IMMUNITY, V8, P395, DOI 10.1016/S1074-7613(00)80545-2; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; SATO S, 1992, J BIOL CHEM, V267, P6983; TREVILLYAN JM, 1990, J IMMUNOL, V145, P3223; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Vespa GNR, 1999, J IMMUNOL, V162, P799; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALL KA, 1988, P NATL ACAD SCI USA, V85, P5644, DOI 10.1073/pnas.85.15.5644; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	30	689	701	3	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					733	739		10.1038/35055582	http://dx.doi.org/10.1038/35055582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217864				2022-12-01	WOS:000166816400047
J	Constantinou, A; Davies, AA; West, SC				Constantinou, A; Davies, AA; West, SC			Branch migration and Holliday junction resolution catalyzed by activities from mammalian cells	CELL			English	Article							HOMOLOGY-DIRECTED REPAIR; DOUBLE-STRAND BREAKS; RUVB-LIKE PROTEIN; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; IN-VITRO; GENETIC-RECOMBINATION; RESOLVING ENZYME; DNA HELICASE; RUVABC	During homologous recombination, DNA strand exchange leads to Holliday junction formation. The movement, or branch migration, of this junction along DNA extends the length of the heteroduplex joint. In prokaryotes, branch migration and Holliday junction resolution are catalyzed by the RuvA and RuvB proteins, which form a complex with RuvC resolvase to form a "resolvasome". Mammalian cell-free extracts have now been fractionated to reveal analogous activities. An ATP-dependent branch migration activity, which migrates junctions through >2700 bp, cofractionates with the Holliday junction resolvase during several chromatographic steps. Together, the two activities promote concerted branch migration/resolution reactions similar to those catalyzed by E. coli RuvABC, highlighting the preservation of this essential pathway in recombination and DNA repair from prokaryotes to mammals.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England		West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.		Constantinou, Angelos/E-5337-2013	Constantinou, Angelos/0000-0002-2994-8140; West, Stephen/0000-0001-8848-9418				Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Chakraverty RK, 1999, BIOESSAYS, V21, P286; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Doe CL, 2000, MOL GEN GENET, V263, P889, DOI 10.1007/s004380000256; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fogg JM, 1999, BIOCHEMISTRY-US, V38, P11349, DOI 10.1021/bi990926n; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; HYDE H, 1994, J BIOL CHEM, V269, P5202; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lilley DMJ, 1999, NAT STRUCT BIOL, V6, P897, DOI 10.1038/13255; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rothstein R, 2000, GENE DEV, V14, P1; Schofield MJ, 1998, BIOCHEMISTRY-US, V37, P7733, DOI 10.1021/bi980399s; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; SYMINGTON LS, 1985, P NATL ACAD SCI USA, V82, P7247, DOI 10.1073/pnas.82.21.7247; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; WEST SC, 1982, MOL GEN GENET, V187, P209, DOI 10.1007/BF00331119; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1997, J MOL BIOL, V272, P509, DOI 10.1006/jmbi.1997.1286; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166; Zerbib D, 1998, J MOL BIOL, V281, P621, DOI 10.1006/jmbi.1998.1959	52	114	116	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					259	268		10.1016/S0092-8674(01)00210-0	http://dx.doi.org/10.1016/S0092-8674(01)00210-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207366	Bronze			2022-12-01	WOS:000166879700009
J	West, SA; Murray, MG; Machado, CA; Griffin, AS; Herre, EA				West, SA; Murray, MG; Machado, CA; Griffin, AS; Herre, EA			Testing Hamilton's rule with competition between relatives	NATURE			English	Article							VISCOUS POPULATIONS; INCLUSIVE FITNESS; KIN SELECTION; FIG WASPS; ENVIRONMENT; EVOLUTION; CONFLICT; ALTRUISM	Hamilton's(1,2) theory of kin selection suggests that individuals should show less aggression, and more altruism, towards closer kin. Recent theoretical work has, however, suggested that competition between relatives can counteract kin selection for altruism(3-11). Unfortunately, factors that tend to increase the average relatedness of interacting individuals-such as limited dispersal-also tend to increase the amount of competition between relatives. Therefore, in most natural systems, the conflicting influences of increased competition and increased relatedness are confounded, limiting attempts to test theory(4,8-10). Fig wasp taxa exhibit varying levels of aggression among non-dispersing males that show a range of average relatedness levels. Thus, across species, the effects of relatedness and competition between relatives can be separated. Here we report that-contrary to Hamilton's original prediction(1,2,12) but in agreement with recent theory(5-11) - the level of fighting between males shows no correlation with the estimated relatedness of interacting males, but is negatively correlated with future mating opportunities.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; Smithsonian Trop Res Inst, Balboa, Panama	University of Edinburgh; Rutgers State University New Brunswick; Smithsonian Institution; Smithsonian Tropical Research Institute	West, SA (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Griffin, Ashleigh/C-6244-2014; West, Stuart A/M-3608-2014; Machado, Carlos A/B-8855-2009	Griffin, Ashleigh/0000-0001-7674-9825; West, Stuart A/0000-0003-2152-3153; Machado, Carlos A/0000-0003-1546-7415; Murray, Martyn/0000-0003-4371-388X				CARCAMO HA, 1994, OIKOS, V70, P412, DOI 10.2307/3545779; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; DUNN PO, 1995, P ROY SOC B-BIOL SCI, V259, P339, DOI 10.1098/rspb.1995.0050; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, P62; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HAMILTON WD, 1979, REPROD COMPETITION M, P167; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Herre EA, 1997, SOCIAL COMPETITION C, P226; KELLY JK, 1994, THEOR POPUL BIOL, V46, P32, DOI 10.1006/tpbi.1994.1018; Machado CA, 1996, J BIOGEOGR, V23, P531, DOI 10.1111/j.1365-2699.1996.tb00015.x; Machado CA, 1998, THESIS U CALIFORNIA; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; MURRAY MG, 1987, ANIM BEHAV, V35, P488, DOI 10.1016/S0003-3472(87)80274-9; MURRAY MG, 1989, ANIM BEHAV, V38, P186, DOI 10.1016/S0003-3472(89)80081-8; MURRAY MG, 1984, J THEOR BIOL, V111, P237, DOI 10.1016/S0022-5193(84)80208-8; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; QUELLER DC, 1992, TRENDS ECOL EVOL, V7, P322, DOI 10.1016/0169-5347(92)90120-Z; READ AF, 1995, P ROY SOC B-BIOL SCI, V260, P359, DOI 10.1098/rspb.1995.0105; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; VINCTENT SL, 1991, POLYMORPHISM FIGHTIN; West SA, 2000, P ROY SOC B-BIOL SCI, V267, P257, DOI 10.1098/rspb.2000.0995; West SA, 1998, J EVOLUTION BIOL, V11, P531, DOI 10.1007/s000360050104; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; YANG ZB, 1994, J MOL EVOL, V39, P105	30	204	214	2	91	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					510	513		10.1038/35054057	http://dx.doi.org/10.1038/35054057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206546	Green Published			2022-12-01	WOS:000166570500047
J	Vergote, I; De Brabanter, J; Fyles, A; Bertelsen, K; Einhorn, N; Sevelda, P; Gore, ME; Kaern, J; Verrelst, H; Sjovall, K; Timmerman, D; Vandewalle, J; Van Gramberen, M; Trope, CG				Vergote, I; De Brabanter, J; Fyles, A; Bertelsen, K; Einhorn, N; Sevelda, P; Gore, ME; Kaern, J; Verrelst, H; Sjovall, K; Timmerman, D; Vandewalle, J; Van Gramberen, M; Trope, CG			Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma	LANCET			English	Article							ADJUVANT TREATMENT; CANCER; SURVIVAL; NEOPLASMS; SPREAD; TRIALS	Background Previous studies on prognostic factors in stage I invasive epithelial ovarian carcinoma have been too small for robust conclusions to be reached. We undertook a retrospective study in a large international database to identify the most important prognostic variables. Methods 1545 patients with invasive epithelial ovarian cancer (International Federation of Gynaecology and Obstetrics [FIGO] stage I) were included. The records of these patients were examined and data extracted for univariate and multivariate analysis of disease-free survival in relation to various clinical and pathological variables. Findings The multivariate analyses identified degree of differentiation as the most powerful prognostic indicator of disease-free survival (moderately vs well differentiated hazard ratio 3.13 [95% CI 1.68-5.85], poorly vs well differentiated 8.89 [4.96-15.9]), followed by rupture before surgery (2.65 [1.53-4.56]), rupture during surgery (1.64 [1.07-2.51]), FIGO 1973 stage Ib vs Ia 1.70 [1.01-2.85]) and age (per year 1.02 [1.00-1.03]). When the effects of these factors were accounted for. none of the following were of prognostic value: histological type, dense adhesions, extracapsular growth, ascites, FIGO stage 1988, and size of tumour. Interpretation Degree of differentiation, the most powerful prognostic indicator in stage I ovarian cancer, should be used in decisions on therapy in clinical practice and in the FIGO classification of stage I ovarian cancer. Rupture should be avoided during primary surgery of malignant ovarian tumours confined to the ovaries.	Univ Hosp Leuven, Dept Gynaecol Oncol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Dept Elect Engn, Louvain, Belgium; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Odense Univ Hosp, DK-5000 Odense, Denmark; Karolinska Hosp, S-10401 Stockholm, Sweden; Univ Hosp, Vienna, Austria; Royal Marsden NHS Trust, London, England; Norwegian Radium Hosp, Oslo, Norway	KU Leuven; University Hospital Leuven; KU Leuven; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Southern Denmark; Odense University Hospital; Karolinska Institutet; Karolinska University Hospital; University Hospital Vienna; Royal Marsden NHS Foundation Trust; University of Oslo	Vergote, I (corresponding author), Univ Hosp Leuven, Dept Gynaecol Oncol, B-3000 Louvain, Belgium.	Ignace.Vergote@UZ.Kuleuven.ac.be	Timmerman, Dirk/AAD-2363-2019	Timmerman, Dirk/0000-0002-3707-6645; Fyles, Anthony/0000-0002-3633-2483				Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P354; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; BEREK JS, 1995, LANCET, V346, P200, DOI 10.1016/S0140-6736(95)91264-9; BERTELSEN K, 1993, INT J GYNECOL CANCER, V3, P211, DOI 10.1046/j.1525-1438.1993.03040211.x; Bolis G, 1995, ANN ONCOL, V6, P887, DOI 10.1093/oxfordjournals.annonc.a059355; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Cox DR., 1984, ANAL SURVIVAL DATA; DELACUESTA RS, 1994, OBSTET GYNECOL, V84, P1; DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263; FAREWELL VT, 1980, BIOMETRIKA, V67, P273, DOI 10.2307/2335471; FINN CB, 1992, BRIT J OBSTET GYNAEC, V99, P54, DOI 10.1111/j.1471-0528.1992.tb14393.x; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Kindermann G, 1995, GEBURTSH FRAUENHEILK, V55, P687, DOI 10.1055/s-2007-1022315; Kodama S, 1997, INT J GYNECOL OBSTET, V56, P147, DOI 10.1016/S0020-7292(96)02798-1; Lehner R, 1998, OBSTET GYNECOL, V92, P967, DOI 10.1016/S0029-7844(98)00323-8; Leminen A, 1999, GYNECOL ONCOL, V75, P387, DOI 10.1006/gyno.1999.5596; MAIMAN M, 1991, OBSTET GYNECOL, V77, P563; PETTERSSON F, 1986, ANN REPORT RESULTS T, P110; Schueler JA, 1996, GYNECOL ONCOL, V62, P59, DOI 10.1006/gyno.1996.0190; Serov SF, 1973, INT HISTOLOGICAL CLA, P17; SEVELDA P, 1990, CANCER-AM CANCER SOC, V65, P2349, DOI 10.1002/1097-0142(19900515)65:10<2349::AID-CNCR2820651031>3.0.CO;2-#; SJOVALL K, 1994, INT J GYNECOL CANCER, V4, P333, DOI 10.1046/j.1525-1438.1994.04050333.x; TRIMBOS JB, 1993, CANCER, V72, P828, DOI 10.1002/1097-0142(19930801)72:3<828::AID-CNCR2820720331>3.0.CO;2-T; Trope C, 2000, ANN ONCOL, V11, P281, DOI 10.1023/A:1008399414923; VEGOTE IB, 1993, AM J OBSTET GYNECOL, V169, P40; WEBB MJ, 1973, AM J OBSTET GYNECOL, V116, P222, DOI 10.1016/0002-9378(73)91054-5; YOUNG RC, 1990, NEW ENGL J MED, V322, P1021, DOI 10.1056/NEJM199004123221501; 1973, ANN REPORT RESULTS T; 1998, J EPIDEMIOL BIOSTAT, V3, P1	30	457	472	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					176	182		10.1016/S0140-6736(00)03590-X	http://dx.doi.org/10.1016/S0140-6736(00)03590-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213094				2022-12-01	WOS:000166593700010
J	Errington, JR; Debenedetti, PG				Errington, JR; Debenedetti, PG			Relationship between structural order and the anomalies of liquid water	NATURE			English	Article							SUPERCOOLED WATER; PHASE-TRANSITION; HEAT-CAPACITY; ENTROPY; DENSITY; DIFFUSION; BEHAVIOR	In contrast to crystalline solids-for which a precise framework exists for describing structure(1)-quantifying structural order in liquids and glasses has proved more difficult because even though such systems possess short-range order, they lack long-range crystalline order. Some progress has been made using model systems of hard spheres(2,3), but it remains difficult to describe accurately liquids such as water, where directional attractions (hydrogen bonds) combine with short-range repulsions to determine the relative orientation of neighbouring molecules as well as their instantaneous separation. This difficulty is particularly relevant when discussing the anomalous kinetic and thermodynamic properties of water, which have long been interpreted qualitatively in terms of underlying structural causes. Here we attempt to gain a quantitative understanding of these structure- property relationships through the study of translational(2,3) and orientational(4) order in a model(5) of water. Using molecular dynamics simulations, we identify a structurally anomalous region-bounded by loci of maximum orientational order (at low densities) and minimum translational order (at high densities)-in which order decreases on compression, and where orientational and translational order are strongly coupled. This region encloses the entire range of temperatures and densities for which the anomalous diffusivity(6-9) and thermal expansion coefficient(10) of water are observed, and enables us to quantify the degree of structural order needed for these anomalies to occur. We also find that these structural, kinetic and thermodynamic anomalies constitute a cascade: they occur consecutively as the degree of order is increased.	Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA	Princeton University	Debenedetti, PG (corresponding author), Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA.	pdebene@princeton.edu	Debenedetti, Pablo/ABD-1497-2021; Errington, Jeffrey/E-8644-2011	Debenedetti, Pablo/0000-0003-1881-1728; Errington, Jeffrey/0000-0003-0365-0271				Allen MP., 1990, COMPUTER SIMULATION; ANGELL CA, 1976, SCIENCE, V193, P1121, DOI 10.1126/science.193.4258.1121; ANGELL CA, 1982, J PHYS CHEM-US, V86, P998, DOI 10.1021/j100395a032; ANGELL CA, 1976, J CHEM PHYS, V65, P3063, DOI 10.1063/1.433518; Ashcroft N W, 1976, SOLID STATE PHYSICS; Bellissent-Funel MC, 1998, EUROPHYS LETT, V42, P161, DOI 10.1209/epl/i1998-00223-5; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Chau PL, 1998, MOL PHYS, V93, P511, DOI 10.1080/002689798169195; Debenedetti P.G, 1996, METASTABLE LIQUIDS C; DEFRIES T, 1977, J CHEM PHYS, V66, P896, DOI 10.1063/1.433995; GOLDSTEIN M, 1969, J CHEM PHYS, V51, P3728, DOI 10.1063/1.1672587; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; NABERUKHIN YI, 1991, MOL PHYS, V73, P917, DOI 10.1080/00268979100101651; NETTLETON RE, 1958, J CHEM PHYS, V29, P1365, DOI 10.1063/1.1744724; Paschek D, 1999, J PHYS CHEM B, V103, P4139, DOI 10.1021/jp984075p; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; PRIELMEIER FX, 1987, PHYS REV LETT, V59, P1128, DOI 10.1103/PhysRevLett.59.1128; RUOCCO G, 1993, J CHEM PHYS, V99, P8095, DOI 10.1063/1.465635; Scala A, 2000, NATURE, V406, P166, DOI 10.1038/35018034; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; SCIORTINO F, 1991, NATURE, V354, P218, DOI 10.1038/354218a0; SCIORTINO F, 1990, PHYS REV LETT, V64, P1686, DOI 10.1103/PhysRevLett.64.1686; Shiratani E, 1998, J CHEM PHYS, V108, P3264, DOI 10.1063/1.475723; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Tanaka H, 1998, PHYS REV LETT, V80, P5750, DOI 10.1103/PhysRevLett.80.5750; Tanaka H, 1999, J PHYS-CONDENS MAT, V11, pL159, DOI 10.1088/0953-8984/11/15/005; Tanaka H, 2000, J CHEM PHYS, V112, P799, DOI 10.1063/1.480609; Tombari E, 1999, CHEM PHYS LETT, V300, P749, DOI 10.1016/S0009-2614(98)01392-X; Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064; Truskett TM, 2000, PHYS REV E, V62, P993, DOI 10.1103/PhysRevE.62.993	33	1134	1142	9	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					318	321		10.1038/35053024	http://dx.doi.org/10.1038/35053024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201735				2022-12-01	WOS:000166434300040
J	Schneider, SH				Schneider, SH			Earth systems engineering and management	NATURE			English	Article							STABILIZATION	Imagine that we could let the world's economy continue to grow, bring the disadvantaged classes up from poverty and at the same time not threaten the atmosphere or global ecosystems with unprecedented build-up of greenhouse gases and the projected climatic risks of such growth. Earth systems engineering and management may just be such a panacea, some have suggested. But could we anticipate the costs or ever truly predict the consequences?	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Inst Int Studies, Stanford, CA 94305 USA	Stanford University; Stanford University	Schneider, SH (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Allenby B., 1998, J IND ECOL, V2, P73, DOI DOI 10.1162/JIEC.1998.2.3.73; [Anonymous], 1989, END NATURE; Budyko M. I., 1977, CLIMATIC CHANGES, DOI [DOI 10.1029/SP010, 10.1029/SP010]; GLAZOVSKY N, 1990, ARAL CRISIS ORIGIN P; Govindasamy B, 2000, GEOPHYS RES LETT, V27, P2141, DOI 10.1029/1999GL006086; Grubb M, 1994, INTEGRATIVE ASSESSME, P513; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; *INT PAN CLIM CHAN, 1995, IPCC WORK GROUP 1; Johansson T.B., 1993, RENEWABLE ENERGY SOU; Keith DW, 2000, IEEE TECHNOL SOC MAG, V19, P25, DOI 10.1109/44.890079; KELLOGG WW, 1974, SCIENCE, V186, P1163, DOI 10.1126/science.186.4170.1163; MARCHETTI C, 1977, CLIMATIC CHANGE, V1, P59, DOI 10.1007/BF00162777; Monastersky R., 1995, SCI NEWS, V148, P220; NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315; *PAN POL IMPL GREE, 1992, POL IMPL GREEN WARM; ROSENBERG NJ, 1998, CARBON SEQUESTRATION; Schneider SH, 1996, CLIMATIC CHANGE, V33, P291, DOI 10.1007/BF00142577; SOCOLOW RE, 1997, 302 PUCEES; WATSON AJ, 1994, NATURE, V371, P143, DOI 10.1038/371143a0; Watson RT, 2000, LAND USE LAND USE CH; World Commission on Environment and Development, 1987, OUR COMMON FUTURE; [No title captured]	22	53	57	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					417	+		10.1038/35053203	http://dx.doi.org/10.1038/35053203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201758	Bronze			2022-12-01	WOS:000166434300066
J	Hu, S; Chapin, FS; Firestone, MK; Field, CB; Chiariello, NR				Hu, S; Chapin, FS; Firestone, MK; Field, CB; Chiariello, NR			Nitrogen limitation of microbial decomposition in a grassland under elevated CO2	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; NET PRIMARY PRODUCTION; TERRESTRIAL ECOSYSTEMS; SOIL-MICROORGANISMS; ENRICHMENT; COMPETITION; RESPIRATION; RESPONSES; FEEDBACK	Carbon accumulation in the terrestrial biosphere could partially offset the effects of anthropogenic CO2 emissions on atmospheric CO2 (refs 1, 2). The net impact of increased CO2 on the carbon balance of terrestrial ecosystems is unclear, however, because elevated CO2 effects on carbon input to soils and plant use of water and nutrients often have contrasting effects on microbial processes(3-5). Here we show suppression of microbial decomposition in an annual grassland after continuous exposure to increased CO2 for five growing seasons. The increased CO2 enhanced plant nitrogen uptake, microbial biomass carbon, and available carbon for microbes. But it reduced available soil nitrogen, exacerbated nitrogen constraints on microbes, and reduced microbial respiration per unit biomass. These results indicate that increased CO2 can alter the interaction between plants and microbes in favour of plant utilization of nitrogen, thereby slowing microbial decomposition and increasing ecosystem carbon accumulation.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Environm Sci, Berkeley, CA 94720 USA; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Carnegie Institution for Science	Hu, S (corresponding author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.		Chapin, F Stuart/AAZ-3931-2020	Chapin, F Stuart/0000-0002-2558-9910; Hu, Shuijin/0000-0002-3225-5126				Ball AS, 1997, GLOB CHANGE BIOL, V3, P379, DOI 10.1046/j.1365-2486.1997.t01-1-00089.x; Berntson GM, 1996, PLANT SOIL, V187, P119, DOI 10.1007/BF00017085; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Field C.B., 1996, CARBON DIOXIDE TERRE, p121e145, DOI DOI 10.1016/B978-012505295-5/50009-4; Fitter AH, 1997, NEW PHYTOL, V137, P247, DOI 10.1046/j.1469-8137.1997.00804.x; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; JACKSON RB, 1994, OECOLOGIA, V98, P257, DOI 10.1007/BF00324212; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Klironomos JN, 1996, FUNCT ECOL, V10, P527, DOI 10.2307/2389946; KOERNER C, 1992, SCIENCE, V257, P1672; Lambers H, 1996, PLANT SOIL, V187, P251, DOI 10.1007/BF00017091; Luo YQ, 1996, OECOLOGIA, V108, P130, DOI 10.1007/BF00333224; MCGUIRE AD, 1995, ANNU REV ECOL SYST, V26, P473, DOI 10.1146/annurev.es.26.110195.002353; Paterson E, 1997, GLOBAL CHANGE BIOL, V3, P363, DOI 10.1046/j.1365-2486.1997.t01-1-00088.x; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RICE CW, 1994, PLANT SOIL, V165, P67, DOI 10.1007/BF00009963; Rillig MC, 1998, OECOLOGIA, V113, P252, DOI 10.1007/s004420050376; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rillig MC, 1999, NATURE, V400, P628, DOI 10.1038/23168; Schimel D., 1996, CLIMATE CHANGE 1995, P65; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Smith JL, 1990, SOIL BIOCH, V6, P357; Stark JM, 1996, SOIL SCI SOC AM J, V60, P1846, DOI 10.2136/sssaj1996.03615995006000060033x; TISDALL JM, 1994, PLANT SOIL, V159, P115, DOI 10.1007/BF00000100; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wang JG, 1997, SOIL BIOL BIOCHEM, V29, P163, DOI 10.1016/S0038-0717(96)00292-1; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791	30	271	353	18	305	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					188	191		10.1038/35051576	http://dx.doi.org/10.1038/35051576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196641				2022-12-01	WOS:000166316200043
J	Schwetz, BA				Schwetz, BA			Drug for esophagitis and GERD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, HF-1,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1696	1696		10.1001/jama.285.13.1696	http://dx.doi.org/10.1001/jama.285.13.1696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277810				2022-12-01	WOS:000167710600004
J	McKinley, RK; Fraser, RC; Baker, R				McKinley, RK; Fraser, RC; Baker, R			Model for directly assessing and improving clinical competence and performance in revalidation of clinicians	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; CONSULTATIONS; EXPERIENCE		Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	McKinley, RK (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England.		McKinley, Robert Kee/H-9211-2013	McKinley, Robert Kee/0000-0002-3684-3435				Allen J, 1998, BRIT J GEN PRACT, V48, P1219; Baker R, 1997, QUAL HEALTH CARE, V6, P201, DOI 10.1136/qshc.6.4.201; Burrows PJ, 1999, BRIT J GEN PRACT, V49, P269; Coleman T, 1998, BRIT J GEN PRACT, V48, P971; Donaldson L., 1999, SUPPORTING DOCTORS P; Frankel S, 2000, BRIT MED J, V320, P489, DOI 10.1136/bmj.320.7233.489; *GEN MED COUNC, 1998, MAINT GOOD MED PRACT; General Medical Council, 2000, REV DOCT ENS STAND S; HARDEN RM, 1988, MED TEACH, V10, P19, DOI 10.3109/01421598809019321; Irvine D, 1997, BRIT MED J, V314, P1540, DOI 10.1136/bmj.314.7093.1540; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; RETHANS JJ, 1991, BRIT MED J, V303, P1377, DOI 10.1136/bmj.303.6814.1377; RETHANS JJ, 1991, BRIT J GEN PRACT, V41, P94; Southgate L, 1999, BMJ-BRIT MED J, V319, P1180, DOI 10.1136/bmj.319.7218.1180; Southgate L, 1998, BMJ-BRIT MED J, V316, P697, DOI 10.1136/bmj.316.7132.697; Spence J, 1960, PURPOSE PRACTICE MED, P271; STREINER DL, 1985, ASSESSING CLIN COMPE, P119; Van der Vleuten CPM, 1996, ADV HEALTH SCI EDUC, V1, P41, DOI 10.1007/BF00596229	18	46	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					712	715		10.1136/bmj.322.7288.712	http://dx.doi.org/10.1136/bmj.322.7288.712			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264212	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000167771000027
J	Andersson, RE; Olaison, G; Tysk, C; Ekbom, A				Andersson, RE; Olaison, G; Tysk, C; Ekbom, A			Appendectomy and protection against ulcerative colitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY BOWEL-DISEASE; ACUTE APPENDICITIS; TONSILLECTOMY; EPIDEMIOLOGY; SMOKING; HYGIENE; SWEDEN; RISK	Background: A history of appendectomy is rare in patients with ulcerative colitis. This suggests a protective effect of appendectomy or that appendicitis and ulcerative colitis are alternative inflammatory responses. We sought to characterize this inverse relation further. Methods: We studied a cohort of 212,963 patients who underwent appendectomy before the age of 50 years between 1964 and 1993 and a cohort of matched controls who were identified from the Swedish Inpatient Register and the nationwide census. The cohort was followed until 1995 for any subsequent diagnosis of ulcerative colitis. Results: Patients who underwent appendectomy for appendicitis and mesenteric lymphadenitis had a low risk of ulcerative colitis (for patients with perforated appendicitis, the adjusted hazard ratio was 0.58 [95 percent confidence interval, 0.38 to 0.87]; for those with nonperforated appendicitis it was 0.76 [95 percent confidence interval, 0.65 to 0.90]; and for those with mesenteric lymphadenitis it was 0.57 [95 percent confidence interval, 0.36 to 0.89]). In contrast, patients who underwent appendectomy for nonspecific abdominal pain had the same risk of ulcerative colitis as the controls (adjusted hazard ratio, 1.06; 95 percent confidence interval, 0.74 to 1.52). For the patients who had appendicitis, an inverse relation with the risk of ulcerative colitis was found only for those who underwent surgery before the age of 20 years (P<0.001). Conclusions: Appendectomy for an inflammatory condition (appendicitis or lymphadenitis) but not for nonspecific abdominal pain is associated with a low risk of subsequent ulcerative colitis. This inverse relation is limited to patients who undergo surgery before the age of 20 years. (N Engl J Med 2001;344:808-14.) Copyright (C) 2001 Massachusetts Medical Society.	Linkoping Univ Hosp, Div Surg, S-58185 Linkoping, Sweden; Cty Hosp Ryhov, Dept Surg, Jonkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, S-70185 Orebro, Sweden; Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Linkoping University; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Andersson, RE (corresponding author), Ryhov Hosp, Dept Surg, S-55185 Jonkoping, Sweden.		Lowenfels, Albert/ABD-8388-2021; Maisonneuve, Patrick/U-9789-2018	Maisonneuve, Patrick/0000-0002-5309-4704; Andersson, Roland/0000-0002-1460-0248				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ANDERSSON R, 1994, BRIT MED J, V308, P107, DOI 10.1136/bmj.308.6921.107; ARNBJORNSSON E, 1982, ACTA CHIR SCAND, V148, P461; Breslin NP, 1997, INFLAMM BOWEL DIS, V3, P1, DOI 10.1002/ibd.3780030102; Butland BK, 1999, LANCET, V353, P1712, DOI 10.1016/S0140-6736(05)77025-2; Dasso JF, 1997, CELL IMMUNOL, V182, P29, DOI 10.1006/cimm.1997.1216; Derby LE, 1998, EPIDEMIOLOGY, V9, P205, DOI 10.1097/00001648-199803000-00018; Dijkstra B, 1999, DIS COLON RECTUM, V42, P334, DOI 10.1007/BF02236349; Duggan AE, 1998, GUT, V43, P494, DOI 10.1136/gut.43.4.494; EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P171; MCCAHY P, 1994, ANN ROY COLL SURG, V76, P282; *MED, 1964, KLASS SJUKD SJATT UP; Minocha A, 1997, DIGEST DIS SCI, V42, P1567, DOI 10.1023/A:1018847617560; Mizoguchi A, 1996, J EXP MED, V184, P707, DOI 10.1084/jem.184.2.707; Montgomery SM, 1999, LANCET, V353, P379, DOI 10.1016/S0140-6736(05)74951-5; Parrello T, 1997, ITAL J GASTROENTEROL, V29, P208; PENNY WJ, 1985, SOC SCI MED, V21, P287, DOI 10.1016/0277-9536(85)90103-0; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P166; Russel MG, 1997, GASTROENTEROLOGY, V113, P377, DOI 10.1053/gast.1997.v113.pm9247453; RUTGEERTS P, 1994, GASTROENTEROLOGY, V106, P1251, DOI 10.1016/0016-5085(94)90016-7; Schattner A, 1999, LANCET, V353, P674, DOI 10.1016/S0140-6736(05)75471-4; SMITHSON JE, 1995, J CLIN GASTROENTEROL, V21, P283, DOI 10.1097/00004836-199512000-00006; *SOC, 1986, KLASS SJUKD 1987; *SOC, 1984, KLASS OP; Socialstyrelsen, 1968, KLASS SJUKD 1968; TYSK C, 1992, SCAND J GASTROENTERO, V27, P945, DOI 10.3109/00365529209000168	28	289	297	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					808	814		10.1056/NEJM200103153441104	http://dx.doi.org/10.1056/NEJM200103153441104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248156				2022-12-01	WOS:000167440400004
J	Beerling, DJ; Osborne, CP; Chaloner, WG				Beerling, DJ; Osborne, CP; Chaloner, WG			Evolution of leaf-form in land plants linked to atmospheric CO2 decline in the Late Palaeozoic era	NATURE			English	Article							STOMATAL DENSITY; LEAVES; MODEL	The widespread appearance of megaphyll leaves, with their branched veins and planate form, did not occur until the close of the Devonian period at about 360 Myr ago. This happened about 40 Myr after simple leafless vascular plants first colonized the land in the Late Silurian/Early Devonian(1,2), but the reason for the slow emergence of this common feature of present-day plants is presently unresolved. Here we show, in a series of quantitative analyses using fossil leaf characters and biophysical principles, that the delay was causally linked with a 90% drop in atmospheric pCO(2) during the Late Palaeozoic era(3,4). In contrast to simulations for a typical Early Devonian land plant, possessing few stomata(5) on leafless stems, those for a planate leaf with the same stomatal characteristics indicate that it would have suffered lethal overheating, because of greater interception of solar energy and low transpiration. When planate leaves first appeared in the Late Devonian and subsequently diversified in the Carboniferous period, they possessed substantially higher stomatal densities(6). This observation is consistent with the effects of the pCO(2) on stomatal development(7) and suggests that the evolution of planate leaves could only have occurred after an increase in stomatal density, allowing higher transpiration rates that were sufficient to maintain cool and viable leaf temperatures.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ London, Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EK, Surrey, England	University of Sheffield; University of London; Royal Holloway University London	Beerling, DJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314				Algeo TJ, 1998, PHILOS T R SOC B, V353, P113, DOI 10.1098/rstb.1998.0195; Beerling DJ, 1997, BOT J LINN SOC, V124, P137, DOI 10.1006/bojl.1997.0098; Beerling DJ, 1998, PHILOS T R SOC B, V353, P131, DOI 10.1098/rstb.1998.0196; BEERLING DJ, 1993, BIOL J LINN SOC, V48, P343, DOI 10.1111/j.1095-8312.1993.tb02096.x; BEERLING DJ, 1995, GLOB CHANGE BIOL, V1, P289, DOI 10.1111/j.1365-2486.1995.tb00027.x; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Chaloner W.G., 1979, SPEC PAP PALAEONTOL, V23, P145; CHALONER WG, 1991, POLLEN SPORES PATTER, P151; Edwards D, 1998, PHILOS T ROY SOC B, V353, P141, DOI 10.1098/rstb.1998.0197; EDWARDS D, 1993, J EXP BOT, V49, P309; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Gensel P.G., 1984, PLANT LIFE DEVONIAN; GENSEL PG, 1984, NATURE, V309, P785, DOI 10.1038/309785a0; Hao S.-G., 1993, PALEONTOTGR ABT B, V230, P27; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; KNOLL AH, 1984, PALEOBIOLOGY, V10, P34, DOI 10.1017/S0094837300008009; Larcher W., 1994, ECOPHYSIOLOGY PHOTOS, P261; Martinelli LA, 1998, OECOLOGIA, V114, P170, DOI 10.1007/s004420050433; MCELWAIN JC, 1995, ANN BOT-LONDON, V76, P389, DOI 10.1006/anbo.1995.1112; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; NIKLAS KJ, 1988, EVOLUTION, V42, P1, DOI 10.1111/j.1558-5646.1988.tb04103.x; NOVEL PS, 1991, PHYSICOCHEMICAL ENV; SCHULTE PJ, 1987, AM J BOT, V74, P1438, DOI 10.2307/2444320; VALDES PJ, 1998, PALAEOCLIMATES, V2, P219; VANCAEMMERER S, 1981, PLANTA, V153, P376; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; ZIMMERMANN W, 1979, PHYLOGENIE PFLANZEN	30	158	168	3	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					352	354		10.1038/35066546	http://dx.doi.org/10.1038/35066546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268207	Green Accepted			2022-12-01	WOS:000167464100045
J	Dominy, NJ; Lucas, PW				Dominy, NJ; Lucas, PW			Ecological importance of trichromatic vision to primates	NATURE			English	Article							COLOR-VISION; TROPICAL FOREST; FRUIT; CHIMPANZEES; HERBIVORY; COMMUNITY; EVOLUTION; SELECTION; FRUGIVORY; MONKEYS	Trichromatic colour vision, characterized by three retinal photopigments tuned to peak wavelengths of similar to 430 nm, similar to 535 nm and similar to 562 nm (refs 1, 2), has evolved convergently in catarrhine primates and one genus of New World monkey, the howlers (genus Alouatta)(3). This uniform capacity to discriminate red- green colours, which is not found in other mammals, has been proposed as advantageous for the long-range detection of either ripe fruits(4,5) or young leaves(6) (which frequently flush red in the tropics(7)) against a background of mature foliage(8,9). Here we show that four trichromatic primate species in Kibale Forest, Uganda, eat leaves that are colour discriminated only by red-greenness, a colour axis correlated with high protein levels and low toughness. Despite their divergent digestive systems, these primates have no significant interspecific differences in leaf colour selection. In contrast, eaten fruits were generally discriminated from mature leaves on both red-green and yellow-blue channels and also by their luminance, with a significant difference between chimpanzees and monkeys in fruit colour choice. Our results implicate leaf consumption, a critical food resource when fruit is scarce(10), as having unique value in maintaining trichromacy in catarrhines.	Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Dominy, NJ (corresponding author), Univ Hong Kong, Dept Anat, 5 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.		Dominy, Nathaniel Jay/A-6151-2013	Dominy, Nathaniel Jay/0000-0001-5916-418X				ALLEN G, 1979, COLOUR SENSE ITS ORI; CHAPMAN CA, 1999, PRIMATE COMMUNITIES, P237; Clutton-Brock TH., 1977, PRIMATE ECOLOGY, P539; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Coley Phyllis D., 1996, P305; Darvell BW, 1996, MEAS SCI TECHNOL, V7, P954, DOI 10.1088/0957-0233/7/6/016; DAVIES AG, 1994, COLOBINE MONKEYS, P229; FISCHER KE, 1993, OIKOS, V66, P472, DOI 10.2307/3544942; GARTLAN JS, 1980, BIOCHEM SYST ECOL, V8, P401, DOI 10.1016/0305-1978(80)90044-7; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Jacobs GH, 1999, P ROY SOC B-BIOL SCI, V266, P2023, DOI 10.1098/rspb.1999.0881; JUNIPER B, 1993, INT DENDROL SOC YB, P49; Kainz PM, 1998, VISION RES, V38, P3315, DOI 10.1016/S0042-6989(98)00078-9; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; Li Wen-Hsiung, 2000, P259; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; Lucas PW, 2001, FOLIA PRIMATOL, V72, P11, DOI 10.1159/000049914; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; Onishi A, 1999, NATURE, V402, P139, DOI 10.1038/45966; OPLER PA, 1980, J ECOL, V68, P167, DOI 10.2307/2259250; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Struhsaker T.T., 1997, ECOLOGY AFRICAN RAIN; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2000, J EXP BIOL, V203, P1963; Terborgh J., 1987, P205; Terborgh J., 1983, 5 NEW WORLD PRIMATES; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257	30	297	301	3	149	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					363	366		10.1038/35066567	http://dx.doi.org/10.1038/35066567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268211				2022-12-01	WOS:000167464100049
J	Hasan, S; Hassa, PO; Imhof, R; Hottiger, MO				Hasan, S; Hassa, PO; Imhof, R; Hottiger, MO			Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; NF-KAPPA-B; POLYMERASE-DELTA; MOUSE FIBROBLASTS; EUKARYOTIC CELLS; GROWTH-FACTORS; CALF THYMUS; PROTEIN; REPLICATION	The transcriptional coactivator p300 interacts with many transcription factors that participate in a broad spectrum of biological activities, such as cellular differentiation, homeostasis and growth control(1,2). Mouse embryos lacking both p300 alleles die around mid-gestation, with pleiotropic defects in morphogenesis, in cell differentiation and, unexpectedly, in cell proliferation because of reduced DNA synthesis(3). Here we show that p300 may have a role in DNA repair synthesis through its interaction with proliferating cell nuclear antigen (PCNA). We show that in vitro and in vivo p300 forms a complex with PCNA that does not depend on the S phase of cell cycle. A large fraction of both p300 and PCNA colocalize to speckled structures in the nucleus. Furthermore, the endogenous p300-PCNA complex stimulates DNA synthesis in vitro. Chromatin immunoprecipitation experiments indicate that p300 is associated with freshly synthesized DNA after ultraviolet irradiation. Our results suggest that p300 may participate in chromatin remodelling at DNA lesion sites to facilitate PCNA function in DNA repair synthesis.	Univ Zurich, Inst Vet Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Hottiger, MO (corresponding author), Univ Zurich, Inst Vet Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hottiger@vetbio.unizh.ch	Hottiger, Michael O./J-7747-2013	Hottiger, Michael O./0000-0002-7323-2270				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cleaver JE, 1997, BIOCHEM J, V328, P1, DOI 10.1042/bj3280001; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DRESLER SL, 1986, NUCLEIC ACIDS RES, V14, P7093, DOI 10.1093/nar/14.17.7093; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Guzder SN, 1997, J BIOL CHEM, V272, P21665, DOI 10.1074/jbc.272.35.21665; HUNTING DJ, 1991, BIOCHEM CELL BIOL, V69, P303, DOI 10.1139/o91-046; Jonsson ZO, 1997, BIOESSAYS, V19, P967, DOI 10.1002/bies.950191106; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WEISER T, 1991, J BIOL CHEM, V266, P10420; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	29	144	151	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					387	391		10.1038/35066610	http://dx.doi.org/10.1038/35066610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268218				2022-12-01	WOS:000167464100056
J	Pfennig, DW; Harcombe, WR; Pfennig, KS				Pfennig, DW; Harcombe, WR; Pfennig, KS			Frequency-dependent batesian mimicry - Predators avoid look-alikes of venomous snakes only when the real thing is around.	NATURE			English	Editorial Material							CORAL		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin	Pfennig, DW (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.							Bates HW, 1862, T LINN SOC LONDON, V23, P495, DOI [10.1111/j.1096-3642.1860.tb00146.x, DOI 10.1111/J.1096-3642.1860.TB00146.X]; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Conant R, 1998, FIELD GUIDE REPTILES; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; King RB, 1997, BIOSCIENCE, V47, P279, DOI 10.2307/1313189; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Maynard Smith, 1998, EVOL GENET; Palmer W. M., 1995, REPTILES N CAROLINA; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Stebbins R. C., 1985, W REPTILES AMPHIBIAN; WALDBAUER GP, 1988, EVOL BIOL, V22, P227; Wallace Alfred Russel, 1870, CONTRIBUTIONS THEORY	12	163	164	4	263	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					323	323		10.1038/35066628	http://dx.doi.org/10.1038/35066628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268195	Bronze			2022-12-01	WOS:000167464100033
J	Mowen, KA; Tang, J; Zhu, W; Schurter, BT; Shuai, K; Herschman, HR; David, M				Mowen, KA; Tang, J; Zhu, W; Schurter, BT; Shuai, K; Herschman, HR; David, M			Arginine methylation of STAT1 modulates IFN alpha/beta-induced transcription	CELL			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE-DEFICIENCY; FIBROBLAST GROWTH-FACTOR; PROTEIN-TYROSINE KINASE; GAMMA SIGNAL-TRANSDUCTION; PURINE METABOLIC ENZYME; INTERFERON-GAMMA; 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE; CELL-LINES; SUBCELLULAR-LOCALIZATION; N-METHYLTRANSFERASE	Transcriptional induction by interferons requires the tyrosine and serine phosphorylation of STAT transcription factors. The N-terminal region is highly homologous among the STAT proteins and surrounds a completely conserved arginine residue. Here we demonstrate arginine methylation of STAT1 by the protein arginine methyl-transferase PRMT1 as a novel requirement for IFN alpha/beta -induced transcription. Methylthioadenosine, a methyl-transferase inhibitor that accumulates in many transformed cells, inhibits STAT1-mediated IFN responses. This inhibition arises from impaired STAT1-DNA binding due to an increased association of the STAT inhibitor PIAS1 with phosphorylated STAT1 dimers in the absence of arginine methylation. Thus, arginine methylation of STAT1 is an additional posttranslational modification regulating transcription factor function, and alteration of arginine methylation might be responsible for the lack of interferon responsiveness observed in many malignancies.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	David, M (corresponding author), Univ Calif San Diego, Div Biol, Bonner Hall 3138,9500 Gilman Dr, La Jolla, CA 92093 USA.				NCI NIH HHS [T32 CA09056, CA80105] Funding Source: Medline; NIAID NIH HHS [AI43438, AI34567] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080105, T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034567, R21AI043438, R01AI043438, U19AI034567] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; BURGESS WH, 1991, CELL REGUL, V2, P87, DOI 10.1091/mbc.2.2.87; Carson D A, 1988, Adv Exp Med Biol, V250, P179; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; David M, 1996, J BIOL CHEM, V271, P4585; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; DAVID M, 1995, MOL CELL BIOL, V15, P7050; David M, 1996, J BIOL CHEM, V271, P15862, DOI 10.1074/jbc.271.27.15862; DELLARAGIONE F, 1995, ONCOGENE, V10, P827; DELLARAGIONE F, 1992, BIOCHEM J, V281, P533, DOI 10.1042/bj2810533; DELLARAGIONE F, 1993, ADV EXP MED BIOL, V348, P31; FITCHEN JH, 1986, CANCER RES, V46, P5409; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; KAMATANI N, 1981, P NATL ACAD SCI-BIOL, V78, P1219, DOI 10.1073/pnas.78.2.1219; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; LAW RE, 1992, MOL CELL BIOL, V12, P103, DOI 10.1128/MCB.12.1.103; Liao JY, 2000, P NATL ACAD SCI USA, V97, P5267, DOI 10.1073/pnas.97.10.5267; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; MAHER PA, 1993, J BIOL CHEM, V268, P4244; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; NOBORI T, 1991, CANCER RES, V51, P3193; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; NOBORI T, 1993, CANCER RES, V53, P1098; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Shuai K, 1996, MOL CELL BIOL, V16, P4932; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SMAALAND R, 1987, BREAST CANCER RES TR, V9, P53, DOI 10.1007/BF01806694; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; TRAWEEK ST, 1988, BLOOD, V71, P1568; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; WILSON KC, 1992, P NATL ACAD SCI USA, V89, P11964, DOI 10.1073/pnas.89.24.11964; Zhang J, 1996, INT J COMP INTEG M, V9, P22, DOI 10.1080/095119296131788	47	383	390	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					731	741		10.1016/S0092-8674(02)08085-6	http://dx.doi.org/10.1016/S0092-8674(02)08085-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257227	Bronze			2022-12-01	WOS:000167531100013
J	Fernandez-Chacon, R; Konigstorfer, A; Gerber, SH; Garcia, J; Matos, MF; Stevens, CF; Brose, N; Rizo, J; Rosenmund, C; Sudhof, TC				Fernandez-Chacon, R; Konigstorfer, A; Gerber, SH; Garcia, J; Matos, MF; Stevens, CF; Brose, N; Rizo, J; Rosenmund, C; Sudhof, TC			Synaptotagmin I functions as a calcium regulator of release probability	NATURE			English	Article							PROTEIN-KINASE-C; TRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; GLUTAMATE RELEASE; C-2 DOMAIN; SENSOR; ASSOCIATION; SENSITIVITY; 1ST	In all synapses, Ca2+ triggers neurotransmitter release to initiate signal transmission. Ca2+ presumably acts by activating synaptic Ca2+ sensors, but the nature of these sensors-which are the gatekeepers to neurotransmission-remains unclear. One of the candidate Ca2+ sensors in release is the synaptic Ca2+-binding protein synaptotagmin I. Here we have studied a point mutation in synaptotagmin I that causes a twofold decrease in overall Ca2+ affinity without inducing structural or conformational changes. When introduced by homologous recombination into the endogenous synaptotagmin I gene in mice, this point mutation decreases the Ca2+ sensitivity of neurotransmitter release twofold, but does not alter spontaneous release or the size of the readily releasable pool of neurotransmitters. Therefore, Ca2+ binding to synaptotagmin I participates in triggering neurotransmitter release at the synapse.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Max Planck Inst Expt Med, D-37070 Gottingen, Germany; Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Salk Institute; Howard Hughes Medical Institute	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu	IBIS, FISIOLOGIA/O-9485-2015; Fernandez-Chacon, Rafael/E-6303-2010; Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Fernandez-Chacon, Rafael/0000-0002-9845-9885				Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bennett MR, 1999, PROG NEUROBIOL, V59, P243, DOI 10.1016/S0301-0082(99)00004-0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Katz B., 1969, RELEASE NEURAL TRANS; Kee Y, 1996, J NEUROSCI, V16, P1975; KELLY RB, 1995, CURR BIOL, V5, P257, DOI 10.1016/S0960-9822(95)00054-6; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MOSIOR M, 1994, J BIOL CHEM, V269, P13798; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; TUGAL HB, 1991, BIOCHEM J, V279, P699, DOI 10.1042/bj2790699; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	49	702	717	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					41	49		10.1038/35065004	http://dx.doi.org/10.1038/35065004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242035				2022-12-01	WOS:000167194300036
J	Hellwig, B; Haussler, S; Schelter, B; Lauk, M; Guschlbauer, B; Timmer, J; Lucking, CH				Hellwig, B; Haussler, S; Schelter, B; Lauk, M; Guschlbauer, B; Timmer, J; Lucking, CH			Tremor-correlated cortical activity in essential tremor	LANCET			English	Article							CROSS-SPECTRAL ANALYSIS; PHYSIOLOGICAL TREMOR; CENTRAL MECHANISMS; MUSCLE-ACTIVITY; TIME-SERIES; ELECTROMYOGRAM; COHERENCE	Background In patients with parkinsonian resting tremor, tremor-correlated activity in the contralateral sensorimotor cortex has been studied by both magnetoencephalography (MEG) and electroencephalography (EEG). In essential tremor, MEG failed to detect cortical involvement. The objective of this study was to investigate whether EEG recording can reveal tremor-correlated cortical activity in patients with essential tremor or enhanced physiological tremor. (MEG) tremor. Methods Seven patients with essential tremor and three patients with enhanced physiological tremor participated in the study. Unilateral postural tremor was activated by wrist extension on the right or on the left side. Electromyography (EMG) signals arising from the wrist extensor and flexor muscles, and a high-resolution EEG were recorded simultaneously. Coherences between the time series of the rectified tremor EMG and the EEG were estimated. Findings In five of nine arms with essential tremor, we found highly significant coherences at the tremor frequency between the tremor EMG and the EEG. Isocoherence maps illustrating the topography of significant coherences over the scalp showed that the maximum coherences were located over the contralateral sensorimotor cortex. In the patients with enhanced physiological tremor, we were unable to detect consistent significant corticomuscular coherences at the tremor frequency. Interpretation Using simultaneous EEG-EMG recordings, we showed that significant corticomuscular coherences at the tremor frequency can be found in essential tremor. This finding contrasts with a recent study based on MEG recordings. The results suggest that the sensorimotor cortex is involved in the generation of essential tremor. in a similar way to that previously shown in parkinsonian resting tremor.	Univ Freiburg, Neurol Klin, Neurozentrum, D-79106 Freiburg, Germany; Zentrum Datenanal & Modellbildung, Freiburg, Germany	University of Freiburg	Lucking, CH (corresponding author), Univ Freiburg, Neurol Klin, Neurozentrum, Hugstetter Str 55, D-79106 Freiburg, Germany.							ALBERTS WW, 1969, NATURE, V221, P670, DOI 10.1038/221670a0; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Brockwell P.J., 1991, TIME SERIES THEORY M; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; ELBIE RJ, 2000, LANCET, V355, P1113; ELBLE RJ, 1986, NEUROLOGY, V36, P225, DOI 10.1212/WNL.36.2.225; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; FINDLEY LJ, 1987, NEUROLOGY, V37, P1194, DOI 10.1212/WNL.37.7.1194; HALLETT M, 1993, J NEUROL SCI, V114, P45, DOI 10.1016/0022-510X(93)90047-3; Halliday DM, 2000, LANCET, V355, P1149, DOI 10.1016/S0140-6736(00)02064-X; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hellwig B, 2000, CLIN NEUROPHYSIOL, V111, P806, DOI 10.1016/S1388-2457(00)00248-0; HJORTH B, 1991, J CLIN NEUROPHYSIOL, V8, P391, DOI 10.1097/00004691-199110000-00004; Hua SE, 1998, J NEUROL NEUROSUR PS, V64, P273, DOI 10.1136/jnnp.64.2.273; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Koster B, 1998, NEUROSCI LETT, V241, P135, DOI 10.1016/S0304-3940(98)00015-9; LAMARRE Y, 1984, MOVEMENT DISORDERS T, P183; LLINAS R, 1973, EXP BRAIN RES, V18, P69; LUCKING CH, 1999, PARKINSONS DIS NEURO, V80, P335; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Priestley M., 1989, SPECTRAL ANAL TIME S; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Timmer J, 1998, INT J BIFURCAT CHAOS, V8, P1505, DOI 10.1142/S0218127498001157; Timmer J, 1998, BIOL CYBERN, V78, P349, DOI 10.1007/s004220050439; Timmer J, 1998, BIOL CYBERN, V78, P359, DOI 10.1007/s004220050440; Timmer J, 1996, ELECTROMYOGR MOTOR C, V101, P461, DOI 10.1016/S0921-884X(96)94658-5; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359	29	129	135	4	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					519	523		10.1016/S0140-6736(00)04044-7	http://dx.doi.org/10.1016/S0140-6736(00)04044-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229671				2022-12-01	WOS:000167011700012
J	Scheer, S; Chu, PL; Klausner, JD; Katz, MH; Schwarcz, SK				Scheer, S; Chu, PL; Klausner, JD; Katz, MH; Schwarcz, SK			Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS	LANCET			English	Article							VIRAL LOAD; COMBINATION THERAPIES; EPIDEMIOLOGIC SYNERGY; ANTIVIRAL TREATMENT; HIV; TRANSMISSION; RISK; PREVENTION; PROTEASE; SEMEN	Background There has been an increase in high-risk sexual behaviour and sexually transmitted diseases (STD) during the time period when highly active antiretroviral therapy (HAART) became widely available. We examined whether taking HAART increased the risk of acquiring an STD-an epidemiological marker of unsafe sex-in people with AIDS. Methods We did a computerised match of people in the San Francisco STD and AIDS registries. People with AIDS who were diagnosed before 1999 and alive in November, 1995, or later, were classified as having had an STD after AIDS diagnosis or not having had an STD after AIDS diagnosis. We used a Cox proportional hazards model to see whether use of antiretroviral therapy was associated with acquiring an STD after AIDS, after adjustment for sex, age, race, HIV-1 risk category, and CD4 count at AIDS diagnosis. Findings People with AIDS who had had HAART showed an independent increase in the risk of developing an STD (hazard ratio 4.10; 95% CI 2.84-5.94). Americans of African origin, younger age, and higher CD4 count at AIDS diagnosis were also associated with acquiring an STD after AIDS. The number of people living with AIDS who acquired an STD increased over time from 60 (0.66%) in 1995 to 113 (1.32%) in 1998 (p<0.001). Interpretation We have shown that people on HAART are more likely to develop an STD, an epidemiological marker of unsafe sex. More intensive risk-reduction counselling and STD screening for people with AIDS is needed.	San Francisco Dept Publ Hlth, Seroepidemiol & Surveillance Sect, San Francisco, CA 94102 USA; San Francisco Dept Publ Hlth, Sexually Transmitted Dis Prevent & Control Serv, San Francisco, CA 94102 USA	San Francisco Department of Public Health; San Francisco Department of Public Health	Scheer, S (corresponding author), San Francisco Dept Publ Hlth, Seroepidemiol & Surveillance Sect, San Francisco, CA 94102 USA.	susan_scheer@dph.sf.ca.us						BOYER CB, 1991, SOC SCI MED, V33, P11, DOI 10.1016/0277-9536(91)90446-J; BUCHBINDER S, 1998, 12 INT AIDS C GEN SW; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P45; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; DETELS R, 1998, JAMA-J AM MED ASSOC, V28, P1497; Dilley JW, 1997, NEW ENGL J MED, V337, P501, DOI 10.1056/NEJM199708143370715; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; EKSTRAND ML, 1990, AM J PUBLIC HEALTH, V80, P973, DOI 10.2105/AJPH.80.8.973; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Haase AT, 1998, NEW ENGL J MED, V339, P1846, DOI 10.1056/NEJM199812173392510; Hamm HE, 1996, FASEB J, V10, P3; Kelly JA, 1998, AIDS, V12, pF91, DOI 10.1097/00002030-199810000-00001; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Kravcik S, 1998, J ACQ IMMUN DEF SYND, V19, P124, DOI 10.1097/00042560-199810010-00004; LEHMAN J, 2000, 7 C RETR OPP INF SAN; Miller M, 2000, AIDS, V14, pF33, DOI 10.1097/00002030-200003100-00001; MURPHY S, 1998, 12 INT C AIDS GEN SW; NABULSI A, 1996, 11 INT C AIDS VANC C; Nieuwkerk PT, 2000, AIDS, V14, P181, DOI 10.1097/00002030-200001280-00014; OSMOND D, 1998, 12 INT AIDS C GEN SW; OTTEN RA, 1996, 12 INT AIDS C VANC C; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PIENIAZEK D, 1996, 3 C RETR OPP INF WAS; Ping LH, 2000, J VIROL, V74, P8946, DOI 10.1128/JVI.74.19.8946-8952.2000; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Remien RH, 1998, AIDS, V12, P1560, DOI 10.1097/00002030-199812000-00025; REMIEN RH, 1998, 12 INT AIDS C GEN SW; *SAN FRANC DEP PUB, 1999, SEX TRANSM DIS PREV; Schwarcz SK, 1999, AIDS, V13, P1109, DOI 10.1097/00002030-199906180-00015; van der Straten A, 2000, AIDS, V14, pF47, DOI 10.1097/00002030-200003100-00003; Vanable PA, 2000, HEALTH PSYCHOL, V19, P134, DOI 10.1037//0278-6133.19.2.134; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001	37	138	144	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					432	435		10.1016/S0140-6736(00)04007-1	http://dx.doi.org/10.1016/S0140-6736(00)04007-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273063				2022-12-01	WOS:000166865600012
J	Moon-van der Staay, SY; De Wachter, R; Vaulot, D				Moon-van der Staay, SY; De Wachter, R; Vaulot, D			Oceanic 18S rDNA sequences from picoplankton reveal unsuspected eukaryotic diversity	NATURE			English	Article							CENTRAL NORTH PACIFIC; SP-NOV; ALGAL CLASS; PROCHLOROCOCCUS; ACANTHAREA; EVOLUTION; ALIGNMENT; POSITION; DATABASE; GEN.	Picoplankton-cells with a diameter of less than 3 mum-are the dominant contributors to both primary production and biomass in open oceanic regions(1,2). However, compared with the prokaryotes(3), the eukaryotic component of picoplankton is still poorly known. Recent discoveries of new eukaryotic algal taxa based on picoplankton cultures(4,5) suggest the existence of many undiscovered taxa. Conventional approaches based on phenotypic criteria have limitations in depicting picoplankton composition due to their tiny size and lack of distinctive taxonomic characters(6). Here we analyse, using an approach that has been very successful for prokaryotes(7) but has so far seldom been applied to eukaryotes(8), 35 full sequences of the small-subunit (18S) ribosomal RNA gene derived from a picoplanktonic assemblage collected at a depth of 75 min the equatorial Pacific Ocean, and show that there is a high diversity of picoeukaryotes. Most of the sequences were previously unknown but could still be assigned to important marine phyla including prasinophytes, haptophytes, dinoflagellates, stramenopiles, choanoflagellates and acantharians. We also found a novel lineage, closely related to dinoflagellates and not previously described.	Biol Stn, CNRS, UPR 9042, F-29682 Roscoff, France; Univ Paris 06, F-29682 Roscoff, France; Univ Instelling Antwerp, Dept Biochem, B-2610 Antwerp, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Antwerp	Vaulot, D (corresponding author), Biol Stn, CNRS, UPR 9042, BP 74, F-29682 Roscoff, France.	vaulot@sb-roscoff.fr	Vaulot, Daniel/T-6649-2019	Vaulot, Daniel/0000-0002-0717-5685				Amann R, 1998, CURR OPIN MICROBIOL, V1, P352, DOI 10.1016/S1369-5274(98)80041-6; ANDERSEN RA, 1993, J PHYCOL, V29, P701, DOI 10.1111/j.0022-3646.1993.00701.x; Bernstein RE, 1998, DEEP-SEA RES PT I, V45, P491, DOI 10.1016/S0967-0637(97)00095-2; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; DERIJK P, 1993, COMPUT APPL BIOSCI, V9, P735; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Guillou L, 1999, PROTIST, V150, P383, DOI 10.1016/S1434-4610(99)70040-4; Gunderson JH, 1999, J EUKARYOT MICROBIOL, V46, P194, DOI 10.1111/j.1550-7408.1999.tb04603.x; HOLLANDE A, 1974, Protistologica, V10, P567; Leipe DD, 1996, EUR J PROTISTOL, V32, P449, DOI 10.1016/S0932-4739(96)80004-6; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; MAIDAK BL, 1994, NUCLEIC ACIDS RES, V22, P3485, DOI 10.1093/nar/22.17.3485; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Melkonian Michael, 1996, Progress in Botany, V57, P281; Moon-van der Staay SY, 2000, LIMNOL OCEANOGR, V45, P98, DOI 10.4319/lo.2000.45.1.0098; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Potter D, 1997, BIODIVERS CONSERV, V6, P99, DOI 10.1023/A:1018379716868; Rappe MS, 1998, APPL ENVIRON MICROB, V64, P294; Sarjeant WAS., 1993, CLASSIFICATION LIVIN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; Van de Peer Y, 2000, NUCLEIC ACIDS RES, V28, P175, DOI 10.1093/nar/28.1.175; VandePeer Y, 1997, NUCLEIC ACIDS RES, V25, P111, DOI 10.1093/nar/25.1.111; Venrick EL, 1999, J PLANKTON RES, V21, P1029, DOI 10.1093/plankt/21.6.1029; Zettler LA, 1997, P NATL ACAD SCI USA, V94, P11411, DOI 10.1073/pnas.94.21.11411; Zettler LAA, 2000, EUR J PROTISTOL, V36, P34, DOI 10.1016/S0932-4739(00)80020-6	30	712	748	4	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					607	610		10.1038/35054541	http://dx.doi.org/10.1038/35054541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214317				2022-12-01	WOS:000166692300041
J	Lu, BW; Roegiers, F; Jan, LY; Jan, YN				Lu, BW; Roegiers, F; Jan, LY; Jan, YN			Adherens junctions inhibit asymmetric division in the Drosophila epithelium	NATURE			English	Article							GENETIC INTERFERENCE; CELL DIVISIONS; PROTEIN; BAZOOKA; LOCALIZATION; ORIENTATION; NEUROBLASTS; SELECTION; PROSPERO; PATHWAY	Asymmetric division is a fundamental mechanism for generating cellular diversity. In the central nervous system of Drosophila, neural progenitor cells called neuroblasts undergo asymmetric division along the apical-basal cellular axis(1,2). Neuroblasts originate from neuroepithelial cells, which are polarized along the apical-basal axis and divide symmetrically along the planar axis. The asymmetry of neuroblasts might arise from neuroblast-specific expression of the proteins required for asymmetric division. Alternatively, both neuroblasts and neuroepithelial cells could be capable of dividing asymmetrically, but in neuroepithelial cells other polarity cues might prevent asymmetric division. Here we show that by disrupting adherens junctions we can convert the symmetric epithelial division into asymmetric division. We further confirm that the adenomatous polyposis coli (APC) tumour suppressor protein is recruited to adherens junctions(3), and demonstrate that both APC and microtubule-associated EB1 homologues(3-5) are required for the symmetric epithelial division along the planar axis. Our results indicate that neuroepithelial cells have all the necessary components to execute asymmetric division, but that this pathway is normally overridden by the planar polarity cue provided by adherens junctions.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Lu, Bingwei/0000-0002-5807-7014				Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jan YN, 2000, CELL, V100, P599, DOI 10.1016/S0092-8674(00)80695-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SU LK, 1995, CANCER RES, V55, P2972; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	30	206	212	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					522	525		10.1038/35054077	http://dx.doi.org/10.1038/35054077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206549				2022-12-01	WOS:000166570500050
J	Curie, C; Panaviene, Z; Loulergue, C; Dellaporta, SL; Briat, JF; Walker, EL				Curie, C; Panaviene, Z; Loulergue, C; Dellaporta, SL; Briat, JF; Walker, EL			Maize yellow stripe1 encodes a membrane protein directly involved in Fe(III) uptake	NATURE			English	Article							IRON-DEFICIENCY; CHELATE REDUCTASE; PLANTS; PHYTOSIDEROPHORE; NICOTIANAMINE; TRANSPORT; YEAST; FE; EXPRESSION; KINETICS	Frequently, crop plants do not take up adequate amounts of iron from the soil, leading to chlorosis, poor yield and decreased nutritional quality. Extremely limited soil bioavailability of iron has led plants to evolve two distinct uptake strategies: chelation, which is used by the world's principal grain crops(1,2); and reduction, which is used by other plant groups(3-5). The chelation strategy involves extrusion of low-molecular-mass secondary amino acids (mugineic acids) known as 'phytosiderophores', which chelate sparingly soluble iron(6). The Fe(III)-phytosiderophore complex is then taken up by an unknown transporter at the root surface(7,8). The maize yellow stripe1 (ys1) mutant is deficient in Fe(III)-phytosiderophore uptake(7-10), therefore YS1 has been suggested to be the Fe(III)-phytosiderophore transporter. Here we show that ys1 is a membrane protein that mediates iron uptake. Expression of YS1 in a yeast iron uptake mutant restores growth specifically on Fe(III)-phytosiderophore media. Under iron-deficient conditions, ys1 messenger RNA levels increase in both roots and shoots. Cloning of ys1 is an important step in understanding iron uptake in grasses, and has implications for mechanisms controlling iron homeostasis in all plants.	Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Montpellier 2, Inst Natl Rech Agron, CNRS, UMR 5004, F-34060 Montpellier 1, France; Ecole Natl Super Agron Montpellier, F-34060 Montpellier 1, France; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Amherst; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Yale University	Walker, EL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.		Walker, Elsbeth L./AAO-4166-2020	Walker, Elsbeth L./0000-0003-4237-9920	NIGMS NIH HHS [R01 GM038148-19, R01 GM038148] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038148] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagnaresi P, 1999, BIOCHEM J, V338, P499, DOI 10.1042/0264-6021:3380499; Briat JF, 1997, TRENDS PLANT SCI, V2, P187, DOI 10.1016/S1360-1385(97)85225-9; DELLAPORTA SL, 1993, MAIZE HDB, P219; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOPKINS BG, 1992, J PLANT NUTR, V15, P1599, DOI 10.1080/01904169209364425; JOLLEY V, 1991, J PLANT NUTR, V14, P45, DOI 10.1080/01904169109364182; Loulergue C, 1998, GENE, V225, P47, DOI 10.1016/S0378-1119(98)00531-9; MINET M, 1992, PLANT J, V2, P417; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STEPHAN UW, 1994, PLANT SOIL, V165, P181, DOI 10.1007/BF00008060; Stephan UW, 1996, BIOMETALS, V9, P84, DOI 10.1007/BF00188095; Tagaki S., 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Thoiron S, 1997, PLANT CELL ENVIRON, V20, P1051, DOI 10.1111/j.1365-3040.1997.tb00681.x; von Wiren N, 1998, BBA-BIOMEMBRANES, V1371, P143, DOI 10.1016/S0005-2736(98)00022-4; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; VONWIREN N, 1995, PHYSIOL PLANTARUM, V93, P611, DOI 10.1111/j.1399-3054.1995.tb05107.x; Yi Y, 1996, PLANT J, V10, P835, DOI 10.1046/j.1365-313X.1996.10050835.x	23	664	730	5	130	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					346	349		10.1038/35053080	http://dx.doi.org/10.1038/35053080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201743				2022-12-01	WOS:000166434300048
J	Mindell, JA; Maduke, M; Miller, C; Grigorieff, N				Mindell, JA; Maduke, M; Miller, C; Grigorieff, N			Projection structure of a CIC-type chloride channel at 6.5 angstrom resolution	NATURE			English	Article							TORPEDO ELECTROPLAX; PURPLE MEMBRANE; RECONSTITUTION; EXPRESSION; PORES	Virtually all cells in all eukaryotic organisms express ion channels of the ClC type, the only known molecular family of chloride-ion-selective channels. The diversity of ClC channels highlights the multitude and range of functions served by gated chloride-ion conduction in biological membranes, such as controlling electrical excitability in skeletal muscle, maintaining systemic blood pressure, acidifying endosomal compartments, and regulating electrical responses of GABA (gamma -aminobutyric acid)-containing interneurons in the central nervous system(1). Previously, we expressed and purified a prokaryotic ClC channel homologue(2). Here we report the formation of two-dimensional crystals of this ClC channel protein reconstituted into phospholipid bilayer membranes. Cryo-electron microscopic analysis of these crystals yields a projection structure at 6.5 Angstrom resolution, which shows off-axis water-filled pores within the dimeric channel complex.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, WM Keck Inst Cellular Visualizat, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University	Mindell, JA (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.		; Mindell, Joseph/P-4461-2017	Maduke, Merritt/0000-0001-7787-306X; Grigorieff, Nikolaus/0000-0002-1506-909X; Mindell, Joseph/0000-0002-6952-8247				Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Fahlke C, 1998, NATURE, V394, P687, DOI 10.1038/29319; GRIGORIEFF N, 1995, J MOL BIOL, V254, P404, DOI 10.1006/jmbi.1995.0627; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Jentsch TJ, 1997, BIOESSAYS, V19, P117, DOI 10.1002/bies.950190206; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Ludewig U, 1997, BIOPHYS J, V73, P789, DOI 10.1016/S0006-3495(97)78111-6; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445	16	99	103	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					219	223		10.1038/35051631	http://dx.doi.org/10.1038/35051631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196649				2022-12-01	WOS:000166316200051
J	Schwetz, BA				Schwetz, BA			Artificial skin for grafts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, HF-1,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1696	1696		10.1001/jama.285.13.1696	http://dx.doi.org/10.1001/jama.285.13.1696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277810				2022-12-01	WOS:000167710600005
J	Pierfitte, C; Macouillard, G; Thicoipe, M; Chaslerie, A; Pehourcq, F; Aissou, M; Martinez, B; Lagnaoui, R; Fourrier, A; Begaud, B; Dangoumau, J; Moore, N				Pierfitte, C; Macouillard, G; Thicoipe, M; Chaslerie, A; Pehourcq, F; Aissou, M; Martinez, B; Lagnaoui, R; Fourrier, A; Begaud, B; Dangoumau, J; Moore, N			Benzodiazepines and hip fractures in elderly people: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NURSING-HOME RESIDENTS; ELIMINATION HALF-LIFE; RISK-FACTORS; COGNITIVE IMPAIRMENT; THIAZIDE DIURETICS; FALLS; COMMUNITY; ANTIDEPRESSANTS; DEMENTIA	Objective To determine whether benzodiazepines are associated with an increased risk of hip facture. Design Case-control study. Participants All incident cases of hip fracture not related to traffic accidents or cancer in patients ol er 65 years of age. 245 cases were matched to 817 controls. Setting Emergency department of a university hospital. Main outcome measures Exposure to benzodiazepines and other potential risk ol protective factors or lifestyle items. Results The use of benzodiazepines as determined from questionnaires, medical records, or plasma samples at admission to hospital was not associated with an increased risk of hip fracture (odds ratio 0.9, 95% confidence interval 0.5 to 1.5). Hip fracture was, however, associated with the use of two of more benzodiazepines, as determined from questionnaires or medical records but not from plasma samples. Of the individual drugs, only lorazepam was significantly associated with an increased risk of hip fracture (1.8, 1.1 to 3.1). Conclusion Except for lorazepam, the presence of benzodiazepines in plasma was not associated with an increased risk of hip fracture. nle method used to ascertain exposure could influence the results of case-control studies.	CHU Bordeaux, Hop Pellegrin, Serv Urgencies, Bordeaux, France; CHU Bordeaux, Hop Pellegrin, Serv Urgencies, F-33076 Bordeaux, France; CHU Bordeaux, Dept Pharmacol, Clin Pharmacol Unit, F-33076 Bordeaux, France; CHU Bordeaux, Hop Pellegrin, Dept Anesthesie Reanimat, F-33076 Bordeaux, France	CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux	Moore, N (corresponding author), Victor Segalen Univ, Dept Pharmacol, F-33076 Bordeaux, France.	nicholas.moore@pharmaco.u-bordeaux2.fr	Moore, Nicholas/B-2368-2013	Moore, Nicholas/0000-0003-1212-2817				BARBERGERGATEAU P, 1992, J AM GERIATR SOC, V40, P1129, DOI 10.1111/j.1532-5415.1992.tb01802.x; BOONEN S, 1993, ACTA CLIN BELG, V48, P190, DOI 10.1080/17843286.1993.11718306; BRUNELLI MP, 1998, CLIN ORTHOP RELAT R, V348, P15; CUMMING RG, 1993, MED J AUSTRALIA, V158, P414, DOI 10.5694/j.1326-5377.1993.tb121839.x; Cumming RG, 1998, DRUG AGING, V12, P43, DOI 10.2165/00002512-199812010-00005; CUMMING RG, 1994, AGE AGEING, V23, P468, DOI 10.1093/ageing/23.6.468; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; Emeriau JP, 1998, B ACAD NAT MED PARIS, V182, P1419; Franssen EH, 1999, J AM GERIATR SOC, V47, P463, DOI 10.1111/j.1532-5415.1999.tb07240.x; Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171; HABOUBI NY, 1991, GERONTOLOGY, V37, P335; HANSEN S, 1988, ACTA OTO-LARYNGOL, P165; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Jacqmin-Gadda H, 1998, EPIDEMIOLOGY, V9, P417, DOI 10.1097/00001648-199807000-00012; Johansson C, 1996, AGING CLIN EXP RES, V8, P189, DOI 10.1007/BF03339676; JONES G, 1995, J BONE MINER RES, V10, P106; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kirby M, 1999, INT J GERIATR PSYCH, V14, P280, DOI 10.1002/(SICI)1099-1166(199904)14:4<280::AID-GPS898>3.3.CO;2-F; LAURITZEN JB, 1992, DAN MED BULL, V39, P91; LICHTENSTEIN MJ, 1994, AM J EPIDEMIOL, V140, P830, DOI 10.1093/oxfordjournals.aje.a117331; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Moore N, 1993, POST MARK SURVEILL, V7, P355; Moritz DJ, 1997, AM J EPIDEMIOL, V145, P653; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; RYYNANEN OP, 1993, SCAND J SOC MED, V21, P264, DOI 10.1177/140349489302100406; SLEMENDA C, 1997, AM J MED, V103, P65; Slovik D M, 1983, Spec Top Endocrinol Metab, V5, P83; Thapa PB, 1996, J AM GERIATR SOC, V44, P273, DOI 10.1111/j.1532-5415.1996.tb00913.x; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WEINTRAUB M, 1993, CLIN PHARMACOL THER, V54, P252, DOI 10.1038/clpt.1993.145; Wysowski DK, 1996, J CLIN EPIDEMIOL, V49, P111, DOI 10.1016/0895-4356(95)00057-7	33	93	95	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2001	322	7288					704	708		10.1136/bmj.322.7288.704	http://dx.doi.org/10.1136/bmj.322.7288.704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264208	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000167771000024
J	Kohara, K; Kitamura, A; Morishima, M; Tsumoto, T				Kohara, K; Kitamura, A; Morishima, M; Tsumoto, T			Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons	SCIENCE			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; HIPPOCAMPAL-NEURONS; VISUAL-CORTEX; ANTEROGRADE TRANSPORT; MESSENGER-RNA; PLASTICITY; BDNF; CNS; RELEASE	Neurotrophins such as brain-derived neurotrophic factor (BDNF) are thought to be transferred from post- to presynaptic neurons and to be involved in the formation and plasticity of neural circuits, However, direct evidence for a transneuronal transfer of BDNF and its relation to neuronal activity remains elusive, We simultaneously injected complementary DNAs of green fluorescent protein (GFP)-tagged BDNF and red fluorescence protein into the nucleus of single neurons and visualized expression, localization, and transport of BDNF in living neurons. Fluorescent puncta representing BDNF moved in axons in the anterograde direction, though some moved retrogradely, and transferred to postsynaptic neurons in an activity-dependent manner.	Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Neurophysiol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Tsumoto, T (corresponding author), Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Neurophysiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Akaneya Y, 1997, J NEUROSCI, V17, P6707; Aloyz R, 1999, LEARN MEMORY, V6, P216; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; Conner JM, 1997, J NEUROSCI, V17, P2295; Fawcett JP, 2000, J NEUROSCI, V20, P274, DOI 10.1523/JNEUROSCI.20-01-00274.2000; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; Fawcett JP, 1998, J NEUROSCI, V18, P2808; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Haubensak W, 1998, J CELL SCI, V111, P1483; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kojima M., 1999, Society for Neuroscience Abstracts, V25, P1785; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Otsu Y, 1995, J NEUROPHYSIOL, V74, P2437, DOI 10.1152/jn.1995.74.6.2437; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WETMORE C, 1991, P NATL ACAD SCI USA, V88, P9843, DOI 10.1073/pnas.88.21.9843; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0	29	282	285	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2419	2423		10.1126/science.1057415	http://dx.doi.org/10.1126/science.1057415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264540				2022-12-01	WOS:000167618700059
J	Horon, IL; Cheng, D				Horon, IL; Cheng, D			Enhanced surveillance for pregnancy-associated mortality - Maryland, 1993-1998	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MATERNAL MORTALITY	Context Deaths occurring among women who are pregnant or who have had a recent pregnancy have a devastating impact on the family and community. It is important to understand the magnitude and causes of pregnancy-associated mortality so that comprehensive strategies can be formulated to prevent such deaths. Objective To ascertain the number and causes of pregnancy-associated deaths using enhanced surveillance techniques. Design, Setting, and Subjects Retrospective, cross-sectional analysis of death certificate data of reproductive-age women, live birth and fetal death records, and medical examiner records in Maryland during 1993-1998. Main Outcome Measure Number of pregnancy-associated deaths, defined as death from any cause during pregnancy or within 1 year of delivery or pregnancy termination, by source of data and cause of death. Results A total of 247 pregnancy-associated deaths were ascertained. Twenty-seven percent (n=67) were identified through cause-of-death information obtained from death certificates, 70% (n=174) through linkage of death records with birth and fetal death records, and 47% (n=116) through review of medical examiner records. Homicide was the leading cause of pregnancy-associated death (n=50; 20%), and cardiovascular disorders were the second-leading cause (n=48; 19%). Conclusions In this Maryland sample, comprehensive identification of pregnancy-associated deaths was accomplished only after collecting information from multiple sources and including all deaths occurring up to 1 year after delivery or pregnancy termination. This enhanced pregnancy mortality surveillance led to the disturbing finding that a pregnant or recently pregnant woman is more likely to be a victim of homicide than to die of any other cause. By broadening pregnancy mortality to include all possible causes, previously neglected factors may assume increased importance in prenatal and postpartum care.	Maryland Dept Hlth & Mental Hyg, Vital Stat Adm, Baltimore, MD 21201 USA; Maryland Dept Hlth & Mental Hyg, Ctr Maternal & Child Hlth, Baltimore, MD 21201 USA	Maryland Department of Health & Mental Hygiene; Maryland Department of Health & Mental Hygiene	Horon, IL (corresponding author), Maryland Dept Hlth & Mental Hyg, Vital Stat Adm, 201 W Preston St, Baltimore, MD 21201 USA.	horoni@dhmh.state.md.us						ALLEN MH, 1991, AM J PUBLIC HEALTH, V81, P380, DOI 10.2105/AJPH.81.3.380; ATRASH HK, 1995, OBSTET GYNECOL, V86, P700, DOI 10.1016/0029-7844(95)00200-B; ATRASH HK, 1992, CURR OPIN OBSTET GYN, V4, P61; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P93; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P621; COMAS A, 1991, MMWR-MORBID MORTAL W, V40, P521; Dietz PM, 1998, AM J PUBLIC HEALTH, V88, P641, DOI 10.2105/AJPH.88.4.641; DYE TD, 1992, AM J OBSTET GYNECOL, V167, P72, DOI 10.1016/S0002-9378(11)91629-9; Jocums SB, 1998, OBSTET GYNECOL, V91, P766, DOI 10.1016/S0029-7844(98)00063-5; Parsons LH, 1999, OBSTET GYNECOL, V94, P990, DOI 10.1016/S0029-7844(99)00466-4; *WHO, 1977, MAN INT STAT CLASS D; *WHO, 1992, INT CLASS IDS 10 REV	12	104	105	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1455	1459		10.1001/jama.285.11.1455	http://dx.doi.org/10.1001/jama.285.11.1455			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255421				2022-12-01	WOS:000167462100027
J	Bozzette, SA; Joyce, G; McCaffrey, DF; Leibowitz, AA; Morton, SC; Berry, SH; Rastegar, A; Timberlake, D; Shapiro, MF; Goldman, DP				Bozzette, SA; Joyce, G; McCaffrey, DF; Leibowitz, AA; Morton, SC; Berry, SH; Rastegar, A; Timberlake, D; Shapiro, MF; Goldman, DP		HIV Cost Services Utilization Stud	Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; UNITED-STATES; SERVICES UTILIZATION; MEDICAL-CARE; COSTS; AIDS; PREVALENCE; SAMPLES; ADULTS	Background: The introduction of expensive but very effective antiviral medications has led to questions about the effects on the total use of resources for the care of patients with human immunodeficiency virus (HIV) infection. We examined expenditures for the care of HIV-infected patients since the introduction of highly active antiretroviral therapy. Methods: We interviewed a random sample of 2864 patients who were representative of all American adults receiving care for HIV infection in early 1996, and followed them for up to 36 months. We estimated the average expenditure per patient per month on the basis of self-reported information about care received. Results: The mean expenditure was $1,792 per patient per month at base line, but it declined to $1,359 for survivors in 1997, since the increases in pharmaceutical expenditures were smaller than the reductions in hospital costs. Use of highly active antiretroviral therapy was independently associated with a reduction in expenditures. After adjustments for the interview date, clinical status, and deaths, the estimated annual expenditure declined from $20,300 per patient in 1996 to $18,300 in 1998. Expenditures among subgroups of patients varied by a factor of as much as three. Pharmaceutical costs were lowest and hospital costs highest among underserved groups, including blacks, women, and patients without private insurance. Conclusions: The total cost of care for adults with HIV infection has declined since the introduction of highly active antiretroviral therapy. Expenditures have increased for medications but have declined for other services. However, there are large variations in expenditures across subgroups of patients. (N Engl J Med 2001;344:817-23.) Copyright (C) 2001 Massachusetts Medical Society.	RAND Corp, Hlth, Santa Monica, CA 90407 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	RAND Corporation; University of California System; University of California San Diego; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bozzette, SA (corresponding author), RAND Corp, Hlth, 1700 Main St, Santa Monica, CA 90407 USA.		Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035040] Funding Source: NIH RePORTER; AHRQ HHS [HS08578] Funding Source: Medline; NICHD NIH HHS [R01-HD35040] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERRY SH, IN PRESS HCSUC BAS P; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Cunningham WE, 2000, J ACQ IMMUN DEF SYND, V25, P115, DOI 10.1097/00126334-200010010-00005; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Goldman DP, 2001, MED CARE RES REV, V58, P31, DOI 10.1177/107755870105800102; HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466; Hellinger FJ, 2000, J ACQ IMMUN DEF SYND, V24, P182; HELLINGER FJ, 1993, JAMA-J AM MED ASSOC, V270, P474, DOI 10.1001/jama.270.4.474; KALTON G, 1983, COMPENSATING MISSING; Keiser P, 1999, J ACQ IMMUN DEF SYND, V20, P28, DOI 10.1097/00042560-199901010-00004; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; Lam NSN, 1996, PROF GEOGR, V48, P321, DOI 10.1111/j.0033-0124.1996.00321.x; LANDON BE, 1999, 16 ANN M ASS HLTH SE, P135; LORD LJ, 1987, US NEWS WORLD R 0615, P16; Moore RD, 2000, PHARMACOECONOMICS, V17, P325, DOI 10.2165/00019053-200017040-00002; Murphy S, 1998, J Health Serv Res Policy, V3, P215; NEWHOUSE JP, 1993, HEALTH AFFAIR, V12, P152, DOI 10.1377/hlthaff.12.suppl_1.152; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rabeneck L, 1999, MED CARE, V37, P748, DOI 10.1097/00005650-199908000-00005; Schwarcz SK, 2000, AM J EPIDEMIOL, V152, P178, DOI 10.1093/aje/152.2.178; SCITOVSKY AA, 1987, PUBLIC HEALTH REP, V102, P5; SCITOVSKY AA, 1990, J ACQ IMMUN DEF SYND, V3, P904; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; SISK JE, 1987, HEALTH AFFAIR, V6, P5, DOI 10.1377/hlthaff.6.2.5; Weissman JS, 1996, AIDS, V10, P775, DOI 10.1097/00002030-199606001-00013	26	208	210	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					817	823		10.1056/NEJM200103153441107	http://dx.doi.org/10.1056/NEJM200103153441107			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410LA	11248159	Green Published			2022-12-01	WOS:000167440400007
J	Rodriguez, J; Tintore, J; Allen, JT; Blanco, JM; Gomis, D; Reul, A; Ruiz, J; Rodriguez, V; Echevarria, F; Jimenez-Gomez, F				Rodriguez, J; Tintore, J; Allen, JT; Blanco, JM; Gomis, D; Reul, A; Ruiz, J; Rodriguez, V; Echevarria, F; Jimenez-Gomez, F			Mesoscale vertical motion and the size structure of phytoplankton in the ocean	NATURE			English	Article							DEEP CHLOROPHYLL MAXIMUM; ALBORAN SEA; POTENTIAL VORTICITY; PACIFIC-OCEAN; PRODUCTIVITY; CIRCULATION; COMMUNITY; PATTERNS; BIOMASS; FRONT	Phytoplankton size structure is acknowledged as a fundamental property determining energy flow through 'microbial' or 'herbivore' pathways(1). The balance between these two pathways determines the ability of the ecosystem to recycle carbon within the upper layer or to export it to the ocean interior(1). Small cells are usually characteristic of oligotrophic, stratified ocean waters, in which regenerated ammonium is the only available form of inorganic nitrogen and recycling dominates. Large cells seem to characterize phytoplankton in which inputs of nitrate enter the euphotic layer and exported production is higher(2-4). But the size structure of phytoplankton may depend more directly on hydrodynamical forces than on the source of available nitrogen(5-7). Here we present an empirical model that relates the magnitude of mesoscale vertical motion to the slope of the size-abundance spectrum(8-10) of phytoplankton in a frontal ecosystem. Our model indicates that the relative proportion of large cells increases with the magnitude of the upward velocity. This suggests that mesoscale vertical motion-a ubiquitous feature of eddies and unstable fronts-controls directly the size structure of phytoplankton in the ocean.	Univ Malaga, Dept Ecol, E-29071 Malaga, Spain; UIB, CSIC, Inst Mediterrani Estudis Avancats, Palma de Mallorca 07071, Spain; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Cadiz, Fac Ciencias Mar, Dept Biol Anim Biol Vegetal & Ecol, Cadiz 11510, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; NERC National Oceanography Centre; University of Southampton; Universidad de Cadiz	Rodriguez, J (corresponding author), Univ Malaga, Dept Ecol, Campus Teatinos, E-29071 Malaga, Spain.	jaime@uma.es	Ruiz, Javier/G-3184-2016; GOMEZ, FRANCISCO JIMENEZ/E-7093-2012; Reul, Andreas/L-7291-2014; Echevarria, Fidel/AAM-8826-2020; Gómez, Francisco Jiménez/AAA-1425-2021; Reul, Andreas/AAI-6720-2020	Ruiz, Javier/0000-0002-3375-2327; GOMEZ, FRANCISCO JIMENEZ/0000-0001-8644-7089; Reul, Andreas/0000-0002-1951-8948; Echevarria, Fidel/0000-0002-2662-5506; Gómez, Francisco Jiménez/0000-0001-8644-7089; Reul, Andreas/0000-0002-1951-8948; Rodriguez Martinez, Valeriano/0000-0003-1150-600X; Rodriguez, Jaime/0000-0002-4143-883X; Tintore, Joaquin/0000-0002-6311-0093				Allen JT, 1996, J PHYS OCEANOGR, V26, P2611, DOI 10.1175/1520-0485(1996)026<2611:PVAVVA>2.0.CO;2; ALLEN JT, IN PRESS DEEP SEA RE; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; CUSHMANROISIN B, 1994, INTRO GEOPHYSICAL FL; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; ESTRADA M, 1993, MAR ECOL PROG SER, V92, P289, DOI 10.3354/meps092289; FIEKAS V, 1994, J PHYS OCEANOGR, V24, P1750, DOI 10.1175/1520-0485(1994)024<1750:MIAUPO>2.0.CO;2; FURUYA K, 1983, J PLANKTON RES, V5, P393, DOI 10.1093/plankt/5.3.393; Gomis D, 2001, DEEP-SEA RES PT I, V48, P269, DOI 10.1016/S0967-0637(00)00060-1; HARRIS GP, 1987, J PLANKTON RES, V9, P1003, DOI 10.1093/plankt/9.5.1003; LEACH H, 1987, DEEP-SEA RES, V34, P2005, DOI 10.1016/0198-0149(87)90095-1; LEGENDRE L, 1989, LIFE SCI R, V44, P49; MALONE TC, 1980, PHYSL ECOLOGY PHYTOP, P433; PENA MA, 1990, DEEP-SEA RES, V37, P295, DOI 10.1016/0198-0149(90)90129-J; Platt T., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V173, P60; POLLARD RT, 1990, NATURE, V348, P227, DOI 10.1038/348227a0; RODRIGUEZ J, 1986, LIMNOL OCEANOGR, V31, P361, DOI 10.4319/lo.1986.31.2.0361; Rodriguez J, 1998, DEEP-SEA RES PT I, V45, P1577, DOI 10.1016/S0967-0637(98)00030-2; Rodriguez Jaime, 1994, Scientia Marina, V58, P1; Ruiz J, 1996, J MARINE SYST, V9, P269, DOI 10.1016/S0924-7963(96)00045-0; SEMINA H J, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P177, DOI 10.1002/iroh.19720570202; SEMINA H J, 1968, Sarsia, V34, P267; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; Viudez A, 1996, J PHYS OCEANOGR, V26, P684, DOI 10.1175/1520-0485(1996)026<0684:CITASA>2.0.CO;2	27	165	168	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					360	363		10.1038/35066560	http://dx.doi.org/10.1038/35066560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268210				2022-12-01	WOS:000167464100048
J	Scott, K; Brady, R; Cravchik, A; Morozov, P; Rzhetsky, A; Zuker, C; Axel, R				Scott, K; Brady, R; Cravchik, A; Morozov, P; Rzhetsky, A; Zuker, C; Axel, R			A chemosensory gene family encoding candidate gustatory and olfactory receptors in Drosophila	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; MAMMALIAN TASTE RECEPTORS; C-ELEGANS; ODORANT RECEPTORS; SENSORY PROJECTIONS; MULTIGENE FAMILY; ANTENNAL LOBE; SOUR TASTE; MELANOGASTER; EXPRESSION	A novel family of candidate gustatory receptors (GRs) was recently identified in searches of the Drosophila genome. We have performed in situ hybridization and transgene experiments that reveal expression of these genes in both gustatory and olfactory neurons in adult flies and larvae. This gene family is likely to encode both odorant and taste receptors. We have visualized the projections of chemosensory neurons in the larval brain and observe that neurons expressing different GRs project to discrete loci in the antennal lobe and subesophageal ganglion. These data provide insight into the diversity of chemosensory recognition and an initial view of the representation of gustatory information in the fly brain.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med Informat, New York, NY 10032 USA; Celera Genom, Med Affairs Dept, Rockville, MD 20850 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	ra27@columbia.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405; Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NCI NIH HHS [2POICA23767-22] Funding Source: Medline; NINDS NIH HHS [NS 29832-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARORA K, 1987, NATURE, V330, P62, DOI 10.1038/330062a0; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Dethier VG, 1976, HUNGRY FLY; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; HARTENSTEIN V, 1987, W ROUXS ARCH DEV BIO, V198, P264; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nassif C, 1998, J COMP NEUROL, V402, P10; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RICE MJ, 1977, NATURE, V268, P747, DOI 10.1038/268747a0; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; RUBIN GM, 1985, COLD SPRING HARB SYM, V50, P329, DOI 10.1101/SQB.1985.050.01.042; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; TAYLOR BJ, 1989, J NEUROGENET, V5, P193, DOI 10.3109/01677068909066208; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Truman James W., 1993, P1245; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	77	488	502	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					661	673		10.1016/S0092-8674(02)02052-4	http://dx.doi.org/10.1016/S0092-8674(02)02052-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257221	Bronze			2022-12-01	WOS:000167531100007
J	Toyoshima-Morimoto, F; Taniguchi, E; Shinya, N; Iwamatsu, A; Nishida, E				Toyoshima-Morimoto, F; Taniguchi, E; Shinya, N; Iwamatsu, A; Nishida, E			Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase	NATURE			English	Article							CELL-CYCLE; SUBCELLULAR-LOCALIZATION; DNA-DAMAGE; M-PHASE; EXPORT; MITOSIS; SIGNAL; PLX1; TRANSPORT; CRM1	In vertebrate cells, the nuclear entry of Cdc2-cyclin B1 (MPF1-3) during prophase(4-6) is thought to be essential for the induction and coordination of M-phase events(7-12). Phosphorylation of cyclin B1 is central to its nuclear translocation(8,13,14), but the kinases that are responsible remain unknown. Here we have purified a protein kinase from Xenopus M-phase extracts that phosphorylates a crucial serine residue (S147) in the middle of the nuclear export signal sequence(10,13,15) of cyclin B1. We have identified this kinase as Plx1 (ref. 16), a Xenopus homologue of Polo-like kinase (Plk)-1 (refs 17, 18). During cell-cycle progression in HeLa cells, a change in the kinase activity of endogenous Plk1 toward S147 and/or S133 correlates with a kinase activity in the cell extracts. An anti-Plk1 antibody depletes the M-phase extracts of the kinase activity toward S147 and/or S133. An anti-phospho-S147 antibody reacts specifically with cyclin B1 only during G2/M phase. A mutant cyclin B1 in which S133 and S147 are replaced by alanines remains in the cytoplasm, whereas wild-type cyclin B1 accumulates in the nucleus during prophase. Co-expression of constitutively active Plk1 stimulates nuclear entry of cyclin B1. Our results indicate that Plk1 may be involved in targeting MPF to the nucleus during prophase.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Kyoto University; Kyoto University; Kirin Brewery Company Limited	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.			Toyoshima, Fumiko/0000-0002-3698-0034				Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hunt T, 1991, Semin Cell Biol, V2, P213; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; IZUMI T, 1991, MOL CELL BIOL, V11, P3860, DOI 10.1128/MCB.11.8.3860; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; LI JK, 1995, MOL BIOL CELL, V6, P1111, DOI 10.1091/mbc.6.9.1111; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NIGG E A, 1992, Current Opinion in Cell Biology, V4, P105, DOI 10.1016/0955-0674(92)90066-L; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OOKATA K, 1992, EMBO J, V11, P1763, DOI 10.1002/j.1460-2075.1992.tb05228.x; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	30	309	319	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					215	220		10.1038/35065617	http://dx.doi.org/10.1038/35065617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242082				2022-12-01	WOS:000167320500048
J	Casellas, R; Shih, TAY; Kleinewietfeld, M; Rakonjac, J; Nemazee, D; Rajewsky, K; Nussenzweig, MC				Casellas, R; Shih, TAY; Kleinewietfeld, M; Rakonjac, J; Nemazee, D; Rajewsky, K; Nussenzweig, MC			Contribution of receptor editing to the antibody repertoire	SCIENCE			English	Article							B-CELL DEVELOPMENT; MOUSE BONE-MARROW; GENE-EXPRESSION; MICE; REARRANGEMENTS; MODEL; LYMPHOCYTES; MATURATION; TOLERANCE; DELETION	Receptor editing, clonal deletion, and anergy are the mechanisms by which B cells maintain tolerance to self antigens. To determine the extent to which receptor editing shapes the normal antibody repertoire, we generated an immunoglobulin kappa polymorphism that facilitates the detection of;editing of immunoglobulin light chains in vivo. We found that B cells are targeted for editing during a 2-hour delay in development at the pre-BII cell stage, and that about 25% of all antibody molecules are produced by gene replacement. These results suggest that receptor editing represents a major force in shaping the antibody repertoire.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Cologne; Scripps Research Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Rakonjac, Jasna V/E-6836-2011; Nussenzweig, Michel/AAE-7292-2019; Kleinewietfeld, Markus/AAI-4497-2021	Rakonjac, Jasna V/0000-0002-6756-4682; Rajewsky, Klaus/0000-0002-6633-6370; Kleinewietfeld, Markus/0000-0002-2832-3149	NIAID NIH HHS [R01 AI033608] Funding Source: Medline; PHS HHS [33890] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033608] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Braun U, 2000, P NATL ACAD SCI USA, V97, P7429, DOI 10.1073/pnas.050578497; BURNET M, 1959, CLONAL SELECTION THE; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARLTEY SB, 1993, CELL, V72, P325; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Kouskoff V, 2000, P NATL ACAD SCI USA, V97, P7435, DOI 10.1073/pnas.130182597; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; ROCHA B, 1990, EUR J IMMUNOL, V20, P1697, DOI 10.1002/eji.1830200812; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	29	248	266	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1541	1544		10.1126/science.1056600	http://dx.doi.org/10.1126/science.1056600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222858				2022-12-01	WOS:000167153400043
J	Lang, P; Stolpa, JC; Freiberg, BA; Crawford, F; Kappler, J; Kupfer, A; Cambier, JC				Lang, P; Stolpa, JC; Freiberg, BA; Crawford, F; Kappler, J; Kupfer, A; Cambier, JC			TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers	SCIENCE			English	Article							B-CELL ACTIVATION; ANTIGEN RECEPTOR; T-CELL; TYROSINE PHOSPHORYLATION; CROSS-LINKING; LYMPHOCYTES-B; MOLECULES; EXPRESSION; PROTEIN; PROLIFERATION	Previous findings suggest that during cognate T cell-B cell interactions, major histocompatability complex (MHC) class II molecules transduce signals, leading to Src-family kinase activation, Ca2+ mobilization, and proliferation. Here, we show that antigen stimulation of resting B cells induces MHC class It molecules to associate with Immunoglobulin (Ig)-alpha /Ig-beta (CD79a/CD79b) heterodimers, which function as signal transducers upon MHC class II aggregation by the T cell receptor (TCR). The B cell receptor (BCR) and MHC class II/Ig-alpha /Ig-beta are distinct complexes, yet class It-associated Ig-alpha/beta appears to be derived from BCR. Hence, Ig-alpha/beta are used in a sequential fashion for transduction of antigen and cognate T cell help signals.	Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; National Jewish Health	Cambier, JC (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.			Cambier, John/0000-0002-7803-242X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI020519] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 20519, AI 22295] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRE P, 1994, J EXP MED, V179, P763, DOI 10.1084/jem.179.2.763; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; CAMBIER JC, 1989, J EXP MED, V170, P877, DOI 10.1084/jem.170.3.877; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CAMBIER JC, UNPUB; CHERONIS JC, 1994, J MED CHEM, V37, P348, DOI 10.1021/jm00029a006; Chirmule N, 2000, J IMMUNOL, V164, P248, DOI 10.4049/jimmunol.164.1.248; Drake JR, 1997, J EXP MED, V186, P1299, DOI 10.1084/jem.186.8.1299; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; KANNER SB, 1995, TISSUE ANTIGENS, V46, P145, DOI 10.1111/j.1399-0039.1995.tb03113.x; KIM KJ, 1979, J IMMUNOL, V122, P549; Lane P, 1996, CURR OPIN IMMUNOL, V8, P331, DOI 10.1016/S0952-7915(96)80121-X; LANE PJL, 1990, J IMMUNOL, V144, P3684; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MORIO T, 1994, EUR J IMMUNOL, V24, P651, DOI 10.1002/eji.1830240325; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schrader CE, 1997, J IMMUNOL, V158, P153; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; WADE WF, 1989, P NATL ACAD SCI USA, V86, P6297, DOI 10.1073/pnas.86.16.6297	27	91	91	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1537	1540		10.1126/science.291.5508.1537	http://dx.doi.org/10.1126/science.291.5508.1537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222857				2022-12-01	WOS:000167153400042
J	Kornak, U; Kasper, D; Bosl, MR; Kaiser, E; Schweizer, M; Schulz, A; Friedrich, W; Delling, G; Jentsch, TJ				Kornak, U; Kasper, D; Bosl, MR; Kaiser, E; Schweizer, M; Schulz, A; Friedrich, W; Delling, G; Jentsch, TJ			Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man	CELL			English	Article							MEDIATED EXTRACELLULAR ACIDIFICATION; OSTEOCLASTIC BONE-RESORPTION; RENAL TUBULAR-ACIDOSIS; RUFFLED BORDER; RESORBING OSTEOCLASTS; MEMBRANE-PROTEIN; PROTON PUMP; GENE; MUTATIONS; CELLS	Chloride channels play important roles in the plasma membrane and in intracellular organelles. Mice deficient for the ubiquitously expressed CIC-7 Cl- channel show severe osteopetrosis and retinal degeneration. Although osteoclasts are present in normal numbers, they fail to resorb bone because they cannot acidify the extracellular resorption lacuna. CIC-7 resides in late endosomal and lysosomal compartments. In osteoclasts, it is highly expressed in the ruffled membrane, formed by the fusion of H+-ATPase-containing vesicles, that secretes protons into the lacuna. We also identified CLCN7 mutations in a patient with human Infantile malignant osteopetrosis. We conclude that CIC-7 provides the chloride conductance required for an efficient proton pumping by the H+-ATPase of the osteoclast ruffled membrane.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Univ Hamburg, Inst Pathol, Abt Osteopathol, D-20246 Hamburg, Germany; Univ Ulm, Univ Kinderklin, D-89075 Ulm, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 52, D-20246 Hamburg, Germany.			Jentsch, Thomas/0000-0002-3509-2553				ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GERRITSEN EJA, 1994, PEDIATRICS, V93, P247; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; KEITH CG, 1968, ARCH OPHTHALMOL-CHIC, V79, P234; KOMAK U, 2000, HUM MOL GENET, V9, P2059; Kornak U, 1999, BBA-GENE STRUCT EXPR, V1447, P100, DOI 10.1016/S0167-4781(99)00128-1; Lazner F, 1999, HUM MOL GENET, V8, P1839, DOI 10.1093/hmg/8.10.1839; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Palokangas H, 1997, J CELL SCI, V110, P1767; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Schlesinger PH, 1997, J BIOL CHEM, V272, P18636, DOI 10.1074/jbc.272.30.18636; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Vaananen HK, 2000, J CELL SCI, V113, P377	40	735	771	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					205	215		10.1016/S0092-8674(01)00206-9	http://dx.doi.org/10.1016/S0092-8674(01)00206-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207362	hybrid			2022-12-01	WOS:000166879700005
J	Iyer, VR; Horak, CE; Scafe, CS; Botstein, D; Snyder, M; Brown, PO				Iyer, VR; Horak, CE; Scafe, CS; Botstein, D; Snyder, M; Brown, PO			Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; GENE-EXPRESSION; DNA-REPLICATION; S-PHASE; IN-VIVO; COMPLEX; KINASE; REGULATOR; MEIOSIS	Proteins interact with genomic DNA to bring the genome to life; and these interactions also define many functional features of the genome. SBF and MBF are sequence-specific transcription factors that activate gene expression during the G1/S transition of the cell cycle in yeast(1,2). SBF is a heterodimer of Swi4 and Swi6, and MBF is a heterodimer of Mbp1 and Swi6 (refs 1, 3). The related Swi4 and Mbp1 proteins are the DNA-binding components of the respective factors, and Swi6 may have a regulatory function(4,5). A small number of SBF and MBF target genes have been identified(3,6-10). Here we define the genomic binding sites of the SBF and MBF transcription factors in vivo, by using DNA microarrays. In addition to the previously characterized targets, we have identified about 200 new putative targets. Our results support the hypothesis that SBF activated genes are predominantly involved in budding, and in membrane and cell-wall biosynthesis, whereas DNA replication and repair are the dominant functions among MBF activated genes(6,11). The functional specialization of these factors may provide a mechanism for independent regulation of distinct molecular processes that normally occur in synchrony during the mitotic cell cycle.	Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Yale University	Brown, PO (corresponding author), Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA.			Snyder, Michael/0000-0003-0784-7987				ANDREWS BJ, 1989, NATURE, V342, P830, DOI 10.1038/342830a0; Ayte J, 1997, MOL CELL BIOL, V17, P6246, DOI 10.1128/MCB.17.11.6246; Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; BREEDEN L, 1994, GENETICS, V138, P1015; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Harrington LA, 1996, NUCLEIC ACIDS RES, V24, P558, DOI 10.1093/nar/24.4.558; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; JOHNSTON LH, 1986, EXP CELL RES, V165, P541, DOI 10.1016/0014-4827(86)90606-3; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; LOWNDES NF, 1991, NATURE, V350, P247, DOI 10.1038/350247a0; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; MCINTOSH EM, 1993, CURR GENET, V24, P185, DOI 10.1007/BF00351790; MEASDAY V, 1994, SCIENCE, V266, P1391, DOI 10.1126/science.7973731; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PRIMIG M, 1992, NATURE, V358, P593, DOI 10.1038/358593a0; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; ZHU Y, 1994, GENE DEV, V8, P885, DOI 10.1101/gad.8.8.885	27	813	849	2	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					533	538		10.1038/35054095	http://dx.doi.org/10.1038/35054095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206552				2022-12-01	WOS:000166570500053
J	Michel, LS; Liberal, V; Chatterjee, A; Kirchwegger, R; Pasche, B; Gerald, W; Dobles, M; Sorger, PK; Murty, VVVS; Benezra, R				Michel, LS; Liberal, V; Chatterjee, A; Kirchwegger, R; Pasche, B; Gerald, W; Dobles, M; Sorger, PK; Murty, VVVS; Benezra, R			MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells	NATURE			English	Article							SISTER-CHROMATID SEPARATION; SPINDLE-ASSEMBLY CHECKPOINT; PROMOTING COMPLEX; HUMAN CANCERS; GENE; MUTATIONS; IDENTIFICATION; CARCINOMAS; MITOSIS	The mitotic checkpoint protein hsMad2 is required to arrest cells in mitosis when chromosomes are unattached to the mitotic spindle(1). The presence of a single, lagging chromosome is sufficient to activate the checkpoint, producing a delay at the metaphase-anaphase transition until the last spindle attachment is made(2). Complete loss of the mitotic checkpoint results in embryonic lethality owing to chromosome mis-segregation in various organisms(3-6). Whether partial loss of checkpoint control leads to more subtle rates of chromosome instability compatible with cell viability remains unknown. Here we report that deletion of one MAD2 allele results in a defective mitotic checkpoint in both human cancer cells and murine primary embryonic fibroblasts. Checkpoint-defective cells show premature sister-chromatid separation in the presence of spindle inhibitors and an elevated rate of chromosome mis-segregation events in the absence of these agents. Furthermore, Mad2(+/-) mice develop lung tumours at high rates after long latencies, implicating defects in the mitotic checkpoint in tumorigenesis.	Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Columbia University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Massachusetts Institute of Technology (MIT)	Benezra, R (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA.		Holt, Janet E/B-2415-2013	Sorger, Peter/0000-0002-3364-1838				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; DeVita VT, 1997, CANC PRINCIPLES PRAC; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DOHNER H, 1992, GENE CHROMOSOME CANC, V5, P392, DOI 10.1002/gcc.2870050415; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Krishnan R, 1998, GENOMICS, V49, P475, DOI 10.1006/geno.1998.5233; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Rashid A, 1999, BRIT J CANCER, V80, P59, DOI 10.1038/sj.bjc.6690321; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Shivapurkar N, 1999, CANCER RES, V59, P3576; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Takahashi N, 1999, SOFTWARE STUDIES, V2, P55; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Verma RS., 1995, HUMAN CHROMOSOMES PR, V2; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	29	626	644	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					355	359		10.1038/35053094	http://dx.doi.org/10.1038/35053094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201745				2022-12-01	WOS:000166434300050
J	Nakazato, M; Murakami, N; Date, Y; Kojima, M; Matsuo, H; Kangawa, K; Matsukura, S				Nakazato, M; Murakami, N; Date, Y; Kojima, M; Matsuo, H; Kangawa, K; Matsukura, S			A role for ghrelin in the central regulation of feeding	NATURE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; MESSENGER-RIBONUCLEIC-ACID; RAT ARCUATE NUCLEUS; GROWTH-HORMONE; NEUROPEPTIDE-Y; GENE-EXPRESSION; LEPTIN ACTION; OBESE GENE; HYPOTHALAMUS; PITUITARY	Ghrelin is an acylated peptide that stimulates the release of growth hormone from the pituitary(1). Ghrelin-producing neurons are located in the hypothalamus, whereas ghrelin receptors are expressed in various regions of the brain(2-4), which is indicative of central-and as yet undefined-physiological functions. Here we show that ghrelin is involved in the hypothalamic regulation of energy homeostasis. Intracerebroventricular injections of ghrelin strongly stimulated feeding in rats and increased body weight gain. Ghrelin also increased feeding in rats that are genetically deficient in growth hormone. Anti-ghrelin immunoglobulin G robustly suppressed feeding. After intracerebroventricular ghrelin administration, Fos protein, a marker of neuronal activation(5), was found in regions of primary importance in the regulation of feeding, including neuropeptide Y-6 (NPY) neurons and agouti-related protein(7) (AGRP) neurons. Antibodies and antagonists of NPY and AGRP abolished ghrelin-induced feeding. Ghrelin augmented NPY gene expression and blocked leptin-induced(8) feeding reduction, implying that there is a competitive interaction between ghrelin and leptin in feeding regulation. We conclude that ghrelin is a physiological mediator of feeding, and probably has a function in growth regulation by stimulating feeding and release of growth hormone.	Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan; Miyazaki Univ, Dept Vet Physiol, Miyazaki 8892192, Japan; Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Osaka 5658565, Japan	University of Miyazaki; University of Miyazaki; National Cerebral & Cardiovascular Center - Japan	Nakazato, M (corresponding author), Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan.							BOWERS CY, 1984, ENDOCRINOLOGY, V114, P1537, DOI 10.1210/endo-114-5-1537; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; CHENG K, 1989, ENDOCRINOLOGY, V124, P2791; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; DANIELS AJ, 1995, P NATL ACAD SCI USA, V92, P9067, DOI 10.1073/pnas.92.20.9067; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Honda K, 1999, NEUROSCIENCE, V90, P875, DOI 10.1016/S0306-4522(98)00532-6; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Ida T, 1999, BRAIN RES, V821, P526, DOI 10.1016/S0006-8993(99)01131-2; Kanatani A, 2000, BIOCHEM BIOPH RES CO, V272, P169, DOI 10.1006/bbrc.2000.2696; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; LOCKE W, 1995, LIFE SCI, V56, P1347, DOI 10.1016/0024-3205(95)00087-9; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Murakami N, 1997, BRAIN RES, V775, P240, DOI 10.1016/S0006-8993(97)01031-7; Okuma S., 1980, EXP ANIM TOKYO, V29, P301; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; STANLEY BG, 1986, PEPTIDES, V7, P1189; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; TAKEUCHI T, 1990, ENDOCRINOLOGY, V126, P31, DOI 10.1210/endo-126-1-31; Wieland HA, 1998, BRIT J PHARMACOL, V125, P549, DOI 10.1038/sj.bjp.0702084; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Yamamoto Y, 1999, MOL BRAIN RES, V65, P14, DOI 10.1016/S0169-328X(98)00320-9; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	32	2721	2859	10	187	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					194	198		10.1038/35051587	http://dx.doi.org/10.1038/35051587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196643				2022-12-01	WOS:000166316200045
J	Wu, E; Judd, RM; Vargas, JD; Klocke, FJ; Bonow, RO; Kim, RJ				Wu, E; Judd, RM; Vargas, JD; Klocke, FJ; Bonow, RO; Kim, RJ			Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction	LANCET			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY DISEASE; DILATED CARDIOMYOPATHY; PROGNOSIS; SIZE; INJURY; DTPA; MRI	Background A technical advance in contrast-enhanced magnetic resonance imaging (MRI) has significantly improved image quality. We investigated whether healed myocardial infarction can be visualised as hyperenhanced regions with this new technique, and whether assessment of the transmural extent of infarction yields new physiological data. Methods 82 MRI examinations were carried out in three groups: patients with healed myocardial infarction; patients with non-ischaemic cardiomyopathy; and healthy volunteers. Patients with healed myocardial infarction were prospectively enrolled after enyzmatically proven necrosis and imaged 3 months (SD 1) or 14 months (7) later. The MRI procedure used a segmented inversion-recovery gradient-echo sequence after gadolinium administration. Findings were compared with those of coronary angiography, electrocardiography, cine MRI, and creatine kinase measurements. Findings 29 (91%) of 32 patients with infarcts imaged at 3 months (13 nonQ-wave) and all of 19 imaged at 14 months (eight non-Q-wave) showed hyperenhancement. In patients in whom the infarct-related-artery was identified by angiography, 24 of 25 imaged at 3 months and all of 14 imaged at 14 months had hyperenhancement in the appropriate territory. None of the 20 patients with non-ischaemic cardiomyopathy or the 11 healthy volunteers showed hyperenhancement. Irrespective of the presence or absence of Q waves, the majority of patients with hyperenhancement had only non-transmural involvement. Normal left-ventricular contraction was shown in seven patients examined at 3 months and three examined at 14 months, but in these cases hyperenhancement was limited to the subendocardium. Interpretation The presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction can be accurately determined by contrast-enhanced MRI.	Northwestern Univ, Sch Med, Fainberg Cardiovasc Res Inst, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Fainberg Cardiovasc Res Inst, Dept Biomed Engn, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Kim, RJ (corresponding author), Northwestern Univ, Sch Med, Fainberg Cardiovasc Res Inst, Dept Med, 303 E Chicago Ave,Tarry 12-733, Chicago, IL 60611 USA.		Kim, Raymond J/B-1426-2008	Wu, Edwin/0000-0002-0771-8395	NHLBI NIH HHS [R01-HL63268, R29-HL53411] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063268, R29HL053411] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 1999, 2000 HEART STROK STA; EICHSTAEDT HW, 1986, CLIN CARDIOL, V9, P527, DOI 10.1002/clc.4960091102; FEDELE F, 1994, AM HEART J, V128, P484, DOI 10.1016/0002-8703(94)90621-1; FICNO DS, 2000, J AM COLL CARDIOL, V36, P1985; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Gibbons RJ, 2000, CIRCULATION, V101, P101, DOI 10.1161/01.CIR.101.1.101; GOLDBERG RJ, 1987, AM HEART J, V113, P273, DOI 10.1016/0002-8703(87)90265-1; GRIMM RH, 1987, CIRCULATION, V75, P116; JUGDUTT BI, 1986, J AM COLL CARDIOL, V7, P91, DOI 10.1016/S0735-1097(86)80265-0; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; Kaul S, 1998, CIRCULATION, V98, P625, DOI 10.1161/01.CIR.98.7.625; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; KLEIGER RE, 1990, AM J CARDIOL, V65, P23, DOI 10.1016/0002-9149(90)90020-2; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; MAHMARIAN JJ, 1988, CIRCULATION, V78, P831, DOI 10.1161/01.CIR.78.4.831; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; NADELMANN J, 1990, AM J CARDIOL, V66, P533, DOI 10.1016/0002-9149(90)90477-I; NICOD P, 1989, CIRCULATION, V79, P528, DOI 10.1161/01.CIR.79.3.528; NISHIMURA T, 1989, AM J ROENTGENOL, V153, P715, DOI 10.2214/ajr.153.4.715; PANDIAN NG, 1985, AM J CARDIOL, V55, P551, DOI 10.1016/0002-9149(85)90245-0; PARODI O, 1993, CIRCULATION, V88, P509, DOI 10.1161/01.CIR.88.2.509; Ramani K, 1998, CIRCULATION, V98, P2687, DOI 10.1161/01.CIR.98.24.2687; Rehwald WG, 1999, CIRCULATION, V100, P797; ROBERTS WC, 1987, AM J CARDIOL, V60, P1340, DOI 10.1016/0002-9149(87)90618-7; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; SIMONETTI OP, IN PRESS RADIOLOGY; VANDIJKMAN PRM, 1991, RADIOLOGY, V180, P147, DOI 10.1148/radiology.180.1.2052683; WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167; WEISS JL, 1981, CIRCULATION, V63, P401, DOI 10.1161/01.CIR.63.2.401	30	549	565	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					21	28		10.1016/S0140-6736(00)03567-4	http://dx.doi.org/10.1016/S0140-6736(00)03567-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197356				2022-12-01	WOS:000166341500011
J	Volkman, BF; Lipson, D; Wemmer, DE; Kern, D				Volkman, BF; Lipson, D; Wemmer, DE; Kern, D			Two-state allosteric behavior in a single-domain signaling protein	SCIENCE			English	Article							ENHANCER-BINDING PROTEIN; MODEL-FREE APPROACH; BACTERIAL CHEMOTAXIS; CHEMICAL-EXCHANGE; TIME-SCALE; RELAXATION; DYNAMICS; NTRC; NMR; CALMODULIN	Protein actions are usually discussed in terms of static structures, but function requires motion. We find a strong correlation between phosphorylation-driven activation of the signaling protein NtrC and microsecond time-scale backbone dynamics. Using nuclear magnetic resonance relaxation, we characterized the motions of NtrC in three functional states: unphosphorylated (inactive), phosphorylated (active), and a partially active mutant. These dynamics are indicative of exchange between inactive and active conformations. Both states are populated in unphosphorylated NtrC, and phosphorylation shifts the equilibrium toward the active species. These results support a dynamic population shift between two preexisting conformations as the underlying mechanism of activation.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Univ Wisconsin, Dept Biochem, NMRFAM, Madison, WI 53706 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Brandeis University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Volkman, BF (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.		Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062117] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62117] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Ishima R, 1999, J BIOMOL NMR, V14, P369, DOI 10.1023/A:1008324025406; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOY FJ, 1994, BIOCHEMISTRY-US, V33, P10731, DOI 10.1021/bi00201a022; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; North AK, 1997, J MOL BIOL, V267, P17, DOI 10.1006/jmbi.1996.0838; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; SCHULAK JA, 1994, CLIN TRANSPLANT, V8, P211; Silversmith RE, 1999, TRENDS MICROBIOL, V7, P16, DOI 10.1016/S0966-842X(98)01409-7; Stock J.B., 1995, 2 COMPONENT SIGNAL T, P25; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658	29	523	526	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2429	2433		10.1126/science.291.5512.2429	http://dx.doi.org/10.1126/science.291.5512.2429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264542				2022-12-01	WOS:000167618700061
J	Samatey, FA; Imada, K; Nagashima, S; Vonderviszt, F; Kumasaka, T; Yamamoto, M; Namba, K				Samatey, FA; Imada, K; Nagashima, S; Vonderviszt, F; Kumasaka, T; Yamamoto, M; Namba, K			Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling	NATURE			English	Article							FILAMENT STRUCTURE; ANGSTROM RESOLUTION; TERMINAL REGIONS; SALMONELLA; PROTEIN; ROTATION; DOMAIN	The bacterial flagellar filament is a helical propeller constructed from 11 protofilaments of a single protein, flagellin. The filament switches between left- and right-handed supercoiled forms when bacteria switch their swimming mode between running and tumbling. Supercoiling is produced by two different packing interactions of flagellin called L and R. In switching from L to R, the intersubunit distance (similar to 52 Angstrom) along the protofilament decreases by 0.8 Angstrom. Changes in the number of L and R protofilaments govern supercoiling of the filament. Here we report the 2.0 Angstrom resolution crystal structure of a Salmonella flagellin fragment of relative molecular mass 41,300. The crystal contains pairs of antiparallel straight protofilaments with the R-type repeat. By simulated extension of the protofilament model, we have identified possible switch regions responsible for the bi-stable mechanical switch that generates the 0.8 Angstrom difference in repeat distance.	JST, ERATO, Proton NanoMachine Project, Kyoto 6190237, Japan; Univ Veszprem, Dept Phys, H-8201 Veszprem, Hungary; RIKEN, Harima Inst, Mikazuki, Hyogo 6795198, Japan; Matsushita Elect Ind Co Ltd, Adv Technol Res Labs, Kyoto 6190237, Japan	Japan Science & Technology Agency (JST); University of Pannonia; RIKEN; Panasonic	Namba, K (corresponding author), JST, ERATO, Proton NanoMachine Project, 3-4 Hikaridai, Kyoto 6190237, Japan.	keiichi@crl.mei.co.jp	Vonderviszt, Ferenc/GLR-5618-2022; Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Samatey, Fadel/A-3204-2012	Vonderviszt, Ferenc/0000-0002-6498-8172; Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Imada, Katsumi/0000-0003-1342-8885; Samatey, Fadel/0000-0002-0733-2863				Asakura S, 1970, Adv Biophys, V1, P99; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CALLADINE CR, 1976, J THEOR BIOL, V57, P469, DOI 10.1016/0022-5193(76)90016-3; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V255, P121, DOI 10.1038/255121a0; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Honda S, 1999, J MOL BIOL, V293, P719, DOI 10.1006/jmbi.1999.3175; HOTANI H, 1982, J MOL BIOL, V156, P791, DOI 10.1016/0022-2836(82)90142-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMIYA R, 1980, NATURE, V286, P628, DOI 10.1038/286628a0; KAMIYA R, 1976, J MOL BIOL, V106, P167, DOI 10.1016/0022-2836(76)90306-5; KAMIYA R, 1976, J MOL BIOL, V108, P513, DOI 10.1016/S0022-2836(76)80133-7; KAMIYA R, 1979, J MOL BIOL, V131, P725, DOI 10.1016/0022-2836(79)90199-2; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Leslie A. G. W., 1992, NEWSLETT PROTEIN CRY, P26; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; Mimori-Kiyosue Y, 1998, J MOL BIOL, V284, P521, DOI 10.1006/jmbi.1998.2184; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Samatey FA, 2000, J STRUCT BIOL, V132, P106, DOI 10.1006/jsbi.2000.4312; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Ueki T, 1999, STRUCT FOLD DES, V7, pR183, DOI 10.1016/S0969-2126(99)80113-0; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; VONDERVISZT F, 1990, J MOL BIOL, V214, P97, DOI 10.1016/0022-2836(90)90149-G; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; YAMASHITA I, 1995, J MOL BIOL, V253, P547, DOI 10.1006/jmbi.1995.0572; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; YOSHIOKA K, 1995, J BACTERIOL, V177, P1090, DOI 10.1128/jb.177.4.1090-1093.1995	46	369	395	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2001	410	6826					331	337		10.1038/35066504	http://dx.doi.org/10.1038/35066504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268201				2022-12-01	WOS:000167464100039
J	Imhof, A; Froehlich, M; Brenner, H; Boeing, H; Pepys, MB; Koenig, W				Imhof, A; Froehlich, M; Brenner, H; Boeing, H; Pepys, MB; Koenig, W			Effect of alcohol consumption on systemic markers of inflammation	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; ALL-CAUSE MORTALITY; ACUTE-PHASE RESPONSE; MYOCARDIAL-INFARCTION; RISK; ASSOCIATION; POPULATION; MEN; INTERLEUKIN-6	Background Epidemiological studies suggest that light to moderate alcohol intake is associated with lower all-cause mortality than abstention or heavy alcohol intake, primarily through reduced risk of coronary heart disease. The underlying mechanisms are incompletely understood. Methods We investigated the association between alcohol consumption (assessed by a 7-day food record) and concentrations of C-reactive protein ICRP), alpha1-globulins, alpha2-globulins, albumin, and transferrin, and leucocyte count in a sample of 2006 men and women aged 18-88 years participating in a national health survey carried out in former West Germany in 1987-88, Analyses were based on 781 men and 995 women with complete data. Findings Among men, alcohol consumption showed a U-shaped association with mean values of CRP (p for linear term 0.65, for quadratic term 0.048), alpha1-globulins (p=0.20, 0.0006). alpha2-globulins (p=0.82, 0.31), and leucocyte count (p=0.51, 0.26) even after adjustment for age, smoking, body-mass index, HDL and LDL cholesterol, history of hypertension, education, and income. There were inverted U-shaped associations between the negative acute-phase reactants albumin (p=0.41, 0.006) and transferrin (p=0.14, 0.28) and alcohol intake. In women, the associations were less strong for CRP (p=0.35, 0.31), leucocyte count (p=0.28, 0.15), and transferrin (p=0.86, 0.83). Concentrations of alpha1-globulins and alpha2-globulins were inversely related to alcohol consumption, and albumin showed a positive association with increasing alcohol intake in women. Interpretation Non-drinkers and heavy drinkers had higher CRP concentrations than moderate drinkers. In view of the robust association between markers of inflammation, especially CRP, and risk of coronary heart disease, an antiinflammatory action of alcohol could contribute to the link between moderate consumption and lower cardiovascular mortality.	Univ Ulm, Abt Innere Med Kardiol 2, Med Ctr, D-89081 Ulm, Germany; German Ctr Res Aging, Dept Epidemiol, Heidelberg, Germany; Univ Ulm, Dept Epidemiol, D-89081 Ulm, Germany; German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; UCL Royal Free & Univ Coll Med Sch, Dept Med, London, England	Ulm University; Ulm University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of London; University College London; UCL Medical School	Koenig, W (corresponding author), Univ Ulm, Abt Innere Med Kardiol 2, Med Ctr, Robert Koch Str 8, D-89081 Ulm, Germany.	wolfgang.koenig@medizin.uni-ulm.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572				BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Boyle JJ, 1997, J PATHOL, V181, P93, DOI 10.1002/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO;2-H; Brenner H, 1997, INT J EPIDEMIOL, V26, P85, DOI 10.1093/ije/26.1.85; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Fuchs CS, 1997, NEW ENGL J MED, V336, P523; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; HESEKER H, 1994, EUR J CLIN NUTR, V48, P18; Hutchinson WL, 2000, CLIN CHEM, V46, P934; JACKSON R, 1991, BRIT MED J, V303, P211, DOI 10.1136/bmj.303.6796.211; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; McCarty MF, 1999, MED HYPOTHESES, V52, P465, DOI 10.1054/mehy.1997.0684; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Mennen LI, 1999, ARTERIOSCL THROM VAS, V19, P887, DOI 10.1161/01.ATV.19.4.887; Muntwyler J, 1998, LANCET, V352, P1882, DOI 10.1016/S0140-6736(98)06351-X; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Romelsjo A, 1999, BRIT MED J, V319, P821, DOI 10.1136/bmj.319.7213.821; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; SHAPER AG, 1988, LANCET, V2, P1267; White IR, 1999, J CLIN EPIDEMIOL, V52, P967, DOI 10.1016/S0895-4356(99)00076-1; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	29	399	407	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					763	767		10.1016/S0140-6736(00)04170-2	http://dx.doi.org/10.1016/S0140-6736(00)04170-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253971				2022-12-01	WOS:000167400900015
J	Sharp, D				Sharp, D			Foot-and-mouth epidemic: the choices	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), Lancet, London WC1X 8RR, England.							BONNER J, 2001, FOOT MOUTHS RESURGEN; Kitching RP, 1998, J COMP PATHOL, V118, P89, DOI 10.1016/S0021-9975(98)80002-9; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; WOODS A, 2001, TIMES           0301, P5	4	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					738	738		10.1016/S0140-6736(00)04181-7	http://dx.doi.org/10.1016/S0140-6736(00)04181-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253964				2022-12-01	WOS:000167400900008
J	Stanley, GD; Fautin, DG				Stanley, GD; Fautin, DG			Paleontology and evolution - The origins of modern corals	SCIENCE			English	Editorial Material							SCLERACTINIAN CORALS; REEFS		Univ Montana, Dept Geol, Missoula, MT 59812 USA; Univ Kansas, Museum Nat Hist, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	University of Montana System; University of Montana; University of Kansas; University of Kansas	Stanley, GD (corresponding author), Univ Montana, Dept Geol, Missoula, MT 59812 USA.							Deng Z.-q., 1984, Acta Palaeontologica Sinica, V23, P489; Erwin D. H., 1993, GREAT PALEOZOIC CRIS; Ezaki Y, 1998, PALEOBIOLOGY, V24, P227; Ezaki Y, 2000, PALAEONTOLOGY, V43, P199, DOI 10.1111/1475-4983.00124; Fautin DG, 1992, P 7 INT COR REEF S, V2, P665; Fedorowski J, 1997, ACTA PALAEONTOL POL, V42, P446; Gattuso JP, 1999, AM ZOOL, V39, P160; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; MORYCOWA E, 1988, Acta Palaeontologica Polonica, V33, P91; OLIVER WA, 1980, PALEOBIOLOGY, V6, P146, DOI 10.1017/S0094837300006709; Oliver William A. Jr, 1996, Paleontological Society Papers, V1, P107; PETERSEN KW, 1979, BIOL SYSTEMATICS COL, P105; QI WT, 1984, PALEONTOGRAPHICA AM, V54, P187; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Scrutton Colin, 1999, Geology Today, V15, P184, DOI 10.1046/j.1365-2451.1999.1505005.x; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; STANLEY G D JR, 1988, Palaios, V3, P170; Veron JEN, 2000, CORALS WORLD, V1-3; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	21	89	91	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1913	1914		10.1126/science.1056632	http://dx.doi.org/10.1126/science.1056632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245198				2022-12-01	WOS:000167401600033
J	Zhang, HZ; Hackbarth, CJ; Chansky, KM; Chambers, HF				Zhang, HZ; Hackbarth, CJ; Chansky, KM; Chambers, HF			A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci	SCIENCE			English	Article							BINDING PROTEIN 2A; METHICILLIN RESISTANCE; BACILLUS-LICHENIFORMIS; TRANSCRIPTION FACTOR; AUREUS; EXPRESSION; SEQUENCES; MEMBRANE; FAMILIES; GENE	beta -Lactamase and penicillin-binding protein Za mediate staphylococcal resistance to beta -lactam antibiotics, which are otherwise highly clinically effective. Production of these inducible proteins is regulated by a signal-transducing integral membrane protein and a transcriptional repressor. The signal transducer is a fusion protein with penicillin-binding and zinc metalloprotease domains. The signal for protein expression is transmitted by site-specific proteolytic cleavage of both the transducer, which autoactivates, and the repressor, which is inactivated, unblocking gene transcription. Compounds that disrupt this regulatory pathway could restore the activity of beta -lactam antibiotics against drug-resistant strains of staphylococci.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Chambers, HF (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, 1001 Potrero Ave, San Francisco, CA 94110 USA.	chipc@itsa.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046610, R29AI040058] Funding Source: NIH RePORTER; NIAID NIH HHS [AI4005804, AI46610] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P447, DOI 10.1128/AAC.38.3.447; CHAMBERS HF, 1990, J INFECT DIS, V161, P1170, DOI 10.1093/infdis/161.6.1170; COHEN S, 1968, J BACTERIOL, V95, P1368, DOI 10.1128/JB.95.4.1368-1374.1968; DELENCASTRE H, 1994, J ANTIMICROB CHEMOTH, V33, P7, DOI 10.1093/jac/33.1.7; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Gregory PD, 1997, MOL MICROBIOL, V24, P1025, DOI 10.1046/j.1365-2958.1997.4051770.x; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HACKBARTH CJ, 1994, ANTIMICROB AGENTS CH, V38, P2568, DOI 10.1128/AAC.38.11.2568; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HIRAMATSU K, 1995, MICROBIOL IMMUNOL, V39, P531, DOI 10.1111/j.1348-0421.1995.tb02239.x; HOFMEISTER AEM, 1995, CELL, V83, P219, DOI 10.1016/0092-8674(95)90163-9; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Kirby WMM, 1944, SCIENCE, V99, P452, DOI 10.1126/science.99.2579.452; KOBAYASHI T, 1987, J BACTERIOL, V169, P3873, DOI 10.1128/jb.169.9.3873-3878.1987; KREISWIRTH B, 1983, NATURE, V227, P680; KuwaharaArai K, 1996, ANTIMICROB AGENTS CH, V40, P2680, DOI 10.1128/AAC.40.12.2680; Marie-Claire C, 1998, J BIOL CHEM, V273, P5697, DOI 10.1074/jbc.273.10.5697; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; ROWLAND SJ, 1989, EMBO J, V8, P2761, DOI 10.1002/j.1460-2075.1989.tb08418.x; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; TESCH W, 1990, ANTIMICROB AGENTS CH, V34, P1703, DOI 10.1128/AAC.34.9.1703; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; VALLEJO AN, 1994, PCR METH APPL, V4, pS123	27	158	168	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1962	1965		10.1126/science.1055144	http://dx.doi.org/10.1126/science.1055144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239156				2022-12-01	WOS:000167401600046
J	Sterling, TR; Vlahov, D; Astemborski, J; Hoover, DR; Margolick, JB; Quinn, TC				Sterling, TR; Vlahov, D; Astemborski, J; Hoover, DR; Margolick, JB; Quinn, TC			Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	13th International AIDS Conference	JUL 09-SEP 14, 2000	DURBAN, SOUTH AFRICA				VIRAL LOAD; NATURAL-HISTORY; SEX-DIFFERENCES; ANTIRETROVIRAL THERAPY; SERUM LEVELS; VIRUS LOAD; DRUG-USERS; SEROCONVERSION; INFECTION; DISEASE	Background: It is unclear whether there are differences between men and women with human immunodeficiency virus type 1 (HIV-1) infection in the plasma level of viral RNA (the viral load). In men, the initial viral load after seroconversion predicts the likelihood of progression to the acquired immunodeficiency syndrome (AIDS), but the relation between the two has not been assessed in women. Currently, the guidelines for initiating antiretroviral therapy are applied uniformly to women and men. Methods: From 1988 through 1998, the viral load and the CD4+ lymphocyte count were measured approximately every six months in 156 male and 46 female injection-drug users who were followed prospectively after HIV-1 seroconversion. Results: The median initial viral load was 50,766 copies of HIV-1 RNA per milliliter in the men but only 15,103 copies per milliliter in the women (P<0.001). The median initial CD4+ count did not differ significantly according to sex (659 and 672 cells per cubic millimeter, respectively). HIV-1 infection progressed to AIDS in 29 men and 15 women, and the risk of progression did not differ significantly according to sex. For each increase of 1 log in the viral load (on a base 10 scale), the hazard ratio for progression to AIDS was 1.55 (95 percent confidence interval, 0.97 to 2.47) among the men and 1.43 (95 percent confidence interval, 0.76 to 2.69) among the women. The median initial viral load was 77,822 HIV-1 RNA copies per milliliter in the men in whom AIDS developed and 40,634 copies per milliliter in the men in whom it did not; the corresponding values in the women were 17,149 and 12,043 copies per milliliter. Given the recommendation that treatment should be initiated when the viral load reaches 20,000 copies per milliliter, 74 percent of the men but only 37 percent of the women in our study would have been eligible for therapy at the first visit after seroconversion (P<0.001). Conclusions: Although the initial level of HIV-1 RNA was lower in women than in men, the rates of progression to AIDS were similar. Treatment guidelines that are based on the viral load, rather than the CD4+ lymphocyte count, will lead to differences in eligibility for antiretroviral treatment according to sex. (N Engl J Med 2001;344:720-5.) Copyright (C) 2001 Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; Rutgers State Univ, Dept Stat, Piscataway, NJ USA; NIAID, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; New York Academy of Medicine; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sterling, TR (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 E Monument St,Rm 444, Baltimore, MD 21287 USA.		Quinn, Thomas/A-2494-2010		NIAID NIH HHS [K23 AI01654] Funding Source: Medline; NIDA NIH HHS [R0-1 DA08009, R0-1 DA04334] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, K23AI001654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anastos K, 1999, AIDS, V13, P1717, DOI 10.1097/00002030-199909100-00016; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; ANASTOS K, 2000, 13 INT AIDS C DURB S, P332; [Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P1; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brown AE, 1997, J INFECT DIS, V176, P794, DOI 10.1086/517304; Bush CE, 1996, J CLIN MICROBIOL, V34, P970, DOI 10.1128/JCM.34.4.970-972.1996; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CHAISSON RE, 1995, NEW ENGL J MED, V333, P751, DOI 10.1056/NEJM199509213331202; Craib KJP, 1997, J INFECT DIS, V176, P798, DOI 10.1086/517305; Evans JS, 1997, J INFECT DIS, V175, P795, DOI 10.1086/513973; Farzadegan H, 1996, J ACQ IMMUN DEF SYND, V13, P448, DOI 10.1097/00042560-199612150-00008; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Henry K, 2000, ANN INTERN MED, V132, P306, DOI 10.7326/0003-4819-132-4-200002150-00009; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; Junghans C, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75645-2; JURRIAANS S, 1994, VIROLOGY, V204, P223, DOI 10.1006/viro.1994.1526; Katzenstein DA, 1997, NEW ENGL J MED, V337, P1097; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Lyles CM, 1999, J INFECT DIS, V180, P1018, DOI 10.1086/314980; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MELNICK SL, 1994, JAMA-J AM MED ASSOC, V272, P1915, DOI 10.1001/jama.272.24.1915; MONTANER J, 2000, 13 INT AIDS C DURB S, P45; Moore RD, 1999, LANCET, V353, P463, DOI 10.1016/S0140-6736(98)05379-3; *NIH, 1998, MMWR-MORBID MORTAL W, V47, P1; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406	33	249	256	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					720	725		10.1056/NEJM200103083441003	http://dx.doi.org/10.1056/NEJM200103083441003			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236775				2022-12-01	WOS:000167305300003
J	Tsubono, Y; Nishino, Y; Komatsu, S; Hsieh, C; Kanemura, S; Tsuji, I; Nakatsuka, H; Fukao, A; Satoh, H; Hisamichi, S				Tsubono, Y; Nishino, Y; Komatsu, S; Hsieh, C; Kanemura, S; Tsuji, I; Nakatsuka, H; Fukao, A; Satoh, H; Hisamichi, S			Green tea and the risk of gastric cancer in Japan.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STOMACH-CANCER; CONSUMPTION; SHANGHAI; CARCINOMA; CHINA	Background: Although laboratory experiments and case-control studies have suggested that the consumption of green tea provides protection against gastric cancer, few prospective studies have been performed. Methods: In January 1984, a total of 26,311 residents in three municipalities of Miyagi Prefecture, in northern Japan (11,902 men and 14,409 women 40 years of age or older), completed a self-administered questionnaire that included questions about the frequency of consumption of green tea. During 199,748 person-years of follow-up, through December 1992, we identified 419 cases of gastric cancer (in 296 men and 123 women). We used Cox regression to estimate the relative risk of gastric cancer according to the consumption of green tea. Results: Green-tea consumption was not associated with the risk of gastric cancer. After adjustment for sex, age, presence or absence of a history of peptic ulcer, smoking status, alcohol consumption, other dietary elements, and type of health insurance, the relative risks associated with drinking one or two, three or four, and five or more cups of green tea per day, as compared with less than one cup per day, were 1.1 (95 percent confidence interval, 0.8 to 1.6), 1.0 (95 percent confidence interval, 0.7 to 1.4), and 1.2 (95 percent confidence interval, 0.9 to 1.6), respectively (P for trend = 0.13). The results were similar after the 117 cases of gastric cancer that were diagnosed in the first three years of follow-up had been excluded, with respective relative risks of 1.2 (95 percent confidence interval, 0.8 to 1.8), 1.0 (95 percent confidence interval, 0.7 to 1.5), and 1.4 (95 percent confidence interval, 1.0 to 1.9) (P for trend = 0.07). Conclusions: In a population-based, prospective cohort study in Japan, we found no association between green-tea consumption and the risk of gastric cancer. (N Engl J Med 2001;344:632-6.) Copyright (C) 2001 Massachusetts Medical Society.	Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Environm Hlth Sci, Sendai, Miyagi 9808575, Japan; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Sendai Coll, Fac Phys Educ, Sendai, Miyagi, Japan; Univ Massachusetts, Med Ctr, Ctr Canc, Div Biostat & Epidemiol, Worcester, MA USA; Miyagi Univ, Sch Nursing, Sendai, Miyagi, Japan; Yamagata Univ, Sch Med, Dept Publ Hlth, Yamagata 99023, Japan	Tohoku University; Tohoku University; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester; Miyagi University; Yamagata University	Tsubono, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan.		Kanemura, Seiki/AAS-5390-2021	Kanemura, Seiki/0000-0003-0454-0322				Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; *AM I CANC RES, 1997, WORLD CANC RES FUND, P467; Asaka M, 1997, GASTROENTEROLOGY, V113, pS56, DOI 10.1016/S0016-5085(97)80013-3; EUROGAST, 1993, LANCET, V341, P16681; FORMAN D, 1993, LANCET, V341, P1359; Galanis DJ, 1998, INT J EPIDEMIOL, V27, P173, DOI 10.1093/ije/27.2.173; Goldbohm RA, 1996, J NATL CANCER I, V88, P93, DOI 10.1093/jnci/88.2.93; HORIBA N, 1991, J ENDODONT, V17, P122, DOI 10.1016/S0099-2399(06)81743-7; Inoue M, 1998, CANCER CAUSE CONTROL, V9, P209, DOI 10.1023/A:1008890529261; Ji BT, 1996, CANCER, V77, P2449, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2449::AID-CNCR6>3.0.CO;2-H; KONO S, 1988, JPN J CANCER RES, V79, P1067, DOI 10.1111/j.1349-7006.1988.tb01528.x; LEE HH, 1990, ANTICANCER RES, V10, P875; PISANI P, 1993, INT J CANCER, V55, P891, DOI 10.1002/ijc.2910550604; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; *SAS I, 1996, SAS STAT SOFTWARE CH; TAJIMA K, 1985, JPN J CANCER RES, V76, P705; Takano A, 1997, IARC SCI PUBL, V7, P386; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; Yam TS, 1997, FEMS MICROBIOL LETT, V152, P169, DOI 10.1016/S0378-1097(97)00197-3; Yang CS, 1997, ENVIRON HEALTH PERSP, V105, P971, DOI 10.2307/3433312; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; YU GP, 1995, CANCER CAUSE CONTROL, V6, P532, DOI 10.1007/BF00054162; YU GP, 1991, CANCER CAUSE CONTROL, V2, P169, DOI 10.1007/BF00056210	23	169	176	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					632	636		10.1056/NEJM200103013440903	http://dx.doi.org/10.1056/NEJM200103013440903			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228277				2022-12-01	WOS:000167177100003
J	Broecker, WS				Broecker, WS			Paleoclimate - Was the medieval warm period global?	SCIENCE			English	Editorial Material							ICE-AGE; TEMPERATURES; CIRCULATION; ATLANTIC		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Broecker, WS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	broecker@ldeo.columbia.edu						Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; CLOW G, COMMUNICATION; Greene AM, 1999, GEOPHYS RES LETT, V26, P1909, DOI 10.1029/1999GL900380; Grove J. M., 1988, LITTLE ICE AGE, P1; HOLZHAUSER H, 1997, ESF PROJECT EUROPEAN, V16, P35; Hormes A, 1998, RADIOCARBON, V40, P809; HORMES A, IN PRESS HOLOCENE; HORMES A, 2001, 14C PERSPECTIVE GLAC, P176; Huang SP, 1997, GEOPHYS RES LETT, V24, P1947, DOI 10.1029/97GL01846; Lotter AF, 2000, PALAEOGEOGR PALAEOCL, V159, P349, DOI 10.1016/S0031-0182(00)00093-6; MAISCH M, 1999, GLETSCHER SCHWEIZER, P221; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; PORTER SC, IN PRESS QUAT SCI RE; Rothlisberger F., 1980, GEOGR HELV, V35, P21; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Stine S, 1998, WATER TRANS, V31, P43; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	21	223	240	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1497	1499		10.1126/science.291.5508.1497	http://dx.doi.org/10.1126/science.291.5508.1497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234078				2022-12-01	WOS:000167153400029
J	Vasioukhin, V; Bauer, C; Degenstein, L; Wise, B; Fuchs, E				Vasioukhin, V; Bauer, C; Degenstein, L; Wise, B; Fuchs, E			Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin	CELL			English	Article							CELL-CELL ADHESION; E-CADHERIN; EPIDERMAL-KERATINOCYTES; RAS ACTIVATION; BETA-CATENIN; EXPRESSION; GROWTH; CANCER; KINASE; GENE	When surface epithelium was conditionally targeted for ablation of alpha -catenin, hair follicle development was blocked and epidermal morphogenesis was dramatically affected, with defects in adherens junction formation, intercellular adhesion, and epithelial polarity. Differentiation occurred, but epidermis displayed hyperproliferation, suprabasal mitoses, and multinucleated cells. In vitro, alpha -catenin null keratinocytes were poorly contact inhibited and grew rapidly. These differences were not dependent upon intercellular adhesion and were in marked contrast to keratinocytes conditionally null for another essential intercellular adhesion protein, desmoplakin (DP). KO keratinocytes exhibited sustained activation of the Ras-MAPK cascade due to aberrations in growth factor responses. Thus, remarkably, features of precancerous lesions often attributed to defects in cell cycle regulatory genes can be generated by compromising the function of alpha -catenin.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Fuchs, E (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Fuchs, Elaine/G-1565-2016	Vasioukhin, Valeri/0000-0002-6730-0281	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011921] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR27883] Funding Source: Medline; NIDCR NIH HHS [5P50 DE11921] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Bagutti C, 1998, J PATHOL, V186, P8, DOI 10.1002/(SICI)1096-9896(199809)186:1<8::AID-PATH156>3.0.CO;2-H; Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; FREEDBERG IM, 1999, DERMATOLOGY GEN MED, V2; FREEDBERG IM, 1999, DERMATOLOGY GEN MED, V1; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardy M.H., 1992, TRENDS GENET, V8, P159; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; HIRAI Y, 1989, DEVELOPMENT, V105, P271; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kofron M, 1997, DEVELOPMENT, V124, P1553; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Macpherson I, 1970, Adv Cancer Res, V13, P169, DOI 10.1016/S0065-230X(08)60166-9; MYERS MG, 1994, J BIOL CHEM, V269, P28783; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; SHIOZAKI H, 1994, AM J PATHOL, V144, P667; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Sun TT, 1984, CANCER CELLS, V1, P169; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; von Schlippe M, 2000, J CELL SCI, V113, P425; Wang XJ, 2000, MOL CARCINOGEN, V27, P200, DOI 10.1002/(SICI)1098-2744(200003)27:3<200::AID-MC7>3.3.CO;2-0; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; YONEMURA S, 1995, J CELL SCI, V108, P127; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	48	347	357	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					605	617		10.1016/S0092-8674(01)00246-X	http://dx.doi.org/10.1016/S0092-8674(01)00246-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239416	Bronze			2022-12-01	WOS:000167181500014
J	Mandelboim, O; Lieberman, N; Lev, M; Paul, L; Arnon, TI; Bushkin, Y; Davis, DM; Strominger, JL; Yewdell, JW; Porgador, A				Mandelboim, O; Lieberman, N; Lev, M; Paul, L; Arnon, TI; Bushkin, Y; Davis, DM; Strominger, JL; Yewdell, JW; Porgador, A			Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells	NATURE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-SUPERFAMILY; MOLECULAR-CLONING; RECEPTOR; CYTOTOXICITY; ANTIGEN; MEMBER; ACID	Natural killer (NK) cells destroy virus-infected and tumour cells, apparently without the need for previous antigen stimulation(1). In part, target cells are recognized by their diminished expression of major histocompatibility complex (MHC) class I molecules, which normally interact with inhibitory receptors on the NK cell surface(2-8). NK cells also express triggering receptors that are specific for non-MHC ligands; but the nature of the ligands recognized on target cells is undefined(9-14). NKp46 is thought to be the main activating receptor for human NK cells(9,15). Here we show that a soluble NKp46-immunoglobulin fusion protein binds to both the haemagglutinin of influenza virus and the haemagglutinin-neuraminidase of parainfluenza virus. In a substantial subset of NK cells, recognition by NKp46 is required to lyse cells expressing the corresponding viral glycoproteins. The binding requires the sialylation of NKp46 oligosaccharides, which is consistent with the known sialic binding capacity of the viral glycoproteins. These findings indicate how NKp46-expressing NK cells may recognize target cells infected by influenza or parainfluenza without the decreased expression of target-cell MHC class I protein.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Ctr Canc Res, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; Publ Hlth Res Inst City New York Inc, Lab Mol Immunol, New York, NY 10016 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Imperial College London; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Porgador, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	angel@bgumail.bgu.ac.il	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Porgador, Angel/0000-0003-1540-4449; Arnon, Tal/0000-0003-4629-5820; Mandelboim, Ofer/0000-0002-9354-1855; Davis, Daniel/0000-0002-9182-291X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000653, Z01AI000653] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALSHEIKHLY A, 1983, SCAND J IMMUNOL, V17, P129, DOI 10.1111/j.1365-3083.1983.tb00775.x; ALSHEIKHLY AR, 1985, SCAND J IMMUNOL, V22, P529, DOI 10.1111/j.1365-3083.1985.tb01912.x; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; BRAND CM, 1972, NATURE-NEW BIOL, V238, P145, DOI 10.1038/newbio238145a0; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; DANDREA A, 1995, J IMMUNOL, V155, P2306; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; DELAU WBM, 1993, J IMMUNOL, V150, P4911; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MAISNER A, 1995, VIROLOGY, V210, P479, DOI 10.1006/viro.1995.1365; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; PETERHANS E, 1983, VIROLOGY, V128, P366, DOI 10.1016/0042-6822(83)90263-5; PINOLA M, 1994, J IMMUNOL, V152, P3586; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; YEWDELL J, 1982, J IMMUNOL, V128, P2670; YEWDELL JW, 1983, J VIROL, V48, P239, DOI 10.1128/JVI.48.1.239-248.1983	29	717	758	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1055	1060		10.1038/35059110	http://dx.doi.org/10.1038/35059110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234016				2022-12-01	WOS:000167148800049
J	Claverie, JM				Claverie, JM			Gene number - What if there are only 30,000 human genes?	SCIENCE			English	Article							DNA-SEQUENCE; GENOME SEQUENCE		Struct Genet Informat Lab, CNRS AVENTIS, UMR 1889, F-13402 Marseille, France	Sanofi-Aventis; Sanofi France	Claverie, JM (corresponding author), Struct Genet Informat Lab, CNRS AVENTIS, UMR 1889, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	Jean-Michel.Claverie@igs.cnrs-mrs.fr	Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AUDIC S, 2000, WORKSH M PLANCK I MO; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Brenner S, 2000, SCIENCE, V287, P2173, DOI 10.1126/science.287.5461.2173; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Huang LL, 1999, CRIT REV EUKAR GENE, V9, P175, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.20; Liang F, 2000, NAT GENET, V26, P501; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11	20	208	220	5	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1255	1257		10.1126/science.1058969	http://dx.doi.org/10.1126/science.1058969			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233450				2022-12-01	WOS:000166993400029
J	Bentley, DR; Deloukas, P; Dunham, A; French, L; Gregory, SG; Humphray, SJ; Mungall, AJ; Ross, MT; Carter, NP; Dunham, I; Scott, CE; Ashcroft, KJ; Atkinson, AL; Aubin, K; Beare, DM; Bethel, G; Brady, N; Brook, JC; Burford, DC; Burrill, WD; Burrows, C; Butler, AP; Carder, C; Catanese, JJ; Clee, CM; Clegg, SM; Cobley, V; Coffey, AJ; Cole, CG; Collins, JE; Conquer, JS; Cooper, RA; Culley, KM; Dawson, E; Dearden, FL; Durbin, RM; de Jong, PJ; Dhami, PD; Earthrowl, ME; Edwards, CA; Evans, RS; Gillson, CJ; Ghori, J; Green, L; Gwilliam, R; Halls, KS; Hammond, S; Harper, GL; Heathcott, RW; Holden, JL; Holloway, E; Hopkins, BL; Howard, PJ; Howell, GR; Huckle, EJ; Hughes, J; Hunt, PJ; Hunt, SE; Izmajlowicz, M; Jones, CA; Joseph, SS; Laird, G; Langford, CF; Lehvaslaiho, MH; Leversha, MA; McCann, OT; McDonald, LM; McDowall, J; Maslen, GL; Mistry, D; Moschonas, NK; Neocleous, V; Pearson, DM; Phillips, KJ; Porter, KM; Prathalingam, SR; Ramsey, YH; Ranby, SA; Rice, CM; Rogers, J; Rogers, LJ; Sarafidou, T; Scott, DJ; Sharp, GJ; Shaw-Smith, CJ; Smink, LJ; Soderlund, C; Sotheran, EC; Steingruber, HE; Sulston, JE; Taylor, A; Taylor, RG; Thorpe, AA; Tinsley, E; Warry, GL; Whittaker, A; Whittaker, P; Williams, SH; Wilmer, TE; Wooster, R; Wright, CL				Bentley, DR; Deloukas, P; Dunham, A; French, L; Gregory, SG; Humphray, SJ; Mungall, AJ; Ross, MT; Carter, NP; Dunham, I; Scott, CE; Ashcroft, KJ; Atkinson, AL; Aubin, K; Beare, DM; Bethel, G; Brady, N; Brook, JC; Burford, DC; Burrill, WD; Burrows, C; Butler, AP; Carder, C; Catanese, JJ; Clee, CM; Clegg, SM; Cobley, V; Coffey, AJ; Cole, CG; Collins, JE; Conquer, JS; Cooper, RA; Culley, KM; Dawson, E; Dearden, FL; Durbin, RM; de Jong, PJ; Dhami, PD; Earthrowl, ME; Edwards, CA; Evans, RS; Gillson, CJ; Ghori, J; Green, L; Gwilliam, R; Halls, KS; Hammond, S; Harper, GL; Heathcott, RW; Holden, JL; Holloway, E; Hopkins, BL; Howard, PJ; Howell, GR; Huckle, EJ; Hughes, J; Hunt, PJ; Hunt, SE; Izmajlowicz, M; Jones, CA; Joseph, SS; Laird, G; Langford, CF; Lehvaslaiho, MH; Leversha, MA; McCann, OT; McDonald, LM; McDowall, J; Maslen, GL; Mistry, D; Moschonas, NK; Neocleous, V; Pearson, DM; Phillips, KJ; Porter, KM; Prathalingam, SR; Ramsey, YH; Ranby, SA; Rice, CM; Rogers, J; Rogers, LJ; Sarafidou, T; Scott, DJ; Sharp, GJ; Shaw-Smith, CJ; Smink, LJ; Soderlund, C; Sotheran, EC; Steingruber, HE; Sulston, JE; Taylor, A; Taylor, RG; Thorpe, AA; Tinsley, E; Warry, GL; Whittaker, A; Whittaker, P; Williams, SH; Wilmer, TE; Wooster, R; Wright, CL			The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X	NATURE			English	Article							HUMAN GENOME	We constructed maps for eight chromosomes (1, 6, 9, 10, 13, 20, X and (previously) 22), representing one-third of the genome, by building landmark maps, isolating bacterial clones and assembling contigs. By this approach, we could establish the long-range organization of the maps early in the project, and all contig extension, gap closure and problem-solving was simplified by containment within local regions. The maps currently represent more than 94% of the euchromatic (gene-containing) regions of these chromosomes in 176 contigs, and contain 96% of the chromosome-specific markers in the human gene map. By measuring the remaining gaps, we can assess chromosome length and coverage in sequenced clones.	Sanger Ctr, Cambridge CB10 1SA, England; Univ Crete, Dept Biol, CY-71409 Iraklion, Crete, Greece; Inst Mol Biol & Biotechnol, CY-71409 Iraklion, Crete, Greece; Cyprus Inst Neurol & Genet, Neurogenet Lab, CY-1683 Nicosia, Cyprus; Childrens Hosp, BACPAC Resources, Oakland, CA 94609 USA	Wellcome Trust Sanger Institute; University of Crete; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Bentley, DR (corresponding author), Sanger Ctr, Wellcome Trust Campus, Cambridge CB10 1SA, England.	drb@sanger.ac.uk	Durbin, Richard/AAE-7178-2019; Mungall, Andrew J./U-7067-2018; Deloukas, Panos/B-2922-2013	Durbin, Richard/0000-0002-9130-1006; Mungall, Andrew J./0000-0002-0905-2742; Deloukas, Panos/0000-0001-9251-070X; Maslen, Gareth/0000-0001-7318-3678; Moschonas, Nicholas/0000-0002-2556-537X; Taylor, Amy/0000-0001-9811-330X; Carter, Emma/0000-0002-0825-2793; Dunham, Ian/0000-0003-2525-5598; Gregory, Simon/0000-0002-7805-1743; Hughes, Jaime/0000-0001-6045-4053; Edwards, Carol/0000-0002-1887-1280; Hunt, Sarah/0000-0002-8350-1235				Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Jackson MS, 1996, GENOMICS, V33, P258, DOI 10.1006/geno.1996.0190; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; 2000, NTURE, V405, P311	11	47	50	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					942	943		10.1038/35057165	http://dx.doi.org/10.1038/35057165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237015	Bronze			2022-12-01	WOS:000166938800062
J	Toh, KL; Jones, CR; He, Y; Eide, EJ; Hinz, WA; Virshup, DM; Ptacek, LJ; Fu, YH				Toh, KL; Jones, CR; He, Y; Eide, EJ; Hinz, WA; Virshup, DM; Ptacek, LJ; Fu, YH			An hPer2 phosphorylation site mutation in familiar advanced sleep phase syndrome	SCIENCE			English	Article							DROSOPHILA CLOCK GENE; CIRCADIAN CLOCK; DOUBLE-TIME; LIGHT; MUTANTS; ENCODES; MPER2	Familiar advanced sleep phase syndrome (FASPS) is an autosomal dominant circadian rhythm variant; affected individuals are "morning Larks" with a 4-hour advance of the sleep, temperature, and melatonin rhythms. Here we report Localization of the FASPS gene near the telomere of chromosome 2q. A strong candidate gene (hPer2), a human homolog of the period gene in Drosophila, maps to the same Locus. Affected individuals have a serine to glycine mutation within the casein kinase I epsilon (CKI epsilon) binding region of hPER2, which causes hypophosphorylation by CKI epsilon in vitro. Thus, a variant in human sleep behavior can be attributed to a missense mutation in a clock component, hPER2, which alters the circadian period.	Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Univ Hosp Sleep Disorders Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Toh, KL (corresponding author), Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA.		Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHLBI NIH HHS [HL/HD 59596] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Duffy J. F, 1999, SLEEP, V22, pS92; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PTACEK LJ, 1994, CELL, V77, P863; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	25	1003	1041	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1040	1043		10.1126/science.1057499	http://dx.doi.org/10.1126/science.1057499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232563				2022-12-01	WOS:000166860100044
J	Crawley, MJ; Brown, SL; Hails, RS; Kohn, DD; Rees, M				Crawley, MJ; Brown, SL; Hails, RS; Kohn, DD; Rees, M			Biotechnology - Transgenic crops in natural habitats	NATURE			English	Article									Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Crawley, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.		Hails, Rosemary S/E-9478-2010	Hails, Rosemary S/0000-0002-6975-1318				BROWN SL, 1999, ENV IMPACT GENETICAL, P132; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; HAILS RS, 1997, P ROY SOC LOND B BIO, V265, P1	3	131	172	5	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					682	683		10.1038/35055621	http://dx.doi.org/10.1038/35055621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217848				2022-12-01	WOS:000166816400031
J	Nishida, H; Sawada, K				Nishida, H; Sawada, K			macho-1 encodes a localized mRNA in ascidian eggs that specifies muscle fate during embryogenesis	NATURE			English	Article							CELL LINEAGE ANALYSIS; INTRACELLULAR INJECTION; GENE-EXPRESSION; TRACER ENZYME; EMBRYOS; DIFFERENTIATION; INFORMATION; CYTOPLASM; MESODERM	Maternal information stored in particular regions of the egg cytoplasm has an important function in the determination of developmental fate during early animal development(1,2). Ascidians show mosaic development(3,4); such autonomous development has been taken as evidence that prelocalized ooplasmic factors specify tissue precursor cells during embryogenesis. Interest has been concentrated on the mechanisms underlying the formation of muscle cells in the tail, as yellow-coloured myoplasm in eggs is preferentially segregated into muscle-lineage blastomeres(5). Here we show that maternal messenger RNA of the macho-1 gene is a determinant of muscle fate in the ascidian Halocynthia roretzi. The macho-1 mRNA encodes a zinc-finger protein, and the mRNA is localized to the myoplasm of eggs. Depletion of the mRNA specifically resulted in the loss of primary muscle cells in the tail, as shown by the expression of muscle-specific molecular markers. The myoplasm of macho-1-deficient eggs lost its ability to promote muscle formation. Injection of synthesized macho-1 mRNA caused ectopic muscle formation in non-muscle-lineage cells. Our results indicate that macho-1 may be both required and sufficient for specification of muscle fate, and that the mRNA is a genuine, localized muscle determinant.	Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Nishida, H (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan.	hnishida@bio.titech.ac.jp	Nishida, Hiroki/B-1851-2008	Nishida, Hiroki/0000-0002-7249-1668				Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Davidson E. H., 1986, GENE ACTIVITY EARLY; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; HOSHI M, 1981, DEV BIOL, V86, P117, DOI 10.1016/0012-1606(81)90322-5; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kawashima T, 2000, NUCLEIC ACIDS RES, V28, P133, DOI 10.1093/nar/28.1.133; Marikawa Y, 1999, MECH DEVELOP, V89, P93, DOI 10.1016/S0925-4773(99)00210-5; MITAMIYAZAWA I, 1985, J EMBRYOL EXP MORPH, V87, P1; Mitani Y, 1999, DEV DYNAM, V215, P62, DOI 10.1002/(SICI)1097-0177(199905)215:1<62::AID-DVDY7>3.0.CO;2-X; NISHIDA H, 1985, DEV BIOL, V110, P440, DOI 10.1016/0012-1606(85)90102-2; NISHIDA H, 1992, ROUX ARCH DEV BIOL, V201, P81, DOI 10.1007/BF00420418; NISHIDA H, 1992, DEVELOPMENT, V116, P521; Nishida H, 1999, INVERTEBR REPROD DEV, V36, P41, DOI 10.1080/07924259.1999.9652676; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1990, DEVELOPMENT, V108, P559; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; NISHIKATA T, 1987, DEVELOPMENT, V99, P163; Reverberi G., 1946, Pubblicazioni della Stazione Zoologica di Napoli, V20, P199; Sasakura Y, 2000, DEV BIOL, V220, P365, DOI 10.1006/dbio.2000.9626; Satoh N, 1996, P NATL ACAD SCI USA, V93, P9315, DOI 10.1073/pnas.93.18.9315; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 1997, DEV BIOL, V192, P467, DOI 10.1006/dbio.1997.8730; SATOU Y, 1995, DEV GROWTH DIFFER, V37, P319; Wada S, 1999, DEV GROWTH DIFFER, V41, P9; WHITTAKER JR, 1990, BIOL BULL-US, V178, P222, DOI 10.2307/1541823; WHITTAKER JR, 1973, P NATL ACAD SCI USA, V70, P2096, DOI 10.1073/pnas.70.7.2096; Wilson E. B., 1925, CELL DEV HEREDITY; Yoshida S, 1996, DEVELOPMENT, V122, P2005	30	213	215	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					724	729		10.1038/35055568	http://dx.doi.org/10.1038/35055568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217862				2022-12-01	WOS:000166816400045
J	Oliveira, RF; Lopes, M; Carneiro, LA; Canario, AVM				Oliveira, RF; Lopes, M; Carneiro, LA; Canario, AVM			Watching fights raises fish hormone levels - Cichlid fish wrestling for dominance induce an androgen surge in male spectators.	NATURE			English	Article							TESTOSTERONE		Inst Super Psicol Aplicada, Unidade Invest Ecoetol, P-1100 Lisbon, Portugal; Univ Algarve, Ctr Ciencias Mar, P-8000 Faro, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade do Algarve	Oliveira, RF (corresponding author), Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Rua Jardim Tabaco 44, P-1100 Lisbon, Portugal.		Oliveira, Rui/A-3581-2013; Canario, Adelino/C-7942-2009	Oliveira, Rui/0000-0003-1528-618X; Canario, Adelino/0000-0002-6244-6468				ANDREW RJ, 1972, NATURE, V237, P343, DOI 10.1038/237343a0; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1376, DOI 10.1073/pnas.89.4.1376; GYGER M, 1986, ANIM BEHAV, V34, P1570, DOI 10.1016/S0003-3472(86)80229-9; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Pusey Anne E., 1997, P254; SCOTT AP, 1989, GEN COMP ENDOCR, V73, P46, DOI 10.1016/0016-6480(89)90054-3; SCOTT AP, 1984, GEN COMP ENDOCR, V56, P349, DOI 10.1016/0016-6480(84)90077-7; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	11	139	144	0	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					475	475		10.1038/35054128	http://dx.doi.org/10.1038/35054128			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206533				2022-12-01	WOS:000166570500034
J	Raymond, PA; Bauer, JE				Raymond, PA; Bauer, JE			Riverine export of aged terrestrial organic matter to the North Atlantic Ocean	NATURE			English	Article							AMAZON RIVER; SOIL CARBON; C-14; FRACTIONS; SEDIMENT; PACIFIC; FLUXES; AMS	Global riverine discharge of organic matter represents a substantial source of terrestrial dissolved and particulate organic carbon to the oceans(1,2). This input from rivers is, by itself, more than large enough to account for the apparent steady-state replacement times of 4,00-6,000 yr for oceanic dissolved organic carbon(3-5). But paradoxically, terrestrial organic matter, derived from land plants, is not detected in seawater and sediments in quantities that correspond to its inputs(6-8). Here we present natural C-14 and C-13 data from four rivers that discharge to the western North Atlantic Ocean and rnd that these rivers are sources of old (C-14-depleted) and young (C-14-enriched) terrestrial dissolved organic carbon, and of predominantly old terrestrial particulate organic carbon. These findings contrast with limited earlier data(9) that suggested terrestrial organic matter transported by rivers might be generally enriched in C-14 from nuclear testing, and hence newly produced. We also rnd that much of the young dissolved organic carbon can be selectively degraded over the residence times of river and coastal waters, leaving an even older and more refractory component for oceanic export. Thus, pre-ageing and degradation may alter significantly the structure, distributions and quantities of terrestrial organic matter before its delivery to the oceans.	Coll William & Mary, Sch Marine Sci, Gloucester Point, VA 23062 USA	William & Mary	Raymond, PA (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.		Raymond, Peter A/C-4087-2009	Raymond, Peter A/0000-0002-8564-7860				ARAVENA R, 1992, RADIOCARBON, V34, P636, DOI 10.1017/S003382220006392X; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; COCH NK, 1986, NE GEOL, V8, P96; DEGENS ET, 1989, PERSPECTIVES BIOGEOC, P303; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; HEDGES JI, 1986, SCIENCE, V231, P1129, DOI 10.1126/science.231.4742.1129; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HEDGES JI, 1992, GEOCHIM COSMOCHIM AC, V56, P1753, DOI 10.1016/0016-7037(92)90241-A; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; HOWARTH RW, 1991, ECOL APPL, V1, P27, DOI 10.2307/1941845; Kao SJ, 1996, LIMNOL OCEANOGR, V41, P1749, DOI 10.4319/lo.1996.41.8.1749; Keil RG, 1997, GEOCHIM COSMOCHIM AC, V61, P1507, DOI 10.1016/S0016-7037(97)00044-6; Levin I, 1997, RADIOCARBON, V39, P205, DOI 10.1017/S0033822200052012; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; MEADE RH, 1985, SCIENCE, V228, P488, DOI 10.1126/science.228.4698.488; MEYBECK M, 1993, WATER AIR SOIL POLL, V70, P443, DOI 10.1007/BF01105015; MEYERSSCHULTE KJ, 1986, NATURE, V321, P61, DOI 10.1038/321061a0; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; NEWBOLD JD, 1982, OIKOS, V38, P266, DOI 10.2307/3544663; OBRIEN BJ, 1981, FLUX ORGANIC CARBON, P46; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Raymond PA, 2000, AQUAT MICROB ECOL, V22, P1, DOI 10.3354/ame022001; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; SPIKER E, 1981, FLUX ORGANIC CARBON, P79; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TRUMBORE SE, 1989, RADIOCARBON, V31, P644; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	32	431	470	10	187	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					497	500		10.1038/35054034	http://dx.doi.org/10.1038/35054034			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206542				2022-12-01	WOS:000166570500043
J	Brooks, R				Brooks, R			The relationship between matter and life	NATURE			English	Article								The disciplines of artificial intelligence and artificial life build computational systems inspired by various aspects of life. Despite the fact that living systems are composed only of non-living atoms there seems to be limits in the current levels of understanding within these disciplines in what is necessary to bridge the gap between non-living and living matter.	MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Brooks, R (corresponding author), MIT, Artificial Intelligence Lab, 545 Technol Sq, Cambridge, MA 02139 USA.							Adams B, 2000, IEEE INTELL SYST APP, V15, P25, DOI 10.1109/5254.867909; BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Chalmers D., 1995, J CONSCIOUSNESS STUD, V2, P200, DOI DOI 10.1093/ACPR0F:0S0/9780195311105.003.0001; GREENBLATT R, 1967, P FALL JOINT COMP C, P801; Kitano H, 2000, NEW GENERAT COMPUT, V18, P199, DOI 10.1007/BF03037529; Langton Christopher G., 1989, ARTIFICIAL LIFE; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Matijevic J, 1998, SCIENCE, V280, P454, DOI 10.1126/science.280.5362.454; MCCORDUCK PA, 1979, MACHINES THINK; Penrose R., 1994, SHADOWS MIND; POMERLEAU D, 1996, PHOTONICS SPECTR APR, P80; Ray TS., 1991, ARTIF LIFE, P371	13	85	88	2	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					409	411		10.1038/35053196	http://dx.doi.org/10.1038/35053196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201756	Bronze			2022-12-01	WOS:000166434300064
J	Ewan, PW; Clark, AT				Ewan, PW; Clark, AT			Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan	LANCET			English	Article							ANAPHYLACTIC REACTIONS; FOOD; CHILDREN	Background Peanut and nut allergy is common and the most frequent cause of severe or fatal reactions to foods. Current advice is poor-doctors give an epinephrine injector to patients, without training or advice on nut avoidance-so that further reactions are common and deaths occur. We devised and assessed a management programme providing advice on nut avoidance and emergency medication. Methods Unselected referrals with confirmed peanut or tree-nut allergy were recruited. Severity of nut allergy was graded 1-5 and emergency medication allocated accordingly: oral antihistamine with or without inhaled or injected epinephrine. Patients, parents, and school staff received verbal and written advice on nut avoidance as well as training in recognition and self-treatment of reactions, with a written treatment plan. At follow-up (more than 13 610 patient months) retraining was given and details of further reactions obtained. Findings 88 (15%) of 567 patients had a follow-up reaction of reduced severity. 62 of 88 were mild (grades 1-3, mainly cutaneous) and 49 patients used oral antihistamine, six inhaled adrenaline, and ten took no treatment. 12 of 12 patients with a moderate follow-up reaction improved after inhaled epinephrine. Only three (0.5%) of 567 patients, aged 27-40 years, had a severe follow-up reaction (involving dyspnoea) compared with 12% initially. Only one of 567 changed from a mild index reaction to a severe follow-up reaction. Patients with a moderate/severe (grade 4-5) reaction were older (median 18 years vs 9 years; p=0.03) and nine of 26 received injected epinephrine which was always effective. 85% of patients had no further reactions. Severity was related to the amount of nut eaten. Interpretation Self-treatment was effective (inhaled epinephrine for early laryngeal oedema and an epinephrine injector for severe reactions) but provision of this treatment, including who should carry epinephrine, required assessment of allergy severity. Our management plan was effective, and our results indicate that patients should be referred to specialist allergy centres for advice on nut avoidance.	Addenbrookes Hosp, Dept Allergy & Clin Immunol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ewan, PW (corresponding author), Addenbrookes Hosp, Dept Allergy & Clin Immunol, Hills Rd, Cambridge CB2 2QQ, England.	pamela.ewan@msexc.addenbrookes.anglox.nhs.uk						Eigenmann PA, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e8; Ewan PW, 1996, BRIT MED J, V312, P1074; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P634, DOI [10.1111/j.1365-2222.1997.tb01190.x, 10.1046/j.1365-2222.1997.d01-559.x]; Hourihane JO, 1998, BRIT MED J, V316, P1271, DOI 10.1136/bmj.316.7140.1271; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sicherer SH, 2000, PEDIATRICS, V105, P359, DOI 10.1542/peds.105.2.359; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; Vickers DW, 1997, CLIN EXP ALLERGY, V27, P898; WARREN JB, 1986, CLIN PHARMACOL THER, V40, P673, DOI 10.1038/clpt.1986.243; YUNGINGER JW, 1988, JAMA-J AM MED ASSOC, V260, P1450, DOI 10.1001/jama.260.10.1450	12	143	144	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2001	357	9250					111	115		10.1016/S0140-6736(00)03543-1	http://dx.doi.org/10.1016/S0140-6736(00)03543-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393NH	11197398				2022-12-01	WOS:000166476200013
J	Kasumov, AY; Kociak, M; Gueron, S; Reulet, B; Volkov, VT; Klinov, DV; Bouchiat, H				Kasumov, AY; Kociak, M; Gueron, S; Reulet, B; Volkov, VT; Klinov, DV; Bouchiat, H			Proximity-induced superconductivity in DNA	SCIENCE			English	Article							TRANSPORT	Conductivity measurements on double-stranded DNA molecules deposited by a combing process across a submicron slit between rhenium/carbon metallic contacts reveal conduction to be ohmic between room temperature and 1 kelvin. The resistance per molecule is Less than 100 kilohm and varies weakly with temperature. Below the superconducting transition temperature (1 kelvin) of the contacts, proximity-induced superconductivity is observed. These results imply that DNA molecules can be conducting down to millikelvin temperature and that phase coherence is maintained over several hundred nanometers.	Univ Paris Sud, Phys Solides Lab, CNRS, F-91405 Orsay, France; Russian Acad Sci, Inst Microelect Technol & High Pur Mat, Chernogolovka 142432, Moscow Region, Russia; Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117871, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences; Institute of Microelectronics Technology & High-Purity Materials, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Kasumov, AY (corresponding author), Starlab, La Tour Freins,555 Rue Engeland, B-1180 Brussels, Belgium.		Klinov, Dmitry/ABF-3830-2020; kociak, mathieu/T-3110-2018	Klinov, Dmitry/0000-0001-8288-2198; kociak, mathieu/0000-0001-8858-0449; Volkov, Vladimir/0000-0002-6005-9536; Bouchiat, Helene/0000-0003-3178-885X				ALBERTS B, 1994, BIOL CELL; Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; COURTOIS H, 1995, PHYS REV B, V52, P1162, DOI 10.1103/PhysRevB.52.1162; Deutscher G., 1969, Superconductivity, vol.2, P1005; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; GRUNER G, 2000, IN PRESS P KIRCHB C; JEROME D, 1982, ADV PHYS, V31, P299, DOI 10.1080/00018738200101398; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Kasumov AY, 1999, SCIENCE, V284, P1508, DOI 10.1126/science.284.5419.1508; KASUMOV AY, 2000, IN PRESS P KIRCHB C; Klinov DV, 1998, NUCLEIC ACIDS RES, V26, P4603, DOI 10.1093/nar/26.20.4603; LUTTINGER JM, 1963, J MATH PHYS, V4, P1154, DOI 10.1063/1.1704046; ODINSTOV AA, IN PRESS PHYSICA B; Okahata Y, 1998, SUPRAMOL SCI, V5, P317, DOI 10.1016/S0968-5677(98)00025-X; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; PROKHOROV VV, 1999, RUSS J BIOORG CHEM+, V25, P211; Ratner M, 1999, NATURE, V397, P480, DOI 10.1038/17232; Safi I, 1995, PHYS REV B, V52, P17040, DOI 10.1103/PhysRevB.52.R17040; THOULESS DJ, 1977, PHYS REV LETT, V39, P1167, DOI 10.1103/PhysRevLett.39.1167; Wan CZ, 1999, P NATL ACAD SCI USA, V96, P6014, DOI 10.1073/pnas.96.11.6014	24	605	634	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					280	282		10.1126/science.291.5502.280	http://dx.doi.org/10.1126/science.291.5502.280			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209072				2022-12-01	WOS:000166352900037
J	Kristiansen, M; Graversen, JH; Jacobsen, C; Sonne, O; Hoffman, HJ; Law, SKA; Moestrup, SK				Kristiansen, M; Graversen, JH; Jacobsen, C; Sonne, O; Hoffman, HJ; Law, SKA; Moestrup, SK			Identification of the haemoglobin scavenger receptor	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; HIGH-AFFINITY; LIGAND RECOGNITION; PROTEIN; BINDING; CELLS; ENDOCYTOSIS; COMPLEX; PHAGOCYTOSIS; SUPERFAMILY	Intravascular haemolysis is a physiological phenomenon as well as a severe pathological complication when accelerated in various autoimmune, infectious (such as malaria) and inherited (such as sickle cell disease) disorders(1). Haemoglobin released into plasma is captured by the acute phase protein haptoglobin, which is depleted from plasma during elevated haemolysis(1). Here we report the identification of the acute phase-regulated and signal-inducing macrophage protein, CD163, as a receptor that scavenges haemoglobin by mediating endocytosis of haptoglobin-haemoglobin complexes. CD163 binds only haptoglobin and haemoglobin in complex, which indicates the exposure of a receptor-binding neoepitope. The receptor-ligand interaction is Ca2+-dependent and of high affinity. Complexes of haemoglobin and multimeric haptoglobin (the 2-2 phenotype) exhibit higher functional affinity for CD163 than do complexes of haemoglobin and dimeric haptoglobin (the 1-1 phenotype). Specific CD163-mediated endocytosis of haptoglobin-haemoglobin complexes is measurable in cells transfected with CD163 complementary DNA and in CD163-expressing myelo-monocytic lymphoma cells.	Univ Aarhus, Dept Med Biochem, DK-8000 Aarhus C, Denmark; Univ Aarhus, Dept Physiol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Dept Resp Dis, DK-8000 Aarhus C, Denmark; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	Aarhus University; Aarhus University; Aarhus University; University of Oxford	Moestrup, SK (corresponding author), Univ Aarhus, Dept Med Biochem, Ole Worms Alle, DK-8000 Aarhus C, Denmark.		Hoffman, Hans Jurgen/I-6969-2018; Moestrup, Søren Kragh/A-1403-2014; Law, Alex/A-2212-2011; Moestrup, Søren Kragh/AAD-1735-2019	Hoffman, Hans Jurgen/0000-0002-6743-7931; Moestrup, Søren Kragh/0000-0003-3862-2107; Graversen, Jonas Heilskov/0000-0001-7119-2108; Madsen, Mette/0000-0001-7241-6505; Graversen, Jonas Heilskov/0000-0002-2411-9933				Andrews NC, 1998, BLOOD, V92, P1845, DOI 10.1182/blood.V92.6.1845.418k35_1845_1851; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Deiss A, 1999, WINTROBES CLIN HEMAT, P267; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Hogger P, 1998, J IMMUNOL, V161, P1883; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; MITANI K, 1992, BLOOD, V79, P1255; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Moestrup SK, 1998, J CLIN INVEST, V102, P902, DOI 10.1172/JCI3772; MOESTRUP SK, 1987, BIOCHIM BIOPHYS ACTA, V930, P297, DOI 10.1016/0167-4889(87)90002-4; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; PULFORD K, 1992, IMMUNOLOGY, V75, P588; PULFORD K, 1997, LEUKOCYTE TYPING, V6, P1089; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; WEJMAN JC, 1984, J MOL BIOL, V174, P343, DOI 10.1016/0022-2836(84)90342-5; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	29	1246	1289	1	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					198	201		10.1038/35051594	http://dx.doi.org/10.1038/35051594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196644				2022-12-01	WOS:000166316200046
J	ter Meulen, J				ter Meulen, J			Response to haemorrhagic fevers in Europe	LANCET			English	Article									Univ Marburg, Inst Virol, D-35037 Marburg, Germany; Hop Donka, Conakry, Guinea	Philipps University Marburg	ter Meulen, J (corresponding author), Hop Donka, Conakry, Guinea.								0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S64	S64		10.1016/S0140-6736(00)92050-6	http://dx.doi.org/10.1016/S0140-6736(00)92050-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191524				2022-12-01	WOS:000166074900066
J	Wilson, RI; Nicoll, RA				Wilson, RI; Nicoll, RA			Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses	NATURE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; LONG-TERM POTENTIATION; SYNAPTIC TRANSMISSION; CALCIUM CHANNELS; MEMBRANE-FUSION; PYRAMIDAL CELLS; CA1 CELLS; N-TYPE; INHIBITION; RECEPTOR	Marijuana affects brain function primarily by activating the G-protein-coupled cannabinoid receptor-1 (CB1)(1-3), which is expressed throughout the brain at high levels(4). Two endogenous lipids, anandamide and 2-arachidonylglycerol (2-AG), have been identified as CB1 ligands(5,6). Depolarized hippocampal neurons rapidly release both anandamide and 2-AG in a Ca2+-dependent manner(6-8). In the hippocampus, CB1 is expressed mainly by GABA (gamma -aminobutyric acid)-mediated inhibitory interneurons, where CB1 clusters on the axon terminal(9-11). A synthetic CB1 agonist depresses GABA release from hippocampal slices(10,12) These findings indicate that the function of endogenous cannabinoids released by depolarized hippocampal neurons might be to downregulate GABA release. Here we show that the transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons(13) is mediated by retrograde signalling through release of endogenous cannabinoids. Signalling by the endocannabinoid system thus represents a mechanism by which neurons fan communicate backwards across synapses to modulate their inputs.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266				Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; BINZ T, 1994, J BIOL CHEM, V269, P1617; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998; CAULFIELD MP, 1992, BRIT J PHARMACOL, V106, P231, DOI 10.1111/j.1476-5381.1992.tb14321.x; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Katona I, 1999, J NEUROSCI, V19, P4544; Lenz RA, 1998, J PHYSIOL-LONDON, V512, P61, DOI 10.1111/j.1469-7793.1998.061bf.x; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Morishita W, 2000, HIPPOCAMPUS, V10, P261, DOI 10.1002/1098-1063(2000)10:3<261::AID-HIPO6>3.3.CO;2-T; Morishita W, 1998, J NEUROSCI, V18, P4870; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1992, J NEUROSCI, V12, P4122; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x	30	1164	1190	3	89	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					588	592		10.1038/35069076	http://dx.doi.org/10.1038/35069076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279497				2022-12-01	WOS:000167859300049
J	Chang, CB; Holtzman, DA; Chau, S; Chickering, T; Woolf, EA; Holmgren, LM; Bodorova, J; Gearing, DP; Holmes, WE; Brivanlou, AH				Chang, CB; Holtzman, DA; Chau, S; Chickering, T; Woolf, EA; Holmgren, LM; Bodorova, J; Gearing, DP; Holmes, WE; Brivanlou, AH			Twisted gastrulation can function as a BMP antagonist	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-4; DORSAL-VENTRAL PATTERN; DROSOPHILA EMBRYO; PRECHORDAL MESODERM; NEURAL INDUCTION; XENOPUS EMBRYOS; GROWTH-FACTOR; GENE; SIGNALS; SPECIFICATION	Bone morphogenetic proteins (BMPs), including the fly homologue Decapentaplegic (DPP), are important regulators of early vertebrate and invertebrate dorsal-ventral development(1-6). An evolutionarily conserved BMP regulatory mechanism operates from fly to fish, frog and mouse to control the dorsal-ventral axis determination. Several secreted factors, including the BMP antagonist chordin/Short gastrulation (SOG)(7-12), modulate the activity of BMPs. In Drosophila, Twisted gastrulation (TSG) is also involved in dorsal-ventral patterning(13-15), yet the mechanism of its function is unclear. Here we report the characterization of the vertebrate Tsg homologues. We show that Tsg can block BMP function in Xenopus embryonic explants and inhibits several ventral markers in whole-frog embryos. Tsg binds directly to BMPs and forms a ternary complex with chordin and BMPs. Coexpression of Tsg with chordin leads to a more efficient inhibition of the BMP activity in ectodermal explants. Unlike other known BMP antagonists, however, Tsg also reduces several anterior markers at late developmental stages. Our data suggest that Tsg can function as a BMP inhibitor in Xenopus; furthermore, Tsg may have additional functions during frog embryogenesis.	Rockefeller Univ, Lab Vertebrate Mol Embryol, New York, NY 10021 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA	Rockefeller University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Brivanlou, AH (corresponding author), Rockefeller Univ, Lab Vertebrate Mol Embryol, Box 32,1230 York Ave, New York, NY 10021 USA.							Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Chang CB, 1999, DEVELOPMENT, V126, P3347; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DALE L, 1992, DEVELOPMENT, V115, P573; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Jones CM, 1996, DEVELOPMENT, V122, P1545; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Schmidt J, 1995, DEVELOPMENT, V121, P4319; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Vesque C, 2000, DEVELOPMENT, V127, P2795; WHARTON KA, 1993, DEVELOPMENT, V117, P807; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yu K, 2000, DEVELOPMENT, V127, P2143; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; ZUSMAN SB, 1985, DEV BIOL, V111, P359, DOI 10.1016/0012-1606(85)90490-7	30	154	165	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					483	487		10.1038/35068583	http://dx.doi.org/10.1038/35068583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260717				2022-12-01	WOS:000167583800045
J	Rodriguez, C; Patel, AV; Calle, EE; Jacob, EJ; Thun, MJ				Rodriguez, C; Patel, AV; Calle, EE; Jacob, EJ; Thun, MJ			Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STATES CASE-CONTROL; UNITED-STATES; COLLABORATIVE ANALYSIS; RISK-FACTORS; WHITE WOMEN; CARCINOMA; DETERMINANTS; PATHOGENESIS; PROGESTINS; MENOPAUSE	Context Postmenopausal estrogen use is associated with increased risk of endometrial and breast cancer, 2 hormone-related cancers. The effect of postmenopausal estrogen use on ovarian cancer is not established. Objectives To examine the association between postmenopausal estrogen use and ovarian cancer mortality and to determine whether the association differs according to duration and recency of use. Design and Setting The American Cancer Society's Cancer Prevention Study II, a prospective US cohort study with mortality follow-up from 1982 to 1996. Participants A total of 211581 postmenopausal women who completed a baseline questionnaire in 1982 and had no history of cancer, hysterectomy, or ovarian surgery at enrollment. Main Outcome Measure Ovarian cancer mortality, compared among never users, users at baseline, and former users as well as by total years of use of estrogen replacement therapy (ERT). Results A total of 944 ovarian cancer deaths were recorded in 14 years of follow-up. Women who were using ERT at baseline had higher death rates from ovarian cancer than never users (rate ratio [RR], 1.51; 95% confidence interval [CI], 1.16-1.96). Risk was slightly but not significantly increased among former estrogen users (RR, 1.16; 95 % CI, 0.99-1.37). Duration of use was associated with increased risk in both baseline and former users, Baseline users with 10 or more years of use had an RR of 2.20 (95% CI, 1.53-3.17), while former users with 10 or more years of use had an RR of 1.59 (95 % CI, 1.13-2.25). Annual age-adjusted ovarian cancer death rates per 100000 Women were 64.4 for baseline users with 10 or more years of use, 38.3 for former users with 10 or more years of use, and 26.4 for never users. Among former users with 10 or more years of use, risk decreased with time since last use reported at study entry (RR for last use <15 years ago, 2.05; 95% CI, 1.29-3.25; RR for last use <greater than or equal to>15 years ago, 1.31;95% CI, 0.79-2.17). Conclusions In this population, postmenopausal estrogen use for 10 or more years was associated with increased risk of ovarian cancer mortality that persisted up to 29 years after cessation of use.	Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA	American Cancer Society	Rodriguez, C (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.							ANNEGERS JF, 1979, CANCER, V43, P723, DOI 10.1002/1097-0142(197902)43:2<723::AID-CNCR2820430248>3.0.CO;2-1; Barrett-Connor E, 1998, BMJ-BRIT MED J, V317, P457; BOOTH M, 1989, BRIT J CANCER, V60, P592, DOI 10.1038/bjc.1989.320; CHIEN CH, 1994, MOL CELL ENDOCRINOL, V99, P11; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; DAVIDSON NE, 1995, NEW ENGL J MED, V332, P1638, DOI 10.1056/NEJM199506153322409; Garg PP, 1998, OBSTET GYNECOL, V92, P472, DOI 10.1016/S0029-7844(98)00139-2; GORSKY RD, 1994, OBSTET GYNECOL, V83, P161; HARLOW BL, 1988, CANCER RES, V48, P5849; HARRIS R, 1992, AM J EPIDEMIOL, V136, P1204, DOI 10.1093/oxfordjournals.aje.a116428; HARTGE P, 1988, AM J EPIDEMIOL, V127, P990, DOI 10.1093/oxfordjournals.aje.a114902; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Hempling RE, 1997, OBSTET GYNECOL, V89, P1012, DOI 10.1016/S0029-7844(97)00118-X; HILDRETH NG, 1981, AM J EPIDEMIOL, V114, P398, DOI 10.1093/oxfordjournals.aje.a113207; HOOVER R, 1977, LANCET, V2, P533; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; KAUFMAN DW, 1989, AM J EPIDEMIOL, V130, P1142, DOI 10.1093/oxfordjournals.aje.a115441; KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441; LARSSONCOHN U, 1977, BRIT J OBSTET GYNAEC, V85, P367; LAVECCHIA C, 1982, J NATL CANCER I, V69, P1207; LEE NC, 1986, AGING REPROD CLIMACT; Markman M, 1996, GYNECOL ONCOL, V62, P4, DOI 10.1006/gyno.1996.0181; Negri E, 1999, INT J CANCER, V80, P848; PARAZZINI F, 1994, INT J CANCER, V57, P135, DOI 10.1002/ijc.2910570124; POLYCHRONOPOULOU A, 1993, INT J CANCER, V55, P402, DOI 10.1002/ijc.2910550312; Purdie DM, 1999, BRIT J CANCER, V81, P559, DOI 10.1038/sj.bjc.6690731; Ries LAG, 1999, SEER CANC STAT REV 1; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; RISCH HA, 1996, GYNECOL ONCOL, V63, P533; RODRIGUEZ C, 1995, AM J EPIDEMIOL, V141, P828, DOI 10.1093/oxfordjournals.aje.a117518; Rodriguez C, 1998, LANCET, V352, P1354, DOI 10.1016/S0140-6736(05)60745-3; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; STELLMAN SD, 1986, JNCI-J NATL CANCER I, V76, P1057; TZONOU A, 1984, EUR J CANC CLIN ONCO, V20, P2045; WEISS NS, 1982, J NATL CANCER I, V68, P95; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1212, DOI 10.1093/oxfordjournals.aje.a116429; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; *WHO, 1979, INT CLASS DIS MAN ST; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F; Young R.C., 1993, CANC PRINCIPLES PRAC, P1226; ZEIL HK, 1975, NEW ENGL J MED, V293, P1167	43	300	317	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1460	1465		10.1001/jama.285.11.1460	http://dx.doi.org/10.1001/jama.285.11.1460			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255422	Bronze			2022-12-01	WOS:000167462100028
J	Schnaufer, A; Panigrahi, AK; Panicucci, B; Igo, RP; Salavati, R; Stuart, K				Schnaufer, A; Panigrahi, AK; Panicucci, B; Igo, RP; Salavati, R; Stuart, K			An RNA ligase essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei	SCIENCE			English	Article							NADH DEHYDROGENASE; MESSENGER-RNA; GENE; MITOCHONDRIA; EXPRESSION; ENZYME; SITE	RNA editing in trypanosomes occurs by a series of enzymatic steps that are catalyzed by a macromolecular complex. The TbMP52 protein is shown to be a component of this complex, to have RNA Ligase activity, and to be one of two adenylatable proteins in the complex. Regulated repression of TbMP52 blocks editing, which shows that it is a functional component of the editing complex. This repression is lethal in bloodforms of the parasite, indicating that editing is essential in the mammalian stage of the life cycle. The editing complex, which is present in all kinetoplastid parasites, may thus be a chemotherapeutic target.	Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stuart, K (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St,Suite 200, Seattle, WA 98109 USA.		Igo, Rob/P-3438-2019	Igo, Rob/0000-0002-0024-1993; Schnaufer, Achim/0000-0003-2132-5560	NIAID NIH HHS [AI14102] Funding Source: Medline; NIGMS NIH HHS [GM42188] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014102, R01AI014102] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beattie DS, 1996, EUR J BIOCHEM, V241, P888, DOI 10.1111/j.1432-1033.1996.00888.x; Estevez AM, 1999, GENE, V240, P247, DOI 10.1016/S0378-1119(99)00437-0; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Hajduk Steven L., 1997, Nucleic Acids Symposium Series, V36, P15; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Ochatt CM, 1999, MOL BIOCHEM PARASIT, V103, P35, DOI 10.1016/S0166-6851(99)00111-5; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; PANIGRAHI AK, UNPUB; Peris M, 1997, MOL BIOCHEM PARASIT, V85, P9, DOI 10.1016/S0166-6851(96)02795-8; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; STUART KD, 1971, J CELL BIOL, V49, P189, DOI 10.1083/jcb.49.1.189; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	20	212	218	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2159	2162		10.1126/science.1058655	http://dx.doi.org/10.1126/science.1058655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251122				2022-12-01	WOS:000167563800042
J	Gomez, TM; Robles, E; Poo, MM; Spitzer, NC				Gomez, TM; Robles, E; Poo, MM; Spitzer, NC			Filopodial calcium transients promote substrate-dependent growth cone turning	SCIENCE			English	Article							NERVE GROWTH; CELL-ADHESION; INTEGRINS; LAMININ; FIBRONECTIN; CONTACTS; NEURONS; SIGNALS; CA2+	Filopodia that extend from neuronal growth cones sample the environment for extracellular guidance cues, but the signals they transmit to growth cones are unknown. Filopodia were observed generating Localized transient elevations of intracellular calcium ([Ca2+](i)) that propagate back to the growth cone and stimulate global Ca2+ elevations, The frequency of filopodial Ca2+ transients was substrate-dependent and may be due in part to influx of Ca2+ through channels activated by integrin receptors. These transients slowed neurite outgrowth by reducing filopodial motility and promoted turning when stimulated differentially within filopodia on one side of the growth cone. These rapid signals appear to serve both as autonomous regulators of filopodial movement and as frequency-coded signals integrated within the growth cone and could be a common signaling process for many motile cells.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gomez, TM (corresponding author), Univ Wisconsin, Sch Med, Dept Anat, Madison, WI 53706 USA.			Gomez, Timothy/0000-0002-1515-8228; Robles, Estuardo/0000-0002-1202-2050; Spitzer, Nicholas/0000-0002-3523-1103				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; BRAY D, 1985, J NEUROSCI, V5, P3204; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Grabham PW, 1997, J NEUROSCI, V17, P5455; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Kuhn TB, 1998, J NEUROSCI, V18, P184; LETOURNEAU PC, 1989, DEVELOPMENT, V105, P505; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Sakaguchi DS, 1996, DEV BRAIN RES, V97, P235, DOI 10.1016/S0165-3806(96)00142-3; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	26	214	217	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1983	1987		10.1126/science.1056490	http://dx.doi.org/10.1126/science.1056490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239161				2022-12-01	WOS:000167401600051
J	Will, CL; Luhrmann, R				Will, CL; Luhrmann, R			Molecular biology - RNP remodeling with DExH/D boxes	SCIENCE			English	Editorial Material							UNWINDING RNA; PROTEIN		Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Will, CL (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.							Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701	13	21	21	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1916	1917		10.1126/science.1059682	http://dx.doi.org/10.1126/science.1059682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11245200				2022-12-01	WOS:000167401600035
J	Domb, LG; Pagel, M				Domb, LG; Pagel, M			Sexual swellings advertise female quality in wild baboons	NATURE			English	Article							PAPIO-ANUBIS; EVOLUTION; PRIMATES	The females of many Old World primate species produce prominent and conspicuous swellings of the perineal skin around the time of ovulation. These sexual swellings have been proposed to increase competition among males for females(1) or to increase the likelihood of a female getting fertilized, by signalling either a female's general reproductive status(1-5), or the timing of her ovulation(6). Here we show that sexual swellings in wild baboons reliably advertise a female's reproductive value over her lifetime, in accordance with a theoretical model of honest signalling(7). Females with larger swellings attained sexual maturity earlier, produced both more offspring and more surviving offspring per year than females with smaller swellings, and had a higher overall proportion of their offspring survive. Male baboons use the size of the sexual swelling to determine their mating effort, fighting more aggressively to consort females with larger swellings, and spending more time grooming these females. Our results document an unusual case of a sexually selected ornament in females, and show how males, by mating selectively on the basis of the size of the sexual swelling, increase their probability of mating with females more likely to produce surviving offspring.	Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England	Harvard University; University of Reading	Domb, LG (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.							Alberts SC, 1996, ANIM BEHAV, V51, P1269, DOI 10.1006/anbe.1996.0131; BIELERT C, 1983, PHYSIOL BEHAV, V30, P103, DOI 10.1016/0031-9384(83)90045-8; BORGERHOFF MM, 1989, BEHAV ECOL SOCIOBIOL, V24, P145; CLUTTONBROCK TH, 1976, GROWING POINTS ETHOL, P195; Collins DA, 1984, INFANTICIDE COMP EVO, P193; CRITESCU M, 1975, J HUM EVOL, V4, P521; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Ellison PT, 1996, AM J HUM BIOL, V8, P725, DOI 10.1002/(SICI)1520-6300(1996)8:6<725::AID-AJHB4>3.0.CO;2-S; Hamilton W.J. III, 1984, P309; Hausfater G., 1975, Contributions Primatol, V7, P1; Heistermann M, 1996, BIOL REPROD, V55, P844, DOI 10.1095/biolreprod55.4.844; Hrdy S.B., 1987, P370; Hrdy S.B., 1988, P101; NASH LT, 1976, AM J PHYS ANTHROPOL, V44, P63, DOI 10.1002/ajpa.1330440109; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; OWENS NW, 1976, BEHAVIOUR, V57, P241, DOI 10.1163/156853976X00541; PACKER C, 1979, ANIM BEHAV, V27, P1, DOI 10.1016/0003-3472(79)90126-X; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PACKER C, 1975, NATURE, V255, P219, DOI 10.1038/255219a0; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; PACKER C, 1979, ANIM BEHAV, V27, P37, DOI 10.1016/0003-3472(79)90127-1; PAGEL M, 1994, ANIM BEHAV, V47, P1333, DOI 10.1006/anbe.1994.1181; Ransom TW., 1981, BEACH TROOP GOMBE; RYAN SM, 1990, OXFORD SURV EVOL BIO, V5, P156; RYDER NB, 1971, REPROD US; SILLENTULLBERG B, 1993, AM NAT, V141, P1, DOI 10.1086/285458; STRUSAKER TT, 1975, RED COLOBUS MONKEY; THOMSON JA, 1992, BIOL REPROD, V46, P879, DOI 10.1095/biolreprod46.5.879; Whitten PL, 1996, AM J PRIMATOL, V40, P67, DOI 10.1002/(SICI)1098-2345(1996)40:1<67::AID-AJP5>3.0.CO;2-Z	29	153	154	1	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					204	206		10.1038/35065597	http://dx.doi.org/10.1038/35065597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242079				2022-12-01	WOS:000167320500045
J	Curtis, CF				Curtis, CF			Insecticide resistance and mosquito-borne disease	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Curtis, CF (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.							CURTIS CF, 1981, T ROY SOC TROP MED H, V75, P736, DOI 10.1016/0035-9203(81)90166-8; CURTIS CF, 1981, B ENTOMOL RES, V71, P153, DOI 10.1017/S0007485300051129; Hawking F, 1976, Trop Dis Bull, V73, P967; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Nicolas L, 1997, PARASITE, V4, P253, DOI 10.1051/parasite/1997043253	5	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					656	656		10.1016/S0140-6736(00)04152-0	http://dx.doi.org/10.1016/S0140-6736(00)04152-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247547				2022-12-01	WOS:000167282400006
J	Hinchcliffe, EH; Miller, FJ; Cham, M; Khodjakov, A; Sluder, G				Hinchcliffe, EH; Miller, FJ; Cham, M; Khodjakov, A; Sluder, G			Requirement of a centrosomal activity for cell cycle progression through G(1) into S phase	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; SPINDLE POLES; REPRODUCTION; CENTRIOLE; MICROTUBULES; CHECKPOINT; CYTOPLASM; DIVISION; ANAPHASE; MITOSIS	Centrosomes were microsurgically removed from BSC-1 African green monkey kidney cells before the completion of S phase, Karyoplasts (acentrosomal cells) entered and completed mitosis, However, postmitotic karyoplasts arrested before S phase, whereas adjacent control cells divided repeatedly. Postmitotic karyoplasts assembled a microtubule-organizing center containing gamma -tubulin and pericentrin, but did not regenerate centrioles. These observations reveal the existence of an activity associated with core centrosomal structures-distinct from elements of the microtubule-organizing center-that is required for the somatic cell cycle to progress through G(1) into S phase. Once the cell is in S phase, these core structures are not needed for the G(2)-M phase transition.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Wadsworth Ctr, Lab Cell Regulat, Albany, NY 12201 USA	University of Massachusetts System; University of Massachusetts Worcester; Wadsworth Center	Sluder, G (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059363-02, R01 GM059363] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; BAILLY E, 1992, NATURE, V355, P300, DOI 10.1038/355300a0; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; GUNDUZ N, 1985, CYTOMETRY, V6, P597, DOI 10.1002/cyto.990060615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hinchcliffe EH, 1998, J CELL BIOL, V140, P1417, DOI 10.1083/jcb.140.6.1417; HINCHCLIFFE EH, UNPUB; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; Marshall WF, 1999, CURR BIOL, V9, pR218, DOI 10.1016/S0960-9822(99)80133-X; MCNIVEN MA, 1984, CELL, V37, P753, DOI 10.1016/0092-8674(84)90411-2; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Pagano RE, 1998, ANN NY ACAD SCI, V845, P152, DOI 10.1111/j.1749-6632.1998.tb09668.x; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pockwinse SM, 1997, P NATL ACAD SCI USA, V94, P3022, DOI 10.1073/pnas.94.7.3022; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; Rodionov VI, 1997, NATURE, V386, P170, DOI 10.1038/386170a0; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; STEFFEN W, 1986, J CELL BIOL, V102, P1679, DOI 10.1083/jcb.102.5.1679; Vaughn KC, 1998, INT REV CYTOL, V181, P75, DOI 10.1016/S0074-7696(08)60417-9	28	289	295	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1547	1550		10.1126/science.1056866	http://dx.doi.org/10.1126/science.1056866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222860				2022-12-01	WOS:000167153400045
J	Fahrer, AM; Bazan, JF; Papathanasiou, P; Nelms, KA; Goodnow, CC				Fahrer, AM; Bazan, JF; Papathanasiou, P; Nelms, KA; Goodnow, CC			A genomic view of immunology	NATURE			English	Article							FAMILY	The outstanding problems facing immunology are whole system issues: curing allergic and autoimmune disease and developing vaccines to stimulate stronger immune responses against pathogenic organisms and cancer. We hope that the human genome sequence will reveal the molecular checks and balances that ensure both an effective immunogenic response against pathogenic microorganisms and a suitably tolerogenic response to self antigens and innocuous environmental antigens. Three synergistic approaches-sequence homology searches, messenger RNA expression profiling on microarrays, and mutagenesis in mice-provide the best opportunities to reveal, in the genome sequence, key proteins and pathways for targeting by new immunomodulatory treatments.	Australian Natl Univ, John Curtin Sch Med Res, ACRF Genet Lab, Canberra, ACT 2601, Australia; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia; DNAX Res Inst Mol & Cellular Biol Inc, Dept Mol Biol, Palo Alto, CA 94304 USA	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Fahrer, AM (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, ACRF Genet Lab, Canberra, ACT 2601, Australia.		Goodnow, Christopher C/V-8108-2018; Bazan, J. Fernando/B-4562-2010; Fahrer, Aude M/C-9318-2009	Goodnow, Christopher C/0000-0001-5296-6155; Fahrer, Aude/0000-0001-8556-0223				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Fischer D, 1999, CURR OPIN STRUC BIOL, V9, P208, DOI 10.1016/S0959-440X(99)80029-3; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow CC, 1999, COLD SPRING HARB SYM, V64, P313, DOI 10.1101/sqb.1999.64.313; Henry J, 1999, IMMUNOL TODAY, V20, P285, DOI 10.1016/S0167-5699(98)01418-2; Justice MJ, 2000, NAT REV GENET, V1, P109, DOI 10.1038/35038549; Mueller DL, 2000, CURR BIOL, V10, pR227, DOI 10.1016/S0960-9822(00)00400-0; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; OPPMANN B, IN PRESS IMMUNITY; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	16	35	39	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					836	838		10.1038/35057020	http://dx.doi.org/10.1038/35057020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237003	Bronze			2022-12-01	WOS:000166938800050
J	Moreno, PI; Jacobson, GL; Lowell, TV; Denton, GH				Moreno, PI; Jacobson, GL; Lowell, TV; Denton, GH			Interhemispheric climate links revealed by a late-glacial cooling episode in southern Chile	NATURE			English	Article							HISTORY; FORESTS; POLLEN	Understanding the relative timings of climate events in the Northern and Southern hemispheres is a prerequisite for determining the causes of abrupt climate changes. But climate records from the Patagonian Andes(1-4) and New Zealand(5-8) for the period of transition from glacial to interglacial conditions-about 14.6-10 kyr before present, as determined by radiocarbon dating-show varying degrees of correlation with similar records from the Northern Hemisphere. It is necessary to resolve these apparent discrepancies in order to be able to assess the relative roles of Northern Hemisphere ice sheets and oceanic, atmospheric and astronomical influences in initiating climate change in the late-glacial period. Here we report pollen records from three sites in the Lake District of southern Chile (41 degrees S) from which we infer conditions similar to modern climate between about 13 and 12.2 C-14 kyr before present (BP), followed by cooling events at about 12.2 and 11.4 (14)Ckyr BP, and then by a warming at about 9.8 (14)Ckyr BP. These events were nearly synchronous with important palaeoclimate changes recorded in the North Atlantic region(9), supporting the idea that interhemispheric linkage through the atmosphere was the primary control on climate during the last deglaciation. In other regions of the Southern Hemisphere, where climate events are not in phase with those in the Northern Hemisphere, local oceanic influences may have counteracted the effects that propagated through the atmosphere.	Univ Maine, Inst Quaternary & Climate Studies, Orono, ME 04469 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA; Univ Maine, Dept Geol Sci, Orono, ME 04469 USA; Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University System of Ohio; University of Cincinnati	Moreno, PI (corresponding author), Univ Maine, Inst Quaternary & Climate Studies, Orono, ME 04469 USA.	pimoreno@uchile.cl	Moreno, Patricio I/D-2317-2012	Moreno, Patricio I/0000-0002-1333-6238; Lowell, Thomas/0000-0001-7826-0636				Ariztegui D, 1997, J QUATERNARY SCI, V12, P333, DOI 10.1002/(SICI)1099-1417(199707/08)12:4<333::AID-JQS312>3.3.CO;2-S; Bennett KD, 2000, SCIENCE, V290, P325, DOI 10.1126/science.290.5490.325; Bjorck S, 1998, J QUATERNARY SCI, V13, P283, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1990, QUATERNARY SCI REV, V9, P305, DOI 10.1016/0277-3791(90)90026-7; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; Denton GH, 1996, SCIENCE, V271, P669, DOI 10.1126/science.271.5249.669; Dillehay Thomas D., 1997, MONTE VERDE LATE PLE, V2; LOWELL TV, 1995, SCIENCE, V269, P1541, DOI 10.1126/science.269.5230.1541; Lusk CH, 1999, PLANT ECOL, V140, P111, DOI 10.1023/A:1009764705942; Lusk CH, 1996, REV CHIL HIST NAT, V69, P401; MERCER JH, 1976, QUATERNARY RES, V6, P125, DOI 10.1016/0033-5894(76)90047-8; MERCER JH, 1972, SCIENCE, V176, P1118, DOI 10.1126/science.176.4039.1118; Newnham RM, 2000, GEOLOGY, V28, P759, DOI 10.1130/0091-7613(2000)028<0759:FRPROL>2.3.CO;2; PAEZ MM, 1994, REV CHIL HIST NAT, V67, P417; PORTER SC, 1981, QUATERNARY RES, V16, P263, DOI 10.1016/0033-5894(81)90013-2; Ramirez C, 1989, MONTE VERDE LATE PLE, P53; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; VILLAGRAN MC, 1980, DISERTATIONES BOTANI, V54, P1; Zhou MM, 1996, REV PALAEOBOT PALYNO, V91, P283, DOI 10.1016/0034-6667(95)00076-3	24	123	127	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					804	808		10.1038/35057252	http://dx.doi.org/10.1038/35057252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236990				2022-12-01	WOS:000166938800036
J	Abel, ED; Peroni, O; Kim, JK; Kim, YB; Boss, O; Hadro, E; Minnemann, T; Shulman, GI; Kahn, BB				Abel, ED; Peroni, O; Kim, JK; Kim, YB; Boss, O; Hadro, E; Minnemann, T; Shulman, GI; Kahn, BB			Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver	NATURE			English	Article							SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; FATTY-ACIDS; RESISTANCE; EXPRESSION; LEPTIN; MICE; RATS; PATHOGENESIS; ACTIVATION	The earliest defect in developing type 2 diabetes is insulin resistance(1,2), characterized by decreased glucose transport and metabolism in muscle and adipocytes(3,4). The glucose transporter GLUT4 mediates insulin-stimulated glucose uptake in adipocytes and muscle by rapidly moving from intracellular storage sites to the plasma membrane(4). In insulin-resistant states such as obesity and type 2 diabetes, GLUT4 expression is decreased in adipose tissue but preserved in muscle(3,4). Because skeletal muscle is the main site of insulin-stimulated glucose uptake, the role of adipose tissue GLUT4 downregulation in the pathogenesis of insulin resistance and diabetes is unclear. To determine the role of adipose GLUT4 in glucose homeostasis, we used Cre/loxP DNA recombination to generate mice with adipose-selective reduction of GLUT4 (G4A(-/-)). Here we show that these mice have normal growth and adipose mass despite markedly impaired insulin-stimulated glucose uptake in adipocytes. Although GLUT4 expression is preserved in muscle, these mice develop insulin resistance in muscle and liver, manifested by decreased biological responses and impaired activation of phosphoinositide-3-OH kinase. G4A(-/-) mice develop glucose intolerance and hyperinsulinaemia. Thus, downregulation of GLUT4 and glucose transport selectively in adipose tissue can cause insulin resistance and thereby increase the risk of developing diabetes.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrine, Diabet Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Yale University; Howard Hughes Medical Institute; Yale University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrine, Diabet Unit, 99 Brookline Ave, Boston, MA 02215 USA.		Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Kim, Jason/0000-0002-7185-042X; Abel, E. Dale/0000-0001-5290-0738	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043051, R01 DK040936] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Burcelin R, 1999, DIABETES, V48, P1264, DOI 10.2337/diabetes.48.6.1264; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; CUSHMAN SW, 1978, J LIPID RES, V19, P269; DeFronzo RA, 1997, DIABETES REV, V5, P177; DONOGHUE MJ, 1991, J CELL BIOL, V115, P423, DOI 10.1083/jcb.115.2.423; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim YB, 1999, DIABETES, V48, P310, DOI 10.2337/diabetes.48.2.310; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sivitz WI, 1997, ENDOCRINOLOGY, V138, P3395, DOI 10.1210/en.138.8.3395; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Tozzo E, 1997, ENDOCRINOLOGY, V138, P1604, DOI 10.1210/en.138.4.1604; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	25	880	918	2	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					729	733		10.1038/35055575	http://dx.doi.org/10.1038/35055575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217863				2022-12-01	WOS:000166816400046
J	Peters, C; Bayer, MJ; Buhler, S; Andersen, JS; Mann, M; Mayer, A				Peters, C; Bayer, MJ; Buhler, S; Andersen, JS; Mann, M; Mayer, A			Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion	NATURE			English	Article							PROTEIN-KINASE-C; SNARE COMPLEX; VACUOLAR ACIDIFICATION; H+-ATPASE; V-ATPASE; RELEASE; DOCKING; VESICLE; CA2+; NSF	SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) and Rab-GTPases, together with their cofactors, mediate the attachment step in the membrane fusion of vesicles. But how bilayer mixing-the subsequent core process of fusion-is catalysed remains unclear. Ca2+/calmodulin controls this terminal process in many intracellular fusion events. Here we identify V0, the membrane-integral sector of the vacuolar H+-ATPase, as a target of calmodulin on yeast vacuoles. Between docking and bilayer fusion, V0 sectors from opposing membranes form complexes. V0 trans-complex formation occurs downstream from trans-SNARE pairing, and depends on both the Rab-GTPase Ypt7 and calmodulin. The maintenance of existing complexes and completion of fusion are independent of trans-SNARE pairs. Reconstituted proteolipids form sealed channels, which can expand to form aqueous pores in a Ca2+/calmodulin-dependent fashion. V0 trans-complexes may therefore form a continuous, proteolipid-lined channel at the fusion site. We propose that radial expansion of such a protein pore may be a mechanism for intracellular membrane fusion.	Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; Univ So Denmark, Dept Mol Biol, DK-5230 Odense M, Denmark	Eberhard Karls University of Tubingen; Max Planck Society; University of Southern Denmark	Mayer, A (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 37-39, D-72076 Tubingen, Germany.	andreas.mayer@tuebingen.mpg.de	Mann, Matthias/A-3454-2013; Mayer, Andreas/AAE-4315-2020; Andersen, Jens S/L-2100-2015	Mann, Matthias/0000-0003-1292-4799; Mayer, Andreas/0000-0001-6131-313X; Andersen, Jens S/0000-0002-6091-140X				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Conchon S, 1999, EMBO J, V18, P3934, DOI 10.1093/emboj/18.14.3934; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Dunant Y, 1998, NEUROCHEM RES, V23, P709, DOI 10.1023/A:1022451224748; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; GARCIASEGURA LM, 1986, NEUROSCIENCE, V19, P63, DOI 10.1016/0306-4522(86)90006-0; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; Harvey WR, 1997, J EXP BIOL, V200, P203; Henkel AW, 1995, J NEUROSCI, V15, P8246; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; ISRAEL M, 1987, J NEUROCHEM, V49, P975, DOI 10.1111/j.1471-4159.1987.tb00989.x; ISRAEL M, 1991, J NEUROCHEM, V57, P2047, DOI 10.1111/j.1471-4159.1991.tb06420.x; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kane PM, 2000, J EXP BIOL, V203, P81; KIBBLE VA, EUR J PHYSL, V431, P464; KLIONSKY DJ, 1992, J BIOL CHEM, V267, P3416; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mayer A, 1999, CURR OPIN CELL BIOL, V11, P447, DOI 10.1016/S0955-0674(99)80064-7; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MORANO KA, 1994, J CELL SCI, V107, P2813; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PLATTNER H, 1993, SIGNAL TRANSDUCTION, P19; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	51	407	416	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					581	588		10.1038/35054500	http://dx.doi.org/10.1038/35054500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214310				2022-12-01	WOS:000166692300034
J	Beattie, TF				Beattie, TF			To blow or not to blow?	LANCET			English	Editorial Material							NASAL FOREIGN-BODIES		Royal Hosp Sick Children, Dept Accid & Emergency, Edinburgh EH9 1LF, Midlothian, Scotland		Beattie, TF (corresponding author), Royal Hosp Sick Children, Dept Accid & Emergency, Edinburgh EH9 1LF, Midlothian, Scotland.							Botma P, 2000, J LARYNGOL OTOL, V114, P598; GUAZZO E, 1985, NEW ENGL J MED, V312, P725; Kadish HA, 1997, AM J EMERG MED, V15, P54, DOI 10.1016/S0735-6757(97)90049-8; Kalan A, 2000, POSTGRAD MED J, V76, P484, DOI 10.1136/pmj.76.898.484; Tong MCF, 1996, INT J PEDIATR OTORHI, V35, P207, DOI 10.1016/0165-5876(95)01305-9	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					250	250		10.1016/S0140-6736(00)03609-6	http://dx.doi.org/10.1016/S0140-6736(00)03609-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214125				2022-12-01	WOS:000166693400007
J	Smith, R				Smith, R			Hyperplastic callus and osteogenesis imperfects	LANCET			English	Editorial Material									Nuffield Orthopaed Ctr, Oxford OX3 7LD, England	Nuffield Orthopaedic Centre	Smith, R (corresponding author), Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.							Brady AF, 1997, CLIN DYSMORPHOL, V6, P329, DOI 10.1097/00019605-199710000-00005; Byers Peter H., 1993, P317; Dobrocky I, 1999, EUR RADIOL, V9, P665, DOI 10.1007/s003300050729; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Gong YQ, 1996, AM J HUM GENET, V59, P146; Kaplan FS, 2000, J BONE MINER RES, V15, P2084, DOI 10.1359/jbmr.2000.15.11.2084; Nakamura K, 1997, ARCH ORTHOP TRAUM SU, V116, P500, DOI 10.1007/BF00387587; Robey PG, 2000, J CLIN INVEST, V105, P1489, DOI 10.1172/JCI10256; Smith R, 1999, CURR ORTHOPAED, V13, P218, DOI 10.1016/S0268-0890(99)90006-3	9	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					248	249		10.1016/S0140-6736(00)03607-2	http://dx.doi.org/10.1016/S0140-6736(00)03607-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214123				2022-12-01	WOS:000166693400005
J	Blackburn, GL				Blackburn, GL			Pasteur's quadrant and malnutrition	NATURE			English	Article								Basic science has been the wellspring of advances in technology in everything from cellular phones to nutrient-fortified foods. Biochemistry and food technology afford new techniques that enrich nutritional science and aid in the fight against malnutrition. Bionutrition, the term used to describe the application of these techniques, can be the source of innovations that will help eradicate malnutrition globally. Which areas of bionutrition research are most likely to yield tomorrow's breakthroughs?	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Blackburn, GL (corresponding author), Beth Israel Deaconess Med Ctr, 1 Autumn St Kennedy 152, Boston, MA 02215 USA.	gblackbu@caregroup.harvard.edu						Blackburn GL, 1997, AM J CLIN NUTR, V66, P1067, DOI 10.1093/ajcn/66.5.1067; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Golden MHN, 1998, BRIT MED BULL, V54, P433, DOI 10.1093/oxfordjournals.bmb.a011699; HARPER AE, 2000, AM J CLIN NUTR S, V71, pS16; *INT FOOD POL RES, 1995, 2020 VIS FOOD AGR EN; James P, 2000, ENDING MALNUTRITION; Mazza G., 1998, FUNCTIONAL FOODS BIO, P91; Reid M, 2000, AM J PHYSIOL-ENDOC M, V278, pE405, DOI 10.1152/ajpendo.2000.278.3.E405; Scrimshaw Nevin S., 1997, American Journal of Clinical Nutrition, V66, p464S; Stokes DE., 1997, PASTEURS QUADRANT BA; SWAILS WS, 1996, NUTR SUBSTRATES CURR, P85; WATERLOW JC, 1984, T ROY SOC TROP MED H, V78, P436, DOI 10.1016/0035-9203(84)90053-1; *WHO, 1999, MAN SEVERE MALNUTRIT; World Health Organization, 1999, WORLD HLTH REP 1999	15	20	20	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					397	401		10.1038/35053187	http://dx.doi.org/10.1038/35053187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201754				2022-12-01	WOS:000166434300062
J	Dohoney, KM; Gelles, J				Dohoney, KM; Gelles, J			chi-Sequence recognition and DNA translocation by single RecBCD helicase/nuclease molecules	NATURE			English	Article							RECOMBINATION HOTSPOT-CHI; ESCHERICHIA-COLI; RECD SUBUNIT; RNA-POLYMERASE; HOMOLOGOUS RECOMBINATION; HELICASE ACTIVITY; ENZYME; KINESIN; ATP; DEOXYRIBONUCLEASE	Major pathways of recombinational DNA repair in Escherichia coli require the RecBCD protein-a heterotrimeric, ATP-driven, DNA translocating motor enzyme. RecBCD combines a highly processive and exceptionally fast helicase (DNA-unwinding) activity with a strand-specific nuclease (DNA-cleaving) activity (refs 1, 2 and references therein). Recognition of the DNA sequence 'chi' (5'-GCTGGTGG-3') switches the polarity of DNA cleavage and stimulates recombination at nearby sequences in vivo. Here we attach microscopic polystyrene beads to biotin-tagged RecD protein subunits and use tethered-particle light microscopy to observe translocation of single RecBCD molecules (with a precision of up to similar to 30 nm at 2 Hz) and to examine the mechanism by which chi modifies enzyme activity. Observed translocation is unidirectional, with each molecule moving at a constant velocity corresponding to the population-average DNA unwinding rate. These observations place strong constraints on possible movement mechanisms. Bead release at chi is negligible, showing that the activity modification at chi does not require ejection of the RecD subunit from the enzyme as previously proposed; modification may occur through an unusual, pure conformational switch mechanism.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.							Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; EICHLER DC, 1977, J BIOL CHEM, V252, P499; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; KOPPEN A, 1995, P NATL ACAD SCI USA, V92, P6249, DOI 10.1073/pnas.92.14.6249; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LOVETT ST, 1988, GENETICS, V120, P37; MYERS RS, 1995, P NATL ACAD SCI USA, V92, P6244, DOI 10.1073/pnas.92.14.6244; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; STAHL FW, 1990, GENETICS, V126, P519; STAHL FW, 1993, GENETICS, V135, P1232; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; Taylor AF, 1999, GENE DEV, V13, P890, DOI 10.1101/gad.13.7.890; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459; Thaler D.S., 1988, MECH CONSEQUENCES DN, P413; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; YOUNG EC, 1995, J BIOL CHEM, V270, P3926, DOI 10.1074/jbc.270.8.3926	31	109	110	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					370	374		10.1038/35053124	http://dx.doi.org/10.1038/35053124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201749				2022-12-01	WOS:000166434300054
J	Irie-Sasaki, J; Sasaki, T; Matsumoto, W; Opavsky, A; Cheng, M; Welstead, G; Griffiths, E; Krawczyk, C; Richardson, CD; Aitken, K; Iscove, N; Koretzky, G; Johnson, P; Liu, P; Rothstein, DM; Penninger, JM				Irie-Sasaki, J; Sasaki, T; Matsumoto, W; Opavsky, A; Cheng, M; Welstead, G; Griffiths, E; Krawczyk, C; Richardson, CD; Aitken, K; Iscove, N; Koretzky, G; Johnson, P; Liu, P; Rothstein, DM; Penninger, JM			CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling	NATURE			English	Article							CELL MATURATION; ACTIVATION; FAMILY; MICE; INTERFERON; DEFICIENT; STATS	The regulation of tyrosine phosphorylation and associated signalling through antigen, growth-factor and cytokine receptors is mediated by the reciprocal activities of protein tyrosine kinases and protein tyrosine phosphatases (PTPases)(1). The transmembrane PTPase CD45 is a key regulator of antigen receptor signalling in T and B cells(2,3). Src-family kinases have been identified as primary molecular targets for CD45 (ref. 4). However, CD45 is highly expressed in all haematopoietic lineages at all stages of development(5), indicating that CD45 could regulate other cell types and might act on additional substrates. Here we show that CD45 suppresses JAK (Janus kinase) kinases and negatively regulates cytokine receptor signalling. Targeted disruption of the cd45 gene leads to enhanced cytokine and interferon-receptor-mediated activation of JAKs and STAT (signal transducer and activators of transcription) proteins. In vitro, CD45 directly dephosphorylates and binds to JAKs. Functionally, CD45 negatively regulates interleukin-3-mediated cellular proliferation, erythropoietin-dependent haematopoieisis and antiviral responses in vitro and in vivo. Our data identify an unexpected and novel function for CD45 as a haematopoietic JAK phosphatase that negatively regulates cytokine receptor signalling.	Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06529 USA; Univ Toronto, Univ Hlth Network, Lewar Ctr Excellence Cardiovasc Res, Toronto, ON M5G 2C4, Canada; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ British Columbia, Dept Microbiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Immunol, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Pennsylvania; University of British Columbia; University of British Columbia	Sasaki, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Aitken, KJ/AAC-5383-2019; Johnson, Pauline/G-9659-2019; Koretzky, Gary/AAU-5381-2021; Penninger, Josef M/I-6860-2013	Johnson, Pauline/0000-0001-7367-4653; Penninger, Josef M/0000-0002-8194-3777; Aitken, Karen/0000-0003-2995-0205; Sasaki, Takehiko/0000-0003-1837-3748				Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; Felberg J, 1998, J BIOL CHEM, V273, P17839, DOI 10.1074/jbc.273.28.17839; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; KANDOLF R, 1985, J MOL CELL CARDIOL, V17, P167, DOI 10.1016/S0022-2828(85)80019-5; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kung C, 2000, NAT MED, V6, P343; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MCKENNEY DW, 1995, J BIOL CHEM, V270, P24949, DOI 10.1074/jbc.270.42.24949; Ozdemirli M, 1996, CANCER, V77, P79, DOI 10.1002/(SICI)1097-0142(19960101)77:1<79::AID-CNCR14>3.0.CO;2-5; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Ratei R, 1998, ANN HEMATOL, V77, P107, DOI 10.1007/s002770050424; Ren JM, 1998, DIABETES, V47, P493, DOI 10.2337/diabetes.47.3.493; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Saad MJA, 1996, J BIOL CHEM, V271, P22100, DOI 10.1074/jbc.271.36.22100; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.iy.07.040189.002011; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Ward AC, 2000, BLOOD, V95, P19; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309	27	422	449	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					349	354		10.1038/35053086	http://dx.doi.org/10.1038/35053086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201744				2022-12-01	WOS:000166434300049
J	Cohen, EP				Cohen, EP			Renal failure after bone-marrow transplantation	LANCET			English	Editorial Material							HEMOLYTIC-UREMIC SYNDROME; TOTAL-BODY IRRADIATION		Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cohen, EP (corresponding author), Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA.							Burnet N G, 1996, Clin Oncol (R Coll Radiol), V8, P25, DOI 10.1016/S0936-6555(05)80035-4; CHAPPELL ME, 1988, BONE MARROW TRANSPL, V3, P339; Cohen EP, 2000, KIDNEY INT, V58, P903, DOI 10.1046/j.1523-1755.2000.00241.x; Imai H, 2000, AM J KIDNEY DIS, V36, P474, DOI 10.1053/ajkd.2000.9787; JUCKETT MB, IN PRESS BONE MARROW; LUXTON RW, 1953, Q J MED, V22, P215; Miralbell R, 1996, J CLIN ONCOL, V14, P579, DOI 10.1200/JCO.1996.14.2.579; *NAT I DIAB DIG KI, 1999, US REN DAT SYST 1999; SARODE R, 1995, BONE MARROW TRANSPL, V16, P271; SHULMAN H, 1981, NEW ENGL J MED, V305, P1392, DOI 10.1056/NEJM198112033052306; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; THOMAS ED, 1975, NEW ENGL J MED, V292, P832, DOI 10.1056/NEJM197504172921605; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; ZAGER RA, 1994, KIDNEY INT, V46, P1443, DOI 10.1038/ki.1994.417	15	56	58	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					6	7		10.1016/S0140-6736(00)03561-3	http://dx.doi.org/10.1016/S0140-6736(00)03561-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197374				2022-12-01	WOS:000166341500005
J	Mitton, S				Mitton, S			The universe weighed and found wanting	LANCET			English	Editorial Material									Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England	University of Cambridge	Mitton, S (corresponding author), Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England.		Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806				Peacock JA, 2001, NATURE, V410, P169, DOI 10.1038/35065528	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					824	824		10.1016/S0140-6736(00)04194-5	http://dx.doi.org/10.1016/S0140-6736(00)04194-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265949				2022-12-01	WOS:000167586300007
J	Yamada, M; Miyakawa, T; Duttaroy, A; Yamanaka, A; Moriguchi, T; Makita, R; Ogawa, M; Chou, CJ; Xia, B; Crawley, JN; Felder, CC; Deng, CX; Wess, J				Yamada, M; Miyakawa, T; Duttaroy, A; Yamanaka, A; Moriguchi, T; Makita, R; Ogawa, M; Chou, CJ; Xia, B; Crawley, JN; Felder, CC; Deng, CX; Wess, J			Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean	NATURE			English	Article							MELANIN-CONCENTRATING HORMONE; LATERAL HYPOTHALAMIC AREA; KNOCKOUT MICE; FEEDING-BEHAVIOR; FOOD-INTAKE; RAT-BRAIN; PROTEIN; GENE; LOCALIZATION; PROJECTIONS	Members of the muscarinic acetylcholine receptor family (M1-M5) have central roles in the regulation of many fundamental physiological functions(1,2). Identifying the specific receptor subtype( s) that mediate the diverse muscarinic actions of acetylcholine is of considerable therapeutic interest, but has proved difficult primarily because of a lack of subtype-selective ligands(3). Here we show that mice deficient in the M3 muscarinic receptor (M3R(-/-) mice) display a significant decrease in food intake, reduced body weight and peripheral fat deposits, and very low levels of serum leptin and insulin. Paradoxically, hypothalamic messenger RNA levels of melanin-concentrating hormone (MCH), which are normally upregulated in fasted animals leading to an increase in food intake(4,5), are significantly reduced in M3R(-/-) mice. Intra-cerebroventricular injection studies show that an agouti-related peptide analogue lacked orexigenic (appetite-stimulating) activity in M3R(-/-) mice. However, M3R(-/-) mice remained responsive to the orexigenic effects of MCH. Our data indicate that there may be a cholinergic pathway that involves M3-receptor-mediated facilitation of food intake at a site downstream of the hypothalamic leptin/melanocortin system and upstream of the MCH system.	NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA; NIDDKD, Diabet Branch, Bethesda, MD 20892 USA; NIDDKD, Biochem & Metab Lab, Bethesda, MD 20892 USA; RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; NIMH, Sect Behav Pharmacol, Expt Therapeut Branch, Bethesda, MD 20892 USA; Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan; NIAAA, Lab Membrane Biochem & Biophys, Rockville, MD 20852 USA; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); RIKEN; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Tsukuba; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Eli Lilly	Wess, J (corresponding author), NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA.		Duttaroy, Asim K./J-9499-2016; Miyakawa, Tsuyoshi/A-7741-2008; deng, chuxia/N-6713-2016	Duttaroy, Asim K./0000-0003-1619-3778; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Felder, Christian/0000-0003-1134-8881	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK032003, ZIADK056001, Z01DK056001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002179, Z01MH002179] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bayer L, 1999, NEUROSCIENCE, V91, P1087, DOI 10.1016/S0306-4522(98)00678-2; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; BOSCHERO AC, 1995, AM J PHYSIOL-ENDOC M, V268, pE336, DOI 10.1152/ajpendo.1995.268.2.E336; Broberger C, 1998, J COMP NEUROL, V402, P460; BROWN JH, 1996, PHARMACOL BASIS THER, P141; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Eglen RM, 1996, PHARMACOL REV, V48, P531; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; KLEIBER M, 1975, FIRE LIFE, P179; LEVEY AI, 1993, LIFE SCI, V52, P441, DOI 10.1016/0024-3205(93)90300-R; LEVEY AI, 1994, NEUROSCIENCE, V63, P207, DOI 10.1016/0306-4522(94)90017-5; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Mystkowski P, 2000, J NEUROSCI, V20, P8637, DOI 10.1523/JNEUROSCI.20-22-08637.2000; PARKES MW, 1972, BRIT J PHARMACOL, V46, P315, DOI 10.1111/j.1476-5381.1972.tb06876.x; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; WESS J, 1990, COMPREHENSIVE MED CH, V3, P423; Zeng FY, 1999, J BIOL CHEM, V274, P16629, DOI 10.1074/jbc.274.23.16629	30	300	315	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					207	212		10.1038/35065604	http://dx.doi.org/10.1038/35065604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242080				2022-12-01	WOS:000167320500046
J	Schwetz, BA				Schwetz, BA			New first-line therapy for advanced breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-01	WOS:000167194700006
J	McKie, AT; Barrow, D; Latunde-Dada, GO; Rolfs, A; Sager, G; Mudaly, E; Mudaly, M; Richardson, C; Barlow, D; Bomford, A; Peters, TJ; Raja, KB; Shirali, S; Hediger, MA; Farzaneh, F; Simpson, RJ				McKie, AT; Barrow, D; Latunde-Dada, GO; Rolfs, A; Sager, G; Mudaly, E; Mudaly, M; Richardson, C; Barlow, D; Bomford, A; Peters, TJ; Raja, KB; Shirali, S; Hediger, MA; Farzaneh, F; Simpson, RJ			An iron-regulated ferric reductase associated with the absorption of dietary iron	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOCHROME B(561); ELECTRON-TRANSFER; TRANSPORTER; MOUSE; MICE; GENE; PURIFICATION; MEMBRANES; PROTEIN	The ability of intestinal mucosa to absorb dietary ferric iron is attributed to the presence of a brush-border membrane reductase activity that displays adaptive responses to iron status. We have isolated a complementary DNA, Dcytb (for duodenal cytochrome b), which encoded a putative plasma membrane di-heme protein in mouse duodenal mucosa. Dcytb shared between 45 and 50% similarity to the cytochrome b561 family of plasma membrane reductases, was highly expressed in the brush-border membrane of duodenal enterocytes, and induced ferric reductase activity when expressed in Xenopus oocytes and cultured cells. Duodenal expression Levels of Dcytb messenger RNA and protein were regulated by changes in physiological modulators of iron absorption. Thus, Dcytb provides an important element in the iron absorption pathway.	Univ London Kings Coll, Rayne Inst, Guys Kings & St Thomas Sch Med, Dept Mol Med, London SE5 9NU, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Dept Diabet Endocrinol & Internal Med, London SE5 9PJ, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Dept Clin Biochem, London SE5 9PJ, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Inst Liver Studies, London SE5 9PJ, England; Univ London Kings Coll, Dept Pharm, London SE1 8WA, England; Harvard Univ, Brigham & Womens Hosp, Sch Med, Membrane Biol Program, Boston, MA 02115 USA	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School	McKie, AT (corresponding author), Univ London Kings Coll, Rayne Inst, Guys Kings & St Thomas Sch Med, Dept Mol Med, Denmark Hill Campus,123 Coldharbour Lane, London SE5 9NU, England.		Simpson, Robert J/A-8776-2013; Bomford, Adrian/A-7462-2011; Farzaneh, Farzin/B-4902-2009	Simpson, Robert J/0000-0002-2196-5368; Farzaneh, Farzin/0000-0002-9275-2415; Hediger, Matthias/0000-0003-1946-027X; Barlow, David/0000-0002-0094-5122				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DeLeo FR, 1999, J LAB CLIN MED, V134, P275, DOI 10.1016/S0022-2143(99)90208-1; ESCRIOU V, 1994, J BIOL CHEM, V269, P14007; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; FONTECAVE M, 1994, BIOMETALS, V7, P3; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HUGGENVIK JI, 1989, BLOOD, V74, P482; Kobayashi K, 1998, J BIOL CHEM, V273, P16038, DOI 10.1074/jbc.273.26.16038; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Okuyama E, 1998, BBA-PROTEIN STRUCT M, V1383, P269, DOI 10.1016/S0167-4838(97)00216-1; ORIORDAN DK, 1995, EUR J CLIN INVEST, V25, P722, DOI 10.1111/j.1365-2362.1995.tb01950.x; POUTNEY DJ, 1999, BIOMETALS, V12, P53; RAJA KB, 1992, BIOCHIM BIOPHYS ACTA, V1135, P141, DOI 10.1016/0167-4889(92)90129-Y; RIEDEL HD, 1995, BIOCHEM J, V309, P745, DOI 10.1042/bj3090745; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMAN DG, 1993, MOL CELL BIOL, V13, P4342, DOI 10.1128/MCB.13.7.4342; SIMPSON RJ, 1984, BIOCHIM BIOPHYS ACTA, V772, P220, DOI 10.1016/0005-2736(84)90047-6; SIMPSON RJ, 1991, BRIT J HAEMATOL, V78, P565, DOI 10.1111/j.1365-2141.1991.tb04490.x; Simpson RJ, 1996, J NUTR, V126, P1858; SIMPSON RJ, 1999, CLIN SCI, V96, pP16; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270	24	761	797	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1755	1759		10.1126/science.1057206	http://dx.doi.org/10.1126/science.1057206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230685				2022-12-01	WOS:000167320600050
J	Choi, JY; Muallem, D; Kiselyov, K; Lee, MG; Thomas, PJ; Muallem, S				Choi, JY; Muallem, D; Kiselyov, K; Lee, MG; Thomas, PJ; Muallem, S			Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis	NATURE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; CHLORIDE CHANNEL ACTIVITY; CYTOPLASMIC LOOP; BINDING; MUCIN; PH; IDENTIFICATION; VISCOSITY; CURRENTS	Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Initially, Cl- conductance in the sweat duct was discovered to be impaired in CF1, a finding that has been extended to all CFTR-expressing cells(2-4). Subsequent cloning of the gene(5,6) showed that CFTR functions as a cyclic-AMP-regulated Cl- channel(7); and some CF-causing mutations inhibit CFTR Cl- channel activity(2-4,8). The identification of additional C-causing mutants with normal Cl- channel activity indicates, however, that other CFTR-dependent processes contribute to the disease. Indeed, CFTR regulates other transporters(3,4), including Cl- -coupled HCO3- transport(9,10). Alkaline fluids are secreted by normal tissues, whereas acidic fluids are secreted by mutant CFTR-expressing tissues(11), indicating the importance of this activity. HCO3- and pH affect mucin viscosity(12,13) and bacterial binding(14,15). We have examined Cl- -coupled HCO3- transport by CFTR mutants that retain substantial or normal Cl- channel activity. Here we show that mutants reported to be associated with CF with pancreatic insufficiency do not support HCO3- transport, and those associated with pancreatic sufficiency show reduced HCO3- transport. Our findings demonstrate the importance of HCO3- transport in the function of secretory epithelia and in CF.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Seoul 120752, South Korea	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Muallem, S (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.		Thomas, Philip J/F-7115-2012; Lee, Min Goo/AAS-4636-2020; Lee, Min Goo/D-5635-2012	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Kiselyov, Kirill/0000-0001-6683-2895	NIDDK NIH HHS [R01 DK049835] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049835] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ARGENT BE, 1994, PHYSL GASTROINTESTIN, P1478; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; FULMER SB, 1995, P NATL ACAD SCI USA, V92, P6832, DOI 10.1073/pnas.92.15.6832; GRAY MA, 1993, AM J PHYSIOL, V264, pC591, DOI 10.1152/ajpcell.1993.264.3.C591; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Linsdell P, 1997, J GEN PHYSIOL, V110, P355, DOI 10.1085/jgp.110.4.355; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; Veerman ECI, 1997, GLYCOBIOLOGY, V7, P737, DOI 10.1093/glycob/7.6.737; VEERMAN ECI, 1989, J BIOL BUCCALE, V17, P297; WANKE CA, 1990, INFECT IMMUN, V58, P794, DOI 10.1128/IAI.58.3.794-800.1990	30	293	306	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					94	97		10.1038/35065099	http://dx.doi.org/10.1038/35065099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242048	Green Accepted			2022-12-01	WOS:000167194300049
J	Furth, SL; Hwang, W; Yang, C; Neu, AM; Fivush, BA; Powe, NR				Furth, SL; Hwang, W; Yang, C; Neu, AM; Fivush, BA; Powe, NR			Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; AMBULATORY PERITONEAL-DIALYSIS; RESOURCE UTILIZATION; MEDICAL SPECIALTIES; HEMODIALYSIS; CARE; MORTALITY; JUDGMENTS; THERAPY; SYSTEMS	Context Children and adolescent patients with renal failure are frequently cared for by adult subspecialists, While peritoneal dialysis is used in less than 17% of adults with kidney failure, it is the preferred dialysis treatment for children. National data show that 45% of children receiving dialysis are treated with peritoneal dialysis and pediatric nephrologists report its use in 65% of patients receiving dialysis. Whether differences in peritoneal dialysis use among children are due to the pediatric experience of the clinician has not been examined. Objective To assess whether the pediatric experience of nephrologists directly affects treatment recommendations for children with kidney failure. Design Cross-sectional survey using 10 case vignettes per survey based on random combinations of 8 patient characteristics (age, sex, race, distance from facility, cause of renal failure, family structure, education, and compliance). Setting and Participants National random sample of office-, hospital-, and academic medical center-based adult and pediatric nephrologists, stratified by geographic region and conducted June to November 1999. Of 519 eligible physicians, 316 (61%) responded, including 191 adult and 125 pediatric nephrologists. Main Outcome Measure Treatment recommendations for peritoneal dialysis vs hemodialysis, compared based on nephrologists' pediatric experience. Results After controlling for patient characteristics, pediatric nephrologists were 60% more likely than adult nephrologists to recommend peritoneal dialysis for identical patients (odds ratio, 1.61; 95% confidence interval, 1.35-1.92). This was true regardless of dialysis training, years in practice, practice setting, geography, or patient characteristics. Conclusions Our data indicate that pediatric specialization of clinicians influences treatment recommendations for children and adolescents with end-stage renal disease. Referring children to adult subspecialists may lead to differences in treatment choices and processes of care.	Johns Hopkins Med Inst, Dept Pediat, Div Pediat Nephrol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Furth, SL (corresponding author), 600 N Wolfe St,Pk 327, Baltimore, MD 21287 USA.	sfurth@jhmi.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002643, K08DK002586] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK02643, K08 DK02586-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alloatti S, 2000, J NEPHROL, V13, P331; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BREM AS, 1988, PEDIATR NEPHROL, V2, P460, DOI 10.1007/BF00853442; BROWNBRIDGE G, 1991, PEDIATR NEPHROL, V5, P612, DOI 10.1007/BF00856653; CHURCHILL DN, 1993, KIDNEY INT, V43, pS16; Coyte PC, 1996, AM J KIDNEY DIS, V27, P557, DOI 10.1016/S0272-6386(96)90167-5; Evans ED, 1995, PEDIATR CLIN N AM, V42, P1579; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; FINE RN, 1987, PEDIATR CLIN N AM, V34, P789; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; FOX MP, 1993, AM J KIDNEY DIS, V22, P32, DOI 10.1016/0272-6386(93)70179-3; Franks P, 2000, J GEN INTERN MED, V15, P163, DOI 10.1046/j.1525-1497.2000.04079.x; Furth SL, 1997, ARCH PEDIAT ADOL MED, V151, P545, DOI 10.1001/archpedi.1997.02170430011002; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; GUTMAN RA, 1981, NEW ENGL J MED, V304, P309, DOI 10.1056/NEJM198102053040601; KAISER BA, 1994, PEDIATR NEPHROL, V8, P733, DOI 10.1007/BF00869106; KRAVITZ RL, 1995, ANNU REV PUBL HEALTH, V16, P431; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; MCFALL SL, 1994, MED CARE, V32, P106, DOI 10.1097/00005650-199402000-00002; Meyer GS, 2000, J GEN INTERN MED, V15, P188, DOI 10.1046/j.1525-1497.2000.06039.x; Murphy SW, 2000, KIDNEY INT, V57, P1720, DOI 10.1046/j.1523-1755.2000.00017.x; NISSENSON AR, 1986, AM J KIDNEY DIS, V7, P229, DOI 10.1016/S0272-6386(86)80009-9; NISSENSON AR, 1993, KIDNEY INT, V43, pS120; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; PERRIN JM, 1989, NEW ENGL J MED, V320, P1183, DOI 10.1056/NEJM198905043201805; STABLEIN DM, 2001, N AM PED REN TRANSPL; Stapleton FB, 1997, J AM SOC NEPHROL, V8, pS5; US Renal Data System, 1999, USRDS 1999 ANN DAT R; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120; YAGER J, 1986, GEN HOSP PSYCHIAT, V8, P152, DOI 10.1016/0163-8343(86)90073-3	30	27	27	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1027	1033		10.1001/jama.285.8.1027	http://dx.doi.org/10.1001/jama.285.8.1027			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	403ME	11209173				2022-12-01	WOS:000167046400024
J	Tucker, M; Valencia-Sanchez, MA; Staples, RR; Chen, JJ; Denis, CL; Parker, R				Tucker, M; Valencia-Sanchez, MA; Staples, RR; Chen, JJ; Denis, CL; Parker, R			The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae	CELL			English	Article							MESSENGER-RNA TURNOVER; GENE-EXPRESSION; REGULATORY COMPLEX; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; MEIOTIC MATURATION; POLY(A) NUCLEASE; DECAPPING ENZYME; YEAST; MUTATIONS	The major pathways of mRNA turnover in eukaryotes initiate with shortening of the poly(A) tail. We demonstrate by several criteria that CCR4 and CAF1 encode critical components of the major cytoplasmic deadenylase in yeast. First, both Ccr4p and Caf1p are required for normal mRNA deadenylation in vivo. Second, both proteins localize to the cytoplasm. Third, purification of Caf1p copurifies with a Ccr4p-dependent poly(A)-specific exonuclease activity. We also provide evidence that the Pan2p/Pan3p nuclease complex encodes the predominant alternative deadenylase. These results, and previous work on Pan2p/Pan3p, define the mRNA deadenylases in yeast. The strong conservation of Ccr4p, Caf1p, Pan2p, and Pan3p indicates that they will function as deadenylases in other eukaryotes. Interestingly, because Ccr4p and Caf1p interact with transcription factors, these results suggest an unexpected link between mRNA synthesis and turnover.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA; Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona; University System Of New Hampshire; University of New Hampshire	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443, R01GM041215] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41215, GM45443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Badarinarayana V, 2000, GENETICS, V155, P1045; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Benson JD, 1998, EMBO J, V17, P6714, DOI 10.1093/emboj/17.22.6714; Boeck R, 1996, J BIOL CHEM, V271, P432, DOI 10.1074/jbc.271.1.432; Brown CE, 1996, MOL CELL BIOL, V16, P5744; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Caponigro G, 1996, NUCLEIC ACIDS RES, V24, P4304, DOI 10.1093/nar/24.21.4304; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; DENIS CL, 1990, GENETICS, V124, P283; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hata H, 1998, GENETICS, V148, P571; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lemaire M, 2000, J BIOL CHEM, V275, P26925; Liu HY, 1997, EMBO J, V16, P5289, DOI 10.1093/emboj/16.17.5289; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; LIU HY, 2001, IN PRESS J BIOL CHEM; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; LOWELL JE, 1992, GENE DEV, V6, P2088, DOI 10.1101/gad.6.11.2088; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Oberholzer U, 1998, GENE, V207, P61, DOI 10.1016/S0378-1119(97)00605-7; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Puisieux A, 1999, B CANCER, V86, P358; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SAKAI A, 1992, NUCLEIC ACIDS RES, V20, P6227, DOI 10.1093/nar/20.23.6227; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Tharun S, 1999, GENETICS, V151, P1273; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Wreden C, 1997, DEVELOPMENT, V124, P3015	52	462	472	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					377	386		10.1016/S0092-8674(01)00225-2	http://dx.doi.org/10.1016/S0092-8674(01)00225-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239395	Bronze			2022-12-01	WOS:000167003100008
J	Stark, H; Dube, P; Luehrmann, R; Kastner, B				Stark, H; Dube, P; Luehrmann, R; Kastner, B			Arrangement of RNA and proteins in the spliceosomal U1 small nuclear ribonucleoprotein particle	NATURE			English	Article							ELECTRON-MICROSCOPY; SNRNP; RESOLUTION; COMPLEXES; IDENTIFICATION; ORGANIZATION; PRINCIPLE; JUNCTIONS; DOMAIN; 70K	In eukaryotic cells, freshly synthesized messenger RNA (pre-mRNA) contains stretches of non-coding RNA that must be excised before the RNA can be translated into protein. Their removal is catalysed by the spliceosome, a large complex formed when a number of small nuclear ribonucleoprotein particles (snRNPs) bind sequentially to the pre-mRNA. The first snRNP to bind is called U1; other snRNPs (U2, U4/U6 and U5) follow(1). Here we describe the three-dimensional structure of human U1 snRNP, determined by single-particle electron cryomicroscopy at 10 Angstrom resolution. The reconstruction reveals a doughnut-shaped central element that accommodates the seven Sm proteins common to all snRNPs, supporting a proposed model of circular Sm protein arrangement(2). By taking earlier biochemical results into account, we were able to assign the remaining density of the map to the other known components of U1 snRNP, deriving a structural model that describes the three-dimensional arrangement of proteins and RNA in U1 snRNP.	Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Stark, H (corresponding author), Inst Mol Biol & Tumorforsch, Emil Mannkopfstr 2, D-35037 Marburg, Germany.	Holger.Stark@mpibpc.mpg.de		Holger, Stark/0000-0002-6161-1118				ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; DUCKETT DR, 1995, CELL, V83, P1027, DOI 10.1016/0092-8674(95)90218-X; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hartmuth K, 1999, J MOL BIOL, V285, P133, DOI 10.1006/jmbi.1998.2300; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HOET RM, 1993, NUCLEIC ACIDS RES, V21, P5130, DOI 10.1093/nar/21.22.5130; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1990, P NATL ACAD SCI USA, V87, P1710, DOI 10.1073/pnas.87.5.1710; KASTNER B, 1992, J CELL BIOL, V116, P839, DOI 10.1083/jcb.116.4.839; KROL A, 1990, NUCLEIC ACIDS RES, V18, P3803, DOI 10.1093/nar/18.13.3803; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; LIN WL, 1984, J MOL BIOL, V180, P947, DOI 10.1016/0022-2836(84)90265-1; Moore M., 1993, RNA WORLD, P303; NAGAI K, 1994, RNA PROTEIN INTERACT, P150; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; TAZI J, 1993, NATURE, V363, P283, DOI 10.1038/363283a0; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; VANHEEL M, 1986, OPTIK, V73, P119; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; vanVenrooij WJ, 1995, CURR OPIN IMMUNOL, V7, P819, DOI 10.1016/0952-7915(95)80054-9; Walter F, 1998, RNA, V4, P719, DOI 10.1017/S135583829898030X; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8	29	194	201	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					539	542		10.1038/35054102	http://dx.doi.org/10.1038/35054102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206553				2022-12-01	WOS:000166570500054
J	Rivkin, RB; Legendre, L				Rivkin, RB; Legendre, L			Biogenic carbon cycling in the upper ocean: Effects of microbial respiration	SCIENCE			English	Article							BACTERIAL PRODUCTION; PLANKTON COMMUNITY; AQUATIC SYSTEMS; GROWTH; TEMPERATURE; ZOOPLANKTON; EXCRETION; BALANCE; RATIO; RATES	Food-web processes are important controls of oceanic biogenic carbon flux and ocean-atmosphere carbon dioxide exchange. Two key controlling parameters are the growth efficiencies of the principal trophic components and the rate of carbon remineralization. We report that bacterial growth efficiency is an inverse function of temperature. This relationship permits bacterial respiration in the euphotic zone to be computed from temperature and bacterial production. Using the temperature-growth efficiency relationship, we show that bacterial respiration generally accounts for most community respiration. This implies that a Larger fraction of assimilated carbon is respired at Low than at high latitudes, so a greater proportion of production can be exported in polar than in tropical regions, Because bacterial production is also a function of temperature, it should be possible to compute euphotic zone heterotrophic respiration at Large scales using remotely sensed information.	Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada; Lab Oceanog Villefranche, F-06234 Villefranche Sur Mer, France	Memorial University Newfoundland; UDICE-French Research Universities; Sorbonne Universite	Rivkin, RB (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada.							ANDERSON TR, 1992, J PLANKTON RES, V14, P1645, DOI 10.1093/plankt/14.12.1645; CARON DA, 1986, APPL ENVIRON MICROB, V52, P1340, DOI 10.1128/AEM.52.6.1340-1347.1986; CHOI JW, 1992, APPL ENVIRON MICROB, V58, P593, DOI 10.1128/AEM.58.2.593-599.1992; CHRISTIAN RR, 1974, CAN J MICROBIOL, V20, P1341, DOI 10.1139/m74-207; Del Giorgio P.A., 2000, MICROBIAL ECOLOGY OC, P289, DOI DOI 10.1146/ANNUREV.ECOLSYS.29.1.503; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fourqurean JW, 1997, ESTUAR COAST SHELF S, V44, P493, DOI 10.1006/ecss.1996.0130; HERBERT RA, 1977, ARCH MICROBIOL, V113, P215, DOI 10.1007/BF00492028; JAHNKE RA, 1995, LIMNOL OCEANOGR, V40, P436, DOI 10.4319/lo.1995.40.2.0436; JENSEN LM, 1990, MAR ECOL PROG SER, V61, P75, DOI 10.3354/meps061075; LEFEVRE D, 1994, J EXP MAR BIOL ECOL, V184, P201, DOI 10.1016/0022-0981(94)90005-1; PAYNE WJ, 1978, ANNU REV MICROBIOL, V32, P155, DOI 10.1146/annurev.mi.32.100178.001103; RASSOULZADEGAN F, 1982, ANN I OCEANOGR PARIS, V58, P177; REID PC, 1988, PROTOZOA THEIR ROLE; SAMPOU P, 1994, MAR ECOL-PROG SER, V110, P240; Sarmiento JL, 1996, SCIENCE, V274, P1346, DOI 10.1126/science.274.5291.1346; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SATHYENDRANATH S, 1991, NATURE, V353, P129, DOI 10.1038/353129a0; Sherr EB, 1996, AQUAT MICROB ECOL, V11, P91, DOI 10.3354/ame011091; Straile D, 1997, LIMNOL OCEANOGR, V42, P1375, DOI 10.4319/lo.1997.42.6.1375; VERITY PG, 1985, LIMNOL OCEANOGR, V30, P1268, DOI 10.4319/lo.1985.30.6.1268; Weiss R. F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147; Williams P.J.I.B., 2000, MICROBIAL ECOLOGY OC, P153; Williams PJL, 1998, NATURE, V394, P55; WILLIAMS PJL, 1983, HETEROTROPHIC ACTIVI, P375; WOODS J, 1993, J PLANKTON RES, V15, P1053, DOI 10.1093/plankt/15.9.1053	32	327	338	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2398	2400		10.1126/science.291.5512.2398	http://dx.doi.org/10.1126/science.291.5512.2398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264533				2022-12-01	WOS:000167618700052
J	Agarwala, S; Sanders, TA; Ragsdale, CW				Agarwala, S; Sanders, TA; Ragsdale, CW			Sonic hedgehog control of size and shape in midbrain pattern formation	SCIENCE			English	Article							FLOOR PLATE; MORPHOGEN GRADIENT; GENE-EXPRESSION; NEURAL-TUBE; INDUCTION; CHICK; SPECIFICATION; NOTOCHORD; HOMOLOG; LIMB	Little is known about how patterns of cell types are organized to form brain structures of appropriate size and shape. To study this process, we employed in vivo electroporation during midbrain development to create ectopic sources of Sonic: Hedgehog, a signaling molecule previously shown to specify different neuronal cell types in a concentration-dependent manner in vitro. We provide direct evidence that a Sonic Hedgehog source can control pattern at a distance in brain development and demonstrate that the sire, shape, and orientation of the cell populations produced depend on the geometry of the morphogen source. Thus, a single regulatory molecule can coordinate tissue size and shape with cell-type identity in brain development.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Ragsdale, CW (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	cliff@drugs.bsd.uchicago.edu						BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Day SJ, 2000, DEVELOPMENT, V127, P2977; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Grove EA, 1998, DEVELOPMENT, V125, P2315; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; JOHNSON AD, 1995, DEV GENET, V17, P280, DOI 10.1002/dvg.1020170313; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Marigo V, 1996, DEVELOPMENT, V122, P1225; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V233, P45, DOI 10.1006/bbrc.1997.6361; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Placzek M, 2000, CURR OPIN NEUROBIOL, V10, P15, DOI 10.1016/S0959-4388(99)00060-4; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Sakamoto K, 1998, FEBS LETT, V426, P337, DOI 10.1016/S0014-5793(98)00369-X; SANDERS T, UNPUB; Watanabe Y, 2000, DEVELOPMENT, V127, P1131; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	26	143	146	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2147	2150		10.1126/science.1058624	http://dx.doi.org/10.1126/science.1058624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251119				2022-12-01	WOS:000167563800039
J	Kessler, A; Baldwin, IT				Kessler, A; Baldwin, IT			Defensive function of herbivore-induced plant volatile emissions in nature	SCIENCE			English	Article							SYSTEMIC PRODUCTION; ENEMIES	Herbivore attack is known to increase the emission of volatiles, which attract predators to herbivore-damaged plants in the laboratory and agricultural systems. We quantified volatile emissions from Nicotiana attenuata plants growing in natural populations during attack by three species of leaf-feeding herbivores and mimicked the release of five commonly emitted volatiles individually. Three compounds (cis-3-hexen-1-ol, Linalool, and cis-alpha -bergamotene) increased egg predation rates by a generalist predator; Linalool and the complete blend decreased Lepidopteran oviposition rates. As a consequence, a plant could reduce the number of herbivores by more than 90% by releasing volatiles. These results confirm that indirect defenses can operate in nature.	Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Kessler, Andre/C-7810-2014	Kessler, Andre/0000-0002-1797-7518; Baldwin, Ian/0000-0001-5371-2974				Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1993, J CHEM ECOL, V19, P581, DOI 10.1007/BF00994327; Halitschke R, 2000, OECOLOGIA, V124, P408, DOI 10.1007/s004420000389; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Karban R., 2007, INDUCED RESPONSES HE; KESSLER A, UNPUB; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1217, DOI 10.1007/BF02228321; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pare PW, 1998, PHYTOCHEMISTRY, V47, P521, DOI 10.1016/S0031-9422(97)00442-1; Preston CA, 2000, ECOLOGY, V81, P293; Scutareanu P, 1997, J CHEM ECOL, V23, P2241, DOI 10.1023/B:JOEC.0000006671.53045.16; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041	21	1438	1609	13	729	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2141	2144		10.1126/science.291.5511.2141	http://dx.doi.org/10.1126/science.291.5511.2141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251117				2022-12-01	WOS:000167563800037
J	Kienast, M; Steinke, S; Stattegger, K; Calvert, SE				Kienast, M; Steinke, S; Stattegger, K; Calvert, SE			Synchronous tropical South China Sea SST change and Greenland warming during deglaciation	SCIENCE			English	Article							LAST DEGLACIATION; SURFACE TEMPERATURES; EQUATORIAL PACIFIC; AMS FACILITY; ATLANTIC; OCEAN; CLIMATE; SYSTEM; U-37(K'); RECORDS	The tropical ocean plays a major role in global climate, It is therefore crucial to establish the precise phase between tropical and high-latitude climate variability during past abrupt climate events in order to gain insight into the mechanisms of global climate change. Here we present alkenone sea surface temperature (SST) records from the tropical South China Sea that show an abrupt temperature increase of at least 1 degreesC at the end of the Last glacial period. Within the recognized dating uncertainties, this SST increase is synchronous with the Bolling warming observed at 14.6 thousand years ago in the Greenland Ice Sheet Project 2 ice core.	Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; Univ Kiel, Inst Geowissensch, Kiel, Germany	University of British Columbia; University of Kiel	Kienast, M (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.							ANDERSON DM, 1993, QUATERNARY SCI REV, V12, P465, DOI 10.1016/S0277-3791(05)80010-1; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cayre O, 1999, QUATERNARY RES, V52, P337, DOI 10.1006/qres.1999.2083; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; DUPLESSY JC, 1991, EARTH PLANET SC LETT, V103, P27, DOI 10.1016/0012-821X(91)90147-A; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; KIENAST SS, IN PRESS GEOPHYS RES; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LYLE MW, 1992, NATURE, V355, P812, DOI 10.1038/355812a0; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Mix AC, 1996, SOUTH ATLANTIC, P503; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Nadeau MJ, 1997, NUCL INSTRUM METH B, V123, P22, DOI 10.1016/S0168-583X(96)00730-6; Nurnberg D, 2000, PALEOCEANOGRAPHY, V15, P124, DOI 10.1029/1999PA000370; Pelejero C, 1997, GEOCHIM COSMOCHIM AC, V61, P4789, DOI 10.1016/S0016-7037(97)00280-9; Pelejero C, 1999, PALEOCEANOGRAPHY, V14, P224, DOI 10.1029/1998PA900015; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Schleicher M, 1998, RADIOCARBON, V40, P85; STATTEGGER K, 1997, 86 U KIEL GEOL PAL I; STEINKE S, IN PRESS QUATL RES; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Villanueva J, 1997, J CHROMATOGR A, V757, P145, DOI 10.1016/S0021-9673(96)00669-3; Wang L, 1999, MAR GEOL, V156, P245, DOI 10.1016/S0025-3227(98)00182-0	28	176	204	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2132	2134		10.1126/science.1057131	http://dx.doi.org/10.1126/science.1057131			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251114				2022-12-01	WOS:000167563800034
J	Chai, JJ; Shiozaki, E; Srinivasula, SM; Wu, Q; Dataa, P; Alnemri, ES; Shi, YG				Chai, JJ; Shiozaki, E; Srinivasula, SM; Wu, Q; Dataa, P; Alnemri, ES; Shi, YG			Structural basis of caspase-7 inhibition by XIAP	CELL			English	Article							APOPTOSIS PROTEIN XIAP; 3-DIMENSIONAL STRUCTURE; BRAIN INJURY; CELL-DEATH; SMAC/DIABLO; ACTIVATION; ENZYME; SPECIFICITIES; BINDING; FAMILY	The inhibitor of apoptosis (IAP) proteins suppress cell death by inhibiting the catalytic activity of caspases. Here we present the crystal structure of caspase-7 in complex with a potent inhibitory fragment from XIAP at 2.45 Angstrom resolution. An 18-residue XIAP peptide binds the catalytic groove of caspase-7, making extensive contacts to the residues that are essential for its catalytic activity. Strikingly, despite a reversal of relative orientation, a subset of interactions between caspase-7 and XIAP closely resemble those between caspase-7 and its tetrapeptide inhibitor DEVD-CHO. Our biochemical and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7. This study provides a structural basis for the design of the next-generation caspase inhibitors.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Princeton University; Jefferson University	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu	Alnemri, Emad S/B-4526-2010	Shi, Yigong/0000-0003-2030-168X; Chai, Jijie/0000-0001-7591-3873				Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; GREEN DR, 1995, CURR OPIN IMMUNOL, V7, P694, DOI 10.1016/0952-7915(95)80079-4; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; SRINIVASULA SM, 2001, IN PRESS NATURE; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SUN C, 2000, IN PRESS J BIOL CHEM; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	39	448	479	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					769	780		10.1016/S0092-8674(02)02034-2	http://dx.doi.org/10.1016/S0092-8674(02)02034-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257230	Bronze			2022-12-01	WOS:000167531100016
J	Kousteni, S; Bellido, T; Plotkin, LI; O'Brien, CA; Bodenner, DL; Han, L; Han, K; DiGregorio, GB; Katzenellenbogen, JA; Katzenellenbogen, BS; Roberson, PK; Weinstein, RS; Jilka, RL; Manolagas, SC				Kousteni, S; Bellido, T; Plotkin, LI; O'Brien, CA; Bodenner, DL; Han, L; Han, K; DiGregorio, GB; Katzenellenbogen, JA; Katzenellenbogen, BS; Roberson, PK; Weinstein, RS; Jilka, RL; Manolagas, SC			Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity	CELL			English	Article							HORMONE-BINDING DOMAIN; OSTEOBLAST APOPTOSIS; PEPTIDE ANTAGONISTS; C-SRC; PHOSPHORYLATION; MECHANISMS; OSTEOCYTE; LIGAND; ALPHA; CELLS	The relationship of the classical receptors and their transcriptional activity to nongenotropic effects of steroid hormones is unknown. We demonstrate herein a novel paradigm of sex steroid action on osteoblasts, osteocytes, embryonic fibroblasts, and HeLa cells involving activation of a Src/Shc/ERK signaling pathway and attenuating apoptosis. This action is mediated by the ligand binding domain and eliminated by nuclear targeting of the receptor protein; ER alpha, ER beta, or AR can transmit it with similar efficiency irrespective of whether the ligand is an estrogen or an androgen. This antiapoptotic action can be dissociated from the transcriptional activity of the receptor with synthetic ligands, providing proof of principle for the development of function-specific-as opposed to tissue-selective-and gender-neutral pharmacotherapeutics.	Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA; Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA; Univ Illinois, Dept Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Manolagas, SC (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA.	manolagasstavros@uams.edu	O'Brien, Charles A./AAL-5078-2020; Plotkin, Lilian/H-7188-2019	Plotkin, Lilian/0000-0002-9537-4544	NIAMS NIH HHS [R01-AR43003] Funding Source: Medline; NIA NIH HHS [P01-AG13918] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BINDAL RD, 1987, J STEROID BIOCHEM, V28, P361, DOI 10.1016/0022-4731(87)91052-1; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Ekena K, 1996, J BIOL CHEM, V271, P20053, DOI 10.1074/jbc.271.33.20053; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; KATZENELLENBOGEN BS, 1978, MOL CELL ENDOCRINOL, V10, P103, DOI 10.1016/0303-7207(78)90063-1; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kraus WL, 1997, J STEROID BIOCHEM, V63, P175, DOI 10.1016/S0960-0760(97)00089-7; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MCEWEN BS, 1909, ENDOCR REV, V20, P279; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nawaz Z, 1999, CANCER RES, V59, P372; Noble BS, 2000, MOL CELL ENDOCRINOL, V159, P7, DOI 10.1016/S0303-7207(99)00174-4; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; OURSLER MJ, 1993, ANN MED, V25, P361, DOI 10.3109/07853899309147298; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; POTTRATZ ST, 1994, J CLIN INVEST, V93, P944, DOI 10.1172/JCI117100; RAYNAUD JP, 1978, CANCER RES, V38, P3044; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schodin DJ, 1995, J BIOL CHEM, V270, P31163, DOI 10.1074/jbc.270.52.31163; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Solomon KR, 2000, J BONE MINER RES, V15, P2380, DOI 10.1359/jbmr.2000.15.12.2380; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SZEDLACSEK SE, 1995, METHOD ENZYMOL, V249, P144; Vanderschueren D, 1998, BONE, V23, P391, DOI 10.1016/S8756-3282(98)00131-8; Walk SF, 1998, EUR J IMMUNOL, V28, P2265, DOI 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WRENN CK, 1993, J BIOL CHEM, V268, P24089; Zhang ZY, 2000, J BIOL CHEM, V275, P37219, DOI 10.1074/jbc.M001818200	49	966	1041	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					719	730		10.1016/S0092-8674(01)00268-9	http://dx.doi.org/10.1016/S0092-8674(01)00268-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257226	Bronze			2022-12-01	WOS:000167531100012
J	Schmitz, D; Mellor, J; Nicoll, RA				Schmitz, D; Mellor, J; Nicoll, RA			Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses	SCIENCE			English	Article							SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; INHIBITION; ACTIVATION; CALCIUM; AMPA; ENHANCEMENT; DEPENDENCE; MODULATION; PLASTICITY	Inhibition of transmitter release by presynaptic receptors is widespread in the central nervous system and is typically mediated via metabotropic receptors; In contrast, very little is known about facilitatory receptors, and synaptic activation of a facilitatory autoreceptor has not been established. Here we show that activation of presynaptic kainate receptors can facilitate transmitter release from hippocampal mossy fiber synapses. Synaptic activation of these presumed ionotropic kainate receptors is very fast (<10 ms) and Lasts for seconds. Thus, these presynaptic kainate receptors contribute to the shortterm plasticity characteristics of mossy fiber synapses, which were previously thought to be an intrinsic property of the synapse.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Byrne JH, 1996, J NEUROSCI, V16, P425; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; DELANEY K, 1991, J NEUROSCI, V11, P2631; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; Eccles, 2013, PHYSL SYNAPSES; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; SCHMITZ D, UNPUB; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	28	217	222	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1972	1976		10.1126/science.1057105	http://dx.doi.org/10.1126/science.1057105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239159				2022-12-01	WOS:000167401600049
J	Chien, P; Weissman, JS				Chien, P; Weissman, JS			Conformational diversity in a yeast prion dictates its seeding specificity	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; SUP35 PROTEIN; TRANSLATION TERMINATION; SPECIES BARRIER; RELEASE FACTOR; RODS CONTAIN; IN-VITRO; PROPAGATION; DETERMINANT; PSI(+)	A perplexing feature of prion-based inheritance is that prions composed of the same polypeptide can evoke different phenotypes (such as distribution of brain lesions), even when propagated in genetically identical hosts(1-3). The molecular basis of this strain diversity and the relationship between strains and barriers limiting transmission between species remain unclear. We have used the yeast prion phenomenon [PSI+](4) to investigate these issues and examine the role that conformational differences(1,2,5) may have in prion strains. We have made a chimaeric fusion between the prion domains of two species (Saccharomyces cerevisae and Candida albicans) of Sup35, the protein responsible for [PSI+](4,6). Here we report that this chimaera forms alternate prion strains in vivo when initiated by transient overexpression of different Sup35 species. Similarly, in vitro the purified chimaera, when seeded with different species of Sup35 fibres, establishes and propagates distinct amyloid conformations. These fibre conformations dictate amyloid seeding specificity: a chimaera seeded by S. cerevisiae fibres efficiently catalyses conversion of S. cerevisiae Sup35 but not of C. albicans Sup35, and vice versa. These and other considerations(1,2,5,7,8) argue that heritable prion strains result from self-propagating conformational differences within the prion protein itself. Moreover, these conformational differences seem to act in concert with the primary structure to determine a prion's propensity for transmission across a species barrier.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, Grad Grp Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, Grad Grp Biophys, San Francisco, CA 94143 USA.			Weissman, Jonathan/0000-0003-2445-670X				Appel TR, 1999, BIOL CHEM, V380, P1295, DOI 10.1515/BC.1999.165; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TUITE MF, 1981, GENETICS, V98, P691; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	30	128	130	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					223	227		10.1038/35065632	http://dx.doi.org/10.1038/35065632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242084				2022-12-01	WOS:000167320500050
J	Stasch, JP; Becker, EM; Alonso-Alija, C; Apeler, H; Dembowsky, K; Feurer, A; Gerzer, R; Minuth, T; Perzborn, E; Pleiss, U; Schroder, H; Schroeder, W; Stahl, E; Steinke, W; Straub, A; Schramm, M				Stasch, JP; Becker, EM; Alonso-Alija, C; Apeler, H; Dembowsky, K; Feurer, A; Gerzer, R; Minuth, T; Perzborn, E; Pleiss, U; Schroder, H; Schroeder, W; Stahl, E; Steinke, W; Straub, A; Schramm, M			NO-independent regulatory site on soluble guanylate cyclase	NATURE			English	Article							NITRIC-OXIDE; NOBEL LECTURE; YC-1; 1H-<1,2,4>OXADIAZOLO<4,3-A>QUINOXALIN-1-ONE; ACTIVATION; EXPRESSION; INHIBITOR; DISCOVERY; CO	Nitric oxide (NO) is a widespread, potent, biological mediator that has many physiological and pathophysiological roles(1). Research in the field of NO appears to have followed a straightforward path, and the findings have been progressive: NO and cyclic GMP are involved in vasodilatation; glycerol trinitrate relaxes vascular smooth muscles by bioconversion to NO; mammalian cells synthesize NO; and last, NO mediates vasodilatation by stimulating the soluble guanylate cyclase (sGC), a heterodimeric (alpha/beta) haem protein that converts GTP to cGMP(2-4). Here we report the discovery of a regulatory site on sGC. Using photoaffinity labelling, we have identified the cysteine 238 and cysteine 243 region in the alpha (1)-subunit of sGC as the target for a new type of sGC stimulator. Moreover, we present a pyrazolopyridine, BAY 41-2272, that potently stimulates sGC through this site by a mechanism that is independent of NO. This results in antiplatelet activity, a strong decrease in blood pressure and an increase in survival in a low-NO rat model of hypertension, and as such may offer an approach for treating cardiovascular diseases.	Bayer AG, Pharma Res Ctr, D-42096 Wuppertal, Germany; Univ Halle Wittenberg, Sch Pharm, D-06099 Halle Saale, Germany; DLR, Inst Aerosp Med, D-51147 Cologne, Germany	Bayer AG; Martin Luther University Halle Wittenberg; Helmholtz Association; German Aerospace Centre (DLR)	Stasch, JP (corresponding author), Bayer AG, Pharma Res Ctr, Aprather Way 18A, D-42096 Wuppertal, Germany.	johannes-peter-stasch.js@bayer-ag.de						AHR HJ, 1994, XENOBIOT METAB DISPO, V9, P371; Becker EM, 1999, NITRIC OXIDE-BIOL CH, V3, P55, DOI 10.1006/niox.1999.0207; Becker EM, 2000, J CARDIOVASC PHARM, V35, P390, DOI 10.1097/00005344-200003000-00007; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Brunner F, 1996, J PHARMACOL EXP THER, V277, P48; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Furchgott RF, 1999, ANGEW CHEM INT EDIT, V38, P1870, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1870::AID-ANIE1870>3.0.CO;2-8; Galle J, 1999, BRIT J PHARMACOL, V127, P195, DOI 10.1038/sj.bjp.0702495; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; HIRTHDIETRICH C, 1994, N-S ARCH PHARMACOL, V350, pR6; Hobbs AJ, 1997, TRENDS PHARMACOL SCI, V18, P484, DOI 10.1016/S0165-6147(97)01137-1; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; Ignarro LJ, 1999, ANGEW CHEM INT EDIT, V38, P1882, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1882::AID-ANIE1882>3.0.CO;2-V; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mulsch A, 1997, BRIT J PHARMACOL, V120, P681, DOI 10.1038/sj.bjp.0700982; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; NAKANE M, 1990, J BIOL CHEM, V265, P16841; Schrammel A, 1996, MOL PHARMACOL, V50, P1; STASCH JP, 1989, EUR J PHARMACOL, V174, P279, DOI 10.1016/0014-2999(89)90321-X; STRAUB A, 2000, Patent No. 200006568; WU CC, 1995, BRIT J PHARMACOL, V116, P1973, DOI 10.1111/j.1476-5381.1995.tb16400.x; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x; Zhao Y, 1998, BIOCHEMISTRY-US, V37, P4502, DOI 10.1021/bi972686m	28	444	468	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					212	215		10.1038/35065611	http://dx.doi.org/10.1038/35065611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242081				2022-12-01	WOS:000167320500047
J	Xu, X; Zhou, HH; Prum, RO				Xu, X; Zhou, HH; Prum, RO			Branched integumental structures in Sinornithosaurus and the origin of feathers	NATURE			English	Article							YIXIAN FORMATION; DINOSAUR	The evolutionary origin of feathers has long been obscured because no morphological antecedents were known to the earliest, structurally modern feathers of Archaeopteryx(1). It has been proposed that the filamentous integumental appendages on several theropod dinosaurs are primitive feathers(2-6); but the homology between these filamentous structures and feathers has been disputed(7-9), and two taxa with true feathers (Caudipteryx and Protarchaeopteryx) have been proposed to be flightless birds(8,10). Confirmation of the theropod origin of feathers requires documentation of unambiguously feather-like structures in a clearly non-avian theropod. Here we describe our observations of the filamentous integumental appendages of the basal dromaeosaurid dinosaur Sinornithosaurus millenii, which indicate that they are compound structures composed of multiple filaments. Furthermore, these appendages exhibit two types of branching structure that are unique to avian feathers: filaments joined in a basal tuft, and filaments joined at their bases in series along a central filament. Combined with the independent phylogenetic evidence supporting the theropod ancestry of birds(11-13), these observations strongly corroborate the hypothesis that the integumental appendages of Sinornithosaurus are homologous with avian feathers. The plesiomorphic feathers of Sinornithosaurus also conform to the predictions of an independent, developmental model of the evolutionary origin of feathers(14).	Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA	University of Kansas; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Kansas	Prum, RO (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	prum@ukans.edu		Prum, Richard/0000-0002-4741-7132				Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Dalton R, 2000, NATURE, V406, P926, DOI 10.1038/35023316; DEBEER G, 1954, STUDY BASED BRIT MUS; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2nd; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Gibbons A, 1997, SCIENCE, V278, P1229; GRAU VJ, 1994, BIOL PATOLOGIA CHINC; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Lucas A.M., 1972, AVIAN ANATOMY INTEGU; Nowak R.M., 1983, WALKERS MAMMALS WORL; Prum RO, 1999, J EXP ZOOL, V285, P291; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	18	146	165	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					200	204		10.1038/35065589	http://dx.doi.org/10.1038/35065589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242078				2022-12-01	WOS:000167320500044
J	Spitz, F; Duboule, D				Spitz, F; Duboule, D			Development - The art of making a joint	SCIENCE			English	Editorial Material							MUTATIONS; MEMBERS; FAMILY; LIMB		Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Spitz, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.			duboule, denis/0000-0001-9961-2960				Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; SHUBIN NH, 1986, EVOL BIOL, V20, P319; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537	10	14	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1713	1714		10.1126/science.1059665	http://dx.doi.org/10.1126/science.1059665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253195				2022-12-01	WOS:000167320600033
J	Galas, DJ				Galas, DJ			Sequence interpretation - Making sense of the sequence	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; PREDICTION; GENES; DNA		Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA	Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Galas, DJ (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.	David_Galas@kgi.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Claverie JM, 1997, HUM MOL GENET, V6, P1735, DOI 10.1093/hmg/6.10.1735; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HAUSSLER D, 1998, TRENDS BIOCH SCI S, V23, P12; Hubbard T, 2000, NATURE, V403, P825, DOI 10.1038/35002770; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lewis S, 2000, CURR OPIN STRUC BIOL, V10, P349, DOI 10.1016/S0959-440X(00)00095-6; Pavy N, 1999, BIOINFORMATICS, V15, P887, DOI 10.1093/bioinformatics/15.11.887; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; 2000, GENOME RES, V10	21	21	23	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1257	+		10.1126/science.291.5507.1257	http://dx.doi.org/10.1126/science.291.5507.1257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233451				2022-12-01	WOS:000166993400030
J	Tomlinson, JW; Holden, N; Hills, RK; Wheatley, K; Clayton, RN; Bates, AS; Sheppard, MC; Stewart, PM				Tomlinson, JW; Holden, N; Hills, RK; Wheatley, K; Clayton, RN; Bates, AS; Sheppard, MC; Stewart, PM		W Midlands Prospective Hypopituita	Association between premature mortality and hypopituitarism	LANCET			English	Article							GROWTH-HORMONE DEFICIENCY; CARDIOVASCULAR RISK-FACTORS; PITUITARY-TUMORS; LIFE EXPECTANCY; ADULTS; DISEASE; REPLACEMENT; RADIATION; THERAPY	Background Four retrospective studies have reported premature mortality in patients with hypopituitarism with standard mortality ratios (SMRs) varying between 1.20 and 2.17. Patients with hypopituitarism have complex endocrine deficiencies, and the mechanisms underpinning any excess mortality are unknown. Furthermore, the suggestion has emerged that endogenous growth-hormone deficiency might account for any excess mortality. We aimed to clarify these issues by doing a large prospective study of total, and specific-cause mortality in patients with hypopituitarism. Methods We followed up 1014 UK patients (514 men, 500 women) with hypopituitarism from January, 1992, to January, 2000, 573 (57%) patients had non-functioning adenomas, 118 (12%) craniopharyngiomas, and 93 (9%) prolactinomas. SMRs were calculated as the ratio of observed deaths to the number of deaths in an age-matched and sex-matched UK population. Findings The number of observed deaths was 181 compared with the 96.7 expected (SMR 1.87 [99% CI 1.62-2.16], p<0.0001). Univariate analysis indicated that mortality was higher in women (2.29 [1.86-2.82]) than men (1.57 [1.28-1.93], p=0.002), in younger patients, in patients with an underlying diagnosis of craniopharyngioma (9.28 [5.84-14.75] vs 1.61 [1.30-1.99], p<0.0001), and in the 353 patients treated with radiotherapy (2.32 [1.71-3.14] vs 1.66 [1.30-2.13], p=0.004). Excess mortality was attributed to cardiovascular (1.82 [1.30-2.54], p<0.0001), respiratory (2.66 [1.72-4.11], p<0.0001), and cerebrovascular (2.44 [1.58-4.18], p<0.0001) causes. There was no effect of hormonal deficiency on mortality, except for gonadotropin deficiency, which, if untreated was associated with excess mortality (untreated 2.97 [2.13-4.13] vs treated 1.42 [0.97-2.07], p<0.0001). Multiple regression analyses identified age at diagnosis, sex, a diagnosis of craniopharyngioma, and untreated gonadotropin deficiency as independent significant factors affecting mortality. Interpretation Patients with hypopituitarism have excess mortality, predominantly from vascular and respiratory disease. Age at diagnosis, female sex, and above all, craniopharyngioma were significant independent risk factors. Specific endocrine-axis deficiency, with the exception of untreated gonadotropin deficiency, does not seem to have a role.	Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England; Univ Birmingham, Clin Trials Unit, Birmingham, W Midlands, England; N Staffordshire Hosp, Postgrad Med Sch, Dept Med, Stoke On Trent, Staffs, England; Sollhill Hosp, Dept Med, Solihull, W Midlands, England	University of Birmingham; University of Birmingham; Keele University; University Hospital of North Staffordshire NHS Trust	Stewart, PM (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.			Hills, Robert/0000-0003-0166-0062; Tomlinson, Jeremy/0000-0002-3170-8533				Bates AS, 1999, CLIN ENDOCRINOL, V50, P315, DOI 10.1046/j.1365-2265.1999.00650.x; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; BATES AS, 1993, Q J MED, V86, P293; BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BITZER M, 1995, STROKE, V26, P131, DOI 10.1161/01.STR.26.1.131; BOWEN J, 1992, STROKE, V23, P908, DOI 10.1161/01.STR.23.6.908; Brada M, 1999, INT J RADIAT ONCOL, V45, P693, DOI 10.1016/S0360-3016(99)00159-5; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Erfurth EM, 1999, GROWTH HORM IGF RES, V9, P21, DOI 10.1016/S1096-6374(99)80005-7; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; Evans LM, 1999, CLIN ENDOCRINOL, V50, P457; FLICKINGER JC, 1989, CANCER, V63, P2404, DOI 10.1002/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; FREY H, 1987, ACATA MED SCAND, V272, P163; Gelding SV, 1998, CLIN ENDOCRINOL, V48, P153, DOI 10.1046/j.1365-2265.1998.3641180.x; Gittoes NJL, 1998, CLIN ENDOCRINOL, V48, P331; Maison P, 1998, BRIT MED J, V316, P1132, DOI 10.1136/bmj.316.7138.1132; MURROS KE, 1989, ARCH NEUROL-CHICAGO, V46, P449, DOI 10.1001/archneur.1989.00520400109029; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; PARLE JV, 1993, BRIT J GEN PRACT, V43, P107; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; POLTZ CM, 1952, AM J MED, V13, P597; Rodriguez-Arnao J, 1999, CLIN ENDOCRINOL, V51, P53, DOI 10.1046/j.1365-2265.1999.00737.x; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Stewart PM, 1999, GROWTH HORM IGF RES, V9, P15, DOI 10.1016/S1096-6374(99)80004-5; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Vahl N, 1998, INT J OBESITY, V22, P529, DOI 10.1038/sj.ijo.0800618	30	757	782	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					425	431		10.1016/S0140-6736(00)04006-X	http://dx.doi.org/10.1016/S0140-6736(00)04006-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273062				2022-12-01	WOS:000166865600011
J	Gomis-Ruth, FX; Moncalian, G; Perez-Luque, R; Gonzalez, A; Cabezon, E; de la Cruz, F; Coll, M				Gomis-Ruth, FX; Moncalian, G; Perez-Luque, R; Gonzalez, A; Cabezon, E; de la Cruz, F; Coll, M			The bacterial conjugation protein TrwB resembles ring helicases and F-1-ATPase	NATURE			English	Article							CRYSTAL-STRUCTURE; DNA; MECHANISM; SUBUNITS; PRIMASE; DOMAIN; GENE; CELL; ATP	The transfer of DNA across membranes and between cells is a central biological process; however, its molecular mechanism remains unknown. In prokaryotes, trans-membrane passage by bacterial conjugation, is the main route for horizontal gene transfer. It is the means for rapid acquisition of new genetic information, including antibiotic resistance by pathogens. Transkingdom gene transfer from bacteria to plants(1) or fungi(2) and even bacterial sporulation(3) are special cases of conjugation. An integral membrane DNA-binding protein, called TrwB in the Escherichia coli R388 conjugative system, is essential for the conjugation process. This large multimeric protein is responsible for recruiting the relaxosome DNA-protein complex, and participates in the transfer of a single DNA strand during cell mating. Here we report the three-dimensional structure of a soluble variant of TrwB. The molecule consists of two domains: a nucleotide-binding domain of alpha/beta topology, reminiscent of RecA and DNA ring helicases, and an all-alpha domain. Six equivalent protein monomers associate to form an almost spherical quaternary structure that is strikingly similar to F-1-ATPase. A central channel, 20 Angstrom in width, traverses the hexamer.	CSIC, Inst Mol Biol Barcelona, ES-08034 Barcelona, Spain; Univ Cantabria, CSIC, Lab CIB, Dept Biol Mol, Santander 39011, Spain; DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Coll, M (corresponding author), CSIC, Inst Mol Biol Barcelona, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	mcccri@ibmb.csic.es	Coll, Miquel/L-5999-2014; de la Cruz, Fernando/L-2812-2014; Cabezon, Elena/K-5874-2014; Moncalian, Gabriel/K-3493-2014	Coll, Miquel/0000-0003-4471-8674; de la Cruz, Fernando/0000-0003-4758-6857; Moncalian, Gabriel/0000-0002-3007-6490; Perez Luque, Rosa/0000-0003-0759-0608; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Cabezon, Elena/0000-0002-6177-5016				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Sastre JI, 1998, J BACTERIOL, V180, P6039, DOI 10.1128/JB.180.22.6039-6042.1998; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sheldrick GM, 1997, METHOD ENZYMOL, V276, P628, DOI 10.1016/S0076-6879(97)76083-X; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; STACHEL SE, 1986, CELL, V47, P155, DOI 10.1016/0092-8674(86)90437-X; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	31	271	278	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					637	641		10.1038/35054586	http://dx.doi.org/10.1038/35054586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214325				2022-12-01	WOS:000166692300049
J	Romanov, SR; Kozakiewicz, BK; Holst, CR; Stampfer, MR; Haupt, LM; Tlsty, TD				Romanov, SR; Kozakiewicz, BK; Holst, CR; Stampfer, MR; Haupt, LM; Tlsty, TD			Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes	NATURE			English	Article							TELOMERE DYSFUNCTION; EXPRESSION; IMMORTALIZATION; INACTIVATION; PASSAGE; ARREST; GROWTH; P16; P53	Senescence and genomic integrity are thought to be important barriers in the development of malignant lesions(1). Human fibroblasts undergo a limited number of cell divisions before entering an irreversible arrest, called senescence(2). Here we show that human mammary epithelial cells (HMECs) do not conform to this paradigm of senescence. In contrast to fibroblasts, HMECs exhibit an initial growth phase that is followed by a transient growth plateau (termed selection or M0; refs 3-5), from which proliferative cells emerge to undergo further population doublings (similar to 20-70), before entering a second growth plateau (previously termed senescence or M1; refs 4-6). We rnd that the first growth plateau exhibits characteristics of senescence but is not an insurmountable barrier to further growth. HMECs emerge from senescence, exhibit eroding telomeric sequences and ultimately enter telomere-based crisis to generate the types of chromosomal abnormalities seen in the earliest lesions of breast cancer. Growth past senescent barriers may be a pivotal event in the earliest steps of carcinogenesis, providing many genetic changes that predicate oncogenic evolution. The differences between epithelial cells and fibroblasts provide new insights into the mechanistic basis of neoplastic transformation.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tlsty, TD (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	ttlsty@itsa.ucsf.edu	Haupt, Larisa M/C-6066-2017	Haupt, Larisa M/0000-0002-7735-8110; Holst, Charles/0000-0001-8010-1677				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; BERG JW, 1995, CANCER, V75, P257, DOI 10.1002/1097-0142(19950101)75:1+<257::AID-CNCR2820751311>3.0.CO;2-Y; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Burbano RR, 2000, CANCER GENET CYTOGEN, V119, P62, DOI 10.1016/S0165-4608(99)00175-2; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Foster SA, 1996, ONCOGENE, V12, P1773; Foster SA, 1998, MOL CELL BIOL, V18, P1793, DOI 10.1128/MCB.18.4.1793; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hara E, 1996, MOL CELL BIOL, V16, P859; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huschtscha LI, 1998, CANCER RES, V58, P3508; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Meyer KM, 1999, ONCOGENE, V18, P5795, DOI 10.1038/sj.onc.1202977; PANDIS N, 1995, CANCER, V76, P250, DOI 10.1002/1097-0142(19950715)76:2<250::AID-CNCR2820760215>3.0.CO;2-W; PIGNOLO RJ, 1994, IN VITRO CELL DEV-AN, V30A, P471; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; SHAY JW, 1993, BREAST CANCER RES TR, V25, P83, DOI 10.1007/BF00662404; Stampfer MR, 1997, MOL BIOL CELL, V8, P2391, DOI 10.1091/mbc.8.12.2391; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; TLSTY TD, IN PRESS J MAMMARY G; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WALEN KH, 1989, CANCER GENET CYTOGEN, V37, P249, DOI 10.1016/0165-4608(89)90056-3; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665	28	372	390	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					633	637		10.1038/35054579	http://dx.doi.org/10.1038/35054579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214324	Green Published			2022-12-01	WOS:000166692300048
J	Vendruscolo, M; Paci, E; Dobson, CM; Karplus, M				Vendruscolo, M; Paci, E; Dobson, CM; Karplus, M			Three key residues form a critical contact network in a protein folding transition state	NATURE			English	Article							FREE-ENERGY; DYNAMICS; KINETICS; BINDING; SINGLE; DOMAIN; ORDER	Determining how a protein folds is a central problem in structural biology. The rate of folding of many proteins is determined by the transition state, so that a knowledge of its structure is essential for understanding the protein folding reaction. Here we use mutation measurements-which determine the role of individual residues in stabilizing the transition state(1,2)-as restraints in a Monte Carlo sampling procedure to determine the ensemble of structures that make up the transition state. We apply this approach to the experimental data for the 98-residue protein acylphosphatase(3), and obtain a transition-state ensemble with the native-state topology and an average root-mean-square deviation of 6 Angstrom from the native structure. Although about 20 residues with small positional fluctuations form the structural core of this transition state, the native-like contact network of only three of these residues is sufficient to determine the overall fold of the protein. This result reveals how a nucleation mechanism involving a small number of key residues can lead to folding of a polypeptide chain to its unique native-state structure.	Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QT, England; Univ Strasbourg 1, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	University of Oxford; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University	Dobson, CM (corresponding author), Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, S Parks Rd, Oxford OX1 3QT, England.		Paci, Emanuele/B-1893-2010; Vendruscolo, Michele/F-5901-2012	Paci, Emanuele/0000-0002-4891-2768; Vendruscolo, Michele/0000-0002-3616-1610				Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Berry R. S., 1988, ADV CHEM PHYS, V90, P75; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; Daggett V, 1996, J MOL BIOL, V257, P430, DOI 10.1006/jmbi.1996.0173; Domany E, 1999, PHYSICA A, V263, P158, DOI 10.1016/S0378-4371(98)00494-4; Fersht A, 1999, STRUCTURE MECH PROTE; FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Li L, 2000, NAT STRUCT BIOL, V7, P336; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613; Taddei N, 2000, J MOL BIOL, V300, P633, DOI 10.1006/jmbi.2000.3870; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Vendruscolo M, 1998, FOLD DES, V3, P329, DOI 10.1016/S1359-0278(98)00045-5; Vendruscolo M, 1998, J CHEM PHYS, V109, P11101, DOI 10.1063/1.477748; Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43937; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	30	368	377	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					641	645		10.1038/35054591	http://dx.doi.org/10.1038/35054591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214326				2022-12-01	WOS:000166692300050
J	Honma, T; Goto, K				Honma, T; Goto, K			Complexes of MADS-box proteins are sufficient to convert leaves into floral organs	NATURE			English	Article							HOMEOTIC GENE APETALA3; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; ANTIRRHINUM-MAJUS; IN-VITRO; TRANSCRIPTION; DOMAIN; PISTILLATA; IDENTITY; EXPRESSION	Genetic studies, using floral homeotic mutants, have led to the ABC model of flower development. This model proposes that the combinatorial action of three sets of genes, the A, B and C function genes, specify the four floral organs (sepals, petals, stamens and carpels) in the concentric floral whorls(1,2). However, attempts to convert vegetative organs into floral organs by altering the expression of ABC genes have been unsuccessful(3-5). Here we show that the class B proteins of Arabidopsis, PISTILLATA (PI) and APETALA3 (AP3), interact with APETALA1 (AP1, a class A protein) and SEPALLATA3 (SEP3, previously AGL9), and with AGAMOUS (AG, a class C protein) through SEP3. We also show that vegetative leaves of triply transgenic plants, 35S::PI;35S::AP3;35S::AP1 or 35S::PI;35S::AP3;35S::SEP3, are transformed into petaloid organs and that those of 35S::PI; 35S::AP3;35S::SEP3;35S::AG are transformed into staminoid organs. Our findings indicate that the formation of ternary and quaternary complexes of ABC proteins may be the molecular basis of the ABC model, and that the flower-specific expression of SEP3 restricts the action of the ABC genes to the flower.	Kyoto Univ, Chem Res Inst, Kyoto 6110011, Japan	Kyoto University	Goto, K (corresponding author), Res Inst Biol Sci, Kayo Cho, Okayama 7161241, Japan.							Bartel PL, 1993, CELLULAR INTERACTION, P153; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hill TA, 1998, DEVELOPMENT, V125, P1711; Honma T, 2000, DEVELOPMENT, V127, P2021; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Krizek BA, 1996, DEVELOPMENT, V122, P11; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mandel MA, 1998, SEX PLANT REPROD, V11, P22, DOI 10.1007/s004970050116; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Pan SQ, 1999, PLANT CELL, V11, P1591, DOI 10.1105/tpc.11.8.1591; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Riechmann JL, 1997, BIOL CHEM, V378, P1079; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Rubinelli P, 1998, PLANT MOL BIOL, V37, P607, DOI 10.1023/A:1005964431302; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; SHIRAISHI H, 1993, PLANT J, V4, P385, DOI 10.1046/j.1365-313X.1993.04020385.x; Smyth D, 2000, TRENDS PLANT SCI, V5, P315, DOI 10.1016/S1360-1385(00)01690-3; Tilly JJ, 1998, DEVELOPMENT, V125, P1647; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	31	856	987	14	213	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					525	529		10.1038/35054083	http://dx.doi.org/10.1038/35054083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206550				2022-12-01	WOS:000166570500051
J	Fournier, AE; GrandPre, T; Strittmatter, SM				Fournier, AE; GrandPre, T; Strittmatter, SM			Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration	NATURE			English	Article							NEURITE GROWTH-INHIBITORS; CONE COLLAPSE; SPINAL-CORD; MYELIN; NEUROPILIN-1	Nogo has been identified as a component of the central nervous system (CNS) myelin that prevents axonal regeneration in the adult vertebrate CNS. Analysis of Nogo-A has shown that an axon-inhibiting domain of 66 amino acids is expressed at the extracellular surface and at the endoplasmic reticulum lumen of transfected cells and oligodendrocytes(1). The acidic amino terminus of Nogo-A is detected at the cytosolic face of cellular membranes(1) and may contribute to inhibition of axon regeneration at sites of oligodendrocyte injury(2,3). Here we show that the extracellular domain of Nogo (Nogo-66) inhibits axonal extension, but does not alter non-neuronal cell morphology. In contrast, a multivalent form of the N terminus of Nogo-A affects the morphology of both neurons and other cell types. Here we identify a brain-specific, leucine-rich-repeat protein with high affinity for soluble Nogo-66. Cleavage of the Nogo-66 receptor and other glycophosphatidylinositol-linked proteins from axonal surfaces renders neurons insensitive to Nogo-66. Nogo-66 receptor expression is sufficient to impart Nogo-66 axonal inhibition to unresponsive neurons. Disruption of the interaction between Nogo-66 and its receptor provides the potential for enhanced recovery after human CNS injury.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, POB 208018, New Haven, CT 06520 USA.		Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Buffo A, 2000, J NEUROSCI, V20, P2275; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373	13	883	1027	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					341	346		10.1038/35053072	http://dx.doi.org/10.1038/35053072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201742				2022-12-01	WOS:000166434300047
J	Szostak, JW; Bartel, DP; Luisi, PL				Szostak, JW; Bartel, DP; Luisi, PL			Synthesizing life	NATURE			English	Article							RNA; FUSION; MEMBRANE; PERMEABILITY; RIBOZYMES; TEMPLATE; MICELLES; VESICLES; CALCIUM; ORIGIN	Advances in directed evolution and membrane biophysics make the synthesis of simple living cells, if not yet foreseeable reality, an imaginable goal. Overcoming the many scientific challenges along the way will deepen our understanding of the essence of cellular life and its origin on Earth.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; ETH Zentrum, Inst Polymere, CH-8092 Zurich, Switzerland	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Swiss Federal Institutes of Technology Domain; ETH Zurich	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.							Albalak A, 1996, BIOCHEMISTRY-US, V35, P7936, DOI 10.1021/bi960497i; BACHMANN PA, 1992, NATURE, V357, P57, DOI 10.1038/357057a0; Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; Bartel David P., 1999, Trends in Cell Biology, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BERCLAZ N, IN PRESS J PHYS CH B; Bergman NH, 2000, BIOCHEMISTRY-US, V39, P3115, DOI 10.1021/bi992654u; Blochliger E, 1998, J PHYS CHEM B, V102, P10383, DOI 10.1021/jp981234w; CHAKRABARTI AC, 1994, J MOL EVOL, V39, P555, DOI 10.1007/BF00160400; DOUDNA JA, 1991, SCIENCE, V251, P1605, DOI 10.1126/science.1707185; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GREEN R, 1992, SCIENCE, V258, P1910, DOI 10.1126/science.1470913; Hager AJ, 1996, CHEM BIOL, V3, P717, DOI 10.1016/S1074-5521(96)90246-X; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; INGOLIA TD, 1978, J BIOL CHEM, V253, P3821; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; JOYCE GF, 1991, NEW BIOL, V3, P399; Khvorova A, 1999, P NATL ACAD SCI USA, V96, P10649, DOI 10.1073/pnas.96.19.10649; Luisi PL, 1998, ORIGINS LIFE EVOL B, V28, P613, DOI 10.1023/A:1006517315105; LUISI PL, 1996, ADV CHEM PHYS, V92, P425; Norris V, 1998, ORIGINS LIFE EVOL B, V28, P523, DOI 10.1023/A:1006568226145; OBERHOLZER T, 1995, CHEM BIOL, V2, P677, DOI 10.1016/1074-5521(95)90031-4; PARENTE RA, 1988, J BIOL CHEM, V263, P4724; PRIANO C, 1987, COLD SPRING HARB SYM, V52, P321, DOI 10.1101/SQB.1987.052.01.037; UENO M, 1989, BIOCHEMISTRY-US, V28, P5631, DOI 10.1021/bi00439a044; WALDE P, 1994, J AM CHEM SOC, V116, P7541, DOI 10.1021/ja00096a010; WALDE P, 1994, J AM CHEM SOC, V116, P11649, DOI 10.1021/ja00105a004; WILSCHUT J, 1980, BIOCHEMISTRY-US, V19, P6011, DOI 10.1021/bi00567a011	33	1111	1147	7	379	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					387	390		10.1038/35053176	http://dx.doi.org/10.1038/35053176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201752				2022-12-01	WOS:000166434300060
J	Roig, FA; Le-Quesne, C; Boninsegna, JA; Briffa, KR; Lara, A; Grudd, H; Jones, PD; Villagran, C				Roig, FA; Le-Quesne, C; Boninsegna, JA; Briffa, KR; Lara, A; Grudd, H; Jones, PD; Villagran, C			Climate variability 50,000 years ago in mid-latitude Chile as reconstructed from tree rings	NATURE			English	Article							SOUTHERN LAKE DISTRICT; LLANQUIHUE GLACIATION; ISLA GRANDE; CHRONOLOGY; PLEISTOCENE; ICE	High-resolution proxies of past climate are essential for a better understanding of the climate system(1). Tree rings are routinely used to reconstruct Holocene climate variations at high temporal resolution(2), but only rarely have they offered insight into climate variability during earlier periods(3). Fitzroya cupressoides-a South American conifer which attains ages up to 3,600 years-has been shown to record summer temperatures in northern Patagonia during the past few millennia(4). Here we report a floating 1,229-year chronology developed from subfossil stumps of F. cupressoides in southern Chile that dates back to approximately 50,000 C-14 years before present. We use this chronology to calculate the spectral characteristics of climate variability in this time, which was probably an interstadial (relatively warm) period. Growth oscillations at periods of 150-250, 87-94, 45.5, 24.1, 17.8, 9.3 and 2.7-5.3 years are identified in the annual subfossil record. A comparison with the power spectra of chronologies derived from living F. cupressoides trees shows strong similarities with the 50,000-year-old chronology, indicating that similar growth forcing factors operated in this glacial interstadial phase as in the current interglacial conditions.	Consejo Nacl Invest Cient & Tecn, IANIGLA, Lab Dendrocronol, RA-5500 Mendoza, Argentina; Univ Oviedo, Fac Biol, Dept Bot, E-33006 Oviedo, Spain; Univ Austral Chile, Inst Silvicultura, Valdivia, Chile; Univ E Anglia, Sch Environm Sci, Climate Res Unit, Norwich NR4 7TJ, Norfolk, England; Stockholm Univ, Dept Phys Geog, S-10691 Stockholm, Sweden; Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of Oviedo; Universidad Austral de Chile; University of East Anglia; Stockholm University; Universidad de Chile	Roig, FA (corresponding author), Consejo Nacl Invest Cient & Tecn, IANIGLA, Lab Dendrocronol, CC 330, RA-5500 Mendoza, Argentina.	froig@lab.cricyt.edu.ar	Briffa, Keith/C-8834-2009; Jones, Philip Douglas/C-8718-2009; Grudd, Håkan/G-7952-2012	Jones, Philip Douglas/0000-0001-5032-5493; Grudd, Håkan/0000-0002-9033-2505; Briffa, Keith/0000-0003-3323-3639; Lara, Antonio/0000-0003-4998-4584				BONINSEGNA JA, 1992, CLIMATE A D 1500; BRADLEY RS, 1992, QUATERNARY PALEOCLIM; Burg J. P, 1978, MODERN SPECTRUM ANAL, P42; CLAPPERTON C, 1993, QUATERNARY GEOLOGY G; Cook E.R., 1990, METHODS DENDROCHRONO, DOI [10.1007/978-94-015-7879-0, DOI 10.1007/978-94-015-7879-0]; COOK JA, 1995, PSYCHOTHERAPY REHABI, V4, P5; Denton GH, 1999, GEOGR ANN A, V81A, P167, DOI 10.1111/1468-0459.00057; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; Fritts H.C., 1991, RECONSTRUCTING LARGE; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; Heusser CJ, 2000, J QUATERNARY SCI, V15, P115, DOI 10.1002/(SICI)1099-1417(200002)15:2<115::AID-JQS502>3.0.CO;2-F; Jenkins G.M., 1968, SPECTRAL ANAL ITS AP; KLOHN C, 1976, Z NATURFREUNDE WANDE, P75; Lamy F, 1998, PALAEOGEOGR PALAEOCL, V141, P233, DOI 10.1016/S0031-0182(98)90052-9; LARA A, 1993, SCIENCE, V260, P1104, DOI 10.1126/science.260.5111.1104; LARA A, 2000, DENDROCRONOLOGIA AM, P217; Lara A., 1991, THESIS U COLORADO; Leventer A, 1996, GEOL SOC AM BULL, V108, P1626, DOI 10.1130/0016-7606(1996)108<1626:PCOYIT>2.3.CO;2; Lomnitz C., 1970, SODERDRUCK GEOLOGISC, P938, DOI [10.1007/BF02042278, DOI 10.1007/BF02042278]; Markgraf V, 1992, CLIM DYNAM, V6, P193, DOI 10.1007/BF00193532; Marple S., 1987, DIGITAL SPECTRAL ANA; Miller A, 1976, WORLD SURVEY CLIMATO, V12, P113; OLDFIELD F, 1998, 45 IGBP; PILCHER JR, 1984, NATURE, V312, P150, DOI 10.1038/312150a0; PORTER SC, 1981, QUATERNARY RES, V16, P263, DOI 10.1016/0033-5894(81)90013-2; Roig F, 1996, HOLOCENE, V6, P469, DOI 10.1177/095968369600600410; ROIG FA, 1996, THESIS BASEL U; SALINGER MJ, 1981, NATURE, V291, P106, DOI 10.1038/291106a0; STUIVER M, 1989, NATURE, V338, P405, DOI 10.1038/286868a0; VILLALBA R, 1994, CLIMATIC CHANGE, V26, P183, DOI 10.1007/BF01092413; Villalba R., 1996, CLIMATIC VARIATIONS, P161, DOI [DOI 10.1007/978-3-642-61113-1_9, 10.1007/978-3-642-61113-1_9]	31	65	72	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					567	570		10.1038/35069040	http://dx.doi.org/10.1038/35069040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279491				2022-12-01	WOS:000167859300043
J	Nucifora, FC; Sasaki, M; Peters, MF; Huang, H; Cooper, JK; Yamada, M; Takahashi, H; Tsuji, S; Troncoso, J; Dawson, VL; Dawson, TM; Ross, CA				Nucifora, FC; Sasaki, M; Peters, MF; Huang, H; Cooper, JK; Yamada, M; Takahashi, H; Tsuji, S; Troncoso, J; Dawson, VL; Dawson, TM; Ross, CA			Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity	SCIENCE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CREB-BINDING PROTEIN; EXPANDED POLYGLUTAMINE; NEURODEGENERATIVE DISEASES; GLUTAMINE REPEATS; MUTANT HUNTINGTIN; TRANSGENIC MICE; PALLIDOLUYSIAN ATROPHY; MOUSE MODEL; IN-VIVO	Expanded polyglutamine repeats have been proposed to cause neuronal degeneration in Huntington's disease (HD) and related disorders, through abnormal interactions with other proteins containing short polyglutamine tracts such as the transcriptional coactivator CREB binding protein, CBP. We found that CBP was depleted from its normal nuclear Location and was present in polyglutamine aggregates in HD cell culture models, HD transgenic: mice, and human HD postmortem brain. Expanded polyglutamine repeats specifically interfere with CBP-activated gene transcription, and overexpression of CBP rescued polyglutamine-induced neuronal toxicity. Thus, polyglutamine-mediated interference with CBP-regulated gene transcription may constitute a genetic gain of function, underlying the pathogenesis of polyglutamine disorders.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neuropathol, Baltimore, MD 21205 USA; Niigata Univ, Brain Res Inst, Dept Pathol & Neurol, Niigata 9518585, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Niigata University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.		Ross, Christopher A/H-8395-2013; NUCIFORA, FREDERICK/X-2364-2019; Dawson, Valina/Y-9757-2019	Cooper, Jillian/0000-0002-5850-563X; Dawson, Valina/0000-0002-2915-3970	NINDS NIH HHS [NS34172, NS16375, NS38144, NS37090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016375, R01NS038144, R01NS034172, R01NS037090, P01NS016375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gusella JF, 1996, ANNU REV MED, V47, P201; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HO HN, 1989, GENE, V77, P51; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; IGARASHI S, 2000, SOC NEUR ABSTR, V382, P1030; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Peters MF, 1999, NEUROSCI LETT, V275, P129, DOI 10.1016/S0304-3940(99)00758-2; Preisinger E, 1999, PHILOS T ROY SOC B, V354, P1029, DOI 10.1098/rstb.1999.0455; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3	44	840	871	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2423	2428		10.1126/science.1056784	http://dx.doi.org/10.1126/science.1056784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264541				2022-12-01	WOS:000167618700060
J	Li, QJ; Xu, ZF; Kress, WJ; Xia, YM; Zhang, L; Deng, XB; Gao, JY; Bai, ZL				Li, QJ; Xu, ZF; Kress, WJ; Xia, YM; Zhang, L; Deng, XB; Gao, JY; Bai, ZL			Pollination - Flexible style that encourages outcrossing	NATURE			English	Article									Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China; Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; Chinese Acad Sci, Kunming Inst Bot, Kunming 650204, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, QJ (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China.							BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Cui X., 1996, P 2 S FAM ZING S CHI, P288; Darwin C, 1916, EFFECTS CROSS SELF F; HOLSINGER KE, 1991, TRENDS ECOL EVOL, V6, P307, DOI 10.1016/0169-5347(91)90033-T; LI QJ, IN PRESS ACTA BOT SI; Richards A.J, 1997, PLANT BREEDING SYSTE; SMITH R M, 1990, Edinburgh Journal of Botany, V47, P1; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A	9	95	147	4	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					432	432		10.1038/35068635	http://dx.doi.org/10.1038/35068635			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260703	Bronze			2022-12-01	WOS:000167583800031
J	Samad, TA; Moore, KA; Sapirstein, A; Billet, S; Allchorne, A; Poole, S; Bonventre, JV; Woolf, CJ				Samad, TA; Moore, KA; Sapirstein, A; Billet, S; Allchorne, A; Poole, S; Bonventre, JV; Woolf, CJ			Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity	NATURE			English	Article							PROSTAGLANDIN E-2 RELEASE; RAT SPINAL-CORD; CYTOSOLIC PHOSPHOLIPASE A(2); ION CHANNELS; HYPERALGESIA; CELLS; CYCLOOXYGENASE-2; MICE; EXPRESSION; ALLODYNIA	Inflammation causes the induction of cyclooxygenase-2 (Cox-2)(1), leading to the release of prostanoids, which sensitize peripheral nociceptor terminals and produce localized pain hypersensitivity(2). Peripheral inflammation also generates pain hypersensitivity in neighbouring uninjured tissue (secondary hyperalgesia), because of increased neuronal excitability in the spinal cord (central sensitization)(3), and a syndrome comprising diffuse muscle and joint pain, fever, lethargy and anorexia(4). Here we show that Cox-2 may be involved in these central nervous system (CNS) responses, by finding a widespread induction of Cox-2 expression in spinal cord neurons and in other regions of the CNS, elevating prostaglandin E(2) (PGE(2)) levels in the cerebrospinal fluid. The major inducer of central Cox-2 upregulation is interleukin-1 beta in the CNS, and as basal phospholipase A(2) activity in the CNS does not change with peripheral inflammation, Cox-2 levels must regulate central prostanoid production. Intraspinal administration of an interleukin-converting enzyme or Cox-2 inhibitor decreases inflammation-induced central PGE(2) levels and mechanical hyperalgesia. Thus, preventing central prostanoid production by inhibiting the interleukin-1 beta -mediated induction of Cox-2 in neurons or by inhibiting central Cox-2 activity reduces centrally generated inflammatory pain hypersensitivity.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; UCL, Dept Anat, London WC1E 6BT, England; Natl Inst Biol Stand & Controls, S Mimms EN6 3QG, Herts, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of London; University College London; National Institute for Biological Standards & Control	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.	woolf.clifford@mgh.harvard.edu	Woolf, Clifford/A-9784-2010					Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; Beiche F, 1998, INFLAMM RES, V47, P482, DOI 10.1007/s000110050362; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; Bingham CO, 1999, J BIOL CHEM, V274, P31476, DOI 10.1074/jbc.274.44.31476; Cartmell T, 2000, J PHYSIOL-LONDON, V526, P653, DOI 10.1111/j.1469-7793.2000.00653.x; Curley J, 1996, ANESTHESIOLOGY, V84, P1401, DOI 10.1097/00000542-199606000-00017; Dantzer R, 1998, ANN NY ACAD SCI, V856, P132, DOI 10.1111/j.1749-6632.1998.tb08321.x; Dirig DM, 1997, EUR J PHARMACOL, V331, P155, DOI 10.1016/S0014-2999(97)01053-4; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Hay CH, 1997, NEUROSCIENCE, V78, P843, DOI 10.1016/S0306-4522(96)00598-2; Hietaranta A, 1999, PANCREAS, V18, P385, DOI 10.1097/00006676-199905000-00009; Lashbrook JM, 1999, PAIN, V82, P65, DOI 10.1016/S0304-3959(99)00031-7; Levy R, 2000, ADV EXP MED BIOL, V479, P125; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; MINAMI T, 1994, BRIT J PHARMACOL, V112, P735, DOI 10.1111/j.1476-5381.1994.tb13139.x; Muth-Selbach US, 1999, ANESTHESIOLOGY, V91, P231, DOI 10.1097/00000542-199907000-00032; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Sapirstein A, 1996, J BIOL CHEM, V271, P21505, DOI 10.1074/jbc.271.35.21505; Saunders MA, 1999, J PHARMACOL EXP THER, V288, P1101; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Southall MD, 1998, PAIN, V78, P39, DOI 10.1016/S0304-3959(98)00113-4; Swiergiel AH, 1997, BRAIN RES, V776, P96, DOI 10.1016/S0006-8993(97)01009-3; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597; Yamamoto T, 1998, NEUROREPORT, V9, P3869, DOI 10.1097/00001756-199812010-00019; Yao JH, 1999, AM J PHYSIOL-REG I, V277, pR1435, DOI 10.1152/ajpregu.1999.277.5.R1435	30	1013	1088	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					471	475		10.1038/35068566	http://dx.doi.org/10.1038/35068566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260714				2022-12-01	WOS:000167583800042
J	Davidson, PU; Kost, J; Myers, GJ; Cox, C; Clarkson, TW; Shamlaye, CF				Davidson, PU; Kost, J; Myers, GJ; Cox, C; Clarkson, TW; Shamlaye, CF			Methylmercury and neurodevelopment: Reanalysis of the Seychelles Child Development Study outcomes at 66 months of age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							EXPOSURE		Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA	University of Rochester	Davidson, PU (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.		Myers, Gary J/I-4901-2013	Myers, Gary J/0000-0003-4317-015X				Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; National Research Council, 2000, TOX EFF METH	3	31	31	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1291	1293		10.1001/jama.285.10.1291-a	http://dx.doi.org/10.1001/jama.285.10.1291-a			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255383				2022-12-01	WOS:000167339000019
J	Frost, G; Dornhorst, A				Frost, G; Dornhorst, A			Starting the day the right way	LANCET			English	Editorial Material							BREAKFAST CONSUMPTION; GLYCEMIC-INDEX; TERM DIETARY; FAT		Hammersmith Hosp NHS Trust, Dept Nutr & Dietet, London W12 0HS, England; Univ London Imperial Coll Sci Technol & Med, Dept Metab Med, Div Invest Sci, London SW7 2AZ, England	Imperial College London; Imperial College London	Frost, G (corresponding author), Hammersmith Hosp NHS Trust, Dept Nutr & Dietet, London W12 0HS, England.							JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392; JENKINS DJA, 1988, DIABETES CARE, V11, P149, DOI 10.2337/diacare.11.2.149; Martin A, 2000, BRIT J NUTR, V84, P337, DOI 10.1017/S0007114500001616; Ruxton CHS, 1997, BRIT J NUTR, V78, P199, DOI 10.1079/BJN19970140; STANTON JL, 1989, J AM COLL NUTR, V8, P567; Tsihlias EB, 2000, AM J CLIN NUTR, V72, P439; WOLEVER TMS, 1995, DIABETES CARE, V18, P962, DOI 10.2337/diacare.18.7.962	7	0	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					736	737		10.1016/S0140-6736(00)04179-9	http://dx.doi.org/10.1016/S0140-6736(00)04179-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253962				2022-12-01	WOS:000167400900006
J	Riedl, SJ; Renatus, M; Schwarzenbacher, R; Zhou, Q; Sun, CH; Fesik, SW; Liddington, RC; Salvesen, GS				Riedl, SJ; Renatus, M; Schwarzenbacher, R; Zhou, Q; Sun, CH; Fesik, SW; Liddington, RC; Salvesen, GS			Structural basis for the inhibition of caspase-3 by XIAP	CELL			English	Article							CRYSTAL-STRUCTURE; CYTOCHROME-C; SURVIVIN REVEALS; NMR STRUCTURE; BIR DOMAIN; PROTEIN; APOPTOSIS; IAP; COMPLEX; BINDING	The molecular mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood. The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7. We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resolution of 2.7 Angstrom, revealing the structural basis for inhibition. The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension. This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding. The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.	Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA	Sanford Burnham Prebys Medical Discovery Institute; Abbott Laboratories	Salvesen, GS (corresponding author), Burnham Inst, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@burnham.org			NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER; NIA NIH HHS [AG15402] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Bode W, 1991, CURR OPIN STRUC BIOL, V1, P45, DOI 10.1016/0959-440X(91)90010-Q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; KASOF GM, 2000, J BIOL CHEM, V9, P9; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; NAVAZZA J, 1994, ACTA CRYSTALLOGR A, V50; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; READ RJ, 1986, PROTEINASE INHIBITOR, P301; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; TURK D, 1992, WEITERENTWICKLUNG PR; Uren AG, 1998, TRENDS BIOCHEM SCI, V23, P159, DOI 10.1016/S0968-0004(98)01198-0; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	60	598	643	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					791	800		10.1016/S0092-8674(01)00274-4	http://dx.doi.org/10.1016/S0092-8674(01)00274-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257232	Bronze			2022-12-01	WOS:000167531100018
J	Ohkusa, T; Fujiki, K; Takashimizu, I; Kumagai, J; Tanizawa, T; Eishi, Y; Yokoyama, T; Watanabe, M				Ohkusa, T; Fujiki, K; Takashimizu, I; Kumagai, J; Tanizawa, T; Eishi, Y; Yokoyama, T; Watanabe, M			Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; INFECTION; CANCER; MUCOSA; CLASSIFICATION; CURE	Background: Glandular atrophy and intestinal metaplasia are precancerous lesions; whether Helicobacter pylori eradication affects: these lesions is controversial. Objective: To determine whether H. pylori eradication is associated with improvement in glandular atrophy and intestinal metaplasia after at least 1 year. Design: Single-blind, uncontrolled prospective trial. Setting: Academic gastroenterology clinic in Japan. Patients: 163 consecutive patients with dyspepsia and H. pylori infection. Intervention: One-week course of a proton-pump inhibitor and antibiotic therapy. Measurements: Endoscopic examination with antral and corporal biopsy was done before treatment and at 1 to 3 and 12 to 15 months after treatment. Gastritis, atrophy, and metaplasia were graded according to the updated Sydney System. Results: In the 115 patients in whom H. pylori was eradicated, inflammation and mean neutrophil activity had decreased by 1 to 3 months, and both glandular atrophy in the corpus and intestinal metaplasia in the antrum had decreased by 12 to 15 months. Glandular atrophy in the corpus improved in 34 (89%) of 38 patients with atrophy before treatment, and intestinal metaplasia in the antrum improved in 28 (61%) of 46 patients who had metaplasia at baseline, In the 48 patients in whom eradication was unsuccessful, no significant histologic changes were observed. Conclusion: In the year after successful H. pylori eradication, precancerous lesions improved in most patients.	Tokyo Med & Dent Univ, Sch Med, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Ohkusa, T (corresponding author), Tokyo Med & Dent Univ, Sch Med, Dept Gastroenterol & Hepatol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ohkusa.gast@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670				Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625; Ciok J, 1997, J Physiol Pharmacol, V48 Suppl 4, P115; CORREA P, 1988, AM J GASTROENTEROL, V83, P504; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ENDO S, 1995, CANCER, V75, P2203, DOI 10.1002/1097-0142(19950501)75:9<2203::AID-CNCR2820750903>3.0.CO;2-6; Enomoto Y, 1999, GASTROENTEROLOGY, V116, pA156; Forbes GM, 1996, J GASTROEN HEPATOL, V11, P670, DOI 10.1111/j.1440-1746.1996.tb00312.x; GENTA RM, 1993, MODERN PATHOL, V6, P281; HEDEKER D, 1994, BIOMETRICS, V50, P933, DOI 10.2307/2533433; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; RUGGE M, 1991, HUM PATHOL, V22, P1002, DOI 10.1016/0046-8177(91)90008-D; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Tepes B, 1999, J PATHOL, V188, P24, DOI 10.1002/(SICI)1096-9896(199905)188:1&lt;24::AID-PATH316&gt;3.0.CO;2-F; Tucci A, 1998, AM J GASTROENTEROL, V93, P1425, DOI 10.1111/j.1572-0241.1998.00454.x; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Valle J, 1996, SCAND J GASTROENTERO, V31, P546, DOI 10.3109/00365529609009126; vanderHulst RWM, 1997, GASTROENTEROLOGY, V113, P25, DOI 10.1016/S0016-5085(97)70076-3; WITTEMAN EM, 1995, J CLIN PATHOL, V48, P250, DOI 10.1136/jcp.48.3.250; Zerbib F, 2000, EUR J GASTROEN HEPAT, V12, P719, DOI 10.1097/00042737-200012070-00001	20	164	173	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2001	134	5					380	386		10.7326/0003-4819-134-5-200103060-00010	http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405ZJ	11242498				2022-12-01	WOS:000167190200004
J	Gregory, RL				Gregory, RL			Perceptions of knowledge	NATURE			English	Editorial Material									Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol	Gregory, RL (corresponding author), Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England.							Gombrich E., 1960, ART ILLUSION STUDY P; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE	2	7	8	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					21	21		10.1038/35065174	http://dx.doi.org/10.1038/35065174			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242020				2022-12-01	WOS:000167194300022
J	Mitton, S				Mitton, S			Light brought to a standstill	LANCET			English	Editorial Material									Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England	University of Cambridge	Mitton, S (corresponding author), Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England.		Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806				Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; WALSWORTH R, 2001, PHY REV LETT, V86, P783	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					496	496		10.1016/S0140-6736(00)04039-3	http://dx.doi.org/10.1016/S0140-6736(00)04039-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229666				2022-12-01	WOS:000167011700007
J	Paabo, S				Paabo, S			Genomics and society - The human genome and our view of ourselves	SCIENCE			English	Article							EVOLUTION; SEQUENCE		Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	paabo@eva.mpg.de						Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Klein R.G., 1999, HUMAN CAREER; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	6	69	76	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1219	+		10.1126/science.1056972	http://dx.doi.org/10.1126/science.1056972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233444				2022-12-01	WOS:000166993400022
J	Jimenez-Sanchez, G; Childs, B; Valle, D				Jimenez-Sanchez, G; Childs, B; Valle, D			Human disease genes	NATURE			English	Article							BIOLOGY	The complete human genome sequence will facilitate the identification of all genes that contribute to disease. We propose that the functional classification of disease genes and their products will reveal general principles of human disease. We have determined functional categories for nearly 1,000 documented disease genes, and found striking correlations between the function of the gene product and features of disease, such as age of onset and mode of inheritance. As knowledge of disease genes grows, including those contributing to complex traits, more sophisticated analyses will be possible; their results will yield a deeper understanding of disease and an enhanced integration of medicine with biology.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Valle, D (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Pediat, Baltimore, MD 21205 USA.	dvalle@jhmi.edu						Antonarakis SE, 2000, NAT GENET, V25, P11, DOI 10.1038/75497; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BRUSILOW SW, 1989, CURRENT THERAPY NEON, P164; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Childs B, 2000, ANNU REV GENOM HUM G, V1, P1, DOI 10.1146/annurev.genom.1.1.1; JIMENEZSANCHEZ G, 2001, METABOLIC MOL BASES, P167; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; TREACY E, 1995, AM J HUM GENET, V56, P359	9	269	280	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					853	855		10.1038/35057050	http://dx.doi.org/10.1038/35057050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237009	Bronze			2022-12-01	WOS:000166938800056
J	Liljedahl, M; Maeda, Y; Colanzi, A; Ayala, I; Van Lint, J; Malhotra, V				Liljedahl, M; Maeda, Y; Colanzi, A; Ayala, I; Van Lint, J; Malhotra, V			Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network	CELL			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; LIVING CELLS; BREFELDIN-A; C FAMILY; COMPARTMENT; ACTIVATION; COMPLEX; YEAST; STACK	When a kinase inactive form of Protein Kinase D (PKD-K618N) was expressed in HeLa cells, it localized to the trans-Golgi network (TGN) and caused extensive tubulation. Cargo that was destined for the plasma membrane was found in PKD-K618N-containing tubes but the tubes did not detach from the TGN. As a result, the transfer of cargo from TGN to the plasma membrane was inhibited. We have also demonstrated the formation and subsequent detachment of cargo-containing tubes from the TGN in cells stably expressing low levels of PKD-K618N. Our results suggest that PKD regulates the fission from the TGN of transport carriers that are en route to the cell surface.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Louvain, Belgium	University of California System; University of California San Diego; KU Leuven	Malhotra, V (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Ayala, Inmaculada/U-4565-2018; Colanzi, Antonino/D-6821-2012; Malhotra, Vivek/O-9811-2014; Van Lint, Johan/P-9073-2019	Ayala, Inmaculada/0000-0002-3329-1428; Colanzi, Antonino/0000-0002-5643-0216; Malhotra, Vivek/0000-0001-6198-7943; Van Lint, Johan/0000-0002-0275-571X				Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; Kuwana T, 1998, P NATL ACAD SCI USA, V95, P1056, DOI 10.1073/pnas.95.3.1056; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STURANY S, 2000, IN PRESS J BIOL CHEM; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Toomre D, 1999, J CELL SCI, V112, P21; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	36	293	298	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					409	420		10.1016/S0092-8674(01)00228-8	http://dx.doi.org/10.1016/S0092-8674(01)00228-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239398	Bronze			2022-12-01	WOS:000167003100011
J	Leidig-Bruckner, G; Hosch, S; Dodidou, P; Ritschel, D; Conradt, C; Klose, C; Otto, G; Lange, R; Theilmann, L; Zimmerman, R; Pritsch, M; Ziegler, R				Leidig-Bruckner, G; Hosch, S; Dodidou, P; Ritschel, D; Conradt, C; Klose, C; Otto, G; Lange, R; Theilmann, L; Zimmerman, R; Pritsch, M; Ziegler, R			Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study	LANCET			English	Article							PRIMARY BILIARY-CIRRHOSIS; QUALITY-OF-LIFE; BONE LOSS; HEART-TRANSPLANTATION; CYCLOSPORINE-A; RECIPIENTS; DEFORMITY; WOMEN; MECHANISMS; PREVENTION	Background Osteoporosis and related fractures are a major complication after organ transplantation. The aim of this study was to find out the frequency and predictors of osteoporotic fractures after cardiac or liver transplantation. Methods 235 consecutive patients who had a cardiac transplant (n=105; 88 men, 17 women) or a liver transplant (130; 75 men, 55 women) were followed. Vertebral fractures were assessed by a standardised analysis of spinal radiographs before and annually after transplantation. Clinical and non-vertebral fracture data were noted from hospital records. Findings in the first and second years after transplantation, the proportion of patients (Kaplan-Meier estimates) who had at least one Vertebral fracture was slightly higher in the cardiac group (first year 21%, second year 27%) than in the liver group (first year 14%, second year 21%). in the third and fourth years, one third of patients from both groups had had one or more vertebral fractures. Non-vertebral fractures occurred in nine patients (7%) after liver transplantation and avascular necrosis of the hip head in three patients (3%) after cardiac transplantation. In both groups, no dose-dependent effect of immunosuppressive therapy on fracture development could be identified. Independent predictors assessed by multivariate analysis were age (hazard ratio [95% CI] increase of 5 years, 1.71 [1.1-2.7]) and lumbar bane-mineral density (decrease of 1 SD t score, 1.97 [1.2-3.2]) in cardiac transplantation patients, and vertebral fractures before transplantation (6.07 [1.7-21.7]) in the liver group. Interpretation The high frequency of osteoporotic fractures in the 2 years after transplantation and the limitations of reliable fracture-risk predictions, show the need to investigate preventive therapies.	Univ Heidelberg, Dept Internal Med, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Endocrinol & Metab, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Gastroenterol, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Cardiol, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Med Biometry, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Surg, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Thorac & Cardiac Surg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Leidig-Bruckner, G (corresponding author), Univ Heidelberg, Dept Internal Med, Bergheimer Str 58, D-69115 Heidelberg, Germany.							Braith RW, 1996, J AM COLL CARDIOL, V28, P1471, DOI 10.1016/S0735-1097(96)00347-6; BURKHARDT R, 1981, LANCET, V1, P844; CUMMINGS SR, 1995, J BONE MINER RES, V10, P518; CVETKOVIC M, 1994, TRANSPLANTATION, V57, P1231, DOI 10.1097/00007890-199404270-00016; DEQUEKER J, 1995, BONE, V17, P247, DOI 10.1016/8756-3282(95)00224-2; EASTELL R, 1991, HEPATOLOGY, V14, P296, DOI 10.1002/hep.1840140215; Ebeling PR, 1999, J BONE MINER RES, V14, P342, DOI 10.1359/jbmr.1999.14.3.342; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; LEE AH, 1994, AM J MED, V96, P35, DOI 10.1016/0002-9343(94)90113-9; Leidig-Bruckner G, 2000, OSTEOPOROSIS INT, V11, P102, DOI 10.1007/PL00004172; LeidigBruckner G, 1997, J BONE MINER RES, V12, P663, DOI 10.1359/jbmr.1997.12.4.663; MCDONALD JA, 1991, HEPATOLOGY, V14, P613, DOI 10.1002/hep.1840140407; MEYS E, 1994, AM J MED, V97, P445, DOI 10.1016/0002-9343(94)90324-7; MINNE HW, 1988, BONE MINER, V3, P335; MUCHMORE JS, 1991, TRANSPLANT P, V23, P1184; NAVASA M, 1994, BRIT J RHEUMATOL, V33, P52; Navasa M, 1996, J HEPATOL, V25, P129, DOI 10.1016/S0168-8278(96)80064-X; Negri AL, 1996, TRANSPLANT P, V28, P3321; Park KM, 1996, TRANSPLANT P, V28, P1738; Pilmore H, 1998, AM J NEPHROL, V18, P57, DOI 10.1159/000013305; PORAYKO MK, 1991, TRANSPLANT P, V23, P1462; Ramsey-Goldman R, 1999, J BONE MINER RES, V14, P456, DOI 10.1359/jbmr.1999.14.3.456; RICH GM, 1992, J HEART LUNG TRANSPL, V11, P950; Riemens SC, 1996, OSTEOPOROSIS INT, V6, P213, DOI 10.1007/BF01622737; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; SAMBROOK PN, 1994, OSTEOPOROSIS INT, V4, P273, DOI 10.1007/BF01623351; Scheidt-Nave C, 1998, MED KLIN, V93, P46, DOI 10.1007/BF03041999; Shane E, 1996, J CLIN ENDOCR METAB, V81, P1740, DOI 10.1210/jc.81.5.1740; Shane E, 1997, J CLIN ENDOCR METAB, V82, P1497, DOI 10.1210/jc.82.5.1497; Shane E, 1998, J HEART LUNG TRANSPL, V17, P1089; Thiebaud D, 1996, EUR J CLIN INVEST, V26, P549, DOI 10.1046/j.1365-2362.1996.00170.x; VanCleemput J, 1996, TRANSPLANTATION, V61, P1495, DOI 10.1097/00007890-199605270-00015; Vedi S, 1999, J BONE MINER RES, V14, P281, DOI 10.1359/jbmr.1999.14.2.281	33	184	196	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					342	347		10.1016/S0140-6736(00)03641-2	http://dx.doi.org/10.1016/S0140-6736(00)03641-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210996				2022-12-01	WOS:000166897900012
J	Karner, MB; DeLong, EF; Karl, DM				Karner, MB; DeLong, EF; Karl, DM			Archaeal dominance in the mesopelagic zone of the Pacific Ocean	NATURE			English	Article							MARINE PLANKTONIC ARCHAEA; IN-SITU HYBRIDIZATION; VERTICAL-DISTRIBUTION; BACTERIA; PROBES; BACTERIOPLANKTON; PICOPLANKTON; ANTARCTICA; SEQUENCES	The ocean's interior is Earth's largest biome. Recently, cultivation-independent ribosomal RNA gene surveys have indicated a potential importance for archaea(1) in the subsurface ocean(2-4). But quantitative data on the abundance of specific microbial groups in the deep sea are lacking(5,6). Here we report a year-long study of the abundance of two specific archaeal groups (pelagic euryarchaeota and pelagic crenarchaeota)(2) in one of the ocean's largest habitats. Monthly sampling was conducted throughout the water column (surface to 4,750 m) at the Hawai'i Ocean Time-series station(7). Below the euphotic zone (>150 m), pelagic crenarchaeota comprised a large fraction of total marine picoplankton, equivalent in cell numbers to bacteria at depths greater than 1,000 m. The fraction of crenarchaeota increased with depth, reaching 39% of total DNA-containing picoplankton detected. The average sum of archaea plus bacteria detected by rRNA-targeted fluorescent probes ranged from 63 to 90% of total cell numbers at all depths throughout our survey. The high proportion of cells containing significant amounts of rRNA suggests that most pelagic deep-sea microorganisms are metabolically active. Furthermore, our results suggest that the global oceans harbour approximately 1.3 x 10(28) archaeal cells, and 3.1 x 10(28) bacterial cells. Our data suggest that pelagic crenarchaeota represent one of the ocean's single most abundant cell types.	Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	University of Hawaii System; Monterey Bay Aquarium Research Institute	Karner, MB (corresponding author), Univ Hawaii, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.		Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 1994, NATURE, V371, P695, DOI 10.1038/371695a0; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Fuhrman Jed. A., 1998, Aquatic Ecology, V32, P3, DOI 10.1023/A:1009974817127; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Karner M, 1997, APPL ENVIRON MICROB, V63, P1208, DOI 10.1128/AEM.63.4.1208-1213.1997; LEE SH, 1994, LIMNOL OCEANOGR, V39, P869, DOI 10.4319/lo.1994.39.4.0869; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Massana R, 1998, LIMNOL OCEANOGR, V43, P607, DOI 10.4319/lo.1998.43.4.0607; MENARD HW, 1966, J GEOPHYS RES, V71, P4305, DOI 10.1029/JZ071i018p04305; Murray AE, 1999, AQUAT MICROB ECOL, V20, P129, DOI 10.3354/ame020129; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; OLSEN GJ, 1994, NATURE, V371, P657, DOI 10.1038/371657a0; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Simon M, 1999, AQUAT MICROB ECOL, V18, P275, DOI 10.3354/ame018275; Stein JL, 1996, P NATL ACAD SCI USA, V93, P6228, DOI 10.1073/pnas.93.13.6228; WILLIAMS PM, 1980, OCEANOL ACTA, V3, P471; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180, DOI 10.1128/AEM.61.6.2180-2185.1995	26	1084	1153	14	224	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					507	510		10.1038/35054051	http://dx.doi.org/10.1038/35054051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206545				2022-12-01	WOS:000166570500046
J	Lok, C				Lok, C			Plans to reduce acceptable arsenic limit put on hold	NATURE			English	News Item																		Chiou HY, 2001, AM J EPIDEMIOL, V153, P411, DOI 10.1093/aje/153.5.411	1	3	3	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					503	503		10.1038/35069212	http://dx.doi.org/10.1038/35069212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279452	Bronze			2022-12-01	WOS:000167859300008
J	Scott, IC; Blitz, IL; Pappano, WN; Maas, SA; Cho, KWY; Greenspan, DS				Scott, IC; Blitz, IL; Pappano, WN; Maas, SA; Cho, KWY; Greenspan, DS			Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP signalling	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-1; DROSOPHILA EMBRYO; GROWTH-FACTOR; ACTIVITY GRADIENT; FAMILY MEMBER; CHORDIN; BINDING; XENOPUS; GENES; SOG	Twisted gastrulation (TSG) is involved in specifying the dorsal-most cell fate in Drosophila embryos(1), but its mechanism of action is poorly understood. TSG has been proposed to modify the action of Short gastrulation (SOG), thereby increasing signalling by the bone morphogenetic protein (BMP) Decapentaplegic. SOG, an inhibitor of BMP signalling, is in turn inactivated by the protease Tolloid(2,3). Here we identify Tsg gene products from human, mouse, Xenopus, zebrafish and chick. Expression patterns in mouse and Xenopus embryos are consistent with in vivo interactions between Tsg, BMPs and the vertebrate SOG orthologue, chordin. We show that Tsg binds both the vertebrate Decapentaplegic orthologue BMP4 and chordin, and that these interactions have multiple effects. Tsg increases chordin's binding of BMP4, potentiates chordin's ability to induce secondary axes in Xenopus embryos, and enhances chordin cleavage by vertebrate tolloid-related proteases at a site poorly used in Tsg's absence; also, the presence of Tsg enhances the secondary axis-inducing activity of two products of chordin cleavage. We conclude that Tsg acts as a cofactor in chordin's antagonism of BMP signalling.	Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of California System; University of California Irvine	Greenspan, DS (corresponding author), Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, 1300 Univ Ave, Madison, WI 53706 USA.			Greenspan, Daniel/0000-0001-8096-7446; Pappano, William/0000-0003-2848-2219				ARORA K, 1992, DEVELOPMENT, V114, P1003; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHO KWY, 1991, CELL, V67, P111; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Furuta Y, 1997, DEVELOPMENT, V124, P2203; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Pappano WN, 1998, GENOMICS, V52, P236, DOI 10.1006/geno.1998.5474; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Yu K, 2000, DEVELOPMENT, V127, P2143; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; ZUSMAN SB, 1988, DEV BIOL, V129, P417, DOI 10.1016/0012-1606(88)90389-2	27	152	170	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					475	478		10.1038/35068572	http://dx.doi.org/10.1038/35068572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260715				2022-12-01	WOS:000167583800043
J	Goldstein, LSB				Goldstein, LSB			Transduction - When worlds collide - Trafficking in JNK	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; SCAFFOLD PROTEINS; AXONAL-TRANSPORT; RECEPTOR; KINASE; MEMBRANE; BINDING; COMPLEX; SIGNAL; MOTOR		Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.							Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	17	31	32	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2102	2103		10.1126/science.1059766	http://dx.doi.org/10.1126/science.1059766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256408				2022-12-01	WOS:000167563800024
J	Tissenbaum, HA; Guarente, L				Tissenbaum, HA; Guarente, L			Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans	NATURE			English	Article							FAMILY-MEMBER; PROTEIN SIR2; C-ELEGANS; LONGEVITY; DIAPAUSE; AGE-1; DAF-2; REPRODUCTION; MUTATION; PATHWAY	In Caenorhabditis elegans, mutations that reduce the activity of an insulin-like receptor (daf-2)(1) or a phosphatidylinositol-3-OH kinase (age-1)(2) favour entry into the dauer state during larval development(3) and extend lifespan in adults(3-6). Downregulation of this pathway activates a forkhead transcription factor (daf-16)(7,8), which may regulate targets that promote dauer formation in larvae and stress resistance and longevity in adults(9). In yeast, the SIR2 gene determines the lifespan of mother cells, and adding an extra copy of SIR2 extends lifespan(10). Sir2 mediates chromatin silencing through a histone deacetylase activity that depends on NAD (nicotinamide adenine dinucleotide) as a cofactor(11-13). We have surveyed the lifespan of C. elegans strains containing duplications of chromosomal regions. Here we report that a duplication containing sir-2.1-the C. elegans gene most homologous to yeast SIR2-confers a lifespan that is extended by up to 50%. Genetic analysis indicates that the sir-2.1 transgene functions upstream of daf-16 in the insulin-like signalling pathway. Our findings suggest that Sir2 proteins may couple longevity to nutrient availability in many eukaryotic organisms.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@MIT.edu						Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BRENNER S, 1974, GENETICS, V77, P71; DORMAN JB, 1995, GENETICS, V141, P1399; FRIEDMAN DB, 1988, GENETICS, V118, P75; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gems D, 1998, GENETICS, V150, P129; HEDGECOCK EM, 1995, GENETICS, V141, P989; HERMAN RK, 1979, DEV BIOL, V49, P200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LARSEN PL, 1995, GENETICS, V139, P1567; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; RIDDLE DL, 1997, ELEGANS, V2, P739; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; Tissenbaum HA, 1998, GENETICS, V148, P703	27	1472	1569	7	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					227	230		10.1038/35065638	http://dx.doi.org/10.1038/35065638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242085				2022-12-01	WOS:000167320500051
J	Feldman, AM; Li, YY; McTiernan, CF				Feldman, AM; Li, YY; McTiernan, CF			Matrix metalloproteinases in pathophysiology and treatment of heart failure	LANCET			English	Editorial Material							TISSUE INHIBITORS; COLLAGEN; EXPRESSION; DISEASE; MICE		Univ Penn, Med Ctr Hlth Syst, Cardiovasc Inst, Pittsburgh, PA 15213 USA	University of Pennsylvania	Feldman, AM (corresponding author), Univ Penn, Med Ctr Hlth Syst, Cardiovasc Inst, Pittsburgh, PA 15213 USA.							BORG TK, 1981, FED PROC, V40, P2037; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; HAMERMAN D, 1993, JOINT CARTILAGE DEGR, P529; Holmgren Emil, 1907, Archiv fuer Mikroskopische Anatomie Bonn, V71, DOI 10.1007/BF02979915; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Li YY, 2000, P NATL ACAD SCI USA, V97, P12746, DOI 10.1073/pnas.97.23.12746; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Spinale FG, 2000, CARDIOVASC RES, V46, P225, DOI 10.1016/S0008-6363(99)00431-9; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Spinale FG, 1998, CIRC RES, V82, P482, DOI 10.1161/01.RES.82.4.482; Spinale FG, 1999, CIRC RES, V85, P364, DOI 10.1161/01.RES.85.4.364; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; WEBER KT, 1988, AM HEART J, V116, P1641, DOI 10.1016/0002-8703(88)90763-6; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4	16	32	37	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					654	655		10.1016/S0140-6736(00)04151-9	http://dx.doi.org/10.1016/S0140-6736(00)04151-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247546				2022-12-01	WOS:000167282400005
J	Spiegel, PB; Salama, P				Spiegel, PB; Salama, P			Emergencies in developed countries: are aid organisations ready to adapt?	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Spiegel, PB (corresponding author), Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.		Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				BURKHOLDER BT, 2000, FORC MIGR MORT P WAS; *STEER COMM HUM RE, 1998, SPHER HUM CHART MIN	2	13	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					714	714		10.1016/S0140-6736(00)04143-X	http://dx.doi.org/10.1016/S0140-6736(00)04143-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247574				2022-12-01	WOS:000167282400041
J	Woo, PCY; Wong, SSY; Lum, PNL; Hui, WT; Yuen, KY				Woo, PCY; Wong, SSY; Lum, PNL; Hui, WT; Yuen, KY			Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients	LANCET			English	Article							RISK-FACTORS; INFECTION	Background Although about 75-80% of neutropenic fevers are thought to be caused by infections, a causal organism can be confirmed microbiologically or suspected clinically in only 30-50%, and even fewer of these cases (16%) have a documented bacteraemia. The cause of neutropenic fever in the remaining cases remains elusive. We investigate the role of cell-wall-deficient bacteria in bone-marrow transplantation (BMT). Methods Blood cultures were obtained from bone-marrow-transplant recipients and were inoculated into an aerobic bottle with resin, an anaerobic bottle, and a bottle to isolate cell-wall deficient bacteria. When growth was detected in the blood-culture bottle for cell-wall-deficient bacteria, 20 muL of the broth was subcultured and the isolate identified by standard biochemical methods. The microbiological findings were correlated with the clinical characteristics of the patients. Findings From the 86 BMT recipients enrolled into the study, 798 sets of blood cultures were sent for laboratory analysis. 55 blood cultures were positive in the aerobic bottle, and the same isolates were also detected in 52 blood-culture bottles for cell-wall-deficient forms. For 20 sets of blood cultures, the isolates were detected only in the bottle for cell-wall-deficient forms. Blood for 13 (65%) of these 20 sets were sampled in the pre-engraftment neutropenic period, three (15%) during conditioning when the absolute neutrophil count was above 0.5x10(9)/L, and four (20%) in the post-engraftment period. 17 (85%) of the isolates were gram positive: four (20%) were Staphylococcus spp and ten (50%) were Bacillus spp. Antibiotic treatment was successful in 19 (95%) of 20 episodes. Interpretation Bacteraemia due to cell-wall-deficient forms causes a significant proportion of so-called culture-negative febrile episodes in BMT recipients.	Univ Hong Kong, Dept Microbiol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, KY (corresponding author), Univ Hong Kong, Dept Microbiol, Queen Mary Hosp, Pathol Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Yuen, Kwok Yung/C-4465-2009; Wong, Samson/C-4446-2009; Woo, Patrick Chiu Yat/C-4449-2009	Yuen, Kwok-yung/0000-0002-2083-1552; Woo, Patrick Chiu Yat/0000-0001-9401-1832				Baron P.R., 1999, MANUAL CLIN MICROBIO; BOW EJ, 1998, J ANTIMICROB CHEMO S, V41, pD1; DePauw BE, 1996, ANN HEMATOL, V72, P273; Dienes L, 1940, P SOC EXP BIOL MED, V44, P470; Dienes L, 1939, J INFECT DIS, V65, P24, DOI 10.1093/infdis/65.1.24; DIENTES L, 1970, ROLE MYCOPLASMAS L F, P185; GOODRICH JM, 1991, J INFECT DIS, V164, P731, DOI 10.1093/infdis/164.4.731; HOLLER GJ, 1968, MICROBIAL PROTOPLAST, P352; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; NIMO LN, 1969, APPL MICROBIOL, V18, P535; PATTERSON SK, 1982, CELL WALL DEFICIENT, P1; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; ROBERTS RICHARD B., 1968, P230; SABLE CA, 1994, CLIN INFECT DIS, V18, P273, DOI 10.1093/clinids/18.3.273; WEIBULL C, 1953, J BACTERIOL, V66, P688, DOI 10.1128/JB.66.6.688-695.1953; Wong SSY, 2000, DIAGN MICR INFEC DIS, V36, P261, DOI 10.1016/S0732-8893(99)00141-8; Woo PCY, 1998, CLIN INFECT DIS, V27, P382, DOI 10.1086/514659; Yuen KY, 1998, BONE MARROW TRANSPL, V21, P1137, DOI 10.1038/sj.bmt.1701246; Yuen KY, 1998, DIAGN MICR INFEC DIS, V30, P75, DOI 10.1016/S0732-8893(97)00213-7	19	42	46	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					675	679		10.1016/S0140-6736(00)04131-3	http://dx.doi.org/10.1016/S0140-6736(00)04131-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247551				2022-12-01	WOS:000167282400012
J	Merscher, S; Funke, B; Epstein, JA; Heyer, J; Puech, A; Lu, MM; Xavier, RJ; Demay, MB; Russell, RG; Factor, S; Tokooya, K; Jore, BS; Lopez, M; Pandita, RK; Lia, M; Carrion, D; Xu, H; Schorle, H; Kobler, JB; Scambler, P; Wynshaw-Boris, A; Skoultchi, AI; Morrow, BE; Kucherlapati, R				Merscher, S; Funke, B; Epstein, JA; Heyer, J; Puech, A; Lu, MM; Xavier, RJ; Demay, MB; Russell, RG; Factor, S; Tokooya, K; Jore, BS; Lopez, M; Pandita, RK; Lia, M; Carrion, D; Xu, H; Schorle, H; Kobler, JB; Scambler, P; Wynshaw-Boris, A; Skoultchi, AI; Morrow, BE; Kucherlapati, R			TBX1 is responsible for cardiovascular defects in Velo-Cardio-Facial/DiGeorge syndrome	CELL			English	Article							CONGENITAL HEART-DISEASE; DIGEORGE-SYNDROME REGION; HOLT-ORAM-SYNDROME; NEURAL CREST CELLS; FACIAL-SYNDROME; 22Q11 DELETIONS; MOLECULAR DEFINITION; MICE DEFICIENT; GENE; MUTATIONS	Velo-cardio-facial syndrome (VCFS)/DiGeorge syndrome (DGS) is a human disorder characterized by a number of phenotypic features including cardiovascular defects. Most VCFS/DGS patients are hemizygous for a 1.5-3.0 Mb region of 22q11. To investigate the etiology of this disorder, we used a cre-loxP strategy to generate mice that are hemizygous for a 1.5 Mb deletion corresponding to that on 22q11. These mice exhibit significant perinatal lethality and have conotruncal and parathyroid defects. The conotruncal defects can be partially rescued by a human BAC containing the TBX1 gene. Mice heterozygous for a null mutation in Tbx1 develop conotruncal defects. These results together with the expression patterns of Tbx1 suggest a major role for this gene in the molecular etiology of VCFS/DGS.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Univ Penn, Div Cardiovasc, Philadelphia, PA 19104 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ London, Coll Med, Inst Child Hlth, London, England; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76133 Karlsruhe, Germany; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med,Dept Otol & Laryngol, HP Mosher Laryngol Res Lab, Boston, MA 02114 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University of California System; University of California San Diego; University of London; University College London; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Helmholtz Association; Karlsruhe Institute of Technology; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Scambler, Peter J/C-4998-2008; Kucherlapati, Raju/ABC-8807-2021; Toyooka, Kazuhito/AAQ-6928-2020; Schorle, Hubert/M-5001-2016; PUECH, Anne/A-7470-2013; Scambler, Peter/AAZ-6026-2020; Schorle, Hubert/S-1713-2019; Toyooka, Kazuhito/AAH-7175-2019	Scambler, Peter J/0000-0002-1487-4628; Toyooka, Kazuhito/0000-0002-0173-0430; Schorle, Hubert/0000-0001-8272-0076; Scambler, Peter/0000-0002-1487-4628; Toyooka, Kazuhito/0000-0002-0173-0430; Merscher, Sandra/0000-0002-4757-7494; Epstein, Jonathan/0000-0001-8637-4465; Morrow, Bernice/0000-0002-8076-4726	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061475, R01HL062974] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61475, HL 62974] Funding Source: Medline; NICHD NIH HHS [HD34980] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BOCKMAN DE, 1987, AM J ANAT, V180, P332; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Epstein JA, 2000, PEDIATR RES, V48, P717, DOI 10.1203/00006450-200012000-00003; FINLEY JP, 1977, CAN MED ASSOC J, V116, P635; FUNKE B, 2001, IN PRESS GENOMICS; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; LEDOUARIN N, 1981, NEURAL CREST; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li QY, 1997, NAT GENET, V15, P21; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43903; Maldonado-Saldivia J, 2000, MECH DEVELOP, V96, P121, DOI 10.1016/S0925-4773(00)00370-1; McKie JM, 1997, HUM GENET, V101, P6, DOI 10.1007/s004390050576; MORROW B, 1995, AM J HUM GENET, V56, P1391; Puech A, 2000, P NATL ACAD SCI USA, V97, P10090, DOI 10.1073/pnas.97.18.10090; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scuccimarri R, 1998, J PEDIATR ENDOCR MET, V11, P273; SHPRINTZEN R J, 1985, American Journal of Human Genetics, V37, pA77; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; VANMIEROP LHS, 1986, AM J CARDIOL, V58, P133, DOI 10.1016/0002-9149(86)90256-0; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; YAGI M, 1994, J BIOL CHEM, V269, P17424	36	688	698	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2001	104	4					619	629		10.1016/S0092-8674(01)00247-1	http://dx.doi.org/10.1016/S0092-8674(01)00247-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	405VP	11239417	Bronze			2022-12-01	WOS:000167181500015
J	Kawai, J; Shinagawa, A; Shibata, K; Yoshino, M; Itoh, M; Ishii, Y; Arakawa, T; Hara, A; Fukunishi, Y; Konno, H; Adachi, J; Fukuda, S; Aizawa, K; Izawa, M; Nishi, K; Kiyosawa, H; Kondo, S; Yamanaka, I; Saito, T; Okazaki, Y; Gojobori, T; Bono, H; Kasukawa, T; Saito, R; Kadota, K; Matsuda, H; Ashburner, M; Batalov, S; Casavant, T; Fleischmann, W; Gaasterland, T; Gissi, C; King, B; Kochiwa, H; Kuehl, P; Lewis, S; Matsuo, Y; Nikaido, I; Pesole, G; Quackenbush, J; Schriml, LM; Staubli, F; Suzuki, R; Tomita, M; Wagner, L; Washio, T; Sakai, K; Okido, T; Furuno, M; Aono, H; Baldarelli, R; Barsh, G; Blake, J; Boffelli, D; Bojunga, N; Carninci, P; de Bonaldo, MF; Brownstein, MJ; Bult, C; Fletcher, C; Fujita, M; Gariboldi, M; Gustincich, S; Hill, D; Hofmann, M; Hume, DA; Kamiya, M; Lee, NH; Lyons, P; Marchionni, L; Mashima, J; Mazzarelli, J; Mombaerts, P; Nordone, P; Ring, B; Ringwald, M; Rodriguez, I; Sakamoto, N; Sasaki, H; Sato, K; Schonbach, C; Seya, T; Shibata, Y; Storch, KF; Suzuki, H; Toyo-oka, K; Wang, KH; Weitz, C; Whittaker, C; Wilming, L; Wynshaw-Boris, A; Yoshida, K; Hasegawa, Y; Kawaji, H; Kohtsuki, S; Hayashizaki, Y				Kawai, J; Shinagawa, A; Shibata, K; Yoshino, M; Itoh, M; Ishii, Y; Arakawa, T; Hara, A; Fukunishi, Y; Konno, H; Adachi, J; Fukuda, S; Aizawa, K; Izawa, M; Nishi, K; Kiyosawa, H; Kondo, S; Yamanaka, I; Saito, T; Okazaki, Y; Gojobori, T; Bono, H; Kasukawa, T; Saito, R; Kadota, K; Matsuda, H; Ashburner, M; Batalov, S; Casavant, T; Fleischmann, W; Gaasterland, T; Gissi, C; King, B; Kochiwa, H; Kuehl, P; Lewis, S; Matsuo, Y; Nikaido, I; Pesole, G; Quackenbush, J; Schriml, LM; Staubli, F; Suzuki, R; Tomita, M; Wagner, L; Washio, T; Sakai, K; Okido, T; Furuno, M; Aono, H; Baldarelli, R; Barsh, G; Blake, J; Boffelli, D; Bojunga, N; Carninci, P; de Bonaldo, MF; Brownstein, MJ; Bult, C; Fletcher, C; Fujita, M; Gariboldi, M; Gustincich, S; Hill, D; Hofmann, M; Hume, DA; Kamiya, M; Lee, NH; Lyons, P; Marchionni, L; Mashima, J; Mazzarelli, J; Mombaerts, P; Nordone, P; Ring, B; Ringwald, M; Rodriguez, I; Sakamoto, N; Sasaki, H; Sato, K; Schonbach, C; Seya, T; Shibata, Y; Storch, KF; Suzuki, H; Toyo-oka, K; Wang, KH; Weitz, C; Whittaker, C; Wilming, L; Wynshaw-Boris, A; Yoshida, K; Hasegawa, Y; Kawaji, H; Kohtsuki, S; Hayashizaki, Y		RIKEN Genome Exploration Res Grp	Functional annotation of a full-length mouse cDNA collection	NATURE			English	Article							PROTEIN SEQUENCES; TOOL	The RIKEN Mouse Gene Encyclopaedia Project, a systematic approach to determining the full coding potential of the mouse genome, involves collection and sequencing of full-length complementary DNAs and physical mapping of the corresponding genes to the mouse genome. We organized an international functional annotation meeting (FANTOM) to annotate the first 21,076 cDNAs to be analysed in this project. Here we describe the first RIKEN clone collection, which is one of the largest described for any organism. Analysis of these cDNAs extends known gene families and identifies new ones.	Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat, Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; JST, CREST, Tsukuba, Ibaraki 3050074, Japan; Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; NTT Software Corp, Naka Ku, Kanagawa 2318554, Japan; Osaka Univ, Osaka 5608531, Japan; European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Iowa, Coordinated Lab Computat Genom, Iowa City, IA 52242 USA; Rockefeller Univ, New York, NY 10021 USA; Univ Milan, Dipartimento Fisiol & Biochim Gen, I-20133 Milan, Italy; Jackson Lab, Bar Harbor, ME 04609 USA; Keio Univ, Fac Environm Informat, Lab Bioinformat, Kanagawa 2520816, Japan; Univ Maryland, Dept Mol & Cell Biol, Baltimore, MD 20201 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Computat Proteom Team,Tsurumi Ku, Kanagawa 2300045, Japan; Tokai Univ, Grad Sch Marine Sci & Technol, Shizuoka 4248610, Japan; Inst Genom Res, Rockville, MD 20850 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; LION Biosci AG, D-69120 Heidelberg, Germany; Stanford Univ, Sch Med, Beckman Ctr B271A, Stanford, CA 94305 USA; Lawrence Berkeley Lab, Berkeley, CA 94710 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; NIMH, Genet Lab, NHGRI, NIH, Bethesda, MD 20892 USA; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; Ist Tumori Milano, I-20133 Milan, Italy; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Cambridge, Addenbrookes Hosp, Wellcome Trust Ctr Mol Mechanisms Dis, Dept Med Genet, Cambridge CB2 2XY, England; LNCIB, I-34012 Trieste, Italy; Univ Penn, Ctr Bioinformat, Computat & Bioinformat Lab, Philadelphia, PA 19104 USA; Univ Buffalo, Roswell Pk Canc Inst, Amherst, NY 14226 USA; Stanford Univ, Dept Genet, Beckman Ctr B281, Stanford, CA 94305 USA; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Natl Canc Res Inst, Chuo Ku, Tokyo 1040045, Japan; Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Computat Genom Team,Tsurumi Ku, Kanagawa 2300045, Japan; Osaka Med Ctr Canc, Higashinari Ku, Osaka 5378511, Japan; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, MIT CCR, Cambridge, MA 02139 USA; Sanger Ctr, Hinxton CB10 1SA, Cambs, England; Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan	RIKEN; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Osaka University; European Molecular Biology Laboratory (EMBL); Novartis; University of Iowa; Rockefeller University; University of Milan; Jackson Laboratory; Keio University; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Berkeley; RIKEN; Tokai University; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Mental Health (NIMH); University of Tokyo; Fondazione IRCCS Istituto Nazionale Tumori Milan; Harvard University; Harvard Medical School; University of Queensland; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Pennsylvania; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Stanford University; RIKEN; National Cancer Center - Japan; RIKEN; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute; University of Tsukuba	Kawai, J (corresponding author), Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat, Res Grp,Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.		Bono, Hidemasa/AAF-3649-2020; Kasukawa, Takeya/N-5070-2015; Nikaido, Itoshi/K-2058-2014; Saito, Takashi/C-9684-2009; Schönbach, Christian/B-1998-2009; Kawai, Jun/A-6451-2016; Brownstein, Michael/B-8609-2009; , Kadota/AAP-2804-2020; Fukunishi, Yoshifumi/L-8063-2018; Konno, Hideaki/A-9191-2012; Schriml, Lynn/AFO-9472-2022; Konno, Hideaki/N-4366-2014; Pesole, Graziano/C-1408-2009; Pesole, Graziano/E-9051-2014; Carninci, Piero/K-1568-2014; Mashima, Jun/F-3706-2010; Kawaji, Hideya/N-5116-2015; Hayashizaki, Yoshihide/N-6590-2015; King, Benjamin/AAI-1492-2019; Pesole, Graziano/K-5283-2019; shibata, kazuhiro/A-9527-2008; Wang, Kuan Hong/J-1150-2016; Toyooka, Kazuhito/AAQ-6928-2020; Hume, David A/C-7695-2013; Kadota, Koji/C-9168-2011; Itoh, Masayoshi/N-5363-2015; Seya, Tsukasa/A-4336-2012; Toyooka, Kazuhito/AAH-7175-2019; Suzuki, Harukazu/N-9553-2015; Marchionni, Luigi/S-6774-2017; Gariboldi, Manuela/K-4744-2016	Bono, Hidemasa/0000-0003-4413-0651; Kasukawa, Takeya/0000-0001-5085-0802; Nikaido, Itoshi/0000-0002-7261-2570; Saito, Takashi/0000-0001-9495-3547; Schönbach, Christian/0000-0002-0693-7617; , Kadota/0000-0002-3907-4336; Fukunishi, Yoshifumi/0000-0002-7264-250X; Konno, Hideaki/0000-0002-8470-4835; Pesole, Graziano/0000-0003-3663-0859; Pesole, Graziano/0000-0003-3663-0859; Carninci, Piero/0000-0001-7202-7243; Mashima, Jun/0000-0003-4138-1893; Kawaji, Hideya/0000-0002-0575-0308; Wang, Kuan Hong/0000-0002-2249-5417; Toyooka, Kazuhito/0000-0002-0173-0430; Kadota, Koji/0000-0002-3907-4336; Itoh, Masayoshi/0000-0002-1772-318X; Toyooka, Kazuhito/0000-0002-0173-0430; Suzuki, Harukazu/0000-0002-8087-0836; Marchionni, Luigi/0000-0002-7336-8071; Batalov, Sergey/0000-0002-0925-0554; Gissi, Carmela/0000-0002-2269-079X; Wilming, Laurens/0000-0002-4154-7358; Fukuda, Shiro/0000-0002-0065-662X; Whittaker, Charles/0000-0002-2400-0094; rodriguez, ivan/0000-0002-6468-0565; Lewis, Suzanna/0000-0002-8343-612X; King, Benjamin/0000-0001-6463-1336; OKIDO, Toshihisa/0000-0002-1662-8949; Quackenbush, John/0000-0002-2702-5879; Gustincich, Stefano/0000-0002-2749-2514; Matsuda, Hideo/0000-0002-4701-3779; Hume, David/0000-0002-2615-1478; Schriml, Lynn/0000-0001-8910-9851; Gariboldi, Manuela/0000-0001-8406-165X; Blake, Judith/0000-0001-8522-334X	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; FUKUNISHI Y, IN PRESS PHYSL GENOM; Gautheret D, 1998, GENOME RES, V8, P524, DOI 10.1101/gr.8.5.524; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Itoh M, 1999, GENOME RES, V9, P463; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Matsuda H, 2000, IEICE T FUND ELECTR, VE83A, P713; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Shibata K, 2000, GENOME RES, V10, P1757, DOI 10.1101/gr.152600; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	25	520	583	2	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					685	690		10.1038/35055500	http://dx.doi.org/10.1038/35055500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217851	Bronze			2022-12-01	WOS:000166816400034
J	Piotrowska, K; Zernicka-Goetz, M				Piotrowska, K; Zernicka-Goetz, M			Role for sperm in spatial patterning of the early mouse embryo	NATURE			English	Article							CELL-DIVISION ORDER; POLAR TROPHECTODERM; BLASTOCYST; AXIS; CONSEQUENCES; BLASTOMERES; ALLOCATION; LINEAGE; MASS; FATE	Despite an apparent lack of determinants that specify cell fate, spatial patterning of the mouse embryo is evident early in development. The axis of the post-implantation egg cylinder can be traced back to organization of the pre-implantation blastocyst(1). This in turn reflects the organization of the cleavage-stage embryo and the animal-vegetal axis of the zygote(2,3). These findings suggest that the cleavage pattern of normal development may be involved in specifying the future embryonic axis; however, how and when this pattern becomes established is unclear. In many animal eggs, the sperm entry position provides a cue for embryonic patterning(4-6), but until now no such role has been found in mammals. Here we show that the sperm entry position predicts the plane of initial cleavage of the mouse egg and can define embryonic and abembryonic halves of the future blastocyst. In addition, the cell inheriting the sperm entry position acquires a division advantage and tends to cleave ahead of its sister. As cell identity reflects the timing of the early cleavages, these events together shape the blastocyst whose organization will become translated into axial patterning after implantation. We present a model for axial development that accommodates these findings with the regulative nature of mouse embryos.	Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England.			Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust [064421] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALAKIER H, 1982, DEV BIOL, V23, P52; BOWERMAN B, 1999, CELL LINEAGE FATE DE, P97; Ciemerych MA, 2000, DEVELOPMENT, V127, P3467; COPP AJ, 1979, J EMBRYOL EXP MORPH, V51, P109; CRUZ YP, 1985, DEV BIOL, V112, P73, DOI 10.1016/0012-1606(85)90120-4; GARBUTT CL, 1987, DEVELOPMENT, V100, P325; GARBUTT CL, 1987, DEVELOPMENT, V100, P125; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 1996, HUM REPROD, V11, P1979; GERHART J, 1989, DEVELOPMENT, V107, P37; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GRAHAM CF, 1979, J EMBRYOL EXP MORPH, V49, P277; GRAHAM CF, 1978, J EMBRYOL EXP MORPH, V48, P53; KELLY SJ, 1978, J EMBRYOL EXP MORPH, V48, P37; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; SURANI MAH, 1984, DEV BIOL, V102, P335, DOI 10.1016/0012-1606(84)90198-2; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803	19	182	196	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					517	521		10.1038/35054069	http://dx.doi.org/10.1038/35054069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206548				2022-12-01	WOS:000166570500049
J	Wade, DP; Owen, JS				Wade, DP; Owen, JS			Regulation of the cholesterol efflux gene, ABCA1	LANCET			English	Editorial Material							LXR-ALPHA; ACCUMULATION; DEFICIENCY; MUTATIONS; RECEPTORS		CV Therapeut Inc, Palo Alto, CA USA; UCL Royal Free & Univ Coll Med Sch, Dept Med, London NW3 2PF, England	CV Therapeutics, Inc.; University of London; University College London; UCL Medical School	Owen, JS (corresponding author), CV Therapeut Inc, Palo Alto, CA USA.	j.owen@rfc.ucl.ac.uk	Owen, James/C-5908-2009; Owen, James S./AAP-8628-2020					Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Costet P, 2000, J BIOL CHEM, V275, P28240; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Owen JS, 1999, LANCET, V354, P1402, DOI 10.1016/S0140-6736(99)00297-4; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; WILLY PJ, 1998, HORMONES SIGNALING, V1, P307	14	20	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					161	163		10.1016/S0140-6736(00)03585-6	http://dx.doi.org/10.1016/S0140-6736(00)03585-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213089				2022-12-01	WOS:000166593700005
J	Rain, JC; Selig, L; De Reuse, H; Battaglia, V; Reverdy, C; Simon, S; Lenzen, G; Petel, F; Wojcik, J; Schachter, V; Chemama, Y; Labigne, A; Legrain, P				Rain, JC; Selig, L; De Reuse, H; Battaglia, V; Reverdy, C; Simon, S; Lenzen, G; Petel, F; Wojcik, J; Schachter, V; Chemama, Y; Labigne, A; Legrain, P			The protein-protein interaction map of Helicobacter pylori	NATURE			English	Article							ESCHERICHIA-COLI; COMPLETE GENOME; RNA-POLYMERASE; SEQUENCE; UREASE; YEAST	With the availability of complete DNA sequences for many prokaryotic and eukaryotic genomes, and soon for the human genome itself, it is important to develop reliable proteome-wide approaches for a better understanding of protein function(1). As elementary constituents of cellular protein complexes and pathways, protein-protein interactions are key determinants of protein function. Here we have built a large-scale protein-protein interaction map of the human gastric pathogen Helicobacter pylori. We have used a high-throughput strategy of the yeast two-hybrid assay to screen 261 H. pylori proteins against a highly complex library of genome-encoded polypeptides(2). Over 1,200 interactions were identired between H. pylori proteins, connecting 46.6% of the proteome. The determination of a reliability score for every single protein-protein interaction and the identification of the actual interacting domains permitted the assignment of unannotated proteins to biological pathways.	Hybrigen SA, F-75012 Paris, France; Inst Pasteur, UnitePathogenie Bacterienne Muqueuses, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Legrain, P (corresponding author), Hybrigen SA, 180 Ave Daumesnil, F-75012 Paris, France.	plegrain@hybrigenics.fr		RAIN, Jean-Christophe/0000-0001-8110-0641; DE REUSE, Hilde/0000-0002-0100-4826				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; CUSSAC V, 1992, J BACTERIOL, V174, P2466, DOI 10.1128/jb.174.8.2466-2473.1992; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Fields S, 1997, NAT GENET, V15, P325, DOI 10.1038/ng0497-325; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; LIU XY, 1995, GENE, V164, P81, DOI 10.1016/0378-1119(95)00480-T; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; Moszer I, 1998, FEBS LETT, V430, P28, DOI 10.1016/S0014-5793(98)00620-6; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Welch M, 1998, NAT STRUCT BIOL, V5, P25, DOI 10.1038/nsb0198-25; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	23	835	901	0	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 11	2001	409	6817					211	215		10.1038/35051615	http://dx.doi.org/10.1038/35051615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196647				2022-12-01	WOS:000166316200049
J	Holick, MF				Holick, MF			Sunlight "D"ilemma: risk of skin cancer or bone disease and muscle weakness	LANCET			English	Editorial Material							VITAMIN-D; CALCIUM		Boston Univ, Sch Med, Dept Med, Vitamin D Skin & Bone Res Lab, Boston, MA 02118 USA	Boston University	Holick, MF (corresponding author), Boston Univ, Sch Med, Dept Med, Vitamin D Skin & Bone Res Lab, Boston, MA 02118 USA.	mfholick@bu.edu		Holick, Michael/0000-0001-6023-9062				Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; [Anonymous], 1956, BRIT MED J, V2, P149; BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995; DawsonHughes B, 1997, AM J CLIN NUTR, V65, P67, DOI 10.1093/ajcn/65.1.67; GARLAND CF, 1991, AM J CLIN NUTR, V54, pS193, DOI 10.1093/ajcn/54.1.193S; GILCHREST BA, 1993, NEW ENGL J MED, V329, P1193, DOI 10.1056/NEJM199310143291611; Glerup H, 2000, CALCIFIED TISSUE INT, V66, P419, DOI 10.1007/s002230010085; Glerup H, 2000, J INTERN MED, V247, P260, DOI 10.1046/j.1365-2796.2000.00595.x; GLOTH FM, 1995, JAMA-J AM MED ASSOC, V274, P1683, DOI 10.1001/jama.274.21.1683; HANCHETTE CL, 1992, CANCER, V70, P2861, DOI 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; MCKENNA MJ, 1992, AM J MED, V93, P69, DOI 10.1016/0002-9343(92)90682-2; REID IR, 1986, AGE AGEING, V15, P35, DOI 10.1093/ageing/15.1.35; Schwartz GG, 1998, CANCER EPIDEM BIOMAR, V7, P391; SEDRANI SH, 1984, ANN NUTR METAB, V28, P181, DOI 10.1159/000176801	16	145	153	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2001	357	9249					4	6		10.1016/S0140-6736(00)03560-1	http://dx.doi.org/10.1016/S0140-6736(00)03560-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197362				2022-12-01	WOS:000166341500004
J	Despres, JP; Lemieux, I; Prud'homme, D				Despres, JP; Lemieux, I; Prud'homme, D			Treatment of obesity: need to focus on high risk abdominally obese patients	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VISCERAL ADIPOSE-TISSUE; WAIST CIRCUMFERENCE; BODY-FAT; CARDIOVASCULAR RISK; LIPOPROTEIN LEVELS; GLUCOSE-TOLERANCE; PARTICLE-SIZE; HEART-DISEASE; DENSE LDL; MEN		Laval Hosp Res Ctr, Quebec Heart Inst, Ste Foy, PQ G1V 4G5, Canada; CHUQ Res Ctr, Lipid Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Phys Act Sci Lab, Ste Foy, PQ G1K 7P4, Canada	Laval University; Laval University	Despres, JP (corresponding author), Laval Hosp Res Ctr, Quebec Heart Inst, Ste Foy, PQ G1V 4G5, Canada.	despres@crchul.ulaval.ca						BERGSTROM RW, 1990, DIABETES, V39, P104, DOI 10.2337/diabetes.39.1.104; Bray G. A., 1998, HDB OBESITY; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; KISSEBAH AH, 1989, MED CLIN N AM, V73, P111, DOI 10.1016/S0025-7125(16)30695-2; Lamarche B, 1998, JAMA-J AM MED ASSOC, V279, P1955, DOI 10.1001/jama.279.24.1955; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Lemieux S, 1996, DIABETES CARE, V19, P983, DOI 10.2337/diacare.19.9.983; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Lemieux S, 1996, INT J OBESITY, V20, P618; MCNAMARA JR, 1992, ARTERIOSCLER THROMB, V12, P1284, DOI 10.1161/01.ATV.12.11.1284; *NAT HEART LUNG BL, 1998, CLIN GUID ID EV TREA, P1; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; POULIOT MC, 1990, INT J OBESITY, V14, P293; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Tchernof A, 1996, DIABETES CARE, V19, P629, DOI 10.2337/diacare.19.6.629; TERRY RB, 1991, METABOLISM, V40, P733, DOI 10.1016/0026-0495(91)90093-C; VAGUE J, 1947, PRESSE MED, V55, P339; Williamson DF, 1999, JAMA-J AM MED ASSOC, V281, P278, DOI 10.1001/jama.281.3.278; World Health Organization, 1997, WORLD HLTH REP 1996, P1	26	511	536	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2001	322	7288					716	720		10.1136/bmj.322.7288.716	http://dx.doi.org/10.1136/bmj.322.7288.716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416GB	11264213	Green Published			2022-12-01	WOS:000167771000028
J	Liu, LM; Hausladen, A; Zeng, M; Que, L; Heitman, J; Stamler, JS				Liu, LM; Hausladen, A; Zeng, M; Que, L; Heitman, J; Stamler, JS			A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans	NATURE			English	Article							DEPENDENT FORMALDEHYDE DEHYDROGENASE; III ALCOHOL-DEHYDROGENASE; NITRIC-OXIDE; NITROSATIVE STRESS; GLUTATHIONE; NITROSOGLUTATHIONE; PROTEIN; FLAVOHEMOGLOBIN; QUANTIFICATION; IDENTIFICATION	Considerable evidence indicates that NO biology involves a family of NO-related molecules and that S-nitrosothiols (SNOs) are central to signal transduction and host defence(1-5). It is unknown, however, how cells switch off the signals or protect themselves from the SNOs produced for defence purposes. Here we have purified a single activity from Escherichia coli, Saccharomyces cerevisiae and mouse macrophages that metabolizes S-nitrosoglutathione (GSNO), and show that it is the glutathione-dependent formaldehyde dehydrogenase. Although the enzyme is highly specific for GSNO, it controls intracellular levels of both GSNO and S-nitrosylated proteins. Such 'GSNO reductase' activity is widely distributed in mammals. Deleting the reductase gene in yeast and mice abolishes the GSNO-consuming activity, and increases the cellular quantity of both GSNO and protein SNO. Furthermore, mutant yeast cells show increased susceptibility to a nitrosative challenge, whereas their resistance to oxidative stress is unimpaired. We conclude that GSNO reductase is evolutionarily conserved from bacteria to humans, is critical for SNO homeostasis, and protects against nitrosative stress.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Pulm, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.		Heitman, Joseph/ABC-6006-2021	Stamler, Jonathan/0000-0002-6866-1572				Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459; ASKEW SC, 1995, J CHEM SOC PERK T 2, P741, DOI 10.1039/p29950000741; Barber RD, 1998, BIOCHEMISTRY-US, V37, P530, DOI 10.1021/bi971463t; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Glover RE, 1999, NITRIC OXIDE-BIOL CH, V3, P439, DOI 10.1006/niox.1999.0256; GUTHEIL WG, 1992, BIOCHEMISTRY-US, V31, P475, DOI 10.1021/bi00117a025; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Kluge I, 1997, J NEUROCHEM, V69, P2599; KUWADA M, 1980, J BIOCHEM-TOKYO, V88, P859, DOI 10.1093/oxfordjournals.jbchem.a133040; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Scorza G, 1997, FREE RADICAL BIO MED, V22, P633, DOI 10.1016/S0891-5849(96)00378-4; Shafqat J, 1996, P NATL ACAD SCI USA, V93, P5595, DOI 10.1073/pnas.93.11.5595; Shen SG, 1998, GENE, V216, P93, DOI 10.1016/S0378-1119(98)00315-1; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Uotila L., 1989, COENZYMES COFACTOR A, P517; WEHNER EP, 1993, MOL GEN GENET, V237, P351, DOI 10.1007/BF00279438	30	709	752	2	64	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					490	494		10.1038/35068596	http://dx.doi.org/10.1038/35068596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260719				2022-12-01	WOS:000167583800047
J	Kagawa, T; Sakai, T; Suetsugu, N; Oikawa, K; Ishiguro, S; Kato, T; Tabata, S; Okada, K; Wada, M				Kagawa, T; Sakai, T; Suetsugu, N; Oikawa, K; Ishiguro, S; Kato, T; Tabata, S; Okada, K; Wada, M			Arabidopsis NPL1: A phototropin homolog controlling the chloroplast high-light avoidance response	SCIENCE			English	Article							BLUE-LIGHT; PROTEIN-KINASE; NPH1; ADIANTUM	Chloroplasts relocate their positions in a cell in response to the intensity of incident Light, moving to the side wall of the cell to avoid strong Light, but gathering at the front face under weak Light to maximize Light interception. Here, Arabidopsis thaliana mutants defective in the avoidance response were isolated, and the mutated gene was identified as NPL1 (NPH-Like 1), a homolog of NPH1 (nonphototropic hypocotyl 1), a blue Light receptor used in phototropism. Hence, NPL1 is Likely a blue Light receptor regulating the avoidance response under strong light.	Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & Combined Circuit, Kawaguchi, Saitama 3320012, Japan; RIKEN, Plant Sci Ctr, Kyoto 6068502, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan; Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); RIKEN; Tokyo Metropolitan University; Kazusa DNA Research Institute; Kyoto University	Wada, M (corresponding author), Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan.	wada-masamitsu@c.metro-u.ac.jp	Sakai, Tatsuya/A-8909-2010; Ishiguro, Sumie/AAH-2592-2019; Suetsugu, Noriyuki/AAB-5274-2019; ISHIGURO, Sumie/I-6903-2014	Sakai, Tatsuya/0000-0002-1589-6247; Ishiguro, Sumie/0000-0002-6160-7434; Suetsugu, Noriyuki/0000-0002-3328-3313; Oikawa, Kazusato/0000-0002-1033-9089				Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HAUPT W, 1959, PLANTA, V53, P484, DOI 10.1007/BF01900644; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; JARILLO JA, 2000, PLANT PHYSIOL, V117, P719; Kagawa T, 2000, PLANT CELL PHYSIOL, V41, P84, DOI 10.1093/pcp/41.1.84; KASAHARA M, COMMUNICATION; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T., UNPUB; SENN G, 1908, GESTALTS LAGEVERANDR; YATSUHASHI H, 1985, PLANTA, V165, P43, DOI 10.1007/BF00392210; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50	16	507	548	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2138	2141		10.1126/science.291.5511.2138	http://dx.doi.org/10.1126/science.291.5511.2138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251116				2022-12-01	WOS:000167563800036
J	Kutateladze, T; Overduin, M				Kutateladze, T; Overduin, M			Structural mechanism of endosome docking by the FYVE domain	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CRYSTAL-STRUCTURE; EEA1; BINDING; LOCALIZATION; RECOGNITION; FUSION; HRS	The recruitment of trafficking and signaling proteins to membranes containing phosphatidylinositol 3-phosphate [Ptdlns(3)P] is mediated by FYVE domains. Here, the solution structure of the FYVE domain of the early endosome antigen 1 protein (EEA1) in the free state was compared with the structures of the domain complexed with Ptdlns(3)P and mixed micelles. The multistep binding mechanism involved nonspecific insertion of a hydrophobic Loop into the Lipid bilayer, positioning and activating the binding pocket. Ligation of Ptdlns(3)P then induced a global structural change, drawing the protein termini over the bound phosphoinositide by extension of a hinge. Specific recognition of the 3-phosphate was determined indirectly and directly by two clusters of conserved arginines.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kutateladze, T (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave, Denver, CO 80262 USA.	tatiana.kutateladze@uchsc.edu		Kutateladze, Tatiana/0000-0001-7375-6990; Overduin, Michael/0000-0002-3114-6585	NATIONAL CANCER INSTITUTE [R01CA085716] Funding Source: NIH RePORTER; NCI NIH HHS [CA85716] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Hayakawa A, 2000, J BIOL CHEM, V275, P29636, DOI 10.1074/jbc.M002696200; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048	18	137	139	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1793	1796		10.1126/science.291.5509.1793	http://dx.doi.org/10.1126/science.291.5509.1793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230696				2022-12-01	WOS:000167320600061
J	Sondermann, H; Scheufler, C; Schneider, C; Hohfeld, J; Hartl, FU; Moarefi, I				Sondermann, H; Scheufler, C; Schneider, C; Hohfeld, J; Hartl, FU; Moarefi, I			Structure of a Bag/Hsc70 complex: Convergent functional evolution of Hsp70 nucleotide exchange factors	SCIENCE			English	Article							APOPTOTIC PROTEIN BAG-1; MOLECULAR CHAPERONES; ATP HYDROLYSIS; DNAK; BINDING; HSC70; RECEPTOR; RELEASE; SYSTEM; CYCLE	Bag (Bcl2-associated athanogene) domains occur in a class of cofactors of the eukaryotic chaperone 70-kilodalton heat shock protein (Hsp70) family. Binding of the Bag domain to the Hsp70 adenosine triphosphatase (ATPase) domain promotes adenosine 5'-triphosphate-dependent release of substrate from Hsp70 in vitro. In a 1.9 angstrom crystal structure of a complex with the ATPase of the 70-kilodalton heat shock cognate protein (Hsc70), the Bag domain forms a three-helix bundle. inducing a, conformational switch in the ATPase that is incompatible with nucleotide binding. The same switch is observed in the bacterial Hsp70 homolog DnaK upon;binding of the structurally unrelated nucleotide exchange factor GrpE, Thus, functional convergence has allowed proteins with different architectures to trigger a conserved conformational shift in Hsp70 that leads to nucleotide exchange.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ Bonn, Inst Zellbiol, D-53121 Bonn, Germany	Max Planck Society; University of Bonn	Moarefi, I (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.	ismail@moarefi.com	Hartl, F. Ulrich/Y-8206-2019	Scheufler, Clemens/0000-0002-3693-3529				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CYR DM, 1992, J BIOL CHEM, V267, P20927; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; HA JH, 1995, BIOCHEMISTRY-US, V34, P11635, DOI 10.1021/bi00036a040; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; SONDERMANN H, UNPUB; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483	36	340	356	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1553	1557		10.1126/science.1057268	http://dx.doi.org/10.1126/science.1057268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222862				2022-12-01	WOS:000167153400047
J	Thoma-Uszynski, S; Stenger, S; Takeuchi, O; Ochoa, MT; Engele, M; Sieling, PA; Barnes, PF; Rollinghoff, M; Bolcskei, PL; Wagner, M; Akira, S; Norgard, MV; Belisle, JT; Godowski, PJ; Bloom, BR; Modlin, RL				Thoma-Uszynski, S; Stenger, S; Takeuchi, O; Ochoa, MT; Engele, M; Sieling, PA; Barnes, PF; Rollinghoff, M; Bolcskei, PL; Wagner, M; Akira, S; Norgard, MV; Belisle, JT; Godowski, PJ; Bloom, BR; Modlin, RL			Induction of direct antimicrobial activity through mammalian toll-like receptors	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR INFECTION; ALVEOLAR MACROPHAGES; MURINE MACROPHAGES; HOST-DEFENSE; LIPOPOLYSACCHARIDE; LIPOPROTEINS; ACTIVATION; MECHANISMS	The mammalian innate immune system retains from Drosophila a family of homologous Toll-like receptors (TLRs) that mediate responses to microbial ligands. Here, we show that TLR2 activation Leads to killing of intracellular Mycobacterium tuberculosis in both mouse and human macrophages, through distinct mechanisms. In mouse macrophages, bacterial lipoprotein activation of TLR2 Leads to a nitric oxide-dependent killing of intracellular tubercle bacilli, but in human monocytes and alveolar macrophages, this pathway was nitric oxide-independent. Thus, mammalian TLRs respond (as Drosophila Toll receptors do) to microbial ligands and also have the ability to activate antimicrobial effector pathways at the site of infection.	Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; Osaka Univ, Dept Host Def, Osaka, Japan; Univ Texas Hlth Ctr, Dept Med, Tyler, TX 75708 USA; Univ Texas Hlth Ctr, Dept Cell Biol, Tyler, TX 75708 USA; Univ Texas Hlth Ctr, Dept Immunol, Tyler, TX 75708 USA; Klinikum Nurnberg, Med Clin 3, D-90419 Nurnberg, Germany; Univ Texas, SW Med Ctr, Dallas, TX 75235 USA; Colorado State Univ, Ft Collins, CO 80523 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA; Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; Osaka University; Klinikum Nurnberg Nord; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Colorado State University; Roche Holding; Genentech; Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014; Takeuchi, Osamu/AAG-9359-2019; Belisle, John T/B-8944-2017; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011	Modlin, Robert L/0000-0003-4720-031X; Takeuchi, Osamu/0000-0002-1260-6232; Belisle, John T/0000-0002-2539-2798; Ochoa, Maria T/0000-0001-6550-5008	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047868, R22AI022553, R37AI147868, R01AI022553, R37AI047868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 47868, AI 22553, AI 07118] Funding Source: Medline; NIAMS NIH HHS [AR 40312] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; COUTO MA, 1994, INFECT IMMUN, V62, P2375, DOI 10.1128/IAI.62.6.2375-2378.1994; ENGELE M, UNPUB; HIRSCH CS, 1994, J IMMUNOL, V152, P743; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Jullien D, 1997, J IMMUNOL, V158, P800; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; STENGER S, 1991, EUR J IMMUNOL, V21, P1669, DOI 10.1002/eji.1830210713; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	23	548	579	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1544	1547		10.1126/science.291.5508.1544	http://dx.doi.org/10.1126/science.291.5508.1544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222859				2022-12-01	WOS:000167153400044
J	Bjornstad, ON; Sait, SM; Stenseth, NC; Thompson, DJ; Begon, M				Bjornstad, ON; Sait, SM; Stenseth, NC; Thompson, DJ; Begon, M			The impact of specialized enemies on the dimensionality of host dynamics	NATURE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; POPULATION REGULATION; TIME-SERIES; CYCLES; TRANSMISSION; MODELS; AGE	Although individual species persist within a web of interactions with other species, data are usually gathered only from the focal species itself. We ask whether evidence of a species' interactions be detected and understood from patterns in the dynamics of that species alone. Theory predicts that strong coupling between a prey and a specialist predator/parasite should lead to an increase in the dimensionality of the prey's dynamics, whereas weak coupling should not. Here we describe a rare test of this prediction. Two natural enemies were added separately to replicate populations of a moth. For biological reasons that we identify here, the prediction of increased dimensionality was confirmed when a parasitoid wasp was added (although this increase had subtleties not previously appreciated), but the prediction failed for an added virus. Thus, an imprint of the interactions may be discerned within time-series data from component species of a system.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Univ Liverpool, Sch Biol Sci, Populat & Evolutionary Biol Res Grp, Liverpool L69 3BX, Merseyside, England; Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway	National Center for Ecological Analysis & Synthesis; University of Liverpool; University of Oslo	Bjornstad, ON (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.	onb1@psu.edu	Stenseth, Nils Chr./G-5212-2016; Bjornstad, Ottar N/I-4518-2012; Thompson, David J/C-3520-2008	Stenseth, Nils Chr./0000-0002-1591-5399; Begon, Mike/0000-0003-1715-5327				Begon M, 1996, NATURE, V381, P311, DOI 10.1038/381311a0; Berryman AA., 2008, POPULATION SYSTEMS G; Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Bjornstad ON, 1999, ECOLOGY, V80, P1278; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; CHENG B, 1994, PHILOS T R SOC A, V348, P325, DOI 10.1098/rsta.1994.0094; CHENG B, 1992, J ROY STAT SOC B MET, V54, P427; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; FREE CA, 1977, J ANIM ECOL, V46, P543, DOI 10.2307/3829; GREEN PJ, 1994, NONPARAMETRIC REGRES, P182; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; HASSELL MP, 1986, J ANIM ECOL, V55, P923, DOI 10.2307/4425; Knell RJ, 1998, J ANIM ECOL, V67, P592, DOI 10.1046/j.1365-2656.1998.00219.x; MURDOCH W W, 1975, P1; Murdoch WW, 1996, ECOLOGY, V77, P2001, DOI 10.2307/2265696; NICHOLSON AJ, 1935, P ZOOL SOC LOND, V3, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Royama T., 1992, ANAL POPULATION ECOL; SAIT SM, 1994, J INVERTEBR PATHOL, V63, P107, DOI 10.1006/jipa.1994.1020; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; Sait SM, 1997, ECOL ENTOMOL, V22, P225, DOI 10.1046/j.1365-2311.1997.t01-1-00051.x; SAIT SM, 1995, ECOL ENTOMOL, V20, P199, DOI 10.1111/j.1365-2311.1995.tb00447.x; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; SCHAFFER WM, 1981, ECOL MONOGR, V51, P383, DOI 10.2307/2937321; SOKAL RR, 1995, BIOMETRY, V1, P887; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; TABASHNIK BE, 1994, J ECON ENTOMOL, V87, P834, DOI 10.1093/jee/87.4.834; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; VENABLES WN, 1994, MODERN APPL STAT SPL, P1; WEI WW, 1989, TIME SERIES ANAL; YAO QW, 1994, J ROY STAT SOC B MET, V56, P701	38	60	68	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1001	1006		10.1038/35059003	http://dx.doi.org/10.1038/35059003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234001				2022-12-01	WOS:000167148800034
J	Birney, E; Bateman, A; Clamp, ME; Hubbard, TJ				Birney, E; Bateman, A; Clamp, ME; Hubbard, TJ			Mining the draft human genome	NATURE			English	Article								Now that the draft human genome sequence is available, everyone wants to be able to use it. However, we have perhaps become complacent about our ability to turn new genomes into lists of genes. The higher volume of data associated with a larger genome is accompanied by a much greater increase in complexity. We need to appreciate both the scale of the challenge of vertebrate genome analysis and the limitations of current gene prediction methods and understanding.	European Bioinformat Inst, Cambridge CB10 1SA, England; Sanger Ctr, Cambridge CB10 1SA, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Birney, E (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	birney@ebi.ac.uk	Bateman, Alex/E-6518-2011; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Bateman, Alex/H-2861-2019	Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Bateman, Alex/0000-0002-6982-4660; Birney, Ewan/0000-0001-8314-8497				[Anonymous], 1997, NATURE, V387, pS; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BURGE, UNPUB NATURE GENET; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Fahrer AM, 2001, NATURE, V409, P836, DOI 10.1038/35057020; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Murray AW, 2001, NATURE, V409, P844, DOI 10.1038/35057033; Nestler EJ, 2001, NATURE, V409, P834, DOI 10.1038/35057015; Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; 2000, NATURE, V406, P929	16	41	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					827	828		10.1038/35057004	http://dx.doi.org/10.1038/35057004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236999	Green Accepted, Bronze			2022-12-01	WOS:000166938800046
J	Nestler, EJ; Landsman, D				Nestler, EJ; Landsman, D			Learning about addiction from the genome	NATURE			English	Article							MU-OPIOID RECEPTOR; PROTEINS; NEUROSCIENCE; SENSITIVITY; PROGRESS; GENES	Drug addiction can be defined as the compulsive seeking and taking of a drug despite adverse consequences. Although addiction involves many psychological and social factors, it also represents a biological process: the effects of repeated drug exposure on a vulnerable brain. The sequencing of the human and other mammalian genomes will help us to understand the biology of addiction by enabling us to identify both genes that contribute to individual risk for addiction and those through which drugs cause addiction. We illustrate this potential impact by searching a draft sequence of the human genome for genes related to desensitization of receptors that mediate the actions of drugs of abuse on the nervous system.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, Computat Biol Branch, Bethesda, MD 20892 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Landsman, David/GZK-5496-2022; Landsman, David/C-5923-2009	Landsman, David/0000-0002-9819-6675	NATIONAL LIBRARY OF MEDICINE [Z01LM000071, ZIALM000071] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Crabbe JC, 1999, TRENDS NEUROSCI, V22, P173, DOI 10.1016/S0166-2236(99)01393-4; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Nestler EJ, 2000, NAT GENET, V26, P277, DOI 10.1038/81570; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Potenza MN, 1999, J PHARMACOL EXP THER, V291, P482; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	15	62	65	2	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					834	835		10.1038/35057015	http://dx.doi.org/10.1038/35057015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237002	Bronze			2022-12-01	WOS:000166938800049
J	Riethman, HC; Xiang, Z; Paul, S; Morse, E; Hu, XL; Flint, J; Chi, HC; Grady, DL; Moyzis, RK				Riethman, HC; Xiang, Z; Paul, S; Morse, E; Hu, XL; Flint, J; Chi, HC; Grady, DL; Moyzis, RK			Integration of telomere sequences with the draft human genome sequence	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCE; COMPLETE SET; GENE FAMILY; CHROMOSOME; POLYMORPHISM; CLONING	Telomeres are the ends of linear eukaryotic chromosomes. To ensure that no large stretches of uncharacterized DNA remain between the ends of the human working draft sequence and the ends of each chromosome, we would need to connect the sequences of the telomeres to the working draft sequence. But telomeres have an unusual DNA sequence composition and organization that makes them particularly difficult to isolate and analyse. Here we use specialized linear yeast artificial chromosome clones, each carrying a large telomere-terminal fragment of human DNA, to integrate most human telomeres with the working draft sequence. Subtelomeric sequence structure appears to vary widely, mainly as a result of large differences in subtelomeric repeat sequence abundance and organization at individual telomeres. Many subtelomeric regions appear to be gene-rich, matching both known and unknown expressed genes. This indicates that human subtelomeric regions are not simply buffers of nonfunctional 'junk DNA' next to the molecular telomere, but are instead functional parts of the expressed genome.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; John Radcliffe Hosp, Inst Mol Med, Oxford, England; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA	The Wistar Institute; University of Oxford; University of California System; University of California Irvine	Riethman, HC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	Riethman@wistar.upenn.edu		Flint, Jonathan/0000-0002-9427-4429				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Blasco Maria A., 1999, Genes and Development, V13, P2353, DOI 10.1101/gad.13.18.2353; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; CARLSON M, 1985, MOL CELL BIOL, V5, P2894, DOI 10.1128/MCB.5.11.2894; Ciccodicola A, 2000, HUM MOL GENET, V9, P395, DOI 10.1093/hmg/9.3.395; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; DOGGETT NA, 1995, NATURE, V377, P335; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Gianfrancesco F, 1998, HUM MOL GENET, V7, P407, DOI 10.1093/hmg/7.3.407; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; LOUIS EJ, 1995, GENETICS, V139, P125; MACINA RA, 1995, GENOME RES, V5, P225, DOI 10.1101/gr.5.3.225; McCulloch R, 1997, MOL CELL BIOL, V17, P833, DOI 10.1128/MCB.17.2.833; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Riethman H, 1997, GENOME ANAL, V1, P83; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R	26	66	69	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					948	951		10.1038/35057180	http://dx.doi.org/10.1038/35057180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237019	Bronze			2022-12-01	WOS:000166938800066
J	Saghatelian, A; Yokobayashi, Y; Soltani, K; Ghadiri, MR				Saghatelian, A; Yokobayashi, Y; Soltani, K; Ghadiri, MR			A chiroselective peptide replicator	NATURE			English	Article							BIOMOLECULAR CHIRALITY; SELF-REPLICATION; OPTICAL-ACTIVITY; AMINO-ACIDS; AMPLIFICATION; TEMPLATE; ORIGIN; HOMOCHIRALITY; LIGATION	The origin of homochirality in living systems is often attributed to the generation of enantiomeric differences in a pool of chiral prebiotic molecules(1,2), but none of the possible physiochemical processes considered(1-7) can produce the significant imbalance required if homochiral biopolymers are to result from simple coupling of suitable precursor molecules. This implies a central role either for additional processes that can selectively amplify an initially minute enantiomeric difference in the starting material(1,8-12), or for a nonenzymatic process by which biopolymers undergo chiroselective molecular replication(13-16). Given that molecular self-replication and the capacity for selection are necessary conditions for the emergence of life, chiroselective replication of biopolymers seems a particularly attractive process for explaining homochirality in nature(13-16). Here we report that a 32-residue peptide replicator, designed according to our earlier principles(17-20), is capable of efficiently amplifying homochiral products from a racemic mixture of peptide fragments through a chiroselective autocatalytic cycle. The chiroselective amplification process discriminates between structures possessing even single stereochemical mutations within otherwise homochiral sequences. Moreover, the system exhibits a dynamic stereochemical 'editing' function; in contrast to the previously observed error correction(20), it makes use of heterochiral sequences that arise through uncatalysed background reactions to catalyse the production of the homochiral product. These results support the idea that self-replicating polypeptides could have played a key role in the origin of homochirality on Earth.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.		Yokobayashi, Yohei/B-5898-2009	Yokobayashi, Yohei/0000-0002-2417-1934				BADA JL, 1995, NATURE, V374, P594, DOI 10.1038/374594a0; Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; BONNER WA, 1991, ORIGINS LIFE EVOL B, V21, P59, DOI 10.1007/BF01809580; BONNER WA, 1981, ORIGINS LIFE EVOL B, V11, P119, DOI 10.1007/BF00928003; CALVIN M, 1969, CHEM EVOLUTION; Case MA, 1998, CHIRALITY, V10, P35, DOI 10.1002/(SICI)1520-636X(1998)10:1/2<35::AID-CHIR7>3.3.CO;2-F; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; GIRDARD C, 1998, ANGEW CHEM INT EDIT, V37, P2923; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; KONDEPUDI DK, 1985, NATURE, V314, P438, DOI 10.1038/314438a0; KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975; Kozlov IA, 1999, J AM CHEM SOC, V121, P1108, DOI 10.1021/ja9836489; Krause E, 2000, J AM CHEM SOC, V122, P4865, DOI 10.1021/ja9940524; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; LI T, 1987, J CHEM SOC CHEM COMM, P1817, DOI 10.1039/c39870001817; ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005; ROTHEMUND S, 1996, PEPTIDE RES, V9, P78; Schmidt JG, 1997, J AM CHEM SOC, V119, P1494, DOI 10.1021/ja963563c; Severin K, 1998, ANGEW CHEM INT EDIT, V37, P126, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<126::AID-ANIE126>3.0.CO;2-4; Severin K, 1997, CHEM-EUR J, V3, P1017, DOI 10.1002/chem.19970030706; Siegel JS, 1998, CHIRALITY, V10, P24, DOI 10.1002/(SICI)1520-636X(1998)10:1/2<24::AID-CHIR5>3.0.CO;2-Y; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; WEISSBUCH I, 1984, NATURE, V310, P161, DOI 10.1038/310161a0	27	211	214	3	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					797	801		10.1038/35057238	http://dx.doi.org/10.1038/35057238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236988				2022-12-01	WOS:000166938800034
J	Sun, Y; Nadal-Vicens, M; Misono, S; Lin, MZ; Zubiaga, A; Hua, XX; Fan, GP; Greenberg, ME				Sun, Y; Nadal-Vicens, M; Misono, S; Lin, MZ; Zubiaga, A; Hua, XX; Fan, GP; Greenberg, ME			Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; HELIX TRANSCRIPTION FACTORS; MAMMALIAN ACHAETE-SCUTE; ZONE PROGENITOR CELLS; CREST STEM-CELLS; NEURONAL DIFFERENTIATION; DETERMINATION GENES; FATE DETERMINATION; VENTRICULAR ZONE; CEREBRAL-CORTEX	The mechanisms by which neural stem cells give rise to neurons, astrocytes, or oligodendrocytes are beginning to be elucidated. However, it is not known how the specification of one cell lineage results in the suppression of alternative fates. We find that in addition to inducing neurogenesis, the bHLH transcription factor neurogenin (Ngn1) inhibits the differentiation of neural stem cells into astrocytes. While Ngn1 promotes neurogenesis by functioning as a transcriptional activator, Ngn1 inhibits astrocyte differentiation by sequestering the CBP-Smad1 transcription complex away from astrocyte differentiation genes, and by inhibiting the activation of STAT transcription factors that are necessary for gliogenesis. Thus, two distinct mechanisms are involved in the activation and suppression of gene expression during cell-fate specification by neurogenin.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Basque Country, Fac Ciencias, Dept Genet, E-48080 Bilbao, Spain; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Basque Country; Massachusetts Institute of Technology (MIT); Whitehead Institute	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	greenberg@a1.tch.harvard.edu	Albertini, David/AAD-3856-2021; zubiaga, ana/S-3457-2019	Albertini, David/0000-0001-6536-2828; zubiaga, ana/0000-0002-2132-9708; Fan, Guoping/0000-0001-5235-6410; Misono, Stephanie/0000-0001-9000-6323; Lin, Michael/0000-0002-0492-1961	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA43855] Funding Source: Medline; NICHD NIH HHS [NIHP30-HD18655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON DJ, 1993, J NEUROBIOL, V24, P185, DOI 10.1002/neu.480240206; Bayer S.A., 1991, NEOCORTICAL DEV, V1; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cau E, 1997, DEVELOPMENT, V124, P1611; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Goodman RH, 2000, GENE DEV, V14, P1553; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Koyano-Nakagawa N, 1999, MOL CELL NEUROSCI, V14, P327, DOI 10.1006/mcne.1999.0783; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; Li WW, 1998, J NEUROSCI, V18, P8853; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; NIETO M, 2001, IN PRESS NEURON, V29; Park JK, 1999, J NEUROSCI, V19, P10383; PEYTON M, 1994, J BIOL CHEM, V269, P25936; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajan P, 1998, J NEUROSCI, V18, P3620; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	51	615	660	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					365	376		10.1016/S0092-8674(01)00224-0	http://dx.doi.org/10.1016/S0092-8674(01)00224-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239394	Bronze			2022-12-01	WOS:000167003100007
J	Kapan, DD				Kapan, DD			Three-butterfly system provides a field test of mullerian mimicry	NATURE			English	Article							MIMETIC ADVANTAGE; NATURAL-SELECTION; BUTTERFLIES; HELICONIUS; DIVERSITY; RESPONSES; EVOLUTION; DYNAMICS	In 1879, Muller proposed that two brightly coloured distasteful butterfly species (co-models) that share a single warning-colour pattern would benefit by spreading the selective burden of educating predators(1-5). The mutual benefit of sharing warning signals among distasteful species, so-called mullerian mimicry, is supported by comparative evidence(2,3), theoretical studies(5,6) and laboratory simulations(7); however, to date, this key exemplar of adaptive evolution has not been experimentally tested in the field. To measure natural selection generated by mullerian mimicry, I exploited the unusual polymorphism of Heliconius cydno (Lepidoptera: Nymphalidae)(8). Here I show increased survival of H. cydno morphs that match locally abundant monomorphic co-model species. This study demonstrates mullerian mimicry in the field. It also shows that mullerian mimicry with several co-models generates geographically divergent selection, which explains the existence of polymorphism in distasteful species with warning coloration(9).	Univ British Columbia, Dept Zool, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada; Univ Texas, Patterson Labs, Sect Integrat Biol, Austin, TX 78712 USA	University of British Columbia; University of Texas System; University of Texas Austin	Kapan, DD (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA.	dkapan@rrpac.upr.clu.edu						Akaike H., 1973, 2 INT S INF THEOR, P267; Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; BROWER LINCOLN PIERSON, 1963, ZOOLOGICA [NEW YORK], V48, P65; BROWER LP, 1967, EVOLUTION, V21, P11, DOI 10.1111/j.1558-5646.1967.tb00126.x; BROWN K S JR, 1974, Biotropica, V6, P205, DOI 10.2307/2989666; CHAI P, 1986, BIOL J LINN SOC, V29, P161, DOI 10.1111/j.1095-8312.1986.tb01772.x; COOK LM, 1969, EVOLUTION, V23, P339, DOI 10.1111/j.1558-5646.1969.tb03516.x; DUNLAPPIANKA H, 1977, SCIENCE, V197, P487, DOI 10.1126/science.197.4302.487; Edwards AWF, 1992, LIKELIHOOD; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; Fisher R., 2005, TEACHING CHILDREN TH; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; Gilbert L.E., 1991, P403; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; KAPAN DD, 1998, THESIS U BRIT COLUMB; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; M³ller, 1879, T ENTOMOL SOC LOND, V1879, P20; MALLET J, 1990, GENETICS, V124, P921; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; MALLET J, 1987, J ANIM ECOL, V56, P377, DOI 10.2307/5054; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Skalski J.R., 1993, P9; Turner J. R. G., 1977, Evolutionary Biol, V10, P163; TURNER JRG, 1996, PHILOS T R SOC B, V351, P835; WALDBAUER GP, 1975, EVOLUTION, V29, P650, DOI 10.1111/j.1558-5646.1975.tb00859.x; Wickler W., 1968, MIMICRY PLANTS ANIMA	30	217	219	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					338	340		10.1038/35053066	http://dx.doi.org/10.1038/35053066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201741				2022-12-01	WOS:000166434300046
J	Alerstam, T; Gudmundsson, GA; Green, M; Hedenstrom, A				Alerstam, T; Gudmundsson, GA; Green, M; Hedenstrom, A			Migration along orthodromic sun compass routes by arctic birds	SCIENCE			English	Article							ORIENTATION	Flight directions of birds migrating at high geographic and magnetic latitudes can be used to test bird orientation by celestial or geomagnetic compass systems under polar conditions. Migration patterns of arctic shorebirds, revealed by tracking radar studies during an icebreaker expedition along the Northwest Passage in 1999, support predicted sun compass trajectories but cannot be reconciled with orientation along either geographic or magnetic loxodromes (rhumb Lines). Sun compass routes are similar to orthodromes (great circle routes) at high latitudes, showing changing geographic courses as the birds traverse longitudes and their internal clock gets out of phase with Local time. These routes bring the shorebirds from high arctic Canada to the east coast of North America, from which they make transoceanic flights to South America. The observations are also consistent with a migration Link between Siberia and the Beaufort Sea region by way of sun compass routes across the Arctic Ocean.	Univ Lund, Dept Anim Ecol, SE-22362 Lund, Sweden; Iceland Inst Nat Hist, IS-125 Reykjavik, Iceland	Lund University	Alerstam, T (corresponding author), Univ Lund, Dept Anim Ecol, Ecol Bldg, SE-22362 Lund, Sweden.		Hedenström, Anders/F-5377-2010	Hedenström, Anders/0000-0002-1757-0945				ABLE KP, 1995, NATURE, V375, P230, DOI 10.1038/375230a0; ALERSTAM T, 1991, J THEOR BIOL, V152, P191, DOI 10.1016/S0022-5193(05)80452-7; Alerstam T, 1999, P ROY SOC B-BIOL SCI, V266, P2499, DOI 10.1098/rspb.1999.0952; ALERSTAM T, 2000, CRUISE REPORT TUNDRA, P122; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; Berthold P., 1991, ORIENTATION BIRDS; EMLEN J. T., 1964, IBIS, V106, P417, DOI 10.1111/j.1474-919X.1964.tb03724.x; Emlen S.T., 1975, AVIAN BIOL, P129; Gudmundsson GA, 2000, J EXP BIOL, V203, P3137; Gudmundsson GA, 1998, J AVIAN BIOL, V29, P597, DOI 10.2307/3677180; Hoffman K., 1954, Zeitschrift fuer Tierpsychologie, V11, P453; KIEPENHEUER J, 1984, BEHAV ECOL SOCIOBIOL, V14, P81, DOI 10.1007/BF00291900; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; MCNEIL R, 1977, WILSON BULL, V89, P167; Morrison R.I.G., 1984, Behavior of Marine Animals, V6, P125; PENNEY RL, 1967, IBIS, V109, P99, DOI 10.1111/j.1474-919X.1967.tb00006.x; Quinn J. M., 2000, GEOMAG; RICHARDSON WJ, 1979, CAN J ZOOL, V57, P107, DOI 10.1139/z79-009; Sandberg R, 1998, J EXP BIOL, V201, P1859; Schmidt-Koenig K., 1958, Zeitschrift fuer Tierpsychologie, V15, P301; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Wehner R, 1998, J AVIAN BIOL, V29, P370, DOI 10.2307/3677156; Williams T. C., 1978, ANIMAL MIGRATION NAV, P239; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 1998, J AVIAN BIOL, V29, P606, DOI 10.2307/3677181	25	84	88	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					300	303		10.1126/science.291.5502.300	http://dx.doi.org/10.1126/science.291.5502.300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209079	Green Submitted			2022-12-01	WOS:000166352900044
J	Halberthal, M; Halperin, ML; Bohn, D				Halberthal, M; Halperin, ML; Bohn, D			Lesson of the week - Acute hyponatraemia in children admitted to hospital: retrospective analysis of factors contributing to its development and resolution	BRITISH MEDICAL JOURNAL			English	Review							PERMANENT BRAIN-DAMAGE; HYPONATREMIA; WOMEN; WATER		Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1A6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Bohn, D (corresponding author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							ADELMAN RD, 1996, TXB PEDIAT, P207; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Chesney RW, 1998, PEDIATRICS, V102, P399, DOI 10.1542/peds.102.2.399; DARROW DC, 1950, JAMA-J AM MED ASSOC, V143, P365, DOI 10.1001/jama.1950.82910390009011; HALLIDAY M, 1957, PEDIATRICS, V19, P823; HALPERIN ML, 1998, CURRENT THERAPY NEPH, P1; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; Soupart A, 1996, CLIN NEPHROL, V46, P149; SPITAL A, 1989, ARCH INTERN MED, V149, P1255, DOI 10.1001/archinte.149.6.1255; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; Sterns Richard H., 1993, P225; WATTAD A, 1992, CLIN PEDIATR, V31, P153, DOI 10.1177/000992289203100305	14	133	143	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					780	782		10.1136/bmj.322.7289.780	http://dx.doi.org/10.1136/bmj.322.7289.780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282868	Green Published			2022-12-01	WOS:000167943200031
J	Shakir, SAW; Wilton, LV; Boshier, A; Layton, D; Heeley, E				Shakir, SAW; Wilton, LV; Boshier, A; Layton, D; Heeley, E			Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England	BRITISH MEDICAL JOURNAL			English	Article									Drug Safety Unit, Southampton SO31 1AA, Hants, England		Shakir, SAW (corresponding author), Drug Safety Unit, Bursledon Hall, Southampton SO31 1AA, Hants, England.			Heeley, Emma/0000-0001-9190-2832				Arora RR, 1999, NEW ENGL J MED, V341, P700, DOI 10.1056/NEJM199908263410915; BAJEKAL M, 1999, HLTH SURVEY ENGLAND; Mann RD, 1998, BRIT J CLIN PHARMACO, V46, P195, DOI 10.1046/j.1365-2125.1998.00774.x; *OFF NAT STAT, 2000, MORT STAT GEN REV RE; *PFIZ, 1998, VIAGR SUMM PROD CHAR	5	86	92	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					651	652		10.1136/bmj.322.7287.651	http://dx.doi.org/10.1136/bmj.322.7287.651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250850	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000167622600025
J	Miller, MA; Nguyen, VQ; Lee, MH; Kosinski, M; Schedl, T; Caprioli, RM; Greenstein, D				Miller, MA; Nguyen, VQ; Lee, MH; Kosinski, M; Schedl, T; Caprioli, RM; Greenstein, D			A sperm cytoskeletal protein that signals oocyte meiotic maturation and ovulation	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEIN; MSP; ACTIN	Caenorhabditis elegans oocytes, Like those of most animals, arrest during meiotic prophase, Sperm promote the resumption of meiosis (maturation) and contraction of smooth muscle-like gonadal sheath cells, which are required for ovulation, We show that the major sperm cytoskeletal protein (MSP) is a bipartite signal for oocyte maturation and sheath contraction. MSP also functions in sperm Locomotion, playing a role analogous to actin, Thus, during evolution, MSP has acquired extracellular signaling and intracellular cytoskeletal functions for reproduction. Proteins with MSP-like domains are found in plants, fungi, and other animals, suggesting that related signaling functions may exist in other phyla.	Vanderbilt Univ, Dept Cell Biol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Mass Spectrometry Res Ctr, Sch Med, Nashville, TN 37232 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Vanderbilt University; Vanderbilt University; Washington University (WUSTL)	Greenstein, D (corresponding author), Vanderbilt Univ, Dept Cell Biol, Sch Med, Nashville, TN 37232 USA.			Miller, Michael/0000-0003-4872-7121; Greenstein, David/0000-0001-8189-2087	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025614] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057173, R56GM057173, R01GM058008] Funding Source: NIH RePORTER; NCI NIH HHS [CA09592] Funding Source: Medline; NICHD NIH HHS [HD25614, HD07043] Funding Source: Medline; NIGMS NIH HHS [R01 GM057173, GM57173, GM58008] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bullock TL, 1996, J MOL BIOL, V263, P284, DOI 10.1006/jmbi.1996.0575; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010; KLASS MR, 1981, DEV BIOL, V84, P299, DOI 10.1016/0012-1606(81)90398-5; L'Hernault SW, 1997, C ELEGANS, P271; Lackner MR, 1998, GENETICS, V150, P103; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Miller M. M., UNPUB; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; SCHEDL T, 1988, GENETICS, V119, P43; Schulz JR, 1998, J BIOL CHEM, V273, P24355, DOI 10.1074/jbc.273.38.24355; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Smith HE, 1998, J MOL BIOL, V279, P605, DOI 10.1006/jmbi.1998.1793; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; WARD S, 1988, J MOL BIOL, V199, P1, DOI 10.1016/0022-2836(88)90374-9; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	21	281	295	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2144	2147		10.1126/science.1057586	http://dx.doi.org/10.1126/science.1057586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251118				2022-12-01	WOS:000167563800038
J	Thompson, AM; Witte, JC; Hudson, RD; Guo, H; Herman, JR; Fujiwara, M				Thompson, AM; Witte, JC; Hudson, RD; Guo, H; Herman, JR; Fujiwara, M			Tropical tropospheric ozone and biomass burning	SCIENCE			English	Article							SOUTH-ATLANTIC; MAPPING SPECTROMETER; EL-NINO; AEROSOL; TOMS; TRANSPORT; OCEAN; TRACE; INDONESIA; MAXIMUM	New methods for retrieving tropospheric ozone column depth and absorbing aerosol (smoke and dust) from the Earth Probe-Total Ozone Mapping Spectrometer (EP/TOMS) are used to follow pollution and to determine interannual variability and trends. During intense fires over Indonesia (August to November 1997), ozone plumes, decoupled from the smoke below, extended as far as India, This ozone overlay a regional ozone increase triggered by atmospheric responses to the El Nino and Indian Ocean Dipole. Tropospheric ozone and smoke aerosol measurements from the Nimbus 7 TOMS instrument show El Nino signals but no tropospheric ozone trend in the 1980s. Offsets between smoke and ozone seasonal maxima point to multiple factors determining tropical tropospheric ozone variability.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; Univ Maryland, Dept Meteorol, College Pk, MD 20742 USA; Sci Syst & Applicat, Lanham, MD 20706 USA; Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Hokkaido University	Thompson, AM (corresponding author), NASA, Goddard Space Flight Ctr, Code 916, Greenbelt, MD 20771 USA.	anne.m.thompson@gsfc.nasa.gov	Hudson, Robert D/F-4506-2010; Thompson, Anne Mee/V-5862-2019; Thompson, Anne M/C-3649-2014; Fujiwara, Masatomo/F-7852-2012; Witte, Jacquelyn/H-7393-2013	Thompson, Anne Mee/0000-0002-7829-0920; Thompson, Anne M/0000-0002-7829-0920; Fujiwara, Masatomo/0000-0001-5567-4692; Witte, Jacquelyn/0000-0002-4110-5277; Herman, Jay/0000-0002-9146-1632				ANDREAE MO, 1994, J GEOPHYS RES-ATMOS, V99, P12793, DOI 10.1029/94JD00263; Burrows JP, 1999, J ATMOS SCI, V56, P151, DOI 10.1175/1520-0469(1999)056<0151:TGOMEG>2.0.CO;2; Chandra S, 1998, GEOPHYS RES LETT, V25, P3867, DOI 10.1029/98GL02695; Chandra S, 1999, GEOPHYS RES LETT, V26, P185, DOI 10.1029/1998GL900272; CHATFIELD RB, 1990, J GEOPHYS RES-ATMOS, V95, P18473, DOI 10.1029/JD095iD11p18473; Fishman J, 1997, J GEOPHYS RES-ATMOS, V102, P19275, DOI 10.1029/97JD01373; Fujiwara M, 1999, GEOPHYS RES LETT, V26, P2417, DOI 10.1029/1999GL900117; Fujiwara M, 2000, J GEOPHYS RES-ATMOS, V105, P1879, DOI 10.1029/1999JD900916; Gleason JF, 1998, J GEOPHYS RES-ATMOS, V103, P31969, DOI 10.1029/98JD00160; Hauglustaine DA, 1999, GEOPHYS RES LETT, V26, P3305, DOI 10.1029/1999GL900610; Herman JR, 1997, J GEOPHYS RES-ATMOS, V102, P16911, DOI 10.1029/96JD03680; HOLLANDSWORTH SM, 1995, GEOPHYS RES LETT, V22, P905, DOI 10.1029/95GL00605; Hsu NC, 1999, J GEOPHYS RES-ATMOS, V104, P6269, DOI 10.1029/1998JD200086; HUDSON RD, 1995, J GEOPHYS RES-ATMOS, V100, P11137, DOI 10.1029/94JD02435; Hudson RD, 1998, J GEOPHYS RES-ATMOS, V103, P22129, DOI 10.1029/98JD00729; HUDSON RD, UNPUB; Jacob DJ, 1996, J GEOPHYS RES-ATMOS, V101, P24235, DOI 10.1029/96JD00336; Jonquieres I, 1998, J GEOPHYS RES-ATMOS, V103, P19059, DOI 10.1029/98JD00819; KIRCHHOFF VWJH, 1991, J GEOPHYS RES-ATMOS, V96, P10899, DOI 10.1029/91JD01212; Kita K, 2000, ATMOS ENVIRON, V34, P2681, DOI 10.1016/S1352-2310(99)00522-1; Krishnamurti TN, 1996, J GEOPHYS RES-ATMOS, V101, P23889, DOI 10.1029/95JD02419; Martin RV, 2000, GEOPHYS RES LETT, V27, P1639, DOI 10.1029/1999GL011181; Matsueda H, 1999, GEOPHYS RES LETT, V26, P2413, DOI 10.1029/1999GL900089; Moxim WJ, 2000, J GEOPHYS RES-ATMOS, V105, P17393, DOI 10.1029/2000JD900175; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Schoeberl MR, 1995, J GEOPHYS RES-ATMOS, V100, P25801, DOI 10.1029/95JD02414; Taupin FG, 1999, J GEOPHYS RES-ATMOS, V104, P8057, DOI 10.1029/98JD02456; Thompson AM, 2000, GEOPHYS RES LETT, V27, P3317, DOI 10.1029/1999GL011273; Thompson AM, 1999, J GEOPHYS RES-ATMOS, V104, P26961, DOI 10.1029/1999JD900470; Thompson AM, 1996, J GEOPHYS RES-ATMOS, V101, P24251, DOI 10.1029/96JD01463; Torres O, 1999, J GEOPHYS RES-ATMOS, V104, P21569, DOI 10.1029/1999JD900410; TSURUTA H, 2001, SE AS INT GLOB ATM C; Tsutsumi Y, 1999, GEOPHYS RES LETT, V26, P595, DOI 10.1029/1999GL900054; Weller R, 1996, J GEOPHYS RES-ATMOS, V101, P1387, DOI 10.1029/95JD02838; Wooster MJ, 1998, INT J REMOTE SENS, V19, P383, DOI 10.1080/014311698216035; Ziemke JR, 1998, J GEOPHYS RES-ATMOS, V103, P13903, DOI 10.1029/97JD00550	36	175	179	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2128	2132		10.1126/science.291.5511.2128	http://dx.doi.org/10.1126/science.291.5511.2128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251113				2022-12-01	WOS:000167563800033
J	Stein, E; Zou, YM; Poo, MM; Tessier-Lavigne, M				Stein, E; Zou, YM; Poo, MM; Tessier-Lavigne, M			Binding of DCC by netrin-1 to mediate axon guidance independent of adenosine A2B receptor activation	SCIENCE			English	Article							COLORECTAL-CANCER DCC; GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; DROSOPHILA; OUTGROWTH; ENCODES; UNC-6; CNS	Netrins stimulate and orient axon growth through a mechanism requiring receptors of the DCC family. it has been unclear, however, whether DCC proteins are involved directly in signaling or are mere accessory proteins in a receptor complex. Further, although netrins bind cells expressing DCC, direct binding to DCC has not been demonstrated. Here we show that netrin-1 binds DCC and that the DCC cytoplasmic domain fused to a heterologous receptor ectodomain can mediate guidance through a mechanism involving derepression of cytoplasmic domain multimerization. Activation of the adenosine A2B receptor, proposed to contribute to netrin effects on axons, is not required for rat commissural axon outgrowth or Xenopus spinal axon attraction to netrin-1: Thus, DCC plays a central role in netrin signaling of axon growth and guidance independent of A2B receptor activation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.		Stein, Elke/E-8107-2013	Stein, Elke/0000-0001-8965-5692	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010273] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS010273] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN C, COMMUNICATION; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON IM, 1998, EUR J PHARMACOL, V26, P342; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Schultz J, 1997, PROTEIN SCI, V6, P249; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; STEIN E, UNPUB; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5	21	197	202	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1976	1982		10.1126/science.1059391	http://dx.doi.org/10.1126/science.1059391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239160				2022-12-01	WOS:000167401600050
J	Fender, GRK; Prentice, A; Nixon, RM; Gorst, T; Duffy, SW; Day, NE; Smith, SK				Fender, GRK; Prentice, A; Nixon, RM; Gorst, T; Duffy, SW; Day, NE; Smith, SK			Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study	BRITISH MEDICAL JOURNAL			English	Article									Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SW, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Prentice, A (corresponding author), Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Rosie Hosp, Box 223, Cambridge CB2 2SW, England.		Smith, Stephen K/F-6938-2012	Smith, Stephen/0000-0003-1912-3935; Nixon, Richard/0000-0002-9991-7833				COULTER A, 1991, BRIT J OBSTET GYNAEC, V98, P789, DOI 10.1111/j.1471-0528.1991.tb13484.x; Fender GRK, 1999, BRIT MED J, V318, P1246; NIXON R, IN PRESS STAT MED; *U YORK NHS CTR RE, 1995, EFF HLTH CAR MAN MEM; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x	5	6	6	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					523	524		10.1136/bmj.322.7285.523	http://dx.doi.org/10.1136/bmj.322.7285.523			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230066	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000167370500025
J	Srinivasula, SM; Hegde, R; Saleh, A; Datta, P; Shiozaki, E; Chai, JJ; Lee, RA; Robbins, PD; Fernandes-Alnemri, T; Shi, YG; Alnemri, ES				Srinivasula, SM; Hegde, R; Saleh, A; Datta, P; Shiozaki, E; Chai, JJ; Lee, RA; Robbins, PD; Fernandes-Alnemri, T; Shi, YG; Alnemri, ES			A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis	NATURE			English	Article							STRUCTURAL BASIS; PROTEIN XIAP; OLIGOMERIZATION; PROCASPASE-9; DROSOPHILA; ACTIVATION; INHIBITOR; CLEAVAGE; BINDING; DOMAIN	X-linked inhibitor-of-apoptosis protein (XIAP) interacts with caspase-9 and inhibits its activity(1-3), whereas Smac (also known as DIABLO) relieves this inhibition through interaction with XIAP(4-7). Here we show that XIAP associates with the active caspase-9-Apaf-1 holoenzyme complex through binding to the amino terminus of the linker peptide on the small subunit of caspase-9, which becomes exposed after proteolytic processing of procaspase-9 at Asp 315. Supporting this observation, point mutations that abrogate the proteolytic processing but not the catalytic activity of caspase-9, or deletion of the linker peptide, prevented caspase-9 association with XIAP and its concomitant inhibition. We note that the N-terminal four residues of caspase-9 linker peptide share significant homology with the N-terminal tetra-peptide in mature Smac and in the Drosophila proteins Hid/Grim/Reaper(8,9), defining a conserved class of IAP-binding motifs. Consistent with this finding, binding of the caspase-9 linker peptide and Smac to the BIR3 domain of XIAP is mutually exclusive, suggesting that Smac potentiates caspase-9 activity by disrupting the interaction of the linker peptide of caspase-9 with BIR3. Our studies reveal a mechanism in which binding to the BIR3 domain by two conserved peptides, one from Smac and the other one from caspase-9, has opposing effects on caspase activity and apoptosis.	Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA.		Alnemri, Emad S/B-4526-2010	Chai, Jijie/0000-0001-7591-3873; Shi, Yigong/0000-0003-2030-168X; Saleh, Ayman M/0000-0003-1126-6018				Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Datta R, 2000, J BIOL CHEM, V275, P31733, DOI 10.1074/jbc.M910231199; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	14	800	869	0	103	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					112	116		10.1038/35065125	http://dx.doi.org/10.1038/35065125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242052				2022-12-01	WOS:000167194300053
J	Wirth, T; Bernatchez, L				Wirth, T; Bernatchez, L			Genetic evidence against panmixia in the European eel	NATURE			English	Article							POPULATION-STRUCTURE; NORTH-ATLANTIC; DIFFERENTIATION; VARIABILITY; LIFE; FLOW	The panmixia hypothesis-that all European eel (Anguilla anguilla) migrate to the Sargasso Sea for reproduction and comprise a single, randomly mating population-is widely accepted(1,2). If true, then this peculiar life history strategy would directly impact the population genetics of this species, and eels from European and north African rivers should belong to the same breeding population through the random dispersal of larvae. To date, the panmixia hypothesis has remained unchallenged: genetic studies realized on eel's mitochondrial DNA failed to detect any genetic structure(3-5); and a similar lack of structure was found using allozymes(6,7), with the exception of clinal variation imposed by selection(8,9). Here we have used highly polymorphic genetic markers that provide better resolution(10,11) to investigate genetic structure in European eel. Analysis of seven microsatellite loci among 13 samples from the north Atlantic, the Baltic Sea and the Mediterranean Sea basins reveals that there is global genetic differentiation(12). Moreover, pairwise Cavalli-Sforza and Edwards' 13 chord distances correlate significantly with coastal geographical distance. This pattern of genetic structure implies non-random mating and restricted gene flow among eels from different sampled locations, which therefore refute the hypothesis of panmixia. Consequently, the reproductive biology of European eel must be reconsidered(14,15).	Univ Laval, Dept Biol, GIROQ, Ste Foy, PQ G1K 7P4, Canada	Laval University	Wirth, T (corresponding author), Univ Laval, Dept Biol, GIROQ, Ste Foy, PQ G1K 7P4, Canada.	wirth_t@mpiib-berlin.mpg.de	Wirth, Thierry/B-4915-2008	Wirth, Thierry/0000-0002-7371-0172; Bernatchez, Louis/0000-0002-8085-9709				AVISE JC, 1990, EVOLUTION, V44, P1254, DOI 10.2307/2409286; AVISE JC, 1986, P NATL ACAD SCI USA, V83, P4350, DOI 10.1073/pnas.83.12.4350; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; COMPARINI A, 1977, MAR BIOL, V43, P109, DOI 10.1007/BF00391258; DELIGNY W, 1973, Nature (London), V246, P518, DOI 10.1038/246518a0; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; LECOMTEFINIGER R, 1994, NATURE, V370, P424, DOI 10.1038/370424a0; Lintas C, 1998, MOL MAR BIOL BIOTECH, V7, P263; Maniatis T, 1982, MOL CLONING; MANTEL N, 1967, CANCER RES, V27, P209; Marchese PJ, 1999, J GEOPHYS RES-OCEANS, V104, P29549, DOI 10.1029/1999JC900254; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PANTELOURIS EM, 1970, GENET RES, V16, P277, DOI 10.1017/S0016672300002536; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruzzante DE, 1997, CAN J FISH AQUAT SCI, V54, P2700, DOI 10.1139/f97-170; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANG TK, 1994, MOL BIOL EVOL, V11, P250; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Tesch F.-W., 1977, EEL, V5; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams G.C., 1984, P529	27	198	220	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1037	1040		10.1038/35059079	http://dx.doi.org/10.1038/35059079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234011				2022-12-01	WOS:000167148800044
J	Cooper, A; Lalueza-Fox, C; Anderson, S; Rambaut, A; Austin, J; Ward, R				Cooper, A; Lalueza-Fox, C; Anderson, S; Rambaut, A; Austin, J; Ward, R			Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution	NATURE			English	Article							DNA-SEQUENCES; BIRDS; BIOGEOGRAPHY; PHYLOGENY; ORIGINS	The origin of the ratites, large flightless birds from the Southern Hemisphere, along with their flighted sister taxa, the South American tinamous, is central to understanding the role of plate tectonics in the distributions of modern birds and mammals. Defining the dates of ratite divergences is also critical for determining the age of modern avian orders(1-6). To resolve the ratite phylogeny and provide biogeographical data to examine these issues, we have here determined the first complete mitochondrial genome sequences of any extinct taxa-two New Zealand moa genera-along with a 1,000-base-pair sequence from an extinct Madagascan elephant-bird. For comparative data, we also generated 12 kilobases of contiguous sequence from the kiwi, cassowary, emu and two tinamou genera. This large dataset allows statistically precise estimates of molecular divergence dates and these support a Late Cretaceous vicariant speciation of ratite taxa, followed by the subsequent dispersal of the kiwi to New Zealand. This first molecular view of the break-up of Gondwana provides a new temporal framework for speciation events within other Gondwanan biota and can be used to evaluate competing biogeographical hypotheses.	Univ Oxford, Dept Biol Anthropol, Oxford OX1 6UE, England; Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 6UE, England; Univ Oxford, Dept Zool, Oxford OX2 3PS, England; Univ Barcelona, Fac Biol, Seccio Antropol, E-08028 Barcelona, Spain; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Oxford; University of Oxford; University of Oxford; University of Barcelona; Natural History Museum London	Cooper, A (corresponding author), Univ Oxford, Dept Biol Anthropol, Oxford OX1 6UE, England.		Anderson, Simon G/AGM-2359-2022; Cooper, Alan/E-8171-2012; LALUEZA-FOX, CARLES/AAG-5341-2020; Anderson, Simon G/B-5244-2009; Rambaut, Andrew/B-2481-2009; Austin, Jeremy J/F-8729-2010	Anderson, Simon G/0000-0002-8896-073X; Cooper, Alan/0000-0002-7738-7851; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Rambaut, Andrew/0000-0003-4337-3707; Austin, Jeremy J/0000-0003-4244-2942				BLEDSOE A H, 1988, Annals of Carnegie Museum, V57, P73; Boles Walter E., 1997, Memoirs of the Queensland Museum, V41, P235; Cooper A, 2000, SCIENCE, V289, P1139; COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Cooper A., 1993, ANCIENT DNA, P149; Cooper Alan, 1997, P345, DOI 10.1016/B978-012498315-1/50019-4; COOPER RA, 1993, TRENDS ECOL EVOL, V8, P429, DOI 10.1016/0169-5347(93)90004-9; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Handt O, 1996, AM J HUM GENET, V59, P368; Herzer RH, 1997, NEW ZEAL J GEOL GEOP, V40, P425, DOI 10.1080/00288306.1997.9514774; HOUDE P, 1986, NATURE, V324, P563, DOI 10.1038/324563a0; Huelsenbeck John P., 1996, P19; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lawver L. A, 1991, GEOLOGICAL EVOLUTION, P533; Lee Krista, 1997, P173, DOI 10.1016/B978-012498315-1/50011-X; Martin P. G., 1993, Australian Systematic Botany, V6, P441, DOI 10.1071/SB9930441; Olson S.L., 1985, Avian Biology, V8, P79; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; SAUER E G F, 1972, Bonner Zoologische Beitraege, V23, P3; Storch G, 1993, AFRICA S AM CONNECTI, P76; van Tuinen M, 1998, MOL BIOL EVOL, V15, P370, DOI 10.1093/oxfordjournals.molbev.a025933	25	314	330	2	98	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					704	707		10.1038/35055536	http://dx.doi.org/10.1038/35055536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217857				2022-12-01	WOS:000166816400040
J	Jacobson, MZ				Jacobson, MZ			Strong radiative heating due to the mixing state of black carbon in atmospheric aerosols	NATURE			English	Article							SINGLE-SCATTERING ALBEDO; TROPICAL INDIAN-OCEAN; ANTHROPOGENIC SULFATE; SOOT; MODEL	Aerosols affect the Earth's temperature and climate by altering the radiative properties of the atmosphere. A large positive component of this radiative forcing from aerosols is due to black carbon-soot-that is released from the burning of fossil fuel and biomass, and, to a lesser extent, natural fires, but the exact forcing is affected by how black carbon is mixed with other aerosol constituents. From studies of aerosol radiative forcing, it is known that black carbon can exist in one of several possible mixing states; distinct from other aerosol particles (externally mixed(1-7)) or incorporated within them (internally mixed(1,3,7)), or a black-carbon core could be surrounded by a well mixed shell 7. But so far it has been assumed that aerosols exist predominantly as an external mixture. Here I simulate the evolution of the chemical composition of aerosols, finding that the mixing state and direct forcing of the black-carbon component approach those of an internal mixture, largely due to coagulation and growth of aerosol particles. This finding implies a higher positive forcing from black carbon than previously thought, suggesting that the warming effect from black carbon may nearly balance the net cooling effect of other anthropogenic aerosol constituents. The magnitude of the direct radiative forcing from black carbon itself exceeds that due to CH4, suggesting that black carbon may be the second most important component of global warming after CO2 in terms of direct forcing.	Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA	Stanford University	Jacobson, MZ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.			Jacobson, Mark/0000-0002-4315-4128				ANDREAE MO, 1986, SCIENCE, V232, P1620, DOI 10.1126/science.232.4758.1620; Cook RD, 1999, AUDIOL NEURO-OTOL, V4, P104, DOI 10.1159/000013827; Dubovik O, 1998, J GEOPHYS RES-ATMOS, V103, P31903, DOI 10.1029/98JD02276; Eck TF, 1998, J GEOPHYS RES-ATMOS, V103, P31865, DOI 10.1029/98JD00399; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Hansen JE, 1998, P NATL ACAD SCI USA, V95, P12753, DOI 10.1073/pnas.95.22.12753; Hayhoe K, 1999, SCIENCE, V286, P905, DOI 10.1126/science.286.5441.905; Haywood JM, 1998, J GEOPHYS RES-ATMOS, V103, P6043, DOI 10.1029/97JD03426; Haywood JM, 1997, J CLIMATE, V10, P1562, DOI 10.1175/1520-0442(1997)010<1562:GCMCOT>2.0.CO;2; Hegg DA, 1997, J GEOPHYS RES-ATMOS, V102, P25293, DOI 10.1029/97JD02293; Husar RB, 1997, J GEOPHYS RES-ATMOS, V102, P16889, DOI 10.1029/96JD04009; IPCC,, 1996, CLIMATE CHANGE 1995; Jacobson MZ, 2000, GEOPHYS RES LETT, V27, P217, DOI 10.1029/1999GL010968; Jacobson MZ, 1997, ATMOS ENVIRON, V31, P131, DOI 10.1016/1352-2310(96)00202-6; Jayaraman A, 1998, J GEOPHYS RES-ATMOS, V103, P13827, DOI 10.1029/98JD00559; Murphy DM, 1998, NATURE, V392, P62, DOI 10.1038/32138; Myhre G, 1998, TELLUS B, V50, P463, DOI 10.1034/j.1600-0889.1998.t01-4-00005.x; Penner JE, 1998, CLIM DYNAM, V14, P839, DOI 10.1007/s003820050259; Posfai M, 1999, J GEOPHYS RES-ATMOS, V104, P21685, DOI 10.1029/1999JD900208; Russell PB, 1999, J GEOPHYS RES-ATMOS, V104, P2213, DOI 10.1029/1998JD200028; Satheesh SK, 1999, J GEOPHYS RES-ATMOS, V104, P27421, DOI 10.1029/1999JD900478	21	1739	1928	47	852	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					695	697		10.1038/35055518	http://dx.doi.org/10.1038/35055518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217854				2022-12-01	WOS:000166816400037
J	Zouni, A; Witt, HT; Kern, J; Fromme, P; Krauss, N; Saenger, W; Orth, P				Zouni, A; Witt, HT; Kern, J; Fromme, P; Krauss, N; Saenger, W; Orth, P			Crystal structure of photosystem II from Synechococcus elongatus at 3.8 angstrom resolution	NATURE			English	Article							NEAREST-NEIGHBOR ANALYSIS; 3-DIMENSIONAL STRUCTURE; COMPLEX; PROTEIN; MODEL; WATER	Oxygenic photosynthesis is the principal energy converter on earth. It is driven by photosystems I and II, two large protein-cofactor complexes located in the thylakoid membrane and acting in series. In photosystem II, water is oxidized; this event provides the overall process with the necessary electrons and protons, and the atmosphere with oxygen. To date, structural information on the architecture of the complex has been provided by electron microscopy of intact, active photosystem II at 15-30 Angstrom resolution(1), and by electron crystallography on two-dimensional crystals of D1-D2-CP47 photosystem II fragments without water oxidizing activity at 8 Angstrom resolution(2). Here we describe the X-ray structure of photosystem II on the basis of crystals fully active in water oxidation(3). The structure shows how protein subunits and cofactors are spatially organized. The larger subunits are assigned and the locations and orientations of the cofactors are defined. We also provide new information on the position, size and shape of the manganese cluster, which catalyzes water oxidation.	Free Univ Berlin, Inst Chem, D-14195 Berlin, Germany; Tech Univ Berlin, Max Volmer Inst Biophys Chem & Biochem, D-10623 Berlin, Germany	Free University of Berlin; Technical University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem, Takustr 6, D-14195 Berlin, Germany.	witt@phosis1.chem.tu-berlin.de; saenger@chemie.fu-berlin.de	Kern, Jan/G-2586-2013	Kern, Jan/0000-0002-7272-1603; Krauss, Norbert/0000-0002-7128-4632				AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRY BA, 1994, MOL BIOL CYANOBACTER, P217; BUSER CA, 1992, BIOCHEMISTRY-US, V31, P11449, DOI 10.1021/bi00161a025; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Ghanotakis DF, 1999, CONCEPTS IN PHOTOBIOLOGY, P264; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Ishikawa Y, 1999, BBA-BIOENERGETICS, V1413, P147, DOI 10.1016/S0005-2728(99)00093-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; MAYES SR, 1993, BIOCHEMISTRY-US, V32, P1454, DOI 10.1021/bi00057a008; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; Nield J, 2000, J BIOL CHEM, V275, P27940; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; RHEE KH, 1998, THESIS U HEIDELBERG; Ruffle S, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1013; SCHELVIS JPM, 1994, BBA-BIOENERGETICS, V1184, P242, DOI 10.1016/0005-2728(94)90229-1; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Shi LX, 1999, PLANT MOL BIOL, V40, P737, DOI 10.1023/A:1006286706708; Summer EJ, 1997, PLANT PHYSIOL, V113, P1359, DOI 10.1104/pp.113.4.1359; Svensson B, 1996, BIOCHEMISTRY-US, V35, P14486, DOI 10.1021/bi960764k; TOMO T, 1993, FEBS LETT, V323, P15, DOI 10.1016/0014-5793(93)81438-6; Witt HT, 1996, BER BUNSEN PHYS CHEM, V100, P1923, DOI 10.1002/bbpc.19961001202; Xiong J, 1998, PHOTOSYNTH RES, V56, P229, DOI 10.1023/A:1006061918025; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Zech SG, 1997, FEBS LETT, V414, P454, DOI 10.1016/S0014-5793(97)01054-5; Zheleva D, 1998, J BIOL CHEM, V273, P16122, DOI 10.1074/jbc.273.26.16122; Zouni A, 2000, BBA-BIOENERGETICS, V1457, P103, DOI 10.1016/S0005-2728(00)00100-6; Zouni A, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P925	30	1714	1778	8	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					739	743		10.1038/35055589	http://dx.doi.org/10.1038/35055589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217865				2022-12-01	WOS:000166816400048
J	Pryer, KM; Schneider, H; Smith, AR; Cranfill, R; Wolf, PG; Hunt, JS; Sipes, SD				Pryer, KM; Schneider, H; Smith, AR; Cranfill, R; Wolf, PG; Hunt, JS; Sipes, SD			Horsetails and ferns are a monophyletic group and the closest living relatives to seed plants	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS; LAND PLANTS; RBCL SEQUENCES; MITOCHONDRIAL; EVOLUTION; BIOLOGY; TOOL	Most of the 470-million-year history of plants on land belongs to bryophytes, pteridophytes and gymnosperms, which eventually yielded to the ecological dominance by angiosperms 90 Myr ago(1-3). Our knowledge of angiosperm phylogeny, particularly the branching order of the earliest lineages, has recently been increased by the concurrence of multigene sequence analyses(4-6). However, reconstructing relationships for all the main lineages of vascular plants that diverged since the Devonian period has remained a challenge. Here we report phylogenetic analyses of combined data-from morphology and from four genes-for 35 representatives from all the main lineages of land plants. We show that there are three monophyletic groups of extant vascular plants: (1) lycophytes, (2) seed plants and (3) a clade including equisetophytes (horsetails), psilotophytes (whisk ferns) and all eusporangiate and leptosporangiate ferns. Our maximum-likelihood analysis shows unambiguously that horsetails and ferns together are the closest relatives to seed plants. This refutes the prevailing view that horsetails and ferns are transitional evolutionary grades between bryophytes and seed plants(7), and has important implications for our understanding of the development and evolution of plants(8).	Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Calif Berkeley, Univ Herbarium, Berkeley, CA 94720 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA	Field Museum of Natural History (Chicago); University of California System; University of California Berkeley; Utah System of Higher Education; Utah State University	Pryer, KM (corresponding author), Field Museum Nat Hist, Dept Bot, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.		Pryer, Kathleen M./ABF-4908-2020; Pryer, Kathleen/X-4635-2019; Wolf, Paul/F-7664-2010; Schneider, Harald/B-6681-2008	Pryer, Kathleen M./0000-0002-9776-6736; Wolf, Paul/0000-0002-4317-6976; Schneider, Harald/0000-0002-4548-7268				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; BREMER K, 1985, Cladistics, V1, P369, DOI 10.1111/j.1096-0031.1985.tb00434.x; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Duff RJ, 1999, AM J BOT, V86, P372, DOI 10.2307/2656759; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Hedderson T.A., 1998, BRYOLOGY 21 CENTURY, P65; HICKOK LG, 1995, INT J PLANT SCI, V156, P332, DOI 10.1086/297255; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P634, DOI 10.1073/pnas.91.2.634; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Kranz HD, 1996, PLANT SYST EVOL, V202, P1, DOI 10.1007/BF00985814; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; MANHART JR, 1994, MOL PHYLOGENET EVOL, V3, P114, DOI 10.1006/mpev.1994.1014; MISHLER BD, 1994, ANN MO BOT GARD, V81, P451, DOI 10.2307/2399900; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Renzaglia KS, 2000, PHILOS T R SOC B, V355, P769, DOI 10.1098/rstb.2000.0615; Rothwell GW, 1999, BOT REV, V65, P188, DOI 10.1007/BF02857629; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stevenson D.W., 1996, PTERIDOLOGY PERSPECT, P435; SWOFFORD DL, 1999, PAUP PHYLOGENETIC AN; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; WAGNER WH, 1977, BRITTONIA, V29, P54, DOI 10.2307/2805741; [No title captured]	30	474	540	5	376	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					618	622		10.1038/35054555	http://dx.doi.org/10.1038/35054555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214320				2022-12-01	WOS:000166692300044
J	Bernstein, E; Caudy, AA; Hammond, SM; Hannon, GJ				Bernstein, E; Caudy, AA; Hammond, SM; Hannon, GJ			Role for a bidentate ribonuclease in the initiation step of RNA interference	NATURE			English	Article							GENE; PLANTS	RNA interference (RNAi) is the mechanism through which double-stranded RNAs silence cognate genes(1-5). In plants, this can occur at both the transcriptional and the post-transcriptional levels(1,2,5); however, in animals, only post-transcriptional RNAi has been reported to date. In both plants and animals, RNAi is characterized by the presence of RNAs of about 22 nucleotides in length that are homologous to the gene that is being suppressed(6-8). These 22-nucleotide sequences serve as guide sequences that instruct a multicomponent nuclease, RISC, to destroy specific messenger RNAs6. Here we identify an enzyme, Dicer, which can produce putative guide RNAs. Dicer is a member of the RNase III family of nucleases that specifically cleave double-stranded RNAs, and is evolutionarily conserved in worms, flies, plants, fungi and mammals. The enzyme has a distinctive structure, which includes a helicase domain and dual RNase III motifs. Dicer also contains a region of homology to the RDE1/QDE2/ARGONAUTE family that has been genetically linked to RNAi(9,10).	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Genetica, Cambridge, MA 01239 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Bernstein, E (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Hannon, Gregory/AAB-3568-2019	Caudy, Amy/0000-0001-6307-8137				Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1490, P163, DOI 10.1016/S0167-4781(99)00221-3; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1111/j.1574-6976.1999.tb00405.x; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Sijen T, 2000, BIOESSAYS, V22, P520, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;520::AID-BIES5&gt;3.0.CO;2-W; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	23	3473	4281	12	466	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					363	366		10.1038/35053110	http://dx.doi.org/10.1038/35053110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201747				2022-12-01	WOS:000166434300052
J	Irwin, DE; Bensch, S; Price, TD				Irwin, DE; Bensch, S; Price, TD			Speciation in a ring	NATURE			English	Article							PHYLLOSCOPUS; ENSATINA; WARBLERS; ECOLOGY	The evolutionary divergence of a single species into two has never been directly observed in nature, primarily because speciation can take a long time to occur. A ring species, in which a chain of intergrading populations encircles a barrier and the terminal forms coexist without interbreeding, provides a situation in which variation in space can be used to infer variation in time(1-3). Here we reconstruct the pathway to speciation between two reproductively isolated forms of greenish warbler (Phylloscopus trochiloides). These two taxa do not interbreed in central Siberia but are connected by a long chain of intergrading populations encircling the Tibetan Plateau to the south(4). Molecular data and climatic history imply that the reproductively isolated taxa came into contact following expansions northward around the western and eastern sides of the plateau. Parallel selection pressures for increased song complexity during the northward expansions have been accompanied by divergence in song structure. Playback experiments show that the two Siberian forms do not recognize each other's songs. Our results show how gradual divergence in a trait involved in mate choice leads to the formation of new species.	Univ Calif San Diego, Dept Biol 0116, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Irwin, DE (corresponding author), Univ Lund, Dept Ecol, Sect Anim Ecol, Ecol Bldg, S-22362 Lund, Sweden.		Irwin, Darren E./G-6183-2012	Irwin, Darren E./0000-0002-1050-5841				Bensch S, 2000, MOL BIOL EVOL, V17, P107, DOI 10.1093/oxfordjournals.molbev.a026223; Bensch S, 1997, MOL ECOL, V6, P91, DOI 10.1046/j.1365-294X.1997.00150.x; FRENZEL B, 1968, SCIENCE, V161, P637, DOI 10.1126/science.161.3842.637; Highton R, 1998, HERPETOLOGICA, V54, P254; Irwin DE, 2000, EVOLUTION, V54, P998; IRWIN DE, IN PRESS IBIS; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Marchetti K, 1997, OIKOS, V79, P410, DOI 10.2307/3546026; Martens Jochen, 1996, P221; Mayr E, 1970, POPULATIONS SPECIES; Mayr E., 1942, SYSTEMATICS ORIGIN S, DOI 10.2307/1790142; Menzies N. K., 1994, FOREST LAND MANAGEME; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; PRICE T, 1991, J ANIM ECOL, V60, P643, DOI 10.2307/5303; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ticehurst CB., 1938, SYSTEMATIC REV GENUS; Wake D.B., 1989, P134; Wake DB, 1998, HERPETOLOGICA, V54, P279; WANG CW, 1961, MM CABOT FDN PUBLICA, V5; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	22	263	278	2	108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					333	337		10.1038/35053059	http://dx.doi.org/10.1038/35053059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201740				2022-12-01	WOS:000166434300045
J	Simkin, T; Siebert, L; Blong, R				Simkin, T; Siebert, L; Blong, R			Policy forum: Disasters - Volcano fatalities - Lessons from the historical record	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; Macquarie Univ, Natl Hazards Res Ctr, N Ryde, NSW 2109, Australia	Smithsonian Institution; Smithsonian National Museum of Natural History; Macquarie University	Simkin, T (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA.							SIMKIN T, 1994, VOLCANOES WORLD, P162; *SMITHS I, 1994, GLOB VOLC NETW B, V19; Tanguy JC, 1998, B VOLCANOL, V60, P137, DOI 10.1007/s004450050222	4	31	31	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					255	255		10.1126/science.291.5502.255	http://dx.doi.org/10.1126/science.291.5502.255			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11253213				2022-12-01	WOS:000166352900028
J	Frisch, M; Biggar, RJ; Engels, EA; Goedert, JJ				Frisch, M; Biggar, RJ; Engels, EA; Goedert, JJ		AIDS-Canc Match Registry Study Grp	Association of cancer with AIDS-related immunosuppression in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-HODGKINS-LYMPHOMA; EPSTEIN-BARR-VIRUS; HUMAN-PAPILLOMAVIRUS; HOMOSEXUAL-MEN; TESTICULAR-CANCER; KAPOSIS-SARCOMA; BREAST-CANCER; SAN-FRANCISCO; RISK-FACTORS; DISEASE	nContext Large-scale studies are needed to determine if cancers other than Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer occur in excess in persons with human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), Objectives To examine the general cancer pattern among adults with HIV/AIDS and to distinguish immunosuppression-associated cancers from other cancers that may occur in excess among persons with HIV/AIDS, Design, Setting, and Subjects Analysis of linked population-based AIDS and cancer registry data from 11 geographically diverse areas in the United States, including 302834 adults aged 15 to 69 years with HIV/AIDS, The period of study varied by registry between 1978 and 1996, Main Outcome Measure Relative risks (RRs) of cancers, calculated by dividing the number of observed cancer cases by the number expected based on contemporaneous population-based incidence rates. We defined cancers potentially influenced by immunosuppression by 3 criteria: (1) elevated overall RR in the period from 60 months before to 27 months after AIDS; (2) elevated RR in the 4- to 27-month post-AIDS period; and (3) increasing trend in RR from before to after AIDS onset, Results Expected excesses were observed for the AIDS-defining cancers, but non-AIDS-defining cancers also occurred in statistically significant excess (n =4422; overall RR, 2.7; 95% confidence interval [CI], 2,7-2,8), Of individual cancers, only Hodgkin disease (n=612; RR, 11.5; 95% CI, 10.6-12,5), particularly of the mixed cellularity (n=217; RR, 18.3; 95% CI, 15.9-20.9) and lymphocytic depletion (n=36; RR, 35.3; 95% CI, 24.7-48.8) subtypes; lung cancer (n=808; RR, 4.5; 95% CI, 4.2-4.8); penile cancer (n=14; RR, 3.9; 95% CI, 2.1-6.5); soft tissue malignancies (n=78; RR, 3.3; 95% CI, 2.6-4.1); lip cancer (n=20; RR, 3,1; 95% CI, 1.9-4.8); and testicular seminoma (n=115; RR, 2.0; 95% CI, 1.7-2.4) met all 3 criteria for potential association with immunosuppression, Conclusion Although occurring in overall excess, most non-AIDS-defining cancers do not appear to be influenced by the advancing immunosuppression associated with HIV disease progression. Some cancers that met our criteria for potential association with immunosuppression may have occurred in excess in persons with HIV/AIDS because of heavy smoking (lung cancer), frequent exposure to human papillomavirus (penile cancer), or inaccurately recorded cases of Kaposi sarcoma (soft tissue malignancies) in these persons. However, Hodgkin disease, notably of the mixed cellularity and lymphocytic depletion subtypes, and possibly lip cancer and testicular seminoma may be genuinely influenced by immunosuppression.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; NCI, Div Canc Epidemiol & Genet, Viral Epidemiol Branch, Rockville, MD USA	Aarhus University; Statens Serum Institut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Frisch, M (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.	mfr@ssi.dk	Frisch, Morten/E-9206-2016	Frisch, Morten/0000-0002-3864-8860	NCI NIH HHS [Y1-CP-8040-02] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akre O, 1999, INT J CANCER, V82, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1996, IARC MON EV CARC RIS; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Biggar RJ, 2000, JAMA-J AM MED ASSOC, V284, P205, DOI 10.1001/jama.284.2.205; Biggar RJ, 1996, INT J CANCER, V68, P754; Biggar RJ, 2000, BAS CLIN ON, V21, P25; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Blot W., 1996, CANC EPIDEMIOL PREV, P666; BLOT WJ, 1996, CANC EPIDEMIOLOGY PR, P637; Brauninger A, 1999, NEW ENGL J MED, V340, P1239, DOI 10.1056/NEJM199904223401604; Brennan P, 2000, BRIT J CANCER, V82, P1344; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Cooksley CD, 1999, INT J STD AIDS, V10, P795, DOI 10.1258/0956462991913574; COX DR, 1974, THEORETICAL STATISTI, P279; Franceschi S, 1998, BRIT J CANCER, V78, P966, DOI 10.1038/bjc.1998.610; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Goedert JJ, 1999, CANCER EPIDEM BIOMAR, V8, P293; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Granovsky MO, 1998, J CLIN ONCOL, V16, P1729, DOI 10.1200/JCO.1998.16.5.1729; Gray A, 1998, J GEN VIROL, V79, P573, DOI 10.1099/0022-1317-79-3-573; GREGOIRE L, 1995, JNCI-J NATL CANCER I, V87, P1705, DOI 10.1093/jnci/87.22.1705; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; GUPTA AK, 1986, ARCH DERMATOL, V122, P1288, DOI 10.1001/archderm.122.11.1288; HESSOL NA, 1992, ANN INTERN MED, V117, P309, DOI 10.7326/0003-4819-117-4-309; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; KARP J, 1993, CHEST, V103, P410, DOI 10.1378/chest.103.2.410; Koblin BA, 1996, AM J EPIDEMIOL, V144, P916, DOI 10.1093/oxfordjournals.aje.a008861; Maurer TA, 1997, ARCH DERMATOL, V133, P577, DOI 10.1001/archderm.133.5.577; MELBYE M, 1994, LANCET, V343, P636, DOI 10.1016/S0140-6736(94)92636-0; Mueller N, 1999, J ACQ IMMUN DEF SYND, V21, pS5; Mueller NE, 1996, CANC EPIDEMIOLOGY PR, P893; O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039; PENN I, 1986, SURG GYNECOL OBSTET, V162, P603; Petruckevitch A, 1999, INT J STD AIDS, V10, P38, DOI 10.1258/0956462991913060; REYNOLDS P, 1993, AM J EPIDEMIOL, V137, P19, DOI 10.1093/oxfordjournals.aje.a116598; ROTHMAN KJ, 1996, CANC EPIDEMIOLOGY PR, P3; Rowlings PA, 1999, J CLIN ONCOL, V17, P3122, DOI 10.1200/JCO.1999.17.10.3122; Serraino D, 1999, AIDS, V13, P2589, DOI 10.1097/00002030-199912240-00013; Shimakage M, 1996, J UROLOGY, V156, P253, DOI 10.1016/S0022-5347(01)66011-7; Stall RD, 1999, AM J PUBLIC HEALTH, V89, P1875, DOI 10.2105/AJPH.89.12.1875; STEWART T, 1995, LANCET, V346, P796, DOI 10.1016/S0140-6736(95)91618-0; Stewart THM, 2000, BRIT J CANCER, V82, P446, DOI 10.1054/bjoc.1999.0941; Tirelli U, 2000, CANCER-AM CANCER SOC, V88, P563, DOI 10.1002/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D; *WHO, 1990, INT CLASS DIS ONC	45	584	591	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1736	1745		10.1001/jama.285.13.1736	http://dx.doi.org/10.1001/jama.285.13.1736			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277828	Bronze			2022-12-01	WOS:000167710600027
J	Siddiqa, A; Sims-Mourtada, JC; Guzman-Rojas, L; Rangel, R; Guret, C; Madrid-Marina, V; Sun, Y; Martinez-Valdez, H				Siddiqa, A; Sims-Mourtada, JC; Guzman-Rojas, L; Rangel, R; Guret, C; Madrid-Marina, V; Sun, Y; Martinez-Valdez, H			Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA	NATURE			English	Article							GERMINAL-CENTERS; B-CELLS; IMMUNE-RESPONSE; BINDING; GENE; EXPRESSION; ACTIVATION; PROTEINS; COSTIMULATION; LYMPHOCYTES	Proteins containing AT hooks bind A/T-rich DNA through a nine-amino-acid motif and are thought to co-regulate transcription by modifying the architecture of DNA, thereby enhancing the accessibility of promoters to transcription factors(1,2). Here we describe AKNA, a human AT-hook protein that directly binds the A/T-rich regulatory elements of the promoters of CD40 and CD40 ligand (CD40L) and coordinately regulates their expression. Consistent with its function, AKNA is a nuclear protein that contains multiple PEST protein-cleavage motifs, which are common in regulatory proteins with high turnover rates(3). AKNA is mainly expressed by B and T lymphocytes, natural killer cells and dendritic cells. During B-lymphocyte differentiation, AKNA is mainly expressed by germinal centre B lymphocytes, a stage in which receptor and ligand interactions are crucial for B-lymphocyte maturation(4-12). Our findings show that an AT-hook molecule can coordinately regulate the expression of a key receptor and its ligand, and point towards a molecular mechanism that explains homotypic cell interactions.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Schering Plough, Lab Immunol Res, F-69571 Dardilly, France; Inst Nacl Salud Publ, Ctr Invest Sobre Enfermedades Infecciosas, Cuernavaca 62508, Morelos, Mexico	University of Texas System; UTMD Anderson Cancer Center; Merck & Company; Instituto Nacional de Salud Publica	Martinez-Valdez, H (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Box 178,1515 Holcombe Blvd, Houston, TX 77030 USA.		Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; CHEVAILLIER P, 1993, INT J BIOCHEM, V25, P479, DOI 10.1016/0020-711X(93)90653-V; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Clodi K, 1998, BRIT J HAEMATOL, V103, P270, DOI 10.1046/j.1365-2141.1998.01031.x; Craxton A, 1998, J IMMUNOL, V161, P3225; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Grammer AC, 1999, J IMMUNOL, V163, P4150; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Guzman-Rojas L, 2000, INT IMMUNOL, V12, P607, DOI 10.1093/intimm/12.5.607; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lo HW, 1997, J BIOL CHEM, V272, P32743, DOI 10.1074/jbc.272.52.32743; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martin G, 1996, ARCH SUICIDE RES, V2, P183, DOI 10.1080/13811119608259000; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; REEVES R, 1990, J BIOL CHEM, V265, P8573; RUDERT F, 1995, DNA CELL BIOL, V14, P931, DOI 10.1089/dna.1995.14.931; SCHUBERT LA, 1995, J BIOL CHEM, V270, P29624; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632	30	62	64	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					383	387		10.1038/35066602	http://dx.doi.org/10.1038/35066602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268217				2022-12-01	WOS:000167464100055
J	Detmar, SB; Muller, MJ; Wever, LDV; Schornagel, JH; Aaronson, NK				Detmar, SB; Muller, MJ; Wever, LDV; Schornagel, JH; Aaronson, NK			Patient-physician communication during outpatient palliative treatment visits - An observational study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CANCER-PATIENTS; CLINICAL-PRACTICE; CONSULTATION; CARE; SATISFACTION; PARTICIPATION; IMPACT; SKILLS	Context Improving health-related quality of life (HRQL) is an important goal of palliative treatment, but little is known about actual patient-physician communication regarding HRQL topics during palliative treatment. Objectives To investigate the content of routine communication regarding 4 specific HRQL issues between oncologists and their patients and to identify patient-, physician-, and visit-specific factors significantly associated with discussion of such issues. Design Observational study conducted between lune 1996 and January 1998, Setting Outpatient palliative chemotherapy clinic of a cancer hospital in the Netherlands, Participants Ten oncologists and 240 of their patients (72% female; mean age, 55 years) who had incurable cancer and were receiving outpatient palliative chemotherapy. Main outcome Measures Patient and physician questionnaires and audiotape analysis of communication regarding daily activities, emotional functioning, pain, and fatigue during an outpatient consultation using the Roter Interaction Analysis System. Results Physicians devoted 64% of their conversation to medical/technical issues and 23% to HRQL issues. Patients' communication behavior was divided more equally between medical/technical issues (41%) and HRQL topics (48%). Of the independent variables investigated, patients' self-reported HRQL was the most powerful predictor of discussing HRQL issues. Nevertheless, in 20% to 54% of the consultations in which patients were experiencing serious HRQL problems, no time was devoted to discussion of those problems. In particular, these patients' emotional functioning and fatigue were unaddressed 54% and 48% of the time, respectively. Discussion of HRQL issues was not more frequent in consultations in which tumor response was evaluated. Conclusion Despite increasing recognition of the importance of maintaining patients' HRQL as a goal of palliative treatment, the amount of patient-physician communication devoted to such issues remains limited and appears to make only a modest contribution, at least in an explicit sense, to the evaluation of treatment efficacy in daily clinical practice.	Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands; Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Aaronson, NK (corresponding author), Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	naaron@nki.nl	Aaronson, Neil K/AAV-8194-2021					AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], 1996, J Clin Oncol, V14, P671; Baile W F, 1997, J Cancer Educ, V12, P166; Boon H, 1998, PATIENT EDUC COUNS, V35, P161, DOI 10.1016/S0738-3991(98)00063-9; BUTOW PN, 1994, ANN ONCOL, V5, P199, DOI 10.1093/oxfordjournals.annonc.a058793; Byrne P., 1976, DOCTORS TALKING PATI; Cella D F, 1990, Oncology (Williston Park), V4, P29; Coulter A, 1997, J Health Serv Res Policy, V2, P112; CULL A, 1995, BRIT J CANCER, V72, P229, DOI 10.1038/bjc.1995.308; Curt GA, 2000, ONCOLOGIST S, V5, P9, DOI DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-9; Davidoff F, 1997, ANN INTERN MED, V127, P483, DOI 10.7326/0003-4819-127-6-199709150-00011; Detmar SB, 2000, J CLIN ONCOL, V18, P3295, DOI 10.1200/JCO.2000.18.18.3295; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Ford S, 1996, SOC SCI MED, V42, P1511, DOI 10.1016/0277-9536(95)00265-0; FUNCH DP, 1988, MED CARE, V26, P1000, DOI 10.1097/00005650-198810000-00008; GANZ PA, 1994, CANCER, V74, P1445, DOI 10.1002/1097-0142(19940815)74:4+<1445::AID-CNCR2820741608>3.0.CO;2-#; Goldberg R, 1990, J Cancer Educ, V5, P193; Goldstein M., 1987, MULTILEVEL MODELS ED; GOUGH IR, 1991, CANCER, V68, P220, DOI 10.1002/1097-0142(19910701)68:1<220::AID-CNCR2820680140>3.0.CO;2-H; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; HALL JA, 1994, HEALTH PSYCHOL, V13, P384, DOI 10.1037/0278-6133.13.5.384; Hancock Barry W., 1993, Current Opinion in Oncology, V5, P655, DOI 10.1097/00001622-199307000-00006; HIGGINSON I, 1993, J PUBLIC HEALTH MED, V15, P3, DOI 10.1093/oxfordjournals.pubmed.a042817; LEVINSON W, 1995, J GEN INTERN MED, V10, P375, DOI 10.1007/BF02599834; MAGUIRE P, 1988, BRIT MED J, V297, P847, DOI 10.1136/bmj.297.6652.847; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; Marvel MK, 1998, J FAM PRACTICE, V47, P343; McCann S, 1996, PSYCHOL HEALTH, V11, P857, DOI 10.1080/08870449608400281; Montazeri A, 1996, EUR J CANCER, V32A, P2284, DOI 10.1016/S0959-8049(96)00288-2; NELSON E, 1987, J CHRON DIS, V40, pS55, DOI 10.1016/S0021-9681(87)80033-4; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Ong LML, 1998, PSYCHO-ONCOL, V7, P387, DOI 10.1002/(SICI)1099-1611(1998090)7:5<387::AID-PON316>3.3.CO;2-7; Ong LML, 2000, J CLIN ONCOL, V18, P3052, DOI 10.1200/JCO.2000.18.16.3052; Ong LML, 1999, PSYCHO-ONCOLOGY, V8, P155; Osoba D, 1996, CANCER TREAT REV, V22, P69, DOI 10.1016/S0305-7372(96)90066-3; PAYNE SA, 1992, SOC SCI MED, V35, P1505, DOI 10.1016/0277-9536(92)90053-S; PORZSOLT F, 1993, J CLIN ONCOL, V11, P378, DOI 10.1200/JCO.1993.11.2.378; Razavi D, 1997, EUR J CANCER, V33, pS15, DOI 10.1016/S0959-8049(97)00195-0; ROLAND MO, 1986, BRIT MED J, V292, P874, DOI 10.1136/bmj.292.6524.874; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; ROTER DL, 1991, HUISARTS WET, V34, P295; Roter DL, 1992, DOCTORS TALKING PATI; SUTHERLAND HJ, 1990, J CLIN EPIDEMIOL, V43, P661, DOI 10.1016/0895-4356(90)90036-O; Taenzer P, 2000, PSYCHO-ONCOLOGY, V9, P203, DOI 10.1002/1099-1611(200005/06)9:3<203::AID-PON453>3.0.CO;2-Y; Taylor KM, 1996, QUAL LIFE RES, V5, P5, DOI 10.1007/BF00435963; Till J E, 1994, Can J Oncol, V4, P243; van Dulmen AM, 2000, EUR J PEDIATR, V159, P489, DOI 10.1007/s004310051316; VANWIJK CMTG, 1991, WOMEN HEALTH, V17, P91; Wagner AK, 1997, QUAL LIFE RES, V6, P329, DOI 10.1023/A:1018479209369; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; WAITZKIN H, 1985, J HEALTH SOC BEHAV, V26, P81, DOI 10.2307/2136599	51	131	132	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1351	1357		10.1001/jama.285.10.1351	http://dx.doi.org/10.1001/jama.285.10.1351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408QK	11255393	Bronze			2022-12-01	WOS:000167339000030
J	Fandrich, M; Fletcher, MA; Dobson, CM				Fandrich, M; Fletcher, MA; Dobson, CM			Amyloid fibrils from muscle myoglobin - Even an ordinary globular protein can assume a rogue guise if conditions are right.	NATURE			English	Article									Univ Oxford, New Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QT, England	University of Oxford	Fandrich, M (corresponding author), Univ Oxford, New Chem Lab, Oxford Ctr Mol Sci, S Parks Rd, Oxford OX1 3QT, England.							ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; EVANS SV, 1988, J BIOL CHEM, V263, P4263; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Smeller L, 1999, BIOCHEMISTRY-US, V38, P3816, DOI 10.1021/bi981693n; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; TAN SY, 1994, HISTOPATHOLOGY, V25, P403, DOI 10.1111/j.1365-2559.1994.tb00001.x; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X	12	695	713	4	114	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					165	166		10.1038/35065514	http://dx.doi.org/10.1038/35065514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242064				2022-12-01	WOS:000167320500030
J	Bannister, AJ; Zegerman, P; Partridge, JF; Miska, EA; Thomas, JO; Allshire, RC; Kouzarides, T				Bannister, AJ; Zegerman, P; Partridge, JF; Miska, EA; Thomas, JO; Allshire, RC; Kouzarides, T			Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain	NATURE			English	Article							FISSION YEAST CENTROMERES; POSITION-EFFECT VARIEGATION; DNA-REPLICATION; PROTEIN; ACETYLTRANSFERASE; HETEROCHROMATIN; BROMODOMAIN; MUTATIONS; DISRUPT; COMPLEX	Heterochromatin protein 1 (HP1) is localized at heterochromatin sites where it mediates gene silencing(1,2). The chromo domain of HP1 is necessary for both targeting and transcriptional repression(3,4). In the fission yeast Schizosaccharomyces pombe, the correct localization of Swi6 (the HP1 equivalent) depends on Clr4, a homologue of the mammalian SUV39H1 histone methylase(5,6). Both Clr4 and SUV39H1 methylate specifically lysine 9 of histone H3 (ref. 6). Here we show that HP1 can bind with high affinity to histone H3 methylated at lysine 9 but not at lysine 4. The chromo domain of HP1 is identified as its methyl-lysine-binding domain. A point mutation in the chromo domain, which destroys the gene silencing activity of HP1 in Drosophila(3), abolishes methyl-lysine-binding activity. Genetic and biochemical analysis in S. pombe shows that the methylase activity of Clr4 is necessary for the correct localization of Swi6 at centromeric heterochromatin and for gene silencing. These results provide a stepwise model for the formation of a transcriptionally silent heterochromatin: SUV39H1 places a 'methyl marker' on histone H3, which is then recognized by HP1 through its chromo domain. This model may also explain the stable inheritance of the heterochromatic state.	Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge; University of Edinburgh; University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.		Partridge, Janet/M-9352-2018; Hu, Ruogu/B-2203-2008	Partridge, Janet/0000-0003-1102-6305; Zegerman, Philip/0000-0002-5707-1083; Miska, Eric/0000-0002-4450-576X; Allshire, Robin/0000-0002-8005-3625; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Partridge JF, 2000, GENE DEV, V14, P783; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thompson J. F., 1998, CHROMATIN PRACTICAL, V21567, P1	21	2075	2133	4	167	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					120	124		10.1038/35065138	http://dx.doi.org/10.1038/35065138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242054				2022-12-01	WOS:000167194300055
J	Rayfield, EJ; Norman, DB; Horner, CC; Horner, JR; Smith, PM; Thomason, JJ; Upchurch, P				Rayfield, EJ; Norman, DB; Horner, CC; Horner, JR; Smith, PM; Thomason, JJ; Upchurch, P			Cranial design and function in a large theropod dinosaur	NATURE			English	Article							ORTHOPEDIC BIOMECHANICS; TYRANNOSAURUS REX; FORCES; EVOLUTION; TISSUE	Finite element analysis (FEA)(1) is used by industrial designers and biomechanicists to estimate the performance of engineered structures or human skeletal and soft tissues subjected to varying regimes of stress and strain(2-4). FEA is rarely applied to problems of biomechanical design in animals, despite its potential to inform structure-function analysis. Non-invasive techniques such as computed tomography scans can be used to generate accurate three-dimensional images of structures, such as skulls, which can form the basis of an accurate finite element model. Here we have applied this technique to the long skull of the large carnivorous theropod dinosaur Allosaurus fragilis(5). We have generated the most geometrically complete and complex FEA model of the skull of any extinct or extant organism and used this to test its mechanical properties and examine, in a quantitative way, long-held hypotheses concerning overall shape and function(6-8). The combination of a weak muscle-driven bite force, a very 'light' and 'open' skull architecture and unusually high cranial strength, suggests a very specific feeding behaviour for this animal. These results demonstrate simply the inherent potential of FEA for testing mechanical behaviour in fossils in ways that, until now, have been impossible.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Cambridge; Montana State University System; Montana State University Bozeman; University of Guelph	Rayfield, EJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.		Rohlf, F J/A-8710-2008; Rayfield, Emily/F-5038-2010; Upchurch, Paul/C-1654-2008	Rayfield, Emily/0000-0002-2618-750X; 				[Anonymous], 1971, FINITE ELEMENT METHO; Auffenberg, 1981, BEHAV ECOLOGY KOMODO; BUCKLANDWRIGHT JC, 1978, J MORPHOL, V155, P35, DOI 10.1002/jmor.1051550104; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Crompton A.W., 1986, P263; Diamond Jared M., 1998, P21; DODSON P, 1980, PALEOBIOLOGY, V6, P208, DOI 10.1017/S009483730000676X; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; FARLOW JO, 1976, AM MIDL NAT, V95, P186, DOI 10.2307/2424244; HUISKES R, 1993, J BIOMECH ENG-T ASME, V115, P520, DOI 10.1115/1.2895534; HUISKES R, 1983, J BIOMECH, V16, P385, DOI 10.1016/0021-9290(83)90072-6; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Molnar R.E., 1990, P210; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Paul G.S., 1988, PREDATORY DINOSAURS, P464; Perez-Moreno BP, 1999, J GEOL SOC LONDON, V156, P449, DOI 10.1144/gsjgs.156.3.0449; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5; ROSS CTF, 1990, FINITE ELEMENT METHO, P519; SINCLAIR AG, 1987, J ZOOL, V213, P107, DOI 10.1111/j.1469-7998.1987.tb03681.x; Sues H.-D., 1990, P498; THOMASON JJ, 1986, J MORPHOL, V189, P199, DOI 10.1002/jmor.1051890210; THOMASON JJ, 1990, CAN J ZOOL, V68, P318, DOI 10.1139/z90-047; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; WATERS NE, 1980, MECH PROPERTIES BIOL, P99; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027	28	190	201	4	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1033	1037		10.1038/35059070	http://dx.doi.org/10.1038/35059070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234010				2022-12-01	WOS:000167148800043
J	Sinnarajah, S; Dessauer, CW; Srikumar, D; Chen, J; Yuen, J; Yilma, S; Dennis, JC; Morrison, EE; Vodyanoy, V; Kehrl, JH				Sinnarajah, S; Dessauer, CW; Srikumar, D; Chen, J; Yuen, J; Yilma, S; Dennis, JC; Morrison, EE; Vodyanoy, V; Kehrl, JH			RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III	NATURE			English	Article							RECEPTOR-CELLS; ODORANT DETECTION; IDENTIFICATION; STIMULATION; INHIBITION; MECHANISM; PROTEINS; ROLES; CAMP	The heterotrimeric G-protein G(s) couples cell-surface receptors to the activation of adenylyl cyclases and cyclic AMP production (reviewed in refs 1, 2). RGS proteins, which act as GTPase-activating proteins (GAPs) for the G-protein alpha -subunits alpha (i) and alpha (q), lack such activity for alpha (s) (refs 3-6). But several RGS proteins inhibit cAMP production by G(s)-linked receptors(7,8). Here we report that RGS2 reduces cAMP production by odorant-stimulated olfactory epithelium membranes, in which the alpha (s) family member alpha (olf) links odorant receptors to adenylyl cyclase activation(9,10). Unexpectedly, RGS2 reduces odorant-elicited cAMP production, not by acting on alpha (olf) but by inhibiting the activity of adenylyl cyclase type III, the predominant adenylyl cyclase isoform in olfactory neurons. Furthermore, whole-cell voltage clamp recordings of odorant-stimulated olfactory neurons indicate that endogenous RGS2 negatively regulates odorant-evoked intracellular signalling. These results reveal a mechanism for controlling the activities of adenylyl cyclases, which probably contributes to the ability of olfactory neurons to discriminate odours.	NIAID, Cell Mol Biol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA; Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; Auburn University System; Auburn University	Kehrl, JH (corresponding author), NIAID, Cell Mol Biol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Kehrl, John/AAE-6292-2019; Dessauer, Carmen/N-6933-2018	Kehrl, John/0000-0002-6526-159X; Dessauer, Carmen/0000-0003-1210-4280	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060419-01A1, R01 GM060419] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Beadling C, 1999, J IMMUNOL, V162, P2677; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1989, CHEM SENSES, V1, P449; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Sinnarajah S, 1998, FEBS LETT, V426, P377, DOI 10.1016/S0014-5793(98)00368-8; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1, P555; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Tseng CC, 1998, ENDOCRINOLOGY, V139, P4470, DOI 10.1210/en.139.11.4470; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9	25	203	209	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1051	1055		10.1038/35059104	http://dx.doi.org/10.1038/35059104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234015				2022-12-01	WOS:000167148800048
J	Tio, M; Udolph, G; Yang, XH; Chia, W				Tio, M; Udolph, G; Yang, XH; Chia, W			cdc2 links the Drosophila cell cycle and asymmetric division machineries	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; LOCALIZATION; PROSPERO; PROTEIN; MITOSIS; NUMB; NEUROBLASTS; SEGREGATION; MIRANDA	Asymmetric cell divisions can be mediated by the preferential segregation of cell-fate determinants into one of two sibling daughters. In Drosophila neural progenitors, Inscuteable(1-3), Partner of Inscuteable(4,5) and Bazooka(6,7) localize as an apical cortical complex at interphase, which directs the apical-basal orientation of the mitotic spindle as well as the basal/cortical localization of the cell-fate determinants Numb(8,9) and/or Prospero(10,11) during mitosis. Although localization of these proteins shows dependence on the cell cycle, the involvement of cell-cycle components in asymmetric divisions has not been demonstrated. Here we show that neural progenitor asymmetric divisions require the cell-cycle regulator cdc2. By attenuating Drosophila cdc2 function without blocking mitosis, normally asymmetric progenitor divisions become defective, failing to correctly localize asymmetric components during mitosis and/or to resolve distinct sibling fates, cdc2 is not necessary for initiating apical complex formation during interphase; however, maintaining the asymmetric localization of the apical components during mitosis requires Cdc2/B-type cyclin complexes. Our findings link cdc2 with asymmetric divisions, and explain why the asymmetric localization of molecules like Inscuteable show cell-cycle dependence.	Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chia, W (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.							BRAND AH, 1993, DEVELOPMENT, V118, P401; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; CLEGG NJ, 1993, GENOME, V36, P676, DOI 10.1139/g93-091; DOE CQ, 1992, DEVELOPMENT, V116, P855; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Lear BC, 1999, MECH DEVELOP, V88, P207, DOI 10.1016/S0925-4773(99)00190-2; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; LUNDELL MJ, 1994, BIOTECHNIQUES, V16, P434; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; SIGRIST S, 1995, MECH DEVELOP, V53, P247, DOI 10.1016/0925-4773(95)00441-3; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STERN B, 1993, DEVELOPMENT, V117, P219; Tio M, 1999, J CELL SCI, V112, P1541; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	30	87	90	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1063	1067		10.1038/35059124	http://dx.doi.org/10.1038/35059124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234018				2022-12-01	WOS:000167148800051
J	Liu, JH; Akoulitchev, S; Weber, A; Ge, H; Chuikov, S; Libutti, D; Wang, XW; Conaway, JW; Harris, CC; Conaway, RC; Reinberg, D; Levens, D				Liu, JH; Akoulitchev, S; Weber, A; Ge, H; Chuikov, S; Libutti, D; Wang, XW; Conaway, JW; Harris, CC; Conaway, RC; Reinberg, D; Levens, D			Defective interplay of activators and repressors with TFIIH in xeroderma pigmentosum	CELL			English	Article							RNA-POLYMERASE-II; GENERAL TRANSCRIPTION FACTORS; FAR UPSTREAM ELEMENT; C-MYC; PROMOTER ESCAPE; TERMINAL DOMAIN; IN-VIVO; DNA; INITIATION; COMPLEX	Inherited mutations of the TFIIH helicase subunits xeroderma pigmentosum (XP) B or XPD yield overlapping DNA repair and transcription syndromes. The high risk of cancer in these patients is not fully explained by the repair defect. The transcription defect is subtle and has proven more difficult to evaluate. Here, XPB and XPD mutations are shown to block transcription activation by the FUSE Binding Protein (FBP), a regulator of c-myc expression, and repression by the FBP Interacting Repressor (FIR). Through TFIIH, FBP facilitates transcription until promoter escape, whereas after initiation, FIR uses TFIIH to delay promoter escape. Mutations in TFIIH that impair regulation by FBP and FIR affect proper regulation of c-myc expression and have implications in the development of malignancy.	NCI, Gene Regulat Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Mol Embryol Lab, NIH, Bethesda, MD 20892 USA; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucl Acids Enzymol,HHMI, Piscataway, NJ 08854 USA; Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Oklahoma Medical Research Foundation	Levens, D (corresponding author), NCI, Gene Regulat Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA.		Levens, David/C-9216-2009; Wang, Xin Wei/B-6162-2009	Levens, David/0000-0002-7616-922X; Wang, Xin Wei/0000-0001-9735-606X; Reinberg, Danny/0000-0003-4288-2016; Weber, Achim/0000-0003-0073-3637; Conaway, Joan/0000-0002-2786-0663	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM037120, R01GM048518, R37GM041628] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM41628, GM48518, GM37120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Albert T, 1997, MOL CELL BIOL, V17, P4363, DOI 10.1128/MCB.17.8.4363; Araujo SJ, 2000, GENE DEV, V14, P349; AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; BAZAR L, 1995, J BIOL CHEM, V270, P8241, DOI 10.1074/jbc.270.14.8241; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Berneburg M, 2000, CANCER RES, V60, P431; Blau J, 1996, MOL CELL BIOL, V16, P2044; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Conaway RC, 1996, METHOD ENZYMOL, V273, P194; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; de Boer J, 1998, CANCER RES, V58, P89; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DRAPKIN R, 1994, TRENDS BIOCHEM SCI, V19, P504, DOI 10.1016/0968-0004(94)90139-2; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Duncan R, 1996, MOL CELL BIOL, V16, P2274; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Fiedler U, 2000, BIOESSAYS, V22, P316, DOI 10.1002/(SICI)1521-1878(200004)22:4<316::AID-BIES2>3.0.CO;2-B; FLORES O, 1992, J BIOL CHEM, V267, P2786; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Ge H, 1996, METHOD ENZYMOL, V274, P57; GERARD M, 1991, J BIOL CHEM, V266, P20940; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Guzman E, 1999, MOL CELL BIOL, V19, P5652; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Kugel JF, 1998, P NATL ACAD SCI USA, V95, P9232, DOI 10.1073/pnas.95.16.9232; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; Lis JT, 1994, TRANSCRIPTION MECH R, P459; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; Samkurashvili I, 1998, MOL CELL BIOL, V18, P5343, DOI 10.1128/MCB.18.9.5343; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; TONG X, 1995, P NATL ACAD SCI USA, V92, P3259, DOI 10.1073/pnas.92.8.3259; van Steeg H, 1999, MOL MED TODAY, V5, P86, DOI 10.1016/S1357-4310(98)01394-X; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	70	104	112	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					353	363		10.1016/S0092-8674(01)00223-9	http://dx.doi.org/10.1016/S0092-8674(01)00223-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239393	Bronze			2022-12-01	WOS:000167003100006
J	Hartley, D				Hartley, D			From the foot of the gurney	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		American Heart Association in collaboration with the International Liaison Committee on Resuscitation, 2000, CIRCULATION S8, V102, pI12; BELENGER M, 1997, J EMERG NURS, V23, P238; Rattrie E, 2000, Nurs Stand, V14, P32; Robinson SM, 1998, LANCET, V352, P614, DOI 10.1016/S0140-6736(97)12179-1	4	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2001	285	4					380	380		10.1001/jama.285.4.380	http://dx.doi.org/10.1001/jama.285.4.380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394CG	11242401				2022-12-01	WOS:000166506000001
J	Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Hartsch, T; Wimberly, BT; Ramakrishnan, V				Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Hartsch, T; Wimberly, BT; Ramakrishnan, V			Crystal structure of an initiation factor bound to the 30S ribosomal subunit	SCIENCE			English	Article							ESCHERICHIA-COLI; TRANSLATIONAL INITIATION; FACTOR IF1; TRANSFER-RNA; PROTEIN-BIOSYNTHESIS; FACTORS IF-1; BINDING; MECHANISM; DISSOCIATION; DOMAINS	Initiation of translation at the correct position on messenger RNA is essential for accurate protein synthesis. In prokaryotes, this process requires three initiation factors: IF1, IF2, and IF3, Here we report the crystal structure of a complex of IF1 and the 30S ribosomal subunit, Binding of IF1 occludes the ribosomal A site and flips out the functionally important bases A1492 and A1493 from helix 44 of 16S RNA, burying them in pockets in IF1. The binding of IF1 causes long-range changes in the conformation of H44 and Leads to movement of the domains of 30S with respect to each other. The structure explains how localized changes at the ribosomal A site lead to global alterations in the conformation of the 30S subunit.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Gottingen, Inst Genet & Mikrobiol, Gottingen Genom Lab, D-37077 Gottingen, Germany	MRC Laboratory Molecular Biology; University of Gottingen	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Brodersen, Ditlev E./AAQ-5241-2020; Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Brodersen, Ditlev/0000-0002-5413-4667; Ramakrishnan, V/0000-0002-4699-2194; Carter, Andrew/0000-0001-7292-5430	NIGMS NIH HHS [GM 44973] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNE R, 1973, EUR J BIOCHEM, V32, P372, DOI 10.1111/j.1432-1033.1973.tb02619.x; BOILEAU G, 1983, BIOCHEMISTRY-US, V22, P3162, DOI 10.1021/bi00282a020; Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; CANONACO MA, 1986, FEBS LETT, V207, P198, DOI 10.1016/0014-5793(86)81488-0; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CUMMINGS HS, 1994, J BACTERIOL, V176, P198, DOI 10.1128/JB.176.1.198-205.1994; Dahlquist KD, 2000, J MOL BIOL, V299, P1, DOI 10.1006/jmbi.2000.3672; DOTTAVIOMARTIN D, 1979, FEBS LETT, V97, P105, DOI 10.1016/0014-5793(79)80062-9; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; GERCHMAN SE, 1994, PROTEIN EXPRES PURIF, V5, P242, DOI 10.1006/prep.1994.1037; GODEFROYCOLBURN T, 1975, J MOL BIOL, V94, P461, DOI 10.1016/0022-2836(75)90215-6; GRIBSKOV M, 1992, GENE, V119, P107, DOI 10.1016/0378-1119(92)90073-X; Gualerzi CO, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P477; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUALERZI CO, 1989, PROTEIN ENG, V3, P133, DOI 10.1093/protein/3.2.133; HARTZ D, 1990, GENE DEV, V4, P1790, DOI 10.1101/gad.4.10.1790; KYCIA JH, 1995, BIOCHEMISTRY-US, V34, P6183, DOI 10.1021/bi00018a022; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Meinnel T, 1999, J MOL BIOL, V290, P825, DOI 10.1006/jmbi.1999.2881; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; MOAZED D, 1995, J MOL BIOL, V248, P207, DOI 10.1016/S0022-2836(95)80042-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; NOLL M, 1972, NATURE-NEW BIOL, V238, P225, DOI 10.1038/newbio238225a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PON CL, 1984, FEBS LETT, V175, P203, DOI 10.1016/0014-5793(84)80737-1; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; STRINGER EA, 1977, J BIOL CHEM, V252, P1739; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1997, STRUCTURE, V5, P1187, DOI 10.1016/S0969-2126(97)00269-4; WINTERMEYER W, 1983, BIOCHEMISTRY-US, V22, P690, DOI 10.1021/bi00272a025; Wu XQ, 1997, J BIOL CHEM, V272, P1891, DOI 10.1074/jbc.272.3.1891	40	292	327	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					498	501		10.1126/science.1057766	http://dx.doi.org/10.1126/science.1057766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228145				2022-12-01	WOS:000166487500046
J	Soengas, MS; Capodieci, P; Polsky, D; Mora, J; Esteller, M; Opitz-Araya, X; McCombie, R; Herman, JG; Gerald, WL; Lazebnik, YA; Cordon-Cardo, C; Lowe, SW				Soengas, MS; Capodieci, P; Polsky, D; Mora, J; Esteller, M; Opitz-Araya, X; McCombie, R; Herman, JG; Gerald, WL; Lazebnik, YA; Cordon-Cardo, C; Lowe, SW			Inactivation of the apoptosis effector Apaf-1 in malignant melanoma	NATURE			English	Article							P53-DEPENDENT APOPTOSIS; METHYLATION; EXPRESSION; CASPASE-9; CHEMORESISTANCE; MUTATIONS; BCL-2; P53	Metastatic melanoma is a deadly cancer that fails to respond to conventional chemotherapy and is poorly understood at the molecular level(1). p53 mutations often occur in aggressive and chemoresistant cancers but are rarely observed in melanoma(1,2). Here we show that metastatic melanomas often lose Apaf-1, a cell-death effector that acts with cytochrome c and caspase-9 to mediate p53-dependent apoptosis(3). Loss of Apaf-1 expression is accompanied by allelic loss in metastatic melanomas, but can be recovered in melanoma cell lines by treatment with the methylation inhibitor 5-aza-2'-deoxycytidine (5aza2dC). Apaf-1-negative melanomas are invariably chemoresistant and are unable to execute a typical apoptotic programme in response to p53 activation. Restoring physiological levels of Apaf-1 through gene transfer or 5aza2dC treatment markedly enhances chemosensitivity and rescues the apoptotic defects associated with Apaf-1 loss. We conclude that Apaf-1 is inactivated in metastatic melanomas, which leads to defects in the execution of apoptotic cell death. Apaf-1 loss may contribute to the low frequency of p53 mutations observed in this highly chemoresistant tumour type.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Baltimore, MD 21231 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.org	Soengas, Maria S/H-6455-2015; Esteller, Manel/L-5956-2014; Clovis, Jeff/C-1020-2009; Polsky, David/AAO-6254-2020	Soengas, Maria S/0000-0003-0612-6299; Esteller, Manel/0000-0003-4490-6093; Polsky, David/0000-0001-9554-5289; McCombie, W. Richard/0000-0003-1899-0682; Mora, Jaume/0000-0002-9386-5980				Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Capodieci P, 1998, DIAGN MOL PATHOL, V7, P69, DOI 10.1097/00019606-199804000-00002; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; Mora J, 2000, J MOL DIAGN, V2, P37, DOI 10.1016/S1525-1578(10)60613-7; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 1999, J PATHOL, V187, P127; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Serrone L, 1999, MELANOMA RES, V9, P51, DOI 10.1097/00008390-199902000-00007; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamamoto H, 2000, CELL DEATH DIFFER, V7, P238, DOI 10.1038/sj.cdd.4400651; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	29	800	836	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2001	409	6817					207	211		10.1038/35051606	http://dx.doi.org/10.1038/35051606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196646				2022-12-01	WOS:000166316200048
J	Sargent, JD; Tickle, JJ; Beach, ML; Dalton, MA; Ahrens, MB; Heatherton, TF				Sargent, JD; Tickle, JJ; Beach, ML; Dalton, MA; Ahrens, MB; Heatherton, TF			Brand appearances in contemporary cinema films and contribution to global marketing of cigarettes	LANCET			English	Article							POPULAR FILMS; TOBACCO	Background The appearance of a cigarette brand in a cinema film gives the brand a certain distinction through its association with the characters and general tone of the film. Through the worldwide distribution of films, brands are promoted globally. We assessed the tobacco-brand appearances in a 10-year sample of contemporary films. Methods We viewed the contents of the top 25 US box-office films for each year of release, from 1988 to 1997 (250 films in total). We compared the prevalence of brand appearances for films produced before a voluntary ban on paid product placement by the tobacco industry (1988-90) with films produced after the ban (1991-97). Tobacco-brand appearance was defined as the screen appearance of a brand name, logo, or identifiable trademark on products or product packaging, billboards, store-front advertising, or tobacco promotional items. We defined actor endorsement of a brand as the display of a brand while being handled or used by an actor. Findings More than 85% of the films contained tobacco use. Tobacco brands appeared in 70 (28%) films. Brand appearances were as common in films suitable for adolescent audiences as they were in films for adult audiences (32 vs 35%), and were also present in 20% of those rated for children, Prevalence of brand appearance did not change overall in relation to the ban. However, there was a striking increase in the type of brand appearance depicted, with actor endorsement increasing from 1% of films before the ban to 11% after. Four US cigarette brands accounted for 80% of brand appearances. Revenues outside the USA accounted for 49% of total revenues for these films, indicating a large international audience. Interpretation Tobacco-brand appearances are common in films and are becoming increasingly endorsed by actors. The most highly advertised US cigarette brands account for most brand appearances, which suggests an advertising motive to this practice.	Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pediat, Hanover, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03756 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Sargent, JD (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Pediat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.		Heatherton, Todd F/H-5478-2011; Sargent, James D/I-2773-2013					BASIL MD, 1997, HEALTH COMMUN, V9, P190; Chapman S, 1997, Tob Control, V6, P269; COLFORD SW, 1990, ADVERTISING AGE, V17, P31; Distefan JM, 1999, PREV MED, V28, P1, DOI 10.1006/pmed.1998.0409; Everett SA, 1998, J COMMUN HEALTH, V23, P317, DOI 10.1023/A:1018727606500; Goldstein AO, 1999, JAMA-J AM MED ASSOC, V281, P1131, DOI 10.1001/jama.281.12.1131; HAZAN AR, 1994, AM J PUBLIC HEALTH, V84, P998, DOI 10.2105/AJPH.84.6.998; HIGGINS KT, 1985, ADVERTISING AGE, V19, P6; Karrh J.A., 1998, J CURRENT ISSUES RES, V20, P31, DOI [https://doi.org/10.1080/10641734.1998.10505081, DOI 10.1080/10641734.1998.10505081]; KENOFF JS, 1993, ENTERTAINMENT LAW FI, V9, P4; KENOFF JS, 1993, ENTERTAINMENT LAW FI, V9, P1; LACKEY WB, 1993, CAN L LANE SMOKE MAR; McIntosh WD, 1998, ADDICT BEHAV, V23, P395, DOI 10.1016/S0306-4603(97)00071-3; Reed J.D., 1989, TIME, P103; Richards J W Jr, 1996, Tob Control, V5, P295, DOI 10.1136/tc.5.4.295; Shields DLL, 1999, TOB CONTROL, V8, P378, DOI 10.1136/tc.8.4.378; SNYDER SL, 1992, U ILLINOIS LAW REV, V1, P301; Stockwell T F, 1997, Tob Control, V6, P282, DOI 10.1136/tc.6.4.282; TERRE L, 1991, J APPL SOC PSYCHOL, V21, P1303, DOI 10.1111/j.1559-1816.1991.tb00472.x; TICKLE J, IN PRESS TOBACCO CON; 1990, ADVERTISING AGE, P27	21	87	87	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					29	32		10.1016/S0140-6736(00)03568-6	http://dx.doi.org/10.1016/S0140-6736(00)03568-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391EQ	11197357				2022-12-01	WOS:000166341500012
J	Ng, CKY; Carr, K; McAinsh, MR; Powell, B; Hetherington, AM				Ng, CKY; Carr, K; McAinsh, MR; Powell, B; Hetherington, AM			Drought-induced guard cell signal transduction involves sphingosine-1-phosphate	NATURE			English	Article							CYTOSOLIC-FREE CALCIUM; STOMATAL CLOSURE; CHANNELS; OSCILLATIONS; ELEVATION; KINASE; CA-2+	Stomata form pores on leaf surfaces that regulate the uptake of CO2 for photosynthesis and the loss of water vapour during transpiration(1), An increase in the cytosolic concentration of free calcium ions ([Ca2+](cyt)) is a common intermediate in many of the pathways leading to either opening or closure of the stomatal pore(2,3). This observation has prompted investigations into how specificity is controlled in calcium-based signalling systems in plants. One possible explanation is that each stimulus generates a unique increase in [Ca2+](cyt), or 'calcium signature: that dictates the outcome of the final response(4). It has been suggested that the key to generating a calcium signature, and hence to understanding how specificity is controlled, is the ability to access differentially the cellular machinery controlling calcium influx and release from internal stores(2-5). Here we report that sphingosine-1-phosphate is a new calcium-mobilizing molecule in plants. We show that after drought treatment sphingosine-1-phosphate levels increase, and we present evidence that this molecule is involved in the signal-transduction pathway linking the perception of abscisic acid to reductions in guard cell turgor.	Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England; Avecia Ltd, Manchester M9 8ZS, Lancs, England	Lancaster University; Avecia	Hetherington, AM (corresponding author), Univ Lancaster, Inst Environm & Nat Sci, Dept Biol Sci, Lancaster LA1 4YQ, England.		Ng, Carl K/B-4626-2013	Hetherington, Alistair/0000-0001-6060-9203; McAinsh, Martin Robert/0000-0003-4294-6470				Berger A, 1996, MOL PHARMACOL, V50, P451; Blatt MR, 2000, CURR OPIN PLANT BIOL, V3, P196, DOI 10.1016/S1369-5266(00)00064-9; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Merrill Jr A. H., 1996, BIOCH LIPIDS LIPOPRO, P309; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SPIEGEL S, 1997, SPHINGOLIPID MEDIATE, P121; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Sullards MC, 2000, J MASS SPECTROM, V35, P347, DOI 10.1002/(SICI)1096-9888(200003)35:3<347::AID-JMS941>3.0.CO;2-3; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8	20	259	273	0	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					596	599		10.1038/35069092	http://dx.doi.org/10.1038/35069092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279499	Green Submitted			2022-12-01	WOS:000167859300051
J	Janetopoulos, C; Jin, T; Devreotes, P				Janetopoulos, C; Jin, T; Devreotes, P			Receptor-mediated activation of heterotrimeric G-proteins in living cells	SCIENCE			English	Article							GTP-GAMMA-S; CHEMOATTRACTANT RECEPTOR; IN-VIVO; DICTYOSTELIUM; CHEMOTAXIS; PHOSPHORYLATION; DESENSITIZATION; STIMULATION; SUBUNITS; BINDING	Receptor-mediated activation of heterotrimeric CTP-binding proteins (C-proteins) was visualized in living Dictyostelium discoideum cells by monitoring fluorescence resonance energy transfer (FRET) between alpha- and beta- subunits fused to cyan and yellow fluorescent proteins. The G-protein heterotrimer rapidly dissociated and reassociated upon addition and removal of chemoattractant, During continuous stimulation, C-protein activation reached a dose-dependent steady-state Level. Even though physiological responses subsided, the activation did not decline. Thus, adaptation occurs at another point in the signaling pathway, and occupied receptors, whether or not they are phosphorylated, catalyze the C-protein cycle. Construction of similar energy-transfer pairs of mammalian G-proteins should enable direct in situ mechanistic studies and applications such as drug screening and identifying Ligands of newly found C-protein-coupled receptors.	Johns Hopkins Med Inst, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Devreotes, P (corresponding author), Johns Hopkins Med Inst, Dept Cell Biol & Anat, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034933, R01GM028007, R37GM028007] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28007, GM34933] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; CATERINA MJ, 1995, J BIOL CHEM, V270, P8667, DOI 10.1074/jbc.270.15.8667; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; JANETOPOULOS C, UNPUB; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Mendez A, 2000, METHOD ENZYMOL, V316, P167; NEUBIG RR, 1994, FEBS LETT, V355, P251, DOI 10.1016/0014-5793(94)01212-1; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SNAARJAGALSKA BE, 1991, EUR J BIOCHEM, V195, P715, DOI 10.1111/j.1432-1033.1991.tb15758.x; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; VAUGHAN RA, 1988, J BIOL CHEM, V263, P14538; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WU LJ, 1991, BIOCHEM BIOPH RES CO, V179, P1141, DOI 10.1016/0006-291X(91)91690-E; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	28	362	379	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2408	2411		10.1126/science.1055835	http://dx.doi.org/10.1126/science.1055835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264536				2022-12-01	WOS:000167618700055
J	Geerlings, MI; Ruitenberg, A; Witteman, JCM; van Swieten, JC; Hofman, A; van Duijn, CM; Breteler, MMB; Launer, LJ				Geerlings, MI; Ruitenberg, A; Witteman, JCM; van Swieten, JC; Hofman, A; van Duijn, CM; Breteler, MMB; Launer, LJ			Reproductive period and risk of dementia in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN-REPLACEMENT THERAPY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; NATURAL MENOPAUSE; OLDER WOMEN; CARDIOVASCULAR-DISEASE; MENTAL STATE; DECLINE; ROTTERDAM; HEALTH	Context Exogenous estrogen use may lower risk of dementia in postmenopausal women. A relationship between long-term exposure to endogenous estrogens and incident dementia has been hypothesized but not studied, Objective To determine whether a longer reproductive period, as an indicator of longer exposure to endogenous estrogens, is associated with lower risk of dementia and Alzheimer disease (AD) in women who have natural menopause. Design and Setting The Rotterdam Study, a population-based prospective cohort study conducted in the Netherlands. Participants A total of 3601 women aged 55 years or older who did not have dementia at baseline (1990-1993) and had information on age at menarche, age at menopause, and type of menopause. Participants were reexamined in 1993-1994 and 1997-1999 and were continuously monitored for development of dementia. Main Outcome Measures Incidence of dementia, based on Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition criteria, and AD, based on National Institute of Neurological Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria, compared by quartiles of reproductive period among women with natural menopause. Results During 21046 person-years of follow-up (median follow-up, 6.3 years), 199 women developed dementia, including 159 who developed AD. After adjusting for age, dementia was not clearly associated with length of reproductive period. However, after adjusting for multiple covariates, women with natural menopause and more reproductive years had an increased risk of dementia (adjusted rate ratio [RR] for women with >39 reproductive years [highest quartile] compared with <34 reproductive years [lowest quartile], 1.78; 95 % confidence interval [CI], 1.12-2.84), The adjusted RR per year of increase was 1.04 (95 % CI, 1.01-1.08), For risk of AD, the adjusted RRs were 1.51 (95% CI, 0.91-2.50) and 1.03 (95% CI, 1.00-1.07), respectively. Risk of dementia associated with a longer reproductive period was most pronounced in APOE <epsilon>4 carriers (adjusted RR for >39 reproductive years compared with <34 reproductive years, 4.20 [95% CI, 1.97-8.92] for dementia and 3.42 [95% CI, 1.51-7.75] for AD), whereas in noncarriers, no clear association with dementia or AD was observed. Conclusion Our findings do not support the hypothesis that a longer reproductive period reduces risk of dementia in women who have natural menopause.	Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; NIA, NIH, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Geerlings, MI (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	geerlings@epib.fgg.eur.nl	Breteler, Monique M.B./J-5058-2014; Geerlings, Mirjam I/F-4087-2015	Breteler, Monique M.B./0000-0002-0626-9305; Geerlings, Mirjam I/0000-0002-4037-036X; van Swieten, John/0000-0001-6278-6844				American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; Baldereschi M, 1998, NEUROLOGY, V50, P996, DOI 10.1212/WNL.50.4.996; Barrett-Connor E, 1999, J AM GERIATR SOC, V47, P1289, DOI 10.1111/j.1532-5415.1999.tb07427.x; BARRETTCONNOR E, 1993, JAMA-J AM MED ASSOC, V269, P2637, DOI 10.1001/jama.269.20.2637; Birge SJ, 1996, J AM GERIATR SOC, V44, P865, DOI 10.1111/j.1532-5415.1996.tb03749.x; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Christiansen C, 1990, Osteoporos Int, V1, P7; CLAYTON D, 1996, STAT MODELS EPIDEMIO; Cooper GS, 1998, ANN EPIDEMIOL, V8, P229, DOI 10.1016/S1047-2797(97)00207-X; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; Costa MM, 1999, BIOL PSYCHIAT, V46, P182, DOI 10.1016/S0006-3223(98)00355-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibbs RB, 1998, HORM BEHAV, V34, P98, DOI 10.1006/hbeh.1998.1451; Haskell SG, 1997, J CLIN EPIDEMIOL, V50, P1249, DOI 10.1016/S0895-4356(97)00169-8; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; Henderson VW, 1997, NEUROLOGY, V48, pS27, DOI 10.1212/WNL.48.5_Suppl_7.27S; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Jacobs H. M., 1998, LAND USE LAW ZONING, V50, P3; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Luoto R, 2000, J AM GERIATR SOC, V48, P467, DOI 10.1111/j.1532-5415.2000.tb04990.x; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monk D, 2000, DEMENT GERIATR COGN, V11, P1, DOI 10.1159/000017206; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; Payami H, 1996, AM J HUM GENET, V58, P803; Peters HW, 1999, J INTERN MED, V246, P521, DOI 10.1046/j.1365-2796.1999.00547.x; Rao VS, 1996, AM J HUM GENET, V59, P664; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Skoog I, 1999, J Epidemiol Biostat, V4, P227; Slooter AJC, 1999, J NEUROL NEUROSUR PS, V67, P779, DOI 10.1136/jnnp.67.6.779; SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709, DOI 10.2105/AJPH.79.6.709; Solerte SB, 1999, MATURITAS, V31, P95, DOI 10.1016/S0378-5122(98)00111-X; Srivastava RAK, 1996, BIOCHEM MOL BIOL INT, V38, P91; Steffens DC, 1999, J AM GERIATR SOC, V47, P1171, DOI 10.1111/j.1532-5415.1999.tb05195.x; Szklo M, 1996, AM J EPIDEMIOL, V144, P1048; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3; Yaffe K, 1998, J AM GERIATR SOC, V46, P816, DOI 10.1111/j.1532-5415.1998.tb02713.x	49	92	95	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1475	1481		10.1001/jama.285.11.1475	http://dx.doi.org/10.1001/jama.285.11.1475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410VQ	11255424	Bronze, Green Published			2022-12-01	WOS:000167462100030
J	Post, JC; Goessier, MC				Post, JC; Goessier, MC			Is pacifier use a risk factor for otitis media?	LANCET			English	Editorial Material							SUDDEN-INFANT-DEATH; CHILDREN; DUMMY; COT		Allegheny Gen Hosp, Dept Paediat Otolaryngol, Pittsburgh, PA 15212 USA; Allegheny Gen Hosp, Dept Paediat, Pittsburgh, PA 15212 USA	Allegheny General Hospital; Allegheny General Hospital	Post, JC (corresponding author), Allegheny Gen Hosp, Dept Paediat Otolaryngol, Pittsburgh, PA 15212 USA.							Adair Steven M., 1995, Pediatric Dentistry, V17, P437; Arnestad M, 1997, EUR J PEDIATR, V156, P968, DOI 10.1007/s004310050753; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Brook I, 1997, J LARYNGOL OTOL, V111, P614, DOI 10.1017/S0022215100138113; Fleming PJ, 1999, ARCH DIS CHILD, V81, P112, DOI 10.1136/adc.81.2.112; Jackson Jonathan M., 1999, Pediatric Dentistry, V21, P255; L'Hoir MP, 1999, EUR J PEDIATR, V158, P896, DOI 10.1007/s004310051237; MITCHELL EA, 1993, ARCH DIS CHILD, V68, P501, DOI 10.1136/adc.68.4.501; NIEMELA M, 1995, PEDIATRICS, V96, P884; NIEMELA M, 1994, INT J PEDIATR OTORHI, V29, P121, DOI 10.1016/0165-5876(94)90091-4; Niemela M, 2000, PEDIATRICS, V106, P483, DOI 10.1542/peds.106.3.483; North K, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.3.e34; Ollila P, 1998, ACTA ODONTOL SCAND, V56, P233, DOI 10.1080/00016359850142853; Righard L, 1998, BIRTH-ISS PERINAT C, V25, P128, DOI 10.1046/j.1523-536x.1998.00128.x; SIO JO, 1987, ARCH DIS CHILD, V4, P406	15	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 17	2001	357	9259					823	824		10.1016/S0140-6736(00)04193-3	http://dx.doi.org/10.1016/S0140-6736(00)04193-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265948				2022-12-01	WOS:000167586300006
J	Lee, LM; Karon, JM; Selik, R; Neal, JJ; Fleming, PL				Lee, LM; Karon, JM; Selik, R; Neal, JJ; Fleming, PL			Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; PNEUMOCYSTIS-CARINII PNEUMONIA; NATIONAL DEATH INDEX; ANTIRETROVIRAL THERAPY; HIV-INFECTION; COMPLETENESS; MORTALITY; TIME; CHEMOPROPHYLAXIS; EXPERIENCE	Context Declines in the number of acquired immunodeficiency syndrome (AIDS) deaths were first observed in 1996, attributed to improvements in antiretroviral therapy and an increase in the proportion of persons receiving therapy. Objective To examine national trends in survival time among persons diagnosed as having AIDS in 1984-1997. Design, Setting, and Subjects Retrospective cohort study using data from a population-based registry of AIDS cases and deaths reported in the United States. Main Outcome Measure Months of survival after AIDS diagnosis through December 31, 1998, compared by year of diagnosis. Results Among 394705 persons with an AIDS-defining opportunistic illness (OI) diagnosed in 1984-1997, median survival time improved from 11 months for 1984 diagnoses to 46 months for 1995 diagnoses. Among persons with an OI diagnosed in 1996 and 1997, 67% were alive at least 36 months after diagnosis and 77% were alive at least 24 months after diagnosis, respectively. Among 296621 AIDS cases diagnosed during 1993-1997, 65% were based on immunologic criteria and 35% on OI criteria; 80% were among men; and 42% were among non-Hispanic blacks, 40% among non-Hispanic whites, 17% among Hispanics, 1% among Asians/Pacific islanders, and less than 1% among American Indians/Alaska natives. The probability of surviving at least 24 months increased from 67% for those with immunologic diagnoses in 1993 to 90% in 1997 and from 49% for those with OI diagnoses in 1993 to 80% in 1997, Survival time increased with each year of diagnosis from 1984 to 1997 for blacks, whites, and Hispanics. The greatest annual survival gains occurred among per sons receiving an AIDS diagnosis in 1995 and 1996. Conclusions Survival time after AIDS diagnosis improved from 1984 to 1997, While AIDS incidence is declining, improved survival times present a growing public health challenge as the number of persons living with chronic human immunodeficiency virus disease/AIDS increases.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lee, LM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, MS E-47,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	LMLee@cdc.gov		Lee, Lisa M/0000-0002-3397-3269				AMATO DA, 1988, COMMUN STAT-THEOR M, V17, P263, DOI 10.1080/03610928808829621; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Baillargeon J, 1999, INT J STD AIDS, V10, P22, DOI 10.1258/0956462991913033; BLUM S, 1994, AM J EPIDEMIOL, V139, P351, DOI 10.1093/oxfordjournals.aje.a117007; BUEHLER JW, 1992, J ACQ IMMUN DEF SYND, V5, P257; *CDC, 1981, MMWR-MORBID MORTAL W, V30, P250; *CDCP, 2000, HIV AIDS SURV REP, V12; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P165; CHANG HGH, 1993, AM J EPIDEMIOL, V138, P341, DOI 10.1093/oxfordjournals.aje.a116864; CHU SY, 1993, 9 INT C AIDS JUN 6 1; Collett, 2014, MODELLING SURVIVAL D; CURTIS JR, 1993, AM J PUBLIC HEALTH, V83, P1425, DOI 10.2105/AJPH.83.10.1425; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; EASTERBROOK PJ, 1991, JAMA-J AM MED ASSOC, V266, P2713, DOI 10.1001/jama.266.19.2713; EDLAVITCH SA, 1988, AM J EPIDEMIOL, V127, P1164, DOI 10.1093/oxfordjournals.aje.a114910; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; GREENBERG AE, 1993, JAMA-J AM MED ASSOC, V269, P2995, DOI 10.1001/jama.269.23.2995; HANKINS CA, 1992, J ACQ IMMUN DEF SYND, V5, P957; HARRIS JE, 1990, JAMA-J AM MED ASSOC, V263, P397, DOI 10.1001/jama.263.3.397; JONES JL, 1992, MMWR-MORBID MORTAL W, V48, P1; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; Klevens RM, 1998, INT J EPIDEMIOL, V27, P1105, DOI 10.1093/ije/27.6.1105; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P402, DOI 10.1001/jama.263.3.402; Lobato MN, 1999, J ACQ IMMUN DEF SYND, V22, P71, DOI 10.1097/00042560-199909010-00009; Martins-Corder MP, 1998, SILVAE GENET, V47, P6; McNaghten AD, 1999, AIDS, V13, P1687, DOI 10.1097/00002030-199909100-00012; MONCROFT A, 1996, AIDS, V10, P1057; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peters K D, 1998, Natl Vital Stat Rep, V47, P1; Pezzotti P, 1999, AIDS, V13, P249, DOI 10.1097/00002030-199902040-00013; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; ROSENBLUM L, 1992, AM J PUBLIC HEALTH, V82, P1495, DOI 10.2105/AJPH.82.11.1495; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Solomon L, 1998, J ACQ IMMUN DEF SYND, V17, P253, DOI 10.1097/00042560-199803010-00011; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TU SM, 1993, J ACQ IMMUN DEF SYND, V6, P1150; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; WILLIAMS BC, 1992, AM J PUBLIC HEALTH, V82, P1145, DOI 10.2105/AJPH.82.8.1145	40	145	157	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1308	1315		10.1001/jama.285.10.1308	http://dx.doi.org/10.1001/jama.285.10.1308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255385				2022-12-01	WOS:000167339000022
J	Cranshaw, J; Evans, TW				Cranshaw, J; Evans, TW			Lung volume reduction surgery: a quality operation?	LANCET			English	Editorial Material							SEVERE EMPHYSEMA; OF-LIFE; EXERCISE; COPD		Royal Brompton Hosp, Imperial Coll Sch Med, Crit Care Unit, London SW3 6NP, England	Imperial College London; Royal Brompton Hospital	Evans, TW (corresponding author), Royal Brompton Hosp, Imperial Coll Sch Med, Crit Care Unit, London SW3 6NP, England.	t.evans@rbh.nthames.nhs.uk						BRANTIGAN O C, 1957, Am Surg, V23, P789; Cooper JD, 1996, J THORAC CARDIOV SUR, V112, P1319, DOI 10.1016/S0022-5223(96)70147-2; Cordova F, 1997, CHEST, V112, P907, DOI 10.1378/chest.112.4.907; CURTIS JR, 1994, THORAX, V49, P162, DOI 10.1136/thx.49.2.162; DIMANGO AM, 1996, CHEST S, V110, pS180; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Gelb AF, 1996, CHEST, V110, P1407, DOI 10.1378/chest.110.6.1407; Leyenson N, 2000, CHEST, V118, P728, DOI 10.1378/chest.118.3.728; Malthaner RA, 2000, CAN J SURG, V43, P377; Marchand E, 1999, EUR RESPIR J, V13, P686, DOI 10.1183/09031936.99.13368699; Miller J D, 2000, Can Respir J, V7, P329; Roue C, 1996, CHEST, V110, P28, DOI 10.1378/chest.110.1.28; Russi EW, 1999, EUR RESPIR J, V13, P480, DOI 10.1183/09031936.99.13348099; *STAND CAR COMM BR, 1997, THORAX, V52, pS1; Szekely LA, 1997, CHEST, V111, P550, DOI 10.1378/chest.111.3.550; Utz JP, 1998, MAYO CLIN PROC, V73, P552, DOI 10.4065/73.6.552; YUSEN RD, 1997, AM J RESP CRIT CARE, V155, pA794	17	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					650	651		10.1016/S0140-6736(00)04148-9	http://dx.doi.org/10.1016/S0140-6736(00)04148-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247543				2022-12-01	WOS:000167282400002
J	Bock, JB; Matern, HT; Peden, AA; Scheller, RH				Bock, JB; Matern, HT; Peden, AA; Scheller, RH			A genomic perspective on membrane compartment organization	NATURE			English	Article								Now that whole genome sequences are available for many eukaryotic organisms from yeast to man, we can form broad hypotheses on the basis of the relative expansion of protein families. To investigate the molecular mechanisms responsible for the organization of membrane compartments, we identified members of the SNARE, coat complex, Rab and Sec1 protein families in four eukaryotic genomes. Of these families only the Rab family expanded from the unicellular yeast to the multicellular fly and worm. All families were expanded in humans, where we find 35 SNAREs, 60 Rabs and 53 coat complex subunits. In addition, we were able to resolve the SNARE class of proteins into four distinct subfamilies.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Scheller, RH (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	scheller@cmgm.stanford.edu		Peden, Andrew/0000-0003-0144-7712				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; [Anonymous], 1997, NATURE, V387, pS; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Skolnick J, 2000, NAT BIOTECHNOL, V18, P283, DOI 10.1038/73723; STEIN L, IN PRESS NUCL ACIDS	9	497	523	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					839	841		10.1038/35057024	http://dx.doi.org/10.1038/35057024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237004	Bronze			2022-12-01	WOS:000166938800051
J	Sachidanandam, R; Weissman, D; Schmidt, SC; Kakol, JM; Stein, LD; Marth, G; Sherry, S; Mullikin, JC; Mortimore, BJ; Willey, DL; Hunt, SE; Cole, CG; Coggill, PC; Rice, CM; Ning, ZM; Rogers, J; Bentley, DR; Kwok, PY; Mardis, ER; Yeh, RT; Schultz, B; Cook, L; Davenport, R; Dante, M; Fulton, L; Hillier, L; Waterston, RH; McPherson, JD; Gilman, B; Schaffner, S; Van Etten, WJ; Reich, D; Higgins, J; Daly, MJ; Blumenstiel, B; Baldwin, J; Stange-Thomann, NS; Zody, MC; Linton, L; Lander, ES; Altshuler, D				Sachidanandam, R; Weissman, D; Schmidt, SC; Kakol, JM; Stein, LD; Marth, G; Sherry, S; Mullikin, JC; Mortimore, BJ; Willey, DL; Hunt, SE; Cole, CG; Coggill, PC; Rice, CM; Ning, ZM; Rogers, J; Bentley, DR; Kwok, PY; Mardis, ER; Yeh, RT; Schultz, B; Cook, L; Davenport, R; Dante, M; Fulton, L; Hillier, L; Waterston, RH; McPherson, JD; Gilman, B; Schaffner, S; Van Etten, WJ; Reich, D; Higgins, J; Daly, MJ; Blumenstiel, B; Baldwin, J; Stange-Thomann, NS; Zody, MC; Linton, L; Lander, ES; Altshuler, D		Int SNP Map Working Grp	A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms	NATURE			English	Article							LIPOPROTEIN-LIPASE GENE; COMMON DISEASE GENES; LINKAGE DISEQUILIBRIUM; CANDIDATE GENES; DNA-SEQUENCES; SNP MAP; DIVERSITY; IDENTIFICATION; POPULATIONS; DISCOVERY	We describe a map of 1.42 million single nucleotide polymorphisms (SNPs) distributed throughout the human genome, providing an average density on available sequence of one SNP every 1.9 kilobases. These SNPs were primarily discovered by two projects: The SNP Consortium and the analysis of clone overlaps by the International Human Genome Sequencing Consortium. The map integrates all publicly available SNPs with described genes and other genomic features. We estimate that 60,000 SNPs fall within exon (coding and untranslated regions), and 85% of exons are within 5 kb of the nearest SNP. Nucleotide diversity varies greatly across the genome, in a manner broadly consistent with a standard population genetic model of human history. This high-density SNP map provides a public resource for defining haplotype variation across the genome, and should help to identify biomedically important genes for diagnosis and therapy.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), 9 Cambridge Ctr, Cambridge, MA 02139 USA.	drb@sanger.ac.uk; altshul@genome.wi.mit.edu	Schaffner, Stephen F/D-1189-2011; Ning, Zemin/D-2411-2013; Altshuler, David M/A-4476-2009; Mardis, Elaine/W-2202-2019; Daly, Mark J/B-2453-2017; sachidanandam, ravi/Q-6916-2019; McPherson, John D/D-2633-2017; Kwok, Pui-Yan/F-7725-2014	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; sachidanandam, ravi/0000-0001-9844-4459; McPherson, John D/0000-0001-8049-9347; Kwok, Pui-Yan/0000-0002-5087-3059; Ning, Zemin/0000-0003-4359-776X; Schaffner, Stephen/0000-0001-6699-3568; Schultz, Brian/0000-0003-4964-976X; Hunt, Sarah/0000-0002-8350-1235; Sherry, Stephen/0000-0002-7982-076X	NATIONAL LIBRARY OF MEDICINE [Z01LM000158] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V23, P373, DOI 10.1038/15564; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1999, GENOME RES, V9, P210; COLLINS FS, 1991, CLIN RES, V39, P615; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; Eaves IA, 2000, NAT GENET, V25, P320; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gu ZJ, 1998, HUM MUTAT, V12, P221, DOI 10.1002/(SICI)1098-1004(1998)12:4<221::AID-HUMU1>3.0.CO;2-I; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Horton R, 1998, J MOL BIOL, V282, P71, DOI 10.1006/jmbi.1998.2018; Hudson R, 1991, OXFORD SURVEYS EVOLU, V7, P1; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kimmel M, 1998, GENETICS, V148, P1921; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1991, GENETICS, V129, P513; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; MARTH GT, UNPUB NATURE GENET; MILLER RD, IN PRESS GENOMICS; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Nachman MW, 1998, GENETICS, V150, P1133; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Reich DE, 1998, P NATL ACAD SCI USA, V95, P11026; REICH DE, UNPUB NATURE; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1983, GENETICS, V105, P437; Templeton AR, 2000, GENETICS, V156, P1259; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Yang ZY, 2000, NAT GENET, V26, P13, DOI 10.1038/79113; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	2184	2392	2	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					928	933		10.1038/35057149	http://dx.doi.org/10.1038/35057149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237013	Bronze			2022-12-01	WOS:000166938800060
J	Tupler, R; Perini, G; Green, MR				Tupler, R; Perini, G; Green, MR			Expressing the human genome	NATURE			English	Article							TRANSCRIPTION FACTOR	We have searched the human genome for genes encoding new proteins that may be involved in three nuclear gene expression processes: transcription, pre-messenger RNA splicing and polyadenylation. A plethora of potential new factors are implicated by sequence in nuclear gene expression, revealing a substantial but selective increase in complexity compared with Drosophila melanogaster and Caenorhabditis elegans. Although the raw genomic information has limitations, its availability offers new experimental approaches for studying gene expression.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; Univ Pavia, I-27100 Pavia, Italy; Univ Bologna, Dipartimento Biol Evoluz & Sperimentale, I-40126 Bologna, Italy	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Pavia; University of Bologna	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct, 373 Plantat St, Worcester, MA 01605 USA.		Tupler, Rossella/C-9500-2015	Tupler, Rossella/0000-0002-3797-1789				Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; Burge C.B., 1999, RNA WORLD, V37, P525; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Mount SM, 2000, J CELL BIOL, V150, pF37, DOI 10.1083/jcb.150.2.F37; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Ouellette Michel M., 1995, Current Opinion in Biotechnology, V6, P65, DOI 10.1016/0958-1669(95)80011-5; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2	15	280	290	1	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					832	833		10.1038/35057011	http://dx.doi.org/10.1038/35057011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237001	Bronze			2022-12-01	WOS:000166938800048
J	Elliott, PM; Blanes, JRG; Mahon, NG; Poloniecki, JD; McKenna, WJ				Elliott, PM; Blanes, JRG; Mahon, NG; Poloniecki, JD; McKenna, WJ			Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy	LANCET			English	Article							BLOOD-PRESSURE RESPONSE; SUDDEN CARDIAC DEATH; BINDING PROTEIN-C; TROPONIN-T; EXERCISE; MUTATIONS; FEATURES; EXTENT; RISK; GENE	Background A previous study suggested that severe left-ventricular hypertrophy (maximum wall thickness greater than or equal to 30 mm) in patients with hypertrophic cardiomyopathy is associated with a risk of sudden cardiac death sufficient to warrant consideration for implantation of a cardioverter defibrillator (ICD). However, the prognostic significance of left-ventricular hypertrophy in relation to other clinical risk factors is poorly characterised. Methods We studied 630 patients consecutively referred to one hospital in London, UK (mean age 37 years [SD 16]; 382 male; mean follow-up 59 months). Patients underwent two dimensional and doppler echocardiography, upright exercise testing, and Holter monitoring. Findings 39 patients died suddenly or had an appropriate ICD discharge; nine died from progressive heart failure; 11 from other cardiovascular causes and 23 from non-cardiac causes. There was a trend towards higher probability of sudden death or ICD discharge with increasing wall thickness (p=0.029, relative risk per 5 mm increment 1.31 [95% CI 1.03-1.66]). Of the 39 patients who died suddenly or had an ICD discharge, ten had a wall thickness of 30 mm or more. Patients with wall thickness of 30 mm or more had higher probability of sudden death or ICD discharge than patients with wall thickness less than 30 mm (p=0.049, 2.07 [1.00-4.25]. When considered together, the number of additional risk factors (one to three) was a better predictor of risk of sudden death or ICD discharge than wall thickness (p=0.0001, relative risk per additional factor 2.00 [1.43-2.79] vs p=0.058, 1.26 per 5 mm increment [0.99-1.60]). There was no relation between the pattern of hypertrophy and survival. Interpretation The risk of sudden death associated with a wall thickness of 30 mm or more in patients without other risk factors is insufficient to justify aggressive prophylactic therapy. Most sudden deaths occurred in patients with wall thickness less than 30 mm, so the presence of mild hypertrophy cannot be used to reassure patients that they are at low risk.	Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England	St Georges University London	Elliott, PM (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England.	pelliott@sghms.ac.uk	Elliott, Perry/AAR-3430-2020; McKenna, William J/C-3243-2008; Blanes, Juan R Gimeno/I-4269-2015	Elliott, Perry/0000-0003-3383-3984; McKenna, William J/0000-0001-7994-2460; Blanes, Juan R Gimeno/0000-0001-5818-1754; Mahon, Niall/0000-0002-2872-2297				Charron P, 1998, CIRCULATION, V97, P2230, DOI 10.1161/01.CIR.97.22.2230; COUNIHAN PJ, 1991, CIRCULATION, V84, P686, DOI 10.1161/01.CIR.84.2.686; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; FRENNEAUX MP, 1990, CIRCULATION, V82, P1995, DOI 10.1161/01.CIR.82.6.1995; LOUIE EK, 1986, J AM COLL CARDIOL, V8, P57, DOI 10.1016/S0735-1097(86)80092-4; Maki S, 1998, AM J CARDIOL, V82, P774, DOI 10.1016/S0002-9149(98)00455-X; MARON BJ, 1981, AM J CARDIOL, V48, P252, DOI 10.1016/0002-9149(81)90604-4; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; MARON BJ, 1982, CIRCULATION, V65, P1388, DOI 10.1161/01.CIR.65.7.1388; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; MCKENNA WJ, 1981, BRIT HEART J, V46, P168; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; NakajimaTaniguchi C, 1997, J MOL CELL CARDIOL, V29, P839, DOI 10.1006/jmcc.1996.0322; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Oliveira VLL, 1999, HYPERTENSION, V33, P1086; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; SHAPIRO LM, 1983, J AM COLL CARDIOL, V2, P437, DOI 10.1016/S0735-1097(83)80269-1; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; SPIRITO P, 1990, J AM COLL CARDIOL, V15, P1521, DOI 10.1016/0735-1097(90)92820-R; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WIGLE ED, 1985, PROG CARDIOVASC DIS, V28, P1, DOI 10.1016/0033-0620(85)90024-6	24	317	337	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					420	424		10.1016/S0140-6736(00)04005-8	http://dx.doi.org/10.1016/S0140-6736(00)04005-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273061				2022-12-01	WOS:000166865600010
J	Hartmann, C; Tabin, CJ				Hartmann, C; Tabin, CJ			Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton	CELL			English	Article							REPLICATION-COMPETENT RETROVIRUSES; PROGRAMMED CELL-DEATH; TGF-BETA-SUPERFAMILY; CHICK LIMB BUD; CARTILAGE DIFFERENTIATION; VERTEBRATE LIMB; GENE-EXPRESSION; METATARSOPHALANGEAL JOINT; PATTERN-FORMATION; DIGIT DEVELOPMENT	The long bones of the vertebrate appendicular skeleton arise from initially continuous condensations of mesenchymal cells that subsequently segment and cavitate to form discrete elements separated by synovial joints, tittle is known, however, about the molecular mechanisms of joint formation. We present evidence that Wnt-14 plays a central role in initiating synovial joint formation in the chick limb. Wnt-14 is expressed in joint-forming regions prior to the segmentation of the cartilage elements, and local misexpression of Wnt-14 induces morphological and molecular changes characteristic of the first steps of joint formation. Induction of an ectopic joint-like region by Wnt-14 suppresses the formation of the immediately adjacent endogenous joint, potentially providing insight into the spacing of joints.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@rascal.med.harvard.edu		Hartmann, Christine/0000-0002-6854-8633				AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; ALLEN T. C., 1994, LAB METHODS HISTOTEC, P53; Arias AM, 1999, CURR OPIN GENET DEV, V9, P447, DOI 10.1016/S0959-437X(99)80068-9; Bachner D, 1999, MECH DEVELOP, V84, P121, DOI 10.1016/S0925-4773(99)00048-9; BALLARD KJ, 1968, J CELL SCI, V3, P245; Bergstein I, 1997, GENOMICS, V46, P450, DOI 10.1006/geno.1997.5041; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; EDWARDS JCW, 1994, J ANAT, V185, P355; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; GAFFNEY E, 1994, LAB METHODS HISTOTEC, P149; Goff DJ, 1997, DEVELOPMENT, V124, P627; GRUNEBERG H, 1973, J EMBRYOL EXP MORPH, V30, P119; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4; Hall BK, 1995, INT J DEV BIOL, V39, P881; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Healy C, 1996, ANN NY ACAD SCI, V785, P261, DOI 10.1111/j.1749-6632.1996.tb56278.x; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; HINCHLIFFE JR, 1994, DEVELOPMENT, P163; HOLDER N, 1977, J EMBRYOL EXP MORPH, V39, P115; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Hurle JM, 1996, ANAT EMBRYOL, V193, P355; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; IZPISUABELMONTE JC, 1992, DEV BIOL, V152, P26, DOI 10.1016/0012-1606(92)90153-8; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kimura S, 1996, J MORPHOL, V229, P337, DOI 10.1002/(SICI)1097-4687(199609)229:3<337::AID-JMOR8>3.0.CO;2-V; KOYAMA E, 1995, DEV DYNAM, V203, P152, DOI 10.1002/aja.1002030204; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; LANDAUER W, 1952, J HERED, V43, P293, DOI 10.1093/oxfordjournals.jhered.a106335; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MITROVIC DR, 1977, AM J ANAT, V150, P333, DOI 10.1002/aja.1001500207; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MORI C, 1995, ANAT REC, V242, P103, DOI 10.1002/ar.1092420114; NAH HD, 1988, COLLAGEN REL RES, V8, P277; NALIN AM, 1995, DEV DYNAM, V203, P352, DOI 10.1002/aja.1002030307; OSTER GF, 1988, EVOLUTION, V42, P862, DOI 10.1111/j.1558-5646.1988.tb02508.x; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856; PITSILLIDES AA, 1999, BIOL SYNOVIAL JOINT, P41; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; ROS MA, 1995, ANAT EMBRYOL, V192, P483; Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536; Schweitzer R, 2000, MECH DEVELOP, V98, P171, DOI 10.1016/S0925-4773(00)00458-5; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Stott NS, 1999, J CELL PHYSIOL, V180, P314, DOI 10.1002/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.3.CO;2-P; SWIDERSKI RE, 1992, DEVELOPMENT, V115, P169; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Wada N, 1999, INT J DEV BIOL, V43, P495; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; WOLPERT L, 1990, J CELL SCI, P199; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu LF, 2000, GENE DEV, V14, P585; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; ZAKANY J, 1993, NATURE, V362, P546, DOI 10.1038/362546a0; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	72	371	383	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					341	351		10.1016/S0092-8674(01)00222-7	http://dx.doi.org/10.1016/S0092-8674(01)00222-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239392	Bronze			2022-12-01	WOS:000167003100005
J	Root, MJ; Kay, MS; Kim, PS				Root, MJ; Kay, MS; Kim, PS			Protein design of an HIV-1 entry inhibitor	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COILED-COIL; POTENT INHIBITORS; SYNTHETIC PEPTIDE; ENVELOPE GLYCOPROTEIN; ATOMIC-STRUCTURE; GP41; FUSION; DOMAIN; EPITOPE	Human immunodeficiency virus type-1 (HIV-1) membrane fusion is promoted by the formation of a trimer-of-hairpins structure that brings the amino- and carboxyl-terminal regions of the gp41 envelope glycoprotein ectodomain into close proximity. Peptides derived from the carboxyl-terminal region (called C-peptides) potently inhibit HIV-1 entry by binding to the gp41 amino-terminal region. To test the converse of this inhibitory strategy, we designed a small protein, denoted 5-Helix, that binds the C-peptide region of gp41. The 5-Helix protein displays potent (nanomolar) inhibitory activity against diverse HIV-1 variants and may serve as the basis for a new class of antiviral agents. The inhibitory activity of 5-Helix also suggests a strategy for generating an HIV-1 neutralizing antibody response that targets the carboxyl-terminal region of the gp41 ectodomain.	MIT, Dept Biol, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Kim, PS (corresponding author), Merck Res Labs, 770 Sumneytown Pike, W Point, PA 19486 USA.				NIGMS NIH HHS [P01 GM56552] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056552] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER S, 1984, SCIENCE, V226, P1328, DOI 10.1126/science.6505693; [Anonymous], UNPUB; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chang KM, 1998, MICROSYST TECHNOL, V5, P93, DOI 10.1007/s005420050148; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; HUGHSON FM, 1997, CURR BIOL, V7, P565; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; PAI E, 2000, Patent No. 0061618; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; RAPAPORT D, 1995, EMBO J, V14, P5524, DOI 10.1002/j.1460-2075.1995.tb00239.x; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; ROOT MJ, UNPUB; Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yao QZ, 1996, VIROLOGY, V223, P103, DOI 10.1006/viro.1996.0459; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	37	360	415	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					884	888		10.1126/science.1057453	http://dx.doi.org/10.1126/science.1057453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11229405				2022-12-01	WOS:000166771700048
J	Burkholder, WF; Kurtser, I; Grossman, AD				Burkholder, WF; Kurtser, I; Grossman, AD			Replication initiation proteins regulate a developmental checkpoint in Bacillus subtilis	CELL			English	Article							ESCHERICHIA-COLI; DNAA PROTEIN; CHROMOSOMAL REPLICATION; TRANSCRIPTION FACTOR; NUCLEOTIDE-SEQUENCE; SENSOR KINASE; SPORULATION; GENE; SPO0A; KINC	We identified a signaling pathway that prevents initiation of sporulation in Bacillus subtillis when replication initiation Is impaired. We isolated mutations that allow a replication initiation mutant (dnaA) to sporulate. These mutations affect a small open reading frame, sda, that was overexpressed in replication initiation mutants and appears to be directly regulated by DnaA. Mutations in replication initiation genes inhibit the onset of sporulation by preventing activation of a transcription factor required for sporulation, Spo0A. Deletion of sda restored activation of Spo0A in replication initiation mutants. Overexpression of sda in otherwise wild-type cells inhibited activation of Spo0A and sporulation. Purified Sda inhibited a histidine kinase needed for activation of Spo0A. Our results indicate that control of sda by DnaA establishes a checkpoint that inhibits activation of Spo0 and prevents futile attempts to initiate sporulation.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68,Room 530, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041934, R37GM041934] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONIEWSKI C, 1990, J BACTERIOL, V172, P86, DOI 10.1128/JB.172.1.86-93.1990; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; BRUAND C, 1995, MICROBIOL-UK, V141, P321, DOI 10.1099/13500872-141-2-321; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burkholder WF, 2000, PROKARYOTIC DEVELOPMENT, P151; Christensen BB, 1999, J BACTERIOL, V181, P2683, DOI 10.1128/JB.181.9.2683-2688.1999; DAWES IW, 1970, J BACTERIOL, V103, P529, DOI 10.1128/JB.103.3.529-535.1970; DUNN G, 1978, J GEN MICROBIOL, V108, P189, DOI 10.1099/00221287-108-2-189; FUKUOKA T, 1990, J BIOCHEM-TOKYO, V107, P732, DOI 10.1093/oxfordjournals.jbchem.a123117; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Garnerone AM, 1999, J BIOL CHEM, V274, P32500, DOI 10.1074/jbc.274.45.32500; GARRITY DB, 1993, J BACTERIOL, V175, P6512, DOI 10.1128/jb.175.20.6512-6517.1993; GROSS JD, 1968, COLD SPRING HARB SYM, V33, P307, DOI 10.1101/SQB.1968.033.01.034; GUZMAN P, 1988, J BACTERIOL, V170, P1598, DOI 10.1128/jb.170.4.1598-1609.1988; HANSEN FG, 1991, RES MICROBIOL, V142, P161, DOI 10.1016/0923-2508(91)90025-6; Harwood C.R., 1990, MOL BIOL METHODS BAC; HAUSER PM, 1995, J BACTERIOL, V177, P3923, DOI 10.1128/jb.177.14.3923-3931.1995; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; IRETON K, 1992, P NATL ACAD SCI USA, V89, P8808, DOI 10.1073/pnas.89.18.8808; IRETON K, 1994, EMBO J, V13, P1566, DOI 10.1002/j.1460-2075.1994.tb06419.x; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; KARAMATA D, 1970, MOL GEN GENET, V108, P277, DOI 10.1007/BF00283358; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; KEYNAN A, 1976, J BACTERIOL, V128, P8, DOI 10.1128/JB.128.1.8-14.1976; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; KOBAYASHI K, 1995, J BACTERIOL, V177, P176, DOI 10.1128/jb.177.1.176-182.1995; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Lemon KP, 2000, J BACTERIOL, V182, P2989, DOI 10.1128/JB.182.10.2989-2991.2000; Levin PA, 2000, PROKARYOTIC DEVELOPMENT, P167; MANDELSTAM J, 1971, BIOCHEM J, V125, P635, DOI 10.1042/bj1250635; MANDELSTAM J, 1974, J BACTERIOL, V120, P38, DOI 10.1128/JB.120.1.38-42.1974; Messer W, 1997, MOL MICROBIOL, V24, P1, DOI 10.1046/j.1365-2958.1997.3171678.x; Messer W., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1579; Miller JH., 1972, EXPT MOL GENETICS; MORIYA S, 1990, EMBO J, V9, P2905, DOI 10.1002/j.1460-2075.1990.tb07481.x; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; OGASAWARA N, 1986, NUCLEIC ACIDS RES, V14, P9989, DOI 10.1093/nar/14.24.9989; PEREGO M, 1989, J BACTERIOL, V171, P6187, DOI 10.1128/jb.171.11.6187-6196.1989; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; TRACH KA, 1993, MOL MICROBIOL, V8, P69, DOI 10.1111/j.1365-2958.1993.tb01204.x; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; WINSTON S, 1980, P NATL ACAD SCI-BIOL, V77, P2834, DOI 10.1073/pnas.77.5.2834; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; Yoshiakwa H., 1993, P507; Zapf J, 1998, BIOCHEMISTRY-US, V37, P7725, DOI 10.1021/bi9729615	54	155	162	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					269	279		10.1016/S0092-8674(01)00211-2	http://dx.doi.org/10.1016/S0092-8674(01)00211-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207367	Bronze, Green Published			2022-12-01	WOS:000166879700010
J	Marmorstein, LY; Kinev, AV; Chan, GKT; Bochar, DA; Beniya, H; Epstein, JA; Yen, TJ; Shiekhattar, R				Marmorstein, LY; Kinev, AV; Chan, GKT; Bochar, DA; Beniya, H; Epstein, JA; Yen, TJ; Shiekhattar, R			A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression	CELL			English	Article							SUSCEPTIBILITY GENE BRCA2; CHROMOSOME CONDENSATION; OVARIAN-CANCER; NUCLEAR MATRIX; RAD51 PROTEIN; CENP-F; BREAST; MUTATIONS; MICE; INTERACTS	Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.	Wistar Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	The Wistar Institute; University of Pennsylvania; Fox Chase Cancer Center	Shiekhattar, R (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Bochar, Daniel A/A-9224-2009; Kinev, Alexander V/K-3970-2013; Chan, Gordon/AAN-7784-2020	Chan, Gordon/0000-0003-0497-9407; Yen, Tim/0000-0003-2159-0997				Aguilera A, 2000, YEAST, V16, P731, DOI 10.1002/1097-0061(20000615)16:8<731::AID-YEA586>3.0.CO;2-L; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; COLLINS N, 1995, ONCOGENE, V10, P1673; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; EASTON DF, 1993, AM J HUM GENET, V52, P678; Friedman LS, 1998, CANCER RES, V58, P1338; Goggins M, 1996, CANCER RES, V56, P5360; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; JENKINS RB, 1993, CANCER GENET CYTOGEN, V71, P76, DOI 10.1016/0165-4608(93)90205-Z; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; LUTZ B, 1994, DEVELOPMENT, V120, P25, DOI 10.1242/dev.120.1.25; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; NICKERSON JA, 1990, P NATL ACAD SCI USA, V87, P2259, DOI 10.1073/pnas.87.6.2259; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang ZJ, 1999, BRIT J CANCER, V80, P70, DOI 10.1038/sj.bjc.6690323; Wattler F, 1999, GENOMICS, V60, P172, DOI 10.1006/geno.1999.5913; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yu VPCC, 2000, GENE DEV, V14, P1400	42	116	119	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					247	257		10.1016/S0092-8674(01)00209-4	http://dx.doi.org/10.1016/S0092-8674(01)00209-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207365	Bronze			2022-12-01	WOS:000166879700008
J	McSween, HY; Grove, TL; Lentz, RCF; Dann, JC; Holzheid, AH; Riciputi, LR; Ryan, JG				McSween, HY; Grove, TL; Lentz, RCF; Dann, JC; Holzheid, AH; Riciputi, LR; Ryan, JG			Geochemical evidence for magmatic water within Mars from pyroxenes in the Shergotty meteorite	NATURE			English	Article							SNC METEORITES; MANTLE; H2O; CONSTRAINTS; SUBDUCTION; ERUPTION; LITHIUM; BORON; MODEL	Observations of martian surface morphology have been used to argue that an ancient ocean once existed on Mars(1). It has been thought that significant quantities of such water could have been supplied to the martian surface through volcanic outgassing, but this suggestion is contradicted by the low magmatic water content that is generally inferred from chemical analyses of igneous martian meteorites(2). Here, however, we report the distributions of trace elements within pyroxenes of the Shergotty meteorite-a basalt body ejected 175 million years ago from Mars(3) - as well as hydrous and anhydrous crystallization experiments that, together, imply that water contents of pre-eruptive magma on Mars could have been up to 1.8%. We found that in the Shergotty meteorite, the inner cores of pyroxene minerals (which formed at depth in the martian crust) are enriched in soluble trace elements when compared to the outer rims (which crystallized on or near to the martian surface). This implies that water was present in pyroxenes at depth but was largely lost as pyroxenes were carried to the surface during magma ascent. We conclude that ascending magmas possibly delivered significant quantities of water to the martian surface in recent times, reconciling geologic and petrologic constraints on the outgassing history of Mars.	Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Oak Ridge Natl Lab, Div Chem & Analyt Sci, Oak Ridge, TN 37831 USA; Univ S Florida, Dept Geol, Tampa, FL 33620 USA	University of Tennessee System; University of Tennessee Knoxville; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Oak Ridge National Laboratory; State University System of Florida; University of South Florida	McSween, HY (corresponding author), Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA.	mcsween@utk.edu	Holzheid, Astrid/S-5513-2018; Grove, Timothy/M-9638-2013	Holzheid, Astrid/0000-0001-5154-9886; Grove, Timothy/0000-0003-0628-1969; Ryan, Jeffrey/0000-0003-3969-1761				ANDERSEN DJ, 1993, COMPUT GEOSCI, V19, P1333, DOI 10.1016/0098-3004(93)90033-2; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Brenan JM, 1998, GEOCHIM COSMOCHIM AC, V62, P3337, DOI 10.1016/S0016-7037(98)00224-5; Hale VPS, 1999, GEOCHIM COSMOCHIM AC, V63, P1459, DOI 10.1016/S0016-7037(99)00095-2; HAMILTON DL, 1964, J PETROL, V5, P21, DOI 10.1093/petrology/5.1.21; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Herd CDK, 2000, METEORIT PLANET SCI, V35, pA70; JOHNSON MC, 1991, GEOCHIM COSMOCHIM AC, V55, P349, DOI 10.1016/0016-7037(91)90423-3; JONES JH, 1989, P LUNAR PLANET SCI C, V19, P465; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; King PL, 1999, GEOCHIM COSMOCHIM AC, V63, P3635, DOI 10.1016/S0016-7037(99)00162-3; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; LONGHI J, 1991, P LUNAR PLANET SCI, V21, P695; McCoy TJ, 1999, EARTH PLANET SC LETT, V173, P397, DOI 10.1016/S0012-821X(99)00241-1; MCKAY G, 2000, LUNAR PLANET SCI, P31; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MCSWEEN HY, 1993, SCIENCE, V259, P1890, DOI 10.1126/science.259.5103.1890; Minitti ME, 2000, GEOCHIM COSMOCHIM AC, V64, P2535, DOI 10.1016/S0016-7037(00)00366-5; Moore G, 1998, AM MINERAL, V83, P36; Mouginis-Mark P.J., 1992, MARS PP, P424; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; Mysen BO, 1998, AM MINERAL, V83, P942; NEAL CR, 1989, GEOCHIM COSMOCHIM AC, V53, P1035, DOI 10.1016/0016-7037(89)90208-1; NEWMAN S, 1988, J VOLCANOL GEOTH RES, V35, P75, DOI 10.1016/0377-0273(88)90007-8; SEYFRIED WE, 1984, GEOCHIM COSMOCHIM AC, V48, P557, DOI 10.1016/0016-7037(84)90284-9; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; WILSON L, 1981, J GEOPHYS RES, V86, P2971, DOI 10.1029/JB086iB04p02971	30	157	158	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					487	490		10.1038/35054011	http://dx.doi.org/10.1038/35054011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206539				2022-12-01	WOS:000166570500040
J	Laurance, WF; Cochrane, MA; Bergen, S; Fearnside, PM; Delamonica, P; Barber, C; D'Angelo, S; Fernandes, T				Laurance, WF; Cochrane, MA; Bergen, S; Fearnside, PM; Delamonica, P; Barber, C; D'Angelo, S; Fernandes, T			Environment - The future of the Brazilian Amazon	SCIENCE			English	Editorial Material							FORESTS; RESPONSES		Smithsonian Trop Res Inst, Balboa, Panama; Natl Inst Amazonian Res, BDFFP, BR-69011970 Manaus, Amazonas, Brazil; Michigan State Univ, BSRSI, E Lansing, MI 48823 USA; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; INPA, Dept Ecol, BR-69011970 Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia; Michigan State University; Oregon State University; Institute Nacional de Pesquisas da Amazonia	Laurance, WF (corresponding author), Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama.		Cochrane, Mark A/A-1735-2018; Laurance, William F/B-2709-2012; Fearnside, Philip M/GQA-6023-2022; Fearnside, Philip M/D-6559-2011	Cochrane, Mark A/0000-0002-4573-568X; Laurance, William F/0000-0003-4430-9408; Fearnside, Philip M/0000-0003-3672-9082; Fearnside, Philip M/0000-0003-3672-9082; Fernandes, Tito/0000-0001-6556-581X				[Anonymous], 2000, DEFORESTATION ESTIMA; FEARNSIDE PM, 1989, BIOSCIENCE, V39, P387, DOI 10.2307/1311068; Fearnside PM, 1999, BIOMASS BIOENERG, V16, P171, DOI 10.1016/S0961-9534(98)00071-3; Fearnside PM, 1997, ECOL ECON, V20, P53, DOI 10.1016/S0921-8009(96)00066-3; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; GOODMAN G, 1990, FUTURE AMAZONIA DEST; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Laurance WF, 1998, TRENDS ECOL EVOL, V13, P411, DOI 10.1016/S0169-5347(98)01433-5; Laurance WF, 1999, TRENDS ECOL EVOL, V14, P457, DOI 10.1016/S0169-5347(99)01731-0; Nepstad D., 1999, FLAMES RAIN FOREST O; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439	12	555	592	3	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					438	439		10.1126/science.291.5503.438	http://dx.doi.org/10.1126/science.291.5503.438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228139				2022-12-01	WOS:000166487500023
J	Tanaka, M; Lisberger, SG				Tanaka, M; Lisberger, SG			Regulation of the gain of visually guided smooth-pursuit eye movements by frontal cortex	NATURE			English	Article							MONKEYS; FIELD; MICROSTIMULATION; RESPONSES; ATTENTION; MECHANISMS; SELECTION; SACCADES; AREA; MT	In studies of the neural mechanisms giving rise to behaviour, changes in the neural and behavioural responses produced by a given stimulus have been widely reported. This `gain control' can boost the responses to sensory inputs that are particularly relevant(1-4), select among reflexes for execution by motoneurons(5,6) or emphasize specific movement targets(7). Gain control is also an integral part of the smooth-pursuit eye movement system(8-13). One signature of gain control is that a brief perturbation of a stationary target during fixation causes tiny eye movements, whereas the same perturbation of a moving target during the active state of accurate pursuit causes large responses(9). Here we show that electrical stimulation of the smooth-pursuit eye movement region in the arcuate sulcus of the frontal lobe (`the frontal pursuit area', FPA) mimics the active state of pursuit. Such stimulation enhances the response to a brief perturbation of target motion, regardless of the direction of motion. We postulate that the FPA sets the gain of pursuit, thereby participating in target selection for pursuit.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tanaka, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.		Tanaka, Masaki/D-9199-2011	Tanaka, Masaki/0000-0002-6177-1314				ADLER SA, 2000, SOC NEUR ABSTR, V26, P1716; CARL JR, 1987, J NEUROPHYSIOL, V57, P1446, DOI 10.1152/jn.1987.57.5.1446; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563, DOI 10.1152/jn.2000.83.1.563; Gardner J. L., 1999, Society for Neuroscience Abstracts, V25, P1398; GOLDBERG ME, 1989, NEUROBIOLOGY SACCADI, V3, P283; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; GRASSE KL, 1992, J NEUROPHYSIOL, V67, P164, DOI 10.1152/jn.1992.67.1.164; Groh JM, 1997, J NEUROSCI, V17, P4312; Keating EG, 1996, BEHAV BRAIN RES, V81, P173, DOI 10.1016/S0166-4328(96)89078-4; KEATING EG, 1991, EXP BRAIN RES, V86, P311; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; Krauzlis RJ, 1998, J NEUROPHYSIOL, V80, P2046, DOI 10.1152/jn.1998.80.4.2046; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P1622, DOI 10.1152/jn.1996.76.3.1622; Krauzlis RJ, 1999, J COGNITIVE NEUROSCI, V11, P641, DOI 10.1162/089892999563706; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MAY J G, 1985, Society for Neuroscience Abstracts, V11, P79; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Roy JE, 1998, NAT NEUROSCI, V1, P404, DOI 10.1038/1619; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHWARTZ JD, 1994, VISUAL NEUROSCI, V11, P411, DOI 10.1017/S0952523800002352; Shi DX, 1998, J NEUROPHYSIOL, V80, P458, DOI 10.1152/jn.1998.80.1.458; Tanaka M, 1998, J NEUROPHYSIOL, V80, P28, DOI 10.1152/jn.1998.80.1.28; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745	30	128	130	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					191	194		10.1038/35051582	http://dx.doi.org/10.1038/35051582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196642				2022-12-01	WOS:000166316200044
J	Nakayam, J; Rice, JC; Strahl, BD; Allis, CD; Grewal, SIS				Nakayam, J; Rice, JC; Strahl, BD; Allis, CD; Grewal, SIS			Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly	SCIENCE			English	Article							FISSION YEAST; PROTEIN; CHROMOSOME; DOMAINS; ACETYLATION; INHERITANCE; DROSOPHILA; MUTATIONS; HOMOLOGS; REPEATS	The assembly of higher order chromatin structures has been Linked to the covalent modifications of histone tails. We provide in vivo evidence that lysine 9 of histone H3 (H3 Lys(9)) is preferentially methylated by the Clr4 protein at heterochromatin-associated regions in fission yeast. Both the conserved chromo- and SET domains of Clr4 are required for H3 Lys(9) methylation in vivo. Localization of Swi6, a homolog of Drosophila HP1, to heterochomatic regions is dependent on H3 Lysg methylation. Moreover, an H3-specific deacetylase Clr3 and a beta -propeller domain protein Rik1 are required for H3 Lys(9) methylation by Clr4 and Swi6 Localization. These data define a conserved pathway wherein sequential histone modifications establish a "histone code" essential for the epigenetic inheritance of heterochromatin assembly.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	grewal@cshl.org	Rice, Judd C/B-7806-2009; Nakayama, Jun-ichi/C-6003-2011; Strahl, Brian/C-7601-2012; jia, xu/A-8386-2016	Nakayama, Jun-ichi/0000-0002-5597-8239; Strahl, Brian/0000-0002-4947-6259; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R37GM053512, R01GM059772] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53512, GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLIS CD, UNPUB; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.3.CO;2-4; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NAKAYAMA J, UNPUB; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Partridge JF, 2000, GENE DEV, V14, P783; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; THON G, 1994, GENETICS, V138, P29; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Holde KE., 1989, SPRINGER SERIES MOL; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000	28	1311	1356	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					110	113		10.1126/science.1060118	http://dx.doi.org/10.1126/science.1060118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11283354				2022-12-01	WOS:000167995200050
J	Delaney, BC				Delaney, BC			10-minute consultation - Dyspepsia	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Delaney, BC (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England.		Delaney, Brendan C/C-5578-2008	Delaney, Brendan/0000-0002-3518-0131				DELANEY BC, 2000, COCHRANE DATABASE SY; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; SOO S, 2000, COCHRANE DATABASE SY; VANPINXTEREN B, 2000, COCHRANE DATABASE SY	4	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					776	776		10.1136/bmj.322.7289.776	http://dx.doi.org/10.1136/bmj.322.7289.776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282866	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000167943200029
J	Schwartz, JCD; Zhang, XW; Fedorov, AA; Nathenson, SG; Almo, SC				Schwartz, JCD; Zhang, XW; Fedorov, AA; Nathenson, SG; Almo, SC			Structural basis for co-stimulation by the human CTLA-4/B7-2 complex	NATURE			English	Article							COUNTER-RECEPTORS CD80; PROTEIN MODELS; SOLUBLE FORM; CD28; BINDING; DIMERIZATION; RECOGNITION; ACTIVATION; B7-1; SITE	Regulation of T-cell activity is dependent on antigen-independent co-stimulatory signals provided by the disulphide-linked homodimeric T-cell surface receptors, CD28 and CTLA-4 (ref, 1), Engagement of CD28 with B7-1 and B7-2 ligands on antigen-presenting cells (APCs) provides a stimulatory signal for T-cell. activation, whereas subsequent engagement of CTLA-4 with these I same ligands results in attenuation of the response(1). Given their central function in immune modulation, CTLA-4- and CD28- associated signalling pathways are primary therapeutic targets for preventing autoimmune disease, graft versus host disease, graft rejection and promoting tumour immunity(1,2). However, little is known about the cell-surface organization of these receptor/ ligand complexes and the structural basis for signal transduction, Here we report the 3.2-Angstrom resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2. The unusual dimerization properties of both CTLA-4 and B7-2 place their respective ligand-binding sites distal to the dimer interface in each molecule and promote the formation of an alternating arrangement of bivalent CTLA-4 and B7-2 dimers that extends throughout the crystal. Direct observation of this CTLA-4/B7-2 network provides a model for the periodic organization of these molecules within the immunological synapse and suggests a distinct mechanism for signalling by dimeric cell-surface receptors.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Almo, SC (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu; almo@aecom.yu.edu	Schwartz, Jean-Claude/U-3163-2019					BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kariv I, 1996, J IMMUNOL, V157, P29; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Morton PA, 1996, J IMMUNOL, V156, P1047; Najafian N, 2000, EXPERT OPIN INV DRUG, V9, P2147, DOI 10.1517/13543784.9.9.2147; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Truneh A, 1996, MOL IMMUNOL, V33, P321, DOI 10.1016/0161-5890(95)00077-1; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wilson IA, 1999, CURR OPIN STRUC BIOL, V9, P696, DOI 10.1016/S0959-440X(99)00032-9; [No title captured]	32	249	300	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					604	608		10.1038/35069112	http://dx.doi.org/10.1038/35069112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279501				2022-12-01	WOS:000167859300053
J	Bebenek, K; Tissier, A; Frank, EG; McDonald, JP; Prasad, R; Wilson, SH; Woodgate, R; Kunkel, TA				Bebenek, K; Tissier, A; Frank, EG; McDonald, JP; Prasad, R; Wilson, SH; Woodgate, R; Kunkel, TA			5 '-Deoxyribose phosphate lyase activity of human DNA polymerase iota in vitro	SCIENCE			English	Article							BASE EXCISION-REPAIR; ESCHERICHIA-COLI; BETA; SITE; FIDELITY; ENZYME; IDENTIFICATION; MUTAGENESIS; BYPASS	DNA polymerase iota (pol iota) is one of several recently discovered DNA polymerases in mammalian cells whose function is unknown. We report here that human pol iota has an intrinsic 5'-deoxyribose phosphate (dRP) Lyase activity. In reactions reconstituted with uracil-DNA glycosylase (UDC), apurinic/apyrimidinic (AP) endonuclease and DNA Ligase I, pol iota can use its dRP Lyase and polymerase activities to repair G . U and A . U pairs in DNA, These data and three distinct catalytic properties of pol iota implicate it in specialized forms of base excision repair (BER).	NIEHS, Genet Mol Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kunkel, TA (corresponding author), NIEHS, Genet Mol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Wilson, Samuel H/E-6644-2019; Tissier, Agnes/I-4850-2018	Kunkel, Thomas A./0000-0002-9900-1788; Wilson, Samuel H/0000-0002-1702-5293; Woodgate, Roger/0000-0001-5581-4616; TISSIER, Agnes/0000-0002-5676-8719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, ZIAES065070, ZIAES050158, Z01ES050158] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Deterding LJ, 2000, J BIOL CHEM, V275, P10463, DOI 10.1074/jbc.275.14.10463; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Gerlach VL, 2001, J BIOL CHEM, V276, P92, DOI 10.1074/jbc.M004413200; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; LU AL, 1988, CELL, V54, P805, DOI 10.1016/S0092-8674(88)91109-9; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Mullen GP, 1997, BIOCHEMISTRY-US, V36, P4713, DOI 10.1021/bi962363a; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Wilson SH, 2000, COLD SPRING HARB SYM, V65, P143, DOI 10.1101/sqb.2000.65.143; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	27	163	173	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2156	2159		10.1126/science.1058386	http://dx.doi.org/10.1126/science.1058386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251121	Green Published			2022-12-01	WOS:000167563800041
J	Jolly, A				Jolly, A			Monkeys in the back garden	SCIENCE			English	Editorial Material									Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Jolly, A (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.								0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1705	1706		10.1126/science.1057629	http://dx.doi.org/10.1126/science.1057629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253192				2022-12-01	WOS:000167320600028
J	Mao, YX; Chen, J; Maynard, JA; Zhang, B; Quiocho, FA				Mao, YX; Chen, J; Maynard, JA; Zhang, B; Quiocho, FA			A novel all helix fold of the AP180 amino-terminal domain for phosphoinositide binding and clathrin assembly in synaptic vesicle endocytosis	CELL			English	Article							TRANSMITTER RELEASE; CRYSTAL-STRUCTURE; PROTEIN; AP-3; LOCALIZATION; MEMBRANE; ADAPTER; COMPLEX; SIZE; IDENTIFICATION	Clathrin-mediated endocytosis plays a major role in retrieving synaptic Vesicles from the plasma membrane following exocytosis. This endocytic process requires AP180 (or a homolog), which promotes the assembly and restricts the size of clathrin-coated vesicles. The highly conserved 33 kDa amino-terminal domain of AP180 plays a critical role in binding to phosphoinositides and in regulating the clathrin assembly activity of AP180. The crystal structure of the aminoterminal domain reported herein reveals a never fold consisting of a large double layer of sheets of ten alpha helices and a unique site for binding phosphoinositides. The finding that the clathrin-box motif is mostly buried and lies in a helix indicates a different site and mechanism for binding of the domain to clathrins than previously assumed.	Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Inst Neurosci, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Quiocho, FA (corresponding author), Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA.	faq@bcm.tmc.edu		Mao, Yuxin/0000-0002-5064-1397				AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang KM, 1999, EMBO J, V18, P3897, DOI 10.1093/emboj/18.14.3897; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morgan JR, 1999, J NEUROSCI, V19, P10201; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; MURPHY JE, 1991, J BIOL CHEM, V266, P4401; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SOUSA R, 1992, J NEUROSCI, V12, P2130; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; YE WL, 1995, J BIOL CHEM, V270, P10933, DOI 10.1074/jbc.270.18.10933; Zhang B, 1999, NEURON, V23, P419, DOI 10.1016/S0896-6273(00)80794-1; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHANG B, 1999, FRONTIERS MOL BIOL N, P389	50	71	73	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					433	440		10.1016/S0092-8674(01)00230-6	http://dx.doi.org/10.1016/S0092-8674(01)00230-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239400	Bronze			2022-12-01	WOS:000167003100013
J	Yamaguchi, S; Kobayashi, M; Mitsui, S; Ishida, Y; van der Horst, GTJ; Suzuki, M; Shibatall, S; Okamura, H				Yamaguchi, S; Kobayashi, M; Mitsui, S; Ishida, Y; van der Horst, GTJ; Suzuki, M; Shibatall, S; Okamura, H			Gene expression - View of a mouse clock gene ticking	NATURE			English	Article									Kobe Univ, Sch Med, Dept Anat & Brain Sci, Kobe, Hyogo 6500017, Japan; Tohoku Inst Technol, Dept Elect, Sendai, Miyagi 9828577, Japan; Erasmus Univ, Dept Cell Biol & Genet, MGC, NL-3000 DR Rotterdam, Netherlands; Kumamoto Univ, Sch Med, Ctr Anim Resources & Dev, Inst Mol Embryol & Genet, Kumamoto 8620976, Japan; Waseda Univ, Sch Human Sci, Dept Pharmacol & Brain Sci, Tokorozawa, Saitama 3591192, Japan	Kobe University; Tohoku Institute Technology; Erasmus University Rotterdam; Kumamoto University; Waseda University	Yamaguchi, S (corresponding author), Kobe Univ, Sch Med, Dept Anat & Brain Sci, Kobe, Hyogo 6500017, Japan.		van der Horst, Gijsbertus TJ/E-3661-2015	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Okamura, Hitoshi/0000-0002-3013-4881				Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3	4	83	87	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					684	684		10.1038/35055628	http://dx.doi.org/10.1038/35055628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217850				2022-12-01	WOS:000166816400033
J	Rizzo, T				Rizzo, T			Habituation technique in study of development of fetal behaviour	LANCET			English	Editorial Material							DIABETIC MOTHERS; HUMAN-FETUS; EMERGENCE; STATES; WOMEN				Rizzo, T (corresponding author), 851 Washington St, Elmhurst, IL 60126 USA.							Doherty NN, 2000, EARLY HUM DEV, V59, P85, DOI 10.1016/S0378-3782(00)00089-X; MCCALL RB, 1993, CHILD DEV, V64, P57, DOI 10.1111/j.1467-8624.1993.tb02895.x; MULDER EJH, 1987, EARLY HUM DEV, V15, P231, DOI 10.1016/0378-3782(87)90082-X; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; Rizzo TA, 1997, CHILD DEV, V68, P26, DOI 10.2307/1131922; ROBERTSON SS, 1986, DEV PSYCHOBIOL, V19, P223, DOI 10.1002/dev.420190308; van Heteren CF, 2000, LANCET, V356, P1169, DOI 10.1016/S0140-6736(00)02766-5; VISSER GHA, 1985, EARLY HUM DEV, V12, P167, DOI 10.1016/0378-3782(85)90179-3; VISSER GHA, 1992, DEV PHARMACOL THERAP, V18, P175, DOI 10.1159/000480620	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					328	329		10.1016/S0140-6736(05)71499-9	http://dx.doi.org/10.1016/S0140-6736(05)71499-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210991				2022-12-01	WOS:000166897900007
J	Wang, GJ; Volkow, ND; Logan, J; Pappas, NR; Wong, CT; Zhu, W; Netusil, N; Fowler, JS				Wang, GJ; Volkow, ND; Logan, J; Pappas, NR; Wong, CT; Zhu, W; Netusil, N; Fowler, JS			Brain dopamine and obesity	LANCET			English	Article							RECEPTOR-BINDING CHARACTERISTICS; STRIATAL DOPAMINE; NUCLEUS-ACCUMBENS; C-11 RACLOPRIDE; COCAINE ABUSERS; IN-VIVO; REWARD; FOOD; ASSOCIATION; GENE	Background The cerebral mechanisms underlying the behaviours that lead to pathological overeating and obesity are poorly understood. Dopamine, a neurotransmitter that modulates rewarding properties of food, is likely to be involved. To test the hypothesis that obese individuals have abnormalities in brain dopamine activity we measured the availability of dopamine D-2 receptors in brain. Methods Brain dopamine D-2 receptor availability was measured with positron emission tomography (PET) and [C-11]raclopride (a radioligand for the dopamine D-2 receptor). Bmax/Kd (ratio of the distribution volumes in striatum to that in cerebellum minus 1) was used as a measure of dopamine D-2 receptor availability. Brain glucose metabolism was also assessed with 2-deoxy-2[F-18]fluoro-D-glucose (FDG). Findings Striatal dopamine D-2 receptor availability was significantly lower in the ten obese individuals (2.47 [SD 0.36]) than in controls (2.99 [0.41]; p less than or equal to0.0075). In the obese individuals body mass index (BMI) correlated negatively with the measures of D-2 receptors (r=0.84; p less than or equal to0.002); the individuals with the lowest D-2 values had the largest BMI. By contrast, neither whole brain nor striatal metabolism differed between obese individuals and controls, indicating that striatal reductions in D-2 receptors were not due to a systematic reduction in radiotracer delivery. Interpretation The availability of dopamine D-2 receptor was decreased in obese individuals in proportion to their BMI. Dopamine modulates motivation and reward circuits and hence dopamine deficiency in obese individuals may perpetuate pathological eating as a means to compensate for decreased activation of these circuits. Strategies aimed at improving dopamine function may be beneficial in the treatment of obese individuals.	Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Wang, GJ (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.				NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006891] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 06891-02] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Balcioglu A, 1998, INT J OBESITY, V22, P325, DOI 10.1038/sj.ijo.0800589; Baptista T, 1999, ACTA PSYCHIAT SCAND, V100, P3, DOI 10.1111/j.1600-0447.1999.tb10908.x; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; Blum K, 1996, AM SCI, V84, P132; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Comings DE, 1996, MOL PSYCHIATR, V1, P325; FARDE L, 1986, SCIENCE, V231, P258, DOI 10.1126/science.2867601; FOLTIN RW, 1990, PHARMACOL BIOCHEM BE, V36, P869, DOI 10.1016/0091-3057(90)90092-V; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; HOEBEL BG, 1985, AM J CLIN NUTR, V42, P1133, DOI 10.1093/ajcn/42.5.1133; LOGAN J, 1994, J CEREBR BLOOD F MET, V14, P995, DOI 10.1038/jcbfm.1994.132; MACRAE PG, 1987, PSYCHOPHARMACOLOGY, V92, P236; Martel P, 1996, PHARMACOL BIOCHEM BE, V53, P221, DOI 10.1016/0091-3057(95)00187-5; MAZZIOTTA J C, 1986, P493; NOBLE EP, 1994, INT J EAT DISORDER, V15, P205, DOI 10.1002/1098-108X(199404)15:3&lt;205::AID-EAT2260150303&gt;3.0.CO;2-P; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; TOWELL A, 1988, PHARMACOL BIOCHEM BE, V30, P641, DOI 10.1016/0091-3057(88)90077-9; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Wang GJ, 1997, EUR ADDICT RES, V3, P49, DOI 10.1159/000259147; Wang GJ, 1997, NEUROPSYCHOPHARMACOL, V16, P174, DOI 10.1016/S0893-133X(96)00184-4; Wang GJ, 1999, J NUCL MED, V40, P1285; WANG GJ, 1994, J NUCL MED, V35, P1457; YANOVSKI SZ, 1993, AM J PSYCHIAT, V150, P1472	29	1335	1364	2	125	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					354	357		10.1016/S0140-6736(00)03643-6	http://dx.doi.org/10.1016/S0140-6736(00)03643-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210998	Green Submitted			2022-12-01	WOS:000166897900014
J	Heldwein, EEZ; Brennan, RG				Heldwein, EEZ; Brennan, RG			Crystal structure of the transcription activator BmrR bound to DNA and a drug	NATURE			English	Article							MULTIDRUG TRANSPORTER; PROTEIN; SOXR; MERR; EXPRESSION; REPRESSOR; REGULATOR; GENE; RECOGNITION; PROMOTER	The efflux of chemically diverse drugs by multidrug transporters that span the membrane(1) is one mechanism of multidrug resistance in bacteria. The concentrations of many of these transporters are controlled by transcription regulators, such as BmrR in Bacillus subtilis(2), EmrR in Escherichia coli(3) and QacR in Staphylococcus aureus(4). These proteins promote transporter gene expression when they bind toxic compounds. BmrR activates transcription of the multidrug transporter gene, bmr, in response to cellular invasion by certain lipophilic cationic compounds (drugs)(2,5,6). BmrR belongs to the MerR family, which regulates response to stress such as exposure to toxic compounds or oxygen radicals in bacteria(7-12). MerR proteins have homologous aminoterminal DNA-binding domains but different carboxy-terminal domains, which enable them to bind specific 'coactivator' molecules. When bound to coactivator, MerR proteins upregulate transcription by reconfiguring the 19-base-pair spacer found between the -35 and -10 promoter elements to allow productive interaction with RNA polymerase(7,9-12). Here we report the 3.0 Angstrom resolution structure of BmrR in complex with the drug tetraphenylphosphonium (TPP) and a 22-base-pair oligodeoxynucleotide encompassing the bmr promoter. The structure reveals an unexpected mechanism for transcription activation that involves localized base-pair breaking, and base sliding and realignment of the -35 and -10 operator elements.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Brennan, RG (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.			Brennan, Richard/0000-0001-7647-485X; Heldwein, Ekaterina/0000-0003-3113-6958				AHMED M, 1994, J BIOL CHEM, V269, P28506; ANSARI AZ, 1995, NATURE, V374, P371; Bradley TM, 1997, NUCLEIC ACIDS RES, V25, P1469, DOI 10.1093/nar/25.8.1469; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Caguiat JJ, 1999, J BACTERIOL, V181, P3462, DOI 10.1128/JB.181.11.3462-3471.1999; COMESS KM, 1994, BIOCHEMISTRY-US, V33, P4175, DOI 10.1021/bi00180a010; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Hidalgo E, 1997, EMBO J, V16, P1056, DOI 10.1093/emboj/16.5.1056; Hidalgo E, 1997, TRENDS BIOCHEM SCI, V22, P207, DOI 10.1016/S0968-0004(97)01068-2; HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Markham PN, 1997, BIOCHEM BIOPH RES CO, V239, P269, DOI 10.1006/bbrc.1997.7467; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; PARKHILL J, 1990, NUCLEIC ACIDS RES, V18, P5157, DOI 10.1093/nar/18.17.5157; Saier MH, 1998, FASEB J, V12, P265, DOI 10.1096/fasebj.12.3.265; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Tronrud DE, 1997, METHOD ENZYMOL, V277, P306, DOI 10.1016/S0076-6879(97)77017-4; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Zeng QD, 1998, BIOCHEMISTRY-US, V37, P15885, DOI 10.1021/bi9817562; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	29	191	196	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					378	382		10.1038/35053138	http://dx.doi.org/10.1038/35053138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201751				2022-12-01	WOS:000166434300056
J	Keenan, JP; Nelson, A; O'Connor, M; Pascual-Leone, A				Keenan, JP; Nelson, A; O'Connor, M; Pascual-Leone, A			Neurology - Self-recognition and the right hemisphere	NATURE			English	Article									Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Behav Neurol Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Behav Neurol,Div Cognit & Behav Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Keenan, JP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Behav Neurol Unit, Boston, MA 02215 USA.		Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382				FEINBERG TE, 1990, NEUROLOGY, V40, P1391, DOI 10.1212/WNL.40.9.1391; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; LEMAY M, 1975, BRAIN BEHAV EVOLUT, V11, P48, DOI 10.1159/000123623; Meador KJ, 2000, NEUROLOGY, V55, P816, DOI 10.1212/WNL.55.6.816; PINEDA JA, 1994, COGNITIVE BRAIN RES, V2, P1, DOI 10.1016/0926-6410(94)90015-9; SPERRY RW, 1979, NEUROPSYCHOLOGIA, V17, P153, DOI 10.1016/0028-3932(79)90006-X; Tormos JM, 1997, NEUROLOGY, V49, P487, DOI 10.1212/WNL.49.2.487; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331	8	239	257	1	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					305	305		10.1038/35053167	http://dx.doi.org/10.1038/35053167			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201730	Bronze			2022-12-01	WOS:000166434300034
J	Drobniewski, FA				Drobniewski, FA			Multiple-drug-resistant tuberculosis	LANCET			English	Article									Kings Coll Hosp Dulwich, Guys Kings & St Thomas Med Sch, London SE22 9QF, England; UK Publ Hlth Lab Serv, Mycobacterium Reference Unit, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Drobniewski, FA (corresponding author), Kings Coll Hosp Dulwich, Guys Kings & St Thomas Med Sch, London SE22 9QF, England.								0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S62	S62		10.1016/S0140-6736(00)92048-8	http://dx.doi.org/10.1016/S0140-6736(00)92048-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191522				2022-12-01	WOS:000166074900064
J	Phillips, RJ; Zuber, MT; Solomon, SC; Golombek, MP; Jakosky, BM; Banerdt, WB; Smith, DE; Williams, RME; Hynek, BM; Aharonson, O; Hauck, SA				Phillips, RJ; Zuber, MT; Solomon, SC; Golombek, MP; Jakosky, BM; Banerdt, WB; Smith, DE; Williams, RME; Hynek, BM; Aharonson, O; Hauck, SA			Ancient geodynamics and global-scale hydrology on Mars	SCIENCE			English	Article							INTERNAL STRUCTURE; EVOLUTION; TOPOGRAPHY; SURVEYOR; SUPPORT; GRAVITY; RISE	Loading of the Lithosphere of Mars by the Tharsis rise explains much of the global shape and Long-wavelength gravity field of the planet, including a ring of negative gravity anomalies and a topographic trough around Tharsis, as well as gravity anomaly and topographic highs centered in Arabia Terra and extending northward toward Utopia. The Tharsis-induced trough and antipodal high were largely in place by the end of the Noachian Epoch and exerted control on the location and orientation of valley networks. The release of carbon dioxide and water accompanying the emplacement of similar to3 x 10(8) Cubic kilometers of Tharsis magmas may have sustained a warmer climate than at present, enabling the formation of ancient valley networks and fluvial landscape denudation in and adjacent to the large-scale trough.	Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63110 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63110 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; NASA, Earth Sci Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	Washington University (WUSTL); Washington University (WUSTL); Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder	Phillips, RJ (corresponding author), Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63110 USA.		Banerdt, William/Q-7324-2019; Hauck, Steven A/A-7865-2008	Banerdt, William/0000-0003-3125-1542; Hauck, Steven A/0000-0001-8245-146X; Aharonson, Oded/0000-0001-9930-2495; Williams, Rebecca/0000-0003-1571-6952				Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; ANDERSON RC, IN PRESS J GEOPHYS R; BANERDT WB, 1986, J GEOPHYS RES-SOLID, V91, P403, DOI 10.1029/JB091iB01p00403; BANERDT WB, 1992, MARS, P249; BANERDT WB, 2000, LUNAR PLANET SCI, V31; BRAIN DA, 1998, J GEOPHYS RES, V103, P22; Carr M.H, 1996, WATER MARS; CARR MH, 1995, J GEOPHYS RES-PLANET, V100, P7479, DOI 10.1029/95JE00260; CARR MH, 1999, J GEOPHYS RES, V104, P21; CHAN K, IN PRESS PHYS REV E; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; GERLACH TM, 1985, NATURE, V313, P273, DOI 10.1038/313273a0; HYNEK BM, IN PRESS GEOLOGY; McEwen AS, 1999, NATURE, V397, P584, DOI 10.1038/17539; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; Saunders R. S, 1980, P LUNAR PLANETARY C, V11, P2423; SCHULTZ RA, 1994, J GEOPHYS RES-PLANET, V99, P8371, DOI 10.1029/94JE00277; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; Tanaka K. L., 1992, MARS, P345; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; WILLEMANN RJ, 1982, J GEOPHYS RES, V87, P9793, DOI 10.1029/JB087iB12p09793; Zuber MT, 1997, J GEOPHYS RES-PLANET, V102, P28673, DOI 10.1029/97JE02527; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	28	377	379	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2587	2591		10.1126/science.1058701	http://dx.doi.org/10.1126/science.1058701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283367				2022-12-01	WOS:000167861000037
J	Mattingley, JB; Rich, AN; Yelland, G; Bradshaw, JL				Mattingley, JB; Rich, AN; Yelland, G; Bradshaw, JL			Unconscious priming eliminates automatic binding of colour and alphanumeric form in synaesthesia	NATURE			English	Article							PERCEPTION	Synaesthesia is an unusual perceptual phenomenon in which events in one sensory modality induce vivid sensations in another(1,2). Individuals may 'taste' shapes(3),'hear' colours', or 'feel' sounds(5). Synaesthesia was first described over a century ago(6), but little is known about its underlying causes or its effects on cognition. Most reports have been anecdotal or have focused on isolated unusual cases(3,7-9). Here we report an investigation of 15 individuals with colour-graphemic synaesthesia, each of whom experiences idiosyncratic but highly consistent colours for letters and digits. Using a colour-form interference paradigm, we show that induced synaesthetic experiences cannot be consciously suppressed even when detrimental to task performance. In contrast, if letters and digits are presented briefly and masked, so that they are processed but unavailable for overt report, the synaesthesia is eliminated. These results show that synaesthetic experiences fan be prevented despite substantial processing of the sensory stimuli that otherwise trigger them. We conclude that automatic binding of colour and alphanumeric form in synaesthesia arises after initial processes of letter and digit recognition are complete.	Univ Melbourne, Sch Behav Sci, Parkville, Vic 3010, Australia; Monash Univ, Dept Psychol, Clayton, Vic 3800, Australia	University of Melbourne; Monash University	Mattingley, JB (corresponding author), Univ Melbourne, Sch Behav Sci, Parkville, Vic 3010, Australia.		Mattingley, Jason/J-1537-2014	Mattingley, Jason/0000-0003-0929-9216; Yelland, Gregory/0000-0002-9439-253X; Rich, Anina/0000-0002-5702-6450				Baron-Cohen S, 1997, SYNAESTHESIA CLASSIC; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Cytowic RE., 1989, SYNESTHESIA UNION SE; Cytowic RE, 1993, MAN WHO TASTED SHAPE; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Galton Francis, 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; GROSSENBACHER PG, 1997, SYNAESTHESIA CLASSIC; LURIA AR, 1969, MIND MNEMONIST; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Mills CB, 1999, COGNITIVE NEUROPSYCH, V16, P181, DOI 10.1080/026432999380951; Odgaard EC, 1999, PERCEPTION, V28, P651, DOI 10.1068/p2910; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wollen KA, 1983, J MENT IMAG, V7, P83	19	219	222	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					580	582		10.1038/35069062	http://dx.doi.org/10.1038/35069062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417WW	11279495				2022-12-01	WOS:000167859300047
J	Biron, D; Libros, P; Sagi, D; Mirelman, D; Moses, E				Biron, D; Libros, P; Sagi, D; Mirelman, D; Moses, E			Asexual reproduction - 'Midwives' assist dividing amoebae	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; ENTAMOEBA-HISTOLYTICA		Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Biron, D (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	elisha.moses@weizmann.ac.il	MIRELMAN, DAVID/K-1596-2012					BAILEY GB, 1985, J PROTOZOOL, V32, P341; Fukui Y, 2000, MICROSC RES TECHNIQ, V49, P183, DOI 10.1002/(SICI)1097-0029(20000415)49:2<183::AID-JEMT11>3.3.CO;2-Y; Makioka A, 2000, PARASITOL RES, V86, P599, DOI 10.1007/PL00008536; MATO JM, 1975, P NATL ACAD SCI USA, V72, P4991, DOI 10.1073/pnas.72.12.4991; Moody-Haupt S, 2000, J MOL BIOL, V297, P409, DOI 10.1006/jmbi.2000.3577; SCHROEDER TE, 1990, ANN NY ACAD SCI, V582, P78; Weber I, 2000, CURR BIOL, V10, P501, DOI 10.1016/S0960-9822(00)00452-8	7	22	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					430	430		10.1038/35068628	http://dx.doi.org/10.1038/35068628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260701	Bronze			2022-12-01	WOS:000167583800029
J	Bolnick, DI				Bolnick, DI			Intraspecific competition favours niche width expansion in Drosophila melanogaster	NATURE			English	Article							SYMPATRIC SPECIATION; GENETIC-BASIS; TRADE-OFF; ENVIRONMENT; EVOLUTION; POLYMORPHISM; RESISTANCE; SELECTION	Ecologists have proposed that when interspecific competition is reduced, competition within a species becomes a potent evolutionary force leading to rapid diversification(1). This view reflects the observation that populations invading species-poor communities frequently evolve broader niches(2). Niche expansion can be associated with an increase in phenotypic variance(3,4) (known as character release(5)), with the evolution of polymorphisms(6-9), or with divergence into many species using distinct resources(10-13) (adaptive radiation). The relationship between intraspecific competition and diversification is known from theory(14,15), and has been used as the foundation for some models of speciation(16-20). However, there has been little empirical proof that niches evolve in response to intraspecific competition. To test this hypothesis, I introduced cadmium-intolerant Drosophila melanogaster populations to environments containing both cadmium-free and cadmium-laced resources. Here I show that populations experiencing high competition adapted to cadmium more rapidly than low competition populations. This provides experimental confirmation that competition in a population can drive niche expansion onto new resources for which competition is less severe.	Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Bolnick, DI (corresponding author), Univ Calif Davis, Ctr Populat Biol, Storer Hall, Davis, CA 95616 USA.	dibolnick@ucdavis.edu	Bolnick, Daniel I./G-4440-2015	Bolnick, Daniel I./0000-0003-3148-6296				Benkman CW, 1996, EVOL ECOL, V10, P119, DOI 10.1007/BF01239352; Coyne JA, 1997, EVOLUTION, V51, P643, DOI 10.1111/j.1558-5646.1997.tb03650.x; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 1996, J EVOLUTION BIOL, V9, P893, DOI 10.1046/j.1420-9101.1996.9060893.x; Drossel B, 2000, J THEOR BIOL, V204, P467, DOI 10.1006/jtbi.2000.2030; FEDER JL, 1995, OECOLOGIA, V101, P416, DOI 10.1007/BF00329420; Fisher R., 2005, TEACHING CHILDREN TH; Fryer G., 1972, CICHLID FISHES GREAT; GIBBONS JRH, 1979, AM NAT, V114, P719, DOI 10.1086/283519; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Jones CD, 1998, GENETICS, V149, P1899; Kambysellis Michael P., 1997, P475; KNERER G, 1973, SCIENCE, V179, P1090, DOI 10.1126/science.179.4078.1090; Lack D., 1947, DARWINS FINCHES; LEROI AM, 1994, EVOLUTION, V48, P1244, DOI [10.2307/2410382, 10.1111/j.1558-5646.1994.tb05309.x]; LISTER BC, 1976, EVOLUTION, V30, P659, DOI 10.1111/j.1558-5646.1976.tb00947.x; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; PROKOPY RJ, 1988, OECOLOGIA, V76, P138, DOI 10.1007/BF00379612; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; ROSENZWEIG ML, 1978, BIOL J LINN SOC, V10, P275, DOI 10.1111/j.1095-8312.1978.tb00016.x; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Shirley MDF, 1999, EVOLUTION, V53, P826, DOI 10.1111/j.1558-5646.1999.tb05376.x; Simpson GG, 1954, MAJOR FEATURES EVOLU; Van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; WERNER TK, 1987, P NATL ACAD SCI USA, V84, P5506, DOI 10.1073/pnas.84.15.5506; WILSON DS, 1986, AM NAT, V127, P835, DOI 10.1086/284528	30	173	175	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					463	466		10.1038/35068555	http://dx.doi.org/10.1038/35068555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260712				2022-12-01	WOS:000167583800040
J	Ek, M; Engblom, D; Saha, S; Blomqvist, A; Jakobsson, PJ; Ericsson-Dahlstrand, A				Ek, M; Engblom, D; Saha, S; Blomqvist, A; Jakobsson, PJ; Ericsson-Dahlstrand, A			Inflammatory response - Pathway across the blood-brain barrier	NATURE			English	Article							PROSTAGLANDIN-E SYNTHASE; RAT-BRAIN; CYCLOOXYGENASE-2; INTERLEUKIN-1; MECHANISMS; NEURONS		Karolinska Inst, Dept Med, Rheumatol Unit, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Linkoping Univ, Dept Biomed & Surg, Div Cell Biol, S-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Linkoping University	Ek, M (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, S-17177 Stockholm, Sweden.		Jakobsson, Per-Johan/ABC-5594-2021; Blomqvist, Anders/K-3990-2019	Blomqvist, Anders/0000-0002-6928-4473				Ek M, 2000, J COMP NEUROL, V428, P5, DOI 10.1002/1096-9861(20001204)428:1<5::AID-CNE2>3.0.CO;2-M; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; ENGLOM D, 2000, NEUROSCI LETT, V281, P163; Ericsson A, 1997, J NEUROSCI, V17, P7166; ERICSSON A, 1994, J NEUROSCI, V14, P897; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Thoren S, 2000, EUR J BIOCHEM, V267, P6428, DOI 10.1046/j.1432-1327.2000.01735.x; VANDAM AM, 1993, BRAIN RES, V613, P331, DOI 10.1016/0006-8993(93)90922-A; Zhang J, 1999, EUR J NEUROSCI, V11, P2651, DOI 10.1046/j.1460-9568.1999.00682.x	11	265	274	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					430	431		10.1038/35068632	http://dx.doi.org/10.1038/35068632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260702				2022-12-01	WOS:000167583800030
J	Wang, ZY; Seto, H; Fujioka, S; Yoshida, S; Chory, J				Wang, ZY; Seto, H; Fujioka, S; Yoshida, S; Chory, J			BRI1 is a critical component of a plasma-membrane receptor for plant steroids	NATURE			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; ARABIDOPSIS-THALIANA; KINASE; BRASSINOLIDE; GROWTH; BIOSYNTHESIS; HORMONE; ENCODES; ACTORS; GENE	Most multicellular organisms use steroids as signalling molecules for physiological and developmental regulation. Two different modes of steroid action have been described in animal systems: the well-studied gene regulation response mediated by nuclear receptors(1,2), and the rapid non-genomic responses mediated by proposed membrane-bound receptors(3,4). Plant genomes do not seem to encode members of the nuclear receptor superfamily(5). However, a transmembrane receptor kinase, brassinosteroid-insensitive1 (BRI1), has been implicated in brassinosteroid-responses(6,7). Here we show that BRI1 functions as a receptor of brassinolide, the most active brassinosteroid. The number of brassinolide-binding sites and the degree of response to brassinolide depend on the level of BRI1 protein. The brassinolide-binding activity co-immunoprecipitates with BRI1, and requires a functional BRI1 extracellular domain. Moreover, treatment of Arabidopsis seedlings with brassinolide induces autophosphorylation of BRI1, which, together with our binding studies, shows that BRI1 is a receptor kinase that transduces steroid signals across the plasma membrane.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; RIKEN, Inst Phys & Chem Res, Plant Funct Lab, Wako, Saitama 3510198, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390				Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1998, PHYTOCHEMISTRY, V49, P1841, DOI 10.1016/S0031-9422(98)00412-9; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Jinn TL, 2000, GENE DEV, V14, P108; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Luo WD, 1998, PHYTOCHEMISTRY, V49, P637, DOI 10.1016/S0031-9422(97)00881-9; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.pp.39.060188.000323; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Schmidt BMW, 2000, FRONT NEUROENDOCRIN, V21, P57, DOI 10.1006/frne.1999.0189; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Seto H, 1998, TETRAHEDRON LETT, V39, P7525, DOI 10.1016/S0040-4039(98)01636-0; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Wang ZY, 2000, RECENT ADV PHYTOCHEM, V34, P409, DOI 10.1016/S0079-9920(00)80014-3; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591	26	568	625	7	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					380	383		10.1038/35066597	http://dx.doi.org/10.1038/35066597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268216				2022-12-01	WOS:000167464100054
J	Khaw, KT; Bingham, S; Welch, A; Luben, R; Wareham, N; Oakes, S; Day, N				Khaw, KT; Bingham, S; Welch, A; Luben, R; Wareham, N; Oakes, S; Day, N			Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study	LANCET			English	Article							CORONARY-HEART-DISEASE; VITAMIN-C STATUS; SUPPLEMENTATION; STROKE; DEATH; RISK	Background Ascorbic acid (vitamin C) might be protective for several chronic diseases. However. findings from prospective studies that relate ascorbic acid to cardiovascular disease or cancer are not consistent. We aimed to assess the relation between plasma ascorbic acid and subsequent mortality due to all causes, cardiovascular disease, ischaemic heart disease, and cancer. Methods We prospectively examined for 4 years the relation between plasma ascorbic acid concentrations and mortality due to all causes, and to cardiovascular disease, ischaemic heart disease, and cancer in 19 496 men and women aged 45-79 years. We recruited individuals by post using age-sex registers of general practices. Participants completed a health and lifestyle questionnaire and were examined at a clinic visit. They were followed-up for causes of death for about 4 years. Individuals were divided into sex-specific quintiles of plasma ascorbic acid. We used the Cox proportional hazard model to determine the effect of ascorbic acid and other risk factors on mortality. Findings Plasma ascorbic acid concentration was inversely related to mortality from all-causes, and from cardiovascular disease, and ischaemic heart disease in men and women. Risk of mortality in the top ascorbic acid quintile was about half the risk in the lowest quintile (p<0.0001). The relation with mortality was continuous through the whole distribution of ascorbic acid concentrations. 20 <mu>mol/L rise in plasma ascorbic acid concentration, equivalent to about 50 g per day increase in fruit and vegetable intake, was associated with about a 20% reduction in risk of all-cause mortality (p<0.0001), independent of age, systolic blood pressure, blood cholesterol, cigarette smoking habit, diabetes, and supplement use. Ascorbic acid was inversely related to cancer mortality in men but not women. Interpretation Small increases in fruit and vegetable intake of about one serving daily has encouraging prospects for possible prevention of disease.	Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England; MRC, Dunn Human Nutr Unit, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Welch, Ailsa Ann/A-4850-2008; Khaw, Kay-Tee/AAZ-3209-2021; Luben, Robert N/H-5519-2015	Welch, Ailsa Ann/0000-0002-6702-3704; Luben, Robert N/0000-0002-5088-6343				Afridi N, 1996, J Cardiovasc Risk, V3, P358; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bates CJ, 1991, DESIGN CONCEPTS NUTR, P192; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; BLOT WJ, 1995, AM J CLIN NUTR, V62, P1424, DOI 10.1093/ajcn/62.6.1424S; COX DR, 1972, J R STAT SOC B, V34, P187; Day N, 1999, BRIT J CANCER, V80, P95; Duthie GG, 1999, BRIT MED BULL, V55, P568, DOI 10.1258/0007142991902637; ENSTROM JE, 1992, EPIDEMIOLOGY, V3, P194, DOI 10.1097/00001648-199205000-00003; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GALE CR, 1995, BRIT MED J, V310, P1563, DOI 10.1136/bmj.310.6994.1563; Gaziano J M, 1996, J Cardiovasc Risk, V3, P368; Hertog MGL, 1997, LANCET, V349, P699, DOI 10.1016/S0140-6736(05)60135-3; HUNT C, 1984, INT J VITAM NUTR RES, V54, P65; JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L; KHAW KT, 1987, AM J EPIDEMIOL, V126, P1093, DOI 10.1093/oxfordjournals.aje.a114748; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Lonn EM, 1997, CAN J CARDIOL, V13, P957; Loria CM, 2000, AM J CLIN NUTR, V72, P139; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ness A R, 1996, J Cardiovasc Risk, V3, P513, DOI 10.1097/00043798-199612000-00006; Ness AR, 1996, J HYPERTENS, V14, P503; Ness AR, 1996, EUR J CLIN NUTR, V50, P724; Rexrode K M, 1996, J Cardiovasc Risk, V3, P363; Sahyoun NR, 1996, AM J EPIDEMIOL, V144, P501, DOI 10.1093/oxfordjournals.aje.a008957; Sargeant LA, 2000, DIABETES CARE, V23, P726, DOI 10.2337/diacare.23.6.726; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25; WILSON T S, 1973, Age and Ageing, V2, P163, DOI 10.1093/ageing/2.3.163; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	30	400	408	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					657	663		10.1016/S0140-6736(00)04128-3	http://dx.doi.org/10.1016/S0140-6736(00)04128-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247548				2022-12-01	WOS:000167282400009
J	Pfeifer, BA; Admiraal, SJ; Gramajo, H; Cane, DE; Khosla, C				Pfeifer, BA; Admiraal, SJ; Gramajo, H; Cane, DE; Khosla, C			Biosynthesis of complex polyketides in a metabolically engineered strain of E-coli	SCIENCE			English	Article							COA; SYNTHASE; PROPIONATE; EXPRESSION; PEPTIDE; DOMAIN; GENE	The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the Limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.	Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Brown Univ, Dept Chem, Providence, RI 02912 USA; Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina	Stanford University; Stanford University; Stanford University; Brown University	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	ck@chemeng.stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	NCI NIH HHS [CA 66736] Funding Source: Medline; NIGMS NIH HHS [GM 22172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMIRAAL SJ, NPUB; CAFFREY P, 1992, FEBS LETT, V304, P225, DOI 10.1016/0014-5793(92)80624-P; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; CORTES J, 1995, SCIENCE, V268, P1487, DOI 10.1126/science.7770773; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; GRAMAJO H, UNPUB; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; Jacobsen JR, 1998, BIOCHEMISTRY-US, V37, P4928, DOI 10.1021/bi9729920; KAO CM, 1994, SCIENCE, V265, P509, DOI 10.1126/science.8036492; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; MANIATIS T, 1982, MOL CLONING LABORATO, P440; Minas W, 1998, BIOTECHNOL PROGR, V14, P561, DOI 10.1021/bp980055t; Mootz HD, 1997, CURR OPIN CHEM BIOL, V1, P543, DOI 10.1016/S1367-5931(97)80051-8; O'Hagan D., 1991, POLYKETIDE METABOLIT; PIEPER R, 1995, NATURE, V378, P263, DOI 10.1038/378263a0; Pohl NL, 1998, J AM CHEM SOC, V120, P11206, DOI 10.1021/ja9830290; Rodriguez E, 1999, MICROBIOL-SGM, V145, P3109, DOI 10.1099/00221287-145-11-3109; Tsang AW, 1998, J BACTERIOL, V180, P6511, DOI 10.1128/JB.180.24.6511-6518.1998	24	562	634	4	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1790	1792		10.1126/science.1058092	http://dx.doi.org/10.1126/science.1058092			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230695				2022-12-01	WOS:000167320600060
J	Labrador, M; Mongelard, F; Plata-Rengifo, P; Baxter, EM; Corces, VG; Gerasimova, TI				Labrador, M; Mongelard, F; Plata-Rengifo, P; Baxter, EM; Corces, VG; Gerasimova, TI			Molecular biology - Protein encoding by both DNA strands	NATURE			English	Article							PRE-MESSENGER-RNAS; CHROMATIN INSULATOR		Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Labrador, M (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.			Mongelard, Fabien/0000-0002-5929-6120; Labrador-San Jose, Mariano/0000-0002-8075-2717; Corces, Victor/0000-0001-5140-4337				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Buchner K, 2000, GENETICS, V155, P141; Burge C.B., 1999, RNA WORLD, V37, P525; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; SOLNICK D, 1985, CELL, V42, P157, DOI 10.1016/S0092-8674(85)80111-2	10	61	63	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1000	1000		10.1038/35059000	http://dx.doi.org/10.1038/35059000			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234000				2022-12-01	WOS:000167148800033
J	Tan, HL; Bink-Boelkens, MTE; Bezzina, CR; Viswanathan, PC; Beaufort-Krol, GCM; van Tintelen, PJ; van den Berg, MP; Wilde, AAM; Balser, JR				Tan, HL; Bink-Boelkens, MTE; Bezzina, CR; Viswanathan, PC; Beaufort-Krol, GCM; van Tintelen, PJ; van den Berg, MP; Wilde, AAM; Balser, JR			A sodium-channel mutation causes isolated cardiac conduction disease	NATURE			English	Article							ST-SEGMENT ELEVATION; LONG-QT SYNDROME; BRUGADA-SYNDROME; MOLECULAR MECHANISM; ARRHYTHMIA; CURRENTS; BLOCK; SCN5A	Cardiac conduction disorders slow the heart rhythm and cause disability in millions of people worldwide. Inherited mutations in SCN5A, the gene encoding the human cardiac sodium (Na+) channel, have been associated with rapid heart rhythms that occur suddenly and are life-threatening(1-3); however, a chief function of the Na+ channel is to initiate cardiac impulse conduction. Here we provide the first functional characterization of an SCN5A mutation that causes a sustained, isolated conduction defect with pathological slowing of the cardiac rhythm. By analysing the SCN5A coding region, we have identified a single mutation in five affected family members; this mutation results in the substitution of cysteine 514 for glycine (G514C) in the channel protein. Biophysical characterization of the mutant channel shows that there are abnormalities in voltage-dependent 'gating' behaviour that can be partially corrected by dexamethasone, consistent with the salutary effects of glucocorticoids on the clinical phenotype. Computational analysis predicts that the gating defects of G514C selectively slow myocardial conduction, but do not provoke the rapid cardiac arrhythmias associated previously with SCN5A mutations.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Beatrix Childrens Hosp, Dept Pediat Cardiol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Med Genet, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Cardiol, NL-9700 RB Groningen, Netherlands; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; University of Groningen; Vanderbilt University	Balser, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA.	jeff.balser@mcmail.vanderbilt.edu	van Tintelen, J. Peter/AAJ-9962-2021; van Tintelen, J. Peter/J-8926-2012	van den Berg, Maarten/0000-0002-1493-2998; Bezzina, Connie/0000-0002-0633-3514				Alings M, 1999, CIRCULATION, V99, P666, DOI 10.1161/01.CIR.99.5.666; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; CASCIO WE, 1995, J CARDIOVASC ELECTR, V6, P1039, DOI 10.1111/j.1540-8167.1995.tb00381.x; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; DOMINGUEZ G, 1970, CIRC RES, V26, P565, DOI 10.1161/01.RES.26.5.565; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; HORN R, 1981, NATURE, V291, P426, DOI 10.1038/291426a0; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Kambouris NG, 1998, CIRCULATION, V97, P640, DOI 10.1161/01.CIR.97.7.640; KRISHNAN SC, 1991, CIRC RES, V69, P277, DOI 10.1161/01.RES.69.2.277; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; Priori SG, 2000, LANCET, V355, P808, DOI 10.1016/S0140-6736(99)05277-0; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; VELKDKAMP MW, 2000, CIRC RES, V86, pE91; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	24	284	306	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1043	1047		10.1038/35059090	http://dx.doi.org/10.1038/35059090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234013				2022-12-01	WOS:000167148800046
J	Bendayan, M				Bendayan, M			Worth its weight in gold	SCIENCE			English	Article							FREEZE-SUBSTITUTION; CRYOFIXATION; ANTIBODY		Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bendayan, M (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada.	bendayam@alize.ere.umontreal.ca						Bendayan M, 2000, BIOTECH HISTOCHEM, V75, P203; BENDAYAN M, 1995, PROG HISTOCHEM CYTOC, V29, P1; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; ELIASSON M, 1988, J BIOL CHEM, V263, P4323; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; HAINFELD JF, 1987, SCIENCE, V236, P450, DOI 10.1126/science.3563522; KELLENBERGER E, 1991, J MICROSC-OXFORD, V161, P183, DOI 10.1111/j.1365-2818.1991.tb03083.x; Mayer G, 2001, PROG HISTOCHEM CYTO, V36, P11, DOI 10.1016/S0079-6336(01)80002-4; SJOSTRAND FS, 1990, J STRUCT BIOL, V103, P135, DOI 10.1016/1047-8477(90)90017-7	10	58	64	3	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1363	+		10.1126/science.291.5507.1363	http://dx.doi.org/10.1126/science.291.5507.1363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233453				2022-12-01	WOS:000166993400042
J	McGuffin, P; Riley, B; Plomin, R				McGuffin, P; Riley, B; Plomin, R			Genomics and behavior - Toward behavioral genomics	SCIENCE			English	Article									Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England	University of London; King's College London	McGuffin, P (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, De Crespigny Pk, London SE5 8AF, England.		McGuffin, Peter/A-1565-2012; Plomin, Robert/B-8911-2008	McGuffin, Peter/0000-0002-9888-2907; Plomin, Robert/0000-0002-0756-3629				Arranz MJ, 2000, LANCET, V355, P1615, DOI 10.1016/S0140-6736(00)02221-2; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; EDWARDS JH, 1965, ANN HUM GENET, V29, P77, DOI 10.1111/j.1469-1809.1965.tb00501.x; McGuffin P, 2001, AM J MED GENET, V105, P39, DOI 10.1002/1096-8628(20010108)105:1<39::AID-AJMG1054>3.0.CO;2-T; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Plomin R, 2000, PSYCHOL BULL, V126, P806, DOI 10.1037/0033-2909.126.6.806; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Plomin R., 2001, BEHAV GENET, V4th; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	11	113	122	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1232	+		10.1126/science.1057264	http://dx.doi.org/10.1126/science.1057264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233447				2022-12-01	WOS:000166993400025
J	Crow, JF				Crow, JF			The beanbag lives on	NATURE			English	Editorial Material									Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Crow, JF (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.							Dawkins, 1989, SELFISH GENE REVISED; HALDANE JBS, 1964, PERSPECT BIOL MED, V7, P343; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; NAGYLAKI T, 1989, GENETICS, V122, P253	4	25	26	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					771	771		10.1038/35057409	http://dx.doi.org/10.1038/35057409			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236977				2022-12-01	WOS:000166938800019
J	McCusker, SM; Curran, MD; Dynan, KB; McCullagh, CD; Urquhart, DD; Middleton, D; Patterson, CC; McIlroy, SP; Passmore, AP				McCusker, SM; Curran, MD; Dynan, KB; McCullagh, CD; Urquhart, DD; Middleton, D; Patterson, CC; McIlroy, SP; Passmore, AP			Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study	LANCET			English	Article							CEREBRAL-ISCHEMIA; PROMOTER REGION; DEPOSITION; INFLAMMATION; MECHANISMS; PROTEIN; DAMAGE	Background Deposition of beta -amyloid in the brains of patients with Alzheimer's disease is thought to precede a chain of events that leads to an inflammatory response by the brain. We postulated that genetic variation in the regulatory region of the gene for the proinflammatory cytokine tumour necrosis factor alpha (TNF-alpha) leads to increased risk of Alzheimer's disease and vascular dementia. Methods A polymorphism in the regulatory region of the TNF-alpha gene was analysed in a case-control study. The polymorphism (C-850T) was typed in 242 patients with sporadic Alzheimer's disease, 81 patients with vascular dementia, 61 stroke patients without dementia, and 235 normal controls. These groups of individuals were also genotyped for the apolipoprotein E polymorphism, and the vascular dementia and stroke groups were typed at the HLA-DR locus. Findings The distribution of TNF-alpha genotypes in the vascular dementia group differed significantly from that in the stroke and normal control groups, giving an odds ratio of 2.51 (95% CI 1.49-4.21) for the development of vascular dementia for individuals with a CT or TT genotype. Logistic regression analysis indicated that the possession of the T allele significantly increased the risk of Alzheimer's disease associated with carriage of the apolipoprotein E epsilon4 allele (odds ratio 2.73 [1.68-4.44] for those with apolipoprotein E epsilon4 but no TNF-alpha T, vs 4.62 [2.38-8.96] for those with apolipoprotein E epsilon4 and TNF-alpha T; p=0.03). Interpretation Possession of the TNF-alpha T allele significantly increases the risk of vascular dementia, and increases the risk of Alzheimer's disease associated with apolipoprotein E. Although further research is needed, these findings suggest a potential role for anti-inflammatory therapy in vascular dementia and Alzheimer's disease, and perhaps especially in patients who have had a stroke.	Queens Univ Belfast, Dept Geriatr Med, Belfast BT9 7BL, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT9 7BL, Antrim, North Ireland; No Ireland Reg Tissue Typing Lab, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	McIlroy, SP (corresponding author), Queens Univ Belfast, Dept Geriatr Med, Whitla Med Bldg, Belfast BT9 7BL, Antrim, North Ireland.	s.mcilroy@qub.ac.uk						ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; CHOCKE J, 1997, HUM GENET, V100, P189; CROOK R, 1994, J NEUROSCI METH, V53, P125, DOI 10.1016/0165-0270(94)90168-6; Eikelenboom P, 1998, EXP NEUROL, V154, P89, DOI 10.1006/exnr.1998.6920; Floyd RA, 1999, FREE RADICAL BIO MED, V26, P1346, DOI 10.1016/S0891-5849(98)00293-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.3.CO;2-E; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; ISHII T, 1992, RES IMMUNOL, V143, P614, DOI 10.1016/0923-2494(92)80043-K; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Kato T, 1999, AM J MED GENET, V88, P301, DOI 10.1002/(SICI)1096-8628(19990820)88:4<301::AID-AJMG4>3.0.CO;2-3; Klegeris A, 1997, BRAIN RES, V747, P114, DOI 10.1016/S0006-8993(96)01229-2; Lin BW, 1999, ACTA NEUROPATHOL, V97, P359, DOI 10.1007/s004010050999; Lue LF, 1996, J NEUROPATH EXP NEUR, V55, P1083, DOI 10.1097/00005072-199655100-00008; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIDDLETON D, 1993, TISSUE ANTIGENS, V42, P160, DOI 10.1111/j.1399-0039.1993.tb02187.x; Middleton D, 1999, ALZHEIMERS REP, V2, P147; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; PAAKKARI I, 1995, ANN MED, V27, P369, DOI 10.3109/07853899509002590; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Sutton ET, 1997, EXP CELL RES, V230, P368, DOI 10.1006/excr.1996.3440; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0	29	160	170	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					436	439		10.1016/S0140-6736(00)04008-3	http://dx.doi.org/10.1016/S0140-6736(00)04008-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273064				2022-12-01	WOS:000166865600013
J	Noctor, SC; Flint, AC; Weissman, TA; Dammerman, RS; Kriegstein, AR				Noctor, SC; Flint, AC; Weissman, TA; Dammerman, RS; Kriegstein, AR			Neurons derived from radial glial cells establish radial units in neocortex	NATURE			English	Article							RAT CEREBRAL-CORTEX; VENTRICULAR ZONE; MIGRATION; ORGANIZATION; LINEAGE; PROLIFERATION; PATTERNS	The neocortex of the adult brain consists of neurons and glia that are generated by precursor cells of the embryonic ventricular zone. In general, glia are generated after neurons during development(1), but radial glia are an exception to this rule. Radial glia are generated before neurogenesis and guide neuronal migration(2). Radial glia are mitotically active throughout neurogenesis(3), and disappear or become astrocytes when neuronal migration is complete(4,5). Although the lineage relationships of cortical neurons and glia have been explored(6,7), the clonal relationship of radial glia to other cortical cells remains unknown. It has been suggested that radial glia may be neuronal precursors(5,8-10), but this has not been demonstrated in vivo. We have used a retroviral vector encoding enhanced green fluorescent protein to label precursor cells in vivo and have examined clones 1-3 days later using morphological, immunohistochemical and electrophysiological techniques. Here we show that clones consist of mitotic radial glia and postmitotic neurons, and that neurons migrate along clonally related radial glia. Time-lapse images show that proliferative radial glia generate neurons. Our results support the concept that a lineage relationship between neurons and proliferative radial glia may underlie the radial organization of neocortex.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kriegstein, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.	ark17@columbia.edu		Flint, Alexander/0000-0002-3721-2694; Weissman, Tamily/0000-0001-9361-6071				ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; [Anonymous], 1970, Anat Rec, V166, P257; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Bittman K, 1997, J NEUROSCI, V17, P7037; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Cai L, 1997, J NEUROSCI, V17, P2088; Chanas-Sacre G, 2000, J NEUROSCI RES, V61, P357, DOI 10.1002/1097-4547(20000815)61:4<357::AID-JNR1>3.0.CO;2-7; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gould E, 1997, J NEUROSCI, V17, P2492; GRAY GE, 1992, DEVELOPMENT, V114, P271; GRESSENS P, 1993, DEV BRAIN RES, V76, P272, DOI 10.1016/0165-3806(93)90218-Y; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; TAKAHASHI T, 1993, J NEUROSCI, V13, P820	30	1423	1457	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					714	720		10.1038/35055553	http://dx.doi.org/10.1038/35055553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217860				2022-12-01	WOS:000166816400043
J	Powell, PA; Wesley, C; Spencer, S; Cagan, RL				Powell, PA; Wesley, C; Spencer, S; Cagan, RL			Scabrous complexes with Notch to mediate boundary formation	NATURE			English	Article							DEVELOPING DROSOPHILA RETINA; EYE DEVELOPMENT; PRONEURAL GENE; EXPRESSION; PROTEIN; RECEPTOR; ENHANCER; DELTA; PHOTORECEPTORS; NEUROGENESIS	The mechanisms that establish and sharpen pattern across epithelia are poorly understood. In the developing nervous system, the first pattern elements appear as 'proneural clusters'. In the morphogenetic furrow of the immature Drosophila retina proneural clusters emerge in a wave as a patterned array of 6-10-cell groups, which are recognizable by expression of Atonal, a basic helix-loop-helix transcription factor that is required to establish and pattern the first cell fate(1-3). The establishment and subsequent patterning of Atonal expression requires activity of the signalling transmembrane receptor Notch(2,4). Here we present in vivo and biochemical evidence that the secreted protein Scabrous associates with Notch, and can stabilize Notch protein at the surface. The result is a regulation of Notch activity that sharpens proneural cluster boundaries and ensures establishment of single pioneer neurons.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Rockefeller Univ, Genet Lab, New York, NY 10021 USA	Washington University (WUSTL); Rockefeller University	Cagan, RL (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA.		Cagan, Ross Leigh/AAV-9528-2021	Cagan, Ross/0000-0001-5297-450X				BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1995, MECH DEVELOP, V49, P173, DOI 10.1016/0925-4773(94)00314-D; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; ELLIS MC, 1994, DEVELOPMENT, V120, P1959; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; HART AC, 1993, NATURE, V361, P732, DOI 10.1038/361732a0; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee EC, 2000, CURR BIOL, V10, P931, DOI 10.1016/S0960-9822(00)00622-9; Lee EC, 1998, GENETICS, V150, P663; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee EC, 1996, BIOCHEM BIOPH RES CO, V225, P720, DOI 10.1006/bbrc.1996.1241; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Parks AL, 2000, DEVELOPMENT, V127, P1373; RABINOW L, 1990, GENETICS, V125, P41; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683	29	65	66	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					626	630		10.1038/35054566	http://dx.doi.org/10.1038/35054566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214322				2022-12-01	WOS:000166692300046
J	Weng, JY; McClelland, J; Pentland, A; Sporns, O; Stockman, I; Sur, M; Thelen, E				Weng, JY; McClelland, J; Pentland, A; Sporns, O; Stockman, I; Sur, M; Thelen, E			Artificial intelligence - Autonomous mental development by robots and animals	SCIENCE			English	Editorial Material									Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; MIT, Media Lab, Cambridge, MA 02139 USA; Indiana Univ, Dept Psychol, Bloomington, IN 47405 USA; Michigan State Univ, Dept Audiol & Speech Sci, E Lansing, MI 48824 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Michigan State University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); Indiana University System; Indiana University Bloomington; Michigan State University; Massachusetts Institute of Technology (MIT)	Weng, JY (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.		Sporns, Olaf/A-1667-2010	Sporns, Olaf/0000-0001-7265-4036				Almassy N, 1998, CEREB CORTEX, V8, P346, DOI 10.1093/cercor/8.4.346; Elman JL, 1997, RETHINKING INNATENES; HWNG WS, 2000, IEE T PATTERN ANAL M, V22, P11; Kuhn T., 1996, STRUCTURE SCI REVOLU; *MICH STAT U, 2000, P WORKSH DEV LEARN 5; ROY D, 1999, WORKSH INT SPEECH IM; THELEN E, IN PRESS BEHAV BRAIN; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WANG X, 1995, NATURE, V378, P13; WENG J, 1998, LEARNING COMPUTER VI; WENG J, 1999, P 2 INT S HUM ROB TO, P57	11	357	381	7	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					599	600		10.1126/science.291.5504.599	http://dx.doi.org/10.1126/science.291.5504.599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11229402				2022-12-01	WOS:000166616000026
J	Wiese, C; Wilde, A; Moore, MS; Adam, SA; Merdes, A; Zheng, YX				Wiese, C; Wilde, A; Moore, MS; Adam, SA; Merdes, A; Zheng, YX			Role of importin-beta in coupling ran to downstream targets in microtubule assembly	SCIENCE			English	Article							NUCLEAR-PROTEIN IMPORT; GTP-BOUND RAN; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; EGG EXTRACTS; NUMA; COMPLEX; ORGANIZATION; ASTERS; P97	The guanosine triphosphatase Ran stimulates assembly of microtubule asters and spindles in mitotic Xenopus egg extracts. A carboxyl-terminal region of the nuclear-mitotic apparatus protein (NuMA), a nuclear protein required for organizing mitotic spindle poles, mimics Ran's ability to induce asters. This NuMA fragment also specifically interacted with the nuclear transport factor, importin-beta. We show that importin-beta is an inhibitor of microtubule aster assembly in Xenopus egg extracts and that Ran regulates the interaction between importin-beta and NuMA, Importin-beta therefore Links NUMA to regulation by Ran. This suggests that similar mechanisms regulate nuclear import during interphase and spindle assembly during mitosis.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Carnegie Inst Washington, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21210 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of Edinburgh; Carnegie Institution for Science; Howard Hughes Medical Institute; Baylor College of Medicine; Northwestern University	Merdes, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.			Wilde, Andrew/0000-0002-9812-3847	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312, R01GM047866] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53678, GM47866, GM56312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen SSL, 1997, J CELL BIOL, V139, P975, DOI 10.1083/jcb.139.4.975; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; MOORE MA, UNPUB; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; WIESE C, UNPUB; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; WILDE A, IN PRESS NATURE CELL; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	26	265	274	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					653	656		10.1126/science.1057661	http://dx.doi.org/10.1126/science.1057661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11229403				2022-12-01	WOS:000166616000044
J	Hollopeter, G; Jantzen, HM; Vincent, D; Li, G; England, L; Ramakrishnan, V; Yang, RB; Nurden, P; Nurden, A; Julius, D; Conley, PB				Hollopeter, G; Jantzen, HM; Vincent, D; Li, G; England, L; Ramakrishnan, V; Yang, RB; Nurden, P; Nurden, A; Julius, D; Conley, PB			Identification of the platelet ADP receptor targeted by antithrombotic drugs	NATURE			English	Article							P2Y(1) RECEPTOR; ADENYLATE-CYCLASE; BLOOD-PLATELETS; CLOPIDOGREL; ACTIVATION; AGGREGATION; PROTEINS; CHANNEL; PATHWAY; BINDING	Platelets have a crucial role in the maintenance of normal haemostasis, and perturbations of this system can lead to pathological thrombus formation and vascular occlusion, resulting in stroke, myocardial infarction and unstable angina. ADP released from damaged vessels and red blood cells induces platelet aggregation through activation of the integrin GPIIb-IIIa and subsequent binding of fibrinogen. ADP is also secreted from platelets on activation, providing positive feedback that potentiates the actions of many platelet activators(1). ADP mediates platelet aggregation through its action on two G-protein-coupled receptor subtypes(2,3). The P2Y(1) receptor couples to G(q) and mobilizes intracellular calcium ions to mediate platelet shape change and aggregation(4,5). The second ADP receptor required for aggregation (variously called P2Y(ADP), P2Y(AC), P2Ycyc or P2T(AC)) is coupled to the inhibition of adenylyl cyclase through G(i). The molecular identity of the G(i)-linked receptor is still elusive, even though it is the target of efrcacious antithrombotic agents, such as ticlopidine and clopidogrel(6-8) and AR-C66096 (ref. 9). Here we describe the cloning of this receptor, designated P2Y(12), and provide evidence that a patient with a bleeding disorder(10) has a defect in this gene. Cloning of the P2Y12 receptor should facilitate the development of better antiplatelet agents to treat cardiovascular diseases.	COR Therapeut Inc, S San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Hop Cardiol, CNRS, UMR 5533, F-33605 Pessac, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CHU Bordeaux	Conley, PB (corresponding author), COR Therapeut Inc, S San Francisco, CA 94080 USA.		Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714				BENNETT CL, 2000, NEW ENGL J MED, V325, P1371; BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cattaneo M, 1999, ARTERIOSCL THROM VAS, V19, P2281, DOI 10.1161/01.ATV.19.10.2281; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Filippov AK, 2000, BRIT J PHARMACOL, V129, P1063, DOI 10.1038/sj.bjp.0703185; GACHET C, 1990, BIOCHEM PHARMACOL, V40, P2683, DOI 10.1016/0006-2952(90)90587-B; GACHET C, 1992, THROMB HAEMOSTASIS, V68, P79; Hechler B, 1998, BRIT J HAEMATOL, V103, P858, DOI 10.1046/j.1365-2141.1998.01056.x; HOURANI SMO, 1994, TRENDS PHARMACOL SCI, V15, P103, DOI 10.1016/0165-6147(94)90045-0; Humbert M, 1996, ARTERIOSCL THROM VAS, V16, P1532, DOI 10.1161/01.ATV.16.12.1532; HUMPHRIES RG, 1994, BRIT J PHARMACOL, V113, P1057, DOI 10.1111/j.1476-5381.1994.tb17100.x; Jantzen HM, 1999, THROMB HAEMOSTASIS, V81, P111; Jantzen HM, 1998, BLOOD, V92, p303A; Jarvis GE, 2000, BRIT J PHARMACOL, V129, P275, DOI 10.1038/sj.bjp.0703046; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; MACFARLANE DE, 1983, J CLIN INVEST, V71, P420, DOI 10.1172/JCI110786; MILLS DCB, 1992, ARTERIOSCLER THROMB, V12, P430, DOI 10.1161/01.ATV.12.4.430; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; NURDEN P, 1995, J CLIN INVEST, V95, P1612, DOI 10.1172/JCI117835; Ohlmann P, 1995, BIOCHEM J, V312, P775, DOI 10.1042/bj3120775; Palmer RK, 1998, MOL PHARMACOL, V54, P1118, DOI 10.1124/mol.54.6.1118; SAVI P, IN PRESS THROMB HAEM; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422	28	1128	1183	2	112	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					202	207		10.1038/35051599	http://dx.doi.org/10.1038/35051599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196645				2022-12-01	WOS:000166316200047
J	Chockalingam, A				Chockalingam, A			Let's not make the same mistakes	LANCET			English	Article									Hlth Canada, Ottawa, ON K1A 0L2, Canada	Health Canada	Chockalingam, A (corresponding author), 1375 Talcy Crescent, Orleans, ON K4A 3C4, Canada.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S9	S9		10.1016/S0140-6736(00)91995-0	http://dx.doi.org/10.1016/S0140-6736(00)91995-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191529				2022-12-01	WOS:000166074900011
J	Rowe, T; Ketcham, RA; Denison, C; Colbert, M; Xu, X; Currie, PJ				Rowe, T; Ketcham, RA; Denison, C; Colbert, M; Xu, X; Currie, PJ			Forensic palaeontology - The Archaeoraptor forgery	NATURE			English	Article									Univ Texas, Dept Geol Sci, High Resolut Xray Comp Tomog Facil, Austin, TX 78712 USA; Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Royal Tyrrel Museum Paleontol, Drumheller, AB T0J 0Y0, Canada	University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Rowe, T (corresponding author), Univ Texas, Dept Geol Sci, High Resolut Xray Comp Tomog Facil, C1100, Austin, TX 78712 USA.	rowe@mail.utexas.edu	Currie, Philip J/A-2628-2014; Ketcham, Richard/B-5431-2011	Currie, Philip J/0000-0001-6857-3161; Ketcham, Richard/0000-0002-2748-0409				Dalton R, 2000, NATURE, V404, P696, DOI 10.1038/35008237; Dalton R, 2000, NATURE, V403, P689, DOI 10.1038/35001723; Dingus L., 1997, MISTAKEN EXTINCTION; Holden C, 2000, SCIENCE, V288, P238; JAHN ME, 1963, LYING STONES JBA BER; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Rowe T, 1997, GEOTIMES, V42, P23; Sloan C.P., 1999, NATL GEOGR, V196, P98; Weiner J. S., 1955, PILTDOWN FORGERY; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	11	34	36	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					539	540		10.1038/35069145	http://dx.doi.org/10.1038/35069145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279483				2022-12-01	WOS:000167859300035
J	Jarillo, JA; Capel, J; Tang, RH; Yang, HQ; Alonso, JM; Ecker, JR; Cashmore, AR				Jarillo, JA; Capel, J; Tang, RH; Yang, HQ; Alonso, JM; Ecker, JR; Cashmore, AR			An Arabidopsis circadian clock component interacts with both CRY1 and phyB	NATURE			English	Article							MOLECULAR-BASES; CONTROLLED GENE; RHYTHMS; NEUROSPORA; PROTEINS; DYSFUNCTION; ENCODES; TIME	Most organisms, from cyanobacteria to mammals, use circadian clocks to coordinate their activities with the natural 24-h light/dark cycle. The clock proteins of Drosophila and mammals exhibit striking homology but do not show similarity with clock proteins found so far from either cyanobacteria or Neurospora(1,2). Each of these organisms uses a transcriptionally regulated negative feedback loop in which the messenger RNA levels of the clock components cycle over a 24-h period. Proteins containing PAS domains are invariably found in at least one component of the characterized eukaryotic clocks(1). Here we describe ADAGIO1 (ADO1), a gene of Arabidopsis thaliana that encodes a protein containing a PAS domain. We found that a loss-of-function ado1 mutant is altered in both gene expression and cotyledon movement in circadian rhythmicity. Under constant white or blue light, the ado1 mutant exhibits a longer period than that of wild-type Arabidopsis seedlings, whereas under red light cotyledon movement and stem elongation are arrhythmic. Both yeast two-hybrid and in vitro binding studies show that there is a physical interaction between ADO1 and the photoreceptors CRY1 and phyB. We propose that ADO1 is an important component of the Arabidopsis circadian system.	Univ Penn, Inst Plant Sci, Dept Biol, Philadelphia, PA 19104 USA; Univ Almeria, Dept Biol Aplicata, Almeria 04120, Spain	University of Pennsylvania; Universidad de Almeria	Cashmore, AR (corresponding author), Univ Penn, Inst Plant Sci, Dept Biol, Philadelphia, PA 19104 USA.	cashmore@sas.upenn.edu	Capel, Juan/M-3772-2018; Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Capel, Juan/0000-0002-4327-0604; Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; Jarillo, Jose Antonio/0000-0002-2963-7641; Tang, Ruhang/0000-0003-4918-3525				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Ballario P, 1997, TRENDS MICROBIOL, V5, P458, DOI 10.1016/S0966-842X(97)01144-X; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; Millar AJ, 1999, NEW PHYTOL, V141, P175, DOI 10.1046/j.1469-8137.1999.00349.x; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	29	159	188	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					487	490		10.1038/35068589	http://dx.doi.org/10.1038/35068589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260718				2022-12-01	WOS:000167583800046
J	Tuomilehto, J; Jousilahti, P; Rastenyte, D; Moltchanov, V; Tanskanen, A; Pietinen, P; Nissinen, A				Tuomilehto, J; Jousilahti, P; Rastenyte, D; Moltchanov, V; Tanskanen, A; Pietinen, P; Nissinen, A			Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study	LANCET			English	Article							LOWER BLOOD-PRESSURE; DIETARY-SODIUM; OBSERVATIONAL DATA; RISK-FACTORS; SALT INTAKE; REDUCTION; DISEASE; POTASSIUM; STROKE	Background The evidence that high salt intake increases the risk of cardiovascular disease has been challenged. We aimed to find out whether salt intake, measured by 24 h urinary sodium excretion, is an independent risk factor for cardiovascular disease frequency and mortality, and all-cause mortality. Methods We prospectively followed 1173 Finnish men and 1263 women aged 25-64 years with complete data on 24 h urinary sodium excretion and cardiovascular risk factors. The endpoints were an incident coronary and stroke event. and death from coronary heart disease. cardiovascular disease, and any cause. Each endpoint was analysed separately with the Cox proportional hazards model. Findings The hazards ratios for coronary heart disease, cardiovascular disease, and all-cause mortality, associated with a 100 mmol increase in 24 h urinary sodium excretion, were 1.51 (95% CI 1.14-2.00), 1.45 (1.14-1.84), and 1.26 (1.06-1.50), respectively, in both men and women. The frequency of acute coronary events. but not acute stroke events, rose significantly with increasing sodium excretion. When analyses were done separately for each sex, the risk ratios were significant in men only. There was a significant interaction between sodium excretion and body mass index for cardiovascular and total mortality; sodium predicted mortality in men who were overweight. Correction for the regression dilution bias increased the hazards ratios markedly. Interpretation High sodium intake predicted mortality and risk of coronary heart disease, independent of other cardiovascular risk factors. including blood pressure. These results provide direct evidence of the harmful effects of high salt intake in the adult population.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Kaunas Univ Med, Inst Cardiol, Kaunas, Lithuania; Univ Kuopio, Dept Psychiat, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Lithuanian University of Health Sciences; University of Eastern Finland; University of Eastern Finland	Tuomilehto, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	Jaakko.Tuomilehto@ktl.fi						ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; ALTSCHUL AM, 1981, INT J OBESITY, V5, P27; BEEVERS DG, 1989, J HUM HYPERTENS, V3, P279; DYER AR, 1994, HYPERTENSION, V23, P729, DOI 10.1161/01.HYP.23.6.729; ELLIOTT P, 1991, HYPERTENSION, V17, pI3, DOI 10.1161/01.HYP.17.1_Suppl.I3; Engelman K, 1998, LANCET, V351, P1508, DOI 10.1016/S0140-6736(05)78895-4; FROST CD, 1991, BRIT MED J, V302, P815, DOI 10.1136/bmj.302.6780.815; GARCIA G, 1997, HYPERTENSION, V29, P802; GLEIBERMANN L., 1973, Ecology of Food and Nutrition, V2, P143, DOI 10.1080/03670244.1973.9990329; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; IKEDA M, 1986, PREV MED, V15, P46, DOI 10.1016/0091-7435(86)90035-6; JACKSON FLC, 1991, HYPERTENSION, V17, pI129, DOI 10.1161/01.HYP.17.1_Suppl.I129; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Karppanen H, 1998, LANCET, V351, P1509, DOI 10.1016/S0140-6736(05)78896-6; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; LUFT FC, 1979, CIRCULATION, V60, P697, DOI 10.1161/01.CIR.60.3.697; MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; NISSINEN A, 1982, MAGNESIUM, V1, P232; PAJAK A, 1988, World Health Statistics Quarterly, V41, P115; PERRY IJ, 1992, J HUM HYPERTENS, V6, P23; PIETINEN P, 1982, ANN NUTR METAB, V26, P90, DOI 10.1159/000176550; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; TUOMILEHTO J, 1984, ANN CLIN RES, V16, P18; TUOMILEHTO J, 1981, ACTA CARDIOL, V36, P83; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; VARTIAINEN E, 1995, BMJ-BRIT MED J, V310, P901, DOI 10.1136/bmj.310.6984.901; XIE JX, 1992, J HUM HYPERTENS, V6, P17; Yamori Y, 1994, Health Rep, V6, P22	32	415	429	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					848	851		10.1016/S0140-6736(00)04199-4	http://dx.doi.org/10.1016/S0140-6736(00)04199-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265954				2022-12-01	WOS:000167586300012
J	Mitch, WE; Price, SR				Mitch, WE; Price, SR			Transcription factors and muscle cachexia: is there a therapeutic target?	LANCET			English	Editorial Material							PROTEASOME PROTEOLYTIC PATHWAY; FACTOR-KAPPA-B; SKELETAL-MUSCLE; MESSENGER-RNA; PROTEIN-DEGRADATION; UBIQUITIN; GLUCOCORTICOIDS; ACTIVATION; MECHANISM; SEPSIS		Emory Univ, Sch Med, Div Renal, Atlanta, GA 30322 USA	Emory University	Mitch, WE (corresponding author), Emory Univ, Sch Med, Div Renal, Atlanta, GA 30322 USA.							Andersen JL, 2000, SCI AM, V283, P48, DOI 10.1038/scientificamerican0900-48; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bertrand F, 1999, J BIOL CHEM, V274, P30596, DOI 10.1074/jbc.274.43.30596; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Kaliman P, 1999, J BIOL CHEM, V274, P17437, DOI 10.1074/jbc.274.25.17437; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143; Tiao G, 1996, J CLIN INVEST, V97, P339, DOI 10.1172/JCI118421; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668	17	34	36	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					734	735		10.1016/S0140-6736(00)04177-5	http://dx.doi.org/10.1016/S0140-6736(00)04177-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253960				2022-12-01	WOS:000167400900004
J	Malleret, G; Haditsch, U; Genoux, D; Jones, MW; Bliss, TVP; Vanhoose, AM; Weitlauf, C; Kandel, ER; Winder, DG; Mansuy, IM				Malleret, G; Haditsch, U; Genoux, D; Jones, MW; Bliss, TVP; Vanhoose, AM; Weitlauf, C; Kandel, ER; Winder, DG; Mansuy, IM			Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CAMP-RESPONSIVE ELEMENT; HIPPOCAMPAL CA1 REGION; MORRIS WATER MAZE; SYNAPTIC TRANSMISSION; PHOSPHATASE-ACTIVITY; EXPLORATORY ACTIVITY; ADENYLYL-CYCLASE; SPATIAL MEMORY; LTP	The threshold for hippocampal-dependent synaptic plasticity and memory storage is thought to be determined by the balance between protein phosphorylation and dephosphorylation mediated by the kinase PKA and the phosphatase calcineurin. To establish whether endogenous calcineurin acts as an inhibitory constraint in this balance, we examined the effect of genetically inhibiting calcineurin on plasticity and memory. Using the doxycycline-dependent rtTA system to express a calcineurin inhibitor reversibly in the mouse brain, we find that the transient reduction of calcineurin activity facilitates LTP in vitro and in vivo. This facilitation is PKA dependent and persists over several days in vivo. It is accompanied by enhanced learning and strengthened short- and long-term memory in several hippocampal-dependent spatial and nonspatial tasks. The LTP and memory improvements are reversed fully by suppression of transgene expression. These results demonstrate that endogenous calcineurin constrains LTP and memory.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Bordeaux 1, Cognit Neurosci Lab, CNRS, Unite Mixte Rech 5807, F-33405 Talence, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; MRC National Institute for Medical Research; Vanderbilt University; Vanderbilt University; Columbia University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Mansuy, IM (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland.		Mansuy, Isabelle M/N-3042-2015; Winder, Danny G./H-4857-2013	Mansuy, Isabelle M/0000-0001-7785-5371; Jones, Matthew/0000-0001-5396-3108				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Allen PB, 2000, J NEUROSCI, V20, P3537, DOI 10.1523/JNEUROSCI.20-10-03537.2000; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BUHOT MC, 1995, HIPPOCAMPUS, V5, P198, DOI 10.1002/hipo.450050306; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Errington ML, 1997, NATURE, V387, P666, DOI 10.1038/42625; Floresco SB, 1997, J NEUROSCI, V17, P1880; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Huang Y Y, 1994, Learn Mem, V1, P74; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Ikegami Shiro, 1996, Molecular Brain Research, V41, P183, DOI 10.1016/0169-328X(96)00094-0; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jerecic J, 1999, ANN NY ACAD SCI, V868, P27, DOI 10.1111/j.1749-6632.1999.tb11271.x; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Makhinson M, 1999, J NEUROSCI, V19, P2500; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; OLTON DS, 1981, EXP BRAIN RES, V41, P380; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Papatheodoropoulos C, 2000, NEUROSCI LETT, V286, P57, DOI 10.1016/S0304-3940(00)01084-3; PATERSON JM, 1995, BIOCHEM BIOPH RES CO, V214, P1000, DOI 10.1006/bbrc.1995.2385; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Vnek N, 1996, J NEUROSCI, V16, P2780; Wang JH, 1997, J NEUROSCI, V17, P4600; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	53	361	376	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					675	686		10.1016/S0092-8674(01)00264-1	http://dx.doi.org/10.1016/S0092-8674(01)00264-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257222	Bronze			2022-12-01	WOS:000167531100008
J	Spahn, CMT; Kieft, JS; Grassucci, RA; Penczek, PA; Zhou, KH; Doudna, JA; Frank, J				Spahn, CMT; Kieft, JS; Grassucci, RA; Penczek, PA; Zhou, KH; Doudna, JA; Frank, J			Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit	SCIENCE			English	Article							15 ANGSTROM RESOLUTION; COLI 70S RIBOSOME; CRYOELECTRON MICROSCOPY; ENTRY SITE; 3-DIMENSIONAL RECONSTRUCTION; TRANSLATION INITIATION; ELECTRON-MICROSCOPY; VISUALIZATION; LOCALIZATION; MODEL	Initiation of protein synthesis in eukaryotes requires recruitment of the 40S ribosomal subunit to the messenger RNA(mRNA). In most cases, this depends on recognition of a modified nucleotide cap on the 5' end of the mRNA. However, an alternate pathway uses a structured RNA element in the 5' untranslated region of the messenger or viral RNA called an internal ribosomal entry site (IRES). Here, we present a cryo-electron microscopy map of the hepatitis C virus (HCV) IRES bound to the 40S ribosomal subunit at about 20 Angstrom resolution. IRES binding induces a pronounced conformational change in the 40S subunit and closes the mRNA binding cleft, suggesting a mechanism for IRES-mediated positioning of mRNA in the ribosomal decoding center.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Wadsworth Ctr, Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA	Yale University; Howard Hughes Medical Institute; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center	Doudna, JA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	doudna@csb.yale.edu; joachim@wadsworth.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM060635] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM29169, GM60635] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, CURR OPIN STRUC BIOL, V9, P215, DOI 10.1016/S0959-440X(99)80031-1; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Honda M, 1999, J VIROL, V73, P1165, DOI 10.1128/JVI.73.2.1165-1174.1999; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; KIEFT JS, UNPUB; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; LUTSCH G, 1983, BIOMED BIOCHIM ACTA, V42, P705; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Merrick WC., 1996, TRANSLATION CONTROL, P31; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Rijnbrand RCA, 2000, CURR TOP MICROBIOL, V242, P85; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; SPAHN CMT, UNPUB; SRIVASTAVA S, 1995, J MOL BIOL, V245, P461, DOI 10.1006/jmbi.1994.0037; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	41	413	427	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1959	1962		10.1126/science.1058409	http://dx.doi.org/10.1126/science.1058409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239155				2022-12-01	WOS:000167401600045
J	Hobson, JP; Rosenfeldt, HM; Barak, LS; Olivera, A; Poulton, S; Caron, MG; Milstien, S; Spiegel, S				Hobson, JP; Rosenfeldt, HM; Barak, LS; Olivera, A; Poulton, S; Caron, MG; Milstien, S; Spiegel, S			Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; BETA-ARRESTIN; KINASE; PROLIFERATION; ENDOCYTOSIS; SURVIVAL	EDG-1 is a heterotrimeric guanine nucleotide binding protein-coupled receptor (GPCR) for sphingosine-1-phosphate (SPP). Cell migration toward platelet-derived growth factor (PDGF). which stimulates sphingosine kinase and increases intracellular SPP, was dependent on expression of EDG-1. Deletion of edg-1 or inhibition of sphingosine kinase suppressed chemotaxis toward PDGF and also activation of the small guanosine triphosphatase Rac, which is essential for protrusion of lamellipodia and forward movement. Moreover, PDGF activated EDG-1, as measured by translocation of beta -arrestin and phosphorylation of EDG-1. Our results reveal a role for receptor cross-communication in which activation of a GPCR by a receptor tyrosine kinase is critical for cell motility.	Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	Georgetown University; Duke University; Duke University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA.				NCI NIH HHS [CA61774] Funding Source: Medline; NHLBI NIH HHS [HL-61365] Funding Source: Medline; NIGMS NIH HHS [GM43880] Funding Source: Medline; NINDS NIH HHS [NS19576] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343	19	368	383	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1800	1803		10.1126/science.1057559	http://dx.doi.org/10.1126/science.1057559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230698				2022-12-01	WOS:000167320600063
J	Kaye, JA; Melero-Montes, MD; Jick, H				Kaye, JA; Melero-Montes, MD; Jick, H			Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis	BRITISH MEDICAL JOURNAL			English	Article								Objective To estimate changes in the risk of autism and assess the relation of autism to the mumps, measles, and rubella (MMR) vaccine. Design Time trend analysis of data from the UK general practice research database (GPRD). Setting General practices in the United Kingdom. Subjects Children aged 12 years or younger diagnosed with autism 1988-99, with further analysis of boys aged 2 to 5 years born 1988-93. Main outcome measures Annual and age specific incidence for first recorded diagnoses of autism (that is, when the diagnosis of autism was first recorded) in the children aged 12 years or younger; annual, birth cohort specific risk of autism diagnosed in the 2 to 5 year old boys; coverage (prevalence) of MMR vaccination in the same birth cohorts. Results The incidence of newly diagnosed autism increased sevenfold, from 0.3 per 10 000 person years in 1988 to 2.1 per 10 000 person years in 1999, The peak incidence was among 3 and 4 year olds, and 83% (254/305) of cases were boys. In an annual birth cohort analysis of 114 boys born in 1988-93, the risk of autism in 2 to 5 year old boys increased nearly fourfold over time, from 8 (95% confidence interval 4 to 14) per 10 000 for boys born in 1988 to 29 (20 to 43) per 10 000 for boys born in 1993. For the same annual birth cohorts the prevalence of MMR vaccination was over 95%. Conclusions Because the incidence of autism among 2 to 5 year olds increased markedly among boys born in each year separately from 1988 to 1993 while MMR vaccine coverage was over 95% for successive annual birth cohorts, the data provide evidence that no correlation exists between the prevalence of MMR vaccination and the rapid increase in the risk of autism over time. The explanation for the marked increase in risk of the diagnosis of autism in the past decade remains uncertain.	Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Kaye, JA (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, 11 Muzzey St, Lexington, MA 02421 USA.			Kaye, James A./0000-0002-9357-4227; Jick, Hershel/0000-0003-4270-5992	NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009001] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1995, BRIT J GEN PRACT, V45, P107; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Wing L, 1997, LANCET, V350, P1761, DOI 10.1016/S0140-6736(97)09218-0	6	235	239	0	108	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					460	463		10.1136/bmj.322.7284.460	http://dx.doi.org/10.1136/bmj.322.7284.460			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222420	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000167243000018
J	Sato, C; Ueno, Y; Asai, K; Takahashi, K; Sato, M; Engel, A; Fujiyoshi, Y				Sato, C; Ueno, Y; Asai, K; Takahashi, K; Sato, M; Engel, A; Fujiyoshi, Y			The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities	NATURE			English	Article							ELECTROPHORUS-ELECTRICUS; POTASSIUM CHANNEL; SKELETAL-MUSCLE; CLASSIFICATION; INACTIVATION; CRYSTALLOGRAPHY; RECONSTRUCTION; IDENTIFICATION; MUTATIONS; RECEPTOR	Voltage-sensitive membrane channels, the sodium channel, the potassium channel and the calcium channel operate together to amplify, transmit and generate electric pulses in higher forms of life. Sodium and calcium channels are involved in cell excitation, neuronal transmission, muscle contraction and many functions that relate directly to human diseases(1-4). Sodium channels-glycosylated proteins with a relative molecular mass of about 300,000 (ref. 5)-are responsible for signal transduction and amplification, and are chief targets of anaesthetic drugs(6) and neurotoxins(1). Here we present the three-dimensional structure of the voltage-sensitive sodium channel from the eel Electrophorus electricus. The 19 Angstrom structure was determined by helium-cooled cryo-electron microscopy and single-particle image analysis of the solubilized sodium channel. The channel has a bell-shaped outer surface of 135 Angstrom in height and 100 Angstrom in side length at the square-shaped bottom, and a spherical top with a diameter of 65 Angstrom. Several inner cavities are connected to four small holes and eight orifices close to the extracellular and cytoplasmic membrane surfaces. Homologous voltage-sensitive calcium and tetrameric potassium channels, which regulate secretory processes and the membrane potential(7), may possess a related structure.	Electrotech Lab, Supermol Sci Div, Tsukuba, Ibaraki 3058568, Japan; Japan Adv Inst Sci & Technol Hokuriku, Sch Knowledge Sci, Tatsunokuchi, Ishikawa 9231211, Japan; Itoham Foods Inc, Cent Res Inst, Moriya 3020104, Japan; Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland; Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Advanced Institute of Science & Technology (JAIST); University of Basel; Kyoto University	Sato, C (corresponding author), Electrotech Lab, Supermol Sci Div, 1-1-4 Umezono, Tsukuba, Ibaraki 3058568, Japan.		Fujiyoshi, Yoshinori/E-5989-2012; Sato, Chikara/M-7183-2016; Ueno, Yutaka/L-8831-2018	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Sato, Chikara/0000-0001-5543-4496; Ueno, Yutaka/0000-0002-3124-2518				Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FRANK J, 1988, J MICROSC-OXFORD, V150, P99, DOI 10.1111/j.1365-2818.1988.tb04602.x; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; GORDON RD, 1987, P NATL ACAD SCI USA, V84, P308, DOI 10.1073/pnas.84.1.308; HARAUZ G, 1986, OPTIK, V73, P146; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; Mitsuoka K, 1997, ULTRAMICROSCOPY, V68, P109, DOI 10.1016/S0304-3991(97)00020-X; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PTACEK LJ, 1991, CELL, V67, P1021; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Sato C, 1998, J STRUCT BIOL, V121, P314, DOI 10.1006/jsbi.1998.3990; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1989, OPTIK, V82, P114; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VANHEEL M, 1987, ULTRAMICROSCOPY, V38, P241; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	30	200	221	2	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1047	1051		10.1038/35059098	http://dx.doi.org/10.1038/35059098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234014				2022-12-01	WOS:000167148800047
J	Pershagen, G				Pershagen, G			Environmental public-health surveillance systems for chemical incidents	LANCET			English	Editorial Material							EXPOSURE		Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden	Karolinska Institutet	Pershagen, G (corresponding author), Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden.			Pershagen, Goran/0000-0002-9701-1130				BERGLUND M, 1994, ARCH ENVIRON HEALTH, V49, P17, DOI 10.1080/00039896.1994.9934410; BERGLUND M, 1993, SCAND J WORK ENV S2, V19; Bowen HJ, 2000, J EPIDEMIOL COMMUN H, V54, P870, DOI 10.1136/jech.54.11.870; DEMARCHI B, 1991, RISK ANAL, V11, P207; EDLING A, 1998, HALLANDSASEN REPORT; KarlsonStiber C, 1996, J INTERN MED, V239, P451, DOI 10.1046/j.1365-2796.1996.484820000.x; Rosenlund M, 1999, ARCH ENVIRON HEALTH, V54, P52, DOI 10.1080/00039899909602237; ZAIDI SH, 1986, AM J IND MED, V9, P215	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2001	357	9254					411	412		10.1016/S0140-6736(00)04025-3	http://dx.doi.org/10.1016/S0140-6736(00)04025-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273057				2022-12-01	WOS:000166865600006
J	Sukharev, S; Betanzos, M; Chiang, CS; Guy, HR				Sukharev, S; Betanzos, M; Chiang, CS; Guy, HR			The gating mechanism of the large mechanosensitive channel MscL	NATURE			English	Article							ESCHERICHIA-COLI; ION-CHANNEL; SINGLE RESIDUE; PROTEIN; PRESSURE; HELIX	The mechanosensitive channel of large conductance, MscL, is a ubiquitous membrane-embedded valve involved in turgor regulation in bacteria(1-5). The crystal structure of MscL from Mycobacterium tuberculosis(6) provides a starting point for analysing molecular mechanisms of tension-dependent channel gating. Here we develop structural models in which a cytoplasmic gate is formed by a bundle of five amino-terminal helices (S1), previously unresolved in the crystal structure. When membrane tension is applied, the transmembrane barrel expands and pulls the gate apart through the S1-M1 linker. We tested these models by substituting cysteines for residues predicted to be near each other only in either the closed or open conformation. Our results demonstrate that S1 segments form the bundle when the channel is closed, and crosslinking between S1 segments prevents opening. S1 segments interact with M2 when the channel is open, and crosslinking of S1 to M2 impedes channel closing. Gating is affected by the length of the S1-M1 linker in a manner consistent with the model, revealing critical spatial relationships between the domains that transmit force from the lipid bilayer to the channel gate.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; NCI, Lab Expt & Computat Biol, DBS, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sukharev, S (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.			betanzos, monica/0000-0002-0358-043X; Sukharev, Sergei/0000-0002-4807-9665				Batiza AF, 1999, STRUCTURE, V7, pR99, DOI 10.1016/S0969-2126(99)80061-6; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu W, 1999, BIOPHYS J, V76, pA203; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Maurer JA, 2000, J BIOL CHEM, V275, P22238, DOI 10.1074/jbc.M003056200; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P448, DOI 10.1016/S0959-440X(99)80063-3; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; SUKHAREV SI, UNPUB BIOPHYS J; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	21	286	300	2	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					720	724		10.1038/35055559	http://dx.doi.org/10.1038/35055559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217861				2022-12-01	WOS:000166816400044
J	Askling, J; Dickman, PW; Karlen, P; Brostrom, O; Lapidus, A; Lofberg, R; Ekbom, A				Askling, J; Dickman, PW; Karlen, P; Brostrom, O; Lapidus, A; Lofberg, R; Ekbom, A			Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study	LANCET			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; INCREASED RISK; COLON-CANCER; SUSCEPTIBILITY	Background Inflammatory bowel disease (IBD) and colorectal cancer might share a common cause and, therefore, relatives of patients with IBD could be at increased risk of this malignant disease. We aimed to assess cancer rates among first-degree relatives of patients with IBD to try to determine whether an association between the two diseases exists. Methods In a population-based study, we identified 114 102 first-degree relatives by registry linkage and followed them up for cancer occurrence. We used standardised incidence ratio (SIR) of cancer as relative risk. Findings 560 colorectal cancers were identified among relatives. First-degree relatives of patients with Crohn's disease or ulcerative colitis were not at increased risk of cancer (SIR 0.90, 95% CI 0.82-0.97). The relative risk was 0.96 (0.87-1.06, n=379) for colon cancer and 0.78 (0.68-0.91, 181) for rectal cancer. The SIRs were not affected by age, relation of patient, or type or extent of IBD in the patient. Relatives of patients with both IBD and colorectal cancer had an 80% increased risk of colorectal cancer. Interpretation Our results do not endorse a common cause of IBD and colorectal cancer. The slightly decreased relative risk for colorectal cancer among relatives could indicate the proportion of all colorectal cancer cases attributable to IBD.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Karolinska Inst, Soder Hosp, Dept Med, Stockholm, Sweden; Ersta Hosp, Dept Gastroenterol, Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Gastroenterol, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Ersta Sjukhus; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Askling, J (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.	johan.askling@mep.ki.se	Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380				[Anonymous], 1999, CANCER CAUSE CONTROL, V10, P167; Bayless TM, 1996, GASTROENTEROLOGY, V111, P573, DOI 10.1053/gast.1996.v111.pm8780559; Breslow N E, 1987, IARC Sci Publ, P1; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fonager K, 1998, CANCER CAUSE CONTROL, V9, P389; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115; GYDE SN, 1988, GUT, V29, P206, DOI 10.1136/gut.29.2.206; Han SW, 1999, AM J GASTROENTEROL, V94, P2323, DOI 10.1111/j.1572-0241.1999.2323a.x; Karlen P, 1999, AM J GASTROENTEROL, V94, P1047; LENNARDJONES JE, 1971, SKANDIA INT S REGION, P105; Lunde A S, 1980, Vital Health Stat 2, P1; Lynch HT, 1999, J MED GENET, V36, P801; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; PERSSON PG, 1994, GASTROENTEROLOGY, V107, P1675, DOI 10.1016/0016-5085(94)90807-9; Pokorny RM, 1997, ANN SURG, V225, P718, DOI 10.1097/00000658-199706000-00009; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; Riegler G, 1998, J CLIN GASTROENTEROL, V27, P211, DOI 10.1097/00004836-199810000-00006; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SONDERGAARD JO, 1991, INT J CANCER, V47, P202, DOI 10.1002/ijc.2910470207; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; *SWED NAT BOARD HL, 1998, HOSP DISCH REG 1987; *WHO, 1955, MAN INT CLASS DIS IN	25	73	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					262	266		10.1016/S0140-6736(00)03612-6	http://dx.doi.org/10.1016/S0140-6736(00)03612-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214128				2022-12-01	WOS:000166693400010
J	Schumacher, MA; Hurlburt, BK; Brennan, RG				Schumacher, MA; Hurlburt, BK; Brennan, RG			Crystal structures of SarA, a pleiotropic regulator of virulence genes in S-aureus	NATURE			English	Article							STAPHYLOCOCCUS-AUREUS; AGR; LOCUS; TRANSCRIPTION; DIFFRACTION; EXPRESSION	Staphylococcus aureus is a major human pathogen, the potency of which can be attributed to the regulated expression of an impressive array of virulence determinants. A key pleiotropic transcriptional regulator of these virulence factors is SarA, which is encoded by the sar (staphylococcal accessory regulator) locus(1-3). SarA was characterized initially as an activator of a second virulence regulatory locus, agr, through its interaction with a series of heptad repeats (AGTTAAG) within the agr promoter(4). Subsequent DNA-binding studies have revealed that SarA binds readily to multiple AT-rich sequences of variable lengths(4-11). Here we describe the crystal structure of SarA and a SarA-DNA complex at resolutions of 2.50 Angstrom and 2.95 Angstrom, respectively. SarA has a fold consisting of a four-helix core region and `inducible regions' comprising a beta -hairpin and a carboxy-terminal loop. On binding DNA, the inducible regions undergo marked conformational changes, becoming part of extended and distorted alpha -helices, which encase the DNA. SarA recognizes an AT-rich site in which the DNA is highly overwound and adopts a D-DNA-like conformation by indirect readout. These structures thus provide insight into SarA-mediated transcription regulation.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Oregon Health & Science University; Oregon Health & Science University; University of Arkansas System; University of Arkansas Medical Sciences	Brennan, RG (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.			Brennan, Richard/0000-0001-7647-485X				BAXEVANIS AD, 1993, CURR OPIN GENET DEV, V3, P278, DOI 10.1016/0959-437X(93)90035-N; Blevins JS, 1999, MOL MICROBIOL, V33, P317, DOI 10.1046/j.1365-2958.1999.01475.x; Chan PF, 1998, J BACTERIOL, V180, P6232; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; CHEUNG AL, 1994, J BACTERIOL, V176, P4168, DOI 10.1128/JB.176.13.4168-4172.1994; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; *COLL COMP PROJ NU, 1994, J APPL CRYSTALLOGR D, V50, P760; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GASKILL ME, 1988, J BIOL CHEM, V263, P6276; Heinrichs JH, 1996, J BACTERIOL, V178, P418, DOI 10.1128/jb.178.2.418-423.1996; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; MAHENDRASINGAM A, 1986, SCIENCE, V233, P195, DOI 10.1126/science.3726529; Manna AC, 1998, J BACTERIOL, V180, P3828, DOI 10.1128/JB.180.15.3828-3836.1998; Morfeldt E, 1996, MOL MICROBIOL, V21, P1227, DOI 10.1046/j.1365-2958.1996.751447.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OBERTO J, 1994, BIOCHIMIE, V76, P901, DOI 10.1016/0300-9084(94)90014-0; PROJAN SJ, 1997, STAPHYLOCOCCI HUMAN, P55; PRUSS GJ, 1989, CELL, V56, P521, DOI 10.1016/0092-8674(89)90574-6; Rechtin TM, 1999, MOL MICROBIOL, V33, P307, DOI 10.1046/j.1365-2958.1999.01474.x; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Saenger W, 2013, PRINCIPLES NUCL ACID; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Wolz C, 2000, MOL MICROBIOL, V36, P230, DOI 10.1046/j.1365-2958.2000.01853.x	29	48	51	2	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					215	219		10.1038/35051623	http://dx.doi.org/10.1038/35051623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196648				2022-12-01	WOS:000166316200050
J	Lagaaij, EL; Cramer-Knijnenburg, GF; van Kemenade, FJ; van Es, LA; Bruijn, JA; van Krieken, JHJM				Lagaaij, EL; Cramer-Knijnenburg, GF; van Kemenade, FJ; van Es, LA; Bruijn, JA; van Krieken, JHJM			Endothelial cell chimerism after renal transplantation and vascular rejection	LANCET			English	Article							MONOCLONAL-ANTIBODIES; INSITU HYBRIDIZATION; ALLOGRAFTS; IMMUNOHISTOCHEMISTRY; SENSITIVITY; XENOGRAFTS; ADAPTATION	Background The blood vessels of a transplanted organ are the interface between donor and recipient. The endothelium in the blood vessels is thought to be the major target for graft rejection. Endothelial cells of a transplanted organ are believed to remain of donor origin after transplantation. We aimed to verify this concept. Methods We studied biopsy samples from 12 renal transplants for the presence of endothelial cells of recipient origin. We used three different techniques: immunohistochemistry for MHC class-I antigens, immunohistochemistry for ABO-blood-group antigens, and in-situ hybridisation for X and Y chromosomes. After we had conformed that these techniques did identify endothelial cells of recipient origin, tests were done in a second group of 26 patients to find out whether endothelial chimerism correlated with graft rejection. Findings We found a strong correlation between the percentage of recipient endothelial cells in the peritubular capillaries and the type of graft rejection (r=0.71, p<0.0001). These cells were found mainly in grafts of patients who had had rejection, especially among patients with vascular rejection. In grafts of patients without rejection only sporadically recipient endothelial cells were delectable. Interpretation Our data show that endothelial cells of the recipient can replace those of the donor. This replacement is associated with graft rejection, We postulate that endothelium that is damaged by vascular rejection is repaired by endothelial cells of the recipient.	Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands; Univ Nijmegen Hosp, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Lagaaij, EL (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, POB 9600, NL-2300 RC Leiden, Netherlands.		van Krieken, Joannes H J M/D-4138-2009	van Krieken, Joannes H J M/0000-0001-6544-1040				ANDERSEN CB, 1991, APMIS, V99, P645, DOI 10.1111/j.1699-0463.1991.tb01240.x; ASHARA T, 1997, SCIENCE, V275, P964; BOGMAN MJJT, 1987, TRANSPLANT P, V19, P205; BURDICK JF, 1979, J IMMUNOL, V123, P1732; HART DNJ, 1980, TRANSPLANTATION, V30, P73, DOI 10.1097/00007890-198007000-00016; JOOSTE SV, 1981, J EXP MED, V154, P1332, DOI 10.1084/jem.154.5.1332; KIBBELAAR RE, 1992, J CLIN PATHOL, V45, P149, DOI 10.1136/jcp.45.2.149; KOENE RAP, 1989, KIDNEY INT, V35, P1073, DOI 10.1038/ki.1989.92; Lagaaij EL, 1997, HISTOPATHOLOGY, V31, P284, DOI 10.1046/j.1365-2559.1997.2590861.x; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lubin BH, 1997, NEW ENGL J MED, V337, P1623, DOI 10.1056/NEJM199711273372210; MEDAWAR PB, 1965, BRIT MED BULL, V21, P97, DOI 10.1093/oxfordjournals.bmb.a070392; NAKANE PK, 1968, J HISTOCHEM CYTOCHEM, V16, P557, DOI 10.1177/16.9.557; SINCLAIR RA, 1972, BRIT MED J, V4, P15, DOI 10.1136/bmj.4.5831.15; Solez K, 1996, TRANSPLANT P, V28, P441; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; VANSAASE JLCM, 1995, TRANSPLANTATION, V59, P1280, DOI 10.1097/00007890-199505000-00010; WILLIAMS GM, 1973, TRANSPL P, V5, P819; WOODRUFF MFA, 1953, TRANSPLAN B, V1, P221	19	242	254	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					33	37		10.1016/S0140-6736(00)03569-8	http://dx.doi.org/10.1016/S0140-6736(00)03569-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197359				2022-12-01	WOS:000166341500013
J	Yusupov, MM; Yusupova, GZ; Baucom, A; Lieberman, K; Earnest, TN; Cate, JHD; Noller, HF				Yusupov, MM; Yusupova, GZ; Baucom, A; Lieberman, K; Earnest, TN; Cate, JHD; Noller, HF			Crystal structure of the ribosome at 5.5 angstrom resolution	SCIENCE			English	Article							ESCHERICHIA-COLI RIBOSOME; PEPTIDYL TRANSFERASE CENTER; SECONDARY STRUCTURE MODEL; TRANSFER-RNA; A-SITE; 70S RIBOSOME; P-SITE; CRYOELECTRON MICROSCOPY; CONFORMATIONAL SWITCH; THERMUS-THERMOPHILUS	We describe the crystal structure of the complete Thermus thermophilus 70S ribosome containing bound messenger RNA and transfer RNAs (tRNAs) at 5.5 angstrom resolution. All of the 16S, 23S, and 5S ribosomal RNA (rRNA) chains, the A-, P-, and E-site tRNAs, and most of the ribosomal proteins can be fitted to the electron density map. The core of the interface between the 30S small subunit and the 50S large subunit, where the tRNA substrates are bound, is dominated by RNA, with proteins located mainly at the periphery, consistent with ribosomal function being based on rRNA. In each of the three tRNA binding sites, the ribosome contacts all of the major elements of tRNA, providing an explanation for the conservation of tRNA structure. The tRNAs are closely juxtaposed with the intersubunit bridges, in a way that suggests coupling of the 20 to 50 angstrom movements associated with tRNA translocation with intersubunit movement.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Sinsheimer Labs, Santa Cruz, CA 95064 USA; Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Phys Biosci Div, Berkeley, CA 94720 USA; Whitehead Inst, Cambridge, MA 01242 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Whitehead Institute	Noller, HF (corresponding author), IGBMC, CNRS, UPR Biol & Genom Struct 9004, BP 163,1 Rue L Fries, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.		Yusupova, Gulnara/E-1877-2014; Yusupov, Marat/I-6126-2013	Yusupov, Marat/0000-0001-5544-0597				Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; BARTA A, 1984, P NATL ACAD SCI-BIOL, V81, P3607, DOI 10.1073/pnas.81.12.3607; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Cooperman BS, 1995, BIOCHEM CELL BIOL, V73, P1087, DOI 10.1139/o95-117; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; DORING T, 1994, EMBO J, V13, P2677, DOI 10.1002/j.1460-2075.1994.tb06558.x; FEINBERG JS, COMMUNICATION; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; GARRETT RA, 2000, RIBOSOME; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Green R, 1998, SCIENCE, V280, P286, DOI 10.1126/science.280.5361.286; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 1994, NUCLEIC ACIDS RES, V22, P3502, DOI 10.1093/nar/22.17.3502; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; HERR W, 1979, J MOL BIOL, V130, P433, DOI 10.1016/0022-2836(79)90433-9; Hill WE., 1990, RIBOSOME STRUCTURE F; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joseph S, 1996, EMBO J, V15, P910, DOI 10.1002/j.1460-2075.1996.tb00425.x; Joseph S, 1997, SCIENCE, V278, P1093, DOI 10.1126/science.278.5340.1093; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; KURLAND CG, 1990, RIBOSOME, P513; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MAKOWSKI I, 1987, J MOL BIOL, V193, P819, DOI 10.1016/0022-2836(87)90362-7; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; MATHESON AT, 1995, BIOCH CELL BIOL, V73; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; Merryman C, 1999, J MOL BIOL, V285, P107, DOI 10.1006/jmbi.1998.2243; MITCHELL P, 1992, BIOCHEMISTRY-US, V31, P3004, DOI 10.1021/bi00126a023; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MOUGEL M, 1987, J MOL BIOL, V198, P91, DOI 10.1016/0022-2836(87)90460-8; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NISSEN P, 2001, PNATL ACAD SCI  0410; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1972, P NATL ACAD SCI USA, V69, P3115, DOI 10.1073/pnas.69.11.3115; OAKES MI, 1990, RIBOSOME, P180; OCONNOR M, 1995, J MOL BIOL, V254, P838, DOI 10.1006/jmbi.1995.0659; OFENGAND J, 1986, STRUCTURE FUNCTION G, P473; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schnitzer W, 1997, P NATL ACAD SCI USA, V94, P12823, DOI 10.1073/pnas.94.24.12823; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STOFFLERMEILICKE M, 1990, RIBOSOME, P123; TRAKHANOV S, 1989, J MOL BIOL, V209, P327, DOI 10.1016/0022-2836(89)90282-9; Uhlein M, 1998, BIOCHEM J, V331, P423; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; WEISER B, UNPUB; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; YUSUPOV MM, 1991, BIOCHIMIE, V73, P887, DOI 10.1016/0300-9084(91)90130-S	86	1598	1704	3	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					883	896		10.1126/science.1060089	http://dx.doi.org/10.1126/science.1060089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11283358				2022-12-01	WOS:000168514900033
J	Vadas, P; Wai, Y; Burks, W; Perelman, B				Vadas, P; Wai, Y; Burks, W; Perelman, B			Detection of peanut allergens in breast milk of lactating women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BOVINE BETA-LACTOGLOBULIN; COWS MILK; MATERNAL DIET; NUT ALLERGY; FED INFANTS; FOOD; CHILDREN; MOTHERS; EGG; HYPERSENSITIVITY	Context Most individuals who react to peanuts do so on their first known exposure. A potential but unproven route of occult exposure resulting in sensitization to peanut is via breast milk during lactation. Objective To investigate the ability of maternal dietary peanut protein to pass into breast milk during lactation, Design and Setting Clinical investigation conducted at 2 North American hospitals from March 1999 to October 2000, Patients Twenty-three healthy, lactating women aged 21 to 35 years. Intervention Each woman consumed 50 g of dry roasted peanuts, after which breast milk samples were collected at hourly intervals. Main Outcome Measures Presence in breast milk of total peanut protein, analyzed by a sandwich enzyme-linked immunosorbent assay, and 2 major peanut allergens, Ara h 1 and Ara h 2, detected by immunoblot analysis. Results Peanut protein was detected in 11 of 23 subjects, It was detected in 10 subjects within 2 hours of ingestion and in 1 subject within 6 hours. The median peak peanut protein concentration in breast milk was 200 ng/mL (mean, 222 ng/mL; range, 120-430 ng/mL). Both major peanut allergens Ara h 1 and Ara h 2 were detected. Conclusions Peanut protein is secreted into breast milk of lactating women following maternal dietary ingestion, Exposure to peanut protein during breastfeeding is a route of occult exposure that may result in sensitization of at-risk infants.	Univ Toronto, St Michaels Hosp, Div Clin Immunol & Allergy, Toronto, ON M5B 1W8, Canada; Univ Arkansas Med Sci, Arkansas Childrens Hosp, Little Rock, AR 72205 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Vadas, P (corresponding author), Univ Toronto, St Michaels Hosp, Div Clin Immunol & Allergy, Room 8-161,Victoria Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.							ASSEM ESK, 1990, BRIT MED J, V300, P1377, DOI 10.1136/bmj.300.6736.1377; AXELSSON I, 1986, ACTA PAEDIATR SCAND, V75, P702, DOI 10.1111/j.1651-2227.1986.tb10277.x; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; CANT A, 1985, BRIT MED J, V291, P932, DOI 10.1136/bmj.291.6500.932; Chirdo FG, 1998, SCAND J GASTROENTERO, V33, P1186, DOI 10.1080/00365529850172557; Duchen K, 1991, Adv Exp Med Biol, V310, P427; Ewan PW, 1996, BRIT MED J, V312, P1074; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Fukushima Y, 1997, AM J CLIN NUTR, V65, P30, DOI 10.1093/ajcn/65.1.30; GERRARD JW, 1986, ANN ALLERGY, V56, P351; HOST A, 1990, CLIN EXP ALLERGY, V20, P383, DOI 10.1111/j.1365-2222.1990.tb02798.x; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P1240, DOI [10.1111/j.1365-2222.1997.tb01167.x, 10.1046/j.1365-2222.1997.1520954.x]; Hourihane JO, 1998, BRIT MED J, V316, P1271, DOI 10.1136/bmj.316.7140.1271; KILSHAW PJ, 1984, INT ARCH ALLER A IMM, V75, P8, DOI 10.1159/000233582; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; SORVA R, 1994, J ALLERGY CLIN IMMUN, V93, P787, DOI 10.1016/0091-6749(94)90259-3; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514; TRONCONE R, 1987, ACTA PAEDIATR SCAND, V76, P453, DOI 10.1111/j.1651-2227.1987.tb10498.x; VANASPEREN PP, 1983, ARCH DIS CHILD, V58, P253, DOI 10.1136/adc.58.4.253; WARNER JO, 1980, CLIN ALLERGY, V10, P133, DOI 10.1111/j.1365-2222.1980.tb02090.x	23	150	155	1	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1746	1748		10.1001/jama.285.13.1746	http://dx.doi.org/10.1001/jama.285.13.1746			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277829	Bronze			2022-12-01	WOS:000167710600028
J	Tchernichovski, O; Mitra, PP; Lints, T; Nottebohm, F				Tchernichovski, O; Mitra, PP; Lints, T; Nottebohm, F			Dynamics of the vocal imitation process: How a zebra finch learns its song	SCIENCE			English	Editorial Material							MODEL; BIRDSONG	Song imitation in birds provides good material for studying the basic biology of vocal learning. Techniques were developed for inducing the rapid onset of song imitation in young zebra finches and for tracking trajectories of vocal change over a 7-week period until a match to a model song was achieved. Exposure to a model song induced the prompt generation of repeated structured sounds (prototypes) followed by a slow transition from repetitive to serial delivery of syllables. Tracking this transition revealed two phenomena: (i) imitations of dissimilar sounds can emerge from successive renditions of the same prototype, and (ii) developmental trajectories for some sounds followed paths of increasing acoustic mismatch until an abrupt correction occurred by period doubling. These dynamics are Likely to reflect underlying neural and articulatory constraints on the production and imitation of sounds.	Rockefeller Univ, Field Res Ctr, Millbrook, NY 12545 USA; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	Rockefeller University; Alcatel-Lucent; Lucent Technologies; AT&T	Tchernichovski, O (corresponding author), Rockefeller Univ, Field Res Ctr, Millbrook, NY 12545 USA.	tcherno@mail.rockefeller.edu	Tchernichovski, Ofer/AAC-5678-2019; Lints, Thierry/K-4408-2012	Tchernichovski, Ofer/0000-0001-6788-614X; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018343, R37MH018343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC04722-01] Funding Source: Medline; NIMH NIH HHS [MH18343] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADRET P, 1993, ANIM BEHAV, V46, P149, DOI 10.1006/anbe.1993.1170; CLARK CW, 1987, ETHOLOGY, V76, P101; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; HULTSCH H, 1992, ANIM BEHAV, V44, P590, DOI 10.1016/0003-3472(92)90074-J; Immelmann K., 1969, P61; Jones AE, 1996, J COMP PSYCHOL, V110, P354; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; Oller D. K., 1980, CHILD PHONOLOGY, V1, P93, DOI [DOI 10.1016/B978-0-12-770601-6.50011-5, 10.1016/B978-0-12-770601-6.50011-5]; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; ROUG L, 1989, J CHILD LANG, V16, P19, DOI 10.1017/S0305000900013416; Stark RE., 1980, CHILD PHONOLOGY, P73, DOI DOI 10.1016/B978-0-12-770601-6.50010-3; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 1998, P NATL ACAD SCI USA, V95, P8951, DOI 10.1073/pnas.95.15.8951; Tchernichovski O, 1999, P NATL ACAD SCI USA, V96, P12901, DOI 10.1073/pnas.96.22.12901; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; VIHMAN MM, 1993, NATO ADV SCI INST SE, V69, P411; Zann R.A., 1996, ZEBRA FINCH SYNTHESI	22	348	351	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2564	2569		10.1126/science.1058522	http://dx.doi.org/10.1126/science.1058522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283361				2022-12-01	WOS:000167861000031
J	Vickers, NJ; Christensen, TA; Baker, TC; Hildebrand, JG				Vickers, NJ; Christensen, TA; Baker, TC; Hildebrand, JG			Odour-plume dynamics influence the brain's olfactory code	NATURE			English	Article							OSCILLATING NEURAL ASSEMBLIES; ODORS; REPRESENTATIONS; INFORMATION; NETWORK; MOTHS; RESPONSES; GLOMERULI	The neural computations used to represent olfactory information in the brain have long been investigated(1-3). Recent studies in the insect antennal lobe suggest that precise temporal and/or spatial patterns of activity underlie the recognition and discrimination of different odours(3-7), and that these patterns may be strengthened by associative learning(8,9). It remains unknown, however, whether these activity patterns persist when odour intensity varies rapidly and unpredictably, as often occurs in nature(10,11). Here we show that with naturally intermittent odour stimulation, spike patterns recorded from moth antennal-lobe output neurons varied predictably with the fine-scale temporal dynamics and intensity of the odour. These data support the hypothesis that olfactory circuits compensate for contextual variations in the stimulus pattern with high temporal precision. The timing of output neuron activity is constantly modulated to reflect ongoing changes in stimulus intensity and dynamics that occur on a millisecond timescale.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	University of Arizona; Iowa State University	Vickers, NJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.			Vickers, Neil/0000-0002-0378-8724				Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Baker TC, 1997, INSECT PHEROMONE RESEARCH, P248; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; CHRISTENSEN TA, 1995, J COMP PHYSIOL A, V177, P545, DOI 10.1007/BF00207184; Christensen TA, 1996, J NEUROBIOL, V30, P82, DOI 10.1002/(SICI)1097-4695(199605)30:1<82::AID-NEU8>3.0.CO;2-C; Christensen TA, 1998, J NEUROSCI, V18, P5999; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CHRISTENSEN TA, 2001, NEUROBIOLOGY TAST SM, V2, P201; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Hansson Bill S., 1999, P125; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; King JR, 2000, J NEUROSCI, V20, P2391; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; LEI H, 2000, SOC NEUR ABSTR, V26, P1208; Murlis J, 1997, INSECT PHEROMONE RESEARCH, P221; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Vickers NJ, 1998, J COMP NEUROL, V400, P35; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	23	185	192	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					466	470		10.1038/35068559	http://dx.doi.org/10.1038/35068559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260713				2022-12-01	WOS:000167583800041
J	Stoler, MH; Schiffman, M				Stoler, MH; Schiffman, M		Atypical Squamous Cells Undetermin	Interobserver reproducibility of cervical cytologic and histologic interpretations - Realistic estimates from the ASCUS-LSIL triage study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATYPICAL GLANDULAR CELLS; HISTOPATHOLOGICAL DIAGNOSIS; UNDETERMINED SIGNIFICANCE; OBSERVER VARIATION; BIOPSY SPECIMENS; VARIABILITY; AGREEMENT; ABNORMALITIES; DYSPLASIA; CRITERIA	Context Despite a critical presumption of reliability, standards of interpathologist agreement have not been well defined for interpretation of cervical pathology specimens. Objective To determine the reproducibility of cytologic, colposcopic histologic, and loop electrosurgical excision procedure (LEEP) histologic cervical specimen interpretations among multiple well-trained observers. Design and Setting The Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion (ASCUS-LSIL) Triage Study (ALTS), an ongoing US multicenter clinical trial. Subjects From women enrolled in ALTS during 1996-1998, 4948 monolayer cytologic slides, 2237 colposcopic biopsies, and 535 LEEP specimens were interpreted by 7 clinical center and 4 Pathology Quality Control Group (QC) pathologists. Main Outcome Measures kappa Values calculated for comparison of the original clinical center interpretation and the first QC reviewer's masked interpretation of specimens. Results For all 3 specimen types, the clinical center pathologists rendered significantly more severe interpretations than did reviewing QC pathologists. The reproducibility of monolayer cytologic interpretations was moderate (kappa =0.46; 95% confidence interval [CI], 0.44-0.48) and equivalent to the reproducibility of punch biopsy histopathologic interpretations (kappa =0.46; 95% CI, 0.43-0.49) and LEEP histopathologic interpretations (kappa =0.49; 95% CI, 0.44-0.55), The lack of reproducibility of histopathology was most evident for less severe interpretations. Conclusions Interpretive variability is substantial for all types of cervical specimens. Histopathology of cervical biopsies is not more reproducible than monolayer cytology, and even the interpretation of LEEP results is variable. Given the degree of irreproducibility that exists among well-trained pathologists, realistic performance expectations should guide use of their interpretations.	Univ Virginia Hlth Syst, Div Surg Pathol & Cytopathol, Charlottesville, VA 22908 USA; NCI, Bethesda, MD 20892 USA	University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stoler, MH (corresponding author), Univ Virginia Hlth Syst, Div Surg Pathol & Cytopathol, Box 800214, Charlottesville, VA 22908 USA.		Schiffman, Mark/B-9766-2015		DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055159, N01CN055105, N01CN055153, N01CN055154, N01CN055156, N01CN055155, N01CN055157] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NCI NIH HHS [CN55155, CN15518, CN55159, CN55105, CN55157, CN55153, CN55156, CN55154] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COCKER J, 1968, J CLIN PATHOL, V21, P67, DOI 10.1136/jcp.21.1.67; CONFORTINI M, 1993, ACTA CYTOL, V37, P49; CREAGH T, 1995, J CLIN PATHOL, V48, P9; Crum CP, 1999, AM J CLIN PATHOL, V112, P384; DEVET HCW, 1992, J CLIN EPIDEMIOL, V45, P785, DOI 10.1016/0895-4356(92)90056-S; DEVET HCW, 1990, J CLIN EPIDEMIOL, V43, P1395, DOI 10.1016/0895-4356(90)90107-Z; DEVET HCW, 1995, J CLIN EPIDEMIOL, V48, P869, DOI 10.1016/0895-4356(94)00225-F; EVANS DMD, 1974, J CLIN PATHOL, V27, P945, DOI 10.1136/jcp.27.12.945; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Ferris D G, 1998, J Low Genit Tract Dis, V2, P195, DOI 10.1097/00128360-199810000-00003; Fleiss JL, 1981, STAT METHODS RATES P, P218; GENEST DR, 1993, HUM PATHOL, V24, P730, DOI 10.1016/0046-8177(93)90009-6; HORN PL, 1985, ACTA CYTOL, V29, P692; ISMAIL SM, 1989, BRIT MED J, V298, P707, DOI 10.1136/bmj.298.6675.707; KLINKHAMER PJJM, 1988, ACTA CYTOL, V32, P794; LAMBOURNE A, 1973, J CLIN PATHOL, V26, P564, DOI 10.1136/jcp.26.8.564; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCluggage WG, 1996, J CLIN PATHOL, V49, P833, DOI 10.1136/jcp.49.10.833; Raab SS, 1997, AM J CLIN PATHOL, V107, P299, DOI 10.1093/ajcp/107.3.299; Raab SS, 1998, AM J CLIN PATHOL, V110, P653, DOI 10.1093/ajcp/110.5.653; RINGSTED J, 1978, ACTA PATH MICRO IM A, V86, P273; ROBERTSON AJ, 1989, J CLIN PATHOL, V42, P231, DOI 10.1136/jcp.42.3.231; Schiffman M, 2000, ACTA CYTOL, V44, P726, DOI 10.1159/000328554; SELLORS JW, 1990, OBSTET GYNECOL, V76, P1005; SEYBOLT JF, 1971, AM J OBSTET GYNECOL, V109, P1089, DOI 10.1016/0002-9378(71)90297-3; SHERMAN ME, 1994, AM J CLIN PATHOL, V102, P182, DOI 10.1093/ajcp/102.2.182; Sherman ME, 1999, MODERN PATHOL, V12, P335; SIEGLER EE, 1956, CANCER, V9, P463, DOI 10.1002/1097-0142(195605/06)9:3<463::AID-CNCR2820090306>3.0.CO;2-8; Stoler MH, 2000, MODERN PATHOL, V13, P275, DOI 10.1038/modpathol.3880048; Stoler MH, 1999, CANCER CYTOPATHOL, V87, P45, DOI 10.1002/(SICI)1097-0142(19990425)87:2<45::AID-CNCR1>3.0.CO;2-J; YOBS AR, 1987, ACTA CYTOL, V31, P900; YOUNG NA, 1994, DIAGN CYTOPATHOL, V11, P352, DOI 10.1002/dc.2840110408	32	766	806	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1500	1505		10.1001/jama.285.11.1500	http://dx.doi.org/10.1001/jama.285.11.1500			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255427	Bronze			2022-12-01	WOS:000167462100033
J	Koch, A; Melbye, M; Sorensen, P; Homoe, P; Madsen, HO; Molbak, K; Hansen, CH; Andersen, LH; Hahn, GW; Garred, P				Koch, A; Melbye, M; Sorensen, P; Homoe, P; Madsen, HO; Molbak, K; Hansen, CH; Andersen, LH; Hahn, GW; Garred, P			Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTEIN GENE; SERINE-PROTEASE; OTITIS-MEDIA; ASSOCIATION; CHILDREN; MUTATIONS; SUSCEPTIBILITY; POPULATIONS; COMPLEMENT; ADULTS	Context Hospital-based studies have found that increased susceptibility to certain infections is associated with low serum levels of mannose-binding lectin (MBL) due to MBL variant alleles, However, the contribution of MBL insufficiency to incidence of common childhood infections at a population level is unknown, Objective To investigate the effect of MBL insufficiency on risk for acute respiratory tract infection (ARI) in unselected children younger than 2 years. Design and Setting Population-based, prospective, cohort study conducted in Sisimiut, Greenland, Participants Two hundred fifty-two children younger than 2 years who were followed up weekly between August 1996 and August 1998 for morbidity surveillance. Main Outcome Measure Risk of ARI, based on medical history and clinical examination, compared by MBL genotype, determined from blood samples based on presence of structural and promoter alleles. Results A 2.08-fold (95% confidence interval [CI], 1.41-3.06) increased relative risk (RR) of ARI was found in MBL-insufficient children (n = 13) compared with MBL sufficient children (n = 239; P < .001), The risk association was largely restricted to children aged 6 to 17 months (RR, 2.92; 95% CI, 1.78-4.79) while less effect (RR, 1.47; 95% CI, 0.45-4.82) and no effect (RR, 1.00; 95% CI, 0.42-2.37) was shown among children aged 0 to 5 months and 18 to 23 months, respectively, Conclusion These data suggest that genetic factors such as MBL insufficiency play an important role in host defense, particularly during the vulnerable period of childhood from age 6 through 17 months, when the adaptive immune system is immature.	Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Natl Univ Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg, Copenhagen, Denmark; Natl Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Koch, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen, Denmark.		Madsen, Hans O/Q-2035-2015; Hahn, Gitte/AAN-4967-2020	Madsen, Hans O/0000-0001-5551-4787; Koch, Anders/0000-0001-9205-1048; Molbak, Kare/0000-0002-3100-4990; melbye, mads/0000-0001-8264-6785; Garred, Peter/0000-0002-2876-8586; Sorensen, Per Soelberg/0000-0002-2818-3780; Homoe, Preben/0000-0003-2877-3518				BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; DENNY FW, 1986, REV INFECT DIS, V8, P527; Diggle P., 2002, ANAL LONGITUDINAL DA; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; GARRED P, 1993, CLIN EXP IMMUNOL, V94, P99; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; Garred P, 2000, J RHEUMATOL, V27, P26; GARRED P, 1995, LANCET, V346, P94; Garred P, 1996, COLLECTINS INNATE IM, P139; *GENMOD PROC, 1996, SAS STAT SOFTW CHANG, P21; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Homoe P, 1999, SCAND J INFECT DIS, V31, P363, DOI 10.1080/00365549950163798; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175; SELWYN BJ, 1990, REV INFECT DIS, V12, P870; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; TAYLOR ME, 1989, BIOCHEM J, V262, P763, DOI 10.1042/bj2620763; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner M W, 1991, Clin Exp Allergy, V21 Suppl 1, P182, DOI 10.1111/j.1365-2222.1991.tb01725.x; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; TURNER MW, 1994, BIOCHEM SOC T, V22, P88, DOI 10.1042/bst0220088	33	349	363	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1316	1321		10.1001/jama.285.10.1316	http://dx.doi.org/10.1001/jama.285.10.1316			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255386	Bronze			2022-12-01	WOS:000167339000023
J	Kahana, JA; Cleveland, DW				Kahana, JA; Cleveland, DW			Cell cycle - Some importin news about spindle assembly	SCIENCE			English	Editorial Material							XENOPUS EGG EXTRACTS; GTP-BOUND RAN; MITOTIC SPINDLE; MICROTUBULE ASTERS; ORGANIZATION; NUMA		Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Kahana, JA (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682				Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhang CM, 1999, J CELL SCI, V112, P2453	14	27	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1718	1719		10.1126/science.1059765	http://dx.doi.org/10.1126/science.1059765			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11253198				2022-12-01	WOS:000167320600036
J	Riha, K; McKnight, TD; Griffing, LR; Shippen, DE				Riha, K; McKnight, TD; Griffing, LR; Shippen, DE			Living with genome instability: Plant responses to telomere dysfunction	SCIENCE			English	Article							CELLS; P53; REPAIR	Loss of telomere function in metazoans results in catastrophic damage to the genome, cell cycle arrest, and apoptosis, Here we show that the mustard weed Arabidopsis thaliana can survive up to 10 generations without telomerase. The Last five generations of telomerase-deficient plants endured increasing Levels of cytogenetic damage, which was correlated with developmental anomalies in both vegetative and reproductive organs. Mutants ultimately arrested at a terminal vegetative state harboring shoot meristems that were grossly enlarged, disorganized, and in some cases, dedifferentiated into a callusoid mass. Unexpectedly, Late-generation mutants had an extended Life-span and remained metabolically active. The differences in plant and animal responses to dysfunctional telomeres may reflect the more plastic nature of plant development and genome organization.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.	dshippen@tamu.edu	McKnight, Thomas/C-1395-2010; Riha, Karel/A-7717-2008; Riha, Karel/AAM-4429-2021; Riha, Karel/P-9614-2018	Riha, Karel/0000-0002-6124-0118; Riha, Karel/0000-0002-6124-0118				Ahmad K, 1999, GENETICS, V151, P1041; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bleecker AB, 1998, CURR OPIN PLANT BIOL, V1, P73, DOI 10.1016/S1369-5266(98)80131-3; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Clark SE, 1997, TRENDS CELL BIOL, V7, P454, DOI 10.1016/S0962-8924(97)01152-5; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Heslop-Harrison JS, 1998, METH MOL B, V82, P119; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Klosterman SJ, 2000, PHYSIOL MOL PLANT P, V56, P197, DOI 10.1006/pmpp.2000.0267; Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1998, SEMIN CELL DEV BIOL, V9, P195, DOI 10.1006/scdb.1997.0208; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Lundblad V, 1998, P NATL ACAD SCI USA, V95, P8415, DOI 10.1073/pnas.95.15.8415; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Oulton R, 2000, CURR OPIN ONCOL, V12, P74, DOI 10.1097/00001622-200001000-00013; RIHA K, UNPUB; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Vasil V, 1984, CELL CULTURE SOMATIC, P738; Walbot V, 1996, TRENDS PLANT SCI, V1, P27, DOI 10.1016/S1360-1385(96)80020-3	29	175	181	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1797	1800		10.1126/science.1057110	http://dx.doi.org/10.1126/science.1057110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230697				2022-12-01	WOS:000167320600062
J	Lin, CLG; Orlov, I; Ruggiero, AM; Dykes-Hoberg, M; Lee, A; Jackson, M; Rothstein, JD				Lin, CLG; Orlov, I; Ruggiero, AM; Dykes-Hoberg, M; Lee, A; Jackson, M; Rothstein, JD			Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18	NATURE			English	Article							CELL-SURFACE EXPRESSION; SYNAPTIC LOCALIZATION; SUBTYPE; ACTIVATION; ASTROCYTES; KIDNEY	Excitatory amino-acid carrier 1 (EAAC1) is a high-affinity Na+-dependent L-glutamate/D, L-aspartate cell-membrane transport protein 1. It is expressed in brain as well as several non-nervous tissues. In brain, EAAC1 is the primary neuronal glutamate transporter(2,3). It has a polarized distribution in cells and mainly functions perisynaptically to transport glutamate from the extracellular environment(2-4). In the kidney it is involved in renal acidic amino-acid re-absorption and amino-acid metabolism(5-7). Here we describe the identification and characterization of an EAAC1-associated protein, GTRAP3-18. Like EAAC1, GTRAP3-18 is expressed in numerous tissues(8,9). It localizes to the cell membrane and cytoplasm, and specifically interacts with carboxy-terminal intracellular domain of EAAC1. Increasing the expression of GTRAP3-18 in cells reduces EAAC1-mediated glutamate transport by lowering substrate affinity. The expression of GTRAP3-18 can be upregulated by retinoic acid, which results in a specific reduction of EAAC1-mediated glutamate transport. These studies show that glutamate transport proteins can be regulated potently and that GTRAP can modulate the transport functions ascribed to EAAC1. GTRAP3-18 may be important in regulating the metabolic function of EAAC1.	Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol & Neurosci, Meyer 6-109,600 N Wolfe St, Baltimore, MD 21287 USA.		rothstein, jeffrey d/C-9470-2013; Lin, Chien-liang G/E-3513-2011					Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 1997, J NEUROSCI, V17, P4672; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; He Y, 2000, J COMP NEUROL, V418, P255; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF487, DOI 10.1152/ajprenal.1999.277.4.F487; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477, DOI 10.1152/ajprenal.1999.277.4.F477; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lin CLG, 1998, MOL BRAIN RES, V63, P174, DOI 10.1016/S0169-328X(98)00256-3; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SEPKUTY JP, 1997, SOC NEUR ABSTR, V23, P1484; Shayakul C, 1997, AM J PHYSIOL-RENAL, V273, pF1023, DOI 10.1152/ajprenal.1997.273.6.F1023; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228	19	180	194	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					84	88		10.1038/35065084	http://dx.doi.org/10.1038/35065084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242046				2022-12-01	WOS:000167194300047
J	Plante, OJ; Palmacci, ER; Seeberger, PH				Plante, OJ; Palmacci, ER; Seeberger, PH			Automated solid-phase synthesis of oligosaccharides	SCIENCE			English	Article							CARBOHYDRATE ANTIGENS; HEPTASACCHARIDE; DONORS	Traditionally, access to structurally defined complex carbohydrates has been very Laborious, Although recent advancements in solid-phase synthesis have made the construction of complex oligosaccharides Less tedious, a high Level of technical expertise is still necessary to obtain the desired structures. We describe the automated chemical synthesis of several oligosaccharides on a solid-phase synthesizer. A branched dodecasaccharide was synthesized through the use of glycosyl phosphate building blocks and an octenediol functionalized resin. The target oligosaccharide was readily obtained after cleavage from the solid support. Access to certain complex oligosaccharides now has become feasible ina fashion much Like the construction of oligopeptides and oligonucleotides.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Seeberger, PH (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	seeberg@mit.edu			NCRR NIH HHS [RR-00995] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andrade RB, 1999, ORG LETT, V1, P1811, DOI 10.1021/ol991071+; [Anonymous], CARBOHYDRATE CHEM; Atherton E., 1989, SOLID PHASE PEPTIDE; BUNDLE DR, 1979, CAN J CHEM, V57, P662, DOI 10.1139/v79-106; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573; DARVILL A, 1992, GLYCOBIOLOGY, V2, P181, DOI 10.1093/glycob/2.3.181; Deshpande PP, 1997, NATURE, V387, P164, DOI 10.1038/387164a0; DOUGLAS SP, 1995, J AM CHEM SOC, V117, P2116, DOI 10.1021/ja00112a035; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; FERFUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FRECHET JM, 1971, J AM CHEM SOC, V93, P492; FUGEDI P, 1987, CARBOHYD RES, V164, P297, DOI 10.1016/0008-6215(87)80137-4; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Ito Y, 1998, CURR OPIN CHEM BIOL, V2, P701, DOI 10.1016/S1367-5931(98)80106-3; KAHNE D, 1989, J AM CHEM SOC, V111, P6881, DOI 10.1021/ja00199a081; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520; LONN H, 1985, CARBOHYD RES, V139, P105, DOI 10.1016/0008-6215(85)90011-4; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Nicolaou KC, 1997, J AM CHEM SOC, V119, P449, DOI 10.1021/ja963482g; Plante OJ, 1999, ORG LETT, V1, P211, DOI 10.1021/ol9905452; Rademann J, 1997, J ORG CHEM, V62, P3650, DOI 10.1021/jo970087f; Seeberger PH, 1997, ANGEW CHEM INT EDIT, V36, P491, DOI 10.1002/anie.199704911; Seeberger PH, 2000, CHEM REV, V100, P4349, DOI 10.1021/cr9903104; SPIJKER NM, 1992, TETRAHEDRON, V48, P6297, DOI 10.1016/S0040-4020(01)88221-1; YAN B, 1998, ACCOUNTS CHEM RES, V31, P621	27	684	710	6	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1523	1527		10.1126/science.1057324	http://dx.doi.org/10.1126/science.1057324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	405HF	11222853				2022-12-01	WOS:000167153400038
J	Hines, LM; Stampfer, MJ; Ma, J; Gaziano, JM; Ridker, PM; Hankinson, SE; Sacks, F; Rimm, EB; Hunter, DJ				Hines, LM; Stampfer, MJ; Ma, J; Gaziano, JM; Ridker, PM; Hankinson, SE; Sacks, F; Rimm, EB; Hunter, DJ			Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; US MALE PHYSICIANS; RISK; POLYMORPHISM; METAANALYSIS; MORTALITY; GENOTYPE; STROKE; LIPIDS; LOCI	Background: A polymorphism in the gene for alcohol dehydrogenase type 3 (ADH3) alters the rate of alcohol metabolism. We investigated the relation among the ADH3 polymorphism, the level of alcohol consumption, and the risk of myocardial infarction in a nested case-control study based on data from the prospective Physicians' Health Study. Methods: We identified 396 patients with eligible newly diagnosed cases of myocardial infarction among men in the Physicians' Health Study. Of these patients, 374 were matched with 2 randomly selected control subjects each and the remaining 22 with 1 control each (total, 770 controls). The ADH3 genotype (gamma (1)gamma (1)), gamma (1)gamma (2), or gamma (2)gamma (2)) was determined in all subjects. We examined the relations among the level of alcohol intake, the ADH3 genotype, and plasma high-density lipoprotein (HDL) levels in this study population and in a similar cohort of women. Results: As compared with homozygosity for the allele associated with a fast rate of ethanol oxidation (gamma (1)), homozygosity for the allele associated with a slow rate of ethanol oxidation (gamma (2)) was associated with a reduced risk of myocardial infarction (relative risk, 0.65; 95 percent confidence interval, 0.43 to 0.99). Moderate alcohol consumption was associated with a decreased risk of myocardial infarction in all three genotype groups (gamma (1)gamma (1)), (gamma (1)gamma (2)), and (gamma (2)gamma (2)); however, the ADH3 genotype significantly modified this association (P=0.01 for the interaction). Among men who were homozygous for the gamma (1) allele, those who consumed at least one drink per day had a relative risk of myocardial infarction of 0.62 (95 percent confidence interval, 0.34 to 1.13), as compared with the risk among men who consumed less than one drink per week. Men who consumed at least one drink per day and were homozygous for the gamma (2) allele had the greatest reduction in risk (relative risk, 0.14; 95 percent confidence interval, 0.04 to 0.45). Such men also had the highest plasma HDL levels (P for interaction = 0.05). We confirmed the interaction among the ADH3 genotype, the level of alcohol consumption, and the HDL level in an independent study of postmenopausal women (P=0.02). Conclusions: Moderate drinkers who are homozygous for the slow-oxidizing ADH3 allele have higher HDL levels and a substantially decreased risk of myocardial infarction. (N Engl J Med 2001;344:549-55.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Div Cardiol, Boston, MA USA; Dept Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Hines, LM (corresponding author), Harvard Univ, Sch Med, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.				NCI NIH HHS [CA49449, CA42182] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049449, U01CA049449, R01CA042182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; Bell JRC, 2000, AM J CLIN NUTR, V71, P103; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BOSRON WF, 1988, MOL ASPECTS MED, V10, P147, DOI 10.1016/0098-2997(88)90019-2; Camargo CA, 1997, ANN INTERN MED, V126, P372, DOI 10.7326/0003-4819-126-5-199703010-00005; CAVALLISFORZA LL, 1999, GENETICS HUMAN POPUL, P57; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; DAY CP, 1991, HEPATOLOGY, V14, P798, DOI 10.1002/hep.1840140509; DAY CP, 1992, HEPATOLOGY, V15, P750; Gaziano JM, 1998, NOVART FDN SYMP, V216, P86; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GROBBEE DE, 1999, HLTH ISSUES RELATED, P126; GROPPI A, 1990, CLIN CHEM, V36, P1765; Haiman CA, 1999, CANCER RES, V59, P1015; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Harty LC, 1997, JNCI-J NATL CANCER I, V89, P1698, DOI 10.1093/jnci/89.22.1698; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MarquesVidal P, 1996, AM J EPIDEMIOL, V143, P1089, DOI 10.1093/oxfordjournals.aje.a008683; MarquesVidal P, 1996, AM J EPIDEMIOL, V144, P622; PARKINSON A, 1990, CASARETT DOULLS TOXI, P113; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sesso HD, 1999, CURR OPIN NEPHROL HY, V8, P353, DOI 10.1097/00041552-199905000-00013; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Whitfield J B, 1994, Alcohol Alcohol Suppl, V2, P59; *WORLD HLTH ORG, 1971, 5 WHO REG OFF EUR	31	223	232	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					549	555		10.1056/NEJM200102223440802	http://dx.doi.org/10.1056/NEJM200102223440802			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207350	Bronze, Green Published			2022-12-01	WOS:000167044600002
J	Tilford, CA; Kuroda-Kawaguchi, T; Skaletsky, H; Rozen, S; Brown, LG; Rosenberg, M; McPherson, JD; Wylie, K; Sekhon, M; Kucaba, TA; Waterston, RH; Page, DC				Tilford, CA; Kuroda-Kawaguchi, T; Skaletsky, H; Rozen, S; Brown, LG; Rosenberg, M; McPherson, JD; Wylie, K; Sekhon, M; Kucaba, TA; Waterston, RH; Page, DC			A physical map of the human Y chromosome	NATURE			English	Article							RADIATION HYBRID MAP; HUMAN GENOME; DELETIONS; REGION	The non-recombining region of the human Y chromosome (NRY), which comprises 95% of the chromosome, does not undergo sexual recombination and is present only in males. An understanding of its biological functions has begun to emerge from DNA studies of individuals with partial Y chromosomes, coupled with molecular characterization of genes implicated in gonadal sex reversal, Turner syndrome, graft rejection and spermatogenic failure(1,2). But mapping strategies applied successfully elsewhere in the genome have faltered in the NRY, where there is no meiotic recombination map and intrachromosomal repetitive sequences are abundant(3). Here we report a high-resolution physical map of the euchromatic, centromeric and heterochromatic regions of the NRY and its construction by unusual methods, including genomic clone subtraction(4) and dissection of sequence family variants(5). Of the map's 758 DNA markers, 136 have multiple locations in the NRY, reflecting its unusually repetitive sequence composition. The markers anchor 1,038 bacterial artificial chromosome clones, 199 of which form a tiling path for sequencing.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Dept Genet, Genome Sequencing Ctr, St Louis, MO 63108 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		McPherson, John D/D-2633-2017; Sekhon, Mandeep/L-4665-2018; Rozen, Steven G./J-5939-2013	McPherson, John D/0000-0001-8049-9347; Sekhon, Mandeep/0000-0002-9993-6938; Rozen, Steven G./0000-0002-4288-0056				Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lunetta KL, 1996, AM J HUM GENET, V59, P717; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mumm S, 1997, GENOME RES, V7, P307, DOI 10.1101/gr.7.4.307; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Schwartz A, 1998, HUM MOL GENET, V7, P1, DOI 10.1093/hmg/7.1.1; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Vogt P. H., 1997, Cytogenetics and Cell Genetics, V79, P1, DOI 10.1159/000134680; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	16	154	164	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					943	945		10.1038/35057170	http://dx.doi.org/10.1038/35057170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237016	Bronze			2022-12-01	WOS:000166938800063
J	Wolfsberg, TG; McEntyre, J; Schuler, GD				Wolfsberg, TG; McEntyre, J; Schuler, GD			Guide to the draft human genome	NATURE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SEQUENCE; GENE; DATABASE; LOCUSLINK; PROTEINS; REFSEQ; MAP	There are a number of ways to investigate the structure, function and evolution of the human genome. These include examining the morphology of normal and abnormal chromosomes, constructing maps of genomic landmarks, following the genetic transmission of phenotypes and DNA sequence variations, and characterizing thousands of individual genes. To this list we can now add the elucidation of the genomic DNA sequence, albeit at 'working draft' accuracy. The current challenge is to weave together these disparate types of data to produce the information infrastructure needed to support the next generation of biomedical research. Here we provide an overview of the different sources of information about the human genome and how modern information technology, in particular the internet, allows us to link them together.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schuler, GD (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	schuler@ncbi.nim.nih.gov	Wolfsberg, Tyra/D-8296-2017	Wolfsberg, Tyra/0000-0001-5646-9455; McEntyre, Jo/0000-0002-1611-6935				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; McKusick V.A., 1998, MENDELIAN INHERITANC; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Poindexter K, 1999, GENE, V237, P61, DOI 10.1016/S0378-1119(99)00302-9; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sagane K, 1998, BIOCHEM J, V334, P93, DOI 10.1042/bj3340093; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Wolfsberg TG, 1997, NUCLEIC ACIDS RES, V25, P1626, DOI 10.1093/nar/25.8.1626; WOLFSBERG TG, 2001, BIOINFORMATICS PRACT; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	25	34	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					824	826		10.1038/35057000	http://dx.doi.org/10.1038/35057000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236998	Green Published, Bronze			2022-12-01	WOS:000166938800045
J	Brune, W; Menard, C; Heesemann, J; Koszinowski, UH				Brune, W; Menard, C; Heesemann, J; Koszinowski, UH			A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism	SCIENCE			English	Article							IN-VITRO; IDENTIFICATION; CONSTRUCTION; MUTAGENESIS; INFECTION; APOPTOSIS; PROTEINS; CLONING; GENOME; GENES	Human cytomegalovirus infects vascular tissues and has been associated with atherogenesis and coronary restenosis. Although established Laboratory strains of human cytomegalovirus have lost the ability to grow on vascular endothelial cells, Laboratory strains of murine cytomegalovirus retain this ability. With the use of a forward-genetic procedure involving random transposon mutagenesis and rapid phenotypic screening, we identified a murine cytomegalovirus gene governing endothelial cell tropism, This gene, M45, shares sequence homology to ribonucleotide reductase genes. Endothelial cells infected with M45-mutant viruses rapidly undergo apoptosis, suggesting that a viral strategy to evade destruction by cellular apoptosis is indispensable for viral growth in endothelial cells.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Munich, Genzentrum, D-80336 Munich, Germany; Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany	Princeton University; University of Munich; University of Munich	Brune, W (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	wbrune@princeton.edu	Brune, Wolfram/H-5058-2019	Brune, Wolfram/0000-0002-6078-5255				Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Brune W, 2000, TRENDS GENET, V16, P254, DOI 10.1016/S0168-9525(00)02015-1; Brune W, 1999, NAT BIOTECHNOL, V17, P360, DOI 10.1038/7914; CHABAUD S, 2000, 25 INT HERP WORKSH P; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Epstein SE, 1996, LANCET, V348, pS13, DOI 10.1016/S0140-6736(96)98005-8; GALLINA A, COMMUNICATION; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; MacCormac LP, 1999, J MED VIROL, V57, P298, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;298::AID-JMV14&gt;3.0.CO;2-P; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Mocarski ES, 1996, FIELDS VIROLOGY, V2, P2447; PERCIVALLE E, 1993, J CLIN INVEST, V92, P663, DOI 10.1172/JCI116635; Plachter B, 1996, ADV VIRUS RES, V46, P195, DOI 10.1016/S0065-3527(08)60073-1; PLENDL J, 1995, VIRCHOWS ARCH, V426, P619; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Smith GA, 1999, J VIROL, V73, P6405, DOI 10.1128/JVI.73.8.6405-6414.1999; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Sun YM, 1999, J GEN VIROL, V80, P2713, DOI 10.1099/0022-1317-80-10-2713; Tanaka K, 1999, CIRCULATION, V99, P1656, DOI 10.1161/01.CIR.99.13.1656; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870	25	178	182	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					303	305		10.1126/science.291.5502.303	http://dx.doi.org/10.1126/science.291.5502.303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209080				2022-12-01	WOS:000166352900045
J	Tramo, MJ				Tramo, MJ			Biology and music - Music of the hemispheres	SCIENCE			English	Editorial Material							DISCRIMINATION; PITCH; REPRESENTATION; PERCEPTION; INFANTS		Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Tramo, MJ (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA.							BERNSTEIN L, 1983, UNANSWERED QUESTION; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; CARLANI PA, 1996, J NEUROPHYSIOL, V76, P1698; Cole MG, 1997, AM J GERIAT PSYCHIAT, V5, P4; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Gardiner MF, 1996, NATURE, V381, P284, DOI 10.1038/381284a0; HULSE SH, 1995, J EXP PSYCHOL GEN, V124, P409, DOI 10.1037/0096-3445.124.4.409; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Lerdahl F., 1983, GENERATIVE THEORY TO; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; LORE D, 1999, ATLANTA J CONST 0705; PANDYA DN, 1995, REV NEUROL, V151, P486; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Rauscher FH, 1997, NEUROL RES, V19, P2; Repp BH, 1998, J ACOUST SOC AM, V104, P1085, DOI 10.1121/1.423325; Sakai K, 1999, J NEUROSCI, V19, P10074; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SIDTIS JJ, 1988, BRAIN LANG, V34, P235, DOI 10.1016/0093-934X(88)90135-6; TRAINOR LJ, 1993, MUSIC PERCEPT, V11, P185; Tramo M. J., 1992, Society for Neuroscience Abstracts, V18, P382; TRAMO MJ, 1991, NEUROPSYCHOLOGIA, V29, P313, DOI 10.1016/0028-3932(91)90045-A; TRAMO MJ, 1993, CONTEMP MUSIC REV, V9, P113, DOI DOI 10.1080/07494469300640381; TRATRAMO JM, 1993, NEUROPSYCHOLOGIA, V9, P113; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2	32	70	74	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2001	291	5501					54	56		10.1126/SCIENCE.1056899	http://dx.doi.org/10.1126/SCIENCE.1056899			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389VJ	11192009				2022-12-01	WOS:000166259100028
J	Hernandez-Pando, R; Jeyanathan, M; Mengistu, G; Aguilar, D; Orozco, H; Harboe, M; Rook, GAW; Bjune, G				Hernandez-Pando, R; Jeyanathan, M; Mengistu, G; Aguilar, D; Orozco, H; Harboe, M; Rook, GAW; Bjune, G			Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; TUBERCLE-BACILLI; EXOGENOUS REINFECTION; EPITHELIAL-CELLS; AVIUM COMPLEX; SITUATION; INVASION; LESIONS; MODELS	Background A third of the world's population has latent infection with Mycobacterium tuberculosis, and in areas of low endemicity, most cases of active tuberculosis arise as a result of reactivation of latent bacilli. We sought to establish the cellular location of these latent organisms to facilitate their elimination. Methods We applied in-situ PCR to sections of macroscopically normal lung tissue from 13 individuals from Ethiopia and 34 from Mexico who had died from causes other than tuberculosis. Sections of lung tissue from six Norwegian individuals (ie, individuals from a non-endemic population) acted as negative. controls, and six Ethiopian tuberculosis cases acted as positive controls. Findings Control necropsy samples from the Norwegian individuals were all negative by in-situ PCR and conventional PCR,whereas all samples from known Ethiopian tuberculosis cases were positive by both methods. However, in macroscopically normal lung tissue from Ethiopian and Mexican individuals without tuberculous lesions, the in-situ PCR revealed five of 13 and ten of 34 positive individuals respectively. These results were confirmed by conventional PCR with extracted DNA. Positive cells included alveolar and interstitial macrophages, type II pneumocytes, endothelial cells, and fibroblasts. Interpretation M tuberculosis can persist intracellularly in lung tissue without histological evidence of tuberculous lesions. M tuberculosis DNA is situated not only in macrophages but also inother non-professional phagocytic cells. These findings contradict the dominant view that latent organisms exist in old classic tuberculous lesions, and have important implications for strategies aimed at the elimination of latent and persistent bacilli.	UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Dept Bacteriol, London W1T 4JF, England; Inst Nacl Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City 14000, DF, Mexico; Armauer Hansen Res Inst, Addis Ababa, Ethiopia; Univ Oslo, Natl Hosp, Inst Immunol, Oslo, Norway; Univ Oslo, Inst Gen Practice & Community Med, Oslo, Norway	University of London; University College London; UCL Medical School; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Oslo; National Hospital Norway; University of Oslo	Rook, GAW (corresponding author), UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Dept Bacteriol, London W1T 4JF, England.	g.rook@ucl.ac.uk		Hernandez-Pando, Rogelio/0000-0003-1292-3833; Rook, Graham/0000-0002-8041-8110				BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; BERMUDEZ LE, 1994, INFECT IMMUN, V62, P2021, DOI 10.1128/IAI.62.5.2021-2026.1994; BERMUDEZ LE, 1991, CLIN IMMUNOL IMMUNOP, V61, P225, DOI 10.1016/S0090-1229(05)80026-1; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dhillon J, 1998, INT J TUBERC LUNG D, V2, P736; DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; EISENACH KD, 1991, AM REV RESPIR DIS, V144, P1160, DOI 10.1164/ajrccm/144.5.1160; FILLEY EA, 1991, INFECT IMMUN, V59, P2567, DOI 10.1128/IAI.59.8.2567-2572.1991; FILLEY EA, 1992, IMMUNOLOGY, V77, P505; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Griffith AS, 1929, J PATHOL BACTERIOL, V32, P813, DOI 10.1002/path.1700320411; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; MAPOTHER ME, 1984, INFECT IMMUN, V45, P67, DOI 10.1128/IAI.45.1.67-73.1984; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Phyu S, 1998, SCAND J INFECT DIS, V30, P59; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; REA TH, 1991, SEMIN DERMATOL, V10, P188; Rook Graham A. W., 1994, P485; SHEPARD CC, 1957, J EXP MED, V105, P39, DOI 10.1084/jem.105.1.39; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491	26	304	319	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 23	2000	356	9248					2133	2138		10.1016/S0140-6736(00)03493-0	http://dx.doi.org/10.1016/S0140-6736(00)03493-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385HD	11191539				2022-12-01	WOS:000165997300011
J	Gao, KQ; Shubin, NH				Gao, KQ; Shubin, NH			Late Jurassic salamanders from northern China	NATURE			English	Article							EVOLUTIONARY; PHYLOGENY; CAUDATA	With ten extant families, salamanders (urodeles) are one of the three major groups of modern amphibians (lissamphibians)(1-6) Extant salamanders are often used as a model system to assess fundamental issues of developmental, morphological and biogeographical evolution(6-11). Unfortunately, our understanding of these issues has been hampered by the paucity of fossil evidence available to assess the early history of the group(5,6,12). Here we report the discovery of an extraordinary sample of salamander fossils, some with rare soft-tissue impressions, from the Upper Jurassic of China(13-16). With over 500 articulated specimens, this assemblage documents the morphological diversity of early urodeles and includes larvae and adults of both neotenic and metamorphosed taxa. Phylogenetic analysis confirms that these salamanders are primitive, and reveals that all basal salamander clades have Asian distributions. This is compelling evidence for an Asian origin of Recent salamanders, as well as for an extensive and early radiation of several major lineages, These discoveries show that the evolution of salamanders has involved phylogenetic and ecological diversification around a body plan that has remained fundamentally stable for over 150 million years.	Amer Museum Nat Hist, New York, NY 10024 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	American Museum of Natural History (AMNH); University of Chicago	Gao, KQ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	kgao@amnh.org						Cannatella David C., 1993, Herpetological Monographs, V7, P1, DOI 10.2307/1466947; Chen Pei-ji, 1996, Museum of Northern Arizona Bulletin, V60, P395; DONG Z, 1998, VERTEBRAT PALASIATIC, V56, P159; Duellman W. E., 1994, BIOL AMPHIBIANS; Estes R., 1981, HDB PALAOHERPETOLO 2; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; Evans SE, 1996, PHILOS T R SOC B, V351, P627, DOI 10.1098/rstb.1996.0061; EVANS SE, 1988, GEOBIOS-LYON, V21, P539, DOI 10.1016/S0016-6995(88)80069-X; Feller AE, 1998, MOL PHYLOGENET EVOL, V9, P509, DOI 10.1006/mpev.1998.0500; Gao K.-Q., 1998, CHINESE GEOLOGY, V248, P40; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; LARSON A, 1991, EVOL BIOL, V25, P211; Larson Allan, 1993, Herpetological Monographs, V7, P77, DOI 10.2307/1466953; LUO X, 1997, ACTA GEOSCIENTIA SIN, V18, P242; Milner A. R., 1983, EVOLUTION TIME SPACE, P431; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; Ren D., 1999, GEOLOGICAL SCI TECHN, V18, P39; SEVER DM, 1991, HERPETOLOGICA, V47, P165; SHUBIN N, 1995, EVOLUTION, V49, P874, DOI 10.1111/j.1558-5646.1995.tb02323.x; Shubin N, 1996, AM ZOOL, V36, P51; Trueb L., 1991, P223; WAKE DB, 1987, SCIENCE, V238, P42, DOI 10.1126/science.238.4823.42; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Wang S.E., 1998, ACTA GEOL SINICA, V72, P11; Wang Yuan, 2000, Vertebrata Palasiatica, V38, P100; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	26	114	131	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					574	577		10.1038/35069051	http://dx.doi.org/10.1038/35069051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279493				2022-12-01	WOS:000167859300045
J	Olson, EN				Olson, EN			Development - The path to the heart and the road not taken	SCIENCE			English	Editorial Material							CARDIAC MYOGENESIS; INDUCTION; ENDODERM		Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.							FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; NASCONE N, 1995, DEVELOPMENT, V121, P515; Polakis P, 2000, GENE DEV, V14, P1837; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P111; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174	11	39	40	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2327	2328		10.1126/science.1060063	http://dx.doi.org/10.1126/science.1060063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11269304				2022-12-01	WOS:000167618700030
J	Rosmond, R; Bouchard, C; Bjorntorp, P				Rosmond, R; Bouchard, C; Bjorntorp, P			Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL OBESITY		Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Sahlgrens Univ Hosp, Dept Heart & Lung Dis, S-41345 Gothenburg, Sweden	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sahlgrenska University Hospital	Rosmond, R (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.		Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019	Bouchard, Claude/0000-0002-0048-491X; 				Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Koper JW, 1997, HUM GENET, V99, P663, DOI 10.1007/s004390050425; Lin RCY, 1999, BMJ-BRIT MED J, V319, P1337, DOI 10.1136/bmj.319.7221.1337; Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853	5	61	62	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					652	653		10.1136/bmj.322.7287.652	http://dx.doi.org/10.1136/bmj.322.7287.652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250851	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000167622600026
J	Oomen, CM; Ocke, MC; Feskens, EJM; van Erp-Baart, MAJ; Kok, FJ; Kromhout, D				Oomen, CM; Ocke, MC; Feskens, EJM; van Erp-Baart, MAJ; Kok, FJ; Kromhout, D			Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HYDROGENATED SOYBEAN OIL; DIETARY-FAT; FISH-OIL; MEN; WOMEN; COUNTRIES; BUTTER; COHORT; EUROPE	Background Evidence on the relation between trans fatty acid intake and coronary heart disease is limited. We investigated this relation in a Dutch population with a fairly high trans fatty acid intake, including trans fatty acids from partly hydrogenated fish oils. Methods We prospectively studied 667 men of the Zutphen Elderly Study aged 64-84 years and free of coronary heart disease at baseline. We used dietary surveys to establish the participants' food consumption patterns. Information on risk factors and diet was obtained in 1985, 1990, and 1995. After 10 years of follow-up from 1985-95, there were 98 cases of fatal or non-fatal coronary heart disease. Findings Between 1985 and 1995, average trans fatty acid intake decreased from 43% to 1.9% of energy. After adjustment for age, body mass index, smoking, and dietary covariates, trans fatty acid intake at baseline was positively associated with the 10-year risk of coronary heart disease. The relative risk for a difference of 2% of energy in trans fatty acid intake at baseline was 1.28 (95% CI 1.01-1.61). Interpretation A high intake of trans fatty acids tall types of isomers) contributes to the risk of coronary heart disease. The substantial decrease in trans fatty acid intake, mainly due to industrial lowering of trans contents in Dutch edible fats, could therefore have had a large public-health impact.	Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands; Natl Inst Publ Hlth & Environm, Div Publ Hlth Res, NL-3720 BA Bilthoven, Netherlands; Univ Wageningen & Res Ctr, Dept Human Nutr & Epidemiol, Wageningen, Netherlands; TNO Nutr & Food Res, Dept Nutr Epidemiol, Zeist, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Netherlands Organization Applied Science Research	Oomen, CM (corresponding author), Natl Inst Publ Hlth & Environm, Dept Chron Dis Epidemiol, POB 1, NL-3720 BA Bilthoven, Netherlands.		Robles-Sardin, Alma E/M-7714-2015; Feskens, Edith/ABI-1446-2020; Feskens, Edith JM/A-3757-2012; Kromhout, Daan/A-8566-2014	Robles-Sardin, Alma E/0000-0003-2044-7793; Feskens, Edith/0000-0001-5819-2488; 				ALMENDINGEN K, 1995, J LIPID RES, V36, P1370; Almendingen K, 1996, ARTERIOSCL THROM VAS, V16, P375, DOI 10.1161/01.ATV.16.3.375; ARO A, 1995, LANCET, V345, P273, DOI 10.1016/S0140-6736(95)90273-2; Aro A., 1998, Journal of Food Composition and Analysis, V11, P137, DOI 10.1006/jfca.1998.0569; Aro A, 1998, J AM OIL CHEM SOC, V75, P977, DOI 10.1007/s11746-998-0275-5; Aro A., 1998, Journal of Food Composition and Analysis, V11, P170, DOI 10.1006/jfca.1998.0572; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; ASCHERIO A, 1994, CIRCULATION, V89, P941; BLOEMBERG BPM, 1989, AM J EPIDEMIOL, V130, P1047, DOI 10.1093/oxfordjournals.aje.a115405; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; Christiansen E, 1997, DIABETES CARE, V20, P881, DOI 10.2337/diacare.20.5.881; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692; HULSHOF PJM, 1998, VOEDING, V5, P24; JUDD JT, 1994, AM J CLIN NUTR, V59, P861, DOI 10.1093/ajcn/59.4.861; KATAN MB, 1995, LANCET, V346, P1245, DOI 10.1016/S0140-6736(95)91858-2; Keys A, 1966, Acta Med Scand Suppl, V460, P1; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Lichtenstein AH, 1999, NEW ENGL J MED, V340, P1933, DOI 10.1056/NEJM199906243402501; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; NESTEL PJ, 1992, AM J CLIN NUTR, V55, P46, DOI 10.1093/ajcn/55.1.46; OOMEN CM, 2000, 441110004 RIJKS VOLK; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Rose G, 1968, CARDIOVASCULAR SURVE; SIEDEL J, 1981, J CLIN CHEM CLIN BIO, V19, P838; SUNDRAM K, 1997, J NUTR S, V127, P514; van de Vijver LPL, 2000, EUR J CLIN NUTR, V54, P126, DOI 10.1038/sj.ejcn.1600906; van Erp-Baart M.-A., 1998, Journal of Food Composition and Analysis, V11, P161, DOI 10.1006/jfca.1998.0571; van Poppel G., 1998, Journal of Food Composition and Analysis, V11, P112, DOI 10.1006/jfca.1998.0568; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; WILLETT WC, 1994, AM J PUBLIC HEALTH, V84, P722, DOI 10.2105/AJPH.84.5.722; ZOCK PL, 1992, J LIPID RES, V33, P399	35	355	377	3	36	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					746	751		10.1016/S0140-6736(00)04166-0	http://dx.doi.org/10.1016/S0140-6736(00)04166-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253967				2022-12-01	WOS:000167400900011
J	Leighton, PA; Mitchell, KJ; Goodrich, LV; Lu, XW; Pinson, K; Scherz, P; Skarnes, WC; Tessler-Lavigne, M				Leighton, PA; Mitchell, KJ; Goodrich, LV; Lu, XW; Pinson, K; Scherz, P; Skarnes, WC; Tessler-Lavigne, M			Defining brain wiring patterns and mechanisms through gene trapping in mice	NATURE			English	Article							TRANSMEMBRANE SEMAPHORIN; EMBRYONIC MOTOR; TYROSINE KINASE; GENOME-WIDE; EXPRESSION; MUTATIONS; RECEPTORS; CLONING; NEUROPILIN-2; DROSOPHILA	The search to understand the mechanisms regulating brain wiring has relied on biochemical purification approaches in vertebrates and genetic approaches in invertebrates to identify molecular cues and receptors for axon guidance. Here we describe a phenotype-based gene-trap screen in mice designed for the large-scale identification of genes controlling the formation of the trillions of connections in the mammalian brain. The method incorporates an axonal marker, which helps to identify cell-autonomous mechanisms in axon guidance, and has generated a resource of mouse lines with striking patterns of axonal labelling, which facilitates analysis of the normal wiring diagram of the brain. Studies of two of these mouse lines have identified an in vivo guidance function for a vertebrate transmembrane semaphorin, Sema6A, and have helped re-evaluate that of the Eph receptor EphA4.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Tessler-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu		Mitchell, Kevin/0000-0002-3433-4530				Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kikuchi K, 1999, MOL CELL NEUROSCI, V13, P9, DOI 10.1006/mcne.1998.0732; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MITCHELL KJ, UNPUB NATURE GENET; Molnar Z, 1998, J NEUROSCI, V18, P5723; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; St Croix B, 2000, SCIENCE, V289, P1197; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Xu XM, 2000, J NEUROSCI, V20, P2638; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	37	336	341	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					174	179		10.1038/35065539	http://dx.doi.org/10.1038/35065539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242070				2022-12-01	WOS:000167320500036
J	Marks, B; Stowell, MHB; Vallis, Y; Mills, IG; Gibson, A; Hopkins, CR; McMahon, HT				Marks, B; Stowell, MHB; Vallis, Y; Mills, IG; Gibson, A; Hopkins, CR; McMahon, HT			GTPase activity of dynamin and resulting conformation change are essential for endocytosis	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; COATED VESICLE FORMATION; CRYSTAL-STRUCTURE; SH3 DOMAIN; AMPHIPHYSIN; RECEPTOR; BINDING; DROSOPHILA; MECHANISM	Dynamin is a large GTPase with a relative molecular mass of 96,000 (M-r 96K) that is involved in clathrin-mediated endocytosis and other vesicular trafficking processes(1,2). Although its function is apparently essential for scission of newly formed vesicles from the plasma membrane, the nature of dynamin's role in the scission process is still unclear(3,4). It has been proposed that dynamin is a regulator (similar to classical G proteins) of downstream effectors(5). Here we report the analysis of several point mutants of dynamin's GTPase effector (GED) and GTPase domains. We show that oligomerization and GTP binding alone, by dynamin, are not sufficient for endocytosis in vivo. Rather, efficient GTP hydrolysis and an associated conformational change are also required. These data argue that dynamin has a mechanochemical function in vesicle scission.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmmb.cam.ac.uk	Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; STOWELL, MICHAEL/0000-0001-7250-1419				Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Roos J, 1997, TRENDS CELL BIOL, V7, P257, DOI 10.1016/S0962-8924(97)01068-4; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wilson-Kubalek EM, 1998, P NATL ACAD SCI USA, V95, P8040, DOI 10.1073/pnas.95.14.8040	29	356	365	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2001	410	6825					231	235		10.1038/35065645	http://dx.doi.org/10.1038/35065645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242086				2022-12-01	WOS:000167320500052
J	Schenk, PM; McKinnon, WB; Gwynn, D; Moore, JM				Schenk, PM; McKinnon, WB; Gwynn, D; Moore, JM			Flooding of Ganymede's bright terrains by low-viscosity water-ice lavas	NATURE			English	Article							GALILEAN SATELLITES; GROOVED TERRAIN; THERMAL EVOLUTION; STEREO IMAGES; STRATIGRAPHY; TOPOGRAPHY; VOLCANISM	Large regions of the jovian moon Ganymede have been resurfaced, but the means has been unclear(1,2). Suggestions have ranged from volcanic eruptions of liquid water(3-5) or solid ice(6) to tectonic deformation(7-9), but definitive high-resolution morphological evidence has been lacking. Here we report digital elevation models of parts of the surface of Ganymede, derived from stereo pairs combining data from the Voyager and Galileo spacecraft, which reveal bright, smooth terrains that lie at roughly constant elevations 100 to 1,000 metres below the surrounding rougher terrains. These topographic data, together with new images that show fine-scale embayment and burial of older features(10), indicate that the smooth terrains were formed by flooding of shallow structural troughs by low-viscosity water-ice lavas. The oldest and most deformed areas (the 'reticulate' terrains) in general have the highest relative elevations, whereas units of the most common resurfaced type-the grooved terrain-lie at elevations between those of the smooth and reticulate terrains. Bright terrain, which accounts for some two-thirds of the surface, probably results from a continuum of processes, including crustal rifting, shallow flooding and groove formation. Volcanism plays an integral role in these processes, and is consistent with partial melting of Ganymede's interior(11,12).	Lunar & Planetary Inst, Houston, TX 77058 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Schenk, PM (corresponding author), Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA.							ALLISON ML, 1987, J GEOPHYS RES-SOLID, V92, P7865, DOI 10.1029/JB092iB08p07865; Belton MJS, 1996, SCIENCE, V274, P377, DOI 10.1126/science.274.5286.377; Collins GC, 1998, ICARUS, V135, P345, DOI 10.1006/icar.1998.5978; DOMBARD AJ, UNPUB ICARUS; Giese B, 1998, ICARUS, V135, P303, DOI 10.1006/icar.1998.5967; Head J. W, 1998, LUN PLAN SCI C CD RO, P1666; HEAD JW, 1992, GEOCHIM COSMOCHIM AC, V56, P2155, DOI 10.1016/0016-7037(92)90183-J; HEAD JW, 1997, LUN PLAN SCI C CD RO, V29, P535; Kay J. E, 1999, LUNAR PLANET SCI C, P1103; KIRK RL, 1987, ICARUS, V69, P91, DOI 10.1016/0019-1035(87)90009-1; LUCCHITTA BK, 1980, ICARUS, V44, P481, DOI 10.1016/0019-1035(80)90039-1; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; Pappalardo RT, 1998, ICARUS, V135, P276, DOI 10.1006/icar.1998.5966; PARMENTIER EM, 1982, NATURE, V295, P290, DOI 10.1038/295290a0; SCHENK PM, 1995, J GEOPHYS RES-PLANET, V100, P19009, DOI 10.1029/95JE01854; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; SCHENK PM, 1996, B AM ASTRON SOC, V28, P1074; Shoemaker E.M., 1982, SATELLITES JUPITER, P435; Showman AP, 1997, ICARUS, V127, P93, DOI 10.1006/icar.1996.5669; Showman AP, 1997, ICARUS, V129, P367, DOI 10.1006/icar.1997.5778; Squyres S. W., 1986, SATELLITES, P293; Zahnle K, 1998, ICARUS, V136, P202, DOI 10.1006/icar.1998.6015; [No title captured]	23	66	67	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					57	60		10.1038/35065027	http://dx.doi.org/10.1038/35065027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242037				2022-12-01	WOS:000167194300038
J	Slep, KC; Kercher, MA; He, W; Cowan, CW; Wensel, TG; Sigler, PB				Slep, KC; Kercher, MA; He, W; Cowan, CW; Wensel, TG; Sigler, PB			Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 angstrom	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; PHOTORECEPTOR G-PROTEIN; CGMP-PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; EFFECTOR-BINDING; ADENYLYL-CYCLASE; TRANSDUCIN; ACTIVATION	A multitude of heptahelical receptors use heterotrimeric G proteins to transduce signals to specific effector target molecules. The G protein transducin, G(t), couples photon-activated rhodopsin with the effector cyclic GMP phosophodiesterase (PDE) in the vertebrate phototransduction cascade. The interactions of the G(t) alpha -subunit (alpha (t)) with the inhibitory PDE gamma -subunit (PDE gamma) are central to effector activation, and also enhance visual recovery in cooperation with the GTPase-activating protein regulator of G-protein signalling (RGS)-9 (refs 1-3). Here we describe the crystal structure at 2.0 Angstrom of rod transducin alpha -GDP . AlF4- in complex with the effector molecule PDE gamma and the GTPase-activating protein RGS9. In addition, we present the independently solved crystal structures of the RGS9 RGS domain both alone and in complex with alpha (t/i1). GDP . AlF4-. These structures reveal insights into effector activation, synergistic GTPase acceleration, RGS9 specificity and RGS activity. Effector binding to a nucleotide-dependent site on at sequesters PDE gamma residues implicated in PDE inhibition, and potentiates recruitment of RGS9 for hydrolytic transition state stabilization and concomitant signal termination.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Yale University; Howard Hughes Medical Institute; Yale University; Baylor College of Medicine	Slep, KC (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Cowan, Christopher W/I-2497-2014	Wensel, Theodore/0000-0003-3518-9352				ANGLESON JK, 1993, NEURON, V11, P939, DOI 10.1016/0896-6273(93)90123-9; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; de Alba E, 1999, J MOL BIOL, V291, P927, DOI 10.1006/jmbi.1999.2989; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; Muradov KG, 2000, J BIOL CHEM, V275, P6969, DOI 10.1074/jbc.275.10.6969; Natochin M, 1998, J BIOL CHEM, V273, P4300, DOI 10.1074/jbc.273.8.4300; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Nekrasova ER, 1997, BIOCHEMISTRY-US, V36, P7638, DOI 10.1021/bi970427r; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Yan SZ, 1997, J BIOL CHEM, V272, P18849, DOI 10.1074/jbc.272.30.18849	30	213	220	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1071	1077		10.1038/35059138	http://dx.doi.org/10.1038/35059138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234020				2022-12-01	WOS:000167148800053
J	Isles, AR; Baum, MJ; Ma, D; Keverne, EB; Allen, ND				Isles, AR; Baum, MJ; Ma, D; Keverne, EB; Allen, ND			Genetic imprinting - Urinary odour preferences in mice	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; KIN RECOGNITION		Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; Boston Univ, Dept Biol, Boston, MA 02215 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Boston University	Isles, AR (corresponding author), Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England.		allen, nick d/A-4336-2010	Isles, Anthony/0000-0002-7587-5712; Allen, Nicholas/0000-0003-4009-186X				Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BARNARD CJ, 1989, ANIM BEHAV, V38, P35, DOI 10.1016/S0003-3472(89)80063-6; FAN WF, 1995, GENOMICS, V27, P119, DOI 10.1006/geno.1995.1013; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; SUNDBERG H, 1982, BEHAV NEURAL BIOL, V34, P113, DOI 10.1016/S0163-1047(82)91501-1; WALDMAN B, 1988, TRENDS ECOL EVOL, V3, P8, DOI 10.1016/0169-5347(88)90075-4; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818	10	67	68	1	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					783	784		10.1038/35057323	http://dx.doi.org/10.1038/35057323			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236984				2022-12-01	WOS:000166938800029
J	Pasvol, G				Pasvol, G			Targeting voracious appetite of malaria-infected red-blood cell	LANCET			English	Editorial Material							TRANSPORT; PATHWAYS; MEMBRANE; CHANNEL		Northwick Pk Hosp & Clin Res Ctr, Imperial Coll, Sch Med, Wellcome Ctr Clin Trop Med,Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England	Imperial College London	Pasvol, G (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Imperial Coll, Sch Med, Wellcome Ctr Clin Trop Med,Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England.	g.pasvol@ic.ac.uk						Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; GINSBURG H, 1994, BIOCHEM PHARMACOL, V48, P1847, DOI 10.1016/0006-2952(94)90582-7; Kaestner L, 1999, BBA-BIOMEMBRANES, V1417, P9, DOI 10.1016/S0005-2736(98)00240-5; Kirk K, 1999, Novartis Found Symp, V226, P55; KIRK K, 1994, J BIOL CHEM, V269, P3339; Kirk K., 1999, NOVART FDN SYMP, V226, P66; Taraschi T F, 1999, Novartis Found Symp, V226, P114; Taraschi TF, 1999, NOVART FDN SYMP, V226, P121; 2000, DRUGD DAT	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2001	357	9254					408	410		10.1016/S0140-6736(00)04023-X	http://dx.doi.org/10.1016/S0140-6736(00)04023-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400HF	11273055				2022-12-01	WOS:000166865600004
J	de Winter, W; Oxnard, CE				de Winter, W; Oxnard, CE			Evolutionary radiations and convergences in the structural organization of mammalian brains	NATURE			English	Article							LOCOMOTION	The sizes of mammalian brain components seem to be mostly related to the sizes of the whole brain (and body), suggesting a one-dimensional scale of encephalization(1-3). Previous multivariate study of such data concludes that evolutionary selection for enlargement of any one brain part is constrained to selection for a concerted enlargement of the whole brain(4). However, interactions between structurally related pairs of brain parts(5) confirm reports of differential change in brain nuclei(6), and imply mosaic rather than concerted evolution. Here we analyse a large number of variables simultaneously using multi-dimensional methods(7). We show that the relative proportions of different systems of functionally integrated brain structures vary independently between different mammalian orders, demonstrating separate evolutionary radiations in mammalian brain organization(8). Within each major order we identify clusters of unrelated species that occupy similar behavioural niches and have convergently evolved similar brain proportions. We conclude that within orders, mosaic brain organization is caused by selective adaptation, whereas between orders it suggests an interplay between selection and constraints.	Univ Western Australia, Dept Anat & Human Biol, Perth, WA 6907, Australia	University of Western Australia	Oxnard, CE (corresponding author), Univ Western Australia, Dept Anat & Human Biol, Perth, WA 6907, Australia.							Altringham J.D., 1996, BATS BIOL BEHAV; Armstrong E., 1982, P131; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Brooks V.B., 1986, NEURAL BASIS MOTOR C; BUTLER AB, 1996, COMP VERTEBRATE NEUR, pCH30; CANT JGH, 1986, FOLIA PRIMATOL, V46, P1, DOI 10.1159/000156232; Cleveland W.S., 1993, VISUALIZING DATA; DEACON TW, 1990, AM ZOOL, V30, P629; DEWINTER W, 1997, AM J PHYS ANTHOL S, V24, P243; DEWINTER W, 1997, THESIS U W AUSTR; Eisenberg J.F., 1981, MAMMALIAN RAD; Eisenberg J. F., 1975, PHYLOGENY PRIMATES, P47; ERIKSON GE, 1963, S ZOOL SOC LOND, V10, P134; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gray Jeffrey A., 1995, P1165; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; KAAS JH, 1995, BRAIN BEHAV EVOLUT, V46, P187, DOI 10.1159/000113273; KRZANOWSKI WJ, 1994, MULTIVARIATE STAT; MARTIN RD, 1990, PRIMATE ORIGINS EVOL, pCH8; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; MITTERMEIER RA, 1978, FOLIA PRIMATOL, V30, P161, DOI 10.1159/000155862; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Oxnard C. E., 1984, ORDER MAN BIOMATHEMA; PASSINGHAM RE, 1975, BRAIN BEHAV EVOLUT, V11, P1, DOI 10.1159/000123620; Schieber M.H., 1999, FUNDAMENTAL NEUROSCI, P931; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stephan H., 1991, INSECTIVORA	27	161	166	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					710	714		10.1038/35055547	http://dx.doi.org/10.1038/35055547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217859				2022-12-01	WOS:000166816400042
J	Pawloski, JR; Hess, DT; Stamler, JS				Pawloski, JR; Hess, DT; Stamler, JS			Export by red blood cells of nitric oxide bioactivity	NATURE			English	Article							HUMAN-ERYTHROCYTE MEMBRANE; ANION-EXCHANGE PROTEIN; S-NITROSOHEMOGLOBIN; HEMOGLOBIN BINDING; CYTOPLASMIC FRAGMENT; MOLECULAR MECHANISMS; BAND-3 INHIBITORS; TRANSPORT SITE; IDENTIFICATION; TRANSLOCATION	Previous studies support a model in which the physiological O-2 gradient is transduced by haemoglobin into the coordinate release from red blood cells of O-2 and nitric oxide (NO)-derived vasoactivity to optimize oxygen delivery in the arterial periphery(1,2). But whereas both O-2 and NO diffuse into red blood cells, only O-2 can diffuse out(3-5). Thus, for the dilation of blood vessels by red blood cells, there must be a mechanism to export NO-related vasoactivity, and current models of NO-mediated intercellular communication should be revised. Here we show that in human erythrocytes haemoglobin-derived S-nitrosothiol (SNO), generated from imported NO, is associated predominantly with the red blood cell membrane, and principally with cysteine residues in the haemoglobin-binding cytoplasmic domain of the anion exchanger AE1. Interaction with AE1 promotes the deoxygenated structure in SNO-haemoglobin, which subserves NO group transfer to the membrane. Furthermore, we show that vasodilatory activity is released from this membrane precinct by deoxygenation. Thus, the oxygen-regulated cellular mechanism that couples the synthesis and export of haemoglobin-derived NO bioactivity operates, at least in part, through formation of AE1-SNO at the membrane-cytosol interface.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 2612, Durham, NC 27710 USA.	STAML001@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572				CHETRITE G, 1985, J MOL BIOL, V185, P639, DOI 10.1016/0022-2836(85)90076-2; CZERWINSKI M, 1988, EUR J BIOCHEM, V174, P647, DOI 10.1111/j.1432-1033.1988.tb14147.x; FALKE JJ, 1986, BIOCHEMISTRY-US, V25, P7899, DOI 10.1021/bi00372a017; FALKE JJ, 1986, BIOCHEMISTRY-US, V25, P7888, DOI 10.1021/bi00372a015; GALANTER WL, 1991, BIOCHIM BIOPHYS ACTA, V1079, P146, DOI 10.1016/0167-4838(91)90119-K; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HSU L, 1983, ARCH BIOCHEM BIOPHYS, V227, P31, DOI 10.1016/0003-9861(83)90345-4; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KONDO T, 1989, METHOD ENZYMOL, V171, P217; LIU SQJ, 1993, AM J PHYSIOL, V264, pC1155, DOI 10.1152/ajpcell.1993.264.5.C1155; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; MACARA IG, 1983, J BIOL CHEM, V258, P1785; McMahon TJ, 2000, J BIOL CHEM, V275, P16738, DOI 10.1074/jbc.M000532200; McMahon TJ, 1999, METHOD ENZYMOL, V301, P99; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Pawloski JR, 1998, CIRCULATION, V97, P263, DOI 10.1161/01.CIR.97.3.263; RAUENBUEHLER PB, 1982, BIOCHIM BIOPHYS ACTA, V692, P361, DOI 10.1016/0005-2736(82)90385-6; SALHANY JM, 1980, BIOCHEMISTRY-US, V19, P1447, DOI 10.1021/bi00548a028; SAYARE M, 1981, J BIOL CHEM, V256, P3152; Shingles R, 1997, J BIOENERG BIOMEMBR, V29, P611, DOI 10.1023/A:1022491220299; Soszynski M, 1997, BIOCHEM MOL BIOL INT, V43, P319; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; TELEN MJ, 1987, VOX SANG, V52, P236, DOI 10.1111/j.1423-0410.1987.tb03035.x; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; WALDER JA, 1984, J BIOL CHEM, V259, P238	28	466	476	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					622	626		10.1038/35054560	http://dx.doi.org/10.1038/35054560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214321				2022-12-01	WOS:000166692300045
J	Abbott, GW; Butler, MH; Bendahhou, S; Dalakas, MC; Ptacek, LJ; Goldstein, SAN				Abbott, GW; Butler, MH; Bendahhou, S; Dalakas, MC; Ptacek, LJ; Goldstein, SAN			MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis	CELL			English	Article							GATED ION CHANNELS; LONG QT SYNDROME; K+ CHANNELS; RAT-BRAIN; MESSENGER-RNA; FUNCTIONAL EXPRESSION; IK(A) CHANNELS; INACTIVATION; GENE; MUTATIONS	The subthreshold, voltage-gated potassium channel of skeletal muscle is shown to contain MinK-related peptide 2 (MiRP2) and the pore-forming subunit Kv3.4. MiRP2-Kv3.4 channels differ from Kv3.4 channels in unitary conductance, voltage-dependent activation, recovery from inactivation, steady-state open probability, and block by a peptide toxin. Thus, MiRP2-Kv3.4 channels set resting membrane potential (RMP) and do not produce afterhyperpolarization or cumulative inactivation to limit action potential frequency. A mis-sense mutation is identified in the gene for MiRP2 (KCNE3) in two families with periodic paralysis and found to segregate with the disease. Mutant MiRP2-Kv3.4 complexes exhibit reduced current density and diminished capacity to set RMP. Thus, MiRP2 operates with a classical potassium channel subunit to govern skeletal muscle function and pathophysiology.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; NINDS, NIH, Bethesda, MD 20892 USA	Yale University; Yale University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 333 Cedar St, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00064] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; ADRIAN RH, 1970, J PHYSIOL-LONDON, V208, P645, DOI 10.1113/jphysiol.1970.sp009140; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BEAM KG, 1983, J GEN PHYSIOL, V81, P485, DOI 10.1085/jgp.81.4.485; Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Camacho J, 1996, BIOPHYS J, V71, P171, DOI 10.1016/S0006-3495(96)79214-7; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; ESCOBAR ALM, 1993, MUSCLE NERVE, V16, P579, DOI 10.1002/mus.880160602; FONTAINE B, 1994, NAT GENET, V6, P267, DOI 10.1038/ng0394-267; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; LAYZER RB, 1982, ANN NEUROL, V11, P547, DOI 10.1002/ana.410110602; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; LESAGE F, 1992, FEBS LETT, V310, P162, DOI 10.1016/0014-5793(92)81320-L; London B, 1997, CIRC RES, V81, P870; Marom S, 1998, J MEMBRANE BIOL, V161, P105, DOI 10.1007/s002329900318; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Ptacek L, 1998, AM J MED, V105, P58, DOI 10.1016/S0002-9343(98)00123-5; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; Ptacek LJ, 1999, SEMIN NEUROL, V19, P363, DOI 10.1055/s-2008-1040851; PTACEK LJ, 1994, CELL, V77, P863; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RIZZO MA, 1992, J NEUROPHYSIOL, V68, P1708, DOI 10.1152/jn.1992.68.5.1708; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tawil R, 2000, ANN NEUROL, V47, P46, DOI 10.1002/1531-8249(200001)47:1<46::AID-ANA9>3.3.CO;2-8; VAZQUEZ M, 1988, EUR J PHYSL, V436, P95; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Vullhorst D, 1998, FEBS LETT, V421, P259, DOI 10.1016/S0014-5793(97)01577-9; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Wymore RS, 1997, CIRC RES, V80, P261, DOI 10.1161/01.RES.80.2.261; Xu HD, 1996, J GEN PHYSIOL, V108, P405, DOI 10.1085/jgp.108.5.405; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017	55	219	244	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					217	231		10.1016/S0092-8674(01)00207-0	http://dx.doi.org/10.1016/S0092-8674(01)00207-0			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207363	Green Published, Bronze			2022-12-01	WOS:000166879700006
J	Bockrath, M; Liang, WJ; Bozovic, D; Hafner, JH; Lieber, CM; Tinkham, M; Park, HK				Bockrath, M; Liang, WJ; Bozovic, D; Hafner, JH; Lieber, CM; Tinkham, M; Park, HK			Resonant electron scattering by defects in single-walled carbon nanotubes	SCIENCE			English	Article							TIGHT-BINDING MODEL; QUANTUM WIRES; BACKSCATTERING; MICROSCOPY; GROWTH	We report the characterization of defects in individual metallic single-walled carbon nanotubes by transport measurements and scanned gate microscopy. A sizable fraction of metallic nanotubes grown by chemical vapor deposition exhibits strongly gate voltage-dependent resistance at room temperature. Scanned gate measurements reveal that this behavior originates from resonant electron scattering by defects in the nanotube as the Fermi Level is varied by the gate voltage. The reflection coefficient at the peak of a scattering resonance was determined to be about 0.5 at room temperature. An intratube quantum dot device formed by two defects is demonstrated by Low-temperature transport measurements.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Park, HK (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.		Park, Hongkun/R-9842-2019; Hafner, Jason H/A-7959-2008	Park, Hongkun/0000-0001-9576-8829; Hafner, Jason H/0000-0002-6943-4232				Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Charlier JC, 1996, PHYS REV B, V53, P11108, DOI 10.1103/PhysRevB.53.11108; Chico L, 1996, PHYS REV LETT, V76, P971, DOI 10.1103/PhysRevLett.76.971; Chico L, 1998, PHYS REV LETT, V81, P1278, DOI 10.1103/PhysRevLett.81.1278; Chico L, 1996, PHYS REV B, V54, P2600, DOI 10.1103/PhysRevB.54.2600; Choi HJ, 2000, PHYS REV LETT, V84, P2917, DOI 10.1103/PhysRevLett.84.2917; Clauss W, 1999, EUROPHYS LETT, V47, P601, DOI 10.1209/epl/i1999-00431-5; Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100; Crespi VH, 1997, PHYS REV LETT, V79, P2093, DOI 10.1103/PhysRevLett.79.2093; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; Grabert H., 1992, SINGLE CHARGE TUNNEL; Hafner JH, 1999, J AM CHEM SOC, V121, P9750, DOI 10.1021/ja992761b; Hafner JH, 1998, CHEM PHYS LETT, V296, P195, DOI 10.1016/S0009-2614(98)01024-0; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Kostyrko T, 1999, PHYS REV B, V60, P10735, DOI 10.1103/PhysRevB.60.10735; Kostyrko T, 1999, PHYS REV B, V59, P3241, DOI 10.1103/PhysRevB.59.3241; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; McEuen PL, 1999, PHYS REV LETT, V83, P5098, DOI 10.1103/PhysRevLett.83.5098; Odom TW, 2000, J PHYS CHEM B, V104, P2794, DOI 10.1021/jp993592k; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Tans SJ, 2000, NATURE, V404, P834, DOI 10.1038/35009026; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Tombler TW, 2000, NATURE, V405, P769, DOI 10.1038/35015519; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241	27	390	395	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					283	285		10.1126/science.291.5502.283	http://dx.doi.org/10.1126/science.291.5502.283			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209073				2022-12-01	WOS:000166352900038
J	Rutgeerts, P; Vermeire, S				Rutgeerts, P; Vermeire, S			Serological diagnosis of inflammatory bowel disease	LANCET			English	Editorial Material							SACCHAROMYCES-CEREVISIAE BAKERS; CROHNS-DISEASE; ANTIBODY; YEAST		Univ Louvain, Dept Med, B-3000 Louvain, Belgium		Rutgeerts, P (corresponding author), Univ Louvain, Dept Med, B-3000 Louvain, Belgium.			Vermeire, Severine/0000-0001-9942-3019				Joossens S, 2000, GASTROENTEROLOGY, V118, pA886, DOI 10.1016/S0016-5085(00)85682-6; MAIN J, 1988, BRIT MED J, V297, P1105, DOI 10.1136/bmj.297.6656.1105; MCKENZIE H, 1990, GUT, V31, P536, DOI 10.1136/gut.31.5.536; PEETERS M, IN PRESS AM J GASTRO; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; RUMP JA, 1990, IMMUNOBIOLOGY, V181, P406, DOI 10.1016/S0171-2985(11)80509-7; SAXON A, 1990, J ALLERGY CLIN IMMUN, V86, P202, DOI 10.1016/S0091-6749(05)80067-3; Sendid B, 1996, CLIN DIAGN LAB IMMUN, V3, P219, DOI 10.1128/CDLI.3.2.219-226.1996; SURTON CL, 2000, GASTROENTEROLOGY, V119, P23; Timmer A, 1999, INFLAMM BOWEL DIS, V5, P79, DOI 10.1097/00054725-199905000-00002; Vasiliauskas EA, 2000, GUT, V47, P487, DOI 10.1136/gut.47.4.487; VERMEIRE S, IN PRESS GASTROENTER	13	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 23	2000	356	9248					2117	2118		10.1016/S0140-6736(00)03488-7	http://dx.doi.org/10.1016/S0140-6736(00)03488-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385HD	11191535				2022-12-01	WOS:000165997300006
J	Schwetz, BA				Schwetz, BA			New formulation of Tripedia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, HF-1,5600 Fishers Ln, Rockville, MD 20857 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1696	1696		10.1001/jama.285.13.1696	http://dx.doi.org/10.1001/jama.285.13.1696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277810				2022-12-01	WOS:000167710600003
J	Vollrath, F; Knight, DP				Vollrath, F; Knight, DP			Liquid crystalline spinning of spider silk	NATURE			English	Review							AMINO-ACID-COMPOSITION; MAJOR AMPULLATE SILK; MECHANICAL-PROPERTIES; DRAGLINE SILK; WEB; PROTEINS; PHASE; MORPHOLOGY; EXPRESSION; SECRETION	Spider silk has outstanding mechanical properties despite being spun at close to ambient temperatures and pressures using water as the solvent The spider achieves this feat of benign fibre processing by judiciously controlling the folding and crystallization of the main protein constituents, and by adding auxiliary compounds, to create a composite material of defined hierarchical structure, Because the 'spinning dope' (the material from which silk is spun) is liquid crystalline, spiders can draw it during extrusion into a hardened fibre using minimal forces. This process involves an unusual internal drawdown within the spider's spinneret that is not seen in industrial fibre processing, followed by a conventional external drawdown after the dope has left the spinneret Successful copying of the spider's internal processing and precise control over protein folding, combined with knowledge of the gene sequences of its spinning dopes, could permit industrial production of silk-based fibres with unique properties under benign conditions.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Dept Zool, DK-8000 Aarhus C, Denmark	University of Oxford	Vollrath, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	fritz.vollrath@zoo.ox.ac.uk		Vollrath, Fritz/0000-0003-3484-9005				AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; ANDERSEN SO, 1970, COMP BIOCHEM PHYSIOL, V35, P705, DOI 10.1016/0010-406X(70)90988-6; Asakura T., 1994, ENCY AGR SCI, V4, P1; Askeland DR., 2003, SCI ENG MAT; Bunning JD, 1996, LIQ CRYST, V20, P381, DOI 10.1080/02678299608032050; CANDELAS G, 1983, BIOCHEM BIOPH RES CO, V116, P1033, DOI 10.1016/S0006-291X(83)80246-0; Case ST, 1999, INT J BIOL MACROMOL, V24, P89, DOI 10.1016/S0141-8130(98)00077-4; Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; DONALD AM, 1992, LIQUID CRYSTALLINE P, P1; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055; ENGSTER MS, 1976, CELL TISSUE RES, V169, P77; *FIB EC BUR, 1999, MAN FIB REV      JAN, P2; Foelix R., 2011, BIOL SPIDERS; Frische S, 1998, J MICROSC-OXFORD, V189, P64, DOI 10.1046/j.1365-2818.1998.00285.x; FUNG YC, 1981, BIOMECHANICS, P1; GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HENDERSON G, 1995, VET DERMATOL, V6, P159, DOI 10.1111/j.1365-3164.1995.tb00060.x; HEPBURN HR, 1988, APIDOLOGIE, V19, P25, DOI 10.1051/apido:19880102; Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN M, 1993, MATER RES SOC SYMP P, V292, P25; HUNT S, 1970, COMP BIOCHEM PHYSIOL, V34, P773, DOI 10.1016/0010-406X(70)90998-9; KAPLAN D, 1994, ACS SYM SER, V544, P2; KAPLAN DL, 1994, SILK POLYM MAT SCI B, P1; KAPLAN DL, 1995, BIOCHEMISTRY-US, V34, P10879; KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; KNIGHT DP, IN PRESS NATURWISSEN; Kovoor J., 1987, P160; KOVOOR J, 1977, Annee Biologique, V16, P97; KOVOOR J, 1982, TISSUE CELL, V14, P519, DOI 10.1016/0040-8166(82)90044-1; Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i; LOMBARDI SJ, 1990, J ARACHNOL, V18, P297; Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4; MAGOSHI J, 1985, POLYM COMMUN, V26, P309; Magoshi J., 1985, J APPL POLYM SCI APP, V41, P187; MAHONEY DV, 1994, ACS SYM SER, V544, P196; Mello C. M., 1994, SILK POLYM MAT SCI B, P67; NAKAMAE K, 1989, POLYMER, V30, P1243, DOI 10.1016/0032-3861(89)90042-6; NORTHOLT MG, 1991, ADV POLYM SCI, V98, P115; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; PETERS HM, 1955, Z NATURFORSCH PT B, V10, P395; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1; RIEKEL G, IN PRESS BIOL MACROM; SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781; SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; Shao Z, 1999, POLYMER, V40, P4709, DOI 10.1016/S0032-3861(99)00072-5; Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3; Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2; SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sirichaisit J, 2000, POLYMER, V41, P1223, DOI 10.1016/S0032-3861(99)00293-1; SIVINSKI J, 1982, ECOL ENTOMOL, V7, P443, DOI 10.1111/j.1365-2311.1982.tb00686.x; Sun YY, 1997, J POLYM SCI POL PHYS, V35, P1405, DOI 10.1002/(SICI)1099-0488(19970715)35:9<1405::AID-POLB10>3.0.CO;2-A; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; THIEL BL, 1995, MRS BULL, V20, P52, DOI 10.1557/S0883769400034941; TILLINGHAST EK, 1984, J INSECT PHYSIOL, V30, P591, DOI 10.1016/0022-1910(84)90088-X; TIRRELL JG, 1994, CHEM ENG NEWS, V72, P40, DOI 10.1021/cen-v072n051.p040; TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203; van Beek JD, 1999, INT J BIOL MACROMOL, V24, P173, DOI 10.1016/S0141-8130(98)00083-X; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Vincent J. F. V., 1982, STRUCTURAL MAT, P1; Viney C., 1994, SILK POLYM MAT SCI B, P120; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447; Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2000, EXPTL BIOL REV, P315; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; VOLLRATH F, IN PRESS P R SOC LON; VOLLRATH F, 1999, Patent No. 0004489; Weiskopf A, 1996, GLYCOBIOLOGY, V6, P1703; Willcox PJ, 1996, MACROMOLECULES, V29, P5106, DOI 10.1021/ma960588n; Winkler S, 2000, J Biotechnol, V74, P85; WINKLER S, IN PRESS REV MOL BIO; WORK RW, 1984, T AM MICROSC SOC, V103, P113, DOI 10.2307/3226233; WORK RW, 1987, J ARACHNOL, V15, P65; Yeh WY, 1999, POLYMER, V40, P857, DOI 10.1016/S0032-3861(98)00308-5; YOON HN, 1992, ADV MATER, V4, P206, DOI 10.1002/adma.19920040311; ZEMLIN JC, 1968, STUDY MECH BEHAVIOR, P1; [No title captured]	97	1195	1272	45	759	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					541	548		10.1038/35069000	http://dx.doi.org/10.1038/35069000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279484				2022-12-01	WOS:000167859300036
J	Chambers, JC; Fusi, L; Malik, IS; Haskard, DO; De Swiet, M; Kooner, JS				Chambers, JC; Fusi, L; Malik, IS; Haskard, DO; De Swiet, M; Kooner, JS			Association of maternal endothelial dysfunction with preeclampsia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTHY-YOUNG ADULTS; OXIDATIVE STRESS; NITRIC-OXIDE; ESSENTIAL-HYPERTENSION; DEPENDENT DILATATION; PASSIVE SMOKING; BLOOD-PRESSURE; RISK-FACTORS; IN-VIVO; WOMEN	Context Preeclampsia is believed to result from release of placental factors that damage maternal vascular endothelium. However, because most studies have been conducted during pregnancy, it has not been possible to separate maternal from placental mechanisms underlying endothelial dysfunction in preeclampsia. Objective To determine whether endothelial function is impaired in nonpregnant women with previous preeclampsia and whether endothelial dysfunction is mediated by oxidative stress. Design and Setting Case-control study conducted at 3 hospital maternity units in London, England, between July 1997 and June 2000. Participants A total of 113 women with previous preeclampsia (n=35 with recurrent episodes; n=78 with a single episode) and 48 women with previous uncomplicated pregnancies, all of whom were at least 3 months (median, 3 years) postpartum. Main Outcome Measures Brachial artery flow-mediated (endothelium-dependent) and glyceryl trinitrate-induced (endothelium-independent) dilatation were compared between previously preeclamptic women and controls. To investigate oxidative stress, these measurements were repeated after administration of ascorbic acid, 1 g intravenously, in 15 cases and 15 controls. Results Mean (SD) flow-mediated dilatation was lower in women with previous preeclampsia compared with controls (recurrent group, 0.9% [4.1 %]; single-episode group, 2.7% [3.5%]; and control group, 4.7% [4.3 % ]; P<.001). In contrast, glyceryl trinitrate-induced dilatation was similar in the 3 groups (recurrent, 19.5% [5.9%]; single-episode, 21.0% [8.0%]; and control, 21.0% [8.3%]; P=.65). Impaired flow-mediated dilatation in previously preeclamptic women was not accounted for by recognized vascular risk factors. Ascorbic acid administration increased flow-mediated dilatation in previously preeclamptic women (baseline, 2.6% [3.3%]; after administration, 5.6% [3.0%]; P=.001) but not in controls (baseline, 6.2% [3.3%]; after administration, 6.7% [5.0%]; P=.72). Conclusions Our results indicate that endothelial function is impaired in women with previous preeclampsia and is not explained by established maternal risk factors but is reversed by antioxidant ascorbic acid administration.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Natl Heart & Lung Inst, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Inst Obstet & Gynaecol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Inst Reprod & Dev Biol, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London	Kooner, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Natl Heart & Lung Inst, Du Cane Rd, London W12 0NN, England.	j.kooner@ic.ac.uk						Caritis S, 1998, AM J OBSTET GYNECOL, V179, P946, DOI 10.1016/S0002-9378(98)70194-2; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Chambers JC, 1999, CIRCULATION, V99, P1156, DOI 10.1161/01.CIR.99.9.1156; Chambers JC, 2000, CIRCULATION, V102, P2479, DOI 10.1161/01.CIR.102.20.2479; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Clarkson P, 1999, J AM COLL CARDIOL, V33, P1379, DOI 10.1016/S0735-1097(99)00036-4; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Evans M, 2000, CIRCULATION, V101, P1773, DOI 10.1161/01.CIR.101.15.1773; FISKERSTRAND T, 1993, CLIN CHEM, V39, P263; Giugliano D, 1998, DIABETES CARE, V21, P631, DOI 10.2337/diacare.21.4.631; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Hart CL, 1999, STROKE, V30, P1999, DOI 10.1161/01.STR.30.10.1999; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; HOLCBERG G, 1995, AM J OBSTET GYNECOL, V173, P528; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Matijevic R, 1999, BRIT J OBSTET GYNAEC, V106, P78, DOI 10.1111/j.1471-0528.1999.tb08089.x; Meeking DR, 1999, DIABETIC MED, V16, P841, DOI 10.1046/j.1464-5491.1999.00158.x; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Muiesan ML, 1999, HYPERTENSION, V33, P575, DOI 10.1161/01.HYP.33.1.575; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; Myatt L, 1996, HYPERTENSION, V28, P488, DOI 10.1161/01.HYP.28.3.488; POHL U, 1986, HYPERTENSION, V8, P37, DOI 10.1161/01.HYP.8.1.37; Raitakari OT, 1999, ANN INTERN MED, V130, P578, DOI 10.7326/0003-4819-130-7-199904060-00017; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; RODGERS GM, 1988, AM J OBSTET GYNECOL, V159, P908, DOI 10.1016/S0002-9378(88)80169-8; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Simons LA, 1998, ATHEROSCLEROSIS, V137, P197, DOI 10.1016/S0021-9150(97)00252-9; SORENSEN KE, 1995, BRIT HEART J, V74, P247; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Virdis A, 2000, CIRCULATION, V101, P2258, DOI 10.1161/01.CIR.101.19.2258; Walker AB, 1999, DIABETES, V48, P1448, DOI 10.2337/diabetes.48.7.1448; Walsh SW, 1998, SEMIN REPROD ENDOCR, V16, P93, DOI 10.1055/s-2007-1016256; Woo KS, 1997, CIRCULATION, V96, P2542, DOI 10.1161/01.CIR.96.8.2542; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6	40	380	397	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1607	1612		10.1001/jama.285.12.1607	http://dx.doi.org/10.1001/jama.285.12.1607			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268269	Bronze			2022-12-01	WOS:000167606600028
J	Chambers, JQ; Higuchi, N; Tribuzy, ES; Trumbore, SE				Chambers, JQ; Higuchi, N; Tribuzy, ES; Trumbore, SE			Carbon sink for a century	NATURE			English	Article							TROPICAL FORESTS; RESPONSES; TREES		Univ Calif Irvine, Irvine, CA 92697 USA; Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; INPA, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, Amazonas, Brazil; Inst Nacl de Pesquisas da Amazonia, BR-69011970 Manaus, Amazonas, Brazil	University of California System; University of California Irvine; National Center for Ecological Analysis & Synthesis; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Chambers, JQ (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.	chambersjq@yahoo.com	Higuchi, Niro/J-1287-2016; Chambers, Jeffrey Q/AAU-7097-2021; Higuchi, Niro/ABC-8890-2020; Trumbore, Susan/B-1948-2013; Higuchi, Niro/ABC-9134-2020; Chambers, Jeffrey Q/J-9021-2014; Tribuzy, Edgard Siza/D-8200-2014	Higuchi, Niro/0000-0002-1203-4502; Higuchi, Niro/0000-0002-1203-4502; Chambers, Jeffrey Q/0000-0003-3983-7847; Siza Tribuzy, Edgard/0000-0002-6834-8535				Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; CHAMBERS JQ, IN PRESS FOR ECOL MA; CHAMBERS JQ, 1998, ROLE LARGE WOOD CARB; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Lloyd J, 1999, FUNCT ECOL, V13, P439, DOI 10.1046/j.1365-2435.1999.00350.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148	12	92	100	2	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					429	429		10.1038/35068624	http://dx.doi.org/10.1038/35068624			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260700	Bronze			2022-12-01	WOS:000167583800028
J	Ross, JJ; Shimmi, O; Vilmos, P; Petryk, A; Kim, H; Gaudenz, K; Hermanson, S; Ekker, SC; O'Connor, MB; Marsh, JL				Ross, JJ; Shimmi, O; Vilmos, P; Petryk, A; Kim, H; Gaudenz, K; Hermanson, S; Ekker, SC; O'Connor, MB; Marsh, JL			Twisted gastrulation is a conserved extracellular BMP antagonist	NATURE			English	Article							DORSAL-VENTRAL PATTERN; DROSOPHILA EMBRYO; ZEBRAFISH EMBRYO; SPEMANNS ORGANIZER; ACTIVITY GRADIENT; MOLECULAR NATURE; DPP ACTIVITY; PROTEIN; XENOPUS; GENES	Bone morphogenetic protein (BMP) signalling regulates embryonic dorsal-ventral cell fate decisions in flies, frogs and fish(1). BMP activity is controlled by several secreted factors including the antagonists chordin and short gastrulation (SOG)(2,3). Here we show that a second secreted protein, Twisted gastrulation (Tsg)(4), enhances the antagonistic activity of Sog/chordin. In Drosophila, visualization of BMP signalling using anti-phospho-Smad staining(5) shows that the tsg and sog loss-of-function phenotypes are very similar. In S2 cells and imaginal discs, TSG and SOG together make a more effective inhibitor of BMP signalling than either of them alone. Blocking Tsg function in zebrafish with morpholino oligonucleotides causes ventralization similar to that produced by chordin mutants. Co-injection of sub-inhibitory levels of morpholines directed against both Tsg and chordin synergistically enhances the penetrance of the ventralized phenotype. We show that Tsgs from different species are functionally equivalent, and conclude that Tsg is a conserved protein that functions with SOG/chordin to antagonize BMP signalling.	Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Dev & Cell Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN 55455 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA.		O'Connor, Michael B/C-9977-2014; , 0000-0001-6341-9130/P-9094-2018	O'Connor, Michael B/0000-0002-3067-5506; , 0000-0001-6341-9130/0000-0001-6341-9130; Vilmos, Peter/0000-0001-5692-8818; Ekker, Stephen/0000-0003-0726-4212				ARORA K, 1992, DEVELOPMENT, V114, P1003; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Dick A, 2000, DEVELOPMENT, V127, P343; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fisher S, 1997, DEVELOPMENT, V124, P1301; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Miller-Bertaglio V, 1999, DEV BIOL, V214, P72, DOI 10.1006/dbio.1999.9384; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; RAY RP, 1991, DEVELOPMENT, V113, P35; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; SEGAL D, 1985, GENETICS, V109, P119; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Yu K, 2000, DEVELOPMENT, V127, P2143	30	228	247	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					479	483		10.1038/35068578	http://dx.doi.org/10.1038/35068578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260716	Green Published			2022-12-01	WOS:000167583800044
J	Lee, IM; Rexrode, KM; Cook, NR; Manson, JE; Buring, JE				Lee, IM; Rexrode, KM; Cook, NR; Manson, JE; Buring, JE			Physical activity and coronary heart disease in women - Is "no pain, no gain" passe?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONFATAL MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; POSTMENOPAUSAL WOMEN; OLDER ADULTS; MORTALITY; HEALTH; EXERCISE; MEN; WALKING	Context Physically active women have lower coronary heart disease (CHD) rates than inactive women. However, whether the association differs by intensity of activity or in women at high risk for CHD is unclear. Objective To examine the relation between physical activity, specifically investigating walking (a light-to-moderate activity depending on pace), and CHD among women, including those at high risk for CHD. Design, Setting, and Participants Cohort study of 39372 healthy female health professionals aged 45 years or older, enrolled throughout the United States between September 1992 and May 1995, with follow-up to March 1999. Recreational activities, including walking and stair climbing, were reported at study entry. Main Outcome Measure Correlation of CHD with energy expended on all activities, vigorous activities, and walking. Results A total of 244 cases of CHD occurred. Adjusting for potential confounders, the relative risks (RRs) of CHD for less than 200, 200-599, 600-1499, and 1500 or more kcal/wk expended on all activities were 1.00 (referent), 0.79 (95% confidence interval [CI], 0.56-1.12), 0.55 (95% CI, 0.37-0.82), and 0.75 (95% CI, 0.50-1.12), respectively (P for linear trend =.03). Vigorous activities were associated with lower risk (RR, 0.63; 95% CI, 0.38-1.04 comparing highest and lowest categories). Walking also predicted lower risk among women without vigorous activities. Among these women, the multivariate RRs for walking 1 to 59 min/wk, 1.0 to 1.5 h/wk, and 2 or more h/wk, compared with no regular walking, were 0.86 (95% CI, 0.57-1.29), 0.49 (95% CI, 0.28-0.86), and 0.48 (95% CI, 0.29-0.78), respectively. For walking paces of less than 3.2 km/h (2.0 mph), 3.2 to 4.7 km/h (2.0-2.9 mph), and 4.8 km/h (3.0 mph) or more, corn pared with no regular walking, RRs were 0.56 (95% CI, 0.32-0.97), 0.71 (95% CI, 0.47-1.05), and 0.52 (95% CI, 0.30-0.90), respectively. When analyzed simultaneously, time spent walking (P for linear trend =.01) but not walking pace (P for linear trend =.55) predicted lower risk. The inverse association between physical activity and CHD risk did not differ by weight or cholesterol levels (P for interaction =.95 and .71, respectively), but there were significant interactions by smoking and hypertension status. Physical activity was inversely related to risk in current smokers but not hypertensive women (P for interaction =.01 and .001, respectively). Conclusions These data indicate that even light-to-moderate activity is associated with lower CHD rates in women. At least 1 hour of walking per week predicted lower risk. The inverse association with physical activity was also present in women at high risk for CHD, including those who were overweight, had increased cholesterol levels, or were smokers.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lee, IM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.		Lee, I-Min/ABD-5409-2021; Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429	NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; *AM COLL SPORTS ME, 1985, GUID GRAD EX TEST EX; *AM HEART ASS, 1998, 1999 HEART STOK STAT; Bassett DR, 2000, MED SCI SPORT EXER, V32, P1018; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; BRUNNER D, 1974, J CHRON DIS, V27, P217, DOI 10.1016/0021-9681(74)90047-2; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P30; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; CHANGCLAUDE J, 1993, INT J EPIDEMIOL, V22, P228, DOI 10.1093/ije/22.2.228; COX DR, 1972, J R STAT SOC B, V34, P187; Dorn JP, 1999, ANN EPIDEMIOL, V9, P366, DOI 10.1016/S1047-2797(99)00025-3; DUNCAN JJ, 1991, JAMA-J AM MED ASSOC, V266, P3295, DOI 10.1001/jama.266.23.3295; Folsom AR, 1997, MED SCI SPORT EXER, V29, P901, DOI 10.1097/00005768-199707000-00009; FRASER GE, 1992, CIRCULATION, V86, P406, DOI 10.1161/01.CIR.86.2.406; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; HAGBERG JM, 1989, AM J CARDIOL, V64, P348, DOI 10.1016/0002-9149(89)90533-X; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KAPLAN GA, 1987, AM J PUBLIC HEALTH, V77, P307, DOI 10.2105/AJPH.77.3.307; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LaCroix AZ, 1996, J AM GERIATR SOC, V44, P113, DOI 10.1111/j.1532-5415.1996.tb02425.x; LAPIDUS L, 1986, BRIT HEART J, V55, P295, DOI 10.1136/hrt.55.3.295; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lee IM, 1996, RES Q EXERCISE SPORT, V67, P206, DOI 10.1080/02701367.1996.10607944; LEMAITRE RN, 1995, ARCH INTERN MED, V155, P2302, DOI 10.1001/archinte.155.21.2302; Lissner L, 1996, AM J EPIDEMIOL, V143, P54; MAGNUS K, 1979, AM J EPIDEMIOL, V110, P724, DOI 10.1093/oxfordjournals.aje.a112853; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MARCEAU M, 1993, CIRCULATION, V88, P2803, DOI 10.1161/01.CIR.88.6.2803; MATSUSAKI M, 1992, CLIN EXP PHARMACOL P, V19, P471, DOI 10.1111/j.1440-1681.1992.tb00492.x; Mensink GBM, 1996, EPIDEMIOLOGY, V7, P391, DOI 10.1097/00001648-199607000-00009; OCONNOR GT, 1995, AM J EPIDEMIOL, V142, P1147, DOI 10.1093/oxfordjournals.aje.a117573; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; SALONEN JT, 1982, AM J EPIDEMIOL, V115, P525; SCRAGG R, 1987, AM J EPIDEMIOL, V126, P77, DOI 10.1093/oxfordjournals.aje.a114664; Sesso HD, 1999, AM J EPIDEMIOL, V150, P408; SHERMAN SE, 1994, AM HEART J, V128, P879, DOI 10.1016/0002-8703(94)90583-5; SIMONSICK EM, 1993, AM J PUBLIC HEALTH, V83, P1443, DOI 10.2105/AJPH.83.10.1443; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; US Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; *WHO, 1971, ISCHAEMIC HEART DIS; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	45	361	366	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1447	1454		10.1001/jama.285.11.1447	http://dx.doi.org/10.1001/jama.285.11.1447			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410VQ	11255420				2022-12-01	WOS:000167462100026
J	Gress, F; Gottlieb, K; Sherman, S; Lehman, G				Gress, F; Gottlieb, K; Sherman, S; Lehman, G			Endoscopic ultrasonography - Guided fine-needle aspiration biopsy of suspected pancreatic cancer	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy/Digestive Diseases Week 1997	MAY 11-14, 1997	WASHINGTON, D.C.	Amer Soc Gastrointestinal Endoscopy			CARCINOMA; DIAGNOSIS	Background: In many institutions, computed tomography (CT) guided percutaneous fine-needle aspiration (FNA) has become the procedure of choice for biopsies of pancreatic mass lesions. This method of biopsy and others, such as endoscopic retrograde cholangiopancreatography (ERCP) cytology, are problematic because of a substantial false-negative rate. Objective: To investigate the yield of endoscopic ultrasonography-guided FNA biopsies in patients who had negative results on CT-guided biopsy or negative cytologic findings on ERCP sampling. Design: Prospective cohort study. Setting: Tertiary care university medical center. Patients: 102 patients (median age, 65 years; 58 men and 44 women) with suspected pancreatic cancer who fulfilled the above criteria were prospectively identified and underwent endoscopic ultrasonography-guided FNA biopsy. Measurements: The operating characteristics of endoscopic ultra; sonography-guided FNA for diagnosing pancreatic masses were determined. Surgical pathology or long-term follow-up (median, 24 months) was used to identify false-positive or false-negative results. Results: Median mass size was 3.5 cm x 2.7 cm. A median of 3.4 passes were performed. Cytologic results on endoscopic ultrasonography-guided FNA biopsy were positive in 57 patients, negative in 37, and inconclusive or nondiagnostic in 8. No false-positive results were observed. A diagnosis of pancreatic cancer was subsequently confirmed in 3 patients who had tested negative (false-negative results) and 1 of the 8 patients with nondiagnostic results. Of these 4 patients, 3 had cytologic evidence of chronic pancreatitis on endoscopic ultrasonography-guided FNA biopsy. The 95% CI for the likelihood ratio for a positive test result contained all values greater than or equal to 9.7. The likelihood ratio for a negative test result was 0.05 (CI, 0.02 to 0.15). The posterior probability of pancreatic cancer after a definitely positive result was at least 93.5% by a conservative lower 95% confidence limit; after a definitely negative test result, it was 6.9%. The prevalence of pancreatic cancer was 59.8% (61 of 102 patients). Self-limited complications occurred in 3 of the 102 patients (2.9% [CI, 0.6% to 8.4%]). Conclusion: Endoscopic ultrasonography-guided FNA biopsy may play a valuable role in the evaluation of a pancreatic mass when results on other biopsy methods are negative but pancreatic cancer is suspected.	SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; Spokane Digest Dis Ctr, Spokane, WA USA; Indiana Univ, Med Ctr, Indianapolis, IN USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Indiana University System; Indiana University-Purdue University Indianapolis	Gress, F (corresponding author), Winthrop Univ Hosp, Div Gastroenterol & Hepatol, 222 Dtn Plaza N,Suite 429, Mineola, NY 11501 USA.			Gottlieb, Klaus/0000-0002-3747-2541				Ayar D, 1998, J THORAC IMAG, V13, P2, DOI 10.1097/00005382-199801000-00002; Bentz JS, 1998, DIAGN CYTOPATHOL, V18, P98, DOI 10.1002/(SICI)1097-0339(199802)18:2<98::AID-DC4>3.0.CO;2-P; BERGENFELDT M, 1988, ACTA CHIR SCAND, V154, P77; Bhutani MS, 1997, ENDOSCOPY, V29, P854, DOI 10.1055/s-2007-1004321; Bret P M, 1986, Diagn Cytopathol, V2, P221, DOI 10.1002/dc.2840020309; Carlucci M, 1989, HPB Surg, V1, P309, DOI 10.1155/1989/84039; CARLUCCI M, 1989, HPB SURG, V1, P315; CATURELLI E, 1985, DIAGN IMAG CLIN MED, V54, P88; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; CHANG KJ, 1994, GASTROINTEST ENDOSC, V40, P694, DOI 10.1016/S0016-5107(94)70112-1; Di Stasi M, 1998, AM J GASTROENTEROL, V93, P1329; Gress FG, 1997, GASTROINTEST ENDOSC, V45, P243, DOI 10.1016/S0016-5107(97)70266-9; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Lee J G, 1998, Gastrointest Endosc Clin N Am, V8, P221; Lerma E, 1996, ACTA CYTOL, V40, P683; Riker A, 1997, SURG ONCOL, V6, P157, DOI 10.1016/S0960-7404(97)00025-X; ROBINS DB, 1995, ACTA CYTOL, V39, P1; SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P119; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; WOOLSON RF, 1987, STAT METHODS ANAL BI, P409; Yeaton P, 1998, CYTOMETRY, V32, P309, DOI 10.1002/(SICI)1097-0320(19980801)32:4<309::AID-CYTO8>3.0.CO;2-C	21	254	260	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					459	464		10.7326/0003-4819-134-6-200103200-00010	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	409VF	11255521				2022-12-01	WOS:000167405800004
J	Snow, V; Mottur-Pilson, C; Cooper, RJ; Hoffman, LR				Snow, V; Mottur-Pilson, C; Cooper, RJ; Hoffman, LR		Amer Coll Phys-Amer Soc Internal Med	Principles of appropriate antibiotic use for acute pharyngitis in adults	ANNALS OF INTERNAL MEDICINE			English	Article									Amer Coll Phys Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA		Snow, V (corresponding author), Amer Coll Phys Amer Soc Internal Med, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.				AHRQ HHS [F32 HS00134-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000134] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)			0	134	146	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					506	508		10.7326/0003-4819-134-6-200103200-00018	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00018			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255529				2022-12-01	WOS:000167405800012
J	Weinstein, MC; Goldie, SJ; Losina, E; Cohen, CJ; Baxter, JD; Zhang, H; Kimmel, AD; Freedberg, KA				Weinstein, MC; Goldie, SJ; Losina, E; Cohen, CJ; Baxter, JD; Zhang, H; Kimmel, AD; Freedberg, KA			Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOBACTERIUM-AVIUM COMPLEX; PROTEASE INHIBITOR THERAPY; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; PLUS INDINAVIR; CELL COUNTS; ZIDOVUDINE; PROPHYLAXIS	Background: Genotypic sequencing for drug-resistant strains of HIV can guide the choice of antiretroviral therapy. Objective: To assess the cost-effectiveness of genotypic resistance testing for patients acquiring drug resistance through failed treatment (secondary resistance) and those infected with resistant virus (primary resistance). Design: Cost-effectiveness analysis with an HIV simulation model incorporating CD4 cell count and HIV RNA level as predictors of disease progression. Data Sources: Published randomized trials and data from the Multicenter AIDS Cohort Study, the national AIDS Cost and Services Utilization Survey, the Red Book, and an institutional cost-accounting system. Target Population: HIV-infected patients in the United States with baseline CD4 counts of 0.250 x 10(9) cells/L. Time Horizon: Lifetime. Perspective: societal. Interventions: Genotypic resistance testing and clinical judgment, compared with clinical judgment alone, in two contexts: after initial treatment failure (secondary resistance testing) and before initiation of antiretroviral therapy (primary resistance testing). Outcome Measures: Life expectancy, quality-adjusted life expectancy, and cost-effectiveness in dollars per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: Secondary resistance testing increased life expectancy by 3 months, at a cost of $17 900 per QALY gained. The cost-effectiveness of primary resistance testing was $22 300 per QALY gained with a 20% prevalence of primary resistance but increased to $69 000 per QALY gained with 4% prevalence. Results of Sensitivity Analysis: The cost-effectiveness ratio for secondary resistance testing remained under $25 000 per QALY gained, even when effectiveness and cost of testing and antiretroviral therapy, quality-of-life weights, and discount rate were varied. Conclusions: Genotypic antiretroviral resistance testing following antiretroviral failure is cost-effective. Primary resistance testing also seems to be reasonably cost-effective and will become more so as the prevalence of primary resistance increases.	Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Community Res Initiat New England, Brookline, MA USA; Univ Med & Dent New Jersey, Cooper Hosp, Camden, NJ 08103 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Camden, NJ 08103 USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Weinstein, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.			Losina, ELENA/0000-0002-3424-0892	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI42006, R01 AI042006] Funding Source: Medline; PHS HHS [U64/CCU 114927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; BALAGUERA HU, 2000, P 40 ANN INT C ANT A; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bayoumi AM, 1998, AIDS, V12, P1503, DOI 10.1097/00002030-199812000-00013; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; CAMERON DW, 2000, P 7 C RETR OPP INF J; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; COHEN C, 2000, ANTIVIR THER S, V5, P67; Cook J, 1999, AIDS RES HUM RETROV, V15, P499, DOI 10.1089/088922299311024; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; FREEDBERG KA, IN PRESS N ENGL J ME; Gold MR., 1996, COST EFFECTIVENESS H; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrigan PR, 1999, AIDS, V13, P1863, DOI 10.1097/00002030-199910010-00008; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HOLTGRAVE DR, 1995, MED DECIS MAKING, V15, P311, DOI 10.1177/0272989X9501500402; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Levitz SM, 1998, NEW ENGL J MED, V338, P1074, DOI 10.1056/NEJM199804093381517; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; MAYNARD JL, 2000, ANTIVIR THER S, V5, P67; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Moore RD, 2000, PHARMACOECONOMICS, V17, P325, DOI 10.2165/00019053-200017040-00002; *NAT TECHN INF SER, 1994, AIDS COST SERV UT SU; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; NIGHTINGALE SD, 1993, NEW ENGL J MED, V329, P828, DOI 10.1056/NEJM199309163291202; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PATICK AK, 1998, ANTIVIR THER, V3, pS39; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Tsevat J, 1996, MED CARE, V34, P44, DOI 10.1097/00005650-199601000-00004; [U.S. Public Health Service (USPHS) Infectious Diseases Society of America (IDSA)], 1999, MMWR-MORBID MORTAL W, V48, p[1, 61]; US Bureau of the Census, 1998, STAT ABSTR US 1998; *US DEP HHS, 2000, HIV CLIN TRIALS, V1, P60; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003; 1998, DRUG TOPICS RED BOOK	47	184	188	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					440	450		10.7326/0003-4819-134-6-200103200-00008	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255519				2022-12-01	WOS:000167405800002
J	Baker, NE; Yu, SY				Baker, NE; Yu, SY			The EGF receptor defines domains of cell cycle progression and survival to regulate cell number in the developing Drosophila eye	CELL			English	Article							GENETIC MOSAICS; PRONEURAL GENE; DIVISION; DEATH; PROLIFERATION; EXPRESSION; HOMOLOG; PROTEIN; RETINA; ARREST	The number of cells in developing organs must be controlled spatially by extracellular signals. Our results show how cell number can be regulated by cell interactions controlling proliferation and survival in local neighborhoods in the case of the Drosophila compound eye. Intercellular signals act during the second mitotic wave, a cell cycle that generates a pool of uncommitted cells used for most ommatidial fates. We find that G1/S progression to start the cell cycle requires EGF receptor inactivity. EGF receptor activation is then required for progression from G2 to M phase of the same cells, and also prevents apoptosis. EGF receptor activation depends on short-range signals from five-cell preclusters of photoreceptor neurons not participating in the second mitotic wave. Through proliferation and survival control, such signals couple the total number of uncommitted cells being generated to the neural patterning of the retina.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047892] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47892] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1995, MECH DEVELOP, V49, P173, DOI 10.1016/0925-4773(94)00314-D; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Dickson Barry, 1993, P1327; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FOE VE, 1989, DEVELOPMENT, V107, P1; FREEMAN M, 1992, DEVELOPMENT, V116, P335; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; HAY BA, 1994, DEVELOPMENT, V120, P2121; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; HORSCHT M, 1990, NEURON, V4, P697; Horsfield J, 1998, DEVELOPMENT, V125, P5069; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kunes S, 2000, CURR OPIN NEUROBIOL, V10, P58, DOI 10.1016/S0959-4388(99)00051-3; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Kylsten P, 1997, DEV BIOL, V192, P509, DOI 10.1006/dbio.1997.8770; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; Miller DT, 1998, DEVELOPMENT, V125, P2327; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; PEIFER M, 1994, DEVELOPMENT, V120, P369; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Sawamoto K, 1998, CELL DEATH DIFFER, V5, P262, DOI 10.1038/sj.cdd.4400342; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; Tio M, 1997, DEVELOPMENT, V124, P343; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223	52	154	156	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					699	708		10.1016/S0092-8674(02)06076-2	http://dx.doi.org/10.1016/S0092-8674(02)06076-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257224	Bronze			2022-12-01	WOS:000167531100010
J	Milojkovic, D; Mufti, GJ				Milojkovic, D; Mufti, GJ			Extending the role of allogeneic stem-cell transplantation	LANCET			English	Editorial Material							BONE-MARROW TRANSPLANTATION; GRAFT-VERSUS-LEUKEMIA; THERAPY; CHEMOTHERAPY; MALIGNANCIES; BUSULFAN		Guys Kings & St Thomas Sch Med, Dept Haematol Med, London SE5 9RS, England	University of London; King's College London	Mufti, GJ (corresponding author), Guys Kings & St Thomas Sch Med, Dept Haematol Med, Kings Denmark Hill Campus, London SE5 9RS, England.							Carella AM, 2000, BONE MARROW TRANSPL, V25, P345, DOI 10.1038/sj.bmt.1702204; Carella AM, 1998, BRIT J HAEMATOL, V103, P565, DOI 10.1046/j.1365-2141.1998.01057.x; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Giralt S, 1997, BLOOD, V89, P4531, DOI 10.1182/blood.V89.12.4531; Hadzic N, 2000, NEW ENGL J MED, V342, P320, DOI 10.1056/NEJM200002033420504; HOROWITZ MM, 1990, BLOOD, V75, P555; Khouri IF, 1998, J CLIN ONCOL, V16, P2817, DOI 10.1200/JCO.1998.16.8.2817; Kirschbaum M, 1996, BLOOD, V88, P3827; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Kottaridis PD, 2000, BLOOD, V96, P2419; MCSWEENEY P, 1999, BLOOD S1, V94, pA1742; MICHAELLET M, 2000, HEMATOL J S1, V1, pA840; PARKER JE, 2000, HEMATOL J S1, V1, pA843; PETERSEN FB, 1989, BONE MARROW TRANSPL, V4, P617; Slattery JT, 1997, BLOOD, V89, P3055, DOI 10.1182/blood.V89.8.3055; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763	16	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					652	654		10.1016/S0140-6736(00)04150-7	http://dx.doi.org/10.1016/S0140-6736(00)04150-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247545				2022-12-01	WOS:000167282400004
J	Luo, ZY; Zhang, QS; Oderaotoshi, Y; Curran, DP				Luo, ZY; Zhang, QS; Oderaotoshi, Y; Curran, DP			Fluorous mixture synthesis: A fluorous-tagging strategy for the synthesis and separation of mixtures of organic compounds	SCIENCE			English	Article							PHASE COMBINATORIAL SYNTHESIS; MAPPICINE KETONE; LIBRARIES; CHEMISTRY; DECONVOLUTION; ISONITRILES; MOLECULES; PRODUCTS; REAGENTS	The solution-phase synthesis of organic compounds as mixtures rather than in individual pure form offers efficiency advantages that are negated by the difficulty in separating and identifying the components of the final mixture. Here, a Strategy for mixture synthesis that addresses these separation and identification problems is presented. A series of organic substrates was tagged with a series of fluorous tags of increasing fluorine content. The compounds were then mixed, and multistep reactions were conducted to make enantiomers or analogs of the natural product mappicine. The resulting tagged products were then demixed by fluorous chromatography (eluting in order of increasing fluorine content) to provide the individual pure components of the mixture, which were detagged to release the final products.	Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Combinatorial Chem, Pittsburgh, PA 15260 USA; Fluorous Technol, Pittsburgh, PA 15238 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Curran, DP (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.			Zhang, Qisheng/0000-0001-9808-5038				An HY, 2000, CHEM REV, V100, P3311, DOI 10.1021/cr990014r; Balkenhohl F, 1996, ANGEW CHEM INT EDIT, V35, P2289; Boger DL, 1998, J AM CHEM SOC, V120, P1218, DOI 10.1021/ja973007y; Boger DL, 1998, J AM CHEM SOC, V120, P7220, DOI 10.1021/ja9803557; Booth RJ, 1999, ACCOUNTS CHEM RES, V32, P18, DOI 10.1021/ar970311n; CARELL T, 1994, ANGEW CHEM INT EDIT, V33, P2059, DOI 10.1002/anie.199420591; Curran DP, 1999, J AM CHEM SOC, V121, P9069, DOI 10.1021/ja991496r; Curran DP, 1996, J AM CHEM SOC, V118, P2531, DOI 10.1021/ja953287m; Curran DP, 1998, ANGEW CHEM INT EDIT, V37, P1175, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1174::AID-ANIE1174>3.0.CO;2-P; CURRAN DP, UNPUB; de Frutos O, 2000, J COMB CHEM, V2, P639, DOI 10.1021/cc000032i; Eliel EL., 1994, STEREOCHEMISTRY ORGA, DOI 10.1002/9780470147306; Flynn DL, 1999, MED RES REV, V19, P408, DOI 10.1002/(SICI)1098-1128(199909)19:5<408::AID-MED7>3.0.CO;2-J; FURKA A, 1996, COMBINATORIAL PEPTID, P111; GOVINDACHARI TR, 1974, J CHEM SOC PERK T 1, P1215, DOI 10.1039/p19740001215; Griffey RH, 1998, TETRAHEDRON, V54, P4067, DOI 10.1016/S0040-4020(98)00135-5; HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Josien H, 1997, TETRAHEDRON, V53, P8881, DOI 10.1016/S0040-4020(97)00575-9; Josien H, 1998, CHEM-EUR J, V4, P67, DOI 10.1002/(SICI)1521-3765(199801)4:1<67::AID-CHEM67>3.0.CO;2-F; Kaldor SW, 1997, CURR OPIN CHEM BIOL, V1, P101, DOI 10.1016/S1367-5931(97)80115-9; Lam KS, 1997, CHEM REV, V97, P411, DOI 10.1021/cr9600114; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891; Studer A, 1997, SCIENCE, V275, P823, DOI 10.1126/science.275.5301.823; VEDEJS E, 1997, J AM CHEM SOC, V119, P2284	26	307	312	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1766	1769		10.1126/science.1057567	http://dx.doi.org/10.1126/science.1057567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230688				2022-12-01	WOS:000167320600053
J	Caicedo, A; Roper, SD				Caicedo, A; Roper, SD			Taste receptor cells that discriminate between bitter stimuli	SCIENCE			English	Article							RAT; TRANSDUCTION; CALCIUM	Recent studies showing that single taste bud cells express multiple bitter taste receptors have reignited a Long-standing controversy over whether single gustatory receptor cells respond selectively or broadly to tastants. We examined calcium responses of rat taste receptor cells in situ to a panel of bitter compounds to determine whether individual cells distinguish between bitter stimuli. Most bitter-responsive taste cells were activated by only one out of five compounds tested. In taste cells that responded to multiple stimuli, there were no significant associations between any two stimuli. Bitter sensation does not; appear to occur through the activation of a homogeneous population of broadly tuned bitter-sensitive taste cells. Instead, different bitter stimuli may activate different subpopulations of bitter-sensitive taste cells.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; Rocky Mt Taste & Smell Ctr, Denver, CO 80262 USA; Ctr Int Fis, Lab Biofis, Bogota, Colombia; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33136 USA	University of Miami; University of Miami	Caicedo, A (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave, Miami, FL 33136 USA.		Caicedo, Alejandro/F-1202-2010; Caicedo, Alejandro/AAC-8544-2020	Roper, Stephen/0000-0001-6049-8320	NIDCD NIH HHS [F32 DC000374, R03 DC004525, DC04525-01, R01 DC000374, DC00374] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000374, R03DC004525, F32DC000374] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADLERE, 2000, CELL, V100, P693; AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; BARTOSHUK LM, 1977, SENS PROCESS, V1, P177; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; CAICEDOA, 2000, J NEUROSCI, V20, P7978; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; DELWICHEJF, 2000, 12 INT S OLF TAST 14; Dess NK, 2000, PHYSIOL BEHAV, V69, P247, DOI 10.1016/S0031-9384(99)00246-2; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; IWASAKI K, 1981, CHEM SENSES, V6, P119, DOI 10.1093/chemse/6.2.119; KOH SD, 1961, J COMP PHYSIOL PSYCH, V54, P223, DOI 10.1037/h0048474; Krimm RF, 1998, J COMP NEUROL, V398, P13; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCBURNEY DH, 1972, PERCEPT PSYCHOPHYS, V11, P228, DOI 10.3758/BF03206255; Ogura T, 1997, J NEUROSCI, V17, P3580; Patton HD, 1944, J COMP PSYCHOL, V37, P35, DOI 10.1037/h0054668; Pfaffmann C., 1959, HDB PHYSL NEUROPHYSI, V1, P507; Richter CP, 1941, AM J PHYSIOL, V134, P0157, DOI 10.1152/ajplegacy.1941.134.1.157; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; Thaw AK, 1996, CHEM SENSES, V21, P189, DOI 10.1093/chemse/21.2.189; TOBACH E, 1974, BEHAV GENET, V4, P405, DOI 10.1007/BF01066160; Whitehead MC, 1999, NEUROSCIENCE, V93, P931, DOI 10.1016/S0306-4522(99)00115-3	25	141	146	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1557	1560		10.1126/science.1056670	http://dx.doi.org/10.1126/science.1056670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222863	Green Accepted			2022-12-01	WOS:000167153400048
J	Olshansky, SJ; Carnes, BA; Desesquelles, A				Olshansky, SJ; Carnes, BA; Desesquelles, A			Demography - Prospects for human longevity	SCIENCE			English	Editorial Material							MORTALITY; METHUSELAH		Univ Illinois, Sch Publ Hlth, Chicago, IL 60637 USA; Univ Illinois, Ctr Aging, Chicago, IL 60637 USA; Univ Chicago, Ctr Aging, Natl Opin Res Ctr, Chicago, IL 60637 USA; Inst Natl Etud Demog, F-75980 Paris 20, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Olshansky, SJ (corresponding author), Univ Illinois, Sch Publ Hlth, Chicago, IL 60637 USA.				NIA NIH HHS [AG00894-01, AG13698-01] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*BOARD TRUST FED O, 1999, 1999 ANN REP; Carnes BA, 1997, EXP GERONTOL, V32, P615, DOI 10.1016/S0531-5565(97)00056-9; GOSS SH, UNPUB; HORIUCHI S, 1990, DIFFERENTIAL MORTALI, P64; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Keyfitz N., 1985, APPL MATH DEMOGRAPHY, Vsecond; Lee R, 2000, POPUL DEV REV, V26, P137, DOI 10.1111/j.1728-4457.2000.00137.x; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; MANTON K, 1991, POPUL DEV REV, V17, P309; Martin L. G., 1994, DEMOGRAPHY AGING; Olshansky S.J., 1996, HLTH MORTALITY ELDER, P39; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 1997, POPUL BULL, V52, P2; POLLARD JH, 1988, DEMOGRAPHY, V25, P265, DOI 10.2307/2061293; Taeuber C. M., 1993, INT POPULATION REPOR; VAUPEL JW, 1986, AM J PUBLIC HEALTH, V76, P430, DOI 10.2105/AJPH.76.4.430; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; WILSON ME, 1994, DIS EVOLUTION GLOBAL	18	165	167	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1491	1492		10.1126/science.291.5508.1491	http://dx.doi.org/10.1126/science.291.5508.1491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405HF	11234076				2022-12-01	WOS:000167153400025
J	Ohtani, N; Zebedee, Z; Huot, TJG; Stinson, JA; Sugimoto, M; Ohashi, Y; Sharrocks, AD; Peters, G; Hara, E				Ohtani, N; Zebedee, Z; Huot, TJG; Stinson, JA; Sugimoto, M; Ohashi, Y; Sharrocks, AD; Peters, G; Hara, E			Opposing effects of Ets and Id proteins on p16(INK4a) expression during cellular senescence	NATURE			English	Article							LOOP-HELIX PROTEINS; REPLICATIVE SENESCENCE; IMMORTALIZATION; BINDING; P16; INHIBITORS; TELOMERES; INK4A; P53	The p16(INK4a) cyclin-dependent kinase inhibitor(1) is implicated in replicative senescence, the state of permanent growth arrest provoked by cumulative cell divisions or as a response to constitutive Ras-Raf-MEK signalling in somatic cells(2-8). Some contribution to senescence presumably underlies the importance of p16(INK4a) as a tumour suppressor(9) but the mechanisms regulating its expression in these different contexts remain unknown. Here we demonstrate a role for the Ets1 and Ets2 transcription factors(10) based on their ability to activate the p16(INK4a) promoter through an ETS-binding site and their patterns of expression during the lifespan of human diploid fibroblasts. The induction of p16(INK4a) by Ets2, which is abundant in young human diploid fibroblasts, is potentiated by signalling through the Ras-Raf-MEK kinase cascade and inhibited by a direct interaction with the helix-loop-helix protein Id1 (ref. 11). In senescent cells, where the Ets2 levels and MEK signalling decline, the marked increase in p16(INK4a) expression is consistent with the reciprocal reduction of Id1 and accumulation of Ets1.	Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC, Cell Cycle Grp, Manchester M20 4BX, Lancs, England; Imperial Canc Res Fund, London WC2A 3PX, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Nihon Schering KK, Mol Biol Lab, Osaka 5320004, Japan; Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; Cancer Research UK; University of Manchester; Juntendo University; University of Manchester	Hara, E (corresponding author), Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC, Cell Cycle Grp, Manchester M20 4BX, Lancs, England.	Ehara@picr.man.ac.uk	Ohtani, Naoko/AAB-1891-2021	Ohtani, Naoko/0000-0001-8934-0797; Sugimoto, Masataka/0000-0001-8737-8097				Alani RM, 1999, P NATL ACAD SCI USA, V96, P9637, DOI 10.1073/pnas.96.17.9637; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Foos G, 1998, J BIOL CHEM, V273, P18871, DOI 10.1074/jbc.273.30.18871; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Hara E, 1996, DEV GENET, V18, P161; Hara E, 1996, MOL CELL BIOL, V16, P859; HARA E, 1994, J BIOL CHEM, V269, P2139; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Loughran O, 1996, ONCOGENE, V13, P561; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Reznikoff CA, 1996, CANCER RES, V56, P2886; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; Takahashi Y, 2000, GENE DEV, V14, P804; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	28	498	533	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1067	1070		10.1038/35059131	http://dx.doi.org/10.1038/35059131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234019				2022-12-01	WOS:000167148800052
J	Cheung, VG; Nowak, N; Jang, W; Kirsch, IR; Zhao, S; Chen, XN; Furey, TS; Kim, UJ; Kuo, WL; Olivier, M; Conroy, J; Kasprzyk, A; Massa, H; Yonescu, R; Sait, S; Thoreen, C; Snijders, A; Lemyre, E; Bailey, JA; Bruzel, A; Burrill, WD; Clegg, SM; Collins, S; Dhami, P; Friedman, C; Han, CS; Herrick, S; Lee, J; Ligon, AH; Lowry, S; Morley, M; Narasimhan, S; Osoegawa, K; Peng, Z; Plajzer-Frick, I; Quade, BJ; Scott, D; Sirotkin, K; Thorpe, AA; Gray, JW; Hudson, J; Pinkel, D; Ried, T; Rowen, L; Shen-Ong, GL; Strausberg, RL; Birney, E; Callen, DF; Cheng, JF; Cox, DR; Doggett, NA; Carter, NP; Eichler, EE; Haussler, D; Korenberg, JR; Morton, CC; Albertson, D; Schuler, G; de Jong, PJ; Trask, BJ				Cheung, VG; Nowak, N; Jang, W; Kirsch, IR; Zhao, S; Chen, XN; Furey, TS; Kim, UJ; Kuo, WL; Olivier, M; Conroy, J; Kasprzyk, A; Massa, H; Yonescu, R; Sait, S; Thoreen, C; Snijders, A; Lemyre, E; Bailey, JA; Bruzel, A; Burrill, WD; Clegg, SM; Collins, S; Dhami, P; Friedman, C; Han, CS; Herrick, S; Lee, J; Ligon, AH; Lowry, S; Morley, M; Narasimhan, S; Osoegawa, K; Peng, Z; Plajzer-Frick, I; Quade, BJ; Scott, D; Sirotkin, K; Thorpe, AA; Gray, JW; Hudson, J; Pinkel, D; Ried, T; Rowen, L; Shen-Ong, GL; Strausberg, RL; Birney, E; Callen, DF; Cheng, JF; Cox, DR; Doggett, NA; Carter, NP; Eichler, EE; Haussler, D; Korenberg, JR; Morton, CC; Albertson, D; Schuler, G; de Jong, PJ; Trask, BJ		BAC Resource Consortium	Integration of cytogenetic landmarks into the draft sequence of the human genome	NATURE			English	Article							IN-SITU HYBRIDIZATION; PHYSICAL MAPS; RESOURCE; CLONES	We have placed 7,600 cytogenetically defined landmarks on the draft sequence of the human genome to help with the characterization of genes altered by gross chromosomal aberrations that cause human disease. The landmarks are large-insert clones mapped to chromosome bands by fluorescence in situ hybridization. Each clone contains a sequence tag that is positioned on the genomic sequence. This genome-wide set of sequence-anchored clones allows structural and functional analyses of the genome. This resource represents the first comprehensive integration of cytogenetic, radiation hybrid, linkage and sequence maps of the human genome; provides an independent validation of the sequence map(1,2) and framework for contig order and orientation; surveys the genome for large-scale duplications, which are likely to require special attention during sequence assembly; and allows a stringent assessment of sequence differences between the dark and light bands of chromosomes. It also provides insight into large-scale chromatin structure and the evolution of chromosomes and gene families and will accelerate our understanding of the molecular bases of human disease and cancer.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; NCI, NIH, Bethesda, MD 20889 USA; Inst Genom Res, Rockville, MD 20850 USA; Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Human Genet, Los Angeles, CA 90048 USA; Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA; Stanford Univ, Genome Lab, Stanford, CA 94305 USA; Sanger Ctr, Cambridge CB10 1SA, England; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Case Western Reserve Univ, Dept Human Genet, Cleveland, OH 44106 USA; Los Alamos Natl Lab, Joint Genome Inst, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Joint Genome Inst, Berkeley, CA 94720 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Res Genet Inc, Huntsville, AL 35801 USA; Inst Syst Biol, Seattle, WA 98105 USA; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia; Univ Calif Santa Cruz, Dept Comp Sci, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); J. Craig Venter Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Santa Cruz; California Institute of Technology; University of California System; University of California San Francisco; Stanford University; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Institute for Systems Biology (ISB); Womens & Childrens Hospital Australia; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Trask, BJ (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N C3-168,POB 19024, Seattle, WA 98109 USA.	btrask@fhcrc.org	Cheung, Vivian G./AAT-3115-2020; Callen, David F/G-1975-2012; Shen-Ong, Grace/C-8327-2014	Furey, Terry/0000-0001-5546-9672; Birney, Ewan/0000-0001-8314-8497; Han, Cliff/0000-0003-1972-0692; Callen, David/0000-0002-6189-9991	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM061354] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; CASPERSSON T, 1968, EXP CELL RES, V49, P219, DOI 10.1016/0014-4827(68)90538-7; Cheung VG, 1999, GENOME RES, V9, P989, DOI 10.1101/gr.9.10.989; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kirsch IR, 2000, SEMIN HEMATOL, V37, P420, DOI 10.1053/shem.2000.16450; Kirsch IR, 2000, NAT GENET, V24, P339, DOI 10.1038/74149; KORENBERG JR, 1995, CYTOGENET CELL GENET, V69, P196, DOI 10.1159/000133962; Korenberg JR, 1999, GENOME RES, V9, P994, DOI 10.1101/gr.9.10.994; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leversha MA, 1999, CHROMOSOME RES, V7, P571, DOI 10.1023/A:1009249830811; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MITELMAN F, 1998, CATALOG CHROMOSOME A; Mitelman F., 1995, INT SYSTEM HUMAN CYT; Morley M, 2001, NUCLEIC ACIDS RES, V29, P144, DOI 10.1093/nar/29.1.144; OHYASHIKI K, 1986, CANCER RES, V46, P3642; OLIVIER M, IN PRESS SCIENCE; OSOEGAWA K, IN PRESS GENOME RES; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; STREINER DL, 1989, J PERS ASSESS, V53, P81, DOI 10.1207/s15327752jpa5301_9; Trask B, 1999, GENOME ANAL, V4, P303; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; TRASK BJ, 1989, AM J HUM GENET, V45, P738; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	231	247	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					953	958		10.1038/35057192	http://dx.doi.org/10.1038/35057192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237021	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-01	WOS:000166938800068
J	Pennock, E; Buckley, K; Lundblad, V				Pennock, E; Buckley, K; Lundblad, V			Cdc13 delivers separate complexes to the telomere for end protection and replication	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; YEAST TELOMERASE; RAD9 CHECKPOINT; RNA COMPONENT; EST GENES; MAINTENANCE; SENESCENCE; MUTANTS; PROTEIN	In Saccharomyces cerevisiae, the telomere binding protein Cdc13 mediates telomere replication by recruiting telomerase, and also performs an essential function in chromosome end protection. We show here that delivery of the Stn1 protein to the telomere, by fusing the DNA binding domain of Cdc13 (DBDCDC13) to Stn1, is sufficient to rescue the lethality of a cdc13 null strain and, hence, provide end protection. Telomere replication is still defective in this strain, but can be restored by delivering telomerase to the telomere as a DBDCDC13-telomerase fusion. These results establish Stn1 as the primary effector of chromosome end protection, whereas the principal function of Cdc13 is to provide a loading platform to recruit complexes that provide end protection and telomere replication.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055867] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams AK, 1996, MOL CELL BIOL, V16, P4614; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; CHANDRA A, 2001, IN PRESS GENES DEV; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Evans SK, 2000, J CELL SCI, V113, P3357; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2000, MOL CELL BIOL, V20, P8397, DOI 10.1128/MCB.20.22.8397-8408.2000; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; McEachern MJ, 2000, P NATL ACAD SCI USA, V97, P11409, DOI 10.1073/pnas.210388397; Morris DK, 1997, CURR BIOL, V7, P969, DOI 10.1016/S0960-9822(06)00416-7; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Qi HY, 2000, GENE DEV, V14, P1777; Sandrock TM, 1997, GENETICS, V147, P1635; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WEINERT TA, 1993, GENETICS, V134, P63; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V	34	345	350	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					387	396		10.1016/S0092-8674(01)00226-4	http://dx.doi.org/10.1016/S0092-8674(01)00226-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239396	Bronze			2022-12-01	WOS:000167003100009
J	Mauron, A				Mauron, A			Is the genome the secular equivalent of the soul?	SCIENCE			English	Review									Univ Geneva, Ctr Med Univ Geneva, Fac Med, Bioeth Res & Teaching Unit, CH-1211 Geneva 4, Switzerland	University of Geneva	Mauron, A (corresponding author), Univ Geneva, Ctr Med Univ Geneva, Fac Med, Bioeth Res & Teaching Unit, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.							DELBRUCK M, 1971, MICROBES LIFE, P50; FORD NM, 1991, DID I BEGING CONCEPT; MALHERBE JF, 1991, ETHIQUE RENNES, V2, P79; Mauron A., 1996, CONCEIVING EMBRYO ET, P55; Mayr E., 1982, GROWTH BIOL THOUGHT; Nelkin D., 1995, DNA MYSTIQUE GENE CU	6	39	42	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					831	832		10.1126/science.1058768	http://dx.doi.org/10.1126/science.1058768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225630	Green Published			2022-12-01	WOS:000166771700026
J	Erbacher, J; Huber, BT; Norris, RD; Markey, M				Erbacher, J; Huber, BT; Norris, RD; Markey, M			Increased thermohaline stratification as a possible cause for an ocean anoxic event in the Cretaceous period	NATURE			English	Article							STRATIGRAPHY; EPISODES; SEA	Ocean anoxic events were periods of high carbon burial that led to drawdown of atmospheric carbon dioxide, lowering of bottom-water oxygen concentrations and, in many cases, significant biological extinction(1-5). Most ocean anoxic events are thought to be caused by high productivity and export of carbon from surface waters which is then preserved in organic-rich sediments, known as black shales. But the factors that triggered some of these events remain uncertain. Here we present stable isotope data from a mid-Cretaceous ocean anoxic event that occurred 112 Myr ago, and that point to increased thermohaline stratification as the probable cause. Ocean anoxic event 1b is associated with an increase in surface-water temperatures and runoff that led to decreased bottom-water formation and elevated carbon burial in the restricted basins of the western Tethys and North Atlantic. This event is in many ways similar to that which led to the more recent Plio-Pleistocene Mediterranean sapropels, but the greater geographical extent and longer duration (similar to 46 kyr) of ocean anoxic event 1b suggest that processes leading to such ocean anoxic events in the North Atlantic and western Tethys were able to act over a much larger region, and sequester far more carbon, than any of the Quaternary sapropels.	Bundesanstalt Geowissensch & Rohstoffe, Referat Meeresgeol, D-30655 Hannover, Germany; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Woods Hole Oceanographic Institution	Erbacher, J (corresponding author), Bundesanstalt Geowissensch & Rohstoffe, Referat Meeresgeol, Stilleweg 2, D-30655 Hannover, Germany.	erbacher@bgr.de		Erbacher, Jochen/0000-0003-2793-0307				[Anonymous], 1999, PROGRAM-ELECTRON LIB; [Anonymous], 1977, SOC EC PALEONTOLOGIS, DOI DOI 10.2110/PEC.77.25; [Anonymous], 1998, P OCEAN DRILL PROGR; ARTHUR MA, 1990, NATO ADV SCI I C-MAT, V304, P75; BARKER CE, IN PRESS W N ATLANTI; BARRON EJ, 1981, ECLOGAE GEOL HELV, V74, P443; Bice KL, 1997, GEOLOGY, V25, P951, DOI 10.1130/0091-7613(1997)025<0951:CRAECB>2.3.CO;2; BRALOWER TJ, 1993, GEOPH MONOG SERIES, V77, P5, DOI DOI 10.1029/GM077P0005; Damste JSS, 1998, EARTH PLANET SC LETT, V158, P165; de Boer P. L., 1983, GEOL ULTRIECTIN, V31, P1; Erbacher J, 1996, GEOLOGY, V24, P499, DOI 10.1130/0091-7613(1996)024<0499:EPORAO>2.3.CO;2; Erbacher J, 1999, MAR MICROPALEONTOL, V38, P7, DOI 10.1016/S0377-8398(99)00036-5; EREZ J, 1983, GEOCHIM COSMOCHIM AC, V47, P1025, DOI 10.1016/0016-7037(83)90232-6; Hochuli PA, 1999, GEOLOGY, V27, P657, DOI 10.1130/0091-7613(1999)027<0657:EOHPAC>2.3.CO;2; HOLBOURN A, IN PRESS J FORAM RES; Huber BT, 1999, J FORAMIN RES, V29, P392; Hut G., 1987, CONS GROUP M STABL I; JENKYNS HC, 1997, ZBL GEOL PALAONT 1, V7, P943; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; Menegatti AP, 1998, PALEOCEANOGRAPHY, V13, P530, DOI 10.1029/98PA01793; Mercone D, 2000, PALEOCEANOGRAPHY, V15, P336, DOI 10.1029/1999PA000397; Myers PG, 2000, QUATERNARY RES, V53, P98, DOI 10.1006/qres.1999.2100; Norris R.D., 1998, P OCEAN DRILLING P B, V171, P1; Ogg J.G., 1999, EOS, V80, pF491; ROHLING EJ, 1994, MAR GEOL, V122, P1, DOI 10.1016/0025-3227(94)90202-X; Shackleton NJ, 1975, INITIAL REPORTS DEEP, V29, P743, DOI DOI 10.2973/DSDP.PROC.29.117.1975; THUROW J, 1992, AM GEOPHYSICAL UNION, V70, P253; Weissert H, 1998, PALAEOGEOGR PALAEOCL, V137, P189, DOI 10.1016/S0031-0182(97)00109-0; WILSON PA, 1999, EOS, V80, pF488; Wortmann UG, 1999, PALEOCEANOGRAPHY, V14, P525, DOI 10.1029/1999PA900015	30	207	219	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					325	327		10.1038/35053041	http://dx.doi.org/10.1038/35053041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201737				2022-12-01	WOS:000166434300042
J	Zhang, Y; Kalderon, D				Zhang, Y; Kalderon, D			Hedgehog acts as a somatic stem cell factor in the Drosophila ovary	NATURE			English	Article							SONIC HEDGEHOG; HUMAN HOMOLOG; CUBITUS INTERRUPTUS; SIGNALING PATHWAY; HAIR FOLLICLE; CARCINOMAS; SKIN; PHOSPHORYLATION; PROLIFERATION; INDUCTION	Secreted signalling molecules of the Hedgehog (Hh) family have many essential patterning roles during development of diverse organisms including Drosophila and humans(1,2). Although Hedge hog proteins most commonly affect cell fate, they can also stimulate cell proliferation, In humans several distinctive cancers, including basal-cell carcinoma, result from mutations that aberrantly activate Hh signal transduction(3). In Drosophila, Hh directly stimulates proliferation of ovarian somatic cells(4-6). Here we show that Hh acts specifically on stem cells in the Drosophila ovary. These cells cannot proliferate as stem cells in the absence of Hh signalling, whereas excessive Hh signalling produces supernumerary stem cells. We deduce that Hh is a stem-cell factor and suggest that human cancers due to excessive Hh signalling might result from aberrant expansion of stem cell pools.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Kalderon, D (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.							Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kruger K, 1999, ARCH DERMATOL RES, V291, P253, DOI 10.1007/s004030050405; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Price MA, 1999, DEVELOPMENT, V126, P4331; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Spradling Allan C., 1993, P1; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang Y, 2000, DEVELOPMENT, V127, P2165	29	631	690	3	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					599	604		10.1038/35069099	http://dx.doi.org/10.1038/35069099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279500				2022-12-01	WOS:000167859300052
J	Makishima, S; Komoriya, K; Yamaguchi, S; Aizawa, SI				Makishima, S; Komoriya, K; Yamaguchi, S; Aizawa, SI			Length of the flagellar hook and the capacity of the type III export apparatus	SCIENCE			English	Article							PROTEIN SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; SUPRAMOLECULAR STRUCTURE; MOTOR; FLIK; COMPLEX; MUTATIONS; COMPONENT; MACHINERY; ROTATION	Length determination in biology generally uses molecular rulers. The hook, a part of the flagellum of motile bacteria, has an invariant Length. Here, we examined hook length and found that it was determined not by molecular rulers but probably by the amount of subunit protein secreted by the flagellar export apparatus. The export apparatus shares common features with the type III virulence-factor secretion machinery and thus may be used more widely in Length determination of structures other than flagella.	Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; Meiji Univ, Tokyo 1680064, Japan	Teikyo University; Utsunomiya University; Meiji University	Aizawa, SI (corresponding author), Teikyo Univ, Dept Biosci, 1-1 Toyosatodai, Utsunomiya, Tochigi 3208551, Japan.			Aizawa, Shin-Ichi/0000-0002-9068-0825				Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; FRANZ WM, 1994, CARDIOSCIENCE, V5, P235; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; KATADA MINORU, 1955, JOUR SHIMONOSEKI COLL FISH, V5, P1; KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Koroyasu S, 1998, BIOPHYS J, V74, P436, DOI 10.1016/S0006-3495(98)77801-4; KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kutsukake K, 1997, J BACTERIOL, V179, P1268, DOI 10.1128/jb.179.4.1268-1273.1997; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; MACNAB RM, 1996, CELLULAR MOL BIOL, P123; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Muramoto K, 1998, J MOL BIOL, V277, P871, DOI 10.1006/jmbi.1998.1659; Muramoto K, 1999, J BACTERIOL, V181, P5808, DOI 10.1128/JB.181.18.5808-5813.1999; OHNISHI K, 1994, J BACTERIOL, V176, P2272, DOI 10.1128/JB.176.8.2272-2281.1994; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; YAMAGUCHI S, 1986, J BACTERIOL, V168, P1172, DOI 10.1128/jb.168.3.1172-1179.1986; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986	25	81	83	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2411	2413		10.1126/science.1058366	http://dx.doi.org/10.1126/science.1058366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264537				2022-12-01	WOS:000167618700056
J	Murphy, AM				Murphy, AM			Searching for Margaret	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2001	285	11					1413	1414		10.1001/jama.285.11.1413	http://dx.doi.org/10.1001/jama.285.11.1413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410VQ	11255399				2022-12-01	WOS:000167462100001
J	Leeson, CPM; Kattenhorn, M; Deanfield, JE; Lucas, A				Leeson, CPM; Kattenhorn, M; Deanfield, JE; Lucas, A			Duration of breast feeding and arterial distensibility in early adult life: population based study	BRITISH MEDICAL JOURNAL			English	Article							CHOLESTEROL; CHILDREN	Objectives To test the hypothesis that duration of breast feeding is related to changes in vascular function relevant to the development of cardiovascular disease. Design Population based observational study, Setting Cambridge. Participants 331 adults 171 women, 160 men) aged between 20 and 28 years, born in Cambridge Maternity Hospital. Main outcome measures Distensibility of brachial artery, type and duration of infant feeding, current lipid profile, and other cardiovascular. risk factors. Results The longer the period of breast feeding the less distensible the artery wall in early adult life, with no ses differences (regression coefficient = - 3.93 mum/month, 95% confidence interval - 7.29 to - 0.57, P = 0.02), However, in those breast fed for less than four months, arterial distensibility was not significantly reduced compared with an exclusively formula fed group. The vascular changes observed were not explained by alterations in plasma cholesterol concentration in adult life. Conclusions Breast feeding in infancy is related to reduced arterial function 20 years later. These data should not alter current recommendations in favour of bl east feeding, which has several benefits for infant health. Further work is needed, however, to explore the optimal duration of breast feeding in relation to cardiovascular outcomes.	Inst Child Hlth, MRC, Childhood Nutr Res Ctr, London WC1N 1EH, England; Great Ormond St Hosp Children, Vasc Physiol Unit, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Leeson, CPM (corresponding author), Inst Child Hlth, MRC, Childhood Nutr Res Ctr, 30 Guilford St, London WC1N 1EH, England.		Leeson, Paul/K-6964-2012; Deanfield, John E/C-5178-2008	Deanfield, John/0000-0001-8806-6052				CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; HOEKS APG, 1990, ULTRASOUND MED BIOL, V16, P121, DOI 10.1016/0301-5629(90)90139-4; KARK JD, 1984, J EPIDEMIOL COMMUN H, V38, P218, DOI 10.1136/jech.38.3.218; Leeson CPM, 1997, CIRCULATION, V96, P2233; Leeson CPM, 2000, CIRCULATION, V101, P1533, DOI 10.1161/01.CIR.101.13.1533; Leeson P, 1997, HEART, V78, P22, DOI 10.1136/hrt.78.1.22; LUCAS A, 1991, CIBA F SYMP, V156, P38; MOTT GE, 1995, J LIPID RES, V36, P299; MOTT GE, 1991, CIBA FDN S CHILDHOOD, P128; *OFF POP CENS SURV, 1997, HLTH SURV ENGL 995; *OFF POP CENS SURV, 1986, OCC MORT DEC SUPPL 1; PHILLIPS DIW, 1993, ACTA ENDOCRINOL-COP, V129, P134, DOI 10.1530/acta.0.1290134; WONG WW, 1993, J LIPID RES, V34, P1403	15	87	87	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2001	322	7287					643	647		10.1136/bmj.322.7287.643	http://dx.doi.org/10.1136/bmj.322.7287.643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413QE	11250848	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000167622600023
J	Bibb, JA; Chen, JS; Taylor, JR; Svenningsson, P; Nishi, A; Snyder, GL; Yan, Z; Sagawa, ZK; Ouimet, CC; Nairn, AC; Nestler, EJ; Greengard, P				Bibb, JA; Chen, JS; Taylor, JR; Svenningsson, P; Nishi, A; Snyder, GL; Yan, Z; Sagawa, ZK; Ouimet, CC; Nairn, AC; Nestler, EJ; Greengard, P			Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5	NATURE			English	Article							MOLECULAR MECHANISMS; OPPOSITE MODULATION; CONDITIONED REWARD; LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; GLUR1 SUBUNIT; MUTANT MICE; DOPAMINE; PHOSPHORYLATION	Cocaine enhances dopamine-mediated neurotransmission by blocking dopamine re-uptake at axon terminals. Most dopamine-containing nerve terminals innervate medium spiny neurons in the striatum of the brain. Cocaine addiction is thought to stem, in part, from neural adaptations that act to maintain equilibrium by countering the effects of repeated drug administration(1,2). Chronic exposure to cocaine upregulates several transcription factors that alter gene expression and which could mediate such compensatory neural and behavioural changes(1-4). One such transcription factor is Delta FosB, a protein that persists in striatum long after the end of cocaine exposure(3,5). Here we identify cyclin-dependent kinase 5 (Cdk5) as a downstream target gene of Delta FosB by use of DNA array analysis of striatal material from inducible transgenic mice. Overexpression of Delta FosB, or chronic cocaine administration, raised levels of Cdk5 messenger RNA, protein, and activity in the striatum. Moreover, injection of Cdk5 inhibitors into the striatum potentiated behavioural effects of repeated cocaine administration. Our results suggest that changes in Cdk5 levels mediated by Delta FosB, and resulting alterations in signalling involving D1 dopamine receptors, contribute to adaptive changes in the brain related to cocaine addiction.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; Kurume Univ, Sch Med, Dept Physiol, Fukuoka 8300011, Japan; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	Rockefeller University; Yale University; Kurume University; State University System of Florida; Florida State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bibb, JA (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.		Svenningsson, Per JL/K-5210-2014	Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Caporaso GL, 2000, NEUROPHARMACOLOGY, V39, P1637, DOI 10.1016/S0028-3908(99)00230-0; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; DREHER JK, 1989, BRAIN RES, V487, P267, DOI 10.1016/0006-8993(89)90831-7; DULUBOVA I, IN PRESS J NEUROCHEM; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Horger BA, 1999, J NEUROSCI, V19, P4110; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Nestler EJ, 1997, CURR OPIN NEUROBIOL, V7, P713, DOI 10.1016/S0959-4388(97)80094-3; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OUIMET CC, 1995, NEUROPROTOCOLS, V6, P84; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Punch LJ, 1997, J NEUROSCI, V17, P8520; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Taylor JR, 1999, PSYCHOPHARMACOLOGY, V142, P31, DOI 10.1007/s002130050859; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Zhang XF, 1998, J NEUROSCI, V18, P488; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4	30	379	398	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					376	380		10.1038/35066591	http://dx.doi.org/10.1038/35066591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268215				2022-12-01	WOS:000167464100053
J	Zhao, HQ; Reed, RR				Zhao, HQ; Reed, RR			X inactivation of the OCNC1 channel gene reveals a role for activity-dependent competition in the olfactory system	CELL			English	Article							UNILATERAL NARIS OCCLUSION; TRANSGENIC MICE; CELL-DYNAMICS; GERM-CELLS; EXPRESSION; MOUSE; BULB; RECEPTOR; EPITHELIUM; NEURONS	The organization of neuronal systems is often dependent on activity and competition between cells. In olfaction, the X-linked OCNC1 channel subunit is subject to random inactivation and is essential for odorant-evoked activity. Reporter-tagged OCNC1 mutant mice permit the visualization of OCNC1-deficient olfactory neurons and their projections. In heterozygous females, X inactivation creates a mosaic with two populations of genetically distinct neurons. OCNC1-deficient neurons are slowly and specifically depleted from the olfactory epithelium and display unusual patterns of projection to the olfactory bulb. Remarkably, this depletion is dependent on odorant exposure and is reversed by odorant deprivation. This suggests that odorants and the activity they evoke are critical for neuronal survival in a competitive environment and implicate evoked activity in the organization and maintenance of the olfactory system.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.							Baker H, 1999, J NEUROSCI, V19, P9313; BAKER H, 1990, NEUROSCIENCE, V36, P761, DOI 10.1016/0306-4522(90)90018-Y; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CUMMINGS DM, 1994, EXP NEUROL, V128, P124, DOI 10.1006/exnr.1994.1119; FARBMAN AI, 1988, J NEUROSCI, V8, P3290; FARBMAN AI, 1992, CELL BIOL OLFACTION; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MATTHEWS PM, 1995, NEUROMUSCULAR DISORD, V5, P209, DOI 10.1016/0960-8966(94)00057-G; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; OTTOSON D, 1971, HDB SENSORY PHYSL, P95; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; REESE BE, 1995, P NATL ACAD SCI USA, V92, P2494, DOI 10.1073/pnas.92.7.2494; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Roskams AJI, 1996, J NEUROSCI, V16, P1294; Royal SJ, 1999, J NEUROSCI, V19, P9856; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Ruiz ML, 1996, J MOL CELL CARDIOL, V28, P1453, DOI 10.1006/jmcc.1996.0136; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	40	156	160	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2001	104	5					651	660		10.1016/S0092-8674(02)01107-8	http://dx.doi.org/10.1016/S0092-8674(02)01107-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257220	Bronze			2022-12-01	WOS:000167531100006
J	Hamano, H; Kawa, S; Horiuchi, A; Unno, H; Furuya, N; Akamatsu, T; Fukushima, M; Nikaido, T; Nakayama, K; Usuda, N; Kiyosawa, K				Hamano, H; Kawa, S; Horiuchi, A; Unno, H; Furuya, N; Akamatsu, T; Fukushima, M; Nikaido, T; Nakayama, K; Usuda, N; Kiyosawa, K			High serum IgG4 concentrations in patients with sclerosing pancreatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE CHRONIC-PANCREATITIS; MEMBRANOUS NEPHROPATHY; PEMPHIGUS-VULGARIS; IMMUNE-COMPLEXES; STEROID-THERAPY; CHOLANGITIS; DISEASE; AUTOANTIBODIES; SUBCLASSES; ANTIBODIES	Background: Sclerosing pancreatitis is a unique form of pancreatitis that is characterized by irregular narrowing of the main pancreatic duct, lymphoplasmacytic inflammation of the pancreas, and hypergammaglobulinemia and that responds to glucocorticoid treatment. Preliminary studies suggested that serum IgG4 concentrations are elevated in this disease but not in other diseases of the pancreas or biliary tract. Methods: We measured serum IgG4 concentrations using single radial immunodiffusion and an enzyme-linked immunosorbent assay in 20 patients with sclerosing pancreatitis, 20 age- and sex-matched normal subjects, and 154 patients with pancreatic cancer, ordinary chronic pancreatitis, primary biliary cirrhosis, primary sclerosing cholangitis, or Sjogren's syndrome. Serum concentrations of immune complexes and the IgG4 subclass of immune complexes were determined by means of an enzyme-linked immunosorbent assay with monoclonal rheumatoid factor. Results: The median serum IgG4 concentration in the patients with sclerosing pancreatitis was 663 mg per deciliter (5th and 95th percentiles, 136 and 1150), as compared with 51 mg per deciliter (5th and 95th percentiles, 15 and 128) in normal subjects (P<0.001). The serum IgG4 concentrations in the other groups of patients were similar to those in the normal subjects. In patients with sclerosing pancreatitis, serum concentrations of immune complexes and the IgG4 subclass of immune complexes were significantly higher before glucocorticoid therapy than after four weeks of such therapy. Glucocorticoid therapy induced clinical remissions and significantly decreased serum concentrations of IgG4, immune complexes, and the IgG4 subclass of immune complexes. Conclusions: Patients with sclerosing pancreatitis have high serum IgG4 concentrations, providing a useful means of distinguishing this disorder from other diseases of the pancreas or biliary tract. (N Engl J Med 2001;344:732-8.) Copyright (C) 2001 Massachusetts Medical Society.	Shinshu Univ, Sch Med, Dept Internal Med 2, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Obstet & Gynecol, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Organ Generat, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Anat, Matsumoto, Nagano 3908621, Japan; Fujita Hlth Univ, Sch Med, Dept Anat, Toyoake, Aichi 47011, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University; Shinshu University; Fujita Health University	Kawa, S (corresponding author), Shinshu Univ, Sch Med, Dept Internal Med 2, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.							AALBERSE RC, 1993, ALLERGY, V48, P559, DOI 10.1111/j.1398-9995.1993.tb00749.x; BHOL K, 1994, DERMATOLOGY, V189, P85, DOI 10.1159/000246938; Ding X, 1999, J INVEST DERMATOL, V112, P739, DOI 10.1046/j.1523-1747.1999.00585.x; DOI T, 1991, NEPHRON, V57, P131, DOI 10.1159/000186239; EPSTEIN O, 1982, GASTROENTEROLOGY, V83, P1177; Erkelens GW, 1999, LANCET, V354, P43, DOI 10.1016/S0140-6736(99)00603-0; GABRIEL A, 1977, J CLIN INVEST, V59, P990, DOI 10.1172/JCI108722; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayashibara Hiroshi, 1993, Acta Paediatrica Japonica, V35, P113; Horiuchi A, 1996, AM J GASTROENTEROL, V91, P2607; Horiuchi A, 1998, AM J GASTROENTEROL, V93, P260, DOI 10.1016/S0002-9270(97)00067-1; HUSSAIN R, 1992, J IMMUNOL, V148, P2731; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Ito T, 1997, DIGEST DIS SCI, V42, P1458, DOI 10.1023/A:1018862626221; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; MONTEFUSCO PP, 1984, AM J SURG, V147, P822, DOI 10.1016/0002-9610(84)90212-5; Motoo Y, 1997, INT J PANCREATOL, V21, P85; NAKANO S, 1978, AM J DIG DIS, V23, P75; OKAZAKI K, 1986, GASTROENTEROLOGY, V91, P409, DOI 10.1016/0016-5085(86)90576-7; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; ROCK B, 1989, NEW ENGL J MED, V320, P1463, DOI 10.1056/NEJM198906013202206; Rosner B., 1995, FUNDAMENTALS BIOSTAT; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; SARLES H, 1965, GUT, V6, P545, DOI 10.1136/gut.6.6.545; SHIRAKATA Y, 1990, Journal of Dermatology (Tokyo), V17, P661; SJOGREN I, 1979, ACTA MED SCAND, V205, P139; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; vanGulik TM, 1997, GASTROINTEST ENDOSC, V46, P417, DOI 10.1016/S0016-5107(97)70034-8; Wakabayashi T, 1998, DIGEST DIS SCI, V43, P2415, DOI 10.1023/A:1026621913192; WALDRAM R, 1975, LANCET, V1, P550; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; ZWEIG MH, 1993, CLIN CHEM, V39, P561; ZWEIG MH, 1993, CLIN CHEM, V39, P1589	33	1800	1952	7	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					732	738		10.1056/NEJM200103083441005	http://dx.doi.org/10.1056/NEJM200103083441005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236777				2022-12-01	WOS:000167305300005
J	Lachner, M; O'Carroll, N; Rea, S; Mechtler, K; Jenuwein, T				Lachner, M; O'Carroll, N; Rea, S; Mechtler, K; Jenuwein, T			Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins	NATURE			English	Article							CHROMO DOMAIN; IN-VITRO; HETEROCHROMATIN; DROSOPHILA; LOCALIZATION; ORGANIZATION; COMPONENT; INTERACTS; GENOME; YEAST	Distinct modifications of histone amino termini, such as acetylation, phosphorylation and methylation, have been proposed to underlie a chromatin-based regulatory mechanism(1,2) that modulates the accessibility of genetic information. In addition to histone modifications that facilitate gene activity, it is of similar importance to restrict inappropriate gene expression(3,4) if cellular and developmental programmes are to proceed unperturbed. Here we show that mammalian methyltransferases that selectively methylate histone H3 on lysine 9 (Suv39h HMTases)(5) generate a binding site for HP1 proteins-a family of heterochromatic adaptor molecules(6,7) implicated in both gene silencing and supra-nucleosomal chromatin structure. High-affinity in vitro recognition of a methylated histone H3 peptide by HP1 requires a functional chromo domain; thus, the HP1 chromo domain is a specific interaction motif for the methyl epitope on lysine 9 of histone H3. In vivo, heterochromatin association of HP1 proteins is lost in Suv39h double-null primary mouse fibroblasts but is restored after the re-introduction of a catalytically active SUV39H1 HMTase. Our data define a molecular mechanism through which the SUV39H-HP1 methylation system can contribute to the propagation of heterochromatic subdomains in native chromatin.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.		Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; O'Carroll, Donal/0000-0002-8626-2217; Rea, Stephen/0000-0001-5797-5157				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Ekwall K, 1996, J CELL SCI, V109, P2637; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Paro R., 1996, EPIGENETIC MECH GENE, P507; PIERCE J, 1992, DEVELOPMENT, V114, P921; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Zhao T, 2000, J BIOL CHEM, V275, P28332	30	2084	2150	2	200	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					116	120		10.1038/35065132	http://dx.doi.org/10.1038/35065132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242053				2022-12-01	WOS:000167194300054
J	Reinhardt, RL; Khoruts, A; Merica, R; Zell, T; Jenkins, MK				Reinhardt, RL; Khoruts, A; Merica, R; Zell, T; Jenkins, MK			Visualizing the generation of memory CD4 T cells in the whole body	NATURE			English	Article							IN-VIVO; CLONAL EXPANSION; PERIPHERAL TOLERANCE; ANTIGEN-RECEPTOR; VIRAL-INFECTION; INDUCTION; IMMUNITY; TISSUE; LYMPHOCYTES; ACTIVATION	It is thought that immunity depends on naive CD4 T cells that proliferate in response to microbial antigens(1-4), differentiate into memory cells that produce anti-microbial lymphokines(5,6), and migrate to sites of infection(7,8). Here we use immunohistology to enumerate individual naive CD4 T cells, specific for a model antigen, in the whole bodies of adult mice. The cells resided exclusively in secondary lymphoid tissues, such as the spleen and lymph nodes, in mice that were not exposed to antigen. After injection of antigen alone into the blood, the T cells proliferated, migrated to the lungs, liver, gut and salivary glands, and then disappeared from these organs. If antigen was injected with the microbial product lipopolysaccharide, proliferation and migration were enhanced, and two populations of memory cells survived for months: one in the lymph nodes that produced the growth factor interleukin-2, and a larger one in the non-lymphoid tissues that produced the anti-microbial lymphokine interferon-gamma. These results show that antigen recognition in the context of infection generates memory cells that are specialized to proliferate in the secondary lymphoid tissues or to fight infection at the site of microbial entry.	Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, MMC 334,420 Delaware St SE, Minneapolis, MN 55455 USA.		Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BELLINI G, 1990, INSULA, V45, P4; Bradley LM, 1996, CURR OPIN IMMUNOL, V8, P312, DOI 10.1016/S0952-7915(96)80118-X; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CHILLER JM, 1971, SCIENCE, V171, P813, DOI 10.1126/science.171.3973.813; CHILLER JM, 1973, J EXP MED, V137, P740, DOI 10.1084/jem.137.3.740; DRESSER DW, 1961, NATURE, V191, P1169, DOI 10.1038/1911169a0; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Kim SK, 1999, J IMMUNOL, V163, P4125; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Merica R, 2000, J IMMUNOL, V164, P4551, DOI 10.4049/jimmunol.164.9.4551; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Pape KA, 1997, J IMMUNOL, V159, P591; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pape KA, 1998, J IMMUNOL, V160, P4719; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SOUTHERN PJ, 1984, NATURE, V312, P555, DOI 10.1038/312555a0; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7	29	813	833	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					101	105		10.1038/35065111	http://dx.doi.org/10.1038/35065111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242050				2022-12-01	WOS:000167194300051
J	Foch, M; Banys, P				Foch, M; Banys, P			Liver transplantation and opioid dependence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C VIRUS-INFECTION; HEPATITIS-C; UNITED-STATES; DRUG-USERS; CIRRHOSIS; OUTCOMES	Context Chronic hepatitis C is the leading cause for liver transplantation in the United States. Intravenous drug use, the major risk factor, accounts for approximately 60% of hepatitis C virus transmission. Information from the United Network of Organ Sharing (UNOS) does not address substance use among liver transplantation patients. Objective To identify addiction-related criteria for admission to the UNOS liver trans plantation waiting list and posttransplantation problems experienced by patients who are prescribed maintenance methadone. Design, Setting, and Participants Mail survey of all 97 adult US liver transplantation programs (belonging to UNOS) in March 2000 with telephone follow-up conducted in May and June 2000. Main Outcome Measures Programs' acceptance and management of patients with past or present substance use disorder. Results Of the 97 programs surveyed, 87 (90%) responded. All accept applicants with a history of alcoholism or other addictions, including heroin dependence. Eighty eight percent of the responding programs require at least 6 months of abstinence from alcohol; 83% from illicit drugs. Ninety-four percent have addiction treatment requirements. Consultations from substance abuse specialists are obtained by 86%. Patients receiving methadone maintenance are accepted by 56% of the responding programs. Approximately 180 patients receiving methadone maintenance are reported to have undergone liver transplantation. Conclusions Most liver transplantation programs have established policies for patients with substance use disorders. Opiate-dependent patients receiving opiate replacement therapy seem underrepresented in transplantation programs. Little anecdotal evidence for negative impact of opiate replacement therapy on liver transplantation outcome was found. Policies requiring discontinuation of methadone in 32% of all programs contradict the evidence base for efficacy of long-term replacement therapies and potentially result in relapse of previously stable patients.	Vet Affairs Med Ctr, Mental Hlth Serv, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Banys, P (corresponding author), Vet Affairs Med Ctr, Mental Hlth Serv, 116-E,4150 Clement St, San Francisco, CA 94121 USA.				NIDA NIH HHS [P50DA09253] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009253] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alter MJ, 1999, J HEPATOL, V31, P88, DOI 10.1016/S0168-8278(99)80381-X; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alter MJ, 1998, J ACQ IMMUN DEF SYND, V18, pS6, DOI 10.1097/00042560-199802001-00003; Ball J. C., 1991, EFFECTIVENESS METHAD; Berlakovich GA, 2000, TRANSPLANT INT, V13, P129, DOI 10.1111/j.1432-2277.2000.tb01052.x; Bonis PAL, 1999, AM J GASTROENTEROL, V94, P1605, DOI 10.1111/j.1572-0241.1999.01151.x; CHETWYND J, 1995, NEW ZEAL MED J, V108, P364; De Maria N, 1998, HEPATO-GASTROENTEROL, V45, P1364; DOHERTY B, 2001, AM METH TREATM ORG N; GORDON MJ, 1987, TRANSPLANTATION, V43, P459; GORDON MJV, 1986, TRANSPLANTATION, V42, P556; Hebert MF, 1997, ADV DRUG DELIVER REV, V27, P201, DOI 10.1016/S0169-409X(97)00043-4; Hu KQ, 1999, HEPATOLOGY, V29, P1311, DOI 10.1002/hep.510290424; KREEK MJ, 1992, RES P ARNMD, V70, P205; KREEK MJ, 1972, ANN INTERN MED, V77, P598, DOI 10.7326/0003-4819-77-4-598; LEVENSON JL, 1993, PSYCHOSOMATICS, V34, P314, DOI 10.1016/S0033-3182(93)71865-4; Lucey MR, 1997, HEPATOLOGY, V25, P1223, DOI 10.1002/hep.510250526; MOODY DE, 1997, DRUG METAB DISPOS, V25, P147; *NAT I DRUG AB, 1997, PUBL NAT I DRUG AB; *NIH CONS DEV C LI, 1984, HEPATOLOGY, V4, pS1; *NIH CONS STAT, 2001, EFF MED TREATM OP AD; O'Connor PG, 2000, ANN INTERN MED, V133, P40, DOI 10.7326/0003-4819-133-1-200007040-00008; Pageaux GP, 1999, GUT, V45, P421, DOI 10.1136/gut.45.3.421; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; STEVENS J, 1983, SURG GYNECOL OBSTET, V156, P651; Van Thiel D H, 1999, Forum (Genova), V9, P157	26	45	45	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1056	1058		10.1001/jama.285.8.1056	http://dx.doi.org/10.1001/jama.285.8.1056			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403ME	11209177	Bronze			2022-12-01	WOS:000167046400028
J	Fries, P; Reynolds, JH; Rorie, AE; Desimone, R				Fries, P; Reynolds, JH; Rorie, AE; Desimone, R			Modulation of oscillatory neuronal synchronization by selective visual attention	SCIENCE			English	Article							FIELD POTENTIAL OSCILLATIONS; CORTICAL AREAS; NEURAL MECHANISMS; CORTEX; RESPONSES; V4; MODEL; V2; ACTIVATION; STIMULUS	In crowded visual scenes, attention is needed to select relevant stimuli. To study the underlying mechanisms, we recorded neurons in cortical area V4 while macaque monkeys attended to behaviorally relevant stimuli and ignored distracters. Neurons activated by the attended stimulus showed increased gamma-frequency (35 to 90 hertz) synchronization but reduced low-frequency (<17 hertz) synchronization compared with neurons at nearby V4 sites activated by distracters. Because postsynaptic integration times;are short, these Localized changes in synchronization may serve to amplify behaviorally relevant signals in the cortex.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Salk Institute	Fries, P (corresponding author), NIMH, Neuropsychol Lab, NIH, Bldg 49,Room 1B80,9000 Rpckville Pike, Bethesda, MD 20892 USA.		Desimone, Robert/G-1121-2018; Fries, Pascal/E-3196-2010	Fries, Pascal/0000-0002-4270-1468	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmed B, 1998, CEREB CORTEX, V8, P462, DOI 10.1093/cercor/8.5.462; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Crick F., 1990, Seminars in the Neurosciences, V2, P263; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; FROST JD, 1967, ELECTROEN CLIN NEURO, V23, P89; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; NIEBUR E, 1993, VISION RES, V33, P2789, DOI 10.1016/0042-6989(93)90236-P; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; TREUE S, 2000, 30 ANN M SOC NEUR NE; Worden MS, 2000, J NEUROSCI, V20	34	1916	1943	3	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1560	1563		10.1126/science.1055465	http://dx.doi.org/10.1126/science.1055465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222864				2022-12-01	WOS:000167153400049
J	Harlow, HJ; Lohuis, T; Beck, TDI; Iaizzo, PA				Harlow, HJ; Lohuis, T; Beck, TDI; Iaizzo, PA			Muscle strength in overwintering bears - Unlike humans, bears retain their muscle tone when moribund for long periods.	NATURE			English	Article							SKELETAL-MUSCLE; WINTER SLEEP; IMMOBILIZATION; METABOLISM		Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; Colorado Div Wildlife, Dolores, CO 81323 USA; Univ Minnesota, Dept Anesthesiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA	University of Wyoming; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harlow, HJ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.							Berg HE, 1997, J APPL PHYSIOL, V82, P182, DOI 10.1152/jappl.1997.82.1.182; BOOTH FW, 1973, PFLUG ARCH EUR J PHY, V342, P231, DOI 10.1007/BF00591371; Brass TJ, 1996, J MED ENG TECHNOL, V20, P67, DOI 10.3109/03091909609008382; MUSACCHIA XJ, 1983, AVIAT SPACE ENVIR MD, V54, P1015; Nelson R. A., 1983, INT C BEAR RES MANAG, V5, P284, DOI [DOI 10.2307/3872551, DOI 10.2307/3872551)]; NELSON RA, 1975, MAYO CLIN PROC, V50, P141; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; NICKS DK, 1989, J ANAT, V163, P1; QUINLAN JG, 1989, MUSCLE NERVE, V12, P119, DOI 10.1002/mus.880120206; SIGG MD, 1998, PROGR ANESTHESIOL, V12, P127; Tinker DB, 1998, PHYSIOL ZOOL, V71, P414, DOI 10.1086/515429	11	118	123	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					997	997		10.1038/35059165	http://dx.doi.org/10.1038/35059165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234052	Bronze			2022-12-01	WOS:000167148800030
J	Murthy, KHM; Smith, SA; Ganesh, VK; Judge, KW; Mullin, N; Barlow, PN; Ogata, CM; Kotwal, GJ				Murthy, KHM; Smith, SA; Ganesh, VK; Judge, KW; Mullin, N; Barlow, PN; Ogata, CM; Kotwal, GJ			RETRACTED: Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans (Retracted article. See vol. 175, pg. 1992, 2018)	CELL			English	Article; Retracted Publication							FACTOR-H; SITES; IDENTIFICATION; INHIBITION; RESIDUES; REVEALS; C3; LOCALIZATION; MECHANISM; DOMAINS	Vaccinia virus complement control protein (VCP) inhibits both pathways of complement activation through binding the third and fourth components. A homolog of mammalian regulators of complement activation, its ability to bind heparin endows VCP with additional activities of significance to viral infectivity. The structure of VCP reveals a highly extended molecule with a putative heparin recognition site at its C-terminal end. A second duster of positive charges provides a possibly overlapping binding site for both heparin and complement components. Experiments suggested by the structure indicate that VCP can bind heparin and control complement simultaneously. This, the structure of any intact regulator of complement activation, along with attendant functional insights, will stimulate the design of new therapeutic inhibitors of complement.	Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; Univ Edinburgh, Edinburgh Ctr Prot Technol, Edinburgh EH9 3JJ, Midlothian, Scotland; Brookhaven Natl Lab, Howard Hughes Med Inst, Upton, NY 11973 USA	University of Alabama System; University of Alabama Birmingham; University of Louisville; University of Edinburgh; Howard Hughes Medical Institute; United States Department of Energy (DOE); Brookhaven National Laboratory	Murthy, KHM (corresponding author), Univ Alabama Birmingham, Ctr Biophys Sci & Engn, 1918 Univ Blvd, Birmingham, AL 35294 USA.	murthy@onyx.cmc.uab.edu	Barlow, Paul N/G-2853-2011					AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; ALMOHANNA PR, 2001, IN PRESS TRANSPLANTA; ALSENZ J, 1990, CURR TOP MICROBIOL, V153, P235; BARLOW PN, 1992, BIOCHEMISTRY-US, V31, P3626, DOI 10.1021/bi00129a011; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BARLOW PN, 1991, BIOCHEMISTRY-US, V30, P997, DOI 10.1021/bi00218a016; *BIOS TECHN, 2000, INSIGHT, V2; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; BRUNGER AT, 1990, XPLOR MANUAL; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; COYNE KE, 1992, J IMMUNOL, V149, P2906; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FISHELSON Z, 1991, MOL IMMUNOL, V28, P545, DOI 10.1016/0161-5890(91)90169-K; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; HENDERSON CE, 2000, IN PRESS J MOL BIOL; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HESSING M, 1990, J IMMUNOL, V144, P204; HILLARP A, 1988, J BIOL CHEM, V263, P12759; Howard J, 1998, J LEUKOCYTE BIOL, V64, P68, DOI 10.1002/jlb.64.1.68; Hughes-Jones Nevin C, 1986, IMMUNOBIOLOGY COMPLE, P21; ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirkitadze MD, 1999, BIOCHEM J, V344, P167, DOI 10.1042/0264-6021:3440167; Kotwal G J, 1994, Am Biotechnol Lab, V12, P76; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Kotwal GJ, 1998, MOL CELL BIOCHEM, V185, P39, DOI 10.1023/A:1006844624825; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Makrides SC, 1998, PHARMACOL REV, V50, P59; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; MOLINA H, 1995, J IMMUNOL, V154, P5426; Murthy H. M. Krishna, 1996, V56, P127; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; OTWINOWSKI Z, 1991, ISOMORPHOUS REPLACEM, P101; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1986, IMMUNOBIOLOGY COMPLE; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prodinger WM, 1998, J IMMUNOL, V161, P4604; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Reynolds DN, 2000, ADVANCES IN ANIMAL VIROLOGY, P337; Sahu A, 1998, J IMMUNOL, V160, P5596; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sharp AH, 1996, NEUROBIOL DIS, V3, P3, DOI 10.1006/nbdi.1996.0002; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Soames CJ, 1996, BIOCHEM J, V315, P523, DOI 10.1042/bj3150523; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241	62	116	118	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					301	311		10.1016/S0092-8674(01)00214-8	http://dx.doi.org/10.1016/S0092-8674(01)00214-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207370				2022-12-01	WOS:000166879700013
J	Perna, NT; Plunkett, G; Burland, V; Mau, B; Glasner, JD; Rose, DJ; Mayhew, GF; Evans, PS; Gregor, J; Kirkpatrick, HA; Posfai, G; Hackett, J; Klink, S; Boutin, A; Shao, Y; Miller, L; Grotbeck, EJ; Davis, NW; Limk, A; Dimalanta, ET; Potamousis, KD; Apodaca, J; Anantharaman, TS; Lin, JY; Yen, G; Schwartz, DC; Welch, RA; Blattner, FR				Perna, NT; Plunkett, G; Burland, V; Mau, B; Glasner, JD; Rose, DJ; Mayhew, GF; Evans, PS; Gregor, J; Kirkpatrick, HA; Posfai, G; Hackett, J; Klink, S; Boutin, A; Shao, Y; Miller, L; Grotbeck, EJ; Davis, NW; Limk, A; Dimalanta, ET; Potamousis, KD; Apodaca, J; Anantharaman, TS; Lin, JY; Yen, G; Schwartz, DC; Welch, RA; Blattner, FR			Genome sequence of enterohaemorrhagic Escherichia coli O157 : H7	NATURE			English	Article							SHIGA-LIKE TOXIN; SUBINHIBITORY CONCENTRATIONS; HEMORRHAGIC COLITIS; ALIGNMENT; EVOLUTION; REGIONS; GENES; K-12	The bacterium Escherichia coli O157:H7 is a worldwide threat to public health and has been implicated in many outbreaks of haemorrhagic colitis, some of which included fatalities caused by haemolytic uraemic syndrome(1,2). Close to 75,000 cases of O157:H7 infection are now estimated to occur annually in the United States(3). The severity of disease, the lack of effective treatment and the potential for large-scale outbreaks from contaminated food supplies have propelled intensive research on the pathogenesis and detection of E. coli O157:H7 (ref. 4). Here we have sequenced the genome of E. coli O157:H7 to identify candidate genes responsible for pathogenesis, to develop better methods of strain detection and to advance our understanding of the evolution of E. coli, through comparison with the genome of the non-pathogenic laboratory strain E. coli K-12 (ref. 5). We rnd that lateral gene transfer is far more extensive than previously anticipated. In fact, 1,387 new genes encoded in strain-specific clusters of diverse sizes were found in O157:H7. These include candidate virulence factors, alternative metabolic capacities, several prophages and other new functions-all of which could be targets for surveillance.	Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biostat, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; Cereon Genom LLC, Cambridge, MA 02139 USA; Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Hungarian Academy of Sciences; Hungarian Biological Research Center	Perna, NT (corresponding author), Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA.		Mayhew, George F/B-4042-2016; Plunkett, Guy/B-8058-2009	Mayhew, George F/0000-0003-0609-6018; Plunkett, Guy/0000-0003-1422-469X; Perna, Nicole/0000-0001-8208-0929	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063250] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK063250] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaisdell JO, 1999, J BACTERIOL, V181, P6396, DOI 10.1128/JB.181.20.6396-6402.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLATTNER FR, 1997, MICROB COMP GENOMICS, V2, P174; Boyd EF, 1997, J BACTERIOL, V179, P1985, DOI 10.1128/jb.179.6.1985-1991.1997; CAMPBELL A, 1983, LAMBDA, V2, P365; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mahillon J, 1998, GENE, V223, P47, DOI 10.1016/S0378-1119(98)00365-5; McDonough MA, 1999, MOL MICROBIOL, V34, P1058, DOI 10.1046/j.1365-2958.1999.01669.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Ohnishi M, 1999, DNA Res, V6, P361, DOI 10.1093/dnares/6.6.361; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; SHARP PM, 1992, P NATL ACAD SCI USA, V89, P9836, DOI 10.1073/pnas.89.20.9836; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889	30	1574	3721	7	199	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					529	533		10.1038/35054089	http://dx.doi.org/10.1038/35054089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206551	Bronze			2022-12-01	WOS:000166570500052
J	Van Trappen, PO; Gyselman, VG; Lowe, DG; Ryan, A; Oram, DH; Bosze, P; Weekes, AR; Shepherd, JH; Dorudi, S; Bustin, SA; Jacobs, IJ				Van Trappen, PO; Gyselman, VG; Lowe, DG; Ryan, A; Oram, DH; Bosze, P; Weekes, AR; Shepherd, JH; Dorudi, S; Bustin, SA; Jacobs, IJ			Molecular quantification and mapping of lymph-node micrometastases in cervical cancer	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; BREAST-CANCER; COLORECTAL-CANCER; REVERSE-TRANSCRIPTASE; PERIPHERAL-BLOOD; MESSENGER-RNA; CELLS; METASTASIS; CARCINOMA; IDENTIFICATION	Background A proportion of patients with cancer and lymph nodes negative on histology will develop recurrence. Reverse-transcriptase PCR (RT-PCR) is a highly sensitive method for detection of lymph-node micrometastases, but accurate quantitative assessment has been difficult. Methods We studied primary tumours and 156 lymph nodes from 32 patients with cervical cancer (stage IA2, IB1, and 1B2) and 32 lymph nodes from nine patients with benign disease. A fully quantitative, real-time RT-PCR assay was used to document absolute copy numbers of the epithelial marker cytokeratin 19. Primers and probe were designed not to amplify either of the two cytokeratin 19 pseudogenes. Findings All primary tumours and histologically involved lymph nodes (six) had more than 10(6) copies of cytokeratin 19 mRNA per mug total RNA. Expression of cytokeratin 19 (up to 1.1x10(5) copies per mug RNA) was detected in 66 (44%) of 150 histologically uninvolved lymph nodes, and in nodes from 16 of 32 patients with cervical cancer. 15 of these 16 patients with evidence of micrometastases had the highest cytokeratin 19 transcription level in a first lymph-node drainage-station (three obturator, six internal, and six external iliac node). Transcription of cytokeratin 19 was found at a low level in just one of 32 lymph nodes obtained from nine patients with benign disease. Median copy number of cytokeratin 19 transcription was significantly higher (>10(3) copies) in association with adverse prognostic features. Interpretation The results suggest that about 50% of early-stage cervical cancers shed tumour cells to the pelvic lymph nodes. The amount of cytokeratin 19 expression was related to clinicopathological features. Further studies are required to document the clinical implications of molecular micrometastases.	St Bartholomews Hosp, Univ London Queen Mary & Westfield Coll, Acad Dept Gynaecol Oncol, London EC1A 7BE, England; Royal London Hosp, Univ London Queen Mary & Westfield Coll, Acad Dept Surg, London E1 1BB, England; St Stephan Hosp, Dept Gynaecol Onocl, Budapest, Hungary; Harold Wood Hosp, Dept Gynaecol, Romford, Essex, England	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Van Trappen, PO (corresponding author), St Bartholomews Hosp, Univ London Queen Mary & Westfield Coll, Acad Dept Gynaecol Oncol, London EC1A 7BE, England.		Van Trappen, Philippe/ABF-7431-2021; Bustin, Stephen/H-3086-2013; Jacobs, Ian J/F-1743-2013	Van Trappen, Philippe/0000-0002-9784-7974; Bustin, Stephen/0000-0003-1870-6098; Jacobs, Ian J/0000-0002-8112-4624; Jacobs, Ian/0000-0002-5005-2672				ALVAREZ RD, 1989, GYNECOL ONCOL, V35, P130, DOI 10.1016/0090-8258(89)90029-2; Benson JR, 1999, LANCET, V354, P1998, DOI 10.1016/S0140-6736(05)76770-2; Bustin SA, 1999, BRIT J CANCER, V79, P1813, DOI 10.1038/sj.bjc.6690289; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIFUENTES N, 1979, J SURG ONCOL, V11, P193, DOI 10.1002/jso.2930110303; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Czegledy J, 1998, J MED VIROL, V54, P183, DOI 10.1002/(SICI)1096-9071(199803)54:3<183::AID-JMV7>3.3.CO;2-O; DARGENT D, 2000, P SGO M, P128; Futamura M, 1998, J SURG ONCOL, V68, P34, DOI 10.1002/(SICI)1096-9098(199805)68:1<34::AID-JSO8>3.0.CO;2-M; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; HAYASHI N, 1995, LANCET, V345, P1257, DOI 10.1016/S0140-6736(95)90922-2; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; INOUE T, 1990, CANCER, V65, P1923, DOI 10.1002/1097-0142(19900501)65:9<1923::AID-CNCR2820650909>3.0.CO;2-M; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; McIntosh SA, 1999, LANCET, V354, P570, DOI 10.1016/S0140-6736(99)02155-8; MOLL R, 1983, LAB INVEST, V49, P599; Pao CC, 1997, J CLIN ONCOL, V15, P1008, DOI 10.1200/JCO.1997.15.3.1008; Raj GV, 1998, CANCER-AM CANCER SOC, V82, P1419, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4; Ruud P, 1999, INT J CANCER, V80, P119, DOI 10.1002/(SICI)1097-0215(19990105)80:1<119::AID-IJC22>3.0.CO;2-X; SAVTCHENKO ES, 1988, AM J HUM GENET, V43, P630; SCHOENFELD A, 1994, CANCER RES, V54, P2986; Schoenfeld A, 1996, BRIT J CANCER, V74, P1639, DOI 10.1038/bjc.1996.601; Slade MJ, 1999, J CLIN ONCOL, V17, P870, DOI 10.1200/JCO.1999.17.3.870; SMITH B, 1991, LANCET, V338, P1227, DOI 10.1016/0140-6736(91)92100-G; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; van der Velde-Zimmermann D, 2000, ANN SURG ONCOL, V7, P51, DOI 10.1007/s10434-000-0051-8	30	150	153	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					15	20		10.1016/S0140-6736(00)03566-2	http://dx.doi.org/10.1016/S0140-6736(00)03566-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197354				2022-12-01	WOS:000166341500010
J	Ribeiro, RC; Bonilla, M				Ribeiro, RC; Bonilla, M			A leukaemia treatment programme in El Salvador	LANCET			English	Article									St Jude Childrens Res Hosp, Dept Hematol & Oncol, Int Outreach Program, Memphis, TN 38105 USA; Hosp Nacl Ninos Benjamin Bloom, San Salvador, El Salvador	St Jude Children's Research Hospital	Ribeiro, RC (corresponding author), St Jude Childrens Res Hosp, Dept Hematol & Oncol, Int Outreach Program, 332 N Lauderdale St, Memphis, TN 38105 USA.								0	13	13	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S7	S7		10.1016/S0140-6736(00)91993-7	http://dx.doi.org/10.1016/S0140-6736(00)91993-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191527				2022-12-01	WOS:000166074900009
J	Felson, DT; Chaisson, CE; Hill, CL; Totterman, SMS; Gale, ME; Skinner, KM; Kazis, L; Gale, DR				Felson, DT; Chaisson, CE; Hill, CL; Totterman, SMS; Gale, ME; Skinner, KM; Kazis, L; Gale, DR			The association of bone marrow lesions with pain in knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							HIP; SCINTIGRAPHY; EDEMA	Background: The cause of pain in osteoarthritis is unknown. Bone has pain fibers, and marrow lesions, which are thought to represent edema, have been noted in osteoarthritis. Objective: To determine whether bone marrow lesions on magnetic resonance imaging (MRI) are associated with pain in knee osteoarthritis. Design: Cross-sectional observational study. Setting: Veterans Affairs Medical Center. Patients: 401 persons (mean age, 66.8 years) with knee osteoarthritis on radiography who were drawn from clinics in the Veterans Administration health care system and from the community. Of these persons, 351 had knee pain and 50 had no knee pain. Measurements: Knee radiography and MRI of one knee were performed in all participants. Those with knee pain quantified the severity of their pain. On MRI, coronal T-2-weighted fat-saturated images were used to score the size of bone marrow lesions, and each knee was characterized as having any lesion or any large lesion, The prevalence of lesions acid large lesions in persons with and without knee pain was compared; in participants with knee pain, the presence of lesions was correlated with severity of pain. Results: Bone marrow lesions were found in 272 of 351 (77.5%) persons with painful knees compared with 15 of 50 (30%) persons with no knee pain (P < 0.001). Large lesions were present almost exclusively in persons with knee pain (35.9% vs. 2%; P < 0.001). After adjustment for severity of radiographic disease, effusion, age, and sex, lesions and large lesions remained associated with the occurrence of knee pain. Among persons with knee pain, bone marrow lesions were not associated with pain severity. Conclusions: Bone marrow lesions on MRI are strongly associated with the presence of pain in knee osteoarthritis.	Boston Univ, Arthrit Ctr, Boston Med Ctr, Vet Affairs Boston Healthcare Syst, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Vet Affairs Hlth Serv Res & Dev Field Program, Ctr Hlth Qual Outcomes & Econ Res, Boston, MA USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Bedford Vet Affairs Med Ctr, Bedford, MA USA	Boston Medical Center; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Rochester	Felson, DT (corresponding author), Boston Univ, Sch Med, 715 Albany St,A203, Boston, MA 02118 USA.		Hill, Catherine L/AAE-7152-2019	Hill, Catherine L/0000-0001-8289-4922; Chaisson, Christine/0000-0002-3207-9257; Felson, David/0000-0002-2668-2447; Kazis, Lewis/0000-0003-1800-5849	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020613] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR20613] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNOLDI CC, 1980, ACTA ORTHOP SCAND, V51, P19, DOI 10.3109/17453678008990764; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Boegard T, 1999, ANN RHEUM DIS, V58, P20, DOI 10.1136/ard.58.1.20; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; Chaisson CE, 2000, RHEUMATOLOGY, V39, P1218, DOI 10.1093/rheumatology/39.11.1218; Creamer P, 1996, J RHEUMATOL, V23, P1031; Felson DT, 1997, OSTEOARTHR CARTILAGE, V5, P241, DOI 10.1016/S1063-4584(97)80020-9; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Fleiss JL, 1981, STATISTICAL METHODS, P217; HADLER NM, 1992, ANN INTERN MED, V116, P598, DOI 10.7326/0003-4819-116-7-598; Hill CL, 1999, ARTHRITIS RHEUM, V42, pS294; HUTTON CW, 1986, ANN RHEUM DIS, V45, P622, DOI 10.1136/ard.45.8.622; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Koo KH, 1999, RADIOLOGY, V213, P715, DOI 10.1148/radiology.213.3.r99dc06715; McAlindon T, 1996, J RHEUMATOL, V23, P332; McNicholas MJ, 1999, J ROY COLL SURG EDIN, V44, P31; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; SPEER KP, 1992, AM J SPORT MED, V20, P382, DOI 10.1177/036354659202000403; WILSON AJ, 1988, RADIOLOGY, V167, P757, DOI 10.1148/radiology.167.3.3363136; WOJTYS E M, 1990, Arthroscopy, V6, P254, DOI 10.1016/0749-8063(90)90054-H; WYKE B, 1981, CLIN RHEUM DIS, V7, P223	22	678	708	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					541	549		10.7326/0003-4819-134-7-200104030-00007	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281736				2022-12-01	WOS:000167931200001
J	Puntes, VF; Krishnan, KM; Alivisatos, AP				Puntes, VF; Krishnan, KM; Alivisatos, AP			Colloidal nanocrystal shape and size control: The case of cobalt	SCIENCE			English	Article							MAGNETIC-PROPERTIES; SUPERLATTICES; NANOSTRUCTURES; PARTICLES	We show that a relatively simple approach for controlling the colloidal synthesis of anisotropic cadmium selenide semiconductor nanorods can be extended to the size-controlled preparation of magnetic cobalt nanorods as well as spherically shaped nanocrystals. This approach helps define a minimum feature set needed to separately control the sizes and shapes of nanocrystals. The resulting cobalt nanocrystals produce interesting two- and three-dimensional superstructures, including ribbons of nanorods.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Puntes, VF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Puntes, Victor/AAL-6081-2021; Puntes, Víctor F./F-8407-2013; Alivisatos, Paul/N-8863-2015	Puntes, Victor/0000-0001-8996-9499; Puntes, Víctor F./0000-0001-8996-9499; Alivisatos, Paul/0000-0001-6895-9048	NCRR NIH HHS [1 R01 RR-14891-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014891] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		deCaro D, 1996, CHEM MATER, V8, P1987, DOI 10.1021/cm950599f; Dinega DP, 1999, ANGEW CHEM INT EDIT, V38, P1788, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1788::AID-ANIE1788>3.0.CO;2-2; Dormann JL, 1997, ADV CHEM PHYS, V98, P283, DOI 10.1002/9780470141571.ch4; HAMZAOUI S, 1980, J MAGN MAGN MATER, V22, P69, DOI 10.1016/0304-8853(80)90010-4; Himpsel FJ, 1998, ADV PHYS, V47, P511, DOI 10.1080/000187398243519; Lieber CM, 1998, SOLID STATE COMMUN, V107, P607, DOI 10.1016/S0038-1098(98)00209-9; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; OULD T, 2000, J PHYS CHEM B, V104, P165; Ould-Ely T, 1999, CHEM MATER, V11, P526, DOI 10.1021/cm980675p; Park SJ, 2000, J AM CHEM SOC, V122, P8581, DOI 10.1021/ja001628c; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Petit C, 1999, J PHYS CHEM B, V103, P1805, DOI 10.1021/jp982755m; PUNTES V, IN PRESS IEEE T MAGN; PUNTES V, IN PRESS APPL PHYS L; Schmid G, 1998, ADV MATER, V10, P515, DOI 10.1002/(SICI)1521-4095(199805)10:7<515::AID-ADMA515>3.0.CO;2-Y; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Sun SH, 1999, J APPL PHYS, V85, P4325, DOI 10.1063/1.370357; THOMAS JR, 1966, J APPL PHYS, V37, P2914, DOI 10.1063/1.1782154; THOMAS JR, 1966, Patent No. 3284358; Wang ZL, 1998, ADV MATER, V10, P13, DOI 10.1002/(SICI)1521-4095(199801)10:1<13::AID-ADMA13>3.0.CO;2-W; YANG MH, 1989, PHYS REV LETT, V62, P1476; Yin JS, 1997, PHYS REV LETT, V79, P2570, DOI 10.1103/PhysRevLett.79.2570	23	2236	2367	7	920	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2115	2117		10.1126/science.1057553	http://dx.doi.org/10.1126/science.1057553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251109	Green Submitted			2022-12-01	WOS:000167563800029
J	Young, L; Leonhard, K; Tatsuta, T; Trowsdale, L; Langer, T				Young, L; Leonhard, K; Tatsuta, T; Trowsdale, L; Langer, T			Role of the ABC transporter Mdl1 in peptide export from mitochondria	SCIENCE			English	Article							INNER MEMBRANE; PROTEIN TRANSLOCATION; AAA PROTEASES; DEGRADATION; IMPORT; IDENTIFICATION; PARAPLEGIN; TIM23	ATP-binding cassette (ABC) adenosine triphosphatases actively transport a wide variety of compounds across biological membranes. Here, the ABC protein Mdl1 was identified as an intracellular peptide transporter localized in the inner membrane of yeast mitochondria. Mdl1 was required for mitochondrial export of peptides with molecular masses of similar to 2100 to 600 daltons generated by proteolysis of inner-membrane proteins by the m-AAA protease in the mitochondrial matrix. Proteolysis by the I-AAA protease in the intermembrane space led to the release of similar-sited peptides independent of Mdl1. Thus, two pathways of peptide efflux from mitochondria exist that may allow communication between mitochondria and their cellular environment.	Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany	University of Cambridge; University of Munich	Young, L (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	lesley.young@lorantis.co.uk; thomas.langer@uni-koeln.de		Langer, Thomas/0000-0003-1250-1462				Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; BUTCHER GW, 2000, MOL B INT U, V8, P47; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Coppola M, 2000, GENOMICS, V66, P48, DOI 10.1006/geno.2000.6136; DAUM G, 1982, J BIOL CHEM, V257, P3075; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; DESAUTELS M, 1982, P NATL ACAD SCI-BIOL, V79, P1869, DOI 10.1073/pnas.79.6.1869; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; Guelin E, 1996, FEBS LETT, V381, P42, DOI 10.1016/0014-5793(96)00074-9; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hogue DL, 1999, J MOL BIOL, V285, P379, DOI 10.1006/jmbi.1998.2259; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KUCHLER K, 1992, COLD SPRING HARB SYM, V57, P579, DOI 10.1101/SQB.1992.057.01.064; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lankat-Buttgereit B, 1999, FEBS LETT, V464, P108, DOI 10.1016/S0014-5793(99)01676-2; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; MANNELLA CA, 1992, TRENDS BIOCHEM SCI, V17, P315, DOI 10.1016/0968-0004(92)90444-E; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; [No title captured]	28	169	174	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2135	2138		10.1126/science.1056957	http://dx.doi.org/10.1126/science.1056957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251115				2022-12-01	WOS:000167563800035
J	Cullington, HE				Cullington, HE			Light eye colour linked to deafness after meningitis	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Inst Sound & Vibrat Res, Hearing & Balance Ctr, Southampton SO17 1BJ, Hants, England	University of Southampton	Cullington, HE (corresponding author), Univ Southampton, Inst Sound & Vibrat Res, Hearing & Balance Ctr, Southampton SO17 1BJ, Hants, England.		Cullington, Helen/B-5540-2016	Cullington, Helen/0000-0002-5093-2020				BARRENAS ML, 1990, SCAND AUDIOL, V19, P97, DOI 10.3109/01050399009070759; HENNEBERGER PK, 1983, AM J EPIDEMIOL, V117, P484, DOI 10.1093/oxfordjournals.aje.a113566; TODD NW, 1995, J LARYNGOL OTOL, V109, P926, DOI 10.1017/S002221510013169X	3	10	10	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					587	587						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238154				2022-12-01	WOS:000167499900024
J	Lindsay, EA; Vitelli, F; Su, H; Morishima, M; Huynh, T; Pramparo, T; Jurecic, V; Ogunrinu, G; Sutherland, HF; Scambler, PJ; Bradley, A; Baldini, A				Lindsay, EA; Vitelli, F; Su, H; Morishima, M; Huynh, T; Pramparo, T; Jurecic, V; Ogunrinu, G; Sutherland, HF; Scambler, PJ; Bradley, A; Baldini, A			Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice	NATURE			English	Article							HOLT-ORAM SYNDROME; CHROMOSOMAL REGION; 22Q11 DELETION; NO OVERLAP; GENE; MOUSE; MUTATIONS; BRACHYURY; DEFICIENT; FAMILY	DiGeorge syndrome is characterized by cardiovascular, thymus and parathyroid defects and craniofacial anomalies, and is usually caused by a heterozygous deletion of chromosomal region 22q11.2 (del22q11) (ref. 1). A targeted, heterozygous deletion, named Df(16)1, encompassing around 1 megabase of the homologous region in mouse causes cardiovascular abnormalities characteristic of the human disease(2). Here we have used a combination of chromosome engineering and P1 artificial chromosome transgenesis to localize the haploinsufficient gene in the region, Tbx1. We show that Tbx1, a member of the T-box transcription factor family, is required for normal development of the pharyngeal arch arteries in a gene dosage-dependent manner. Deletion of one copy of Tbx1 affects the development of the fourth pharyngeal arch arteries, whereas homozygous mutation severely disrupts the pharyngeal arch artery system. Our data show that haploinsufficiency of Tbx1 is sufficient to generate at least one important component of the DiGeorge syndrome phenotype in mice, and demonstrate the suitability of the mouse for the genetic dissection of microdeletion syndromes.	Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Miami, Sch Med, Miami, FL 33136 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Inst Child Hlth, London WC1N, England; Sanger Ctr, Cambridge CB10 1S, England; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Miami; University of Texas System; UTMD Anderson Cancer Center; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute	Baldini, A (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, 1 Baylor Plaza, Houston, TX 77030 USA.		genes, anthony/F-2541-2012; Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008; Baldini, Antonio/M-2355-2015	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Baldini, Antonio/0000-0002-5330-0256; Bradley, Allan/0000-0002-2349-8839				Albrecht U, 1997, MOL CELLULAR METHODS, P23; Amati F, 1999, EUR J HUM GENET, V7, P903, DOI 10.1038/sj.ejhg.5200399; Baldini A, 1994, Methods Mol Biol, V33, P75; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Begbie J, 1999, DEVELOPMENT, V126, P895; Botta A, 1997, MAMM GENOME, V8, P890, DOI 10.1007/s003359900606; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; Galili N, 1997, GENOME RES, V7, P17, DOI 10.1101/gr.7.1.17; Gong LM, 2000, BBA-GENE STRUCT EXPR, V1494, P185, DOI 10.1016/S0167-4781(00)00189-5; Kirby ML, 1997, DEV DYNAM, V208, P34, DOI 10.1002/(SICI)1097-0177(199701)208:1<34::AID-AJA4>3.0.CO;2-2; Li QY, 1997, NAT GENET, V15, P21; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43903; Lund J, 1999, MAMM GENOME, V10, P438, DOI 10.1007/s003359901019; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MCKUSICK V, 2000, LINE MENDELIAN INHER; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; ODonnell H, 1997, AM J HUM GENET, V60, P1544; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; Puech A, 2000, P NATL ACAD SCI USA, V97, P10090, DOI 10.1073/pnas.97.18.10090; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; Sutherland HF, 1998, GENOMICS, V52, P37, DOI 10.1006/geno.1998.5414	26	683	697	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					97	101		10.1038/35065105	http://dx.doi.org/10.1038/35065105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242049				2022-12-01	WOS:000167194300050
J	Mason, GJ; Cooper, J; Clarebrough, C				Mason, GJ; Cooper, J; Clarebrough, C			Frustrations of fur-farmed mink	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; De Montfort Univ, Sch Agr & Hort, Caythorpe NG32 3EP, Lincoln, England	University of Oxford; De Montfort University	Mason, GJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.			Cooper, Jonathan/0000-0002-9014-4395				*AN AID, 1999, FUR TRAD FACTSH; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; Dunstone N., 1993, MINK; Hartwick J.M., 1998, EC NATURAL RESOURCE, V2; HURSH SR, 1980, J EXP ANAL BEHAV, V34, P219, DOI 10.1901/jeab.1980.34-219; *INT FUR TRAD FED, FUR FARM; JOERGENSON G, 1985, MINK PRODUCTION; NG YK, 1983, WELFARE EC; Reilly S, 1999, PHARMACOL BIOCHEM BE, V63, P301, DOI 10.1016/S0091-3057(99)00009-X; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; STEPHENS DW, 1998, FORAGING THEORY; Toates F.M., 1995, STRESS CONCEPTUAL BI; Varian H. R., 1996, INTERMEDIATE MICROEC	13	223	234	0	121	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					35	36		10.1038/35065157	http://dx.doi.org/10.1038/35065157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242031	Green Accepted			2022-12-01	WOS:000167194300032
J	Cole, ST; Eiglmeier, K; Parkhill, J; James, KD; Thomson, NR; Wheeler, PR; Honore, N; Garnier, T; Churcher, C; Harris, D; Mungall, K; Basham, D; Brown, D; Chillingworth, T; Connor, R; Davies, RM; Devlin, K; Duthoy, S; Feltwell, T; Fraser, A; Hamlin, N; Holroyd, S; Hornsby, T; Jagels, K; Lacroix, C; Maclean, J; Moule, S; Murphy, L; Oliver, K; Quail, MA; Rajandream, MA; Rutherford, KM; Rutter, S; Seeger, K; Simon, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Taylor, K; Whitehead, S; Woodward, JR; Barrell, BG				Cole, ST; Eiglmeier, K; Parkhill, J; James, KD; Thomson, NR; Wheeler, PR; Honore, N; Garnier, T; Churcher, C; Harris, D; Mungall, K; Basham, D; Brown, D; Chillingworth, T; Connor, R; Davies, RM; Devlin, K; Duthoy, S; Feltwell, T; Fraser, A; Hamlin, N; Holroyd, S; Hornsby, T; Jagels, K; Lacroix, C; Maclean, J; Moule, S; Murphy, L; Oliver, K; Quail, MA; Rajandream, MA; Rutherford, KM; Rutter, S; Seeger, K; Simon, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Taylor, K; Whitehead, S; Woodward, JR; Barrell, BG			Massive gene decay in the leprosy bacillus	NATURE			English	Article							MYCOBACTERIUM-LEPRAE; GENOME SEQUENCE; TUBERCULOSIS; IDENTIFICATION; CLUSTER; DOMAIN	Leprosy, a chronic human neurological disease, results from infection with the obligate intracellular pathogen Mycobacterium leprae, a close relative of the tubercle bacillus. Mycobacterium leprae has the longest doubling time of all known bacteria and has thwarted every effort at culture in the laboratory. Comparing the 3.27-megabase (Mb) genome sequence of an armadillo-derived Indian isolate of the leprosy bacillus with that of Mycobacterium tuberculosis (4.41 Mb) provides clear explanations for these properties and reveals an extreme case of reductive evolution. Less than half of the genome contains functional genes but pseudogenes, with intact counterparts in M. tuberculosis, abound. Genome downsizing and the current mosaic arrangement appear to have resulted from extensive recombination events between dispersed repetitive sequences. Gene deletion and decay have eliminated many important metabolic activities including siderophore production, part of the oxidative and most of the microaerophilic and anaerobic respiratory chains, and numerous catabolic systems and their regulatory circuits.	Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris 15, France; Sanger Ctr, Hinxton CB10 1SA, England; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Wellcome Trust Sanger Institute; Veterinary Laboratories Agency	Cole, ST (corresponding author), Inst Pasteur, Unite Genet Mol Bacterienne, 28 Rue Docteur Roux, F-75724 Paris 15, France.		Rutherford, Kim/Y-7995-2018; Parkhill, Julian/G-4703-2011; Wheeler, Paul/C-6709-2011; Quail, michael/ABE-6131-2020; Thomson, Nicholas/P-5988-2014	Rutherford, Kim/0000-0001-6277-726X; Parkhill, Julian/0000-0002-7069-5958; Thomson, Nicholas/0000-0002-4432-8505; Murphy, Lee/0000-0001-6467-7449				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brosch R, 2000, RES MICROBIOL, V151, P135, DOI 10.1016/S0923-2508(00)00117-0; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; DRAPER P, 1982, ANN INST PASTEUR MIC, VB133, P39; EIGLMEIER K, 1993, MOL MICROBIOL, V7, P197, DOI 10.1111/j.1365-2958.1993.tb01111.x; Eiglmeier K, 1997, FEMS MICROBIOL LETT, V149, P273, DOI 10.1111/j.1574-6968.1997.tb10340.x; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; FRANZBLAU SG, 1989, ANTIMICROB AGENTS CH, V33, P2115, DOI 10.1128/AAC.33.12.2115; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; HALL RM, 1983, INT J LEPROSY, V51, P490; Hansen GHA., 1874, NORSK MAG LAEGEVIDEN, V4, P1; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MELANCONKAPLAN J, 1988, P NATL ACAD SCI USA, V85, P1917, DOI 10.1073/pnas.85.6.1917; Mizrahi V, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P159; NORDEEN SK, 1993, TROPICAL DIS RES PRO, P47; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peterson JA, 1998, STRUCTURE, V6, P1079, DOI 10.1016/S0969-2126(98)00109-9; Philipp WJ, 1998, ELECTROPHORESIS, V19, P573, DOI 10.1002/elps.1150190418; POULET S, 1995, ARCH MICROBIOL, V163, P79, DOI 10.1007/BF00381780; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; RATLEDGE CR, 1982, BIOL MYCOBACTERIA, P53; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sheppard CC, 1985, LEPROSY, P269; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Smith DR, 1997, GENOME RES, V7, P802, DOI 10.1101/gr.7.8.802; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Wheeler Paul R., 1994, P353; WHEELER PR, 1984, J GEN MICROBIOL, V130, P381; *WHO, 1998, WHO WEEKLY EPIDEMIOL, V73, P40; Wolf YI, 1999, GENOME RES, V9, P689; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; ZUBENTRUP KH, 1999, J BACTERIOL, V181, P7161	50	1280	2011	1	106	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1007	1011		10.1038/35059006	http://dx.doi.org/10.1038/35059006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234002				2022-12-01	WOS:000167148800035
J	Inoue, T; Higuchi, M; Hashimoto, Y; Seki, M; Kobayashi, M; Kato, T; Tabata, S; Shinozaki, K; Kakimoto, T				Inoue, T; Higuchi, M; Hashimoto, Y; Seki, M; Kobayashi, M; Kato, T; Tabata, S; Shinozaki, K; Kakimoto, T			Identification of CRE1 as a cytokinin receptor from Arabidopsis	NATURE			English	Article							SIGNAL-TRANSDUCTION; RESPONSE REGULATORS; HISTIDINE KINASE; THALIANA; ETHYLENE; MUTANTS; GENE; SIMILARITY; OSMOSENSOR; VECTORS	Cytokinins are a class of plant hormones that are central to the regulation of cell division and differentiation in plants(1,2). It has been proposed that they are detected by a two-component system, because overexpression of the histidine kinase gene CKI1 induces typical cytokinin responses(3) and genes for a set of response regulators of two-component systems can be induced by cytokinins(4,5). Two-component systems use a histidine kinase as an environmental sensor and rely on a phosphorelay for signal transduction. They are common in microorganisms, and are also emerging as important signal detection routes in plants(6-9). Here we report the identification of a cytokinin receptor. We identified Arabidopsis cre1 (cytokinin response 1) mutants, which exhibited reduced responses to cytokinins. The mutated gene CRE1 encodes a histidine kinase. CRE1 expression conferred a cytokinin-dependent growth phenotype on a yeast mutant that lacked the endogenous histidine kinase SLN1 (ref. 10), providing direct evidence that CRE1 is a cytokinin receptor. We also provide evidence that cytokinins can activate CRE1 to initiate phosphorelay signalling.	Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; RIKEN, Tsukuba Inst, Plant Mol Biol Lab, Tsukuba, Ibaraki 3050074, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan	Osaka University; RIKEN; Kazusa DNA Research Institute	Kakimoto, T (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan.		Shinozaki, Kazuo/G-4202-2013; Seki, Motoaki/I-2854-2012; Ding, Cheng-Qiang/B-6287-2011	Shinozaki, Kazuo/0000-0002-6317-9867; Seki, Motoaki/0000-0001-8288-0467; 				AKAMA K, 1992, PLANT CELL REP, V12, P7, DOI 10.1007/BF00232413; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; HAYASHI H, 1992, SCIENCE, V258, P1350, DOI 10.1126/science.1455228; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Miyata S, 1998, FEBS LETT, V437, P11, DOI 10.1016/S0014-5793(98)01188-0; Mizuno T, 1998, J BIOCHEM, V123, P555; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Sakakibara H, 1998, PLANT J, V14, P337, DOI 10.1046/j.1365-313X.1998.00134.x; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; SCHMITZ RY, 1972, PLANT PHYSIOL, V50, P702, DOI 10.1104/pp.50.6.702; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Suzuki T, 1998, PLANT CELL PHYSIOL, V39, P1258, DOI 10.1093/oxfordjournals.pcp.a029329; UEGUCHI C, IN PRESS PLANT CELL; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743	27	658	710	1	136	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1060	1063		10.1038/35059117	http://dx.doi.org/10.1038/35059117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234017				2022-12-01	WOS:000167148800050
J	Murray, AW; Marks, D				Murray, AW; Marks, D			Can sequencing shed light on cell cycling?	NATURE			English	Article							DEPENDENT KINASES; ACTIVATION; CHECKPOINT; YEAST	Every organism must have cells that can replicate indefinitely. Can the draft human genome sequence tell us how the cell cycle works and how it evolved? We studied two protein families-the cyclins and their partners the cyclin-dependent kinases (Cdks)-and a conserved regulatory circuit, the spindle checkpoint. Disappointingly, we discovered a few novel cyclins and no new Cdks or components of the spindle checkpoint, and could shed little light on the organization of the cell cycle.	Harvard Univ, Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, BCMP & Cell Biol, Boston, MA 02115 USA; Harvard Univ, Ctr Cellular & Mol Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University	Murray, AW (corresponding author), Harvard Univ, Ctr Genom Res, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu						Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee KM, 1999, CURR BIOL, V9, P441, DOI 10.1016/S0960-9822(99)80194-8; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; PLFLEGER CM, 2000, GENE DEV, V14, P655	10	65	72	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					844	846		10.1038/35057033	http://dx.doi.org/10.1038/35057033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237006	Bronze			2022-12-01	WOS:000166938800053
J	Tokumaru, H; Umayahara, K; Pellegrini, LL; Ishizuka, T; Saisu, H; Betz, H; Augustine, GJ; Abe, T				Tokumaru, H; Umayahara, K; Pellegrini, LL; Ishizuka, T; Saisu, H; Betz, H; Augustine, GJ; Abe, T			SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; PRESYNAPTIC TERMINALS; CALCIUM CHANNELS; ALPHA-SNAP; DOCKING; SYNTAXIN; SYNAPTOBREVIN; NSF	Synaphin/complexin is a cytosolic protein that preferentially binds to syntaxin within the SNARE complex. We find that synaphin promotes SNAREs to form pre-complexes that oligomerize into higher order structures. A peptide from the central, syntaxin binding domain of synaphin competitively inhibits these two proteins from interacting and prevents SNARE complexes from oligomerizing. Injection of this peptide into squid giant presynaptic terminals inhibited neurotransmitter release at a late prefusion step of synaptic vesicle exocytosis. We propose that oligomerization of SNARE complexes into a higher order structure creates a SNARE scaffold for efficient, regulated fusion of synaptic vesicles.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany	Duke University; Marine Biological Laboratory - Woods Hole; Niigata University; Max Planck Society	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.		Ishizuka, Toru/L-8191-2017; Augustine, George James/J-9228-2013	Ishizuka, Toru/0000-0003-4405-8792; 				Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Ishizuka T, 1997, NEUROSCI LETT, V232, P107, DOI 10.1016/S0304-3940(97)00586-7; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MORITA T, 1992, BIOMED RES-TOKYO, V13, P357, DOI 10.2220/biomedres.13.357; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SANCHEZ ME, 1990, J EXP BIOL, V152, P369; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	59	121	126	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					421	432		10.1016/S0092-8674(01)00229-X	http://dx.doi.org/10.1016/S0092-8674(01)00229-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239399	Bronze			2022-12-01	WOS:000167003100012
J	Ma, LQ; Komar, KM; Tu, C; Zhang, WH; Cai, Y; Kennelley, ED				Ma, LQ; Komar, KM; Tu, C; Zhang, WH; Cai, Y; Kennelley, ED			A fern that hyperaccumulates arsenic - A hardy, versatile, fast-growing plant helps to remove arsenic from contaminated soils.	NATURE			English	Article									Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA; Univ Georgia, Cooperat Extens Serv, Dawson, GA 31742 USA; Florida Int Univ, Dept Chem, Miami, FL 33199 USA; Florida Int Univ, SE Environm Res Ctr, Miami, FL 33199 USA	State University System of Florida; University of Florida; University System of Georgia; University of Georgia; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Ma, LQ (corresponding author), Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA.		Ma, Lena Q/E-5854-2010; Tu, Cong/H-9750-2013; Cai, Yong/K-9868-2015	Ma, Lena Q/0000-0002-8463-9957; Cai, Yong/0000-0002-2811-4638				Brooks R.R., 1998, PLANTS HYPERACCUMULA; Jones DL., 1987, ENCY FERNS; KABATAPENDIAS A, 1991, TRACE ELEMENTS SOILS, P203; Koch I, 2000, ENVIRON SCI TECHNOL, V34, P22, DOI 10.1021/es9906756; Nriagu JO, 1994, ARSENIC ENV	5	1264	1438	24	466	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					579	579		10.1038/35054664	http://dx.doi.org/10.1038/35054664			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214308				2022-12-01	WOS:000166692300032
J	She, QX; Peng, X; Zillig, W; Garrett, RA				She, QX; Peng, X; Zillig, W; Garrett, RA			Genome evolution - Gene capture in archaeal chromosomes	NATURE			English	Article							FAMILY		Univ Copenhagen, Inst Mol Biol, Microbial Genome Grp, DK-1307 Copenhagen K, Denmark; Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Copenhagen; Max Planck Society	She, QX (corresponding author), Univ Copenhagen, Inst Mol Biol, Microbial Genome Grp, Solvgade 83H, DK-1307 Copenhagen K, Denmark.		She, Qunxin/E-4311-2012; Peng, Xu/M-8980-2014; Garrett, Roger A/M-2450-2014	She, Qunxin/0000-0002-4448-6669; Peng, Xu/0000-0003-3926-7514; Garrett, Roger A/0000-0001-8452-9099				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kletzin A, 1999, GENETICS, V152, P1307; Makino S, 1999, P JPN ACAD B-PHYS, V75, P166, DOI 10.2183/pjab.75.166; MUSKHELISHVILI G, 1993, MOL GEN GENET, V237, P334, DOI 10.1007/BF00279436; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Peng X, 2000, J MOL BIOL, V303, P449, DOI 10.1006/jmbi.2000.4160; REITER WD, 1990, MOL GEN GENET, V221, P65, DOI 10.1007/BF00280369; Rowe-Magnus DA, 1999, CURR OPIN MICROBIOL, V2, P483, DOI 10.1016/S1369-5274(99)00004-1; She QX, 2000, DNA SEQUENCE, V11, P183, DOI 10.3109/10425170009033231	12	47	50	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					478	478		10.1038/35054138	http://dx.doi.org/10.1038/35054138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206536				2022-12-01	WOS:000166570500037
J	Kyne, L; Warny, M; Qamar, A; Kelly, CP				Kyne, L; Warny, M; Qamar, A; Kelly, CP			Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea	LANCET			English	Article							RISK-FACTORS; DISEASE; PURIFICATION; SEVERITY; ILLNESS; COLITIS	Background We have reported that symptom-free carriers of Clostridium difficile have a systemic anamnestic immune response to toxin A. The aim of this study was to determine whether an acquired immune response to toxin A, during an episode of C difficile diarrhoea, influences risk of recurrence. Methods We prospectively studied 63 patients with nosocomial C difficile diarrhoea. Serial serum IgA, IgG, and IgM concentrations against C difficile toxin A, toxin B, or non-toxin antigens were measured by ELISA. Individuals were followed for 60 days. Findings 19 patients died (30%). Of the 44 who survived, 22 had recurrent C difficile diarrhoea. Patients with a single episode of C difficile diarrhoea (n=22) had higher concentrations of serum IgM against toxin A on day 3 of their first episode of diarrhoea than those with recurrent diarrhoea (n=22, p=0.004). On day 12, serum IgG values against toxin A were higher in patients who had a single episode of diarrhoea (n=7) than in those who subsequently had recurrent diarrhoea (n=9, p=0.009). The odds ratio for recurrence associated with a low concentration of serum IgG against toxin A. measured 12 days after onset of C difficile diarrhoea, was 48.0 (95% CI 3.5-663). Interpretation A serum antibody response to toxin A, during an initial episode of C difficile diarrhoea, is associated with protection against recurrence.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Gerontol Div, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kyne, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Gerontol Div, Boston, MA 02215 USA.	lkyne@caregroup.harvard.edu			NCRR NIH HHS [RR-01032] Funding Source: Medline; NIA NIH HHS [AG08812, AG16956] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008812, R03AG016956, P60AG008812] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARONSSON B, 1985, INFECTION, V13, P97, DOI 10.1007/BF01642866; BACON AE, 1994, DIAGN MICR INFEC DIS, V18, P205, DOI 10.1016/0732-8893(94)90021-3; BENTLEY DW, 1990, INFECT CONT HOSP EP, V11, P434; CHARLSON ME, 1986, J CHRON DIS, V39, P439, DOI 10.1016/0021-9681(86)90111-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Do AN, 1998, CLIN INFECT DIS, V26, P954, DOI 10.1086/513952; Fekety R, 1997, AM J GASTROENTEROL, V92, P739; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; HORN SD, 1983, MED CARE, V21, P14, DOI 10.1097/00005650-198301000-00002; JOHNSON S, 1992, J INFECT DIS, V166, P1287, DOI 10.1093/infdis/166.6.1287; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kelly CP, 1996, EUR J GASTROEN HEPAT, V8, P1048, DOI 10.1097/00042737-199611000-00004; KELLY CP, 1992, GASTROENTEROLOGY, V102, P35, DOI 10.1016/0016-5085(92)91781-X; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 1998, BIODRUGS, V10, P173, DOI 10.2165/00063030-199810030-00001; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Nair S, 1998, AM J GASTROENTEROL, V93, P1873; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Pothoulakis C, 1996, EUR J GASTROEN HEPAT, V8, P1041, DOI 10.1097/00042737-199611000-00003; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; SULLIVAN NM, 1982, INFECT IMMUN, V35, P1032, DOI 10.1128/IAI.35.3.1032-1040.1982; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994; Wilcox MH, 1998, J ANTIMICROB CHEMOTH, V41, P41, DOI 10.1093/jac/41.suppl_3.41; Wilcox MH, 1998, J HOSP INFECT, V39, P181, DOI 10.1016/S0195-6701(98)90256-0	28	600	638	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					189	193		10.1016/S0140-6736(00)03592-3	http://dx.doi.org/10.1016/S0140-6736(00)03592-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213096				2022-12-01	WOS:000166593700012
J	Wolpoff, MH; Hawks, J; Frayer, DW; Hunley, K				Wolpoff, MH; Hawks, J; Frayer, DW; Hunley, K			Modern human ancestry at the peripheries: A test of the replacement theory	SCIENCE			English	Article								The replacement theory of modern human origins stipulates that populations outside of Africa were replaced by a new African species of modern humans. Here we test the replacement theory in two peripheral areas far from Africa by examining the ancestry of early modern Australians and Central Europeans. Analysis of pairwise differences was used to determine if dual ancestry in Local archaic populations and earlier modern populations from the Levant and/or Africa could be rejected. The data imply that both have a dual ancestry. The diversity of recent humans cannot result exclusively from a single Late Pleistocene dispersal.	Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Kansas	Wolpoff, MH (corresponding author), Univ Michigan, Dept Anthropol, 500 S State, Ann Arbor, MI 49109 USA.	wolpoff@umich.edu	Hawks, John/H-5737-2015	Hawks, John/0000-0003-3187-3755; Hunley, Keith/0000-0003-0987-8277				Brauer G., 1992, CONTINUITY REPLACEME, P83; Brauer G., 1998, ORIGINS MODERN HUMAN, P106; BROWN P, 1989, COOBOOL CREEK TERRA, V13; CADDIE D, 1987, ARCHAEOMETRY FURTHER, P156; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; FRAYER DW, 1986, BRNO ANTHROPOS, V23, P243; FRAYER DW, 1993, PREHIST EUR, V2, P9; Hawks J, 2000, J HUM EVOL, V39, P1, DOI 10.1006/jhev.1999.0384; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; JELINEK J., 1983, ANTHROPOLOGIE BRNO, V21, P57; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lahr MM, 1996, J HUM EVOL, V31, P157, DOI 10.1006/jhev.1996.0056; MANN AE, 1991, AM J PHYS ANTHROPOL, V86, P175, DOI 10.1002/ajpa.1330860207; Relethford JH, 1999, EVOL ANTHROPOL, V8, P7, DOI 10.1002/(SICI)1520-6505(1999)8:1<7::AID-EVAN4>3.0.CO;2-O; Rightmire, 1990, EVOLUTION HOMO ERECT; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Simpson JJ, 1998, QUATERNARY SCI REV, V17, P1009, DOI 10.1016/S0277-3791(97)00088-7; SMITH FH, 1982, CURR ANTHROPOL, V23, P667, DOI 10.1086/202920; SMITH FH, 1997, HIST PHYS ANTHR ENCY, P659; SOLOW B, 1966, ACTA ODONT SCAND S46, V24, P1; Stringer C, 1998, J HUM EVOL, V34, P327, DOI 10.1006/jhev.1997.0204; STRINGER C, 1992, NATURE, V356, P201, DOI 10.1038/356201a0; STRINGER CB, 1994, INTERD CONT, P149; Svoboda J, 2000, J HUM EVOL, V38, P523, DOI 10.1006/jhev.1999.0361; Swed FS, 1943, ANN MATH STAT, V14, P66, DOI 10.1214/aoms/1177731494; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Szilvassy JV, 1987, ANN VIENNA NAT HIST, V89, P313; SZOMBATHY J, 1925, EISZEIT, V2, P73; TATTERSALL I, 1995, LAST NEANDERTHAL RIS; Templeton AR., 1997, CONCEPTUAL ISSUES MO, P329; Willermet C. M., 1997, CONCEPTUAL ISSUES MO; Wolpoff M. H., 1997, RACE HUMAN EVOLUTION; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K	33	149	176	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					293	297		10.1126/science.291.5502.293	http://dx.doi.org/10.1126/science.291.5502.293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209077				2022-12-01	WOS:000166352900042
J	Phillips, DIW; Handelsman, DJ; Eriksson, JG; Forsen, T; Osmond, C; Barker, DJP				Phillips, DIW; Handelsman, DJ; Eriksson, JG; Forsen, T; Osmond, C; Barker, DJP			Prenatal growth and subsequent marital status: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland; ANZAC Res Inst, Sydney, NSW 2006, Australia; Concord Hosp, Dept Androl, Sydney, NSW 2006, Australia	University of Southampton; Finland National Institute for Health & Welfare; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital	Phillips, DIW (corresponding author), Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.		Ekanayake, Kanchana/P-8817-2016; Handelsman, David/AAR-9580-2021; Research Institute, ANZAC/CAE-9030-2022	Handelsman, David/0000-0002-4200-7476; Osmond, Clive/0000-0002-9054-4655	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barker D.J.P., 1998, MOTHERS BABIES HLTH; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019	4	52	52	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2001	322	7289					771	771		10.1136/bmj.322.7289.771	http://dx.doi.org/10.1136/bmj.322.7289.771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419HL	11282863	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000167943200027
J	Stamper, CC; Zhang, Y; Tobin, JF; Erbe, DV; Ikemizu, S; Davis, SJ; Stahl, ML; Seehra, J; Somers, WS; Mosyak, L				Stamper, CC; Zhang, Y; Tobin, JF; Erbe, DV; Ikemizu, S; Davis, SJ; Stahl, ML; Seehra, J; Somers, WS; Mosyak, L			Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses	NATURE			English	Article							MOLECULAR-BASIS; CELL-ADHESION; SOLUBLE FORM; CTLA-4; COSTIMULATION; ACTIVATION; BLOCKADE; RECEPTOR; SYSTEM	Optimal immune responses require both an antigen-specific and a co-stimulatory signal. The shared ligands B7-1 and B7-2 on antigen-presenting cells deliver the co-stimulatory signal through CD28 and CTLA-4 on T cells. Signalling through CD28 augments the T-cell response, whereas CTLA-4 signalling attenuates it. Numerous animal studies(1,2) and recent clinical trials(3,4) indicate that manipulating these interactions holds considerable promise for immunotherapy, With the consequences of these signals well established, and details of the downstream signalling events emerging(5-7), understanding the molecular nature of these extracellular interactions becomes crucial. Here we report the crystal structure of the human CTLA-4/B7-1 co-stimulatory complex at 3.0 Angstrom resolution. In contrast to other interacting cell-surface molecules, the relatively small CTLA-4/B7-1 binding interface exhibits an unusually high degree of shape complementarity. CTLA-4 forms homodimers through a newly defined interface of highly conserved residues. In the crystal lattice, CTLA-4 and B7-1 pack in a strikingly periodic arrangement in which bivalent CTLA-4 homodimers bridge bivalent B7-1 homodimers. This zipper-like oligomerization provides the structural basis for forming unusually stable signalling complexes at the T-cell surface, underscoring the importance of potent inhibitory signalling in human immune responses.	Wyeth Ayerst Res, Dept Biol Chem, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Dept Musculoskeletal Sci, Cambridge, MA 02140 USA; Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Pfizer; Pfizer; University of Oxford; University of Oxford	Somers, WS (corresponding author), Wyeth Ayerst Res, Dept Biol Chem, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	wsomers@genetics.com; lmosyak@genetics.com						Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Bachmann MF, 1999, J IMMUNOL, V163, P1128; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Guinan EC, 1999, NEW ENGL J MED, V340, P1704, DOI 10.1056/NEJM199906033402202; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4	30	331	412	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					608	611		10.1038/35069118	http://dx.doi.org/10.1038/35069118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279502				2022-12-01	WOS:000167859300054
J	Chow, DC; He, XL; Snow, AL; Rose-John, S; Garcia, KC				Chow, DC; He, XL; Snow, AL; Rose-John, S; Garcia, KC			Structure of an extracellular gp130 cytokine receptor signaling complex	SCIENCE			English	Article							CRYSTAL-STRUCTURE; 2 DISTINCT; INTERLEUKIN-6; BINDING; IL-6; PROGRAM; REGION; RECOGNITION; TRANSDUCER; ACTIVATION	The activation of gp130, a shared signal-transducing receptor for a family of cytokines, is initiated by recognition of Ligand followed by oligomerization into a higher order signaling complex. Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (IL-6) that activates human gp130. In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation. Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine Largely uses hydrophobic amino acids to contact gp 130, which enhances the complementarity of the viral IL-6-gp130 binding interfaces. The cross-reactivity of gp130 is apparently due to a chemical plasticity evident in the amphipathic gp130 cytokine-binding sites.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; Univ Kiel, Dept Biochem, D-24098 Kiel, Germany	Stanford University; Stanford University; University of Kiel	Garcia, KC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Fairchild D319,299 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279; Snow, Andrew/0000-0002-8728-6691	NIAID NIH HHS [R01-AI-48540-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHOW DC, UNPUB; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Grotzinger J, 1997, PROTEINS, V27, P96; Hammacher A, 1998, J BIOL CHEM, V273, P22701, DOI 10.1074/jbc.273.35.22701; Hammacher A, 2000, BIOCHEM J, V345, P25, DOI 10.1042/0264-6021:3450025; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hoischen SH, 2000, EUR J BIOCHEM, V267, P3604, DOI 10.1046/j.1432-1327.2000.01389.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsten U, 1997, J BIOL CHEM, V272, P23748, DOI 10.1074/jbc.272.38.23748; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; INOUE M, 1995, P NATL ACAD SCI USA, V92, P8579, DOI 10.1073/pnas.92.19.8579; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; Kurth I, 1999, J IMMUNOL, V162, P1480; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Moritz RL, 1999, GROWTH FACTORS, V16, P265, DOI 10.3109/08977199909069145; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ward LD, 1995, ANN NY ACAD SCI, V762, P471; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Wilson IA, 1999, CURR OPIN STRUC BIOL, V9, P696, DOI 10.1016/S0959-440X(99)00032-9	53	207	225	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2001	291	5511					2150	2155		10.1126/science.1058308	http://dx.doi.org/10.1126/science.1058308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251120				2022-12-01	WOS:000167563800040
J	Kleiman, FE; Manley, JL				Kleiman, FE; Manley, JL			The BARD1-CstF-50 interaction links mRNA 3 ' end formation to DNA damage and tumor suppression	CELL			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; B-CELL DIFFERENTIATION; POLYADENYLATION FACTOR; POLY(A) POLYMERASE; INDUCED UBIQUITINATION; TERMINAL DOMAIN; LARGE SUBUNIT; IN-VIVO; BRCA1	The mRNA polyadenylation factor CstF interacts with the BRCA1-associated protein BARD1, and this interaction represses the nuclear mRNA polyadenylation machinery in vitro. Given the suspected role of BRCA1/BARD1 in DNA repair, we tested whether inhibition of mRNA processing is linked to DNA damage. Strikingly, we found that 3' cleavage in extracts from cells treated with hydroxyurea or ultraviolet light was strongly, but transiently, inhibited. Although no changes were detected in CstF, BARD1, and BRCA1 protein levels, increased amounts of a CstF/BARD1/BRCA1 complex were detected. Supporting the physiological significance of these results, a previously identified tumor-associated germline mutation in BARD1 (Gln564His) reduced binding to CstF and abrogated inhibition of polyadenylation. Together these results indicate a link between mRNA 3' processing and DNA repair and tumor suppression.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu		Manley, James/0000-0002-8341-1459	NIGMS NIH HHS [GM28983] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028983] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Ayi TC, 1998, ONCOGENE, V17, P2143, DOI 10.1038/sj.onc.1202123; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen Z, 2000, MOL CELL BIOL, V20, P5064, DOI 10.1128/MCB.20.14.5064-5076.2000; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 2000, GENE DEV, V14, P1415; Irminger-Finger I, 1998, J CELL BIOL, V143, P1329, DOI 10.1083/jcb.143.5.1329; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kumar A, 1995, LEUKEMIA RES, V19, P831, DOI 10.1016/0145-2126(95)00063-1; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Ljungman M, 1999, CARCINOGENESIS, V20, P395, DOI 10.1093/carcin/20.3.395; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Schwartz E, 1998, BIOCHEM BIOPH RES CO, V246, P217, DOI 10.1006/bbrc.1998.8601; Scorilas A, 1998, J EXP CLIN CANC RES, V17, P511; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; TAKAGAKI Y, 1992, J BIOL CHEM, V267, P23471; TAKAGAKI Y, 1994, NATURE, V372, P471, DOI 10.1038/372471a0; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010	53	167	173	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					743	753		10.1016/S0092-8674(01)00270-7	http://dx.doi.org/10.1016/S0092-8674(01)00270-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257228	Bronze			2022-12-01	WOS:000167531100014
J	Wierenga, KJJ; Hambleton, IR; Lewis, NA				Wierenga, KJJ; Hambleton, IR; Lewis, NA			Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study	LANCET			English	Article							NATURAL-HISTORY; CHILDREN; COHORT; MORTALITY; MANAGEMENT; DIAGNOSIS; LESSONS; ANEMIA; TRIAL; DEATH	Background Information about life expectancy of patients with homozygous sickle-cell disease is needed for research and patient counselling. Our aim was to study two Jamaican populations, one clinic-based and one birth cohort and, by careful consideration of data quality and statistical analysis, to identify ways to increase the chances of obtaining valid and generalisable results. Methods We investigated the survival experience of 3301 patients with homozygous sickle-cell disease attending the Jamaican sickle-cell clinic between Jan 1, 1987, and Dec 31, 1996. We applied and assessed a simulation technique for incorporating early life mortality using a birth cohort, and analysed the precision of this technique. Kaplan-Meier survival estimates are produced. Findings 290 of the 3301 patients died. Median survival calculated with the excess mortality rate simulation data was 53 years (95% CI 49.3-57.0) for men and 58.5 (55.1-67.5) for women. Interpretation Our simulation technique, with realistic assumptions based on empirical evidence, offers a new estimate of median survival for patients with homozygous sickle-cell disease. We present the precision of these survival estimates, which introduces an important level of uncertainty. The inherent biases of clinically ascertained populations of patients, and the assumptions underlying analysis techniques are crucial features of survival studies in sickle-cell disease, and can modify summary statistics substantially.	Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton, Hants, England	University West Indies Mona Jamaica; University of Southampton	Wierenga, KJJ (corresponding author), Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica.		Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794				Bowman A. W., 1997, APPL SMOOTHING TECHN; BROOKMEYER R, 1987, BIOMETRICS, V43, P739, DOI 10.2307/2531529; CNAAN A, 1989, STAT MED, V8, P1255, DOI 10.1002/sim.4780081009; Corey M, 1996, PEDIATR PULM, V21, P149, DOI 10.1002/1099-0496(199603)21:3<149::AID-PPUL1950210302>3.0.CO;2-C; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Hendriks JCM, 1998, AIDS, V12, P1537, DOI 10.1097/00002030-199812000-00017; HOOVER DR, 1991, STAT MED, V10, P1993, DOI 10.1002/sim.4780101212; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; LEIKIN SL, 1989, PEDIATRICS, V84, P500; Magnus SA, 1999, ARCH DIS CHILD, V80, P537, DOI 10.1136/adc.80.6.537; METTERS J S, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P935; MORGAN AG, 1981, BMJ-BRIT MED J, V282, P1181, DOI 10.1136/bmj.282.6271.1181; MORRIS J, 1991, BRIT J HAEMATOL, V77, P382, DOI 10.1111/j.1365-2141.1991.tb08588.x; *PAN AM HLTH ORG, 1994, SCI PUBL PAN AM HLTH, V549; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1989, PEDIATRICS, V83, P830; ROGERS DW, 1978, BRIT MED J, V1, P1515, DOI 10.1136/bmj.1.6126.1515; SERJEANT BE, 1974, CLIN CHEM, V20, P666; SERJEANT GR, 1981, BRIT J HAEMATOL, V48, P533, DOI 10.1111/j.1365-2141.1981.tb02750.x; SERJEANT GR, 1993, BLOOD REV, V7, P137, DOI 10.1016/0268-960X(93)90001-K; SERJEANT GR, 1986, BRIT J HAEMATOL, V64, P253, DOI 10.1111/j.1365-2141.1986.tb04117.x; SERJEANT GR, 1984, T ROY SOC TROP MED H, V78, P648, DOI 10.1016/0035-9203(84)90229-3; SERJEANT GR, 1968, BMJ-BRIT MED J, V3, P86, DOI 10.1136/bmj.3.5610.86; Serjeant GR., 1992, SICKLE CELL DIS; SIMON R, 1980, AM J EPIDEMIOL, V111, P444, DOI 10.1093/oxfordjournals.aje.a112920; Tsodikov A, 1998, STAT MED, V17, P1909, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1909::AID-SIM890>3.0.CO;2-0; VICHINSKY E, 1988, PEDIATRICS, V81, P749	31	127	133	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2001	357	9257					680	683		10.1016/S0140-6736(00)04132-5	http://dx.doi.org/10.1016/S0140-6736(00)04132-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407QN	11247552				2022-12-01	WOS:000167282400013
J	Devlin, RH; Biagi, CA; Yesaki, TY; Smailus, DE; Byatt, JC				Devlin, RH; Biagi, CA; Yesaki, TY; Smailus, DE; Byatt, JC			Growth of domesticated transgenic fish - A growth-hormone transgene boosts the size of wild but not domesticated trout.	NATURE			English	Article							ONCORHYNCHUS-KISUTCH; GENE CONSTRUCT; SALMON; ENHANCEMENT; SELECTION; RELEASE		Fisheries & Oceans Canada, W Vancouver, BC V7V 1N6, Canada; Monsanto Corp, St Louis, MO 63198 USA	Fisheries & Oceans Canada; Monsanto	Devlin, RH (corresponding author), Fisheries & Oceans Canada, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada.		Biagi, Carlo/AAN-2030-2020	Biagi, Carlo/0000-0002-6345-9674				Devlin RH, 1995, AQUACULTURE, V137, P161, DOI 10.1016/0044-8486(95)01090-4; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 1997, TRANSGENIC ANIMALS G, P105; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Eisen EJ, 1995, J ANIM BREED GENET, V112, P401, DOI 10.1111/j.1439-0388.1995.tb00579.x; HERSHBERGER WK, 1990, AQUACULTURE, V85, P1; McLean E, 1997, AQUACULTURE, V156, P113, DOI 10.1016/S0044-8486(97)00071-9; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; PURSEL VG, 1989, SCIENCE, V244, P1281, DOI 10.1126/science.2499927; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299	10	164	178	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					781	782		10.1038/35057314	http://dx.doi.org/10.1038/35057314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236982				2022-12-01	WOS:000166938800026
J	Hedges, JI; Baldock, JA; Gelinas, Y; Lee, C; Peterson, M; Wakeham, SG				Hedges, JI; Baldock, JA; Gelinas, Y; Lee, C; Peterson, M; Wakeham, SG			Evidence for non-selective preservation of organic matter in sinking marine particles	NATURE			English	Article							CHEMICAL-COMPOSITION; AMINO-ACIDS; FLUX; SOILS; C-13	The sinking of particulate organic matter from ocean surface waters transports carbon to the ocean interior(1,2), where almost all is then recycled. The unrecycled fraction of this organic matter can become buried in ocean sediments, thus sequestering carbon and so influencing atmospheric carbon dioxide concentrations(3). The processes controlling the extensive biodegradation of sinking particles remain unclear, partly because of the difficulty in resolving the composition of the residual organic matter at depth with existing chromatographic techniques(4). Here, using solid-state C-13 NMR spectroscopy(5), we characterize the chemical structure of organic carbon in both surface plankton and sinking particulate matter from the Pacific Ocean(4) and the Arabian Sea(6). We found that minimal changes occur in bulk organic composition, despite extensive (>98%) biodegradation, and that aminoacid-like material predominates throughout the water column in both regions. The compositional similarity between phytoplankton biomass and the small remnant of organic matter reaching the ocean interior indicates that the formation of unusual biochemicals, either by chemical recombination(7) or microbial biosynthesis(8), is not the main process controlling the preservation of particulate organic carbon within the water column at these two sites. We suggest instead that organic matter might be protected from degradation by the inorganic matrix of sinking particles.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; CSIRO Land & Water, Glen Osmond, SA 5064, Australia; SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Skidaway Inst Oceanog, Savannah, GA 31411 USA	University of Washington; University of Washington Seattle; Commonwealth Scientific & Industrial Research Organisation (CSIRO); State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Hedges, JI (corresponding author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.	jihedges@u.washington.edu	Lee, Cindy/B-1456-2009; Gélinas, Yves/K-4019-2013; Baldock, Jeffrey A/G-1362-2010	Lee, Cindy/0000-0002-7608-6213; Gélinas, Yves/0000-0001-5751-8378; Baldock, Jeffrey A/0000-0002-6428-8555				ANDERSON LA, 1995, DEEP-SEA RES, V38, P143; ARMSTRONG RA, IN PRESS DEEP SEA RE; Baldock J., 2000, HDB SOIL SCI, pB25, DOI DOI 10.1038/194324B0; BISHOP JKB, 1977, DEEP-SEA RES, V24, P511, DOI 10.1016/0146-6291(77)90526-4; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Broecker W., 1982, TRACERS SEA; COWIE GL, 1992, LIMNOL OCEANOGR, V37, P703, DOI 10.4319/lo.1992.37.4.0703; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges J. I., 1988, Humic substances and their role in the environment., P45; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; HERNES PJ, IN PRESS DEEP SEA RE; Honjo S, 1999, DEEP-SEA RES PT II, V46, P1859, DOI 10.1016/S0967-0645(99)00047-8; ITTEKKOT V, 1992, GEOL SOC SPEC PUBL, V64, P167, DOI DOI 10.1144/GSL.SP.1992.064.01.11; KINCHESH P, 1995, EUR J SOIL SCI, V46, P125, DOI 10.1111/j.1365-2389.1995.tb01819.x; Knicker H, 1996, ORG GEOCHEM, V24, P661, DOI 10.1016/0146-6380(96)00057-5; Largeau C, 1993, ORGANIC GEOCHEMISTRY, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lee C, 1998, DEEP-SEA RES PT II, V45, P2489, DOI 10.1016/S0967-0645(98)00079-4; Lee C, 2000, DEEP-SEA RES PT I, V47, P1535, DOI 10.1016/S0967-0637(99)00116-8; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; MURRAY JW, 1994, SCIENCE, V266, P58, DOI 10.1126/science.266.5182.58; Nelson PN, 1999, AUST J SOIL RES, V37, P289, DOI 10.1071/S98076; PARSONS TR, 1961, J FISH RES BOARD CAN, V18, P1001, DOI 10.1139/f61-063; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Smith SL, 1998, DEEP-SEA RES PT II, V45, P1905, DOI 10.1016/S0967-0645(98)00058-7; STEVENSON F. J, 1994, HUMUS CHEM; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Wilson M. A., 1987, NMR TECHNIQUES APPL	31	263	270	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					801	804		10.1038/35057247	http://dx.doi.org/10.1038/35057247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236989				2022-12-01	WOS:000166938800035
J	Le Van Quyen, M; Martinerie, J; Navarro, V; Boon, P; D'Have, M; Adam, C; Renault, B; Varela, F; Baulac, M				Le Van Quyen, M; Martinerie, J; Navarro, V; Boon, P; D'Have, M; Adam, C; Renault, B; Varela, F; Baulac, M			Anticipation of epileptic seizures from standard EEG recordings	LANCET			English	Article							CEREBRAL-BLOOD-FLOW; REAL-TIME; SIMILARITY; PREDICTION; CHAOS	Background New methods derived from non-linear analysis of intracranial recordings permit the anticipation of an epileptic seizure several minutes before the seizure. Nevertheless, anticipation of seizures based on standard scalp electroencephalographical (EEG) signals has not been reported yet. The accessibility to preictal changes from standard EEGs is essential for expanding the clinical applicability of these methods. Methods We analysed 26 scalp-EEG/video recordings, from 60 min before a seizure, in 23 patients with temporal-lobe epilepsy. For five patients, simultaneous scalp and intracranial EEG recordings were assessed. Long-term changes before seizure onset were identified by a measure of non-linear similarity, which is very robust in spite of large artifacts and runs in real-time. Findings In 25 of 26 recordings, measurement of non-linear changes in EEG signals allowed the anticipation of a seizure several minutes before it occurred (mean 7 min). These preictal changes in the scalp EEG correspond well with concurrent changes in depth recordings. Interpretation Scalp-EEG recordings retain sufficient dynamical information which can be used for the analysis of preictal changes leading to seizures. Seizure anticipation strategies in real-time can now be envisaged for diverse clinical applications, such as devices for patient warning, for efficacy of ictal-single photon emission computed tomography procedures, and eventual treatment interventions for preventing seizures.	Hop La Pitie Salpetriere, Lab Neurosci Cognit & Imagerie Cerebrale, F-75651 Paris 13, France; Hop La Pitie Salpetriere, CNRS, UPR 640, Unite Epileptol, F-75651 Paris 13, France; Univ Ghent, Dept Neurol, Epilepsy Monitoring Unit, B-9000 Ghent, Belgium; Univ Ghent, Clin Neurophysiol Lab, B-9000 Ghent, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Ghent University; Ghent University	Varela, F (corresponding author), Hop La Pitie Salpetriere, Lab Neurosci Cognit & Imagerie Cerebrale, F-75651 Paris 13, France.	fv@ccr.jussieu.fr	Navarro, Vincent/G-1534-2013	Navarro, Vincent/0000-0003-0077-8114; Boon, Paul/0000-0002-4180-8896				Akinbi MS, 1999, ANN PHARMACOTHER, V33, P99, DOI 10.1345/aph.17306; ALARCON G, 1994, J NEUROL NEUROSUR PS, V57, P233; [Anonymous], 1989, SEIZURE EPILEPSY; Baumgartner C, 1998, J NUCL MED, V39, P978; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Kantz H., 2003, NONLINEAR TIME SERIE; KATZ A, 1991, ELECTROEN CLIN NEURO, V79, P153, DOI 10.1016/0013-4694(91)90054-8; Le van Quyen M, 1999, PHYSICA D, V127, P250; Le Van Quyen M, 2000, EUR J NEUROSCI, V12, P2124, DOI 10.1046/j.1460-9568.2000.00088.x; Le Van Quyen M, 1999, NEUROREPORT, V10, P2149; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Manuca R, 1996, PHYSICA D, V99, P134, DOI 10.1016/S0167-2789(96)00139-X; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Osorio I, 1998, EPILEPSIA, V39, P615, DOI 10.1111/j.1528-1157.1998.tb01430.x; QUESNEY LF, 1987, SURGICAL TREATMENT E, P129; ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9, DOI 10.1007/BF00335153; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Schreiber T, 1997, PHYS REV LETT, V79, P1475, DOI 10.1103/PhysRevLett.79.1475; Schreiber T, 1996, PREDICTABILITY COMPL; Spencer SS, 1998, EPILEPSIA, V39, P114, DOI 10.1111/j.1528-1157.1998.tb01349.x; TAKEN F, 1981, LECT NOTES MATH DYNA; Theiler J, 1996, ELECTROEN CLIN NEURO, V98, P213, DOI 10.1016/0013-4694(95)00240-5; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226	27	243	248	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					183	188		10.1016/S0140-6736(00)03591-1	http://dx.doi.org/10.1016/S0140-6736(00)03591-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213095				2022-12-01	WOS:000166593700011
J	Nicolelis, MAL				Nicolelis, MAL			Actions from thoughts	NATURE			English	Article							MOTOR CORTEX; STIMULATION; PLASTICITY; SEIZURES; NEURONS	Real-time direct interfaces between the brain and electronic and mechanical devices could one day be used to restore sensory and motor functions lost through injury or disease. Hybrid brain-machine interfaces also have the potential to enhance our perceptual, motor and cognitive capabilities by revolutionizing the way we use computers and interact with remote environments.	Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Dept Expt Psychol, Durham, NC 27710 USA; Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Nicolelis, MAL (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu						BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHAPIN KJ, 2000, NEURLA PROSTHESES RE; Fanselow EE, 2000, J NEUROSCI, V20, P8160; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; MEAD C, 1989, ANAL VLSI NEURAL SYS; MERZENICH MM, 1974, LARYNGOSCOPE, V84, P1887, DOI 10.1002/lary.5540841105; MOXON KA, 2000, NEURAL PROSTHESES RE; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; Pfingst BE, 2001, METH NE FRO NEUROSCI, P3; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; SCHMIDT EM, 1980, ANN BIOMED ENG, V8, P339, DOI 10.1007/BF02363437; Schutz S, 1999, NATURE, V398, P298, DOI 10.1038/18585; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; SRINIVASAN MA, 1994, VIRTUAL REALITY SCI, P161; UTHMAN BM, 1990, EPILEPSIA, V31, pS44, DOI 10.1111/j.1528-1157.1990.tb05849.x; Webber WRS, 1996, ELECTROEN CLIN NEURO, V98, P250, DOI 10.1016/0013-4694(95)00277-4; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wu CWH, 1999, J NEUROSCI, V19, P7679, DOI 10.1523/JNEUROSCI.19-17-07679.1999; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x	30	454	480	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					403	407		10.1038/35053191	http://dx.doi.org/10.1038/35053191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201755	Bronze			2022-12-01	WOS:000166434300063
J	Pfeiffer, T; Schuster, S; Bonhoeffer, S				Pfeiffer, T; Schuster, S; Bonhoeffer, S			Cooperation and competition in the evolution of ATP-producing pathways	SCIENCE			English	Article							MECHANISTIC STOICHIOMETRY; DIMORPHISM; METABOLISM; GLUCOSE; EFFICIENCY; GROWTH; ORIGIN	Heterotrophic organisms generally face a trade-off between rate and yield of adenosine triphosphate (ATP) production. This trade-off may result in an evolutionary dilemma, because cells with a higher rate but lower yield of ATP production may gain a selective advantage when competing for shared energy resources. Using an analysis of model simulations and biochemical observations, we show that ATP production with a low rate and high yield can be viewed as a form of cooperative resource use and may evolve in spatially structured environments. Furthermore, we argue that the high ATP yield of respiration may have facilitated the evolutionary transition from unicellular to undifferentiated multicellular organisms.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Friedrich Miescher Institute for Biomedical Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bonhoeffer, S (corresponding author), Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland.	bonhoeffer@eco.umnw.ethz.ch	Pfeiffer, Thomas/R-1339-2019; Bonhoeffer, Sebastian/A-2735-2008	Pfeiffer, Thomas/0000-0002-0592-577X; Bonhoeffer, Sebastian/0000-0001-8052-3925				ANGULOBROWN F, 1995, NUOVO CIMENTO D, V17, P87, DOI 10.1007/BF02451604; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; BEAVIS AD, 1986, EUR J BIOCHEM, V158, P315, DOI 10.1111/j.1432-1033.1986.tb09753.x; Bonner John Tyler, 1998, Integrative Biology, V1, P27; CALHOUN MW, 1993, J BACTERIOL, V175, P3020, DOI 10.1128/JB.175.10.3020-3025.1993; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DICKERSON RE, 1980, SCI AM, V242, P137; Fiechter A, 1989, Adv Biochem Eng Biotechnol, V39, P1; FITTON V, 1994, BIOCHEMISTRY-US, V33, P9692, DOI 10.1021/bi00198a039; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heinrich R., 1996, REGULATION CELLULAR; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; INDERLIED CB, 1978, J BACTERIOL, V133, P1282, DOI 10.1128/JB.133.3.1282-1286.1978; Lee CP, 1996, FASEB J, V10, P345, DOI 10.1096/fasebj.10.2.8641569; MAC ARTHUR ROBERT H., 1967; Margulis L., 1993, SYMBIOSIS CELL EVOLU; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; NEIJSSEL OM, 1994, MOL MICROBIOL, V13, P179, DOI 10.1111/j.1365-2958.1994.tb00413.x; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Press W. H., 1992, NUMERICAL RECIPES; ROFF D, 1992, EVOLUTION LIF HIST; ROGERS PJ, 1974, J BACTERIOL, V119, P282, DOI 10.1128/JB.119.1.282-293.1974; SCHULZ BE, 1974, J GEN MICROBIOL, V82, P1; Stearns S.C., 1992, pi; STUCKI JW, 1980, EUR J BIOCHEM, V109, P269, DOI 10.1111/j.1432-1033.1980.tb04792.x; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; Voet D., 2004, BIOCHEMISTRY-US; Waddell TG, 1999, BIOCHEM EDUC, V27, P12, DOI 10.1016/S0307-4412(98)00266-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	34	849	868	2	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					504	507		10.1126/science.1058079	http://dx.doi.org/10.1126/science.1058079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11283355				2022-12-01	WOS:000168187300047
J	Feenstra, H; Grobbee, RE; in't Veld, BA; Stricker, BHC				Feenstra, H; Grobbee, RE; in't Veld, BA; Stricker, BHC			Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine	ANNALS OF INTERNAL MEDICINE			English	Article								Background: outcomes may differ in treated and untreated patients because of a contraindication for treatment in the latter that is independently associated with the outcome of interest. Objective: To evaluate the effects of confounding by contraindication on risk factors for death in patients taking ibopamine after its use was restricted in early September 1995. Design: Retrospective cohort study, Setting: The Netherlands, Patients: 1146 patients with congestive heart failure who were prescribed ibopamine at least once and for whom medication history and medical data were available, Measurements: Cardiovascular risk factors, clinical characteristics, and medication use. Each patient was assigned an index date (the date of death, or a random date for patients still alive at the end of the study). Results: In univariate analyses comparing patients with an index date before and those with an index date after 8 September 1995, the relative risk for death associated with current use of ibopamine was 3.02 (95% CI, 2.12 to 4.30) compared with 0.71 (CI, 0.53 to 0.96), respectively. In multivariate analyses, the risk for death was 2.62 (CI, 1.76 to 3.90) and 0.93 (CI, 0.84 to 1.02), respectively. Conclusion: The marked inversion of the relative risk estimate can be considered a practical example of confounding by contraindication.	Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Inspectorate Hlth Care, Rijswijk, Netherlands; Univ Utrecht, Sch Med, Julius Ctr Patient Oriented Res, Utrecht, Netherlands	Erasmus University Rotterdam; Utrecht University	Stricker, BHC (corresponding author), Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, Box 1738, NL-3000 DR Rotterdam, Netherlands.							DATTA M, 1993, LANCET, V342, P345, DOI 10.1016/0140-6736(93)91478-5; Feenstra J, 1998, BRIT J CLIN PHARMACO, V46, P71, DOI 10.1046/j.1365-2125.1998.00046.x; Grobbee DE, 1997, BRIT MED J, V315, P1151; Hampton JR, 1997, LANCET, V349, P971, DOI 10.1016/S0140-6736(96)10488-8; Sjahid SI, 1998, BRIT J CLIN PHARMACO, V45, P591, DOI 10.1046/j.1365-2125.1998.00716.x; Walker AM, 1996, LANCET, V348, P489, DOI 10.1016/S0140-6736(05)64664-8; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8; 1995, NED TIJDSCHR GENEESK, V139, P2059	8	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2001	134	7					569	572		10.7326/0003-4819-134-7-200104030-00010	http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419CF	11281739				2022-12-01	WOS:000167931200004
J	Yin, L; Wu, L; Wesche, H; Arthur, CD; White, JM; Goeddel, DV; Schreiber, RD				Yin, L; Wu, L; Wesche, H; Arthur, CD; White, JM; Goeddel, DV; Schreiber, RD			Defective lymphotoxin-beta receptor-induced NF-kappa B transcriptional activity in NIK-deficient mice	SCIENCE			English	Article							KINASE COMPLEX; LIVER DEGENERATION; IKK-BETA; ACTIVATION; ALPHA; GENE; ALYMPHOPLASIA; INDUCTION; PROTEINS; MUTATION	The role of NF-kappaB-inducing kinase (NIK) in cytokine signaling remains controversial To identify the physiologic functions of NIK, we disrupted the NIK locus by gene targeting. Although NIK-/- mice displayed abnormalities in both lymphoid tissue development and antibody responses, NIK-/- cells manifested normal NF-kappaB DNA binding activity when treated with a variety of cytokines, including tumor necrosis factor (TNF), interleukin-1 (IL-1), and lymphotoxin-beta (LT beta). However, NIK was selectively required for gene transcription induced through ligation of LT beta receptor but not TNF receptors. These results reveal that NIK regulates the transcriptional activity of NF-kappaB in a receptor-restricted manner.	Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA; Tularik Inc, S San Francisco, CA 94080 USA	Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA.		Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; White, James Michael/0000-0001-5110-6567; Schreiber, Robert/0000-0003-1590-2341				Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Browning JL, 1997, J IMMUNOL, V159, P3288; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	23	336	348	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2162	2165		10.1126/science.1058453	http://dx.doi.org/10.1126/science.1058453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11251123				2022-12-01	WOS:000167563800043
J	Cabrillac, D; Cock, JM; Dumas, C; Gaude, T				Cabrillac, D; Cock, JM; Dumas, C; Gaude, T			The S-locus receptor kinase is inhibited by thioredoxins and activated by pollen coat proteins	NATURE			English	Article							SELF-INCOMPATIBILITY; BRASSICA-OLERACEA; MALE DETERMINANT; DOMAIN; GLYCOPROTEINS; DIMERIZATION; ENVIRONMENT; STIGMA; GENE	The self-incompatibility response in Brassica allows recognition and rejection of self-pollen by the stigmatic papillae. The transmembrane S-locus receptor kinase (SRK), a member of the receptor-like kinase superfamily in plants, mediates recognition of self-pollen on the female side(1), whereas the S-locus cysteine-rich protein (SCR) is the male component of the self-incompatibility response(2). SCR is presumably located in the pollen coat, and is thought to be the SRK ligand(2,3). Although many receptorlike kinases have been isolated in plants, the mechanisms of signal transduction mediated by these molecules remain largely unknown. Here we show that SRK is phosphorylated in vivo within one hour of self-pollination. We also show that, in vitro, autophosphorylation of SRK is prevented by the stigma thioredoxin THL1 in the absence of a ligand. This inhibition is released in a haplotype-specific manner by the addition of pollen coat proteins. Our data indicate that SRK is inhibited by thioredoxins and activated by pollen coat proteins.	UCBL, Ecole Normale Super Lyon, INRA, CNRS,UMR 5667, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Gaude, T (corresponding author), UCBL, Ecole Normale Super Lyon, INRA, CNRS,UMR 5667, 46 Allee Italie, F-69364 Lyon 07, France.			GAUDE, Thierry/0000-0002-0804-9445; Cock, J. Mark/0000-0002-2650-0383				Bower MS, 1996, PLANT CELL, V8, P1641, DOI 10.1105/tpc.8.9.1641; DELORME A, 1995, STUD PERCEPT ACTION, V3, P7; DICKINSON H, 1995, SEX PLANT REPROD, V8, P1, DOI 10.1007/BF00228756; DOUGHTY J, 1993, P NATL ACAD SCI USA, V90, P467, DOI 10.1073/pnas.90.2.467; FLANNERY AV, 1989, PROTEOLYTIC ENZYMES, P145; GAUDE T, 1993, PLANT CELL, V5, P75, DOI 10.1105/tpc.5.1.75; Giranton JL, 1995, PLANT J, V8, P827, DOI 10.1046/j.1365-313X.1995.8060827.x; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; KANDASAMY MK, 1989, DEV BIOL, V134, P462, DOI 10.1016/0012-1606(89)90119-X; Meyer Y, 1999, TRENDS PLANT SCI, V4, P388, DOI 10.1016/S1360-1385(99)01475-2; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SARKER RH, 1988, P NATL ACAD SCI USA, V85, P4340, DOI 10.1073/pnas.85.12.4340; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628	20	173	217	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					220	223		10.1038/35065626	http://dx.doi.org/10.1038/35065626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242083	Green Submitted			2022-12-01	WOS:000167320500049
J	Champagne, P; Ogg, GS; King, AS; Knabenhans, C; Ellefsen, K; Nobile, M; Appay, V; Rizzardi, GP; Fleury, S; Lipp, M; Forster, R; Rowland-Jones, S; Sekaly, RP; McMichael, AJ; Pantaleo, G				Champagne, P; Ogg, GS; King, AS; Knabenhans, C; Ellefsen, K; Nobile, M; Appay, V; Rizzardi, GP; Fleury, S; Lipp, M; Forster, R; Rowland-Jones, S; Sekaly, RP; McMichael, AJ; Pantaleo, G			Skewed maturation of memory HIV-specific CD8 T lymphocytes	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; EFFECTOR; CELLS; INFECTION; EXPANSION; SUBSETS; USAGE; AIDS	Understanding the lineage differentiation of memory T cells is a central question in immunology. We investigated this issue by analysing the expression of the chemokine receptor CCR7, which defines distinct subsets of naive and memory T lymphocytes with different homing and effector capacities(1-3) and antiviral immune responses to HIV and cytomegalovirus. Ex vivo analysis of the expression of CD45RA and CCR7 antigens, together with in vitro analysis of the cell-division capacity of different memory CD8(+) T-cell populations, identified four subsets of HIV- and CMV-specific CD8(+) T lymphocytes, and indicated the following lineage differentiation pattern: CD45RA(+)CCR7(+) --> CD45RA(-) CCR7(+) --> CD45RA(-) CCR7(-) --> CD45RA(+) CCR7(-). Here we demonstrate through analysis of cell division (predominantly restricted to the CCR7(+) CD8(+) T-cell subsets) that the differentiation of antigen-specific CD8(+) T cells is a two-step process characterized initially by a phase of proliferation largely restricted to the CCR7(+) CD8(+) cell subsets, followed by a phase of functional maturation encompassing the CCR7(-) CD8(+) cell subsets. The distribution of these populations in HIV- and CMV-specific CD8(+) T cells showed that the HIV-specific cell pool was predominantly (70%) composed of pre-terminally differentiated CD45RA(-)CCR7(-) cells, whereas the CMV-specific cell pool consisted mainly (50%) of the terminally differentiated CD45RA(+) CCR7(-) cells. These results demonstrate a skewed maturation of HIV-specific memory CD8(+) T cells during HIV infection.	Univ Lausanne, CHU Vaudois, Dept Med, Div Immunol & Allergy,Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland; Univ Lausanne, CHU Vaudois, Dept Med, Div Infect Dis,Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland; Univ Montreal, Ctr Hosp, Ctr Rech, Immunol Lab, Montreal, PQ H2W 1T8, Canada; McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 2T5, Canada; John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2T5, Canada; Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H2W 1T8, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Montreal; McGill University; University of Oxford; Helmholtz Association; Max Delbruck Center for Molecular Medicine; McGill University; Universite de Montreal	Pantaleo, G (corresponding author), Univ Lausanne, CHU Vaudois, Dept Med, Div Immunol & Allergy,Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland.	Giuseppe.Pantaleo@chuv.hospvd.ch	Appay, Victor/AAM-7701-2021; Appay, Victor/M-4830-2017; Pantaleo, Giuseppe/K-6163-2016; Förster, Reinhold/D-6770-2011; Lipp, Martin/G-2235-2010	Forster, Reinhold/0000-0001-6190-7923; Appay, Victor/0000-0001-5434-3963; Ogg, Graham/0000-0002-3097-045X; Lipp, Martin/0000-0002-0087-2672				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersson J, 1998, AIDS, V12, pF123, DOI 10.1097/00002030-199811000-00004; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Fleury S, 2000, P NATL ACAD SCI USA, V97, P5393, DOI 10.1073/pnas.97.10.5393; Fleury S, 1998, NAT MED, V4, P794, DOI 10.1038/nm0798-794; GERDES J, 1984, J IMMUNOL, V133, P1710; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PANTALEO G, 1990, P NATL ACAD SCI USA, V87, P4818, DOI 10.1073/pnas.87.12.4818; PANTALEO G, 1990, J IMMUNOL, V144, P1696; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.3.CO;2-M; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	26	851	870	0	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					106	111		10.1038/35065118	http://dx.doi.org/10.1038/35065118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242051				2022-12-01	WOS:000167194300052
J	Muller, A; Homey, B; Soto, H; Ge, NF; Catron, D; Buchanan, ME; McClanahan, T; Murphy, E; Yuan, W; Wagner, SN; Barrera, JL; Mohar, A; Verastegui, E; Zlotnik, A				Muller, A; Homey, B; Soto, H; Ge, NF; Catron, D; Buchanan, ME; McClanahan, T; Murphy, E; Yuan, W; Wagner, SN; Barrera, JL; Mohar, A; Verastegui, E; Zlotnik, A			Involvement of chemokine receptors in breast cancer metastasis	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SKIN-ASSOCIATED CHEMOKINE; CELL-DERIVED FACTOR-1; FACTOR-I; FUNCTIONAL-RESPONSE; TUMOR PROGRESSION; STROMAL CELLS; MICE LACKING; CXCR4; EXPRESSION	Breast cancer is characterized by a distinct metastatic pattern involving the regional lymph nodes, bone marrow, lung and liver. Tumour cell migration and metastasis share many similarities with leukocyte trafficking, which is critically regulated by chemokines and their receptors. Here we report that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases. Their respective ligands CXCL12/SDF-1 alpha and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis. In breast cancer cells, signalling through CXCR4 or CCR7 mediates actin polymerization and pseudopodia formation, and subsequently induces chemotactic and invasive responses. In vivo, neutralizing the interactions of CXCL12/CXCR4 significantly impairs metastasis of breast cancer cells to regional lymph nodes and lung. Malignant melanoma, which has a similar metastatic pattern as breast cancer but also a high incidence of skin metastases, shows high expression levels of CCR10 in addition to CXCR4 and CCR7. Our findings indicate that chemokines and their receptors have a critical role in determining the metastatic destination of tumour cells.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; Univ Dusseldorf, Dept Radiat Oncol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Univ Essen, Dept Dermatol, D-45147 Essen, Germany; Inst Nacl Cancerol, Mexico City 14000, DF, Mexico; Natl Autonomous Univ Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Duisburg Essen; Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Zlotnik, A (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, 901 Calif Ave, Palo Alto, CA 94304 USA.		Zlotnik, Albert/C-3791-2011	Wagner, Stephan/0000-0003-4941-7029				Arai J, 2000, EUR J HAEMATOL, V64, P323, DOI 10.1034/j.1600-0609.2000.90147.x; Beahrs OH, 1992, MANUAL STAGING CANC; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BRUCE J, 1970, LANCET, V1, P433; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hedrick JA, 1997, J IMMUNOL, V159, P1589; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; HOLLON SD, 1991, J CONSULT CLIN PSYCH, V59, P88, DOI 10.1037/0022-006X.59.1.88; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; HOWARD TH, 1984, J CELL BIOL, V98, P1265, DOI 10.1083/jcb.98.4.1265; Hromas R, 1997, J IMMUNOL, V159, P2554; HUJANEN ES, 1985, CANCER RES, V45, P3517; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Luboshits G, 1999, CANCER RES, V59, P4681; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mohle R, 2000, BRIT J HAEMATOL, V110, P563, DOI 10.1046/j.1365-2141.2000.02157.x; Mohle R, 1999, LEUKEMIA, V13, P1954, DOI 10.1038/sj.leu.2401602; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NICOLSON GL, 1993, CANCER METAST REV, V12, P325, DOI 10.1007/BF00665961; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; SAIKI I, 1990, CANCER RES, V50, P3631; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; VERSCHUEREN H, 1994, J LEUKOCYTE BIOL, V55, P552, DOI 10.1002/jlb.55.4.552; Vicari AP, 2000, J IMMUNOL, V165, P1992, DOI 10.4049/jimmunol.165.4.1992; Wang JM, 1998, J IMMUNOL METHODS, V220, P1, DOI 10.1016/S0022-1759(98)00128-8; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	39	4143	4586	13	586	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					50	56		10.1038/35065016	http://dx.doi.org/10.1038/35065016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242036				2022-12-01	WOS:000167194300037
J	Shen, YA; Buick, R; Canfield, DE				Shen, YA; Buick, R; Canfield, DE			Isotopic evidence for microbial sulphate reduction in the early Archaean era	NATURE			English	Article							SEDIMENTARY-ROCKS; WARRAWOONA GROUP; SULFUR; AUSTRALIA; SULFATE; CARBON; LIFE; RECORD	Sulphate-reducing microbes affect the modern sulphur cycle, and may be quite ancient(1,2), though when they evolved is uncertain. These organisms produce sulphide while oxidizing organic matter or hydrogen with sulphate(3). At sulphate concentrations greater than 1 mM, the sulphides are isotopically fractionated (depleted in S-34) by 10-40 parts per thousand compared to the sulphate, with fractionations decreasing to near 0 parts per thousand at lower concentrations(2,4-6). The isotope record of sedimentary sulphides shows large fractionations relative to seawater sulphate by 2.7 Gyr ago, indicating microbial sulphate reduction(7). In older rocks, however, much smaller fractionations are of equivocal origin, possibly biogenic but also possibly volcanogenic(2,8-10). Here we report microscopic sulphides in similar to3.47-Gyr-old barites from North Pole, Australia, with maximum fractionations of 21.1 parts per thousand, about a mean of 11.6 parts per thousand, clearly indicating microbial sulphate reduction. Our results extend the geological record of microbial sulphate reduction back more than 750 million years, and represent direct evidence of an early specific metabolic pathway-allowing time calibration of a deep node on the tree of life.	Odense Univ, SDU, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Odense Univ, SDU, Inst Biol, DK-5230 Odense, Denmark; Univ Sydney, Sch Geosci FO5, Sydney, NSW 2006, Australia	University of Southern Denmark; University of Southern Denmark; University of Sydney	Shen, YA (corresponding author), Odense Univ, SDU, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.		Sontag, Philip T/G-3927-2011; Canfield, Don/C-1735-2012; Shen, Yanan/L-3724-2018	Canfield, Don/0000-0001-7602-8366; Shen, Yanan/0000-0001-8343-6763; Buick, Roger/0000-0003-0139-1659				[Anonymous], [No title captured]; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1995, NATURE, V375, P574, DOI 10.1038/375574a0; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CAMERON EM, 1987, ECON GEOL, V82, P1177, DOI 10.2113/gsecongeo.82.5.1177; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; GOODWIN AM, 1976, ECON GEOL, V71, P870, DOI 10.2113/gsecongeo.71.5.870; GROVES DI, 1981, SCI AM, V245, P64, DOI 10.1038/scientificamerican1081-64; HARDIE LA, 1967, AM MINERAL, V52, P171; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Knoll AH, 1999, SCIENCE, V285, P1025, DOI 10.1126/science.285.5430.1025; Knoll Andrew H., 1998, Paleontological Society Papers, V4, P212; LAMBERT IB, 1978, NATURE, V276, P808, DOI 10.1038/276808a0; Nijman W, 1998, PRECAMBRIAN RES, V88, P25, DOI 10.1016/S0301-9268(97)00062-4; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Postgate JR, 1984, SULPHATE REDUCING BA, V2nd; RANKIN AH, 1978, MINERAL MAG, V42, P408, DOI 10.1180/minmag.1978.042.323.16; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; STETTER KO, 1996, EVOLUTION HYDROTHERM, P1; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; WIDDEL F, 1988, BIOL ANAEROBIC MICRO, P496	30	425	453	6	165	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					77	81		10.1038/35065071	http://dx.doi.org/10.1038/35065071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242044				2022-12-01	WOS:000167194300045
J	Emlen, DJ				Emlen, DJ			Costs and the diversification of exaggerated animal structures	SCIENCE			English	Article							HORNED BEETLE; SEXUAL SELECTION; EVOLUTION; COMPETITION; DROSOPHILA; BODY; COLEOPTERA; SPECIATION; CHARACTER; MODELS	Sexual selection can favor production of extravagant ornaments and weapons in the contest for access to the opposite sex. Existing explanations for the diversity of sexually selected structures focus on reproductive benefits conferred by particular ornament or weapon morphologies. Here, I show that costs of weapon production also may drive patterns of weapon evolution. In beetles, production of horns reduces the size of neighboring morphological structures (antennae, eyes, pr wings, depending on the location of the horns), and these tradeoffs reveal unexpected functional associations between ecology and horn morphology. This study illustrates a critical but overlooked role of costs in sexual selection and has implications for understanding the evolution of animal morphology.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Emlen, DJ (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	demlen@selway.umt.edu						Andersson Malte, 1994; [Anonymous], 1982, NESTING BEHAV DUNG B; Arrow, 1951, HORNED BEETLES; BALMFORD A, 1993, NATURE, V361, P628, DOI 10.1038/361628a0; BOUCOMONT A., 1932, ANN SOC ENT FRANCE, V101, P293; Britton JS, 1998, DEVELOPMENT, V125, P2149; D'Orbigny H., 1913, ANN SOC ENTOMOLOGIQU, V82, P1; Darwin C., 1871, DESCENT MAN SELECTIO; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Enrodi S., 1985, DYNASTINAE WORLD; EVANS MR, 1992, ANIM BEHAV, V43, P337, DOI 10.1016/S0003-3472(05)80229-5; Fisher R.A., 1930, GENETICAL THEORY NAT; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Hanski I., 1991, DUNG BEETLE ECOLOGY; Howden H. F., 1963, Proceedings of the United States National Museum, V114, P1; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kawano K, 1997, ANN ENTOMOL SOC AM, V90, P453, DOI 10.1093/aesa/90.4.453; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1135, DOI 10.1098/rspb.1998.0409; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; MADHAVAN K, 1969, BIOL BULL-US, V137, P321, DOI 10.2307/1540104; Matthews E. G, 1972, AUSTR J ZOOLOGY S, V9, P3, DOI DOI 10.1071/AJZS009; McIntyre P, 1998, J COMP PHYSIOL A, V183, P45, DOI 10.1007/s003590050233; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; MOLLER AP, 1989, NATURE, V339, P132; Moller AP, 1997, ANIM BEHAV, V54, P1545, DOI 10.1006/anbe.1997.9998; Moller AP, 1999, J EVOLUTION BIOL, V12, P296; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; Nijhout HF, 1996, AM NAT, V148, P40, DOI 10.1086/285910; OTRONEN M, 1988, ANIM BEHAV, V36, P741, DOI 10.1016/S0003-3472(88)80157-X; Otte D., 1989, SPECIATION ITS CONSE; PALMER TJ, 1978, NATURE, V274, P583, DOI 10.1038/274583a0; RASMUSSEN JL, 1994, J INSECT BEHAV, V7, P67, DOI 10.1007/BF01989828; Saino N, 1996, BEHAV ECOL, V7, P227, DOI 10.1093/beheco/7.2.227; SEHNAL F, 1993, J INSECT PHYSIOL, V39, P1051, DOI 10.1016/0022-1910(93)90129-F; Stern DL, 1999, DEVELOPMENT, V126, P1091; Stevens DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1049, DOI 10.1098/rspb.1999.0742; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WU CI, 1985, EVOLUTION, V39, P66, DOI 10.1111/j.1558-5646.1985.tb04080.x	41	263	272	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1534	1536		10.1126/science.1056607	http://dx.doi.org/10.1126/science.1056607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222856				2022-12-01	WOS:000167153400041
J	Myung, KJ; Datta, A; Kolodner, RD				Myung, KJ; Datta, A; Kolodner, RD			Suppression of spontaneous chromosomal rearrangements by S phase checkpoint functions in Saccharomyces cerevisiae	CELL			English	Article							STRAND BREAK REPAIR; COMPARATIVE GENOMIC HYBRIDIZATION; DNA-DAMAGE CHECKPOINTS; CELL-CYCLE CHECKPOINT; ATAXIA-TELANGIECTASIA; TELOMERE LENGTH; PROTEIN-KINASE; BUDDING YEAST; REPLICATION; GENE	Cancer cells show increased genome rearrangements, although it is unclear what defects cause these rearrangements. Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect. The rearrangements were primarily deletion of a portion of a chromosome arm along with TEL1-dependent addition of a new telomere. tell mutations increased the proportion of translocations observed, and in some cases showed synergistic interactions when combined with mutations that increased the genome rearrangement rate. These data suggest that one role of S phase checkpoint functions in normal cells is to suppress spontaneous genome rearrangements resulting from DNA replication errors.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu			NIGMS NIH HHS [GM26017] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026017, R37GM026017] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Brown EJ, 2000, GENE DEV, V14, P397; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen C, 1999, MOL CELL BIOL, V19, P7801; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clarke DJ, 1999, CURR BIOL, V9, P365, DOI 10.1016/S0960-9822(99)80163-8; Coleman WB, 1999, ANTICANCER RES, V19, P4645; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fried LM, 1996, P NATL ACAD SCI USA, V93, P13825, DOI 10.1073/pnas.93.24.13825; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Gretarsdottir S, 1998, CANCER RES, V58, P859; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Hermsen MAJA, 1996, HUM PATHOL, V27, P342, DOI 10.1016/S0046-8177(96)90106-9; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; KATO R, 1994, NUCLEIC ACIDS RES, V22, P3104, DOI 10.1093/nar/22.15.3104; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Kohno T, 1996, DNA Res, V3, P421, DOI 10.1093/dnares/3.6.421; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Lavin LF, 1999, INT J RADIAT BIOL, V75, P1201; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li GM, 1999, ONCOL RES, V11, P393; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu Y, 2000, MOL GEN GENET, V262, P1132, DOI 10.1007/PL00008656; LOEB LA, 1991, CANCER RES, V51, P3075; Longhese MP, 1996, MOL CELL BIOL, V16, P3235; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Paciotti V, 2000, GENE DEV, V14, P2046; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; PONDER BAJ, 1995, GENETICS CANC 2 LOOK; Ritchie KB, 2000, GENETICS, V155, P475; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sharan SK, 1998, J MAMMARY GLAND BIOL, V3, P413, DOI 10.1023/A:1018788132560; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; SUN Z, 1996, GENE DEV, V10, P295; Taylor SS, 1999, CURR BIOL, V9, pR562, DOI 10.1016/S0960-9822(99)80355-8; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vessey CJ, 2000, PROG NUCLEIC ACID RE, V63, P189, DOI 10.1016/S0079-6603(08)60723-0; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; WANG YC, 1995, MOL CELL BIOL, V15, P6838; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; ZHANG JG, 1995, BRIT J HAEMATOL, V90, P138, DOI 10.1111/j.1365-2141.1995.tb03392.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	100	266	269	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					397	408		10.1016/S0092-8674(01)00227-6	http://dx.doi.org/10.1016/S0092-8674(01)00227-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239397	Bronze			2022-12-01	WOS:000167003100010
J	Preston, BT; Stevenson, IR; Pemberton, JM; Wilson, K				Preston, BT; Stevenson, IR; Pemberton, JM; Wilson, K			Dominant rams lose out by sperm depletion - A waning success in siring counters a ram's high score in competition for ewes.	NATURE			English	Article									Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Stirling; University of Edinburgh	Preston, BT (corresponding author), Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland.	b.t.preston@stir.ac.uk	Pemberton, Josephine M/F-3100-2010; Wilson, Kenneth/B-7452-2008	Wilson, Kenneth/0000-0001-5264-6522				Andersson Malte, 1994; Clutton-Brock J., 1990, Bulletin of the British Museum (Natural History) Zoology, V56, P1; FULKERSON WJ, 1982, J REPROD FERTIL, V66, P129, DOI 10.1530/jrf.0.0660129; *GENST 5 COMM, 1993, GENST 5 REL 3 REF MA; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Grubb P., 1974, P195; Jewell P.A., 1974, P224; MOLLER AP, 1989, BIOL J LINN SOC, V38, P119, DOI 10.1111/j.1095-8312.1989.tb01569.x; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Pemberton JM, 1999, BIOL J LINN SOC, V68, P289, DOI 10.1111/j.1095-8312.1999.tb01170.x; STEVENSON IR, 1994, THESIS U CAMBRIDGE; SYNNOTT AL, 1981, J REPROD FERTIL, V61, P355, DOI 10.1530/jrf.0.0610355; THWAITES CJ, 1995, ANIM REPROD SCI, V37, P299, DOI 10.1016/0378-4320(94)01343-K	13	279	284	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					681	682		10.1038/35055617	http://dx.doi.org/10.1038/35055617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217847	Green Published			2022-12-01	WOS:000166816400030
J	Scolding, N				Scolding, N			New cells from old	LANCET			English	Editorial Material							NEURAL STEM-CELLS; BRAIN		Univ Bristol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1JE, Avon, England	University of Bristol	Scolding, N (corresponding author), Univ Bristol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1JE, Avon, England.							Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chief Medical Officer's Expert Group, 2000, STEM CELL RES MED PR; Folkerth RD, 1996, NEUROLOGY, V46, P1219, DOI 10.1212/WNL.46.5.1219; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Mezey E, 2000, EUR J PHARMACOL, V405, P297, DOI 10.1016/S0014-2999(00)00561-6; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richards T, 2000, BRIT MED J, V321, P1427, DOI 10.1136/bmj.321.7274.1427; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089; 2000, NATURE, V408, P275	19	10	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					329	330		10.1016/S0140-6736(00)03637-0	http://dx.doi.org/10.1016/S0140-6736(00)03637-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210992				2022-12-01	WOS:000166897900008
J	Levy, JA				Levy, JA			What can be achieved with an HIV vaccine?	LANCET			English	Editorial Material							INFECTION; MEASLES; IMMUNITY; VIRUS; TRANSMISSION; INDIVIDUALS; CHILDREN		Univ Calif San Francisco, Dept Med, Div Haematol Oncol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Haematol Oncol, San Francisco, CA 94143 USA.							Damien B, 1998, J MED VIROL, V56, P85, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;85::AID-JMV14&gt;3.0.CO;2-V; Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483; FOGEL A, 1978, J PEDIATR-US, V92, P26, DOI 10.1016/S0022-3476(78)80064-X; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HARCOURT GC, 1980, J INFECT DIS, V142, P145, DOI 10.1093/infdis/142.2.145; Levy JA, 1998, HIV PATHOGENESIS AID; Nathanson N, 1999, AIDS, V13, pS113; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PEDERSEN IR, 1989, VACCINE, V7, P345, DOI 10.1016/0264-410X(89)90199-0; PLOTKIN SA, 1998, VACCINES; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; ROWLANDJONES SL, 1995, CURR OPIN IMMUNOL, V7, P448, DOI 10.1016/0952-7915(95)80087-5; Shearer GM, 1996, IMMUNOL TODAY, V17, P21, DOI 10.1016/0167-5699(96)80564-0; Stranford SA, 1999, P NATL ACAD SCI USA, V96, P1030, DOI 10.1073/pnas.96.3.1030; SUTTER RW, 1991, LANCET, V338, P715, DOI 10.1016/0140-6736(91)91442-W; Vardas E, 1999, J CLIN VIROL, V13, P173, DOI 10.1016/S1386-6532(99)00026-8; Whittle HC, 1999, LANCET, V353, P98, DOI 10.1016/S0140-6736(98)02364-2; WILKINS J, 1969, AM J DIS CHILD, V118, P275, DOI 10.1001/archpedi.1969.02100040277025	18	21	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					223	224		10.1016/S0140-6736(00)03601-1	http://dx.doi.org/10.1016/S0140-6736(00)03601-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213112				2022-12-01	WOS:000166593700036
J	Umans-Eckenhausen, MAW; Defesche, JC; Sijbrands, EJG; Scheerder, RLJM; Kastelein, JJP				Umans-Eckenhausen, MAW; Defesche, JC; Sijbrands, EJG; Scheerder, RLJM; Kastelein, JJP			Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands	LANCET			English	Article							CHOLESTEROL; MUTATIONS	Background Familial hypercholesterolaemia is a common lipid disorder that predisposes for premature cardiovascular disease (CVD). We set up a screening programme in the Netherlands in 1994 to: establish the feasibility of active family screening supported by DNA diagnostics; assess whether or not active identification of these patients with familial hypercholesterolaemia would lead to more cholesterol-lowering treatment; and compare diagnosis by DNA analysis with that by cholesterol measurement. Methods Both DNA analysis and measurement of cholesterol concentrations were used to screen families in which a functional mutation in the LDL-receptor gene had been detected. Findings In the first 5 years, 5442 relatives of 237 people with familial hypercholesterolaemia were screened; 2039 individuals were identified as heterozygous by LDL-receptor gene mutation analysis. At the time of examination. 667 of these adults with familial hypercholesterolaemia (39%) received some form of lipid-lowering treatment; 1 year later, this percentage had increased to 93%. In addition, laboratory analysis showed that for carriers as well as noncarriers 18% would have been misdiagnosed by cholesterol measurement alone, with sex-specific and age-specific 90th percentiles of the general Dutch population as diagnostic criteria. Interpretation Targeted family screening with DNA analysis proved to be highly effective in identifying patients with hypercholesterolaemia. Most of the identified patients sought treatment and were successfully started on cholesterol-lowering treatment to lower the risk of premature CVD. Our findings could have wider relevance for the screening of other prevalent genetic population at large.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, POB 27700, NL-1100 DE Amsterdam, Netherlands.	e.vandongen@amc.uva.ni	Kastelein, John/AAF-7950-2020; Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389				ASSOULINE L, 1995, PEDIATRICS, V96, P239; Defesche J., 2000, LIPIDS VASCULAR DIS, V6, P65; DEFESCHE JC, 1993, ARCH INTERN MED, V153, P2349, DOI 10.1001/archinte.153.20.2349; *FAM HYP FH, WHOHGNCONS987 FAM HY; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; Gould AL, 1998, CIRCULATION, V97, P946; KOTZE MJ, 1992, CLIN GENET, V42, P43; Kotze MJ, 1998, CLIN GENET, V54, P74; KWITEROVICH PO, 1989, ARTERIOSCLEROSIS, V9, pI111; LEONARD JV, 1977, BRIT MED J, V1, P1566, DOI 10.1136/bmj.1.6076.1566; Lombardi MP, 2000, CLIN GENET, V57, P116, DOI 10.1034/j.1399-0004.2000.570205.x; Maat-Kievit A, 1999, PRENATAL DIAG, V19, P450, DOI 10.1002/(SICI)1097-0223(199905)19:5<450::AID-PD568>3.0.CO;2-L; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Sijbrands EJG, 2000, ATHEROSCLEROSIS, V149, P421, DOI 10.1016/S0021-9150(99)00336-6; Vatta M, 2000, CURR OPIN CARDIOL, V15, P12, DOI 10.1097/00001573-200001000-00003; VERSCHUREN WMM, 1994, INT J EPIDEMIOL, V23, P948, DOI 10.1093/ije/23.5.948; Vuorio AF, 1997, ARTERIOSCL THROM VAS, V17, P3332, DOI 10.1161/01.ATV.17.11.3332; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	20	337	345	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					165	168		10.1016/S0140-6736(00)03587-X	http://dx.doi.org/10.1016/S0140-6736(00)03587-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213091				2022-12-01	WOS:000166593700007
J	Endy, D; Brent, R				Endy, D; Brent, R			Modelling cellular behaviour	NATURE			English	Article							DIVISION INHIBITOR MINC; ESCHERICHIA-COLI; POLE OSCILLATION; GENE; CYTOPLASM; CYCLE; EXPRESSION; EVOLUTION; RHYTHMS; LAMBDA	Representations of cellular processes that can be used to compute their future behaviour would be of general scientific and practical value. But past attempts to construct such representations have been disappointing. This is now changing. Increases in biological understanding combined with advances in computational methods and in computer power make it possible to foresee construction of useful and predictive simulations of cellular processes.	Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Endy, D (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.			Endy, Drew/0000-0001-6952-8098				AHO AC, 1988, NATURE, V334, P348, DOI 10.1038/334348a0; [Anonymous], 1993, ORIGINS ORDER; Arkin A, 1998, GENETICS, V149, P1633; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; COLMANLERNER A, 2000, TRENDS CELL BI S DEC, P56; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Endy D, 1997, BIOTECHNOL BIOENG, V55, P375, DOI 10.1002/(SICI)1097-0290(19970720)55:2<375::AID-BIT15>3.0.CO;2-G; Endy D, 2000, ANTIMICROB AGENTS CH, V44, P1097, DOI 10.1128/AAC.44.4.1097-1099.2000; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; HUTCHESON GD, 1996, SCI AM           JAN, P54; KANANYAN GK, 1980, GENETIKA+, V16, P2009; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Morton-Firth CJ, 1998, J THEOR BIOL, V192, P117, DOI 10.1006/jtbi.1997.0651; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Soong NW, 2000, NAT GENET, V25, P436, DOI 10.1038/78132; STUDIER FW, 1979, VIROLOGY, V95, P70; SUSSMAN GJ, 1992, SCIENCE, V257, P56, DOI 10.1126/science.257.5066.56; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WONG A, 1995, GENETICS, V139, P1247; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	41	273	288	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					391	395		10.1038/35053181	http://dx.doi.org/10.1038/35053181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201753	Bronze			2022-12-01	WOS:000166434300061
J	Podos, J				Podos, J			Correlated evolution of morphology and vocal signal structure in Darwin's finches	NATURE			English	Article							SPECIATION; SELECTION; SONG; PHYLOGENY; TRACT; RESPONSES; MOVEMENTS; BIRDSONG; SPARROWS	Speciation in many animal taxa is catalysed by the evolutionary diversification of mating signals(1). According to classical theories of speciation, mating signals diversify, in part, as an incidental byproduct of adaptation by natural selection to divergent ecologies(2,3), although empirical evidence in support of this hypothesis has been limited(4-6). Here I show, in Darwin's finches of the Galapagos Islands, that diversification of beak morphology and body size has shaped patterns of vocal signal evolution, such that birds with large beaks and body sizes have evolved songs with comparatively low rates of syllable repetition and narrow frequency bandwidths. The converse is true for small birds. Patterns of correlated evolution among morphology and song are consistent with the hypothesis that beak morphology constrains vocal evolution, with different beak morphologies differentially limiting a bird's ability to modulate vocal tract configurations during song production. These data illustrate how morphological adaptation may drive signal evolution and reproductive isolation, and furthermore identify a possible cause for rapid speciation in Darwin's finches.	Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	University of Arizona	Podos, J (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.		Podos, Jeff/I-3843-2019	Podos, Jeffrey/0000-0002-2546-7999				Bowman R.I., 1983, P237; BOWMAN ROBERT I., 1961, UNIV CALIFORNIA PUBL ZOOL, V58, P1; CUTLER B, 1970, ANATOMICAL STUDIES S; Dobzhansky T., 1951, A MONTAGU PAPERS, V3rd; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fletcher NH, 1999, J ACOUST SOC AM, V105, P35, DOI 10.1121/1.424620; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Grant P.R., 1999, ECOLOGY EVOLUTION DA; Grant PR, 1996, PHILOS T ROY SOC B, V351, P765, DOI 10.1098/rstb.1996.0071; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; Hoese WJ, 2000, J EXP BIOL, V203, P1845; MARTINS EP, 1999, COMPARE VERSION 4 2; Mayr E, 1963, ANIMAL SPECIES EVOLU; Mooers AO, 1999, AM NAT, V154, P249, DOI 10.1086/303226; NOWICKI S, 1987, NATURE, V325, P53, DOI 10.1038/325053a0; Nowicki Stephen, 1992, Seminars in the Neurosciences, V4, P385, DOI 10.1016/1044-5765(92)90046-5; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; PODOS J, 1995, ANIM BEHAV, V50, P1287, DOI 10.1016/0003-3472(95)80044-1; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Podos J, 1996, ANIM BEHAV, V51, P1061, DOI 10.1006/anbe.1996.0107; RATCLIFFE LM, 1985, ANIM BEHAV, V33, P290, DOI 10.1016/S0003-3472(85)80143-3; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Sato A, 1999, P NATL ACAD SCI USA, V96, P5101, DOI 10.1073/pnas.96.9.5101; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1985, SCIENCE, V227, P1056, DOI 10.1126/science.227.4690.1056; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WESTNEAT MW, 1993, J EXP BIOL, V182, P147	30	512	526	1	352	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					185	188		10.1038/35051570	http://dx.doi.org/10.1038/35051570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196640				2022-12-01	WOS:000166316200042
J	Bosman, M; Mwinga, A				Bosman, M; Mwinga, A			Tropical diseases and the 10/90 gap	LANCET			English	Article									WHO, Stop TB Initiat, CH-1211 Geneva 27, Switzerland; Univ Teaching Hosp, Lusaka, Zambia; Royal Netherlands TB Assoc, The Hague, Netherlands; Minist Hlth, Tech TB Working Grp, Lusaka, Zambia	World Health Organization; University of Zambia	Bosman, M (corresponding author), WHO, Stop TB Initiat, CH-1211 Geneva 27, Switzerland.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S63	S63		10.1016/S0140-6736(00)92049-X	http://dx.doi.org/10.1016/S0140-6736(00)92049-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191523				2022-12-01	WOS:000166074900065
J	Robinson, KA; Baughman, W; Rothrock, G; Barrett, NL; Pass, M; Lexau, C; Damaske, B; Stefonek, K; Barnes, B; Patterson, J; Zell, ER; Schuchat, A; Whitney, CG				Robinson, KA; Baughman, W; Rothrock, G; Barrett, NL; Pass, M; Lexau, C; Damaske, B; Stefonek, K; Barnes, B; Patterson, J; Zell, ER; Schuchat, A; Whitney, CG		ABCs Emerging Infect Program Netw	Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 - Opportunities for prevention in the conjugate vaccine era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION-BASED SURVEILLANCE; PNEUMOCOCCAL DISEASE; RISK-FACTORS; EFFICACY; CHILDREN; BACTEREMIA; COUNTY; SOUTH	Context Pneumococcal polysaccharide Vaccine is recommended for elderly persons and adults with certain chronic illnesses. Additionally, a recently licensed pneumococcal 7-valent conjugate vaccine has been recommended for use in young children and could dramatically change the epidemiology of pneumococcal disease. Objectives To assess pneumococcal disease burden in the United States, estimate the potential impact of new vaccines, and identify gaps in vaccine recommendations, Design and Setting Analysis of data from the Active Bacterial Core Surveillance (ABCs)/Emerging infections Program Network, an active, population-based system in 9 states. Patients A total of 15860 cases of invasive pneumococcal disease occurring between January 1, 1995, and December 31, 1998, Main Outcome Measures Age- and race-specific pneumoccocal disease incidence rates per 100000 persons, case-fatality rates, and vaccine preventability. Results In 1998, overall incidence was 23.2 cases per 100000, corresponding to an estimated 62840 cases in the United States. Incidence was highest among children younger than 2 years (166.9) and adults aged 65 years or older (59.7). Incidence among blacks was 2.6 times higher than among whites (95% confidence interval [CI], 2,4-2.8). Overall, 28.6% of case-patients were at least 65 years old and 85.9% of cases in this age group were due to serotypes included in the 23-valent polysaccharide vaccine; 19.3% of case-patients were younger than 2 years and 82.2% of cases in this age group were due to serotypes included in the 7-valent conjugate vaccine. Among patients aged 2 to 64 years, 50.6% had a vaccine indication as defined by the Advisory Committee on Immunization Practices (ACIP), The case-fatality rate among patients aged 18 to 64 years with an ACIP indication was 12.1% compared with 5.4% for those without an indication (relative risk, 2.2; 95% CI, 1.7-2.9). Conclusions Young children, elderly persons, and black persons of ail ages are disproportionately affected by invasive pneumococcal disease. Current ACIP recommendations do not address a subset of persons aged 18 to 64 years but do include those at highest risk for death from invasive pneumococcal disease.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Biostat & Informat Management Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Georgia Dept Human Resources, Emerging Infect Program, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Calif Dept Hlth Serv, Emerging Infect Program, Berkeley, CA 94704 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Connecticut Dept Publ Hlth, Emerging Infect Program, Hartford, CT USA; Maryland Dept Hlth & Mental Hyg, Emerging Infect Program, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Emerging Infect Program, Minneapolis, MN USA; New York State Dept Hlth, Emerging Infect Program, Albany, NY USA; Oregon Dept Human Resources, Hlth Div, Emerging Infect Program, Portland, OR USA; Tennessee Dept Hlth, Emerging Infect Program, Knoxville, TN USA; Vanderbilt Univ, Med Ctr, Knoxville, TN USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; California Department of Health Care Services; University of California System; University of California Berkeley; Maryland Department of Health & Mental Hygiene; Johns Hopkins University; Minnesota Department of Health (MHD); State University of New York (SUNY) System; Tennessee Department Health; Vanderbilt University; University of Texas System; University of Texas Health San Antonio	Robinson, KA (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, MS D-65,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	kad2@cdc.gov		Patterson, Jan/0000-0002-6459-9783				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLUESTONE CD, 1992, PEDIATR INFECT DIS J, V11, pS7, DOI 10.1097/00006454-199208001-00002; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; Butler JC, 1997, MICROB DRUG RESIST, V3, P125, DOI 10.1089/mdr.1997.3.125; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P993; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P961; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; CORTESE MM, 1997, PEDIATR INFECT DIS J, V16, P555; DAVIDSON M, 1999, 39 INT C ANT AG CHEM; ESKOLA J, 1992, JAMA-J AM MED ASSOC, V268, P3323, DOI 10.1001/jama.268.23.3323; GESSNER BD, 1995, PEDIATR INFECT DIS J, V14, P123, DOI 10.1097/00006454-199502000-00008; Harrison LH, 2000, ARCH INTERN MED, V160, P89, DOI 10.1001/archinte.160.1.89; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Nichol KL, 1999, ARCH INTERN MED, V159, P2437, DOI 10.1001/archinte.159.20.2437; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; OBRIEN KL, 1999, 39 INT C ANT AG CHEM; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHUCHAT A, 1991, JAMA-J AM MED ASSOC, V265, P3275, DOI 10.1001/jama.265.24.3275; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; Smith MD, 1998, EPIDEMIOL INFECT, V120, P117, DOI 10.1017/S0950268897008522; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; US Department of Health and Human Services, 2000, HLTH PEOPL 2010; Zangwill KM, 1996, J INFECT DIS, V174, P752, DOI 10.1093/infdis/174.4.752	31	499	540	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2001	285	13					1729	1735		10.1001/jama.285.13.1729	http://dx.doi.org/10.1001/jama.285.13.1729			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415FR	11277827	Bronze			2022-12-01	WOS:000167710600026
J	Berardini, TZ; Bollman, K; Sun, H; Poethig, RS				Berardini, TZ; Bollman, K; Sun, H; Poethig, RS			Regulation of vegetative phase change in Arabidopsis thaliana by cyclophilin 40	SCIENCE			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; GENE FAMILY; PROTEIN; HSP90; BINDING; CYP-40; IMMUNOPHILINS; THERMOTOLERANCE; COMPONENT; IDENTITY	During its development, a plant shoot progresses from a juvenile to an adult phase of vegetative growth and from a reproductively incompetent to a reproductively competent state. In Arabidopsis, Loss-of-function mutations in SQUINT (SQN) reduced the number of juvenile Leaves and had subtle effects on inflorescence morphology but had no effect on flowering time or on reproductive competence. SQN encodes the Arabidopsis homolog of cyclophilin 40 (CyP40), a protein found in association with the Hsp90 chaperone complex in yeast, mammals, and plants. Thus, in Arabidopsis, CyP40 is specifically required for the vegetative but not the reproductive maturation of the shoot.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	spoethig@sas.upenn.edu	Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Berardini, Tanya/0000-0002-3837-8864	NIGMS NIH HHS [R01-GM1893-04] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allsopp A, 1967, Adv Morphog, V6, P127; BRINK RA, 1962, Q REV BIOL, V37, P1, DOI 10.1086/403567; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Duina AA, 1998, J BIOL CHEM, V273, P10819, DOI 10.1074/jbc.273.18.10819; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Goebel K, 1900, ORGANOGRAPHY PLANT 1; Hackett W., 1993, MICROPROPAGATION WOO, P93, DOI DOI 10.1007/978-94-015-8116-5_6; Kerstetter RA, 1998, ANNU REV CELL DEV BI, V14, P373, DOI 10.1146/annurev.cellbio.14.1.373; KIEFFER LJ, 1993, J BIOL CHEM, V268, P12303; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; OwensGrillo JK, 1996, BIOCHEMISTRY-US, V35, P15249, DOI 10.1021/bi9615349; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Prandl R, 1998, MOL GEN GENET, V258, P269, DOI 10.1007/s004380050731; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; ROBBELEN GERHARD, 1957, BER DEUTSCH BOT GES, V70, P39; SCHIRMER EC, 1994, PLANT CELL, V6, P1899, DOI 10.1105/tpc.6.12.1899; Telfer A, 1998, DEVELOPMENT, V125, P1889; Telfer A, 1997, DEVELOPMENT, V124, P645; Tsukaya H, 2000, PLANTA, V210, P536, DOI 10.1007/s004250050042; Vittorioso P, 1998, MOL CELL BIOL, V18, P3034, DOI 10.1128/MCB.18.5.3034; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; Weisman R, 1996, EMBO J, V15, P447, DOI 10.1002/j.1460-2075.1996.tb00377.x	33	129	140	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2001	291	5512					2405	2407		10.1126/science.1057144	http://dx.doi.org/10.1126/science.1057144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264535				2022-12-01	WOS:000167618700054
J	Xu, GZ; Cirilli, M; Huang, YH; Rich, RL; Myszka, DG; Wu, H				Xu, GZ; Cirilli, M; Huang, YH; Rich, RL; Myszka, DG; Wu, H			Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex	NATURE			English	Article							BACULOVIRUS P35 PROTEIN; CELL-DEATH; APOPTOSIS; SITE; EXPRESSION; DROSOPHILA; CLEAVAGE; SUITE; GENE	Apoptosis is a highly regulated process that is crucial for normal development and homeostasis of multicellular organisms(1,2). The p35 protein from baculoviruses effectively prevents apoptosis by its broad-spectrum caspase inhibition(3-7). Here we report the crystal structure of p35 in complex with human caspase-8 at 3.0 Angstrom resolution, and biochemical and mutagenesis studies based on the structural information. The structure reveals that the caspase is inhibited in the active site through a covalent thioester linkage to p35, which we confirmed by gel electrophoresis, hydroxylamine treatment and mass spectrometry experiments. The p35 protein undergoes dramatic conformational changes on cleavage by the caspase. The repositioning of the amino terminus of p35 into the active site of the caspase eliminates solvent accessibility of the catalytic dyad. This may be crucial for preventing hydrolysis of the thioester intermediate, which is supported by the abrogation of inhibitory activity through mutations at the N terminus of p35. The p35 protein also makes conserved contacts with the caspase outside the active-site region, providing the molecular basis for the broad-spectrum inhibitory activity of this protein. We demonstrate a new molecular mechanism of caspase inhibition, as well as protease inhibition in general.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Program Physiol Biophys & Mol Med, New York, NY 10021 USA; CNR, Ist Strutturist Chim Giordano Giacomello, Monterotondo Stn, Italy; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Cornell University; Cornell University; Consiglio Nazionale delle Ricerche (CNR); Utah System of Higher Education; University of Utah	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.							BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; Bertin J, 1996, J VIROL, V70, P6251, DOI 10.1128/JVI.70.9.6251-6259.1996; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BRUICE TC, 1966, BIOORGANIC MECH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 1999, MOL RECOGNIT, V12, P1; OWEN WG, 1976, THROMB HAEMOSTASIS, V35, P87, DOI 10.1055/s-0038-1647914; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Robertson NM, 1997, CANCER RES, V57, P43; Sambrook J., 1989, MOL CLONING; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Zoog SJ, 1999, J BIOL CHEM, V274, P25995, DOI 10.1074/jbc.274.37.25995	30	146	154	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					494	497		10.1038/35068604	http://dx.doi.org/10.1038/35068604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260720				2022-12-01	WOS:000167583800048
J	Navas-Nacher, EL; Colangelo, L; Beam, C; Greenland, P				Navas-Nacher, EL; Colangelo, L; Beam, C; Greenland, P			Risk factors for coronary heart disease in men 18 to 39 years of age	ANNALS OF INTERNAL MEDICINE			English	Article							CHOLESTEROL SCREENING GUIDELINES; FOLLOW-UP; SERUM-CHOLESTEROL; BLOOD-PRESSURE; ATHEROSCLEROSIS; MORTALITY; ADULTS; ASSOCIATION; PRAVASTATIN; CONSENSUS	Background: Few studies have evaluated the long-term predictive capacity of risk factors for death from coronary heart disease in men younger than 40 years of age. Objective: To assess the predictive capacity and discriminatory ability of major coronary risk factors in predicting death from coronary heart disease in young men. Design: Prospective cohort study with 20 years of follow-up. Setting: 84 companies in the Chicago area that participated in the Chicago Heart Association Detection Project in Industry (1967-1973). Participants: 11 016 men 18 to 39 years of age (mean age, 29.7 years) at baseline were the primary focus of this report; 8955 men 40 to 59 years of age at baseline served as a reference group. Measurements: The main end point was death from coronary heart disease. Results: All major risk factors-age, serum cholesterol level, systolic blood pressure, and cigarette smoking-were significantly associated with death from coronary heart disease over 20 years in young men. Relative risks for the major risk factors were of generally similar magnitude in young and middle-aged men. Receiver-operating characteristic curves for the best predictive model yielded an area under the curve of 0.82, indicating that standard risk factors were highly predictive of long-term outcome in young men. Conclusions: Major coronary disease risk factors, many of which are modifiable, are strong contributors to prediction of future risk, even in young men. These data may help in formulating appropriate strategies to identify young men at heightened risk for death from coronary heart disease in later adulthood.	Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Northwestern University; Medical College of Wisconsin	Greenland, P (corresponding author), Northwestern Univ, Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Heart Association, 1999, HEART STROK STAT UPD; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BYINGTON RP, 1995, CIRCULATION, V92, P2419, DOI 10.1161/01.CIR.92.9.2419; Cleeman JI, 1997, CIRCULATION, V95, P1646; DAVIS CE, 1990, JAMA-J AM MED ASSOC, V264, P3044, DOI 10.1001/jama.264.23.3044; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Garber AM, 1996, ANN INTERN MED, V124, P515, DOI 10.7326/0003-4819-124-5-199603010-00013; Garber AM, 1997, CIRCULATION, V95, P1642; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HAWK PB, 1954, PRACTICAL PHYSL CHEM, P564; Hoffman WS, 1937, J BIOL CHEM, V120, P51; *JOINT NAT COMM PR, 1997, NAT HEART LUNG BLOOD; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; LaRosa JC, 1997, CIRCULATION, V95, P1651; LEVINE JB, 1964, CLIN CHIM ACTA, V10, P381, DOI 10.1016/0009-8981(64)90073-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; McGill HC, 2000, CIRCULATION, V102, P374; *NAT CTR HLTH STAT, 1967, INT CLASS DIS, P49; PEDERSEN TR, 1994, LANCET, V344, P1383; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; PRINEAS RJ, 1983, HYPERTENSION, V5, P160; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; STAMLER J, 1975, J CHRON DIS, V28, P499, DOI 10.1016/0021-9681(75)90059-4; Therneau T.M., 2000, MODELLING SURVIVAL D, P39, DOI [10.1007/978-1-4757-3294-8_3, DOI 10.1007/978-1-4757-3294-8]; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	87	93	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					433	439		10.7326/0003-4819-134-6-200103200-00007	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255518				2022-12-01	WOS:000167405800001
J	Kumar, JP; Moses, K				Kumar, JP; Moses, K			EGF receptor and notch signaling act upstream of Eyeless/Pax6 to control eye specification	CELL			English	Article							CELL-FATE; TYROSINE KINASE; HOMEOBOX GENE; ABSENT GENE; WILD-TYPE; DROSOPHILA; PROTEIN; DIFFERENTIATION; WINGLESS; HOMOLOG	The Drosophila compound eye is specified by the concerted action of seven nuclear factors that include Eyeless/Pax6. These factors have been called "master control" proteins because loss-of-function mutants lack eyes and ectopic expression can direct ectopic eye development. However, inactivation of these genes does not cause the presumptive eye to change identity. Surprisingly, we find that several of these eye specification genes are not coexpressed in the same embryonic cells-or even in the presumptive eye. We demonstrate that the EGF Receptor and Notch signaling pathways have homeotic functions that are genetically upstream of the eye specification genes, and show that specification occurs much later than previously thought-not during embryonic development but in the second larval stage.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University	Moses, K (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 1648 Pierce Dr, Atlanta, GA 30322 USA.	kmoses@cellbio.emory.edu			NATIONAL EYE INSTITUTE [F32EY006763, R01EY012537] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY-12537, 5 F32 EY06763, F32 EY006763] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Apidianakis Y, 1999, MECH DEVELOP, V86, P39, DOI 10.1016/S0925-4773(99)00099-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; Baker CVH, 2000, DEVELOPMENT, V127, P3045; Baker NE, 2000, BIOESSAYS, V22, P264, DOI 10.1002/(SICI)1521-1878(200003)22:3<264::AID-BIES8>3.0.CO;2-M; Baonza A, 2000, P NATL ACAD SCI USA, V97, P7331, DOI 10.1073/pnas.97.13.7331; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bhat KM, 2000, DEVELOPMENT, V127, P655; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Blair SS, 1999, CURR BIOL, V9, pR356, DOI 10.1016/S0960-9822(99)80226-7; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boube M, 1997, GENETICS, V146, P619; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boyle M, 1997, DEVELOPMENT, V124, P971; Brennan K, 1997, GENETICS, V147, P177; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; CLIFFORD RJ, 1989, GENETICS, V123, P771; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Dickson BJ, 1998, CURR BIOL, V8, pR90, DOI 10.1016/S0960-9822(98)70054-5; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Dong PDS, 2000, DEVELOPMENT, V127, P209; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FREEMAN M, 1994, DEVELOPMENT, V120, P2297; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Gehring W.J., 1998, MASTER CONTROL GENES; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Hadorn E, 1978, GENETICS BIOL DROS C, V2c, P555; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Hayashi T, 1998, DEV BIOL, V200, P131, DOI 10.1006/dbio.1998.8959; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Heberlein U, 2000, Results Probl Cell Differ, V31, P37; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Hidalgo A, 1996, TRENDS GENET, V12, P1, DOI 10.1016/0168-9525(96)81373-4; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Ito K, 1997, DEVELOPMENT, V124, P761; Jones NA, 1998, DEVELOPMENT, V125, P4163; Karim FD, 1998, DEVELOPMENT, V125, P1; KASSIS JA, 1990, GENE DEV, V4, P433, DOI 10.1101/gad.4.3.433; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Kramer S, 1999, DEVELOPMENT, V126, P2515; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kumar J P, 2000, Results Probl Cell Differ, V31, P93; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Lawrence PA, 1995, DEVELOPMENT, V121, P4303; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Li W, 1997, DEVELOPMENT, V124, P4163; Manning L, 1999, DEVELOPMENT, V126, P2063; MARDON G, 1994, DEVELOPMENT, V120, P3473; Martin-Blanco E, 1998, INT J DEV BIOL, V42, P363; Maurel-Zaffran C, 2000, DEVELOPMENT, V127, P1007; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; POSTLETHWAIT JH, 1971, DEV BIOL, V24, P477, DOI 10.1016/0012-1606(71)90061-3; Price JV, 1997, GENETICS, V147, P1139; Queenan AM, 1997, DEVELOPMENT, V124, P3871; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Royet J, 1997, DEVELOPMENT, V124, P4793; Royet J, 1996, DEVELOPMENT, V122, P1849; Sawamoto K, 1996, NEUROSCI RES, V26, P205, DOI 10.1016/S0168-0102(96)01110-8; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Scholz H, 1997, MECH DEVELOP, V64, P137; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Seimiya M, 2000, DEVELOPMENT, V127, P1879; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; Tio M, 1997, DEVELOPMENT, V124, P343; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; WIESCHAUS E, 1974, THESIS YALE U NEW HA, P1; YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891; zur Lage P, 1999, DEVELOPMENT, V126, P3149	92	171	175	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					687	697		10.1016/S0092-8674(01)00265-3	http://dx.doi.org/10.1016/S0092-8674(01)00265-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257223	Bronze			2022-12-01	WOS:000167531100009
J	Tudhope, AW; Chilcott, CP; McCulloch, MT; Cook, ER; Chappell, J; Ellam, RM; Lea, DW; Lough, JM; Shimmield, GB				Tudhope, AW; Chilcott, CP; McCulloch, MT; Cook, ER; Chappell, J; Ellam, RM; Lea, DW; Lough, JM; Shimmield, GB			Variability in the El Nino - Southern oscillation through a glacial-interglacial cycle	SCIENCE			English	Article							SEA-SURFACE TEMPERATURES; OXYGEN-ISOTOPE RECORDS; PAPUA-NEW-GUINEA; HUON-PENINSULA; PENULTIMATE DEGLACIATION; TROPICAL PACIFIC; CORAL-SKELETONS; CLIMATE-CHANGE; NORTH PACIFIC; LEVEL CHANGES	The El Nino-Southern Oscillation (ENSO) is the most potent source of interannual climate variability. Uncertainty surrounding the impact of greenhouse warming on ENSO strength and frequency has stimulated efforts to develop a better understanding of the sensitivity of ENSO to climate change, Here we use annually banded corals from Papua New Guinea to show that ENSO has existed for the past 130,000 years, operating even during "glacial" times of substantially reduced regional and global temperature and changed solar forcing. However, we also find that during the 20th century ENSO has been strong compared with ENSO of previous cool (glacial) and warm (interglacial) times. The observed pattern of change in amplitude may be due to the combined effects of ENSO dampening during cool glacial conditions and ENSO forcing by precessional orbital variations.	Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland; Australian Inst Marine Sci, Townsville, Qld 4810, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Lamont Doherty Earth Observ, Tree Ring Lab, Palisades, NY 10964 USA; Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Dunstaffnage Marine Lab, Oban PA34 4AD, Argyll, Scotland	University of Edinburgh; Australian Institute of Marine Science; Australian National University; Columbia University; Scottish Universities Research & Reactor Center; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Tudhope, AW (corresponding author), Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland.		McCulloch, Malcolm T/C-3651-2009; Ellam, Rob M/B-7878-2009; Lough, Janice M/L-1682-2013	McCulloch, Malcolm T/0000-0003-1538-1558; Ellam, Rob M/0000-0001-8159-4864; Lough, Janice M/0000-0002-3789-1009				AHARON P, 1986, PALAEOGEOGR PALAEOCL, V56, P337, DOI 10.1016/0031-0182(86)90101-X; Andreasen DJ, 1997, PALEOCEANOGRAPHY, V12, P395, DOI 10.1029/97PA00822; BARMATTHEWS M, 1993, GEOCHIM COSMOCHIM AC, V57, P257, DOI 10.1016/0016-7037(93)90429-Z; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Broecker WS, 1989, PALEOCEANOGRAPHY, V4, P207, DOI 10.1029/PA004i002p00207; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; CHAPPELL J, 1974, GEOL SOC AM BULL, V85, P553, DOI 10.1130/0016-7606(1974)85<553:GOCTHP>2.0.CO;2; CHAPPELL J, 1991, NATURE, V349, P147, DOI 10.1038/349147a0; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; CLIMAP (Climate: Long Range Investigation Mapping and Prediction) Project Members, 1981, GEOL SOC AM MAP CHAR, V36; Collins M, 2000, J CLIMATE, V13, P1299, DOI 10.1175/1520-0442(2000)013<1299:TENOSO>2.0.CO;2; CONOVER WJ, 1999, PRACTICAL NONPARAMET, P300; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Evans MN, 1998, NATURE, V394, P732, DOI 10.1038/29424; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; GRAHAM NE, 1994, CLIM DYNAM, V10, P135, DOI 10.1007/BF00210626; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI [10.1029/97JC01736, 10.1029/97JC01734]; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Latif M, 1998, J GEOPHYS RES-OCEANS, V103, P14375, DOI 10.1029/97JC03413; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Leder JJ, 1996, GEOCHIM COSMOCHIM AC, V60, P2857, DOI 10.1016/0016-7037(96)00118-4; Lee KE, 1999, NATURE, V397, P512, DOI 10.1038/17357; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; MARTIN PA, 1999, GEOCHEM GEOPHYS GEOS; McCulloch MT, 1999, SCIENCE, V283, P202, DOI 10.1126/science.283.5399.202; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Otto-Bliesner BL, 1999, GEOPHYS RES LETT, V26, P87, DOI 10.1029/1998GL900236; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI DOI 10.1029/96E000259; PHILANDER SG, 1990, EL NINO LA NINA SO O; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; RAYNER NA, 74 HADL CTR CLIM PRE; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; Rittenour TM, 2000, SCIENCE, V288, P1039, DOI 10.1126/science.288.5468.1039; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; ROPELEWSKI C. F., 1987, MON WEA REV, V115, P2352; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; SHULMEISTER J, 1995, HOLOCENE, V5, P10, DOI 10.1177/095968369500500102; Stoll HM, 1998, GEOCHIM COSMOCHIM AC, V62, P1107, DOI 10.1016/S0016-7037(98)00042-8; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Tudhope AW, 1995, EARTH PLANET SC LETT, V136, P575, DOI 10.1016/0012-821X(95)00156-7; TUDHOPE AW, UNPUB; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	57	643	675	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1511	1517		10.1126/science.1057969	http://dx.doi.org/10.1126/science.1057969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222850				2022-12-01	WOS:000167153400035
J	Wadhwa, M				Wadhwa, M			Redox state of Mars' upper mantle and crust from Eu anomalies in shergottite pyroxenes	SCIENCE			English	Article							RARE-EARTH ELEMENTS; OXIDATION-STATE; METEORITES; PETROGENESIS; CRYSTALLIZATION; CONSTRAINTS; PETROLOGY; PLANET	The oxidation state of basaltic martian meteorites is determined from the partitioning of europium (Eu) in their pyroxenes. The estimated redox conditions far these samples correlate with their initial neodymium and strontium isotopic compositions. This is interpreted to imply varying degrees of interaction between the basaltic parent melts, derived from a source in the martian mantle, and a crustal component. Thus, the mantle source of these martian basalts may have a redox state close to that of the iron-wustite buffer, whereas the martian crust may be more oxidized (with a redox state higher than or equal to that of the quartz-fayalite-magnetite buffer). A difference in redox state of more than 3 log units between mantle and crustal reservoirs on Mars could result from oxidation of the crust by a process such as aqueous alteration, together with a subsequent lack of recycling of this oxidized crust through the reduced upper mantle.	Field Museum, Dept Geol, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Wadhwa, M (corresponding author), Field Museum, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	mwadhwa@fieldmuseum.org						ANDERSON DL, 1972, J GEOPHYS RES, V77, P789, DOI 10.1029/JB077i005p00789; Barrat JA, 2001, METEORIT PLANET SCI, V36, P23, DOI 10.1111/j.1945-5100.2001.tb01807.x; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; BORG LE, 2000, LUNAR PLANET SCI, V31; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; DREIBUS G, 1987, ICARUS, V71, P225, DOI 10.1016/0019-1035(87)90148-5; DREIBUS G, 1985, METEORITICS, V20, P367; Dreibus G., 1996, METEORIT PLANET SCI, V31, pA39; GHOSAL S, 1998, CONTRIB MINERAL PETR, V119, P197; GOETTEL KA, 1983, CARNEGIE I WASHINGTO, V82, P363; HAGGERTY SE, 1983, NATURE, V303, P295, DOI 10.1038/303295a0; Hale VPS, 1999, GEOCHIM COSMOCHIM AC, V63, P1459, DOI 10.1016/S0016-7037(99)00095-2; Herd CDK, 2000, METEORIT PLANET SCI, V35, pA70; JONES JH, 1986, GEOCHIM COSMOCHIM AC, V50, P969, DOI 10.1016/0016-7037(86)90377-7; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; LONGHI J, 1992, MARS, P184; LUNDBERG LL, 1988, GEOCHIM COSMOCHIM AC, V52, P2147, DOI 10.1016/0016-7037(88)90194-9; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MCGRETCHIN TR, 1978, ICARUS, V34, P512; MCKAY G, 1994, GEOCHIM COSMOCHIM AC, V58, P2911, DOI 10.1016/0016-7037(94)90124-4; MCKAY GA, 1989, GEOCHIM COSMOCHIM AC, V50, P927; MCKAY GA, COMMUNICATION; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 1996, GEOCHIM COSMOCHIM AC, V60, P4563, DOI 10.1016/S0016-7037(96)00265-7; MCSWEEN HY, 1983, GEOCHIM COSMOCHIM AC, V47, P1501, DOI 10.1016/0016-7037(83)90309-5; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; MERRILL RB, 1981, BASALTIC VOLCANISM T, P633; MEYER C, 1998, NASA JOHNSON SPACE C, P88; MORGAN JW, 1979, GEOCHIM COSMOCHIM AC, V43, P1601, DOI 10.1016/0016-7037(79)90180-7; NYQUIST LE, 1979, GEOCHIM COSMOCHIM AC, V43, P1057, DOI 10.1016/0016-7037(79)90094-2; NYQUIST LE, 1995, LUNAR PLANET SCI, V26, P1065; NYQUIST LE, 2001, LUNAR PLANET SCI, V32; Rubin AE, 2000, GEOLOGY, V28, P1011, DOI 10.1130/0091-7613(2000)028<1011:LATMDB>2.3.CO;2; SAXENA SK, 1989, GEOCHIM COSMOCHIM AC, V53, P89, DOI 10.1016/0016-7037(89)90275-5; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; SMITH JV, 1979, METEORITICS, V14, P121, DOI 10.1111/j.1945-5100.1979.tb00486.x; STOLPER E, 1977, GEOCHIM COSMOCHIM AC, V41, P587, DOI 10.1016/0016-7037(77)90300-3; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; WADHWA M, 1994, GEOCHIM COSMOCHIM AC, V58, P4213, DOI 10.1016/0016-7037(94)90274-7; Wadhwa M, 1998, METEORIT PLANET SCI, V33, P321, DOI 10.1111/j.1945-5100.1998.tb01636.x; Wadhwa M, 2001, METEORIT PLANET SCI, V36, P195, DOI 10.1111/j.1945-5100.2001.tb01864.x; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337; [No title captured]; [No title captured]; [No title captured]	45	214	215	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1527	1530		10.1126/science.1057594	http://dx.doi.org/10.1126/science.1057594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222854				2022-12-01	WOS:000167153400039
J	Pack, CC; Born, RT				Pack, CC; Born, RT			Temporal dynamics of a neural solution to the aperture problem in visual area MT of macaque brain	NATURE			English	Article							PURSUIT EYE-MOVEMENTS; MOTION; DIRECTION; SELECTIVITY; NEURONS; MONKEYS; ORIENTATION; SPEED	A critical step in the interpretation of the visual world is the integration of the various local motion signals generated by moving objects. This process is complicated by the fact that local velocity measurements can differ depending on contour orientation and spatial position. Specifically, any local motion detector can measure only the component of motion perpendicular to a contour that extends beyond its field of view(1,2). This "aperture problem''(3) is particularly relevant to direction-selective neurons early in the visual pathways, where small receptive fields permit only a limited view of a moving object. Here we show that neurons in the middle temporal visual area (known as MT or V5) of the macaque brain reveal a dynamic solution to the aperture problem. MT neurons initially respond primarily to the component of motion perpendicular to a contour's orientation, but over a period of approximately 60 ms the responses gradually shift to encode the true stimulus direction, regardless of orientation. We also report a behavioural correlate of these neural responses: the initial velocity of pursuit eye movements deviates in a direction perpendicular to local contour orientation, suggesting that the earliest neural responses influence the oculomotor response.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Chey J, 1997, J OPT SOC AM A, V14, P2570, DOI 10.1364/JOSAA.14.002570; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; Groh JM, 1997, J NEUROSCI, V17, P4312; Hildreth E., 1984, MEASUREMENT VISUAL M; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P150, DOI 10.1152/jn.1994.72.1.150; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; Lisberger SG, 1999, J NEUROSCI, V19, P2224; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Masson GS, 2000, VISUAL NEUROSCI, V17, P753, DOI 10.1017/S0952523800175091; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Pack C., 1999, Society for Neuroscience Abstracts, V25, P673; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; YO C, 1992, VISION RES, V32, P135, DOI 10.1016/0042-6989(92)90121-X	27	269	270	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1040	1042		10.1038/35059085	http://dx.doi.org/10.1038/35059085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234012				2022-12-01	WOS:000167148800045
J	Barton, ES; Forrest, JC; Connolly, JL; Chappell, JD; Liu, Y; Schnell, FJ; Nusrat, A; Parkos, CA; Dermody, TS				Barton, ES; Forrest, JC; Connolly, JL; Chappell, JD; Liu, Y; Schnell, FJ; Nusrat, A; Parkos, CA; Dermody, TS			Junction adhesion molecule is a receptor for reovirus	CELL			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; ATTACHMENT PROTEIN SIGMA-1; CELL-SURFACE RECEPTOR; TRANSCRIPTIONAL ACTIVITY; NEUTROPHIL MIGRATION; FUNCTIONAL DOMAINS; MAMMALIAN REOVIRUS; TYPE-3 REOVIRUS; APOPTOSIS	Virus attachment to cells plays an essential role in Viral tropism and disease. Reovirus serotypes 1 and 3 differ in the capacity to target distinct cell types in the murine nervous system and in the efficiency to induce apoptosis. The binding of viral attachment protein ol to unidentified receptors controls these phenotypes. We used expression cloning to identify junction adhesion molecule (JAM), an integral tight junction protein, as a reovirus receptor. JAM binds directly to al and permits reovirus infection of nonpermissive cells. Ligation of JAM is required for reovirus-induced activation of NF-KB and apoptosis. Thus, reovirus interaction with cell-surface receptors is a critical determinant of both cell-type specific tropism and virus-induced intracellular signaling events that culminate in cell death.	Vanderbilt Univ, Dept Microbiol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Immunol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Elizabeth B Lamb Ctr Pediat Res, Sch Med, Nashville, TN 37232 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Div Gastrointestinal Pathol, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Dermody, TS (corresponding author), Vanderbilt Univ, Dept Microbiol, Sch Med, Nashville, TN 37232 USA.		Nusrat, Asma/B-3887-2009; Parkos, Charles a/B-3896-2009		NCI NIH HHS [T32 CA09385, CA68485] Funding Source: Medline; NHLBI NIH HHS [HL54229, HL60540] Funding Source: Medline; NIAID NIH HHS [AI38296] Funding Source: Medline; NIDDK NIH HHS [DK20593, DK10013] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009385, P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060540, R01HL054229, R29HL054229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038296, R01AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, F32DK010013] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Baer GS, 1997, J VIROL, V71, P4921, DOI 10.1128/JVI.71.7.4921-4928.1997; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Bazzoni G, 1999, TRENDS CARDIOVAS MED, V9, P147, DOI 10.1016/S1050-1738(99)00022-5; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; BURSTIN SJ, 1982, VIROLOGY, V117, P146, DOI 10.1016/0042-6822(82)90514-1; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; CHOI AHC, 1990, VIROLOGY, V178, P316, DOI 10.1016/0042-6822(90)90412-K; Clarke H, 2000, ADV DRUG DELIVER REV, V41, P283, DOI 10.1016/S0169-409X(00)00047-8; CO MS, 1985, P NATL ACAD SCI USA, V82, P1494, DOI 10.1073/pnas.82.5.1494; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; Ebnet K, 2000, J BIOL CHEM, V275, P27979; FRASER RDB, 1990, J VIROL, V64, P2990, DOI 10.1128/JVI.64.6.2990-3000.1990; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hopkins AM, 2000, ADV DRUG DELIVER REV, V41, P329, DOI 10.1016/S0169-409X(00)00050-8; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; KAYE KM, 1986, J VIROL, V59, P90, DOI 10.1128/JVI.59.1.90-97.1986; Lechner F, 2000, J INFECT DIS, V182, P978, DOI 10.1086/315765; LEONE G, 1992, CELL, V71, P479, DOI 10.1016/0092-8674(92)90516-F; LIU Y, 2000, J CELL SCI, V113, P1; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; McCormick BA, 1997, INFECT IMMUN, V65, P1414, DOI 10.1128/IAI.65.4.1414-1421.1997; NAGATA L, 1987, VIROLOGY, V160, P162, DOI 10.1016/0042-6822(87)90056-0; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; NIBERT ML, 1995, J VIROL, V69, P5057, DOI 10.1128/JVI.69.8.5057-5067.1995; Norris JL, 1999, J BIOL CHEM, V274, P13841, DOI 10.1074/jbc.274.20.13841; NOSEWORTHY JH, 1983, J IMMUNOL, V131, P2533; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Oberhaus SM, 1997, J VIROL, V71, P2100, DOI 10.1128/JVI.71.3.2100-2106.1997; Obert G, 2000, J VIROL, V74, P4645, DOI 10.1128/JVI.74.10.4645-4651.2000; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; RUBIN DH, 1992, J CLIN INVEST, V90, P2536, DOI 10.1172/JCI116147; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SHARPE AH, 1985, NEW ENGL J MED, V312, P486, DOI 10.1056/NEJM198502213120806; SPRIGGS DR, 1983, SCIENCE, V220, P505, DOI 10.1126/science.6301010; TARDIEU M, 1983, ANN NEUROL, V13, P602, DOI 10.1002/ana.410130604; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; TYLER KL, 1995, J VIROL, V69, P6972, DOI 10.1128/JVI.69.11.6972-6979.1995; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; TYLER KL, 1996, FIELDS VIROLOGY, P1597; VIRGIN HW, 1991, J VIROL, V65, P6772, DOI 10.1128/JVI.65.12.6772-6781.1991; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737	59	505	529	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2001	104	3					441	451		10.1016/S0092-8674(01)00231-8	http://dx.doi.org/10.1016/S0092-8674(01)00231-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239401	Bronze			2022-12-01	WOS:000167003100014
J	Heintzen, C; Loros, JJ; Dunlap, JC				Heintzen, C; Loros, JJ; Dunlap, JC			The PAS protein VIVID defines a clock-associated feedback loop that represses light input, modulates gating, and regulates clock resetting	CELL			English	Article							CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; NEUROSPORA; GENES; TRANSCRIPTION; EXPRESSION; RHYTHMS; COMPLEX; OUTPUT; DBP	vvd, a gene regulating light responses in Neurospora, encodes a novel member of the PAS/LOV protein superfamily. VVD defines a circadian clock-associated autoregulatory feedback loop that influences light resetting, modulates circadian gating of input by connecting output and input, and regulates light adaptation. Rapidly light induced, vvd is an early repressor of light-regulated processes. Further, vvd is clock controlled; the clock gates light induction of vvd and the clock gene fro so identical signals yield greater induction in the morning. Mutation of vvd severely dampens gating, especially of fro, consistent with VVD modulating gating and phasing right-resetting responses. vvd null strains display distinct alterations in the phase-response curve to light. Thus VVD, although not part of the clock, contributes significantly to regulation within the Neurospora circadian system.	Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Loros, JJ (corresponding author), Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA.	jennifer.loros@dartmouth.edu; jay.c.dunalp@dartmouth.edu	Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457	NIGMS NIH HHS [R37-GM 34985] Funding Source: Medline; NIMH NIH HHS [MH44651] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; DAVIS RL, 1970, METHOD ENZYMOL, V72, P79; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; DHARMANANDA S, 1980, THESIS U CALIFORNIA; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edmunds L.N., 1988, CELLULAR MOL BASES B; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FLEISSNER G, 1992, CIRCADIAN RHYTHMS, P79; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Hall M.D., 1993, GEORGIA J SCI, V51, P27; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Iwasaki H, 2000, CURR OPIN MICROBIOL, V3, P189, DOI 10.1016/S1369-5274(00)00074-6; Jelinkova D, 2000, NEUROSCI LETT, V280, P143, DOI 10.1016/S0304-3940(00)00773-4; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KAY SA, 1993, MOL GENETICS BIOL RH, P73; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Linden H, 1999, ADV GENET, V41, P35, DOI 10.1016/S0065-2660(08)60150-9; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MROSOVSKY N, 1989, EXPERIENTIA, V45, P696, DOI 10.1007/BF01974561; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; ORBACH MJ, 1994, GENE, V150, P159, DOI 10.1016/0378-1119(94)90877-X; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; PITTENDRIGH CS, 1981, HDB BEHAVIORAL NEURO, V4, P95; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JA, 2000, GENE DEV, V14, P679; Roenneberg T, 1999, REPROD NUTR DEV, V39, P277, DOI 10.1051/rnd:19990301; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SHRODE L, 2001, IN PRESS FUNGAL GENE; SOMMER T, 1989, NUCLEIC ACIDS RES, V17, P5713, DOI 10.1093/nar/17.14.5713; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Wan YH, 1997, FUNGAL GENET BIOL, V21, P329, DOI 10.1006/fgbi.1997.0988; Winfree A.T., 1980, GEOMETRY BIOL TIME, V8; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	50	257	262	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2001	104	3					453	464		10.1016/S0092-8674(01)00232-X	http://dx.doi.org/10.1016/S0092-8674(01)00232-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402RZ	11239402	Bronze			2022-12-01	WOS:000167003100015
J	Carroll, SB				Carroll, SB			The big picture	NATURE			English	Editorial Material									Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.							Erwin DH, 2000, EVOL DEV, V2, P78, DOI 10.1046/j.1525-142x.2000.00045.x; Lerner LS, 2000, NATURE, V407, P287, DOI 10.1038/35030204; Leroi AM, 2000, EVOL DEV, V2, P67, DOI 10.1046/j.1525-142x.2000.00044.x	3	15	15	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					669	669		10.1038/35055637	http://dx.doi.org/10.1038/35055637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217840				2022-12-01	WOS:000166816400023
J	Lopez-Garcia, P; Rodriguez-Valera, F; Pedros-Alio, C; Moreira, D				Lopez-Garcia, P; Rodriguez-Valera, F; Pedros-Alio, C; Moreira, D			Unexpected diversity of small eukaryotes in deep-sea Antarctic plankton	NATURE			English	Article							EVOLUTION; PHYLOGENY; SEQUENCES; ARCHAEA	Phylogenetic information from ribosomal RNA genes directly amplified from the environment changed our view of the biosphere, revealing an extraordinary diversity of previously undetected prokaryotic lineages. Using ribosomal RNA genes from marine picoplankton, several new groups of bacteria and archaea have been identified, some of which are abundant2-4. Little is known, however, about the diversity of the smallest planktonic eukaryotes, and available information in general concerns the phytoplankton of the euphotic region. Here we recover eukaryotes in the size fraction 0.2-5 mum from the aphotic zone (250-3,000 m deep) in the Antarctic polar front. The most diverse and relatively abundant were two new groups of alveolate sequences, related to dinoflagellates that are found at all studied depths. These may be important components of the microbial community in the deep ocean. Their phylogenetic position suggests a radiation early in the evolution of alveolates.	Univ Miguel Hernandez, Div Microbiol, San Juan De Alicante 03550, Spain; CSIC, Inst Ciences Mar, E-08039 Barcelona, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Moreira, D (corresponding author), Univ Miguel Hernandez, Div Microbiol, San Juan De Alicante 03550, Spain.		Moreira, David/F-7445-2012; Pedrós-Alió, Carlos/H-1222-2011; Rodriguez-Valera, Francisco/M-2782-2013; Lopez-Garcia, Purificacion/B-6775-2012	Moreira, David/0000-0002-2064-5354; Pedrós-Alió, Carlos/0000-0003-1009-4277; Rodriguez-Valera, Francisco/0000-0002-9809-2059; Lopez-Garcia, Purificacion/0000-0002-0927-0651				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FENCHEL T, 1998, BACTERIAL BIOGEOCHEM; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; GIOVANNONI SJ, 1992, NATURE, V356, P148; Guillou L, 1999, APPL ENVIRON MICROB, V65, P4528; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; LENAERS G, 1991, J MOL EVOL, V32, P53, DOI 10.1007/BF02099929; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; MCRAE RA, 1996, CAN J BOT, V74, P1987; Moldowan JM, 1998, SCIENCE, V281, P1168, DOI 10.1126/science.281.5380.1168; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pawlowski J, 1997, MOL BIOL EVOL, V14, P498, DOI 10.1093/oxfordjournals.molbev.a025786; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Raghukumar S, 1999, MAR ECOL PROG SER, V190, P133, DOI 10.3354/meps190133; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; Takami H, 1997, FEMS MICROBIOL LETT, V152, P279, DOI 10.1016/S0378-1097(97)00211-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	27	689	735	5	123	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					603	607		10.1038/35054537	http://dx.doi.org/10.1038/35054537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214316				2022-12-01	WOS:000166692300040
J	Brugarolas, J; Haynes, BF; Nevins, JR				Brugarolas, J; Haynes, BF; Nevins, JR			Towards a genomic-based diagnosis	LANCET			English	Editorial Material							GENE-EXPRESSION; PATTERNS; CANCER; ARRAYS		Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA	Duke University; Duke University	Brugarolas, J (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; DeRisi J, 1996, NAT GENET, V14, P457; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Masters JRW, 2000, NATURE, V404, P921, DOI 10.1038/35010139; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roses AD, 2000, LANCET, V355, P1358, DOI 10.1016/S0140-6736(00)02126-7; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343	15	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					249	250		10.1016/S0140-6736(00)03608-4	http://dx.doi.org/10.1016/S0140-6736(00)03608-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214124				2022-12-01	WOS:000166693400006
J	Muniz, M; Morsomme, P; Riezman, H				Muniz, M; Morsomme, P; Riezman, H			Protein sorting upon exit from the endoplasmic reticulum	CELL			English	Article							COPII-COATED VESICLES; GPI-ANCHORED PROTEINS; GOLGI-COMPLEX; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; PLASMA-MEMBRANE; SECRETORY PATHWAY; IN-VITRO; BETA-COP; YEAST	It is currently thought that all secretory proteins travel together to the Golgi apparatus where they are sorted to different destinations. However, the specific requirements for transport of GPI-anchored proteins from the endoplasmic reticulum to the Golgi apparatus in yeast could be explained if protein sorting occurs earlier in the pathway. Using an in vitro assay that reconstitutes a single round of budding from the endoplasmic reticulum, we found that GPI-anchored proteins and other secretory proteins exit the endoplasmic reticulum in distinct vesicles. Therefore, GPI-anchored proteins are sorted from other proteins, in particular other plasma membrane proteins, at an early stage of the secretory pathway. These results have wide implications for the mechanism of protein exit from the endoplasmic reticulum.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland	University of Basel	Riezman, H (corresponding author), Univ Basel, Bioctr, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Nakano, Akihiko/A-6420-2016; Morsomme, Pierre/AAD-9600-2019; muñiz, manuel/Q-2890-2019; IBIS, EUCARIONTES/H-7494-2016	Nakano, Akihiko/0000-0003-3635-548X; muñiz, manuel/0000-0001-8011-6991; Riezman, Howard/0000-0003-4680-9422; Morsomme, Pierre/0000-0001-7780-7230				Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Hicke L, 1997, MOL BIOL CELL, V8, P13, DOI 10.1091/mbc.8.1.13; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Sipos G, 1997, EMBO J, V16, P3494, DOI 10.1093/emboj/16.12.3494; Sutterlin C, 1997, J CELL SCI, V110, P2703; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	43	206	209	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					313	320		10.1016/S0092-8674(01)00215-X	http://dx.doi.org/10.1016/S0092-8674(01)00215-X			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207371	Bronze			2022-12-01	WOS:000166879700014
J	Ostareck, DH; Ostareck-Lederer, A; Shatsky, IN; Hentze, MW				Ostareck, DH; Ostareck-Lederer, A; Shatsky, IN; Hentze, MW			Lipoxygenase mRNA silencing in erythroid differentiation: The 3 ' UTR regulatory complex controls 60S ribosomal subunit joining	CELL			English	Article							CAP-INDEPENDENT TRANSLATION; MESSENGER-RNA; INITIATION-FACTORS; BINDING-PROTEIN; CYTOPLASMIC POLYADENYLATION; PREVENTS; YEAST; RECRUITMENT; SEQUENCE; FERRITIN	15-lipoxygenase (LOX) expression is translationally silenced in early erythroid precursor cells by a specific mRNA-protein complex formed between the differentiation control element in the 3' untranslated region (UTR) and hnRNPs K and E1. The 3'UTR regulatory complex prevents translation initiation by an unknown mechanism. We demonstrate that the 40S ribosomal subunit can be recruited and scan to the translation initiation codon even when the silencing complex is bound to the 3'UTR. However, the joining of the 60S ribosomal subunit at the AUG codon to form a translation competent 80S ribosome is inhibited, unless initiation is mediated by the IGR-IRES of the cricket paralysis virus. These findings identify the critical step at which LOX mRNA translation is controlled and reveal that 60S subunit joining can be specifically regulated.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia	European Molecular Biology Laboratory (EMBL); Lomonosov Moscow State University	Hentze, MW (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl-heidelberg.de	Hentze, Matthias W/V-3980-2017; Shatsky, Ivan N/A-5331-2012	Hentze, Matthias W/0000-0002-4023-7876; Ostareck-Lederer, Antje/0000-0003-0733-7071; Ostareck, Dirk/0000-0001-9406-7190				Allen E, 1999, VIROLOGY, V253, P139, DOI 10.1006/viro.1998.9507; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; CHAKRABARTI A, 1991, J BIOL CHEM, V266, P14039; Cuesta R, 2000, GENE DEV, V14, P1460; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; Das S, 2000, MOL CELL BIOL, V20, P3942, DOI 10.1128/MCB.20.11.3942-3950.2000; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; EHRENFELD E, 1996, TRANSLATIONAL CONTRO, P549; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goodwin EB, 1997, DEVELOPMENT, V124, P749; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; HERSHEY JWB, 1966, J MOL BIOL, V18, P68, DOI 10.1016/S0022-2836(66)80077-3; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HOHNE M, 1988, BIOMED BIOCHIM ACTA, V47, P75; HUNT T, 1989, TRENDS BIOCHEM SCI, V14, P393, DOI 10.1016/0968-0004(89)90280-6; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; Jan E, 1997, EMBO J, V16, P6301, DOI 10.1093/emboj/16.20.6301; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; Merrick WC., 1996, TRANSLATION CONTROL, P31; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; RAPOPORT SM, 1986, BIOCHIM BIOPHYS ACTA, V864, P471, DOI 10.1016/0304-4157(86)90006-7; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schneider RJ, 1995, CURR TOP MICROBIOL, V203, P117; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1997, CRIT REV EUKAR GENE, V7, P73, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.50; STRIPECKE R, 1992, NUCLEIC ACIDS RES, V20, P5555, DOI 10.1093/nar/20.21.5555; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Thompson SR, 2000, MOL CELL BIOL, V20, P2129, DOI 10.1128/MCB.20.6.2129-2137.2000; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wickens M, 2000, TRANSLATIONAL CONTRO; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wormington M, 1996, EMBO J, V15, P900, DOI 10.1002/j.1460-2075.1996.tb00424.x; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	53	210	218	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					281	290		10.1016/S0092-8674(01)00212-4	http://dx.doi.org/10.1016/S0092-8674(01)00212-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207368	hybrid			2022-12-01	WOS:000166879700011
J	Sampson, SD; Carrano, MT; Forster, CA				Sampson, SD; Carrano, MT; Forster, CA			A bizarre predatory dinosaur from the Late Cretaceous of Madagascar	NATURE			English	Article							EVOLUTION	Here we report the discovery of a small-bodied (similar to1.8 m) predatory dinosaur from the Late Cretaceous (Maastrichtian) of Madagascar. Masiakasaurus knopfleri, gen. et sp. nov., represented by several skull elements and much of the postcranial skeleton, is unique in being the only known theropod with a highly procumbent and distinctly heterodont lower dentition. Such a derived dental morphology is otherwise unknown among dinosaurs. Numerous skeletal characteristics indicate that Masiakasaurus is a member of Abelisauroidea, an enigmatic clade of Gondwanan theropods. Previously, small-bodied abelisauroids were known only from Argentina(1-3). The occurrence of Masiakasaurus on Madagascar suggests that small-bodied abelisauroids, like their larger-bodied counterparts, were more cosmopolitan, radiating throughout much of Gondwana and paralleling the diversification of small coelurosaur theropods in Laurasia.	Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Sampson, SD (corresponding author), Univ Utah, Utah Museum Nat Hist, 1390 E Presidents Circle, Salt Lake City, UT 84112 USA.		Carrano, Matthew/C-7601-2011	Carrano, Matthew/0000-0003-2129-1612				[Anonymous], 1980, MEM S GEO F; Bonaparte J.F., 1991, Historical Biology, V5, P1; BONAPARTE JF, 1991, PALEONTOLOGIA, V4, P16; BONAPARTE JF, 1996, GEOLOGIE PALAONTOLOG, V30, P73; Carrano M. T., 1999, Journal of Vertebrate Paleontology, V19, p36A; Forster CA, 1999, J AFR EARTH SCI, V28, P169, DOI 10.1016/S0899-5362(99)00023-8; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Krause D.W., 1999, GSA TODAY, V9, P1; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Novas FE, 1997, ENCY DINOSAURS; Rauhut Oliver W. M., 1998, Journal of Vertebrate Paleontology, V18, p71A; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1	19	102	107	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					504	506		10.1038/35054046	http://dx.doi.org/10.1038/35054046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206544				2022-12-01	WOS:000166570500045
J	Hill, CL; Zhang, YQ; Sigurgeirsson, B; Pukkala, E; Mellemkjaer, L; Airio, A; Evans, SR; Felson, DT				Hill, CL; Zhang, YQ; Sigurgeirsson, B; Pukkala, E; Mellemkjaer, L; Airio, A; Evans, SR; Felson, DT			Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study	LANCET			English	Article							AMYOPATHIC DERMATOMYOSITIS; NASOPHARYNGEAL CARCINOMA; ASSOCIATION; MALIGNANCY; FINLAND; RISK	Background Dermatomyositis and polymyositis are associated with cancer, but previous nationwide studies have not had sufficient cases to test the association between myositis and specific cancer types. Our aim was to investigate the risk of specific cancer types in individuals with dermatomyositis and polymyositis. Methods We did a pooled analysis of published national data from Sweden. Denmark, and Finland. All patients with dermatomyositis and polymyositis (greater than or equal to 15 years old) were identified by discharge diagnosis from the Swedish National Board of Health (1964-83), Danish Hospital Discharge Registry (1977-89), and Finnish National Board of Health (1969-85). Personal details were matched to national cancer registries, to identify ail cases of cancer up to 1987 in Sweden, 1995 in Denmark, and 1997 in Finland, and to national death registries for the same periods. We calculated standardised incidence ratios (SIR) for individual cancer sites for dermatomyositis and polymyositis separately, using national cancer rates by country, sex, age, and date. Findings We identified 618 cases of dermatomyositis, of whom 198 had cancer. 115 of the 198 developed cancer after diagnosis of dermatomyositis. This disease was strongly associated with malignant disease (SIR 3.0, 95% CI 2.5-3.6), particularly ovarian (10.5, 6.1-18.1), lung (5.9, 3.7-9.2), pancreatic(3.8, 1.6-9.0), stomach (3.5, 1.7-7.3), and colorectal (2.5, 1.4-4.4) cancers, and non-Hodgkin lymphoma (3.6, 1.2-11.1). 137 of the 914 cases of polymyositis had cancer, which developed after diagnosis of polymyositis in 95. Polymyositis was associated with a raised risk of non-Hodgkin lymphoma (3.7, 1.7-8.2), and lung (2.8, 1.8-4.4) and bladder cancers (2.4, 1.3-4.7). In both dermatomyositis and polymyositis, risk of malignant disease was highest at time of myositis diagnosis. Interpretation Our results provide evidence that dermatomyositis is strongly associated with a wide range of cancers. The overall risk of malignant disease is also modestly increased among patients with polymyositis, with an excess for some cancers.	Boston Univ, Arthrit Ctr, Boston, MA 02118 USA; Karolinska Hosp, S-10401 Stockholm, Sweden; Landspitalinn, Dept Dermatol, Reykjavik, Iceland; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Turku City Hosp, Turku, Finland	Boston University; Karolinska Institutet; Karolinska University Hospital; Finnish Cancer Registry; Danish Cancer Society; University of Turku	Felson, DT (corresponding author), Boston Univ, Arthrit Ctr, A203, Boston, MA 02118 USA.		Sigurgeirsson, Bárður/B-6130-2011; Hill, Catherine L/AAE-7152-2019; Sigurgeirsson, Bardur/AAP-7755-2020	Hill, Catherine L/0000-0001-8289-4922; Sigurgeirsson, Bardur/0000-0002-9733-9742; Zhang, Yuqing/0000-0001-7954-1149; Felson, David/0000-0002-2668-2447	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020613] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR20613] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIRIO A, 1995, J RHEUMATOL, V22, P1300; BARNES BE, 1976, ANN INTERN MED, V84, P68, DOI 10.7326/0003-4819-84-1-68; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BRADLEY WG, 1989, TXB RHEUMATOLOGY, P1263; Buchbinder R, 1998, ARTHRITIS RHEUM, V41, pS204; Callen JP, 2000, LANCET, V355, P53, DOI 10.1016/S0140-6736(99)05157-0; CHOW WH, 1995, CANCER CAUSE CONTROL, V6, P9, DOI 10.1007/BF00051675; Dalakas MC, 1991, NEW ENGL J MED, V325, P1498; Darnell RB, 1999, NEW ENGL J MED, V340, P1831, DOI 10.1056/NEJM199906103402311; Davis MDP, 1997, J AM ACAD DERMATOL, V37, P730, DOI 10.1016/S0190-9622(97)70109-9; Dickman PW, 1999, ACTA ONCOL, V38, P1; FUDMAN EJ, 1986, AM J MED, V80, P329, DOI 10.1016/0002-9343(86)90036-7; Fung WKJ, 1998, INT J DERMATOL, V37, P659, DOI 10.1046/j.1365-4362.1998.00453.x; Goyal S, 1999, J AM ACAD DERMATOL, V41, P874, DOI 10.1016/S0190-9622(99)70349-X; HAFTEL HM, 1993, NEW ENGL J MED, V327, P207; Klippel JH, 1998, RHEUMATOLOGY; Koopman W.J., 1996, ARTHRITIS ALLIED CON; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; PENG JC, 1995, ARCH OTOLARYNGOL, V121, P1298; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; STORM HH, 1997, DAN MED B, V44, P549; SUNNENBERG TD, 1983, CANCER, V51, P2157, DOI 10.1002/1097-0142(19830601)51:11<2157::AID-CNCR2820511135>3.0.CO;2-Q; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; VERDUCCI MA, 1984, OBSTET GYNECOL, V64, P695; Voltz R, 1999, NEW ENGL J MED, V340, P1788, DOI 10.1056/NEJM199906103402303; ZANTOS D, 1994, J RHEUMATOL, V21, P1855	26	695	735	0	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 13	2001	357	9250					96	100		10.1016/S0140-6736(00)03540-6	http://dx.doi.org/10.1016/S0140-6736(00)03540-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393NH	11197446				2022-12-01	WOS:000166476200010
J	Nishimura, H; Okazaki, T; Tanaka, Y; Nakatani, K; Hara, M; Matsumori, A; Sasayama, S; Mizoguchi, A; Hiai, H; Minato, N; Honjo, T				Nishimura, H; Okazaki, T; Tanaka, Y; Nakatani, K; Hara, M; Matsumori, A; Sasayama, S; Mizoguchi, A; Hiai, H; Minato, N; Honjo, T			Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice	SCIENCE			English	Article							ANTIBODIES; DISEASES	Dilated cardiomyopathy is a severe pathology of the heart with poorly understood etiology. Disruption of the gene encoding the negative immunoregulatory receptor PD-1 in BALB/c mice, but not in BALB/c RAG-2(-/-) mice, caused dilated cardiomyopathy with severely impaired contraction and sudden death by congestive heart failure. Affected hearts showed diffuse deposition of immunoglobulin G (IgG) on the surface of cardiomyocytes. ALL of the affected PD-1(-/-) mice exhibited high-titer circulating IgG autoantibodies reactive to a 33-kilodalton protein expressed specifically on the surface of cardiomyocytes. These results indicate that PD-1 may be an important factor contributing to the prevention of autoimmune diseases.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Osaka City Univ, Sch Med, Dept Anat 2, Osaka 5458585, Japan; Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Osaka Metropolitan University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.		Honjo, Tasuku/N-4470-2016	Okazaki, Taku/0000-0003-4790-1925; Tanaka, Yoshimasa/0000-0002-5024-0614				CAFORIO ALP, 1994, LANCET, V344, P773, DOI 10.1016/S0140-6736(94)92339-6; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; HOSENPUD JD, 2000, CONGESTIVE HEART FAI, P281; KLEIN R, 1984, CLIN EXP IMMUNOL, V58, P283; Matsumori A, 1997, JPN CIRC J, V61, P275, DOI 10.1253/jcj.61.275; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NISHIMURA H, UNPUB; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; SABN DJ, 1978, CIRCULATION, V58, P1072; Sambrook J., 1989, MOL CLONING LAB MANU; SCHULZE K, 1989, CIRC RES, V64, P179, DOI 10.1161/01.RES.64.2.179; Sedarat F, 2000, AM J PHYSIOL-HEART C, V279, pH202, DOI 10.1152/ajpheart.2000.279.1.H202	16	1282	1471	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					319	322		10.1126/science.291.5502.319	http://dx.doi.org/10.1126/science.291.5502.319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209085				2022-12-01	WOS:000166352900050
J	Wang, SQ; Song, LS; Lakatta, EG; Cheng, HP				Wang, SQ; Song, LS; Lakatta, EG; Cheng, HP			Ca2+ signalling between single L-type Ca2+ channels and ryanodine receptors in heart cells	NATURE			English	Article							FROG SKELETAL-MUSCLE; CARDIAC MYOCYTES; CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; SPARKS; INACTIVATION	Ca2+-induced Ca2+ release is a general mechanism that most cells use to amplify Ca2+ signals(1-5). In heart cells, this mechanism is operated between voltage-gated L-type Ca2+ channels (LCCs) in the plasma membrane and Ca2+ release channels, commonly known as ryanodine receptors, in the sarcoplasmic reticulum(3-5) The Ca2+ influx through LCCs traverses a deft of roughly 12 nm formed by the cell surface and the sarcoplasmic reticulum membrane, and activates adjacent ryanodine receptors to release Ca2+ in the form of Ca2+ sparks(6). Here we determine the kinetics, fidelity and stoichiometry of coupling between LCCs and ryanodine receptors. We show that the local Ca2+ signal produced by a single opening of an LCC named a 'Ca2+ sparklet: can trigger about 4-6 ryanodine receptors to generate a Ca2+ spark. The coupling between LCCs and ryanodine receptors is stochastic, as judged by the exponential distribution of the coupling latency. The fraction of sparklets that successfully triggers a spark is less than unity and declines in a use-dependent manner. This optical analysis of single-channel communication affords a powerful means for elucidating Ca2+-signalling mechanisms at the molecular level.	NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University	Cheng, HP (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.		Lakatta, Edward G/AAL-1447-2020; Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011; Song, Long-Sheng/D-5899-2012	Heping, Cheng/0000-0002-9604-6702; Song, Long-Sheng/0000-0002-6035-8106; Lakatta, Edward/0000-0002-4772-0035; Wang, Shi-Qiang/0000-0001-7784-4461	NATIONAL INSTITUTE ON AGING [Z01AG000853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Blatter LA, 1997, P NATL ACAD SCI USA, V94, P4176, DOI 10.1073/pnas.94.8.4176; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Bridge JHB, 1999, J PHYSIOL-LONDON, V518, P469, DOI 10.1111/j.1469-7793.1999.0469p.x; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; CARL SL, 1995, J CELL BIOL, V129, P672; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Gonzalez A, 2000, P NATL ACAD SCI USA, V97, P4380, DOI 10.1073/pnas.070056497; GYORKE S, 1993, SCIENCE, V260, P807, DOI 10.1126/science.8387229; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARKINS AB, 1993, BIOPHYS J, V65, P865, DOI 10.1016/S0006-3495(93)81112-3; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; Lipp P, 1998, J PHYSIOL-LONDON, V508, P801, DOI 10.1111/j.1469-7793.1998.801bp.x; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Mejia-Alvarez R, 1999, J GEN PHYSIOL, V113, P177, DOI 10.1085/jgp.113.2.177; NIGGLI E, 1990, SCIENCE, V250, P565, DOI 10.1126/science.2173135; Santana LF, 1996, CIRC RES, V78, P166, DOI 10.1161/01.RES.78.1.166; Schneider MF, 1999, J GEN PHYSIOL, V113, P365, DOI 10.1085/jgp.113.3.365; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; Shorofsky SR, 1998, CIRC RES, V82, P424, DOI 10.1161/01.RES.82.4.424; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559	29	324	345	4	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					592	596		10.1038/35069083	http://dx.doi.org/10.1038/35069083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279498				2022-12-01	WOS:000167859300050
J	Martin, SL; Mackie, L; Kupper, LL; Buescher, P; Moracco, KE				Martin, SL; Mackie, L; Kupper, LL; Buescher, P; Moracco, KE			Physical abuse of women before, during, and after pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIOLENCE; MOTHERS; IDENTIFICATION; POSTPARTUM; RISK	Context Clinicians who care for new mothers and infants need information concerning postpartum physical abuse of women as a foundation on which to develop appropriate clinical screening and intervention procedures. However, no previous population-based studies have been conducted of postpartum physical abuse. Objectives To examine patterns of physical abuse before. during, and after pregnancy in a representative statewide sample of North Carolina women. Design, Setting, and Participants Survey of participants in the North Carolina Pregnancy Risk Assessment Monitoring System (NC PRAMS). Of the 3542 women invited to participate in NC PRAMS between July 1, 1997, and December 31, 1998, 75% (n=2648) responded. Main Outcome Measures Prevalence of physical abuse during the 12 months before pregnancy, during pregnancy, and after infant delivery; injuries and medical interventions resulting from postpartum abuse; and patterns of abuse over time in relation to sociodemographic characteristics and use of well-baby care. Results The prevalence of abuse before pregnancy was 6.9% (95% confidence interval [CI], 5.6%-8.2%) compared with 6.1% (95% CI, 4.8%-7.4%) during pregnancy and 3.2% (95% CI, 2.3%-4.1%) during a mean postpartum period of 3.6 months. Abuse during a previous period was strongly predictive of later abuse, Most women who were abused after pregnancy (77%) were injured, but only 23% received medical treatment for their injuries. Virtually all abused and nonabused women used well-baby care; private physicians were the most common source of care. The mean number of well-baby care visits did not differ significantly by maternal patterns of abuse. Conclusion Since well-baby care use is similar for abused and nonabused mothers, pediatric practices may be important settings for screening women for violence.	Univ N Carolina, Sch Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Hlth Behav & Hlth Educ, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; State Ctr Hlth Stat, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Martin, SL (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Maternal & Child Hlth, CB 7400, Chapel Hill, NC 27599 USA.	sandra_martin@unc.edu			PHS HHS [R49/CCR402444-15] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM COLL OBST GYN, 1989, ACOG TECHN B, V124; [Anonymous], 2000, INTIMATE PARTNER VIO; Bays JA, 1998, PEDIATRICS, V101, P1091; BELSKY J, 1983, J MARRIAGE FAM, V45, P567, DOI 10.2307/351661; *BUR JUST STAT, 2001, CRIM VICT US 1998 ST; Clark KA, 2000, ARCH FAM MED, V9, P1093, DOI 10.1001/archfami.9.10.1093; Council on Scientific Affairs American Medical Association, 1992, JAMA-J AM MED ASSOC, V267, P3184, DOI DOI 10.1001/JAMA.1992.03480230076032; GAZMARARIAN JA, 1995, OBSTET GYNECOL, V85, P1031, DOI 10.1016/0029-7844(95)00057-X; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; GELLES RJ, 1988, J MARRIAGE FAM, V50, P841, DOI 10.2307/352652; GIELEN AC, 1994, SOC SCI MED, V39, P781, DOI 10.1016/0277-9536(94)90039-6; Hedin LW, 2000, EUR J OBSTET GYN R B, V89, P41; HELTON AS, 1987, AM J PUBLIC HEALTH, V77, P1337, DOI 10.2105/AJPH.77.10.1337; Kerker BD, 2000, ARCH PEDIAT ADOL MED, V154, P457, DOI 10.1001/archpedi.154.5.457; Martin SL, 1996, AM J PUBLIC HEALTH, V86, P991, DOI 10.2105/AJPH.86.7.991; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; MILLER BC, 1980, FAM RELAT, V29, P459, DOI 10.2307/584459; Shah BV, 1996, SUDAAN USERS MANUAL; Spivak H, 1999, PEDIATRICS, V103, P173; STEWART DE, 1993, CAN MED ASSOC J, V149, P1257; STEWART DE, 1994, CAN MED ASSOC J, V151, P1601; Tjaden P, 2000, EXTENT NATURE CONSEQ; Tjaden P., 1998, PREVALENCE INCIDENCE; Wright RJ, 2000, ARCH PEDIAT ADOL MED, V154, P431, DOI 10.1001/archpedi.154.5.431; Wright RJ, 1997, PEDIATRICS, V99, P186, DOI 10.1542/peds.99.2.186	25	224	228	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1581	1584		10.1001/jama.285.12.1581	http://dx.doi.org/10.1001/jama.285.12.1581			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413HH	11268265	Bronze			2022-12-01	WOS:000167606600024
J	Leakey, MG; Spoor, F; Brown, FH; Gathogo, PN; Kiarie, C; Leakey, LN; McDougall, I				Leakey, MG; Spoor, F; Brown, FH; Gathogo, PN; Kiarie, C; Leakey, LN; McDougall, I			New hominin genus from eastern Africa shows diverse middle Pliocene lineages	NATURE			English	Article							AUSTRALOPITHECUS-AFARENSIS; HADAR FORMATION; SOUTH-AFRICA; FOSSIL HOMINIDS; TURKANA BASIN; LAKE TURKANA; KOOBI FORA; ETHIOPIA; KENYA; SKULL	Most interpretations of early hominin phylogeny recognize a single early to middle Pliocene ancestral lineage, best represented by Australopithecus afarensis, which gave rise to a radiation of taxa in the late Pliocene. Here we report on new fossils discovered west of Lake Turkana, Kenya, which differ markedly from those of contemporary A. afarensis, indicating that hominin taxonomic diversity extended back, well into the middle Pliocene. A 3.5 Myr-old cranium, showing a unique combination of derived facial and primitive neurocranial features, is assigned to a new genus of hominin. These findings point to an early diet-driven adaptive radiation, provide new insight on the association of hominin craniodental features, and have implications for our understanding of Plio-Pleistocene hominin phylogeny.	Natl Museums Kenya, Div Palaeontol, Nairobi, Kenya; UCL, Dept Anat & Dev Biol, London WC1E 6JJ, England; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of London; University College London; Utah System of Higher Education; University of Utah; Australian National University	Leakey, MG (corresponding author), Natl Museums Kenya, Div Palaeontol, POB 40658, Nairobi, Kenya.	meave@swiftkenya.com	Spoor, Fred/C-1718-2008	Leakey, Louise/0000-0003-3420-6341				Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; BILSBOROUGH A, 1988, AM J PHYS ANTHROPOL, V76, P61, DOI 10.1002/ajpa.1330760107; BROWN B, IN PRESS J HUM EVOL; BROWN FH, 1978, GEOPHYS J ROY ASTR S, V54, P519, DOI 10.1111/j.1365-246X.1978.tb05492.x; BRUNET M, 1995, NATURE, V378, P273, DOI 10.1038/378273a0; Brunet M, 1996, CR ACAD SCI II A, V322, P907; DEMENOCAL PB, 1999, HOMINID EVOLUTION CL, V1, P23; ECK GG, 1993, THEROPITHECUS, P15, DOI 10.1017/CBO9780511565540.003; Feibel C.S., 1991, P321; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; GRINE FE, 1994, J HUM EVOL, V26, P57, DOI 10.1006/jhev.1994.1004; HAILEAB B, 1995, GEOCHEMISTRY GEOCHRO; Harris J.M., 1987, P524; HARRIS M, 1988, CONT SCI NAT HIST MU, V399, P1; Harrison Terry, 1993, P345; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P373, DOI 10.1002/ajpa.1330570402; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Keyser AW, 2000, S AFR J SCI, V96, P189; Kimbel W.H., 1988, P259; KIMBEL WH, 1988, J HUM EVOL, V17, P647, DOI 10.1016/0047-2484(88)90022-X; KIMBEL WH, 1984, AM J PHYS ANTHROPOL, V64, P337, DOI 10.1002/ajpa.1330640403; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; LEAKEY M.D., 1987, LAETOLI PLIOCENE SIT; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lockwood CA, 1999, J HUM EVOL, V36, P637, DOI 10.1006/jhev.1999.0299; Lockwood CA, 2000, J HUM EVOL, V39, P23, DOI 10.1006/jhev.2000.0401; McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301; MCDOUGALL I, 1985, GEOL SOC AM BULL, V96, P159, DOI 10.1130/0016-7606(1985)96<159:KAADOT>2.0.CO;2; MCDOUGALL I, 1992, GEOPHYS RES LETT, V19, P2349, DOI 10.1029/92GL02714; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; ROBINSON J. T., 1956, TRANSVAAL MUS MEM, V9, P1; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Strait DS, 1997, J HUM EVOL, V32, P17, DOI 10.1006/jhev.1996.0097; Suwa G, 1997, NATURE, V389, P489, DOI 10.1038/39037; Tobias PV, 1991, OLDUVAI GORGE, V4; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; WALTER RC, 1993, J HUM EVOL, V25, P229, DOI 10.1006/jhev.1993.1046; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; White TD, 2000, AM J PHYS ANTHROPOL, V111, P45, DOI 10.1002/(SICI)1096-8644(200001)111:1<45::AID-AJPA4>3.0.CO;2-I; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD B, 2000, HOMO EVOL ANTHR, V8, P195	48	207	219	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2001	410	6827					433	440		10.1038/35068500	http://dx.doi.org/10.1038/35068500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260704				2022-12-01	WOS:000167583800032
J	McJunkin, JE; de los Reyes, EC; Irazuzta, JE; Caceres, MJ; Khan, RR; Minnich, LL; Fu, KD; Lovett, GD; Tsai, T; Thompson, A				McJunkin, JE; de los Reyes, EC; Irazuzta, JE; Caceres, MJ; Khan, RR; Minnich, LL; Fu, KD; Lovett, GD; Tsai, T; Thompson, A			La crosse encephalitis in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; BACTERIAL-MENINGITIS; INTRACRANIAL-PRESSURE; INAPPROPRIATE SECRETION; BRAIN; HYPOTHERMIA; DIAGNOSIS; VIRUS	Background: La Crosse encephalitis is a mosquito-borne disease that can be mistaken for herpes simplex encephalitis. It has been reported in 28 states but may be underrecognized. Methods: We investigated the manifestations and clinical course of La Crosse encephalitis in 127 patients hospitalized from 1987 through 1996. The diagnosis was established by serologic testing for IgM and IgG antibodies to La Crosse virus. Data were collected by chart review. Results: Most of the patients were school-aged children (mean [+/-SD] age, 7.8+/-3.5 years; range, 0.5 to 15.0). Symptoms included headache, fever, and vomiting (each in 70 percent or more of the patients), seizures (in 46 percent), and disorientation (in 42 percent). Thirteen percent had aseptic meningitis. Hyponatremia developed in 21 percent, and there were signs of increased intracranial pressure in 13 percent. Six patients, including three with cerebral herniation, underwent intracranial-pressure monitoring. The 13 patients (11 percent) whose condition deteriorated in the hospital had decreases in serum sodium levels (P=0.007) and increases in body temperature (P=0.003) at the time of deterioration. At admission, these patients more often had a history of vomiting (P=0.047) and a score of 12 or lower on the Glasgow Coma Scale (P=0.02) than the others; a trend toward a greater prevalence of seizures at admission was also evident in this group (P=0.07). All the patients survived, but 15 of them (12 percent) had neurologic deficits at discharge. Follow-up assessments, performed in 28 children, suggested an increase in cognitive and behavioral deficits 10 to 18 months after the episode of encephalitis. Conclusions: La Crosse virus infection should be considered in children who present with aseptic meningitis or encephalitis. Hyponatremia and increasing body temperature may be related to clinical deterioration. (N Engl J Med 2001;344:801-7.) Copyright (C) 2001 Massachusetts Medical Society.	W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Charleston Div, Charleston, WV 25304 USA; Charleston Area Med Ctr, Charleston, WV USA; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	West Virginia University; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McJunkin, JE (corresponding author), W Virginia Univ, Dept Pediat, POB 9214, Morgantown, WV 26506 USA.	jmcjunkin@hsc.wvu.edu	de los Reyes, Emily C/AAP-3836-2020					Achenbach T.M., 1991, BURLINGTON VT, V7, P371; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P82; ASHLEY R, 1995, 10 POST SESS PAN AM; BALFOUR HH, 1973, PEDIATRICS, V52, P680; CAMPBELL WP, 1995, J VIROL METHODS, V53, P55, DOI 10.1016/0166-0934(94)00176-H; CASSIDY LF, 1989, ANTIMICROB AGENTS CH, V33, P2009, DOI 10.1128/AAC.33.11.2009; Chun R W, 1983, Prog Clin Biol Res, V123, P193; CHUN RWM, 1968, NEUROLOGY, V18, P369; *COMM HOSP CAR SEC, 1999, PEDIATRICS, V103, P840; Conners C.K., 2008, CONNERS COMPREHENSIV; CRAMBLETT HG, 1966, J AMER MED ASSOC, V198, P108, DOI 10.1001/jama.198.2.108; DUCK SC, 1988, J PEDIATR-US, V113, P10, DOI 10.1016/S0022-3476(88)80521-3; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Floret D, 1999, ARCH PEDIATRIE, V6, P199, DOI 10.1016/S0929-693X(99)80209-7; GRABOW JD, 1969, NEUROLOGY, V19, P394, DOI 10.1212/WNL.19.4.394; Grimstad P. R., 1988, The arboviruses: epidemiology and ecology. Volume II., P99; Gundersen C B, 1983, Prog Clin Biol Res, V123, P169; HARRIS GD, 1988, J PEDIATR-US, V113, P65, DOI 10.1016/S0022-3476(88)80529-8; HAYNES RE, 1969, J AMER MED ASSOC, V208, P1657, DOI 10.1001/jama.208.9.1657; HILTY MD, 1972, AM J DIS CHILD, V124, P530, DOI 10.1001/archpedi.1972.02110160068006; Huang C, 1999, CLIN INFECT DIS, V28, P1294, DOI 10.1086/514789; Huang C, 1999, NEW ENGL J MED, V340, P483, DOI 10.1056/NEJM199902113400616; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; JANSSEN R, 1984, LAB INVEST, V50, P447; JOHNSON KP, 1968, J NEUROPATH EXP NEUR, V27, P390, DOI 10.1097/00005072-196807000-00003; KAPLAN SL, 1978, J PEDIATR-US, V92, P758, DOI 10.1016/S0022-3476(78)80144-9; Kappus K D, 1983, Prog Clin Biol Res, V123, P31; KATSUMURA H, 1995, ACTA NEUROCHIR, V135, P62, DOI 10.1007/BF02307416; MACK K, 1996, 12 M PAN AM SOC CLIN; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATTHEWS CG, 1968, NEUROLOGY, V18, P1023, DOI 10.1212/WNL.18.10.1023; MCGILLICUDDY JE, 1985, CHEST, V87, P85, DOI 10.1378/chest.87.1.85; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 1997, PEDIATRICS, V99, P261, DOI 10.1542/peds.99.2.261; MCJUNKIN JE, 1998, TXB PEDIAT INFECT DI, V2, P2150; MUNOZ SJ, 1993, TRANSPLANTATION, V55, P1071, DOI 10.1097/00007890-199305000-00025; Nara I, 1998, ACT NEUR S, V71, P22; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; PATWARI AK, 1995, ANN TROP PAEDIATR, V15, P179, DOI 10.1080/02724936.1995.11747769; Rauf SJ, 1999, INFECT DIS CLIN N AM, V13, P647, DOI 10.1016/S0891-5520(05)70099-4; RIE HE, 1973, AM J DIS CHILD, V125, P824, DOI 10.1001/archpedi.1973.04160060036007; ROGERS MC, 1996, TXB PEDIAT INTENSIVE, P657; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; SATTLER JM, 1992, ASSESSMENT CHILDREN, P1152; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SILBERMAN AW, 1986, CANCER, V57, P1401, DOI 10.1002/1097-0142(19860401)57:7<1401::AID-CNCR2820570727>3.0.CO;2-2; SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003; Sormunen P, 1999, J PEDIATR-US, V134, P725, DOI 10.1016/S0022-3476(99)70288-X; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P230, DOI 10.1093/oxfordjournals.aje.a120511; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; TROST HA, 1992, ACTA NEUROCHIR, V116, P33, DOI 10.1007/BF01541250; WATTS DM, 1975, ANN NY ACAD SCI, V266, P135, DOI 10.1111/j.1749-6632.1975.tb35094.x; Wechsler D, 1991, WECHSLER INTELLIGENC, V3rd; WOODRUFF BA, 1992, AM J EPIDEMIOL, V136, P320, DOI 10.1093/oxfordjournals.aje.a116497; 1988, MMWR MORB MORTAL WKL, V37, P79	55	160	167	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2001	344	11					801	807		10.1056/NEJM200103153441103	http://dx.doi.org/10.1056/NEJM200103153441103			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410LA	11248155				2022-12-01	WOS:000167440400003
J	Shors, TJ; Miesegaes, G; Beylin, A; Zhao, MR; Rydel, T; Gould, E				Shors, TJ; Miesegaes, G; Beylin, A; Zhao, MR; Rydel, T; Gould, E			Neurogenesis in the adult is involved in the formation of trace memories	NATURE			English	Article							NICTITATING-MEMBRANE RESPONSE; HIPPOCAMPAL-NEURONS; DENTATE GYRUS; RAT NEOCORTEX; BRAIN; MIGRATION; PROLIFERATION; AWARENESS; CELLS	The vertebrate brain continues to produce new neurons throughout life(1-12). In the rat hippocampus, several thousand are produced each day, many of which die within weeks(13). Associative learning can enhance their survival(13,14); however, until now it was unknown whether new neurons are involved in memory formation. Here we show that a substantial reduction in the number of newly generated neurons in the adult rat impairs hippocampal-dependent trace conditioning, a task in which an animal must associate stimuli that are separated in time(15). A similar reduction did not affect learning when the same stimuli are not separated in time, a task that is hippocampal-independent(16,17). The reduction in neurogenesis did not induce death of mature hippocampal neurons or permanently alter neurophysiological properties of the CA1 region, such as long-term potentiation. Moreover, recovery of cell production was associated with the ability to acquire trace memories. These results indicate that newly generated neurons in the adult are not only affected by the formation of a hippocampal-dependent memory(13), but also participate in it.	Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.							ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BERGER TW, 1983, BEHAV BRAIN RES, V8, P49, DOI 10.1016/0166-4328(83)90171-7; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; JOHNSTON MV, 1979, BRAIN RES, V170, P135, DOI 10.1016/0006-8993(79)90946-6; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; LaBar KS, 1998, HIPPOCAMPUS, V8, P620, DOI 10.1002/(SICI)1098-1063(1998)8:6<620::AID-HIPO4>3.0.CO;2-6; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOPEZGARCIA C, 1988, BRAIN RES, V471, P167; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MINGER SL, 1992, EXP NEUROL, V117, P124, DOI 10.1016/0014-4886(92)90121-6; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; SCHMALTZ LW, 1972, J COMP PHYSIOL PSYCH, V79, P328, DOI 10.1037/h0032531; Shors TJ, 2000, BEHAV BRAIN RES, V110, P39, DOI 10.1016/S0166-4328(99)00183-7; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WEISS C, 1990, BEHAV NEUROSCI, V104, P243; WOOD KA, 1995, J NEUROSCI, V15, P5851	30	1575	1649	1	116	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					372	376		10.1038/35066584	http://dx.doi.org/10.1038/35066584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268214				2022-12-01	WOS:000167464100052
J	Levashina, EA; Moita, LF; Blandin, S; Vriend, G; Lagueux, M; Kafatos, FC				Levashina, EA; Moita, LF; Blandin, S; Vriend, G; Lagueux, M; Kafatos, FC			Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae	CELL			English	Article							ESCHERICHIA-COLI; IMMUNE-RESPONSES; INNATE IMMUNITY; EXPRESSION; DROSOPHILA; MODEL; TRANSFORMATION; GENES; C3	We characterize a novel hemocyte-specific acute phase glycoprotein from the malaria vector, Anopheles gambiae. It shows substantial structural and functional similarities, including the highly conserved thioester motif, to both a central component of mammalian complement system, factor C3, and to a pan-protease inhibitor, alpha (2)-macroglobulin. Most importantly, this protein serves as a complement-like opsonin and promotes phagocytosis of some Gram-negative bacteria in a mosquito hemocyte-like cell line. Chemical inactivation by methylamine and depletion by double-stranded RNA knockout demonstrate that this function is dependent on the internal thioester bond. This evidence of a complement-like function in a protostome animal adds substantially to the accumulating evidence of a common ancestry of immune defenses in insects and vertebrates.	European Mol Biol Lab, D-69117 Heidelberg, Germany; IBMC, CNRS, UPR 9022, F-67084 Strasbourg, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kafatos, FC (corresponding author), European Mol Biol Lab, 1 Meyerhofstr, D-69117 Heidelberg, Germany.	kafatos@embl-heidelberg.de	Moita, Luis/HCI-2793-2022; Vriend, G./H-8112-2014; Blandin, Stephanie/ABH-2267-2021; Moita, Luis F./L-1296-2013; Vriend, Gert/D-6730-2011; Blandin, Stephanie/I-2786-2016	Moita, Luis/0000-0003-0707-315X; Blandin, Stephanie/0000-0003-4566-1200; Moita, Luis F./0000-0003-0707-315X; Blandin, Stephanie/0000-0003-4566-1200; Levashina, Elena/0000-0003-4605-906X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [1PO1 AI44220] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Sharif WZ, 1998, J IMMUNOL, V160, P2983; ARAUJOJORGE TC, 1990, PARASITOL RES, V76, P545, DOI 10.1007/BF00932558; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; ARMSTRONG PB, 1987, BIOCHEM J, V248, P703, DOI 10.1042/bj2480703; Barillas-Mury C, 2000, INSECT BIOCHEM MOLEC, V30, P429, DOI 10.1016/S0965-1748(00)00018-7; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Catteruccia F, 2000, P NATL ACAD SCI USA, V97, P2157, DOI 10.1073/pnas.040568397; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2; Dodds AW, 1998, IMMUNOL REV, V166, P15; DREVETS DA, 1991, J IMMUNOL METHODS, V142, P31, DOI 10.1016/0022-1759(91)90289-R; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; FRORATH B, 1992, BIOTECHNIQUES, V12, P558; Gorman MJ, 2000, GENE, V251, P9, DOI 10.1016/S0378-1119(00)00181-5; Gorman MJ, 1998, J INSECT PHYSIOL, V44, P947, DOI 10.1016/S0022-1910(98)00056-0; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOFFMANN JA, 1966, C R ACAD SCI HEBD D, V262, P1471; HOWARD JB, 1980, J BIOL CHEM, V255, P7082; Kopacek P, 2000, EUR J BIOCHEM, V267, P465, DOI 10.1046/j.1432-1327.2000.01020.x; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nonaka M, 1999, DEV COMP IMMUNOL, V23, P421, DOI 10.1016/S0145-305X(99)00021-X; Nonaka M, 2000, CURR TOP MICROBIOL, V248, P37; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Salam T A, 1993, Ann Vasc Surg, V7, P21, DOI 10.1007/BF02042655; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; VOLANAKIS JE, 1995, ANNU REV IMMUNOL, V13, P277, DOI 10.1146/annurev.iy.13.040195.001425; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WIGGLESWORTH VB, 1970, J RETICULOENDOTH SOC, V7, P208	43	408	433	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2001	104	5					709	718		10.1016/S0092-8674(01)00267-7	http://dx.doi.org/10.1016/S0092-8674(01)00267-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	412AD	11257225	Bronze			2022-12-01	WOS:000167531100011
J	Dales, L; Hammer, SJ; Smith, NJ				Dales, L; Hammer, SJ; Smith, NJ			Time trends in autism and in MMR immunization coverage in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Considerable concern has been generated in the lay and medical communities by a theory that increased measles-mumps-rubella (MMR) immunization among young children may be the cause of an apparent marked increase in autism occurrence. Objective To determine if a correlation exists in secular trends of MMR immunization coverage among young children and autism occurrence. Design, Setting, and Participants Retrospective analyses of MMR immunization coverage rates among children born in 1980-1994 who were enrolled in California kindergartens (survey samples of 600-1900 children each year) and whose school immunization records were reviewed to retrospectively determine the age at which they first received MMR immunization; and of autism caseloads among children born in these years who were diagnosed with autism and were enrolled in the California Department of Developmental Services regional service center system. Main Outcome Measures Measles-mumps-rubella immunization coverage rates as of ages 17 months and 24 months and numbers of Department of Developmental Services system enrollees diagnosed with autism, grouped by year of birth. Results Essentially no correlation was observed between the secular trend of early childhood MMR immunization rates in California and the secular trend in numbers of children with autism enrolled in California's regional service center system. For the 1980-1994 birth cohorts, a marked, sustained increase in autism case numbers was noted, from 44 cases per 100000 live births in the 1980 cohort to 208 cases per 100000 live births in the 1994 cohort (a 373% relative increase), but changes in early childhood MMR immunization coverage over the same time period were much smaller and of shorter duration. Immunization coverage by the age of 24 months increased from 72% to 82%, a relative increase of only 14%, over the same time period. Conclusions These data do not suggest an association between MMR immunization among young children and an increase in autism occurrence.	Calif Dept Hlth Serv, Immunizat Branch, Berkeley, CA 94704 USA	California Department of Health Care Services	Dales, L (corresponding author), Calif Dept Hlth Serv, Immunizat Branch, 2151 Berkeley Way,Room 712, Berkeley, CA 94704 USA.							*CA DEP DEV SERV, 1999, CHAN POP PERS AUT PE; Fombonne E, 2001, PEDIATRICS, V107, P411, DOI 10.1542/peds.107.2.411; FRIEDMAN GD, 1987, PRIMER EPIDEMIOLOGY, P170; GILLBERG C, 1998, AUTISM, V2, P423; MANNING A, 2001, VACCINE AUTISM LINK; RIMLAND B, 2001, LOS ANGELES TIM 0429; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8	9	192	196	0	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1183	1185		10.1001/jama.285.9.1183	http://dx.doi.org/10.1001/jama.285.9.1183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231748	Bronze			2022-12-01	WOS:000167194700022
J	Zhu, M; Yu, XB; Ahlberg, PE				Zhu, M; Yu, XB; Ahlberg, PE			A primitive sarcopterygian fish with an eyestalk	NATURE			English	Article							FOSSIL FISH; PALEONTOLOGY; COELACANTH; TETRAPODS	The discovery of two Early Devonian osteichthyan (bony fish) fossils(1-4) has challenged established ideas about the origin of osteichthyans and their divergence into actinopterygians (teleosts and their relatives) and sarcopterygians (tetrapods, coelacanths, lungfishes and related groups)(5-7). Psarolepis from China(1,2,8,9) and an unnamed braincase from Australia(3) combine derived sarcopterygian and actinopterygian characters with primitive features previously restricted to non-osteichthyans, suggesting that early osteichthyan evolution may have involved substantial parallellism between sarcopterygians and actinopterygians. But interpretation of these fossils has been hampered by poor phylogenetic resolution(1,3). Here we describe a basal sarcopterygian fish, Achoania gen, et sp. nov., that fills the morphological gap between Psarolepis and higher sarcoptergyians. We also report the presence of eyestalk attachments in both Achoania and Psarolepis, showing that this supposedly non-osteichthyan feature occurs in basal sarcopterygians as well as the actinoptergyian-like Australian braincase(3).	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Kean Univ, Dept Biol Sci, Union, NJ 07083 USA; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Natural History Museum London	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.		Yu, Xiaobo/G-7160-2011; Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Ahlberg, Per/E-8086-2013	Yu, Xiaobo/0000-0001-9600-7888; Zhu, Min/0000-0002-4786-0898; Ahlberg, Per/0000-0001-9054-2900				AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 1999, NATURE, V397, P564, DOI 10.1038/17484; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Chang M.-M., 1982, THESIS STOCKHOLM U; Chang Mee-Mann, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P235; Chang MM, 2000, NATURE, V403, P152, DOI 10.1038/35003093; Cloutier Richard, 1996, P227; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Forey PL, 2000, J VERTEBR PALEONTOL, V20, P243, DOI 10.1671/0272-4634(2000)020[0243:ANCFTM]2.0.CO;2; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Goujet D. F., 1984, POISSONS PLACODERMS; JANVIER P., 1996, EARLY VERTEBRATES; Janvier Philippe, 1999, Geodiversitas, V21, P33; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; LONG JA, 1993, PALAEOZOIC VERTEBRAT; MAISEY JG, IN PRESS MAJOR EVENT, pCH16; Min Z, 1997, LETHAIA, V30, P293; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; SCHULTZE HP, IN PRESS MAJOR EVENT, pCH18; Swofford D., 1998, PAUP PHYLOGENETIC AN; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zardoya R, 1998, MOL BIOL EVOL, V15, P506, DOI 10.1093/oxfordjournals.molbev.a025950; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594	24	84	92	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					81	84		10.1038/35065078	http://dx.doi.org/10.1038/35065078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242045				2022-12-01	WOS:000167194300046
J	Piel, M; Nordberg, J; Euteneuer, U; Bornens, M				Piel, M; Nordberg, J; Euteneuer, U; Bornens, M			Centrosome-dependent exit of cytokinesis in animal cells	SCIENCE			English	Article							CHECKPOINTS; MITOSIS; BLOCKS; PHASE	As an organelle coupling nuclear and cytoplasmic divisions, the centrosome is essential to mitotic fidelity, and its inheritance could be critical to understanding cell transformation. Investigating the behavior of the centrosome in Living mitotic cells, we documented a transient and remarkable postanaphase repositioning of this organelle, which apparently controls the release of central microtubules from the midbody and the completion of cell division. We also observed that the absence of the centrosome Leads to defects in cytokinesis. Together with recent results in yeasts, our data point to a conserved centrosome-dependent pathway that integrates spatial controls into the decision of completing cell division, which requires the repositioning of the centrosome organelle.	Inst Curie, Sect Rech, CNRS, UMR 144, F-75248 Paris 05, France; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; University of Massachusetts System; University of Massachusetts Worcester; University of Munich	Bornens, M (corresponding author), Inst Curie, Sect Rech, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.							Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Burton K, 1997, NATURE, V385, P450, DOI 10.1038/385450a0; BYERS B, 1968, PROTOPLASMA, V66, P413, DOI 10.1007/BF01255868; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; DEBEC A, 1989, BIOL CELL, V67, P307, DOI 10.1016/0248-4900(89)90068-3; DEBEC A, 1978, NATURE, V274, P255, DOI 10.1038/274255a0; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hoyt MA, 2000, CELL, V102, P267, DOI 10.1016/S0092-8674(00)00031-3; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; MULLINS JM, 1973, TISSUE CELL, V5, P47, DOI 10.1016/S0040-8166(73)80005-9; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(00)00002-2; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Whitehead CM, 1998, J CELL SCI, V111, P2551; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Zang JH, 1997, MOL BIOL CELL, V8, P2617, DOI 10.1091/mbc.8.12.2617	27	315	319	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1550	1553		10.1126/science.1057330	http://dx.doi.org/10.1126/science.1057330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222861				2022-12-01	WOS:000167153400046
J	Sikes, HD; Smalley, JF; Dudek, SP; Cook, AR; Newton, MD; Chidsey, CED; Feldberg, SW				Sikes, HD; Smalley, JF; Dudek, SP; Cook, AR; Newton, MD; Chidsey, CED; Feldberg, SW			Rapid electron tunneling through oligophenylenevinylene bridges	SCIENCE			English	Article							MONOLAYERS; FERROCENE; SOLVENTS; KINETICS; DIODES; MATRIX; GOLD	We measured rate constants of thermal, interfacial electron transfer through oligophenylenevinylene bridges between a gold electrode and a tethered redox species in contact with an aqueous electrolyte using the indirect laser-induced temperature jump technique. Analysis of the distance dependence indicates that, unlike other bridges studied to date, the rate constants are not limited by electronic coupling for bridges up to 28 angstroms long. The energy Levels of the bridges relative to those of the redox species rule out hopping through the bridge. We conclude that, out to 28 angstroms, the transfer is Limited by structural reorganization and that electron tunneling occurs in less than 20 picoseconds, suggesting that oligophenylenevinylene bridges could be useful for wiring molecular electronic elements.	Brookhaven Natl Lab, Upton, NY 11973 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University	Smalley, JF (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.		Cook, Andrew/AAP-7649-2020	Cook, Andrew/0000-0001-6633-3447; /0000-0002-7096-138X	NIGMS NIH HHS [5 T32 GM08412] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1992, CHEM REV, V92; BARTHEL J, 1990, CHEM PHYS LETT, V165, P369, DOI 10.1016/0009-2614(90)87204-5; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Cave RJ, 1996, CHEM PHYS LETT, V249, P15, DOI 10.1016/0009-2614(95)01310-5; Chen J, 1999, SCIENCE, V286, P1550, DOI 10.1126/science.286.5444.1550; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; Davis WB, 1998, NATURE, V396, P60, DOI 10.1038/23912; DUDEK S, UNPUB; MCCONNELL H, 1961, J CHEM PHYS, V35, P508, DOI 10.1063/1.1731961; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; MILLER JR, 1981, J CHEM PHYS, V74, P6746, DOI 10.1063/1.441078; NEWTON MD, 1991, CHEM REV, V91, P767, DOI 10.1021/cr00005a007; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; ROWE GK, 1991, LANGMUIR, V7, P2307, DOI 10.1021/la00058a055; Sachs SB, 1997, J AM CHEM SOC, V119, P10563, DOI 10.1021/ja972244y; SMALLEY JF, 1988, J ELECTROANAL CHEM, V248, P255, DOI 10.1016/0022-0728(88)85090-3; SMALLEY JF, 1995, J PHYS CHEM-US, V99, P13141, DOI 10.1021/j100035a016; Smalley JF, 2000, ELECTROCHEM COMMUN, V2, P832, DOI 10.1016/S1388-2481(00)00132-6; SMALLEY JF, 1993, J ELECTROANAL CHEM, V356, P181, DOI 10.1016/0022-0728(93)80520-R; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; ZERNER MC, 1980, J AM CHEM SOC, V102, P589, DOI 10.1021/ja00522a025; ZUSMAN LD, 1980, CHEM PHYS, V49, P295, DOI 10.1016/0301-0104(80)85267-0	23	320	324	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1519	1523		10.1126/science.1055745	http://dx.doi.org/10.1126/science.1055745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222852				2022-12-01	WOS:000167153400037
J	Peltonen, L; McKusick, VA				Peltonen, L; McKusick, VA			Genomics and medicine - Dissecting human disease in the postgenomic era	SCIENCE			English	Article							SIMPLE MENDELIAN DISORDERS; GENE-EXPRESSION; COMPLEX; PREDICTION; LOCUS		Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Johns Hopkins Med Inst, Dept Med Genet, Baltimore, MD 21205 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Medicine	Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	lpeltonen@mednet.ucla.edu						Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brand MD, 1997, J EXP BIOL, V200, P193; Chang YPC, 1997, BRIT J HAEMATOL, V96, P806, DOI 10.1046/j.1365-2141.1997.d01-2094.x; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Karim FD, 1996, GENETICS, V143, P315; Krauss S, 1996, J THEOR BIOL, V182, P381, DOI 10.1006/jtbi.1996.0177; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McKusick V.A., 1998, MENDELIAN INHERITANC; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Patel M, 2001, AM J HUM GENET, V68, P275, DOI 10.1086/316932; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramirez F, 1999, ANN MED, V31, P202, DOI 10.3109/07853899909115979; Rogers J, 2000, GENOMICS, V67, P237, DOI 10.1006/geno.2000.6245; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473	27	251	288	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1224	+		10.1126/science.291.5507.1224	http://dx.doi.org/10.1126/science.291.5507.1224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233446				2022-12-01	WOS:000166993400024
J	Bordenstein, SR; O'Hara, FP; Werren, JH				Bordenstein, SR; O'Hara, FP; Werren, JH			Wolbachia-induced incompatibility precedes other hybrid incompatibilities in Nasonia	NATURE			English	Article							REPRODUCTIVE ISOLATION; CYTOPLASMIC INCOMPATIBILITY; GENETICS; CHROMOSOME; SPECIATION	Wolbachia are cytoplasmically inherited bacteria that cause a number of reproductive alterations in insects, including cytoplasmic incompatibility(1,2), an incompatibility between sperm and egg that results in loss of sperm chromosomes following fertilization. Wolbachia are estimated to infect 15-20% of all insect species(3), and also are common in arachnids, isopods and nematodes(3,4). Therefore, Wolbachia-induced cytoplasmic incompatibility could be an important factor promoting rapid speciation in invertebrates(5), although this contention is controversial(6,7). Here we show that high levels of bidirectional cytoplasmic incompatibility between two closely related species of insects (the parasitic wasps Nasonia giraulti and Nasonia longicornis) preceded the evolution of other postmating reproductive barriers. The presence of Wolbachia severely reduces the frequency of hybrid offspring in interspecies crosses. However, antibiotic curing of the insects results in production of hybrids. Furthermore, F-1 and F-2 hybrids are completely viable and fertile, indicating the absence of F-1 and F-2 hybrid breakdown. Partial interspecific sexual isolation occurs, yet it is asymmetric and incomplete. Our results indicate that Wolbachia-induced reproductive isolation occurred in the early stages of speciation in this system, before the evolution of other postmating isolating mechanisms (for example, hybrid inviability and hybrid sterility).	Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Bordenstein, SR (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.			Werren, John/0000-0001-9353-2070				Bordenstein SR, 1998, GENETICS, V148, P1833; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; CAMPBELL BC, 1993, INSECT MOL BIOL, V22, P255; DARLING DC, 1990, ANN ENTOMOL SOC AM, V83, P352, DOI 10.1093/aesa/83.3.352; Gadau J, 1999, GENETICS, V153, P1731; Hoffmann AA, 1997, INFLUENTIAL PASSENGE; Hurst GDD, 1998, HEREDITY, V80, P2, DOI 10.1046/j.1365-2540.1998.00337.x; Margulis L, 1991, SYMBIOSIS SOURCE EVO; Mood A. M., 1973, INTRO THEORY STAT; Noor MAF, 1997, EVOLUTION, V51, P809, DOI [10.2307/2411156, 10.1111/j.1558-5646.1997.tb03663.x]; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; PALOPOLI MF, 1994, GENETICS, V138, P329; PerrotMinnot MJ, 1996, GENETICS, V143, P961; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI 10.1111/j.1558-5646.1999.tb04529.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; True JR, 1996, GENETICS, V142, P819; WADE MJ, 1995, HEREDITY, V75, P453, DOI 10.1038/hdy.1995.161; Werren J. H., 1998, ENDLESS FORMS SPECIE; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WERREN JH, 1997, ANNU REV ENTOMOL, V423, P5887; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	26	298	307	6	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					707	710		10.1038/35055543	http://dx.doi.org/10.1038/35055543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217858				2022-12-01	WOS:000166816400041
J	Grill, SW; Gonczy, P; Stelzer, EHK; Hyman, AA				Grill, SW; Gonczy, P; Stelzer, EHK; Hyman, AA			Polarity controls forces governing asymmetric spindle positioning in the Caenorhabditis elegans embryo	NATURE			English	Article							KINESIN-RELATED PROTEIN; CELL-DIVISION; CYTOPLASMIC LOCALIZATION; CLEAVAGE SPINDLE; LASER MICROBEAM; IDENTIFICATION; EMBRYOGENESIS; ORIENTATION; SEPARATION; MECHANISMS	Cell divisions that create daughter cells of different sizes are crucial for the generation of cell diversity during animal development(1). In such asymmetric divisions, the mitotic spindle must be asymmetrically positioned at the end of anaphase(2,3). The mechanisms by which cell polarity translates to asymmetric spindle positioning remain unclear. Here we examine the nature of the forces governing asymmetric spindle positioning in the single-cell-stage Caenorhabditis elegans embryo. To reveal the forces that act on each spindle pole, we removed the central spindle in living embryos either physically with an ultraviolet laser microbeam, or genetically by RNA-mediated interference of a kinesin(4). We show that pulling forces external to the spindle act on the two spindle poles. A stronger net force acts on the posterior pole, thereby explaining the overall posterior displacement seen in wild-type embryos. We also show that the net force acting on each spindle pole is under control of the par genes that are required for cell polarity along the anterior-posterior embryonic axis. Finally, we discuss simple mathematical models that describe the main features of spindle pole behaviour. Our work suggests a mechanism for generating asymmetry in spindle positioning by varying the net pulling force that acts on each spindle pole, thus allowing for the generation of daughter cells with different sizes.	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Hyman, AA (corresponding author), Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@embl-heidelberg.de	Hyman, Anthony A/B-3917-2017; Grill, Stephan/D-9427-2012; Stelzer, Ernst H K/A-7648-2011; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Stelzer, Ernst H K/0000-0003-1545-0736; Gonczy, Pierre/0000-0002-6305-6883				AIST JR, 1993, J CELL SCI, V104, P1207; AIST JR, 1981, J CELL BIOL, V91, P446, DOI 10.1083/jcb.91.2.446; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; CHENG NN, 1995, GENETICS, V139, P549; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gonczy P, 1996, TRENDS CELL BIOL, V6, P382, DOI 10.1016/0962-8924(96)10035-0; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KEMPHUES KJ, 1997, C ELEGANS, V0002, P00335; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; LESLIE RJ, 1983, J CELL BIOL, V96, P548, DOI 10.1083/jcb.96.2.548; MORTON DG, 1992, GENETICS, V130, P771; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Rose LS, 1998, DEVELOPMENT, V125, P1337; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WATERS JC, 1993, J CELL BIOL, V122, P361, DOI 10.1083/jcb.122.2.361; Wein H, 1996, J CELL BIOL, V133, P595, DOI 10.1083/jcb.133.3.595; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	385	394	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					630	633		10.1038/35054572	http://dx.doi.org/10.1038/35054572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214323				2022-12-01	WOS:000166692300047
J	Oshima, H; Rochat, A; Kedzia, C; Kobayashi, K; Barrandon, Y				Oshima, H; Rochat, A; Kedzia, C; Kobayashi, K; Barrandon, Y			Morphogenesis and renewal of hair follicles from adult multipotent stem cells	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; ROOT SHEATH-CELLS; DERMAL PAPILLA; VIBRISSAL FOLLICLES; SONIC-HEDGEHOG; NUDE LOCUS; MOUSE; EXPRESSION; KERATINOCYTE; CYCLE	The upper region of the outer root sheath of vibrissal follicles of adult mice contains multipotent stem cells that respond to morphogenetic signals to generate multiple hair follicles, sebaceous glands, and epidermis, i.e., all the lineages of the hairy skin. At the time when hair production ceases and when the lower region of the follicle undergoes major structural changes, the lower region contains a significant number of clonogenic keratinocytes, and can then respond to morphogenetic signals. This demonstrates that multipotent stem cells migrate to the root of the follicle to produce whisker growth. Moreover, our results indicate that the clonogenic keratinocytes are closely related, if not identical, to the multipotent stem cells, and that the regulation of whisker growth necessitates a precise control of stem cell trafficking.	Ecole Normale Super, Dept Biol, F-75230 Paris 05, France; Chiba Univ, Fac Sci, Inage Ku, Chiba 263, Japan	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Chiba University	Barrandon, Y (corresponding author), Ecole Normale Super, Dept Biol, 46 Rue Ulm, F-75230 Paris 05, France.	barrand@wotan.ens.fr						BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DHOUAILLY D, 1984, DERMATOLOGICA, V169, P228; DORFL J, 1982, J ANAT, V135, P147; DUCROS DL, 1993, J INVEST DERMATOL, V101, pS106, DOI 10.1111/1523-1747.ep12363020; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GREEN MR, 1984, J INVEST DERMATOL, V83, P118, DOI 10.1111/1523-1747.ep12263298; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARDY MH, 1968, J EMBRYOL EXP MORPH, V19, P157; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kamimura J, 1997, J INVEST DERMATOL, V109, P534, DOI 10.1111/1523-1747.ep12336704; Kishimoto J, 2000, GENE DEV, V14, P1181; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; LAVKER RM, 1991, ANN NY ACAD SCI, V642, P214; LAVKER RM, 1993, J INVEST DERMATOL, V101, pS16, DOI 10.1111/1523-1747.ep12362556; LENOIR MC, 1988, DEV BIOL, V130, P610, DOI 10.1016/0012-1606(88)90356-9; LIMAT A, 1991, EXP CELL RES, V194, P218, DOI 10.1016/0014-4827(91)90357-Z; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Matsuzaki T, 1996, DIFFERENTIATION, V60, P287, DOI 10.1046/j.1432-0436.1996.6050287.x; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MONTAGNA W, 1962, STRUCTURE FUNCTION S, P174; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V15, P331; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P186, DOI 10.1111/1523-1747.ep12371760; REYNOLDS AJ, 1993, J INVEST DERMATOL, V101, P634, DOI 10.1111/1523-1747.ep12366095; REYNOLDS AJ, 1991, J CELL SCI, V99, P373; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; SALAUN J, 1986, EUR J IMMUNOL, V16, P523, DOI 10.1002/eji.1830160511; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; STRAILE WE, 1961, J EXP ZOOL, V148, P205, DOI 10.1002/jez.1401480304; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vincent SB, 1913, J COMP NEUROL, V23, P1, DOI 10.1002/cne.900230101; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; YOUNG RD, 1976, J EMBRYOL EXP MORPH, V36, P597; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	65	764	847	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					233	245		10.1016/S0092-8674(01)00208-2	http://dx.doi.org/10.1016/S0092-8674(01)00208-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207364	Bronze			2022-12-01	WOS:000166879700007
J	Freedman, DJ; Riesenhuber, M; Poggio, T; Miller, EK				Freedman, DJ; Riesenhuber, M; Poggio, T; Miller, EK			Categorical representation of visual stimuli in the primate prefrontal cortex	SCIENCE			English	Article							RHESUS-MONKEYS; TEMPORAL CORTEX; MACAQUE; CATEGORIZATION; IMAGES; MEMORY; NEURONS	The ability to group stimuli into meaningful categories is a fundamental cognitive process. To explore its neural basis. we trained monkeys to categorize computer-generated stimuli as "cats" and "dogs." A morphing system was used to systematically vary stimulus shape and precisely define the category boundary. Neural activity in the Lateral prefrontal cortex reflected the category of visual stimuli, even when a monkey was retrained with the stimuli assigned to new categories.	MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Ctr Biol & Computat Learning, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA.		Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958; Riesenhuber, Maximilian/0000-0002-5744-0408				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Barsalou L. W., 1992, COGNITIVE PSYCHOL OV; Beymer D, 1996, SCIENCE, V272, P1905, DOI 10.1126/science.272.5270.1905; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; GAFFAN D, 1995, EXP BRAIN RES, V105, P175; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lakoff G., 1987, WOMEN FIRE DANGEROUS, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Miller EK, 1996, J NEUROSCI, V16, P5154; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Shelton CR, 2000, INT J COMPUT VISION, V38, P75, DOI 10.1023/A:1008170818506; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	30	729	743	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					312	316		10.1126/science.291.5502.312	http://dx.doi.org/10.1126/science.291.5502.312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209083				2022-12-01	WOS:000166352900048
J	Chisholm, JRM; Kelley, R				Chisholm, JRM; Kelley, R			Marine ecology - Worms start the reef-building process	NATURE			English	Article									Observ Oceanol Europeen, Ctr Sci Monaco, MC-98000 Monaco, Monaco; Watermark Films, Townsville, Qld 4810, Australia		Chisholm, JRM (corresponding author), Observ Oceanol Europeen, Ctr Sci Monaco, Ave St Martin, MC-98000 Monaco, Monaco.							ADEY WH, 1985, ECOLOGY DEEP SHALLOW, V2, P163; JACKSON JBC, 1982, J EXP MAR BIOL ECOL, V57, P135, DOI 10.1016/0022-0981(82)90188-5; JACKSON JBC, 1986, B MAR SCI, V39, P588; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; PARKER SP, 1982, SYNOPSIS CLASSIFICAT, V2, P18; Wood R., 1999, REEF EVOLUTION	6	11	12	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					152	152		10.1038/35051660	http://dx.doi.org/10.1038/35051660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196630	Bronze			2022-12-01	WOS:000166316200031
J	Gonzales, R; Bartlett, JC; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, JR; Sande, MA				Gonzales, R; Bartlett, JC; Besser, RE; Cooper, RJ; Hickner, JM; Hoffman, JR; Sande, MA			Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; CLINICAL-PRACTICE GUIDELINES; DAY-CARE-CENTER; MEDICAL LITERATURE; PNEUMOCOCCAL PNEUMONIA; UNITED-STATES; RISK-FACTORS; AMBULATORY PRACTICE; PENICILLIN; MENINGITIS	The need to decrease excess antibiotic use in ambulatory practice has been fueled by the epidemic increase in antibiotic-resistant Streptococcus pneumoniae. The majority of antibiotics prescribed to adults in ambulatory practice in the United States are for acute sinusitis, acute pharyngitis, acute bronchitis, and nonspecific upper respiratory tract infections (including the common cold). For each of these conditions-especially colds, nonspecific upper respiratory tract infections, and acute bronchitis (for which routine antibiotic treatment is not recommended)-a large proportion of the antibiotics prescribed are unlikely to provide clinical benefit to patients. Because decreasing community use of antibiotics is an important strategy for combating the increase in community-acquired antibiotic-resistant infections, the Centers for Disease Control and Prevention convened a panel of physicians representing the disciplines of internal medicine, family medicine, emergency medicine, and infectious diseases to develop a series of "Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults." These principles provide evidence-based recommendations far evaluation and treatment of adults with acute respiratory illnesses. This paper describes the background and specific aims of and methods used to develop these principles. The goal of the principles is to provide clinicians with practical strategies for limiting antibiotic use to the patients who are most likely to benefit from it. These principles should be used in conjunction with effective patient educational campaigns and enhancements to the health care delivery system that facilitate nonantibiotic treatment of the conditions in question.	Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif Los Angeles, Los Angeles, CA USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ Utah, Salt Lake City, UT USA	Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; University of California System; University of California Los Angeles; Michigan State University; Utah System of Higher Education; University of Utah	Besser, RE (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rbesser@cdc.gov			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000134] Funding Source: NIH RePORTER; AHRQ HHS [F32 HS00134-1] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Arason VA, 1996, BMJ-BRIT MED J, V313, P387; Arnold KE, 1996, J PEDIATR-US, V128, P757, DOI 10.1016/S0022-3476(96)70326-8; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Bauchner H, 1999, PEDIATRICS, V103, P395, DOI 10.1542/peds.103.2.395; BOKEN DJ, 1995, PEDIATR INFECT DIS J, V14, P879, DOI 10.1097/00006454-199510000-00012; Bradley JS, 1995, PEDIATR INFECT DIS J, V14, P1037, DOI 10.1097/00006454-199512000-00002; Butler JC, 1996, J INFECT DIS, V174, P986, DOI 10.1093/infdis/174.5.986; CHESNEY PJ, 1995, PEDIATR INFECT DIS J, V14, P1013; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; DELMAR CB, 2000, COCHRANE DATABASE SY, V4; Doone JL, 1997, CLIN PEDIATR, V36, P187, DOI 10.1177/000992289703600401; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; FRIEDLAND IR, 1992, LANCET, V339, P405, DOI 10.1016/0140-6736(92)90087-J; Gonzales R, 2000, J GEN INTERN MED, V15, P118; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; GONZALES R, 2000, J GEN INTERN MED S, V15; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Guyatt GH, 1999, JAMA-J AM MED ASSOC, V281, P1836, DOI 10.1001/jama.281.19.1836; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hayward RSA, 1996, J GEN INTERN MED, V11, P176, DOI 10.1007/BF02600272; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; HUTCHINSON JM, 1997, 37 INT C ANT AG CHEM; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; LONKS JR, 1995, NEW ENGL J MED, V332, P893, DOI 10.1056/NEJM199503303321317; Mainous AG, 2000, FAM MED, V32, P22; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MORENO F, 1995, J INFECT DIS, V172, P427, DOI 10.1093/infdis/172.2.427; Musher DM, 1995, MANDELL DOUGLAS BENN, P1811; NAVA JM, 1994, CLIN INFECT DIS, V19, P884, DOI 10.1093/clinids/19.5.884; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; O'Connor PJ, 1999, J FAM PRACTICE, V48, P690; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Poole Michael D., 1995, Pediatric Infectious Disease Journal, V14, pS23, DOI 10.1097/00006454-199504001-00005; POSES RM, 1995, MED DECIS MAKING, V15, P65, DOI 10.1177/0272989X9501500110; RADETSKY MS, 1981, LANCET, V2, P771; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; Reid R, 1995, PEDIATR INFECT DIS J, V14, P1104, DOI 10.1097/00006454-199512000-00016; Sackett DL., 2000, EVIDENCE BASED MED P, P173; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630; 1994, MMWR MORB MORTAL WKL, V43, P23	54	178	185	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2001	134	6					479	486		10.7326/0003-4819-134-6-200103200-00013	http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409VF	11255524				2022-12-01	WOS:000167405800007
J	Platts-Mills, T; Vaughan, J; Squillace, S; Woodfolk, J; Sporik, R				Platts-Mills, T; Vaughan, J; Squillace, S; Woodfolk, J; Sporik, R			Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study	LANCET			English	Article							INNER-CITY CHILDREN; RISK FACTOR; IGG4 ANTIBODIES; SENSITIZATION; CHILDHOOD; MITE; IGE; LYMPHOCYTES; REACTIVITY; SUBCLASS	Background Although asthma is strongly associated with immediate hypersensitivity to indoor allergens, several studies have suggested that a cat in the house can decrease the risk of asthma. We investigated the immune response to cat and mite allergens, and asthma among children with a wide range of allergen exposure. Methods We did a population-based cross-sectional study of children (aged 12-14 years), some of whom had symptoms of asthma and bronchial hyper-reactivity, Antibodies to mite (Der f 1) and cat (Fel d 1) allergens measured by isotype (IgG and IgG4) specific radioimmunoprecipitation assays were compared with sensitisation and allergen concentrations in house dust. Findings 226 children were recruited, 47 of whom had symptoms of asthma and bronchial hyper-reactivity, Increasing exposure to mite was associated with increased prevalence of sensitisation and IgG antibody to Der f 1. By contrast, the highest exposure to cat was associated with decreased sensitisation, but a higher prevalence of IgG antibody to Fel d 1, Thus, among children with high exposure, the odds of sensitisation to mite rather than cat was 4.0 (99% CI 1.49-10.00). Furthermore. 31 of 76 children with 23 mug Fel d 1 at home, who were not sensitised to cat allergen had >125 units of IgG antibody to Fel d 1. Antibodies to Fel d 1 of the IgG4 isotype were strongly correlated with IgG antibody in both allergic and non-allergic children (r=0.84 and r=0.66, respectively). Sensitisation to mite or cat allergens was the strongest independent risk factor for asthma (p<0.001). Interpretation Exposure to cat allergen can produce an IgG and IgG4 antibody response without sensitisation or risk of asthma, This modified T-helper-2 cell response should be regarded as a form of tolerance and may be the correct objective of immunotherapy. The results may also explain the observation that animals in the house can decrease the risk of asthma.	Univ Virginia, Dept Med, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA	University of Virginia	Platts-Mills, T (corresponding author), Univ Virginia Hlth Syst, Asthma & Allerg Dis Ctr, POB 801355, Charlottesville, VA 22908 USA.			Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI034607, U01AI034607, R01AI020565, R37AI020565] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-34607, AI-20565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AALBERSE RC, 1983, J IMMUNOL, V130, P722; Agresti A, 1999, INT ARCH ALLERGY IMM, V118, P279, DOI 10.1159/000024099; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Borish L, 1997, J ALLERGY CLIN IMMUN, V99, P161, DOI 10.1016/S0091-6749(97)70090-3; CALL RS, 1992, J PEDIATR-US, V121, P862, DOI 10.1016/S0022-3476(05)80329-4; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; HUSSAIN R, 1992, J IMMUNOL, V148, P2731; ISHIZAKA K, 1967, J IMMUNOL, V98, P490; Jeannin P, 1998, J IMMUNOL, V160, P3555; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PLATTSMILLS TAE, 1978, J IMMUNOL, V120, P1201; Prescott SL, 1998, J IMMUNOL, V160, P4730; Ronmark E, 1999, ALLERGY, V54, P926, DOI 10.1034/j.1398-9995.1999.00044.x; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; ROWNTREE S, 1987, J ALLERGY CLIN IMMUN, V80, P622, DOI 10.1016/0091-6749(87)90017-0; Sawyer G, 1998, J ALLERGY CLIN IMMUN, V102, P765, DOI 10.1016/S0091-6749(98)70016-8; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Squillace SP, 1997, AM J RESP CRIT CARE, V156, P1760, DOI 10.1164/ajrccm.156.6.9704026; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; ZHANG K, 1994, J IMMUNOL, V152, P3427	33	626	640	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 10	2001	357	9258					752	756		10.1016/S0140-6736(00)04168-4	http://dx.doi.org/10.1016/S0140-6736(00)04168-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409TC	11253969				2022-12-01	WOS:000167400900013
J	Butcher, SJ; Grimes, JM; Makeyev, EV; Bamford, DH; Stuart, DL				Butcher, SJ; Grimes, JM; Makeyev, EV; Bamford, DH; Stuart, DL			A mechanism for initiating RNA-dependent RNA polymerization	NATURE			English	Article							HEPATITIS-C VIRUS; PLUS-STRAND SYNTHESIS; CRYSTAL-STRUCTURE; DSRNA BACTERIOPHAGE-PHI-6; POLYMERASE-ACTIVITY; REPLICATION; RESOLUTION; SYSTEM; GENOME; MINUS	In most RNA viruses, genome replication and transcription are catalysed by a viral RNA-dependent RNA polymerase. Double-stranded RNA viruses perform these operations in a capsid (the polymerase complex), using an enzyme that can read both single- and double-stranded RNA. Structures have been solved for such viral capsids, but they do not resolve the polymerase subunits in any detail(1,2). Here we show that the 2 Angstrom resolution X-ray structure of the active polymerase subunit from the double-stranded RNA bacteriophage phi6 (refs 3, 4) is highly similar to that of the polymerase of hepatitis C virus, providing an evolutionary link between double-stranded RNA viruses and flaviviruses. By crystal soaking and co-crystallization, we determined a number of other structures, including complexes with oligonucleotide and/or nucleoside triphosphates (NTPs), that suggest a mechanism by which the incoming double-stranded RNA is opened up to feed the template through to the active site, while the substrates enter by another route. The template strand initially overshoots, locking into a specificity pocket, and then, in the presence of cognate NTPs, reverses to form the initiation complex; this process engages two NTPs, one of which acts with the carboxy-terminal domain of the protein to prime the reaction. Our results provide a working model for the initiation of replication and transcription.	Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; Univ Helsinki, Dept Biosci, Viikkki Bioctr, Helsinki 00014, Finland; Oxford Ctr Mol Sci, Oxford OX1 3QT, England	University of Oxford; University of Helsinki; University of Helsinki; University of Oxford	Stuart, DL (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.		Butcher, Sarah J/H-5579-2012	Bamford, Dennis/0000-0002-6438-8118; Makeyev, Eugene/0000-0001-6034-6896; Stuart, David/0000-0002-3426-4210; Butcher, Sarah/0000-0001-7060-5871; Grimes, Jonathan Mark/0000-0001-9698-0389				Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2000, ACTA CRYSTALLOGR D, V56, P1473, DOI 10.1107/S0907444900010702; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRILANDER M, 1995, RNA, V1, P510; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; MERRITT EA, 1997, MACROMOLECULAR CRY B, P505; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P164; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; OLLIS DL, 1985, NATURE, V313, P818, DOI 10.1038/313818a0; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; VANDIJK AA, 1995, VIROLOGY, V211, P320, DOI 10.1006/viro.1995.1409; YAZAKI K, 1980, VIROLOGY, V105, P467, DOI 10.1016/0042-6822(80)90047-1; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	26	417	441	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2001	410	6825					235	240		10.1038/35065653	http://dx.doi.org/10.1038/35065653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HJ	11242087				2022-12-01	WOS:000167320500053
J	Dixon-Woods, M; Findlay, M; Young, B; Cox, H; Heney, D				Dixon-Woods, M; Findlay, M; Young, B; Cox, H; Heney, D			Parents' accounts of obtaining a diagnosis of childhood cancer	LANCET			English	Article							ILLNESS; HEALTH	Background Quick diagnosis and treatment of cancers is a UK government priority. However, the process of arriving at a diagnosis of childhood cancer has been neglected in comparison with the attention given to cancers in adults. We investigated parents' narratives about the period before their child's diagnosis. Methods We undertook semistructured interviews with 20 parents whose children (aged 4-18 years) had a confirmed diagnosis of cancer or brain tumour. All interviews were recorded and fully transcribed. Dates of consultations and investigations were noted from children's medical records. Data were analysed by the constant comparison method. Findings The time before diagnosis is very significant for parents and might affect their adaptation and reaction to their child's diagnosis. Parents were first alerted to their child's illness by a range of signs and symptoms, and by behavioural and affective changes, These early symptoms were often vague, non-specific, and common, and some older children were reluctant to disclose symptoms. Ten families' accounts of this period before diagnosis included a dispute with doctors. Disagreements between parents and doctors about the seriousness of children's symptoms and the need for investigations occurred in both primary and secondary care. Some parents felt that doctors discounted their special knowledge of their child. Interpretation Parents' accounts offer valuable insights into their experiences of obtaining a diagnosis of childhood cancer and into possible sources of delays in this complex process. If delays are to be avoided or reduced, attention must be given to the different roles of parents, children, general practitioners, hospital specialists, and type of cancer. Our findings have important implications for policy, practice, and research, and for the management of childhood illnesses.	Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ Leicester, Fac Med & Biol Sci, Leicester LE1 6TP, Leics, England; Leicester Royal Infirm, Childrens Hosp, Leicester, Leics, England	University of Leicester; University of Leicester; University of Leicester	Dixon-Woods, M (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.	md11@ie.ac.uk	Young, Bridget/A-2184-2014	Dixon-Woods, Mary/0000-0002-5915-0041; Young, Bridget/0000-0001-6041-9901				Amir Z, 1999, EUR J CANCER CARE, V8, P198; Arksey H, 1999, SOC SCI MED, V49, P483, DOI 10.1016/S0277-9536(99)00143-4; Aynsley-Green A, 2000, BRIT MED J, V321, P229, DOI 10.1136/bmj.321.7255.229; Baruch G., 1981, SOCIOLOGY HLTH ILLNE, V3, P275, DOI DOI 10.1111/1467-9566.EP10486851; CUNNINGHAMBURLE.S, 1991, CHILD HLTH MATTERS, P29; CUNNINGHAMBURLEY S, 1987, BMJ-BRIT MED J, V295, P700, DOI 10.1136/bmj.295.6600.700; *DEP HLTH, 2000, REF GUID SUSP CANC; Dixon-Woods M, 1999, BRIT MED J, V319, P778, DOI 10.1136/bmj.319.7212.778; EISER C, 1994, PSYCHO-ONCOL, V3, P197, DOI 10.1002/pon.2960030306; Glaser B. G., 1978, THEORETICAL SENSITIV; HALLIDAY J, 1990, LISTEN MY CHILD HAS, P19; Hamre MR, 2000, MED PEDIATR ONCOL, V34, P343, DOI 10.1002/(SICI)1096-911X(200005)34:5<343::AID-MPO5>3.0.CO;2-B; Hyden LC, 1997, SOCIOL HEALTH ILL, V19, P48, DOI 10.1111/1467-9566.00040; IRVINE S, 1991, BRIT J GEN PRACT, V41, P371; Murphy MK., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [10.3310/hta2030, DOI 10.3310/HTA2030]; Neill SJ, 2000, J ADV NURS, V31, P821, DOI 10.1046/j.1365-2648.2000.01340.x; Pidgeon N., 1996, HDB QUALITATIVE RES, P86; POLNAY L, 1989, BRIT MED J, V299, P1351, DOI 10.1136/bmj.299.6712.1351; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; SAHA V, 1993, ARCH DIS CHILD, V68, P771, DOI 10.1136/adc.68.6.771	20	116	118	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2001	357	9257					670	674		10.1016/S0140-6736(00)04130-1	http://dx.doi.org/10.1016/S0140-6736(00)04130-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	407QN	11247550				2022-12-01	WOS:000167282400011
J	Jackson, M; Song, W; Liu, MY; Jin, L; Dykes-Hoberg, M; Lin, CLG; Bowers, WJ; Federoff, HJ; Sternweis, PC; Rothstein, JD				Jackson, M; Song, W; Liu, MY; Jin, L; Dykes-Hoberg, M; Lin, CLG; Bowers, WJ; Federoff, HJ; Sternweis, PC; Rothstein, JD			Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins	NATURE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CEREBELLAR PURKINJE-CELLS; GATED CHLORIDE CHANNEL; SIMPLEX VIRUS VECTORS; RAT-BRAIN; SYNAPTIC TRANSMISSION; SURFACE EXPRESSION; PACKAGING SYSTEM; LOCALIZATION; RHO	Glutamate is the main excitatory neurotransmitter in the mammalian central nervous system and is removed from the synaptic cleft by sodium-dependent glutamate transporters. To date, five distinct glutamate transporters have been cloned from animal and human tissue: GLAST (EAAT1), GLT-1 (EAAT2), EAAC1 (EAAT3), EAAT4, and EAAT5 (refs 1-5). GLAST and GLT-1 are localized primarily in astrocytes(6,7), whereas EAAC1 (refs 8, 9), EAAT4 (refs 9-11) and EAAT5 (ref. 5) are neuronal. Studies of EAAT4 and EAAC1 indicate an extrasynaptic localization on perisynaptic membranes that are near release sites(8-10). This localization facilitates rapid glutamate binding, and may have a role in shaping the amplitude of postsynaptic responses in densely packed cerebellar terminals(12-15). We have used a yeast two-hybrid screen to identify interacting proteins that may be involved in regulating EAAT4- the glutamate transporter expressed predominately in the cerebellum-or in targeting and/or anchoring or clustering the transporter to the target site. Here we report the identification and characterization of two proteins, GTRAP41 and GTRAP48 (for glutamate transporter EAAT4 associated protein) that specifically interact with the intracellular carboxy-terminal domain of EAAT4 and modulate its glutamate transport activity.	Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Rochester, NY 14642 USA	Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Rochester; University of Rochester	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA.		rothstein, jeffrey d/C-9470-2013; Lin, Chien-liang G/E-3513-2011					Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Bowers WJ, 2000, MOL THER, V1, P294, DOI 10.1006/mthe.2000.0039; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Davis KE, 1998, J NEUROSCI, V18, P2475; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Diamond JS, 1997, J NEUROSCI, V17, P4672; Duan SM, 1999, J NEUROSCI, V19, P10193; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; GELLER AI, 1990, P NATL ACAD SCI USA, V87, P8950, DOI 10.1073/pnas.87.22.8950; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He Y, 2000, J COMP NEUROL, V418, P255; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Nagao S, 1997, NEUROSCIENCE, V78, P929; Overstreet LS, 1999, J NEUROSCI, V19, P9663; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Stavropoulos TA, 1998, J VIROL, V72, P7137, DOI 10.1128/JVI.72.9.7137-7143.1998; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4	26	188	200	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2001	410	6824					89	93		10.1038/35065091	http://dx.doi.org/10.1038/35065091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242047				2022-12-01	WOS:000167194300048
J	Ludwig, DS; Peterson, KE; Gortmaker, SL				Ludwig, DS; Peterson, KE; Gortmaker, SL			Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis	LANCET			English	Article							BODY-MASS INDEX; CHILDREN; REPRODUCIBILITY; ADOLESCENTS; VALIDITY; HEALTH; QUESTIONNAIRE; COMPENSATION; INTERVENTION; OVERWEIGHT	Background The rising prevalence of obesity in children has been linked in part to the consumption of sugar-sweetened drinks. Our aim was to examine this relation. Methods We enrolled 548 ethnically diverse schoolchildren (age 11.7 years, SD 0.8) from public schools in four Massachusetts communities, and studied them prospectively for 19 months from October, 1995, to May. 1997. We examined the association between baseline and change in consumption of sugar-sweetened drinks (the independent variables), and difference in measures of obesity, with linear and logistic regression analyses adjusted for potentially confounding variables and clustering of results within schools. Findings For each additional serving of sugar-sweetened drink consumed, both body mass index (BMI) (mean 0.24 kg/m(2); 95% CI 0.10-0.39; p=0.03) and frequency of obesity (odds ratio 1.60; 95% CI 1.14-2.24; p=0.02) increased after adjustment for anthropometric, demographic, dietary. and lifestyle variables. Baseline consumption of sugar-sweetened drinks was also independently associated with change in BMI (mean 0.18 kg/m(2) for each daily serving; 95% CI 0.09-0.27; p=0.02). Interpretation Consumption of sugar-sweetened drinks is associated with obesity in children.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Boston, MA 02115 USA.	david.ludwig@tch.harvard.edu	Fahimifar, Sepideh/M-5303-2019; Atta, Hussein/B-9059-2009	Atta, Hussein/0000-0003-1118-8347; Ludwig, David/0000-0003-3307-8544	NICHD NIH HHS [HD-30780] Funding Source: Medline; NIDDK NIH HHS [1K08 DK02440] Funding Source: Medline; PHS HHS [U48/CCU115807] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002440] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Allshouse JJ., 1999, FOOD CONSUMPTION PRI; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; BORRUD L, 1997, COMMUN NUTR I, V27, P4; BOWMAN SA, 1999, FAM EC NUTR REV, V12, P31; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cook T.D., 1979, QUASIEXPERIMENTATION; Daniels SR, 1997, PEDIATRICS, V99, P804, DOI 10.1542/peds.99.6.804; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; Field AE, 1999, PUBLIC HEALTH NUTR, V2, P293, DOI 10.1017/S1368980099000397; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; HILL JO, 1995, AM J CLIN NUTR, V62, p264S, DOI 10.1093/ajcn/62.1.264S; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579; Lawton CL, 1998, BRIT J NUTR, V80, P149, DOI 10.1017/S0007114598001056; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; Morton J. F., 1998, FAM EC NUTR REV, V11, P44; MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839; PETERSON KE, 1996, VALIDATION YRBSS QUE; Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200; ROSNER B, 1988, AM J EPIDEMIOL, V127, P377, DOI 10.1093/oxfordjournals.aje.a114811; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; TROWBRIDGE F, 1993, PUBLIC HEALTH REP, V108, P37; *US BUR CENS, 1998, 1996 STAT ABSTR US; WESTAT I, 1988, NATL HLTH NUTR EXAMI, V3; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	1540	1585	1	277	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2001	357	9255					505	508		10.1016/S0140-6736(00)04041-1	http://dx.doi.org/10.1016/S0140-6736(00)04041-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229668				2022-12-01	WOS:000167011700009
J	Li, WH; Gu, ZL; Wang, HD; Nekrutenko, A				Li, WH; Gu, ZL; Wang, HD; Nekrutenko, A			Evolutionary analyses of the human genome	NATURE			English	Article							SEQUENCES	The completion of the human genome will greatly accelerate the development of a new branch of science - evolutionary genomics. We can now directly address important questions about the evolutionary history of human genes and their regulatory sequences. Computational analyses of the human genome will reveal the number of genes and repetitive elements, the extent of gene duplication and compositional heterogeneity in the human genome, and the extent of domain shuffling and domain sharing among proteins. Here we present some first glimpses of these features.	Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Li, WH (corresponding author), Univ Chicago, 1101 E 57th St, Chicago, IL 60637 USA.	whli@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456; Nekrutenko, Anton/0000-0002-5987-8032				Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3	5	301	317	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					847	849		10.1038/35057039	http://dx.doi.org/10.1038/35057039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237007	Bronze			2022-12-01	WOS:000166938800054
J	Madsen, O; Scally, M; Douady, CJ; Kao, DJ; DeBry, RW; Adkins, R; Amrine, HM; Stanhope, MJ; de Jong, WW; Springer, MS				Madsen, O; Scally, M; Douady, CJ; Kao, DJ; DeBry, RW; Adkins, R; Amrine, HM; Stanhope, MJ; de Jong, WW; Springer, MS			Parallel adaptive radiations in two major clades of placental mammals	NATURE			English	Article							MOLECULAR SEQUENCES; EUTHERIAN MAMMALS; DIVERGENCE; TREE; PHYLOGENY; EVOLUTION; ORIGINS	Higher level relationships among placental mammals, as well as the historical biogeography and morphological diversification of this group, remain unclear(1-3). Here we analyse independent molecular data sets, having aligned lengths of DNA of 5,708 and 2,947 base pairs, respectively, for all orders of placental mammals. Phylogenetic analyses resolve placental orders into four groups: Xenarthra, Afrotheria, Laurasiatheria, and Euarchonta plus Glires. The first three groups are consistently monophyletic with different methods of analysis. Euarchonta plus Glires is monophyletic or paraphyletic depending on the phylogenetic method. A unique nine-base-pair deletion in exon 11 of the BRCA1 gene provides additional support for the monophyly of Afrotheria, which includes proboscideans, sirenians, hyracoids, tubulidentates, macroscelideans, chrysochlorids and tenrecids. Laurasiatheria contains cetartiodactyls, perissodactyls, carnivores, pangolins, bats and eulipotyphlan insectivores. Parallel adaptive radiations have occurred within Laurasiatheria and Afrotheria. In each group, there are aquatic, ungulate and insectivore-like forms.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Queens Univ Belfast, Belfast BT9 7BL, Antrim, North Ireland; Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Calif Riverside, Grad Grp Genet, Riverside, CA 92521 USA; SmithKline Beecham Pharmaceut, Collegeville, PA 19426 USA; Inst Biodivers & Ecosyst Dynam, NL-1090 GT Amsterdam, Netherlands	University of California System; University of California Riverside; Radboud University Nijmegen; Queens University Belfast; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Riverside; GlaxoSmithKline; University of Amsterdam	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.		DeBry, Ronald/K-3444-2015; Madsen, Ole/E-3730-2012; Douady, Christophe J/N-1357-2014; Douady, Christophe/N-3069-2019	Madsen, Ole/0000-0001-8082-7881; Douady, Christophe J/0000-0002-4503-8040; Douady, Christophe/0000-0002-4503-8040				Asher RJ, 1999, CLADISTICS, V15, P231, DOI 10.1111/j.1096-0031.1999.tb00266.x; de Jong WW, 1998, TRENDS ECOL EVOL, V13, P270, DOI 10.1016/S0169-5347(98)01335-4; Easteal S, 1999, BIOESSAYS, V21, P1052, DOI 10.1002/(SICI)1521-1878(199912)22:1<1052::AID-BIES9>3.0.CO;2-6; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Krajewski C, 1997, MOL PHYLOGENET EVOL, V8, P236, DOI 10.1006/mpev.1997.0421; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Matthew W. D, 1909, MEM AM MUS NAT HIST, V9, P291; McKenna MC, 1997, CLASSIFICATION MAMMA; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Penny D, 1999, SYST BIOL, V48, P76, DOI 10.1080/106351599260454; RAINGER R, 1991, AGENDA ANTIQUITY HF; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P303; RASMUSSEN DT, 1989, EVOLUTION PERISSODAC, P57; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 1997, P NATL ACAD SCI USA, V94, P13754, DOI 10.1073/pnas.94.25.13754; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Swofford David L., 1996, P407; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Waddell PJ, 1999, SYST BIOL, V48, P31, DOI 10.1080/106351599260427	28	517	540	1	128	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					610	614		10.1038/35054544	http://dx.doi.org/10.1038/35054544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214318				2022-12-01	WOS:000166692300042
J	Munte, TF; Kohlmetz, C; Nager, W; Altenmuller, E				Munte, TF; Kohlmetz, C; Nager, W; Altenmuller, E			Neuroperception - Superior auditory spatial tuning in conductors	NATURE			English	Article							ATTENTION		Univ Magdeburg, Dept Neuropsychol, D-39016 Magdeburg, Germany; Hannover Acad Music & Theatre, Inst Music Physiol & Performing Arts, D-30175 Hannover, Germany; Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany	Otto von Guericke University; Hannover Medical School	Munte, TF (corresponding author), Univ Magdeburg, Dept Neuropsychol, POB 4120, D-39016 Magdeburg, Germany.		Münte, Thomas/C-2077-2014; Altenmuller, Eckart/AAB-9948-2021					Bregman A. S, 1990, AUDITORY SCENE ANAL; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Schuller Gunther, 1997, COMPLEAT CONDUCTOR; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722	8	84	84	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					580	580		10.1038/35054668	http://dx.doi.org/10.1038/35054668			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214309				2022-12-01	WOS:000166692300033
J	Carr, PD; Gustin, SE; Church, AP; Murphy, JM; Ford, SC; Mann, DA; Woltring, DM; Walker, I; Ollis, DL; Young, IG				Carr, PD; Gustin, SE; Church, AP; Murphy, JM; Ford, SC; Mann, DA; Woltring, DM; Walker, I; Ollis, DL; Young, IG			Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration	CELL			English	Article							COLONY-STIMULATING FACTOR; HIGH-AFFINITY BINDING; CRYSTAL-STRUCTURE; HUMAN INTERLEUKIN-5; ALPHA-CHAIN; ERYTHROPOIETIN RECEPTOR; CYTOKINE RECEPTORS; GROWTH-HORMONE; PROTEIN AIC2A; IDENTIFICATION	The receptor systems for the hemopoietic cytokines GM-CSF, IL-3, and IL-5 consist of ligand-specific alpha receptor subunits that play an essential role in the activation of the shared betac subunit, the major signaling entity. Here, we report the structure of the complete betac extracellular domain. It has a structure unlike any class I cytokine receptor described thus far, forming a stable interlocking dimer in the absence of ligand in which the G strand of domain 1 hydrogen bonds into the corresponding beta sheet of domain 3 of the dimer-related molecule. The G strand of domain 3 similarly partners with the dimer-related domain 1. The structure provides new insights into receptor activation by the respective ru receptor:ligand complexes.	Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 2601, Australia; Australian Natl Univ, Res Sch Chem, Acton, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Young, IG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 2601, Australia.	ian.young@anu.edu.au	Ollis, David/I-5967-2014; Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949				Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRY SC, 1994, J BIOL CHEM, V269, P8488; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1996, X PLOR VERSION 3 85; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dickason RR, 1996, NATURE, V379, P652, DOI 10.1038/379652a0; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Haman A, 1999, J BIOL CHEM, V274, P34155, DOI 10.1074/jbc.274.48.34155; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HERCUS TR, 1994, P NATL ACAD SCI USA, V91, P5838, DOI 10.1073/pnas.91.13.5838; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Ihle JN, 1997, STEM CELLS, V15, P105, DOI 10.1002/stem.5530150814; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kishore R, 1997, J BIOL CHEM, V272, P17078, DOI 10.1074/jbc.272.27.17078; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LOCK P, 1994, P NATL ACAD SCI USA, V91, P252, DOI 10.1073/pnas.91.1.252; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Mulhern TD, 2000, J MOL BIOL, V297, P989, DOI 10.1006/jmbi.2000.3610; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Niu LH, 2000, BLOOD, V95, P3357, DOI 10.1182/blood.V95.11.3357.011k43_3357_3362; OGOROCHI T, 1992, BLOOD, V79, P895; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Rossjohn J, 2000, BLOOD, V95, P2491; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SATO N, 1994, CURR OPIN CELL BIOL, V6, P174, DOI 10.1016/0955-0674(94)90133-3; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Verschelde JL, 1998, FEBS LETT, V424, P121, DOI 10.1016/S0014-5793(98)00146-X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WANG HM, 1992, J BIOL CHEM, V267, P979; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Zhang J, 1999, ANAL BIOCHEM, V268, P134, DOI 10.1006/abio.1998.3058	52	81	88	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					291	300		10.1016/S0092-8674(01)00213-6	http://dx.doi.org/10.1016/S0092-8674(01)00213-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207369	Bronze			2022-12-01	WOS:000166879700012
J	Pham, P; Bertram, JG; O'Donnell, M; Woodgate, R; Goodman, MF				Pham, P; Bertram, JG; O'Donnell, M; Woodgate, R; Goodman, MF			A model for SOS-lesion-targeted mutations in Escherichia coli	NATURE			English	Article							DNA-POLYMERASE-III; MUTAGENESIS; REPAIR; RECA; PROTEINS; COMPLEX; DAMAGE; CLAMP	The UmuD'C-2 protein complex (Escherichia coli pol V)(1-3) is a low-fidelity DNA polymerase (pol) that copies damaged DNA in the presence of RecA, single-stranded-DNA binding protein (SSB) and the beta,gamma -processivity complex of E. coli pol III (ref. 4). Here we propose a model to explain SOS-lesion-targeted mutagenesis, assigning specific biochemical functions for each protein during translesion synthesis. (SOS lesion-targeted mutagenesis occurs when pol V is induced as part of the SOS response to DNA damage and incorrectly incorporates nucleotides opposite template lesions.) Pol V plus SSB catalyses RecA filament disassembly in the 3' to 5' direction on the template, ahead of the polymerase, in a reaction that does not involve ATP hydrolysis. Concurrent ATP-hydrolysis-driven filament disassembly in the 5' to 3' direction results in a bidirectional stripping of RecA from the template strand. The bidirectional collapse of the RecA filament restricts DNA synthesis by pol V to template sites that are proximal to the lesion, thereby minimizing the occurrence of untargeted mutations at undamaged template sites.	Univ So Calif, Dept Biol Sci & Chem, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	University of Southern California; Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci & Chem, Hedco Mol Biol Labs, Univ Pk, Los Angeles, CA 90089 USA.			Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAILONE A, 1991, BIOCHIMIE, V73, P479, DOI 10.1016/0300-9084(91)90115-H; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Creighton S, 1995, METHOD ENZYMOL, V262, P232; ECHOLS H, 1990, MUTAT RES, V236, P301, DOI 10.1016/0921-8777(90)90013-U; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, V1, P407; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Goodman MF, 2000, TRENDS BIOCHEM SCI, V25, P189, DOI 10.1016/S0968-0004(00)01564-4; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755	19	99	109	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					366	370		10.1038/35053116	http://dx.doi.org/10.1038/35053116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201748				2022-12-01	WOS:000166434300053
J	Visscher, PM; Smith, D; Hall, SJG; Williams, JA				Visscher, PM; Smith, D; Hall, SJG; Williams, JA			A viable herd of genetically uniform cattle - Deleterious alleles seem to have been purged in a feral strain of inbred cows.	NATURE			English	Article							EXTINCTION		Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; De Montfort Univ, Sch Agr, Grantham NG32 3EP, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; De Montfort University	Visscher, PM (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Visscher, Peter/ABB-6151-2020	Visscher, Peter/0000-0002-2143-8760; Hall, Stephen/0000-0003-2666-1715; Williams, John/0000-0001-5188-7957				ANDERSON C, 1992, NATURE, V355, P382; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; HALL SJG, 1988, J ZOOL, V216, P479, DOI 10.1111/j.1469-7998.1988.tb02444.x; KIMURA M, 1955, P NATL ACAD SCI USA, V41, P144, DOI 10.1073/pnas.41.3.144; Lacy RC, 1998, EVOLUTION, V52, P900, DOI 10.1111/j.1558-5646.1998.tb03715.x; MACHUGH DE, 1994, P ROY SOC B-BIOL SCI, V256, P25, DOI 10.1098/rspb.1994.0044; MANOTTIRAYMOND MA, 1995, J HERED, V86, P319; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; STAM P, 1980, GENET RES, V35, P131, DOI 10.1017/S0016672300014002; WIENER G, 1992, ANIM PROD, V55, P89, DOI 10.1017/S0003356100037314	13	73	74	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					303	303		10.1038/35053160	http://dx.doi.org/10.1038/35053160			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201728	Bronze			2022-12-01	WOS:000166434300032
J	Watanabe, Y; Yokobayashi, S; Yamamoto, M; Nurse, P				Watanabe, Y; Yokobayashi, S; Yamamoto, M; Nurse, P			Pre-meiotic S phase is linked to reductional chromosome segregation and recombination	NATURE			English	Article							SISTER-CHROMATID COHESION; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; DNA-REPLICATION; MEIOSIS; PROTEIN; GENE; CENTROMERE; REC8	Meiosis is initiated from G1 of the cell cycle and is characterized by a pre-meiotic S phase followed by two successive nuclear divisions. The first of these, meiosis I, differs from mitosis in having a reductional pattern of chromosome segregation(1,2). Here we show that meiosis can be initiated from G2 in fission yeast cells by ectopically activating the meiosis-inducing network. The subsequent meiosis I occurs without a pre-meiotic S phase and with decreased recombination, and exhibits a mitotic pattern of equational chromosome segregation. The subsequent meiosis II results in random chromosome segregation. This behaviour is similar to that observed in cells lacking the meiotic cohesin Rec8 (refs 3, 4), which becomes associated with chromosomes at G1/S phase, including the inner centromere, a region that is probably critical for sister-centromere orientation(5). If the expression of Rec8 is delayed to S phase/G2, then the centromeres behave equationally. We propose that the presence of Rec8 in chromatin is required at the pre-meiotic S phase to construct centromeres that behave reductionally and chromosome arms capable of a high level of recombination, and that this explains why meiosis is initiated from G1 of the cell cycle.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; Imperial Canc Res Fund, London WC2A 3PX, England	University of Tokyo; Japan Science & Technology Agency (JST); Cancer Research UK	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	ywatanab@ims.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812				BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Cha RS, 2000, GENE DEV, V14, P493; DEVEAUX LC, 1994, GENE DEV, V8, P203, DOI 10.1101/gad.8.2.203; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; IINO Y, 1985, P NATL ACAD SCI USA, V82, P2447, DOI 10.1073/pnas.82.8.2447; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; LIN YK, 1994, GENETICS, V136, P769; MCLEOD M, 1988, NATURE, V332, P509, DOI 10.1038/332509a0; MOLNAR M, 1995, GENETICS, V141, P61; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; NIWA O, 1988, NATURE, V336, P430, DOI 10.1038/336430a0; Partridge JF, 2000, GENE DEV, V14, P783; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Yamamoto M., 1997, MATING SPORULATION S, P1037	25	115	119	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					359	363		10.1038/35053103	http://dx.doi.org/10.1038/35053103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201746				2022-12-01	WOS:000166434300051
J	Ma, DK; Zerangue, N; Lin, YF; Collins, A; Yu, M; Jan, YN; Jan, LY				Ma, DK; Zerangue, N; Lin, YF; Collins, A; Yu, M; Jan, YN; Jan, LY			Role of ER export signals in controlling surface potassium channel numbers	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; GOLGI	Little is known about the identity of endoplasmic reticulum (ER) export signals and how they are used to regulate the number of proteins on the cell surface. Here, we describe two ER export signals that profoundly altered the steady-state distribution of potassium channels and were required for channel localization to the plasma membrane. When transferred to other potassium channels or a G protein-coupled receptor, these ER export signals increased the number of functional proteins on the cell surface. Thus, ER export of membrane proteins is not necessarily limited by folding or assembly, but may be under the control of specific export signals.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Oregon State University	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			/0000-0002-6129-2938; Lin, Yu-Fung/0000-0003-1471-949X; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; Hille B., 1992, IONIC CHANNELS EXCIT; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MIZUNO M, 1993, P NATL ACAD SCI USA, V90, P5732, DOI 10.1073/pnas.90.12.5732; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; ROTHMAN JE, 1987, CELL, V50, P521, DOI 10.1016/0092-8674(87)90024-9; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	15	309	344	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					316	319		10.1126/science.291.5502.316	http://dx.doi.org/10.1126/science.291.5502.316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209084				2022-12-01	WOS:000166352900049
J	Lee, DS; Lee, JS; Oh, SH; Kim, SK; Kim, JW; Chung, JK; Lee, MC; Kim, CS				Lee, DS; Lee, JS; Oh, SH; Kim, SK; Kim, JW; Chung, JK; Lee, MC; Kim, CS			Deafness - Cross-modal plasticity and cochlear implants	NATURE			English	Article							AUDITORY-CORTEX; ACTIVATION		Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Nucl Med, 28 Yungun Dong, Seoul 110799, South Korea.	dsl@plaza.snu.ac.kr	Lee, Dong Soo/J-2778-2012; Lee, Jae Sung/J-2781-2012					Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CATALANAHUMADA M, 1993, BRAIN RES, V623, P287, DOI 10.1016/0006-8993(93)91439-Y; Cohen LG, 1999, EEG CL N SU, P174; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Naito Y, 1997, ACTA OTO-LARYNGOL, V117, P490, DOI 10.3109/00016489709113426; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; Okazawa H, 1996, BRAIN, V119, P1297, DOI 10.1093/brain/119.4.1297; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0	9	299	316	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2001	409	6817					149	150		10.1038/35051653	http://dx.doi.org/10.1038/35051653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196628				2022-12-01	WOS:000166316200029
J	Norell, MA; Clarke, JA				Norell, MA; Clarke, JA			Fossil that fills a critical gap in avian evolution	NATURE			English	Article							BIRDS; RADIATION; PATAGONIA	Despite the discoveries of well-preserved Mesozoic birds(1-5), a key part of avian evolution, close to the radiation of all living birds (Aves), remains poorly represented(6). Here we report on a new taxon from the Late Cretaceous locality of Ukhaa Tolgod, Mongolia(7), that offers insight into this critically unsampled period. Apsaravis and the controversial alvarezsaurids(8) are the only avialan(9) taxa known from the continental deposits at Ukhaa Tolgod, which have produced hundreds of fossil mammals, lizards and other small inosaurs(7). The new taxon, Apsaravis ukhaana, is the best-preserved specimen of a Mesozoic ornithurine bird discovered in over a century. It provides data important for assessing morphological evolution across Avialae, with implications for, first, the monophyly of Enantiornithes and Sauriurae; second, the proposition that the Mesozoic sister taxa of extant birds, as part of an `ecological bottleneck', inhabited exclusively near-shore and marine environments(2); and third, the evolution of flight after its origin.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Yale University; American Museum of Natural History (AMNH)	Clarke, JA (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.		/B-4978-2011	/0000-0003-2218-2637				Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; CHIAPPE LM, 1994, J VERTEBR PALEONTOL, V14, P230, DOI 10.1080/02724634.1994.10011554; CHIAPPE LM, 1991, ALCHERINGA, V15, P333, DOI 10.1080/03115519108619028; Chiappe LM, 1999, AM MUS NOVIT, V242, P1; Chiappe Luis M., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P203; CLARKE JA, IN PRESS AM MUS NOVI; DASHZEVEG D, 1995, NATURE, V374, P446, DOI 10.1038/374446a0; Feduccia A., 1996, ORIGIN EVOLUTION BIR; FORESTER CA, 1996, SCIENCE, V382, P532; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou LH, 1996, SCIENCE, V274, P1164, DOI 10.1126/science.274.5290.1164; KUROCHKIN EN, 1996, NEW ENANTIORNITHID M; Marsh O.C., 1880, ODONTORNITHES MONOGR, DOI [10.5962/bhl.title.61298, DOI 10.5962/BHL.TITLE.61298]; Martin L.D., 1983, P291, DOI 10.1017/CBO9780511759994.011; MOLNAR RE, 1986, NATURE, V322, P736, DOI 10.1038/322736a0; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Ostrom J.H., 1974, Postilla, VNo. 165, P1; Ostrom John H., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V195, P253; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Sanz Jose L., 1995, American Museum Novitates, V3133, P1; SWOFFORD PL, 1998, PAUP STAR PHYLOGENET; VAZQUEZ RJ, 1994, ZOOMORPHOLOGY, V114, P59, DOI 10.1007/BF00574915; WALKER CA, 1981, NATURE, V292, P51, DOI 10.1038/292051a0	25	79	83	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					181	184		10.1038/35051563	http://dx.doi.org/10.1038/35051563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196639				2022-12-01	WOS:000166316200041
J	Reeder, GS				Reeder, GS			Exercise testing in rapid-access clinics for assessment of chest pain	LANCET			English	Editorial Material									Mayo Clin & Mayo Fdn, Dept Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Reeder, GS (corresponding author), Mayo Clin & Mayo Fdn, Dept Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.							Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Stein RA, 2000, CIRCULATION, V102, P1463, DOI 10.1161/01.CIR.102.12.1463	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 23	2000	356	9248					2116	2116		10.1016/S0140-6736(00)03487-5	http://dx.doi.org/10.1016/S0140-6736(00)03487-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385HD	11191534				2022-12-01	WOS:000165997300005
J	van Helden, PD; Hoal-van Helden, EG				van Helden, PD; Hoal-van Helden, EG			Molecular answers to tuberculous questions	LANCET			English	Article									Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, ZA-7505 Tygerberg, South Africa; Univ Stellenbosch, Dept Biochem, ZA-7505 Tygerberg, South Africa	Stellenbosch University; Stellenbosch University	van Helden, PD (corresponding author), Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, POB 19063, ZA-7505 Tygerberg, South Africa.			Hoal, Eileen/0000-0002-6444-5688					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S61	S61		10.1016/S0140-6736(00)92047-6	http://dx.doi.org/10.1016/S0140-6736(00)92047-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191521				2022-12-01	WOS:000166074900063
J	Roska, B; Werblin, F				Roska, B; Werblin, F			Vertical interactions across ten parallel, stacked representations in the mammalian retina	NATURE			English	Article							CONE BIPOLAR CELLS; GANGLION-CELLS; FUNCTIONAL ARCHITECTURE; RESPONSES; INHIBITION; RECEPTORS; CAT; ROD	The mammalian visual system analyses the world through a set of separate spatio-temporal channels(1,2). The organization of these channels begins in the retina(1,3), where the precise laminations of both the axon terminals of bipolar cells and the dendritic arborizations of ganglion cells suggests the presence of a vertical stack of neural strata at the inner plexiform layer (IPL)(3-11), Conversely, many inhibitory amacrine cell classes are multiply or diffusely stratified(12), indicating that they might convey information between strata, On the basis of the diverse stratification and physiological properties of ganglion cells, it was suggested that the IPL contains a parallel set of representations of the visual world(3,7) embodied in the strata and conveyed to higher centres by the classes of ganglion cells whose dendrites ramify at that stratum. Here we show that each stratum receives unique and substantively different excitatory and inhibitory neural inputs that are integrated to form at least ten different, parallel spacetime spiking outputs. The response properties of these strata are ordered in the time domain. Inhibition through GABA(C) receptors extracts spatial edges in neural representations and seems to separate the functional properties of the strata, We describe a new form of neuronal interaction that we call 'vertical inhibition' that acts not laterally, but between strata.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Werblin, F (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 145 LSA, Berkeley, CA 94720 USA.	werblin@socrates.berkeley.edu	Roska, Botond/AAD-7268-2021					Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; BLOOMFIELD SA, 1986, J NEUROSCI, V6, P1; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; DIAMOND JS, 1995, J PHYSIOL-LONDON, V487, P711, DOI 10.1113/jphysiol.1995.sp020912; Enz R, 1996, J NEUROSCI, V16, P4479; Euler T, 1996, J NEUROSCI, V16, P2934; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; FISHER SK, 1974, PROC R SOC SER B-BIO, V186, P317, DOI 10.1098/rspb.1974.0052; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; MATURANA HUMBERTO R., 1960, JOUR GEN PHYSIOL, V43, P129, DOI 10.1085/jgp.43.6.129; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Ramon, 1892, CELLULE, V1, P119; Rodieck R, 1998, 1 STEPS SEEING; Roska B, 2000, J NEUROSCI, V20, P1941; Shields CR, 2000, J NEUROSCI, V20, P2673; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Zhang J, 1999, INVEST OPHTH VIS SCI, V40, pS812	26	369	373	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					583	587		10.1038/35069068	http://dx.doi.org/10.1038/35069068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279496				2022-12-01	WOS:000167859300048
J	Woolhouse, M; Donaldson, A				Woolhouse, M; Donaldson, A			Managing foot-and-mouth - The science of controlling disease outbreaks.	NATURE			English	Editorial Material							VACCINATION; EPIDEMICS; DYNAMICS		Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Inst Anim Hlth, Woking GU24 0NF, Surrey, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.			Woolhouse, Mark/0000-0003-3765-8167				ANDERSON R M, 1991; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; Donaldson AI, 1996, REV SCI TECH OIE, V15, P863, DOI 10.20506/rst.15.3.957; DONALDSON AI, 1999, DIS SHEEP, P254; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; Knowles NJ, 2001, VET REC, V148, P258; Salt J. S., 1997, VET VACCINOLOGY, P641; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westergaard J., 1982, REPORT ERADICATION F; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X; 2001, VET REC, V148, P286	14	52	54	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2001	410	6828					515	516		10.1038/35069250	http://dx.doi.org/10.1038/35069250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279464				2022-12-01	WOS:000167859300018
J	Gilsdorf, JR				Gilsdorf, JR			A simple song of gratitude	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2001	285	12					1555	1556		10.1001/jama.285.12.1555	http://dx.doi.org/10.1001/jama.285.12.1555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HH	11268244				2022-12-01	WOS:000167606600001
J	Andrews, GR				Andrews, GR			Care of older people - Promoting health and function in an ageing population	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY; LIFE-STYLE; RANDOMIZED TRIAL; COLLEGE ALUMNI; EXERCISE; MORBIDITY; MORTALITY; STRENGTH; DISEASE; MUSCLE		Flinders Univ S Australia, Ctr Aging Studies, Bedford Pk, SA 5042, Australia	Flinders University South Australia	Andrews, GR (corresponding author), Flinders Univ S Australia, Ctr Aging Studies, Sci Pk, Bedford Pk, SA 5042, Australia.							ABDELLAH FG, 1988, SURG GEN WORKSH HLTH; Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335; BLAIR SN, 1985, PUBLIC HEALTH REP, V100, P172; *CAN MIN SUPPL SER, 1994, STRAT POP HLTH INV H; COOPER C, 1988, BRIT MED J, V297, P1443, DOI 10.1136/bmj.297.6661.1443; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; FRISCH RE, 1986, DIABETES, V35, P1101, DOI 10.2337/diabetes.35.10.1101; GINN J, 1997, RES OLDER PEOPLES HL; KOHL HW, 1988, SPORTS MED, V6, P222, DOI 10.2165/00007256-198806040-00004; Malbut-Shennan K, 1999, CORONARY ARTERY DIS, V10, P37; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; MCMURDO MET, 1993, AGE AGEING, V22, P11, DOI 10.1093/ageing/22.1.11; McMurdo MET, 1999, BRIT J SPORT MED, V33, P295, DOI 10.1136/bjsm.33.5.295; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PAFFENBARGER RS, 1983, AM J EPIDEMIOL, V117, P245, DOI 10.1093/oxfordjournals.aje.a113537; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Richmond DE, 1996, NEW ZEAL MED J, V109, P122; *ROYAL COMM LONG T, 1999, ESP OLD AG LONG TERM; RUUSKANEN JM, 1995, AGE AGEING, V24, P292, DOI 10.1093/ageing/24.4.292; Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579; SPSS Inc, 2006, HLTH ED J, DOI DOI 10.1177/001789699705600102; TAYLOR CB, 1985, PUBLIC HEALTH REP, V100, P195; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; *WHO, 1998, WORLD HLTH REP LIF 2	29	54	54	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 24	2001	322	7288					728	729		10.1136/bmj.322.7288.728	http://dx.doi.org/10.1136/bmj.322.7288.728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	416GB	11264216	Green Published			2022-12-01	WOS:000167771000031
J	Berman, DE; Dudai, Y				Berman, DE; Dudai, Y			Memory extinction, learning anew, and learning the new: Dissociations in the molecular machinery of learning in cortex	SCIENCE			English	Article							RAT INSULAR CORTEX; PROTEIN-SYNTHESIS; UNFAMILIAR TASTE; RECONSOLIDATION; CONSOLIDATION; ACTIVATION; RETRIEVAL; AMYGDALA	The rat insular cortex (IC) subserves the memory of conditioned taste aversion (CTA), in which a taste is associated with malaise. When the conditioned taste is unfamiliar, formation of Long-term CTA memory depends on muscarinic and beta -adrenergic receptors, mitogen-activated protein kinase (MAPK), and protein synthesis. We show that extinction of CTA memory is also dependent on protein synthesis and beta -adrenergic receptors in the IC, but independent of muscarinic receptors and MAPK. This resembles the molecular signature of the formation of Long-term memory of CTA to a familiar taste. Thus, memory extinction shares molecular mechanisms with Learning, but the mechanisms of learning anew differ from those of Learning the new.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							AGRANOFF BW, 1964, SCIENCE, V146, P952, DOI 10.1126/science.146.3646.952; Berman D.S., UNPUB; Berman DE, 1998, J NEUROSCI, V18, P10037; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; BOUTON ME, 1994, J EXP PSYCHOL-ANIM B, V20, P219, DOI 10.1037/0097-7403.20.3.219; BRAUD W G, 1973, Pharmacology Biochemistry and Behavior, V1, P651, DOI 10.1016/0091-3057(73)90028-2; Bures J., 1998, CONDITIONED TASTE AV; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FALLS WA, 1992, J NEUROSCI, V12, P854; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; FLOOD JF, 1977, PHARMACOL BIOCHEM BE, V7, P71, DOI 10.1016/0091-3057(77)90013-2; Garcia J, 1966, PSYCHON SCI, V5, P121, DOI [10.3758/BF03328311, DOI 10.3758/BF03328311]; MCCORMICK DA, 1982, BRAIN RES, V245, P239, DOI 10.1016/0006-8993(82)90806-X; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; Pavlov IP, 1927, CONDITIONED REFLEXES; PRADOALCALA RA, 1994, PHYSIOL BEHAV, V56, P27, DOI 10.1016/0031-9384(94)90257-7; Rescorla RA, 1996, Q J EXP PSYCHOL-B, V49, P245; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73	23	377	382	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2417	2419		10.1126/science.1058165	http://dx.doi.org/10.1126/science.1058165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	413UH	11264539				2022-12-01	WOS:000167618700058
J	Topfer, K				Topfer, K			Climate change - Whither after The Hague?	SCIENCE			English	Article									UN Environm Program, Nairobi, Kenya		Topfer, K (corresponding author), UN Environm Program, POB 30552, Nairobi, Kenya.							[Anonymous], 1998, HUM DEV REP 1998; *INT EN AG, 1998, EN STAT BAL OECD NON; *IPCC, 2001, SUMM POL MAK WORK GR; *PEW CTR GLOB CLIM, 2000, RED EM MAINT EC GROW; *UN FOOD AGR ORG, IN PRESS STAT WORLDS; United Nations, 1998, FRAM CONV CLIM CHANG; [No title captured]	7	1	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2001	291	5511					2095	2096		10.1126/science.1059490	http://dx.doi.org/10.1126/science.1059490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412PP	11256405				2022-12-01	WOS:000167563800020
J	Becker, K; Southwick, K; Reardon, J; Berg, R; MacCormack, JN				Becker, K; Southwick, K; Reardon, J; Berg, R; MacCormack, JN			Histamine poisoning associated with eating tuna burgers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Histamine poisoning occurs when persons ingest fish in which bacteria have converted histidine to histamine, a process that usually can be controlled by storage at low temperatures. From 1994 to 1997, North Carolina averaged 2 cases annually; however, from July 1998 to February 1999, a total of 22 cases of histamine fish poisoning were reported. Objectives To examine the increase in histamine case reports, identify risk factors for poisoning, and develop recommendations for prevention. Design and Setting Case series evaluated in North Carolina from July 1998 to February 1999, Subjects Reported case-patients with 2 of the following symptoms within 2 hours of eating tuna: rash, facial flushing, vomiting, diarrhea, dyspnea, a tight feeling in the throat, headache, or a metallic or peppery taste in the mouth. Results Twenty cases occurred during 5 outbreaks, and there were 2 single occurrences. Of the 22 persons affected, 19 (86%) sought emergency medical care. All case-patients ate tuna: 18 ate tuna burgers, 2 ate salad containing tuna, and 2 ate filets, Tuna samples (available from 3 outbreaks) had histamine levels above the Food and Drug Administration regulatory level of 50 ppm (levels were between 213 and 3245 ppm). In 19 cases, the tuna used to prepare burgers or salads was frozen and thawed more than once before serving. Violations of recommended temperature controls were identified in 2 of the 5 restaurants, accounting for 14 (64%) cases. Conclusions Tuna burgers, a relatively new menu item in restaurants, were associated with an increase in histamine poisoning cases in North Carolina. Tuna ground for burgers can be susceptible to both temperature fluctuations and bacterial contamination.	Ctr Dis Control & Prevent, Raleigh, NC USA; N Carolina Dept Hlth & Human Serv, Raleigh, NC USA; N Carolina Dept Agr & Consumer Serv, Raleigh, NC USA; US FDA, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Becker, K (corresponding author), US Dept HHS, Off Int & Refugee Hlth, 5600 Fishers Ln,Parklawn Bldg,Room 18-105, Rockville, MD 20857 USA.	kbecker@osophs.dhhs.gov						[Anonymous], 1995, FED REG, V60, P65096; BAGNIS R, 1970, B WORLD HEALTH ORGAN, V42, P69; *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P140; *CDCP, 1980, MMWR-MORBID MORTAL W, V29, P106; *CDCP, 1985, 1982 FOODB DIS SURV; *CDCP, 1980, MMWR-MORBID MORTAL W, V29, P167; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P264; CHIN J, 2000, CONTROL COMMUNICABLE, P209; ETKIND P, 1987, JAMA-J AM MED ASSOC, V258, P3409, DOI 10.1001/jama.258.23.3409; *FDA, 1994, FDA PUBL; GILBERT RJ, 1980, BMJ-BRIT MED J, V281, P71; HUI JY, 1985, TOXICOL APPL PHARM, V81, P241, DOI 10.1016/0041-008X(85)90160-7; LOPEZSABATER EI, 1994, J FOOD PROTECT, V57, P318, DOI 10.4315/0362-028X-57.4.318; LopezSabater EI, 1996, J FOOD PROTECT, V59, P167, DOI 10.4315/0362-028X-59.2.167; Maher J. P., 2000, Morbidity and Mortality Weekly Report, V49, P398; MURRAY CK, 1982, J HYG-CAMBRIDGE, V88, P215, DOI 10.1017/S002217240007008X; ROGERS PR, 1993, LAB INFORMATION B, V3794; SENANAYAKE N, 1978, BRIT MED J, V2, P1127, DOI 10.1136/bmj.2.6145.1127-a; SMART DR, 1992, MED J AUSTRALIA, V157, P748; STRATTON JE, 1988, SEAFOOD SAFETY, P331; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; Taylor S.L., 1986, SEAFOOD QUALITY DETE, P235; Taylor S.L., 1985, HISTAMINE POISONING; TAYLOR SL, 1986, CRC CR REV TOXICOL, V17, P91, DOI 10.3109/10408448609023767; TAYLOR SL, 1988, FOOD TECHNOL-CHICAGO, V42, P94; TAYLOR SL, 1989, J TOXICOL-CLIN TOXIC, V27, P225, DOI 10.3109/15563658908994420	26	77	85	3	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1327	1330		10.1001/jama.285.10.1327	http://dx.doi.org/10.1001/jama.285.10.1327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255388				2022-12-01	WOS:000167339000025
J	Kern, KB; Halperin, HR; Field, J				Kern, KB; Halperin, HR; Field, J			New guidelines for cardiopulmonary resuscitation and emergency cardiac care - Changes in the management of cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPRESSION-DECOMPRESSION RESUSCITATION; TRIAL		Amer Heart Assoc, Adv Cardiac Life Support Subcomm, Dallas, TX USA; Univ Arizona, Sarver Heart Ctr, Cardiol Sect, Coll Med, Tucson, AZ 85724 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Penn State Univ, Coll Med, Hershey, PA USA	University of Arizona; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kern, KB (corresponding author), Univ Arizona, Sarver Heart Ctr, Cardiol Sect, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	kernk@u.arizona.edu						[Anonymous], 1986, JAMA-J AM MED ASSOC, V255, P2905; [Anonymous], 1980, JAMA-J AM MED ASSOC, V244, P453; COHEN TJ, 1993, NEW ENGL J MED, V329, P1918, DOI 10.1056/NEJM199312233292603; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; KERBER RE, 1992, JAMA-J AM MED ASSOC, V268, P2172; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Lindner KH, 1997, LANCET, V349, P535, DOI 10.1016/S0140-6736(97)80087-6; Plaisance P, 1997, CIRCULATION, V95, P955; Plaisance P, 1999, NEW ENGL J MED, V341, P569, DOI 10.1056/NEJM199908193410804; Plaisance P, 2000, CIRCULATION, V101, P989, DOI 10.1161/01.CIR.101.9.989; SACK JB, 1992, JAMA-J AM MED ASSOC, V267, P379; SACK JB, 1992, CIRCULATION, V86, P1692, DOI 10.1161/01.CIR.86.6.1692; SCHWAB TM, 1995, JAMA-J AM MED ASSOC, V273, P1261, DOI 10.1001/jama.273.16.1261; Standards for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC), 1974, JAMA-J AM MED ASSOC, V227, P833; Stiell IG, 1996, JAMA-J AM MED ASSOC, V275, P1417, DOI 10.1001/jama.275.18.1417; TUCKER KJ, 1994, J AM COLL CARDIOL, V24, P201, DOI 10.1016/0735-1097(94)90564-9; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Willerson JT, 2000, CIRCULATION, V102, P1	18	18	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2001	285	10					1267	1269		10.1001/jama.285.10.1267	http://dx.doi.org/10.1001/jama.285.10.1267			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408QK	11255370				2022-12-01	WOS:000167339000002
J	Stein, E; Tessier-Lavigne, M				Stein, E; Tessier-Lavigne, M			Hierarchical organization of guidance receptors: Silencing of netrin attraction by slit through a Robo/DCC receptor complex	SCIENCE			English	Article							REPULSIVE AXON GUIDANCE; GROWTH CONE GUIDANCE; COLORECTAL-CANCER; DCC; ROUNDABOUT; DROSOPHILA; REPELLENT; PROTEINS; PATTERNS; ENCODES	Axonal growth cones that cross the nervous system midline change their responsiveness to midline guidance cues: They become repelled by the repellent Slit and simultaneously lose responsiveness to the attractant netrin. These mutually reinforcing changes help to expel growth cones from the midline by making a once-attractive environment appear repulsive. Mere; we provide evidence that these two changes are causally Linked: In the growth cones of embryonic Xenopus spinal axons, activation of the Slit receptor Roundabout (Robo) silences the attractive effect of netrin-1, but not its growth-stimulatory effect, through direct binding of the cytoplasmic domain of Robe to that of the netrin receptor DCC. Biologically, this hierarchical silencing mechanism helps to prevent a tug-of-war between attractive and repulsive signals in the growth cone that might cause confusion. Molecularly, silencing is enabled by a modular and interlocking design of the cytoplasmic domains of these potentially antagonistic receptors that predetermines the outcome of their simultaneous activation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu	Stein, Elke/E-8107-2013	Stein, Elke/0000-0001-8965-5692				Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Erskine L, 2000, J NEUROSCI, V20, P4975; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Schultz J, 1997, PROTEIN SCI, V6, P249; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TABTI N, 1994, NEUROSCI LETT, V173, P21, DOI 10.1016/0304-3940(94)90141-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	28	455	463	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1928	1938		10.1126/science.1058445	http://dx.doi.org/10.1126/science.1058445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239147				2022-12-01	WOS:000167401600037
J	de Fockert, JW; Rees, G; Frith, CD; Lavie, N				de Fockert, JW; Rees, G; Frith, CD; Lavie, N			The role of working memory in visual selective attention	SCIENCE			English	Article							PERCEPTUAL LOAD; SYSTEM; AREA	The hypothesis that working memory is crucial for reducing distraction by maintaining the prioritization of relevant information was tested in neuroimaging and psychological experiments with humans. Participants performed a selective attention task that required them to ignore distracter faces while holding in working memory a sequence of digits that were in the same order (Low memory Load) or a different order thigh memory Load) on every trial. Higher memory Load, associated with increased prefrontal activity, resulted in greater interference effects on behavioral performance from the distracter faces, plus increased face-related activity in the visual cortex. These findings confirm a major role for working memory in the control of visual selective attention.	UCL, Dept Psychol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	de Fockert, JW (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	j.de-fockert@ucl.ac.uk	Frith, Chris D/A-2171-2009; Rees, Geraint/C-1493-2008	Frith, Chris D/0000-0002-8665-0690; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Lavie N, 2000, J EXP PSYCHOL HUMAN, V26, P1038, DOI 10.1037//0096-1523.26.3.1038; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Shallice T., 1991, FRONTAL LOBE FUNCTIO; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; YOUNG AW, 1986, J EXP PSYCHOL HUMAN, V12, P466, DOI 10.1037/0096-1523.12.4.466	22	644	658	3	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1803	1806		10.1126/science.1056496	http://dx.doi.org/10.1126/science.1056496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HK	11230699	Green Accepted, Green Submitted			2022-12-01	WOS:000167320600064
J	Vukusic, P; Sambles, JR; Lawrence, CR; Wootton, RJ				Vukusic, P; Sambles, JR; Lawrence, CR; Wootton, RJ			Structural colour - Now you see it now you don't	NATURE			English	Article									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; DERA, Mech Sci Sector, Farnborough GU14 0LX, Hants, England; Univ Exeter, Sch Biol Sci, Exeter EX4 4PS, Devon, England	University of Exeter; University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	p.vukusic@ex.ac.uk	Sambles, John Roy/X-8675-2019	SAMBLES, John/0000-0003-2721-0692	Biotechnology and Biological Sciences Research Council [JF16983] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		DeVries PJ., 1997, BUTTERFLIES COSTA RI; GREENEWALT CH, 1960, J OPT SOC AM, V50, P1005, DOI 10.1364/JOSA.50.001005; Guinier A, 1963, XRAY STUDIES MAT; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Magnus D. B. E., 1958, Proceedings 10th International Congress of Entomology Montreal 1956, V2, P405; SILBERGLIED RE, 1984, S ROYAL ENTOMOLOGICA, V11, P207; SMART P, 1976, ENCY BUTTERFLY; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794	8	122	132	7	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2001	410	6824					36	36		10.1038/35065161	http://dx.doi.org/10.1038/35065161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406BD	11242032	Bronze			2022-12-01	WOS:000167194300033
J	Fernandez, A; Davis, SB; Wendt, JOL; Cenni, R; Young, RS; Witten, ML				Fernandez, A; Davis, SB; Wendt, JOL; Cenni, R; Young, RS; Witten, ML			Public health - Particulate emission from biomass combustion	NATURE			English	Article									Univ Arizona, Dept Environm Chem & Engn, Tucson, AZ 85721 USA; Univ Stuttgart, Inst Verfahrenstech & Dampfkesselwesen, D-70569 Stuttgart, Germany; Univ Arizona, Arizona Hlth Sci Ctr, Dept Pediat, Lung Injury Lab, Tucson, AZ 85721 USA	University of Arizona; University of Stuttgart; University of Arizona; University of Arizona Health Sciences	Fernandez, A (corresponding author), Univ Arizona, Dept Environm Chem & Engn, Tucson, AZ 85721 USA.	wendt@u.arizona.edu						Adamson IYR, 2000, TOXICOL APPL PHARM, V166, P111, DOI 10.1006/taap.2000.8955; Cenni R, 1998, WASTE MANAGE, V18, P433, DOI 10.1016/S0956-053X(98)00127-5; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; FERNANDEZ A, UNPUB J AIR WASTE MA; Lighty JS, 2000, J AIR WASTE MANAGE, V50, P1565, DOI 10.1080/10473289.2000.10464197	5	32	37	0	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					998	998		10.1038/35059169	http://dx.doi.org/10.1038/35059169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234053	Bronze			2022-12-01	WOS:000167148800031
J	Futreal, PA; Kasprzyk, A; Birney, E; Mullikin, JC; Wooster, R; Stratton, MR				Futreal, PA; Kasprzyk, A; Birney, E; Mullikin, JC; Wooster, R; Stratton, MR			Cancer and genomics	NATURE			English	Article								Identification of the genes that cause oncogenesis is a central aim of cancer research. We searched the proteins predicted from the draft human genome sequence for paralogues of known tumour suppressor genes, but no novel genes were identified. We then assessed whether it was possible to search directly for oncogenic sequence changes in cancer cells by comparing cancer genome sequences against the draft genome. Apparently chimaeric transcripts (from oncogenic fusion genes generated by chromosomal translocations, the ends of which mapped to different genomic locations) were detected to the same degree in both normal and neoplastic tissues, indicating a significant level of false positives. Our experiment underscores the limited amount and variable quality of DNA sequence from cancer cells that is currently available.	Sanger Ctr, Canc Genome Project, Cambridge CB10 1SA, England; Sanger Ctr, Informat Div, Cambridge CB10 1SA, England; EBI, EMBL, Cambridge CB10 1SD, England; Inst Canc Res, Sutton SM2 5NG, Surrey, England	University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Sanger Ctr, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk		Birney, Ewan/0000-0001-8314-8497				Bell RS, 1999, CAN J SURG, V42, P259; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Higginson J, 1992, HUMAN CANC EPIDEMIOL; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495	6	106	113	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					850	852		10.1038/35057046	http://dx.doi.org/10.1038/35057046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237008	Bronze			2022-12-01	WOS:000166938800055
J	Thorrold, SR; Latkoczy, C; Swart, PK; Jones, CM				Thorrold, SR; Latkoczy, C; Swart, PK; Jones, CM			Natal homing in a marine fish metapopulation	SCIENCE			English	Article							WEAKFISH CYNOSCION-REGALIS; CORAL-REEF FISH; MASS-SPECTROMETRY; OTOLITHS; RECRUITMENT; POPULATION; SIGNATURES; SALMON; BAY	Identifying natal origins of marine fishes is challenging because of difficulties in conducting mark-recapture studies in marine systems. We used natural geochemical signatures in otoliths (ear bones) to determine natal sources in weakfish (Cynoscion regalis), an estuarine-spawning marine fish, in eastern North America. Spawning site fidelity ranged from 60 to 81%, comparable to estimates of natal homing in birds and anadromous fishes. These data were in contrast to genetic analyses of population structure in weakfish. Our findings highlight the need for consideration of spatial processes in fisheries models and have implications for the design of marine reserves in coastal regions.	Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; Old Dominion Univ, Lab Isotope & Trace Element Res, Norfolk, VA 23529 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, Miami, FL 33149 USA	Old Dominion University; Old Dominion University; University of Miami	Thorrold, SR (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.		Swart, Peter/K-7041-2016; Thorrold, Simon R/B-7565-2012	Swart, Peter/0000-0002-6743-6162; Thorrold, Simon R/0000-0002-1533-7517				Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2000, FISH RES, V46, P343, DOI 10.1016/S0165-7836(00)00158-2; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; CORDES JF, 2000, THESIS COLLEGE WILLI; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; CRAWFORD MK, 1989, FISH B-NOAA, V87, P205; Fogarty MJ, 1999, TRENDS ECOL EVOL, V14, P133, DOI 10.1016/S0169-5347(98)01579-1; GRAVES JE, 1992, FISH B-NOAA, V90, P469; Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1363, DOI 10.1039/a901648a; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; LowerreBarbieri SK, 1996, T AM FISH SOC, V125, P532, DOI 10.1577/1548-8659(1996)125<0532:VSAAAF>2.3.CO;2; LOWERREBARBIERI SK, 1995, FISH B-NOAA, V93, P643; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Nevitt G., 1998, INTEGR BIOL, V1, P215, DOI [10.1002/(SICI)1520-6602(1998)1:6%3C215:AID-INBI3%3E3.0.CO;2-V, DOI 10.1002/(SICI)1520-6602(1998)1:6<215::AID-INBI3>3.0.C0;2-V]; Nichols James D., 1996, P147; OBANNON BK, 1999, CURRENT FISHERY STAT; QUINN TP, 1993, FISH RES, V18, P29, DOI 10.1016/0165-7836(93)90038-9; Rosenthal Y, 1999, ANAL CHEM, V71, P3248, DOI 10.1021/ac981410x; ROWE PM, 1994, MAR ECOL PROG SER, V110, P105, DOI 10.3354/meps110105; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thorrold SR, 1998, MAR ECOL PROG SER, V173, P253, DOI 10.3354/meps173253; Thorrold SR, 1998, LIMNOL OCEANOGR, V43, P1826; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438	26	521	543	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					297	299		10.1126/science.291.5502.297	http://dx.doi.org/10.1126/science.291.5502.297			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209078				2022-12-01	WOS:000166352900043
J	Zhao, YD; Christensen, SK; Fankhauser, C; Cashman, JR; Cohen, JD; Weigel, D; Chory, J				Zhao, YD; Christensen, SK; Fankhauser, C; Cashman, JR; Cohen, JD; Weigel, D; Chory, J			A role for flavin monooxygenase-like enzymes in auxin biosynthesis	SCIENCE			English	Article							CONTAINING MONO-OXYGENASE; ARABIDOPSIS-THALIANA; HALF-REACTION; NITRILASE; GENE; ELONGATION; TOBACCO; ROOT; INDOLE-3-ACETONITRILE; OVERPRODUCTION	Although auxin is known to regulate many processes in plant development and has been studied for over a century, the mechanisms whereby plants produce it have remained elusive. Here we report the characterization of a dominant Arabidopsis mutant,yucca, which contains elevated Levels of free auxin. YUCCA encodes a flavin monooxygenase-like enzyme and belongs to a family that includes at Least nine other homologous Arabidopsis genes, a subset of which appears to have redundant functions, Results from tryptophan analog feeding experiments and biochemical assays indicate that YUCCA catalyzes hydroxylation of the amino group of tryptamine, a rate-limiting step in tryptophan-dependent auxin biosynthesis.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Human Biomol Res Inst, San Diego, CA 92121 USA; Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Weigel, Detlef/AAR-3312-2021; Fankhauser, Christian/C-4291-2018; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Fankhauser, Christian/ABE-8757-2021; Cohen, Jerry/AAF-3737-2020	Fankhauser, Christian/0000-0003-4719-5901; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Fankhauser, Christian/0000-0003-4719-5901; Cohen, Jerry/0000-0003-2816-8676	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413, R01GM036426] Funding Source: NIH RePORTER; NIGMS NIH HHS [2R01GM52413, R01GM36426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTEL B, 1994, P NATL ACAD SCI USA, V91, P6649, DOI 10.1073/pnas.91.14.6649; Bartel Bonnie, 1997, Annu Rev Plant Physiol Plant Mol Biol, V48, P51, DOI 10.1146/annurev.arplant.48.1.51; BARTLING D, 1992, EUR J BIOCHEM, V205, P417, DOI 10.1111/j.1432-1033.1992.tb16795.x; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Brunelle A, 1997, DRUG METAB DISPOS, V25, P1001; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; CHEN KH, 1988, PLANT PHYSIOL, V86, P822, DOI 10.1104/pp.86.3.822; Davies Peter J., 1995, P1; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Gallois P, 1995, Methods Mol Biol, V49, P39; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; Mathur J, 1998, METH MOL B, V82, P31; Normanly J, 1997, PLANT CELL, V9, P1781, DOI 10.1105/tpc.9.10.1781; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; ROMANO CP, 1995, PLANT MOL BIOL, V27, P1071, DOI 10.1007/BF00020881; ROMANO CP, 1991, GENE DEV, V5, P438, DOI 10.1101/gad.5.3.438; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schmidt RC, 1996, PLANT J, V9, P683, DOI 10.1046/j.1365-313X.1996.9050683.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Zhao Y. Y., UNPUB; ZIEGLER DM, 1988, DRUG METAB REV, V19, P1, DOI 10.3109/03602538809049617	26	817	890	8	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					306	309		10.1126/science.291.5502.306	http://dx.doi.org/10.1126/science.291.5502.306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209081				2022-12-01	WOS:000166352900046
J	Freeman, C; Ostle, N; Kang, H				Freeman, C; Ostle, N; Kang, H			An enzymic 'latch' on a global carbon store - A shortage of oxygen locks up carbon in peatlands by restraining a single enzyme.	NATURE			English	Article							ORGANIC-MATTER; PHENOLIC MATERIALS; ECOSYSTEMS; WATER; SOIL		Univ Coll N Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales	Bangor University	Freeman, C (corresponding author), Univ Coll N Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.		Kang, Hojeong/C-7208-2011; Ostle, Nick J/K-6891-2012; Ostle, Nicholas J/E-4847-2014	Ostle, Nicholas J/0000-0003-3263-3702				CARPENTER A, 1976, ANAL CHEM, V48, P225, DOI 10.1021/ac60365a067; Freeman C., 1993, CHEM ECOL, V8, P49, DOI DOI 10.1080/02757549308035300; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Kang HJ, 1999, SOIL BIOL BIOCHEM, V31, P449, DOI 10.1016/S0038-0717(98)00150-3; Lee SS, 1999, ASIAN AUSTRAL J ANIM, V12, P988, DOI 10.5713/ajas.1999.988; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268, DOI 10.2134/jeq1998.00472425002700050036x; MITCHELL JFB, 1987, NATURE, V330, P238, DOI 10.1038/330238a0; NYBROE O, 1992, WATER RES, V26, P579, DOI 10.1016/0043-1354(92)90230-2; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; PAINTER TJ, 1991, CARBOHYD POLYM, V15, P123, DOI 10.1016/0144-8617(91)90028-B; PIND A, 1994, PLANT SOIL, V159, P227, DOI 10.1007/BF00009285; Vuorinen AH, 1996, SOIL BIOL BIOCHEM, V28, P1477, DOI 10.1016/S0038-0717(96)00166-6; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000	13	791	846	29	491	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2001	409	6817					149	149		10.1038/35051650	http://dx.doi.org/10.1038/35051650			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390UV	11196627				2022-12-01	WOS:000166316200028
J	Bacchetti, P				Bacchetti, P			Unexamined assumptions in explorations of upper limit for cases of variant Creutzfeldt-Jakob disease	LANCET			English	Editorial Material							INCUBATION PERIOD; AIDS; INFECTION; EPIDEMIC		Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bacchetti, P (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.							BACCHETTI P, 1993, STAT SCI, V8, P82, DOI 10.1214/ss/1177010994; BACCHETTI P, 1990, J AM STAT ASSOC, V85, P1002, DOI 10.2307/2289596; BACCHETTI P, 1989, NATURE, V338, P251, DOI 10.1038/338251a0; BROOKMEYER R, 1986, LANCET, V2, P1320; *CJD SURV UN, 2000, CJD STAT; COOPER JD, 2000, J EPIDEMIOL BIOSTAT, V4, P209; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; Donnelly C. A., 2000, STAT ASPECTS BSE VCJ; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; Verity CM, 2000, LANCET, V356, P1224, DOI 10.1016/S0140-6736(00)02785-9	11	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					3	4		10.1016/S0140-6736(00)03559-5	http://dx.doi.org/10.1016/S0140-6736(00)03559-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197358				2022-12-01	WOS:000166341500003
J	Joza, N; Susin, SA; Daugas, E; Stanford, WL; Cho, SK; Li, CYJ; Sasaki, T; Elia, AJ; Cheng, HYM; Ravagnan, L; Ferri, KF; Zamzami, N; Wakeham, A; Hakem, R; Yoshida, H; Kong, YY; Mak, TW; Zuniga-Pflucker, JC; Kroemer, G; Penninger, JM				Joza, N; Susin, SA; Daugas, E; Stanford, WL; Cho, SK; Li, CYJ; Sasaki, T; Elia, AJ; Cheng, HYM; Ravagnan, L; Ferri, KF; Zamzami, N; Wakeham, A; Hakem, R; Yoshida, H; Kong, YY; Mak, TW; Zuniga-Pflucker, JC; Kroemer, G; Penninger, JM			Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death	NATURE			English	Article							EMBRYONIC STEM-CELLS; BLOOD-ISLAND FORMATION; CYTOCHROME-C; BCL-2; ELEGANS; REQUIREMENT; HOMOLOG; COMPLEX; DIFFERENTIATION; CAVITATION	Programmed cell death is a fundamental requirement for embryogenesis, organ metamorphosis and tissue homeostasis, In mammals, release of mitochondrial cytochrome c leads to the cytosolic assembly of the apoptosome - a caspase activation complex involving Apaf1 and caspase-9 that induces hallmarks of apoptosis, There are, however, mitochondrially regulated cell death pathways that are independent of Apaf1/caspase-9, We have previously cloned a molecule associated with programmed cell death called apoptosis-inducing factor (AIF), Like cytochrome c,AIF is localized to mitochondria and released in response to death stimuli. Here we show that genetic inactivation of AIF renders embryonic stem cells resistant to cell death after serum deprivation, Moreover, AIF is essential for programmed cell death during cavitation of embryoid bodies-the very first wave of cell death indispensable for mouse morphogenesis, AIF-dependent cell death displays structural features of apoptosis, and can be genetically uncoupled from Apaf1 and caspase-9 expression. Our data provide genetic evidence for a caspase-independent pathway of programmed cell death that controls early morphogenesis.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Inst Gustave Roussy, CNRS, UMR 1599, F-94805 Villejuif, France; Hop Tenon, Serv Nephrol B, Hop Paris, Assistance Publ, F-75020 Paris, France; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		KROEMER, Guido/B-4263-2013; Susin, Santos A/Q-6754-2017; Penninger, Josef M/I-6860-2013; Kroemer, Guido/AAY-9859-2020; Zuniga-Pflucker, Juan C/H-1295-2012	KROEMER, Guido/0000-0002-9334-4405; Susin, Santos A/0000-0002-3366-1628; Penninger, Josef M/0000-0002-8194-3777; DAUGAS, Eric/0000-0001-7256-7979; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Hakem, Razqallah/0000-0001-5948-7931; Stanford, William/0000-0002-5813-8016; Sasaki, Takehiko/0000-0003-1837-3748				Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Bautch VL, 1996, DEV DYNAM, V205, P1; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; ROBERTSON EJ, 1987, EMBRYO DERIVED STEM; SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	38	1043	1121	4	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					549	554		10.1038/35069004	http://dx.doi.org/10.1038/35069004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279485				2022-12-01	WOS:000167859300037
J	Li, P; Chan, HC; He, B; So, SC; Chung, YW; Shang, Q; Zhang, YD; Zhang, YL				Li, P; Chan, HC; He, B; So, SC; Chung, YW; Shang, Q; Zhang, YD; Zhang, YL			An antimicrobial peptide gene found in the male reproductive system of rats	SCIENCE			English	Article							INNATE HOST-DEFENSE; CHLAMYDIA-TRACHOMATIS; ANION SECRETION; MESSENGER-RNA; EPIDIDYMIS; ANTIBIOTICS; EPITHELIA; BETA-DEFENSIN-1; EXPRESSION; CHANNEL	Little is known about the innate defense mechanisms of the male reproductive tract. We cloned a 385-base pair complementary DNA and its genomic DNA named Bin1b that is exclusively expressed in the caput region of the rat epididymis and that is responsible for sperm maturation, storage, and protection. Bin1b exhibits structural characteristics and antimicrobial activity similar to that of cationic antimicrobial peptides, beta -defensins. Bin1b is maximally expressed when the rats are sexually mature and can be up-regulated by inflammation. Bin1b appears to be a natural epididymis-specific antimicrobial peptide that plays a role in reproductive tract host defense and male fertility.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong	Zhang, YL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.		Chan, Hsiao Chang/E-1507-2016					APTE AN, 1995, REVERSER TRANSCRIPTA, P232; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; BLANCHARD TJ, 1994, BRIT J CLIN PRACT, V48, P201; CHAN HC, 1995, BIOL REPROD, V52, P192, DOI 10.1095/biolreprod52.1.192; Cooper TG, 1999, HUM REPROD UPDATE, V5, P141, DOI 10.1093/humupd/5.2.141; CUTHBERT AW, 1986, J PHYSIOL-LONDON, V378, P335, DOI 10.1113/jphysiol.1986.sp016222; DCRUZ OJ, 1995, J ANDROL, V16, P432; Diamond G, 1996, P NATL ACAD SCI USA, V93, P5156, DOI 10.1073/pnas.93.10.5156; Diamond G, 1998, CLIN IMMUNOL IMMUNOP, V88, P221, DOI 10.1006/clin.1998.4587; FLICKINGER CJ, 1990, BIOL REPROD, V43, P34, DOI 10.1095/biolreprod43.1.34; Frohlich O, 2000, J ANDROL, V21, P421; Ganz T, 1997, SEMIN HEMATOL, V34, P343; Grandjean V, 1997, BIOL REPROD, V57, P1115, DOI 10.1095/biolreprod57.5.1115; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; JANTOS C, 1992, INFECT IMMUN, V60, P2324, DOI 10.1128/IAI.60.6.2324-2328.1992; Lencer WI, 1997, P NATL ACAD SCI USA, V94, P8585, DOI 10.1073/pnas.94.16.8585; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MOU LJ, 1994, BIOCHEM BIOPH RES CO, V199, P564, DOI 10.1006/bbrc.1994.1265; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; PerezSanchez F, 1996, MOL REPROD DEV, V45, P364, DOI 10.1002/(SICI)1098-2795(199611)45:3<364::AID-MRD14>3.0.CO;2-Z; Sawicki W, 1999, LANCET, V353, P464, DOI 10.1016/S0140-6736(98)04648-0; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; So SC, 1998, BBA-BIOMEMBRANES, V1415, P261, DOI 10.1016/S0005-2736(98)00201-6; TAMAMURA H, 1994, BIOCHEM BIOPH RES CO, V205, P1729, DOI 10.1006/bbrc.1994.2868; TSUKAMOTO T, 1991, International Journal of Developmental Biology, V35, P25; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Yasin B, 1996, INFECT IMMUN, V64, P709, DOI 10.1128/IAI.64.3.709-713.1996	29	195	228	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1783	1785		10.1126/science.1056545	http://dx.doi.org/10.1126/science.1056545			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230693				2022-12-01	WOS:000167320600058
J	Nadeau, JH; Balling, R; Barsh, G; Beier, D; Brown, SDM; Bucan, M; Camper, S; Carlson, G; Copeland, N; Eppig, J; Fletcher, C; Frankel, WN; Ganten, D; Goldowitz, D; Goodnow, C; Guenet, JL; Hicks, G; de Angelis, MH; Jackson, I; Jacob, HJ; Jenkins, N; Johnson, D; Justice, M; Kay, S; Kingsley, D; Lehrach, H; Magnuson, T; Meisler, M; Poustka, AM; Rinchik, EM; Rossant, J; Russell, LB; Schimenti, J; Shiroishi, T; Skarnes, WC; Soriano, P; Stanford, W; Takahashi, JS; Wurst, W; Zimmer, A				Nadeau, JH; Balling, R; Barsh, G; Beier, D; Brown, SDM; Bucan, M; Camper, S; Carlson, G; Copeland, N; Eppig, J; Fletcher, C; Frankel, WN; Ganten, D; Goldowitz, D; Goodnow, C; Guenet, JL; Hicks, G; de Angelis, MH; Jackson, I; Jacob, HJ; Jenkins, N; Johnson, D; Justice, M; Kay, S; Kingsley, D; Lehrach, H; Magnuson, T; Meisler, M; Poustka, AM; Rinchik, EM; Rossant, J; Russell, LB; Schimenti, J; Shiroishi, T; Skarnes, WC; Soriano, P; Stanford, W; Takahashi, JS; Wurst, W; Zimmer, A		Int Mouse Mutagenesis Consortium	Sequence interpretation - Functional annotation of mouse genome sequences	SCIENCE			English	Article							MUTANT MICE; MUTAGENESIS; CHROMOSOME; WIDE		Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University	Nadeau, JH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, BRB 624,10900 Euclid Ave, Cleveland, OH 44106 USA.	jhn4@po.cwru.edu	Zimmer, Andreas/B-8357-2009; Takahashi, Joseph S./Y-2781-2019; Goodnow, Christopher C/V-8108-2018; Soriano, Philippe M/E-5797-2015; Balling, Rudi/E-9680-2010; Takahashi, Joseph S/E-8482-2012; de Angelis, Martin Hrabe/F-5531-2012	Takahashi, Joseph S./0000-0003-0384-8878; Goodnow, Christopher C/0000-0001-5296-6155; Soriano, Philippe M/0000-0002-0427-926X; Balling, Rudi/0000-0003-2902-5650; Takahashi, Joseph S/0000-0003-0384-8878; de Angelis, Martin Hrabe/0000-0002-7898-2353; Hicks, Geoffrey/0000-0003-4688-2312; Stanford, William/0000-0002-5813-8016; Wurst, Wolfgang/0000-0003-4422-7410; Camper, Sally/0000-0001-8556-3379; Goldowitz, Daniel/0000-0003-4756-4017				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Justice MJ, 2000, NAT REV GENET, V1, P109, DOI 10.1038/35038549; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; NADEAU J, IN PRESS NATURE REV; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	14	114	117	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1251	+		10.1126/science.1058244	http://dx.doi.org/10.1126/science.1058244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233449				2022-12-01	WOS:000166993400028
J	Roos, DS				Roos, DS			Computational biology - Bioinformatics - Trying to swim in a sea of data	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; SEQUENCE		Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Genom Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Roos, DS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.			Roos, David Siker/0000-0001-6725-4089				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bell E, 2000, SCIENCE, V290, P1696; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gottlieb M, 2000, NATURE, V406, P121, DOI 10.1038/35018270; Hyman RW, 2001, SCIENCE, V291, P827; Jasny BR, 2001, SCIENCE, V291, P1153, DOI 10.1126/science.291.5506.1153; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Macilwain C, 2000, NATURE, V405, P601, DOI 10.1038/35015216; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rowen L, 2000, SCIENCE, V289, P1881, DOI 10.1126/science.289.5486.1881; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; 2000, NATURE, V405, P719	20	59	74	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1260	+		10.1126/science.291.5507.1260	http://dx.doi.org/10.1126/science.291.5507.1260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233452				2022-12-01	WOS:000166993400031
J	Montgomery, KT; Lee, E; Miller, A; Lau, S; Shim, C; Decker, J; Chiu, D; Emerling, S; Sekhon, M; Kim, R; Lenz, J; Han, JH; Ioshikhes, I; Renault, B; Marondel, I; Yoon, SJK; Song, K; Murty, VVVS; Scherer, S; Yonescu, R; Kirsch, IR; Ried, T; McPherson, J; Gibbs, R; Kucherlapati, R				Montgomery, KT; Lee, E; Miller, A; Lau, S; Shim, C; Decker, J; Chiu, D; Emerling, S; Sekhon, M; Kim, R; Lenz, J; Han, JH; Ioshikhes, I; Renault, B; Marondel, I; Yoon, SJK; Song, K; Murty, VVVS; Scherer, S; Yonescu, R; Kirsch, IR; Ried, T; McPherson, J; Gibbs, R; Kucherlapati, R			A high-resolution map of human chromosome 12	NATURE			English	Article							PHYSICAL MAP; HUMAN GENOME; SEQUENCE	Our sequence-tagged site-content map of chromosome 12 is now integrated with the whole-genome fingerprinting effort(1,2). It provides accurate and nearly complete bacterial clone coverage of chromosome 12. We propose that this integrated mapping protocol serves as a model for constructing physical maps for entire genomes.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Catholic Univ, Coll Med, Res Inst Med Sci, Seoul 137404, South Korea; Univ Ulsan, Coll Med, Seoul 138736, South Korea; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; NCI, Dept Genet, Med Branch, NIH, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Yeshiva University; Albert Einstein College of Medicine; Catholic University of Korea; University of Ulsan; Columbia University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Kucherlapati, R (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Kucherlapati, Raju/ABC-8807-2021; Sekhon, Mandeep/L-4665-2018; McPherson, John D/D-2633-2017	Sekhon, Mandeep/0000-0002-9993-6938; McPherson, John D/0000-0001-8049-9347				Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Kirsch IR, 2000, NAT GENET, V24, P339, DOI 10.1038/74149; KRAUTER K, 1995, NATURE, V377, P321; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MONTGOMERY KT, 1993, GENOMICS, V17, P682, DOI 10.1006/geno.1993.1390; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Renault B, 1997, GENOMICS, V45, P271, DOI 10.1006/geno.1997.4888; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422	14	18	18	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					945	946		10.1038/35057174	http://dx.doi.org/10.1038/35057174			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237017	Green Published, Bronze			2022-12-01	WOS:000166938800064
J	Rowland, M; Drumm, B				Rowland, M; Drumm, B			Helicobacter pylori and sudden-infant-death syndrome	LANCET			English	Editorial Material									Univ Coll Dublin, Conway Inst, Dept Paediat, Dublin 12, Ireland; Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland	University College Dublin; Our Ladys Children Hospital Crumlin	Rowland, M (corresponding author), Univ Coll Dublin, Conway Inst, Dept Paediat, Dublin 12, Ireland.		Drumm, Brendan/AAL-2361-2020	Drumm, Brendan/0000-0002-9322-5086				BOSELEY S, 2000, GUARDIAN        1031; Elitsur Y, 2000, HELICOBACTER, V5, P227, DOI 10.1046/j.1523-5378.2000.00035.x; GOTTRAND F, 1992, LANCET, V340, P495, DOI 10.1016/0140-6736(92)91824-R; HALL C, 2000, DAILY TELEGRAPH 1024; Kattwinkel J, 2000, PEDIATRICS, V105, P650, DOI 10.1542/peds.105.3.650; Kerr JR, 2000, ARCH DIS CHILD, V83, P429, DOI 10.1136/adc.83.5.429; ORENSTEIN SR, 1983, J PEDIATR-US, V103, P534, DOI 10.1016/S0022-3476(83)80578-2; Pattison CP, 1997, MED HYPOTHESES, V49, P365, DOI 10.1016/S0306-9877(97)90080-3; RAYMOND J, 1995, EUR J CLIN MICROBIOL, V14, P727, DOI 10.1007/BF01690886; Rowland M, 2000, LANCET, V355, P332, DOI 10.1016/S0140-6736(99)00427-4	10	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					327	327		10.1016/S0140-6736(00)03634-5	http://dx.doi.org/10.1016/S0140-6736(00)03634-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210989				2022-12-01	WOS:000166897900005
J	Ridanpaa, M; van Eenennaam, H; Pelin, K; Chadwick, R; Johnson, C; Yuan, B; vanVenrooij, W; Pruijn, G; Salmela, R; Rockas, S; Makitie, O; Kaitila, I; de la Chapelle, A				Ridanpaa, M; van Eenennaam, H; Pelin, K; Chadwick, R; Johnson, C; Yuan, B; vanVenrooij, W; Pruijn, G; Salmela, R; Rockas, S; Makitie, O; Kaitila, I; de la Chapelle, A			Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia	CELL			English	Article							RIBONUCLEOPROTEIN ENDORIBONUCLEASE; PROTEIN SUBUNIT; RIBONUCLEASE-P; POLYMERASE-III; NUCLEAR GENE; CONTAINS; TRANSCRIPTION; POPULATIONS; FINLAND; REGION	The recessively inherited developmental disorder, cartilage-hair hypoplasia (CHH) is highly pleiotropic with manifestations including short stature, defective cellular immunity, and predisposition to several cancers. The endoribonuclease RNase MRP consists of an RNA molecule bound to several proteins. It has at least two functions, namely, cleavage of RNA in mitochondrial DNA synthesis and nucleolar cleaving of pre-rRNA. We describe numerous mutations in the untranslated RMRP gene that cosegragate with the CHH phenotype. Insertion mutations immediately upstream of the coding sequence silence transcription while mutations in the transcribed region do not. The association of protein subunits with RNA appears unaltered. We conclude that mutations in RMRP cause CHH by disrupting a function of RNase MRP RNA that affects multiple organ systems.	Helsinki Univ Hosp, Dept Clin Genet, Helsinki 00290, Finland; Folkhalsan Inst Genet, Helsinki 00280, Finland; Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Helsinki Univ Hosp, Hosp Children & Adolescents, Helsinki 00290, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Radboud University Nijmegen; University System of Ohio; Ohio State University; University of Helsinki; Helsinki University Central Hospital	de la Chapelle, A (corresponding author), Helsinki Univ Hosp, Dept Clin Genet, Helsinki 00290, Finland.	delachapelle-1@medctr.osu.edu	Pruijn, Ger/D-6664-2012	Makitie, Outi/0000-0002-4547-001X	NATIONAL CANCER INSTITUTE [U01CA067941, P30CA016058, R01CA067941] Funding Source: NIH RePORTER; NCI NIH HHS [CA67941, CA16058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ben-Yosef T, 1999, GENOMICS, V62, P316, DOI 10.1006/geno.1999.6019; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; Cai T, 1999, MOL CELL BIOL, V19, P7857; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; CLAYTON DA, 1994, P NATL ACAD SCI USA, V91, P4615, DOI 10.1073/pnas.91.11.4615; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Eder PS, 1997, P NATL ACAD SCI USA, V94, P1101, DOI 10.1073/pnas.94.4.1101; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HSIEH CL, 1990, GENOMICS, V6, P540, DOI 10.1016/0888-7543(90)90483-B; Kurz JC, 2000, CURR OPIN CHEM BIOL, V4, P553, DOI 10.1016/S1367-5931(00)00131-9; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LUX SE, 1970, NEW ENGL J MED, V282, P231, DOI 10.1056/NEJM197001292820501; Lygerou Z, 1996, EMBO J, V15, P5936, DOI 10.1002/j.1460-2075.1996.tb00980.x; Makitie O, 1999, J PEDIATR-US, V134, P315, DOI 10.1016/S0022-3476(99)70456-7; MAKITIE O, 1993, EUR J PEDIATR, V152, P211, DOI 10.1007/BF01956147; MAKITIE O, 1992, THESIS U HELSINKI, P1; McKusick VA, 2000, NAT GENET, V24, P203, DOI 10.1038/73389; MCKUSICK VA, 1965, B JOHNS HOPKINS HOSP, V116, P285; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; PIERCE GF, 1982, J IMMUNOL, V129, P570; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; Sbisa E, 1996, J MOL EVOL, V43, P46, DOI 10.1007/BF02352299; SCHMITT ME, 1993, FASEB J, V7, P208, DOI 10.1096/fasebj.7.1.7678563; SCHMITT ME, 1992, GENE DEV, V6, P1975, DOI 10.1101/gad.6.10.1975; SULISALO T, 1994, AM J HUM GENET, V55, P937; SULISALO T, 1995, HUM GENET, V95, P157, DOI 10.1007/BF00209394; SULISALO T, 1993, NAT GENET, V3, P338, DOI 10.1038/ng0493-338; Sulisalo T, 1997, EUR J HUM GENET, V5, P35, DOI 10.1159/000484729; SULISALO T, 1994, GENOMICS, V20, P347, DOI 10.1006/geno.1994.1187; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; TOPPER JN, 1990, NUCLEIC ACIDS RES, V18, P793, DOI 10.1093/nar/18.4.793; Vakkilainen T, 1999, GENOMICS, V59, P319, DOI 10.1006/geno.1999.5883; van Eenennaam H, 1999, NUCLEIC ACIDS RES, V27, P2465, DOI 10.1093/nar/27.12.2465; van Eenennaam H, 2000, IUBMB LIFE, V49, P265; VERHEIJEN R, 1994, J IMMUNOL METHODS, V169, P173, DOI 10.1016/0022-1759(94)90261-5; VIROLAINEN M, 1978, PEDIATR RES, V12, P961, DOI 10.1203/00006450-197810000-00002; YUAN Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P33, DOI 10.1016/0167-4781(91)90081-V	43	324	331	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					195	203		10.1016/S0092-8674(01)00205-7	http://dx.doi.org/10.1016/S0092-8674(01)00205-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207361	Bronze			2022-12-01	WOS:000166879700004
J	Steppan, CM; Bailey, ST; Bhat, S; Brown, EJ; Banerjee, RR; Wright, CM; Patel, HR; Ahima, RS; Lazar, MA				Steppan, CM; Bailey, ST; Bhat, S; Brown, EJ; Banerjee, RR; Wright, CM; Patel, HR; Ahima, RS; Lazar, MA			The hormone resistin links obesity to diabetes	NATURE			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; LEPTIN; MELLITUS; MICE; IDENTIFICATION; ADIPOGENESIS; ALPHA	Diabetes mellitus is a chronic disease that leads to complications including heart disease, stroke, kidney failure, blindness and nerve damage. Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Here we show that adipocytes secrete a unique signalling molecule, which we have named resistin (for resistance to insulin). Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity. Moreover, treatment of normal mice with recombinant resistin impairs glucose tolerance and insulin action. Insulin-stimulated glucose uptake by adipocytes is enhanced by neutralization of resistin and is reduced by resistin treatment. Resistin is thus a hormone that potentially links obesity to diabetes.	Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.		Banerjee, Ronadip/U-6649-2019; Lazar, Mitchell A/AAF-3738-2019; Ahima, Rexford/W-1394-2019; Bailey, Shannon/B-8045-2014					Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; BODEN G, 1997, DIABETES, V46, P1; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hausdorff SF, 1999, J BIOL CHEM, V274, P24677, DOI 10.1074/jbc.274.35.24677; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Huang EY, 2000, GENE DEV, V14, P45; Kahn CR, 1996, ANNU REV MED, V47, P509; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Seed B, 1998, NAT MED, V4, P1004, DOI 10.1038/1990; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; SPEICHER DW, 1997, CURRENT PROTOCOLS PR; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; STEPPAN CM, IN PRESS P NATL ACAD; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g	35	3506	3929	10	508	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					307	312		10.1038/35053000	http://dx.doi.org/10.1038/35053000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201732				2022-12-01	WOS:000166434300037
J	Hales, CN				Hales, CN			Suicide of the nephron	LANCET			English	Article							INTRAUTERINE GROWTH-RETARDATION	There are various causes of renal disease. However, progressive renal disease is closely linked to the degree and duration of proteinuria. At first sight, this seems a perverse response in which a compromised organ unleashes a coordinated series of reactions that exacerbate the damage already done. Although the nephron has mechanisms whereby it can compensate for damage both by hypertrophy and hyperfunction after renal injury or ablation, these changes seem to provide only a temporary compensation. I and my colleagues found altered renal telomere shortening in the male rat linked to increased or decreased proteinuria and longevity, which suggests a mechanism whereby this compensatory process may be limited. I hypothesise that when the damaging or hypertrophic processes shorten renal telomeres to a critical length, the cells senesce with loss of function. I also suggest that the complex series of responses triggered in a protein-leaking nephron is normally a beneficial and limited process. It leads to the replacement by fibrosis of a malfunctioning unit in an otherwise healthy organ that has substantial spare capacity. The response only becomes life threatening when there is widespread nephron damage, the acceleration of which results in the ablation of all nephron function.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England	Addenbrooke's Hospital; University of Cambridge	Hales, CN (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Hills Rd, Cambridge CB2 2QR, England.	cnh1000@cam.ac.uk						BRENNER BM, 1985, AM J PHYSIOL, V249, pF324, DOI 10.1152/ajprenal.1985.249.3.F324; BURTON CJ, 1994, EXP NEPHROL, V2, P345; De Jong PE, 1999, LANCET, V354, P352, DOI 10.1016/S0140-6736(99)90122-8; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; INUI K, 1999, J AM SOC NEPHROL, V10, P548; IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Remuzzi G, 1999, CURR OPIN NEPHROL HY, V8, P655, DOI 10.1097/00041552-199911000-00001; RODRIGUEZLOPEZ AM, 1998, KIDNEY INT, V68, P536; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x	17	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2001	357	9250					136	137		10.1016/S0140-6736(00)03553-4	http://dx.doi.org/10.1016/S0140-6736(00)03553-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393NH	11197414				2022-12-01	WOS:000166476200033
J	Chan, AWS; Chong, KY; Martinovich, C; Simerly, C; Schatten, G				Chan, AWS; Chong, KY; Martinovich, C; Simerly, C; Schatten, G			Transgenic monkeys produced by retroviral gene transfer into mature oocytes	SCIENCE			English	Article							MOUSE MODEL; NUCLEAR TRANSFER; RHESUS-MONKEY; DISEASE; FETAL; INJECTION	Transgenic rhesus monkeys carrying the green fluorescent protein (GFP) gene were produced by injecting pseudotyped replication-defective retroviral vector into the perivitelline space of 224 mature rhesus oocytes, Later fertilized by intracytoplasmic sperm injection. Of the three males born from 20 embryo transfers, one was transgenic when accessible tissues were assayed for transgene DNA and messenger RNA. ALL tissues that were studied from a fraternal set of twins, miscarried at 73 days, carried the transgene, as confirmed by Southern analyses, and the GFP transgene reporter was detected by both direct and indirect fluorescence imaging.	Oregon Reg Primate Res Ctr, Ctr Womens Hlth, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Cell Dev Biol, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Obstet Gynecol, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University	Schatten, G (corresponding author), Oregon Reg Primate Res Ctr, Ctr Womens Hlth, 505 NW 185th Ave, Beaverton, OR 97006 USA.	schatten@ohsu.edu	Schatten, Gerald/B-3253-2009; simerly, Calvin/AAC-9564-2021	Schatten, Gerald/0000-0001-5206-7782; 				Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Blouin MJ, 2000, NAT MED, V6, P177, DOI 10.1038/72279; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028; Chan AWS, 2000, MOL HUM REPROD, V6, P26, DOI 10.1093/molehr/6.1.26; Chien KR, 1996, J CLIN INVEST, V98, pS19; Chinnasamy N, 2000, HUM GENE THER, V11, P1901, DOI 10.1089/10430340050129512; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Eckert RL, 2000, INT J ONCOL, V16, P853; Erickson RP, 1996, BIOESSAYS, V18, P993, DOI 10.1002/bies.950181209; Hewitson L, 1998, HUM REPROD, V13, P3449, DOI 10.1093/humrep/13.12.3449; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kuroda MJ, 2000, J VIROL, V74, P8751, DOI 10.1128/JVI.74.18.8751-8756.2000; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Muller U, 1999, MECH DEVELOP, V82, P3, DOI 10.1016/S0925-4773(99)00021-0; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Nathanson N, 1999, AIDS, V13, pS113; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Schott B, 1997, NUCLEIC ACIDS RES, V25, P2940, DOI 10.1093/nar/25.14.2940; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weinstein EJ, 2000, MOL MED, V6, P4, DOI 10.1007/BF03401930; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf DP, 1999, BIOL REPROD, V60, P199, DOI 10.1095/biolreprod60.2.199; Wu GJ, 1996, BIOL REPROD, V55, P260, DOI 10.1095/biolreprod55.2.260; YEE JK, 1994, METHOD CELL BIOL, V43, P99	33	224	252	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					309	312		10.1126/science.291.5502.309	http://dx.doi.org/10.1126/science.291.5502.309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209082				2022-12-01	WOS:000166352900047
J	Attaran, A; Sachs, J				Attaran, A; Sachs, J			Defining and refining international donor support for combating the AIDS pandemic	LANCET			English	Article								The international aid effort against AIDS is greatly incommensurate with the severity of the epidemic. Drawing on the data that international aid donors self-reported to the Organization for Economic Cooperation and Development (OECD), we find that, between 1996 and 1998, finance from all rich countries to sub-Saharan Africa for projects designated as AIDS control averaged US$69 million annually, and, assuming a safe margin for under-reporting and misreporting, we estimate that total donor spending on HIV/AIDS control was perhaps twice that at most. Since the late 1980s, aid levels have dropped relative to the prevalence of HIV infection, and stood recently at about $3 per HIV-infected person. Lack of finance is now the primary constraint on progress against AIDS, notwithstanding the widespread belief that a lack of interest from the governments of poor countries is limiting. We argue that to produce a meaningful response to the pandemic, international assistance must be based on grants, not loans, for the poorest countries; be increased within the next 3 years to a minimum of $7.5 billion or more; be directed toward funding projects which are proposed and desired by the affected countries themselves, and which are judged as having epidemiological merit against the pandemic by a panel of independent scientific experts; and fund concurrent needs, including prevention, drug treatment (such as highly active antiretroviral therapy), and blocking mother-to-child HIV transmission. An effort of this scope and scale will both radically alter the prospects for intervention against AIDS in poor countries, and together with comparable efforts to control other infectious diseases, is easily afforded by the OECD donor economies, whose aggregate national income recently surpassed $21 trillion annually.	Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA	Harvard University	Attaran, A (corresponding author), Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA.							Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; DAYTON J, 1998, 389 WORLD BANK HIV A; GIBBONS A, 1990, SCIENCE, V248, P1306, DOI 10.1126/science.2356466; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; *LOND SCH HYG TROP, 1999, MAL CONS 1999 LOND; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Thaineua Vallop, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P429; The Panos Institute, 1989, AIDS 3 WORLD; *UNAIDS, 1999, LEV FLOW NAT INT RES; *UNAIDS, 2000, REP GLOB HIV AIDS EP; UNICEF, 2000, PROGR NAT 2000; *US CENTR INT AG, 1999, GLOB INF DIS THREAT; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; *WHO, 2000, WHO WORLD HLTH REP; World Bank, 1999, INT ACT HIV AIDS AFR	15	82	84	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 6	2001	357	9249					57	61		10.1016/S0140-6736(00)03576-5	http://dx.doi.org/10.1016/S0140-6736(00)03576-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197373				2022-12-01	WOS:000166341500035
J	High, KA				High, KA			Gene therapy in haematology and oncology	LANCET			English	Article									Childrens Hosp Philadelphia, Abramson Res Ctr, Div Hematol, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	High, KA (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Div Hematol, Philadelphia, PA 19104 USA.		High, Katherine A./AAB-9322-2020						0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2000	356			S			S8	S8		10.1016/S0140-6736(00)91994-9	http://dx.doi.org/10.1016/S0140-6736(00)91994-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386RG	11191528				2022-12-01	WOS:000166074900010
J	De Moraes, CM; Mescher, MC; Tumlinson, JH				De Moraes, CM; Mescher, MC; Tumlinson, JH			Caterpillar-induced nocturnal plant volatiles repel conspecific females	NATURE			English	Article							COLORADO POTATO BEETLE; HOST-PLANT; PARASITIC WASPS; DAMAGE; ATTRACTION; COLEOPTERA; KAIROMONE; PHEROMONE; RESPONSES; LARVAE	Plants respond to insect herbivory by synthesizing and releasing complex blends of volatile compounds, which provide important host-location cues for insects that are natural enemies of herbivores(1-3). The effects of these volatile blends on herbivore behaviour have been investigated to only a limited extent(4,5), in part because of the assumption that herbivore-induced volatile emissions occur mainly during the light phase of the photoperiod(6,7). Because many moths-whose larvae are some of the most important insect herbivores-are nocturnal, herbivore-induced plant volatiles have not hitherto been considered to be temporally available as host-location cues for ovipositing females. Here we present chemical and behavioural assays showing that tobacco plants (Nicotiana tabacum) release herbivore-induced volatiles during both night and day. Moreover, several volatile compounds are released exclusively at night and are highly repellent to female moths (Heliothis virescens). The demonstration that tobacco plants release temporally different volatile blends and that lepidopteran herbivores use induced plant signals released during the dark phase to choose sites for oviposition adds a new dimension to our understanding of the role of chemical cues in mediating tritrophic interactions.	USDA ARS, CMAVE, Gainesville, FL 32604 USA; Univ Georgia, Dept Entomol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Tumlinson, JH (corresponding author), USDA ARS, CMAVE, POB 14565, Gainesville, FL 32604 USA.	jtumlinson@gainesville.usda.ufl.edu	Tumlinson, James H/G-8358-2011					Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; DICKE M, 1986, PHYSIOL ENTOMOL, V11, P251, DOI 10.1111/j.1365-3032.1986.tb00412.x; HARARI AR, 1994, J CHEM ECOL, V20, P361, DOI 10.1007/BF02064443; HEATH RR, 1994, J CHEM ECOL, V20, P593, DOI 10.1007/BF02059600; HEATH RR, 1986, J CHEM ECOL, V12, P2133, DOI 10.1007/BF01020315; HEATH RR, 1986, J CHEM ECOL, V12, P2081, DOI 10.1007/BF01041998; KARBAN R, 1985, ENTOMOL EXP APPL, V37, P137, DOI 10.1111/j.1570-7458.1985.tb03464.x; Karban R., 2007, INDUCED RESPONSES HE; LANDOLT PJ, 1993, ENTOMOL EXP APPL, V67, P79, DOI 10.1007/BF02382720; Landolt PJ, 1999, ENVIRON ENTOMOL, V28, P973, DOI 10.1093/ee/28.6.973; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1217, DOI 10.1007/BF02228321; MATTIACCI L, 1994, J CHEM ECOL, V20, P2229, DOI 10.1007/BF02033199; MCCALL PJ, 1993, J INSECT BEHAV, V6, P625, DOI 10.1007/BF01048128; Pallini A, 1997, OECOLOGIA, V110, P179, DOI 10.1007/s004420050147; Pare PW, 1997, NATURE, V385, P30, DOI 10.1038/385030a0; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251	24	708	744	9	224	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					577	580		10.1038/35069058	http://dx.doi.org/10.1038/35069058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279494				2022-12-01	WOS:000167859300046
J	Masopust, D; Vezys, V; Marzo, AL; Lefrancois, L				Masopust, D; Vezys, V; Marzo, AL; Lefrancois, L			Preferential localization of effector memory cells in nonlymphoid tissue	SCIENCE			English	Article							CD8 T-CELLS; VIRUS-INFECTION; INFLUENZA PNEUMONIA; BACTERIAL-INFECTION; ANTIGEN; LYMPHOCYTES; MICE; VISUALIZATION; MECHANISMS	Many intracellular pathogens infect a broad range of host tissues, but the importance of T cells for immunity in these sites is unclear because most of our understanding of antimicrobial T cell responses comes from analyses of lymphoid tissue. Here, we show that in response to viral or bacterial infection, antigen-specific CD8 T cells migrated to nonlymphoid tissues and were present as Long-Lived memory cells. Strikingly, CD8 memory T cells isolated from nonlymphoid tissues exhibited effector Levels of Lytic activity directly ex vivo, in contrast to their splenic counterparts. These results point to the existence of a population of extralymphoid effector memory T cells poised for immediate response to infection.	Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, Farmington, CT 06030 USA.		masopust, david/B-5027-2008; Vezys, Vaiva/N-3144-2013	Marzo, amanda/0000-0002-5839-0430	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, T32AI007080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER; NIAID NIH HHS [T32-AI07080, AI41576] Funding Source: Medline; NIDDK NIH HHS [DK45260] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Dobber R, 1992, Dev Immunol, V2, P141, DOI 10.1155/1992/57057; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kim SK, 1999, J IMMUNOL, V163, P4125; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D., UNPUB; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; PUDDINGTON L, 1986, J VIROL, V60, P708, DOI 10.1128/JVI.60.2.708-717.1986; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Selin LK, 1997, J IMMUNOL, V158, P5366; Slifka MK, 1997, BLOOD, V90, P2103, DOI 10.1182/blood.V90.5.2103; Usherwood EJ, 1999, J VIROL, V73, P7278, DOI 10.1128/JVI.73.9.7278-7286.1999; VANBLEEK GM, 1990, NATURE, V348, P213; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; WAGNER RR, 1987, RHABDOVIRUSES; YEWDELL JW, 1986, J EXP MED, V163, P1529, DOI 10.1084/jem.163.6.1529; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	31	1481	1518	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2001	291	5512					2413	2417		10.1126/science.1058867	http://dx.doi.org/10.1126/science.1058867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	413UH	11264538				2022-12-01	WOS:000167618700057
J	Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ				Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ			An exceptionally preserved vermiform mollusc from the Silurian of England	NATURE			English	Article							PHYLOGENY; GOTLAND; SWEDEN	Studies of the origin and radiation of the molluscs have yet to resolve many issues regarding their nearest relatives, phylogeny and ancestral characters(1-11). The Polyplacophora (chitons) and the Aplacophora are widely interpreted as the most primitive extant molluscs(2,3,9,10), but Lower Palaeozoic fossils of the former lack soft parts, and the latter were hitherto unrecognized as fossils. The Herefordshire Lagerstatte(12) is a Silurian (about 425 Myr BP) deposit that preserves a marine biota in remarkable three-dimensional detail. The external surface of even non-biomineralized cuticle was preserved by entombment in volcanic ash, subsequent incorporation into concretions, and infilling of the fossils with sparry calcite(13). Here we describe, from this deposit, a complete vermiform mollusc, which we interpret as a plated aplacophoran. Serial grinding at intervals of tens of micrometres, combined with computer-based reconstruction methods, renders the fossils in the round(14).	Univ Oxford, Dept Earth Sci, Oxford OX1 3PS, England; Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Univ Museum Nat Hist, Oxford OX1 3PW, England	University of Oxford; University of Leicester; University of Oxford	Siveter, DJ (corresponding author), Univ Oxford, Dept Earth Sci, S Parks Rd, Oxford OX1 3PS, England.	derek.siveter@earth.ox.ac.uk	Sutton, Mark/A-4189-2010					BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Cherns L, 1998, PALAEONTOLOGY, V41, P939; Cherns L, 1998, PALAEONTOLOGY, V41, P545; Lindberg David R., 1996, P67; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; Orr PJ, 2000, J GEOL SOC LONDON, V157, P173, DOI 10.1144/jgs.157.1.173; OVANOV DL, 1996, ORIGIN EVOLUTIONARY, P59; PEEL JS, 1991, GRONLANDS GEOLOGISKE, V161, P1; Rosenberg G, 1997, J MOLLUS STUD, V63, P301, DOI 10.1093/mollus/63.3.301; RUNNEGAR B., 1985, MOLLUSCA, V10, DOI DOI 10.1016/B978-0-12-751408-6.50008-4; Runnegar Bruce, 1996, P77; Scheltema Amelie H., 1996, P53; SUTTON MD, IN PRESS PALEONTOL E; VONSALVINIPLAWE.L, 1996, ORIGIN EVOLUTIONARY, P29; Wingstrand K.G., 1985, Galathea Report, V16, P7; Winnepenninckx B, 1996, MOL BIOL EVOL, V13, P1306, DOI 10.1093/oxfordjournals.molbev.a025577	17	64	69	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					461	463		10.1038/35068549	http://dx.doi.org/10.1038/35068549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260711				2022-12-01	WOS:000167583800039
J	Lincoln, T				Lincoln, T			Animal behaviour - Greensleaves	NATURE			English	Editorial Material																		Cholewa E, 2001, BIOL J LINN SOC, V72, P179, DOI [10.1006/bijl.2000.0493, 10.1111/j.1095-8312.2001.tb01310.x]	1	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2001	410	6826					318	318		10.1038/35066669	http://dx.doi.org/10.1038/35066669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	410WM	11268190				2022-12-01	WOS:000167464100029
J	Volchkov, VE; Volchkova, VA; Muhlberger, E; Kolesnikova, LV; Weik, M; Dolnik, O; Klenk, HD				Volchkov, VE; Volchkova, VA; Muhlberger, E; Kolesnikova, LV; Weik, M; Dolnik, O; Klenk, HD			Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity	SCIENCE			English	Article							MARBURG-VIRUS; MESSENGER-RNA; GLYCOPROTEIN; REPLICATION; REGION; DOMAIN; TRANSCRIPTION; CONTAINS; PROTEIN; CDNA	To study the mechanisms underlying the high pathogenicity of Ebola virus, we have established a system that allows the recovery of infectious virus from cloned cDNA and thus permits genetic manipulation. We created a mutant in which the editing site of the gene encoding envelope glycoprotein (CP) was eliminated. This mutant no longer expressed the nonstructural glycoprotein sGP, Synthesis of CP increased, but most of it accumulated in the endoplasmic reticulum as immature precursor. The mutant was significantly more cytotoxic than wild-type virus, indicating that cytotoxicity caused by CP is down-regulated by the virus through transcriptional RNA editing and expression of sGP.	Univ Marburg, Inst Virol, D-35037 Marburg, Germany; Univ Lyon 1, Filovirus Lab, F-69365 Lyon 07, France	Philipps University Marburg; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Volchkov, VE (corresponding author), Univ Marburg, Inst Virol, Robert Koch Str 17, D-35037 Marburg, Germany.	viktor.volchkov@ens-lyon.fr	Muhlberger, Elke/AAD-6924-2019; Volchkov, Viktor/M-7846-2014	Volchkov, Viktor/0000-0001-7896-8706; Muhlberger, Elke/0000-0003-3547-9376; Valentina A, Volchkova/0000-0003-4028-782X				Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; BUKREYEV AA, 1993, FEBS LETT, V323, P183, DOI 10.1016/0014-5793(93)81476-G; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Feldmann H, 1999, CURR TOP MICROBIOL, V235, P1; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Muhlberger E, 1998, J VIROL, V72, P8756; Muhlberger E, 1999, J VIROL, V73, P2333; PATTNAIK AK, 1992, CELL, V69, P1011, DOI 10.1016/0092-8674(92)90619-N; PERROTTA AT, 1991, NATURE, V350, P434, DOI 10.1038/350434a0; Peters C.J., 1996, FIELDS VIROLOGY, P1161; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; VIDAL S, 1990, EMBO J, V9, P2017, DOI 10.1002/j.1460-2075.1990.tb08330.x; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; VOLCHKOV VE, 1992, FEBS LETT, V305, P181, DOI 10.1016/0014-5793(92)80662-Z; Volchkov VE, 1999, J GEN VIROL, V80, P355, DOI 10.1099/0022-1317-80-2-355; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WILL C, 1993, J VIROL, V67, P1203, DOI 10.1128/JVI.67.3.1203-1210.1993; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	21	226	263	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1965	1969		10.1126/science.1057269	http://dx.doi.org/10.1126/science.1057269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239157				2022-12-01	WOS:000167401600047
J	Yoder, J; Pham, C; Iizuka, YM; Kanagawa, O; Liu, SK; McGlade, J; Cheng, AM				Yoder, J; Pham, C; Iizuka, YM; Kanagawa, O; Liu, SK; McGlade, J; Cheng, AM			Requirement for the SLP-76 adaptor CADS in T cell development	SCIENCE			English	Article							THYMOCYTE DEVELOPMENT; PROTEIN SLP-76; RECEPTOR; LAT; ACTIVATION; MICE; BETA; DELETION; KINASES; PATHWAY	GADS is an adaptor protein implicated in CD3 signaling because of its ability to link SLP-76 to LAT. A GADS-deficient mouse was generated by gene targeting, and the function of GADS in T cell development and activation was examined. GADS(-) CD4(-)CD8(-) thymocytes exhibited a severe block in proliferation but still differentiated into mature T cells. GADS(-) thymocytes failed to respond to CD3 cross-linking in vivo and were-impaired in positive and negative selection. Immunoprecipitation experiments revealed that the association between SLP-76 and LAT was uncoupled in GADS(-) thymocytes. These observations indicate that CADS is a critical adaptor for CD3 signaling.	Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Med Sci Training Program, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cheng, AM (corresponding author), Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA.	acheng@im.wustl.edu		Liu, Stanley/0000-0001-6851-0857				Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Bourette RP, 1998, EMBO J, V17, P7273, DOI 10.1093/emboj/17.24.7273; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	26	122	125	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1987	1991		10.1126/science.1057176	http://dx.doi.org/10.1126/science.1057176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239162				2022-12-01	WOS:000167401600052
J	Marteau, TM; Senior, V; Sasieni, P				Marteau, TM; Senior, V; Sasieni, P			Women's understanding of a "normal smear test result": experimental questionnaire based study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To describe women's understanding of a negative smear test result when presented using the term "normal smear result," as required by the NHS cervical screening programme, and to evaluate the impact on understanding of different ways of presenting the residual risk inherent in such a result. Design Experimental questionnaire based study. Interventions Participants were asked to imagine that they had received a normal smear result The meaning of this result was then presented using different combinations of three different expressions of residual risk of having or developing cervical cancer over the next five years: a verbal probability of absolute risk (low risk), a numerical probability of absolute risk(1 in 5000), or a numerical probability of risk relative to an unscreened woman (five times lower). Participants: 1027 women aged 20 to 64. Results When informed only that their smear result was normal, 52% (80 of 153 women) of participants correctly understood that this entailed a residual risk of cervical cancer, compared with 70% (107 of 152) given the additional sentence explaining the meaning of a normal smear result using a verbal probability of absolute risk (difference 18%; 95% confidence interval 7% to 29%). Additionally: explaining the results using a numerical probability of absolute or relative risk did not increase the proportion who correctly understood that there was a residual risk of cervical cancer. Conclusions NHS policy for reporting normal smears needs to change to make it a definite requirement that the reporting of a "normal smear result" is accompanied by a sentence stating that this means a low risk for having or developing cervical cancer in the next five years.	Kings Coll London, Psychol & Genet Res Grp, London SE1 9RT, England; Imperial Canc Res Fund, Math Stat & Epidemiol Lab, London WC1A 3PX, England	University of London; King's College London; Cancer Research UK	Marteau, TM (corresponding author), Kings Coll London, Psychol & Genet Res Grp, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk		Marteau, Theresa/0000-0003-3025-1129; Sasieni, Peter/0000-0003-1509-8744; /0000-0001-7745-8341	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AUSTOKER J, 1997, IMPROVING QUALITY WR; Brun W, 1994, SUBJECTIVE PROBABILI, P295; Edwards A, 1996, BRIT MED J, V313, P1483, DOI 10.1136/bmj.313.7070.1483; EDWARDS AGK, IN PRESS J HLTH COMM; General Medical Council, 1999, SEEK PAT CONS ETH CO; Hall S, 2000, BMJ-BRIT MED J, V320, P407, DOI 10.1136/bmj.320.7232.407; Marteau TM, 2000, PRENATAL DIAG, V20, P714, DOI 10.1002/1097-0223(200009)20:9<714::AID-PD906>3.0.CO;2-4; PETTICREW M, 2000, HEALTH TECHNOL ASSES, P4	8	40	41	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					526	528		10.1136/bmj.322.7285.526	http://dx.doi.org/10.1136/bmj.322.7285.526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230068	Green Published, Green Submitted			2022-12-01	WOS:000167370500028
J	Radcliffe, A; Brown, G				Radcliffe, A; Brown, G			Will MRI provide maps of lines of excision for rectal cancer?	LANCET			English	Editorial Material							PROGNOSTIC FACTORS; CARCINOMA		Llandough Hosp, Cardiff & Vale NHS Trust, Dept Surg, Penarth CF64 2XX, S Glam, Wales; Llandough Hosp, Cardiff & Vale NHS Trust, Dept Radiol, Penarth CF64 2XX, S Glam, Wales		Radcliffe, A (corresponding author), Llandough Hosp, Cardiff & Vale NHS Trust, Dept Surg, Penarth CF64 2XX, S Glam, Wales.		BROWN, GINA/F-8081-2012	Brown, Gina/0000-0002-2336-622X				Brown G, 1999, RADIOLOGY, V211, P215, DOI 10.1148/radiology.211.1.r99ap35215; CAWTHORN SJ, 1990, LANCET, V335, P1055, DOI 10.1016/0140-6736(90)92631-Q; HEALD RJ, 1986, LANCET, V1, P1479; HERMANEK P, 1995, TUMORI, V81, P60; Lindsey I, 2000, BRIT J SURG, V87, P1288, DOI 10.1046/j.1365-2168.2000.01542.x; NICHOLLS RJ, 1982, BRIT J SURG, V69, P404, DOI 10.1002/bjs.1800690716; QUIRKE P, 1988, INT J COLORECTAL DIS, V3, P127, DOI 10.1007/BF01645318	7	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					495	496		10.1016/S0140-6736(00)04038-1	http://dx.doi.org/10.1016/S0140-6736(00)04038-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229665				2022-12-01	WOS:000167011700006
J	Fields, S				Fields, S			Proteomics - Proteomics in genomeland	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; YEAST GENOME; IDENTIFICATION; COMPLEX; GENES		Univ Washington, Howard Hughes Med Inst, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Genet, Seattle, WA 98195 USA.	fields@u.washington.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BLACKSTOCK W, 2000, PROTEOMICS TRENDS GU, P12; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; JENSEN ON, 2000, PROTEOMICS TRENDS GU, P36; Johnston M, 2000, NAT GENET, V24, P5, DOI 10.1038/71681; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; MacBeath G, 2000, SCIENCE, V289, P1760; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SCHWIKOWSKI B, IN PRESS NATURE BIOT; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WASHBURN MP, IN PRESS NATURE BIOT; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	33	191	246	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1221	+		10.1126/science.291.5507.1221	http://dx.doi.org/10.1126/science.291.5507.1221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233445				2022-12-01	WOS:000166993400023
J	Priest, ND				Priest, ND			Toxicity of depleted uranium	LANCET			English	Editorial Material							MORTALITY; WORKERS; PLANT		Middlesex Univ, Sch Hlth Biol & Environm Sci, London N11 2NQ, England	Middlesex University	Priest, ND (corresponding author), Middlesex Univ, Sch Hlth Biol & Environm Sci, London N11 2NQ, England.							*APEI, 1995, HLTH ENV CONS DEPL U; CHECKOWAY H, 1988, AM J EPIDEMIOL, V127, P255, DOI 10.1093/oxfordjournals.aje.a114801; Ellender M, 2001, INT J RADIAT BIOL, V77, P41, DOI 10.1080/095530001453104; Fetter S., 1999, SCI GLOB SECURITY, V8, P125, DOI DOI 10.1080/08929880008426473; FRIBERG L, 1986, HDB TOXICOLOGY METAL, V2, P623; Hodge H.C., 1973, HDB EXPT PHARM, V36, P165; *INT COMM RAD PROT, 1994, ANN ICRP, V25, P57; McGeoghegan D., 2000, Journal of Radiological Protection, V20, P111, DOI 10.1088/0952-4746/20/2/301; POLEDNAK AP, 1981, J OCCUP ENVIRON MED, V23, P169; Priest N.D., 1990, TRACE METALS FLUORID, P83; Ritz B, 1999, EPIDEMIOLOGY, V10, P531, DOI 10.1097/00001648-199909000-00012	11	130	133	0	33	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					244	246		10.1016/S0140-6736(00)03605-9	http://dx.doi.org/10.1016/S0140-6736(00)03605-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214120				2022-12-01	WOS:000166693400002
J	Harlow, ML; Ress, D; Stoschek, A; Marshall, RM; McMahan, UJ				Harlow, ML; Ress, D; Stoschek, A; Marshall, RM; McMahan, UJ			The architecture of active zone material at the frog's neuromuscular junction	NATURE			English	Article							TRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; ELECTRON TOMOGRAPHY; CALCIUM-CHANNEL; RECONSTRUCTIONS; ORGANIZATION; RECEPTORS; PROTEIN; SITES; ICE	Active zone material at the nervous system's synapses is situated next to synaptic vesicles that are docked at the presynaptic plasma membrane, and calcium channels that are anchored in the membrane. Here we use electron microscope tomography to show the arrangement and associations of structural components of this compact organelle at a model synapse, the frog's neuromuscular junction. Our findings indicate that the active zone material helps to dock the vesicles and anchor the channels, and that its architecture provides both a particular spatial relationship and a structural linkage between them. The structural linkage may include proteins that mediate the calcium-triggered exocytosis of neurotransmitter by the synaptic vesicles during synaptic transmission.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	McMahan, UJ (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ujmcmahan@stanford.edu						Bewick GS, 1996, J NEUROCYTOL, V25, P367; BRAUNFELD MB, 1994, J MICROSC-OXFORD, V174, P75, DOI 10.1111/j.1365-2818.1994.tb03451.x; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Cohen MW, 2000, J NEUROSCI, V20, P4912; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; DIERKSEN K, 1993, ULTRAMICROSCOPY, V49, P109, DOI 10.1016/0304-3991(93)90217-L; DIERKSEN K, 1995, BIOPHYS J, V68, P1416, DOI 10.1016/S0006-3495(95)80314-0; Gray E. G., 1966, International Review of General and Experimental Zoology, V2, P139; GRAY EG, 1963, J ANAT, V97, P101; HAZUKA CD, 1999, FR MOLEC B, V23, P81; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Heuser JE, 1977, HDB PHYSL, VI, P261; Hoenger A, 1996, J STRUCT BIOL, V117, P99, DOI 10.1006/jsbi.1996.0075; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Katz B., 1969, RELEASE NEURAL TRANS; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Luther P.K., 1992, ELECT TOMOGRAPHY 3 D, P39; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; PETERS A, 1991, FINE STRUCTURE NERVO, P198; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Radermacher M., 1992, ELECT TOMOGRAPHY, P91, DOI DOI 10.1007/978-1-4757-2163-8_5; Ress D, 1999, J ELECTRON MICROSC, V48, P277, DOI 10.1093/oxfordjournals.jmicro.a023679; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Stoschek A, 1997, J STRUCT BIOL, V120, P257, DOI 10.1006/jsbi.1997.3925; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; ZHOU ZH, 1994, J MOL BIOL, V242, P456, DOI 10.1006/jmbi.1994.1594; ZWICKL P, 1994, BIOCHEMISTRY-US, V31, P964	41	272	285	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					479	484		10.1038/35054000	http://dx.doi.org/10.1038/35054000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206537				2022-12-01	WOS:000166570500038
J	Bianco, PR; Brewer, LR; Corzett, M; Balhorn, R; Yeh, Y; Kowalczykowski, SC; Baskin, RJ				Bianco, PR; Brewer, LR; Corzett, M; Balhorn, R; Yeh, Y; Kowalczykowski, SC; Baskin, RJ			Processive translocation and DNA unwinding by individual RecBCD enzyme molecules	NATURE			English	Article							DOUBLE-STRANDED DNA; ESCHERICHIA-COLI; HELICASE ACTIVITY; DUPLEX DNA; BINDING; ASSAY; DISPLACEMENT; FLUORESCENT; RECA	RecBCD enzyme is a processive DNA helicase(1) and nuclease(2) that participates in the repair of chromosomal DNA through homologous recombination(3,4). We have visualized directly the movement of individual RecBCD enzymes on single molecules of double-stranded DNA (dsDNA). Detection involves the optical trapping of solitary, fluorescently tagged dsDNA molecules that are attached to polystyrene beads, and their visualization by fluorescence microscopy(5,6). Both helicase translocation and DNA unwinding are monitored by the displacement of fluorescent dye from the DNA by the enzyme(7). Here we show that unwinding is both continuous and processive, occurring at a maximum rate of 972 +/- 172 base pairs per second (0.30 mum s(-1)), with as many as 42,300 base pairs of dsDNA unwound by a single RecBCD enzyme molecule. The mean behaviour of the individual RecBCD enzyme molecules corresponds to that observed in bulk solution.	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; Univ Calif Lawrence Livermore Natl Lab, Elect Engn Technol Div, Livermore, CA 94550 USA; Univ Calif Lawrence Livermore Natl Lab, Biotechnol Res Program, Livermore, CA 94550 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.							Anderson DG, 1998, J MOL BIOL, V282, P275, DOI 10.1006/jmbi.1998.2013; ARNOLD DA, 1999, ENCY LIFE SCI; Bennink ML, 1999, CYTOMETRY, V36, P200, DOI 10.1002/(SICI)1097-0320(19990701)36:3<200::AID-CYTO9>3.0.CO;2-T; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; EGGLESTON AK, 1993, J MOL BIOL, V231, P621, DOI 10.1006/jmbi.1993.1314; Eggleston AK, 1996, NUCLEIC ACIDS RES, V24, P1179, DOI 10.1093/nar/24.7.1179; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650	19	267	273	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					374	378		10.1038/35053131	http://dx.doi.org/10.1038/35053131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201750				2022-12-01	WOS:000166434300055
J	Stirling, CH; Esat, TM; Lambeck, K; McCulloch, MT; Blake, SG; Lee, DC; Halliday, AN				Stirling, CH; Esat, TM; Lambeck, K; McCulloch, MT; Blake, SG; Lee, DC; Halliday, AN			Orbital forcing of the marine isotope stage 9 interglacial	SCIENCE			English	Article							PAPUA-NEW-GUINEA; MASS-SPECTROMETRY; SEA-LEVEL; U-SERIES; HENDERSON ISLAND; PITCAIRN GROUP; TH-230 AGES; DEVILS-HOLE; CORALS; DURATION	Milankovitch orbital forcing theory has been used to assign time scares to many paleoclimate records. However, the validity of this theory remains uncertain, and independent sea-level chronologies used to test its applicability have been restricted Largely to the past similar to 135,000 years. Here, we report U-series ages for coral reefs formed on Henderson Island during sea-level high-stands occurring at similar to 630,000 and similar to 330,000 years ago. These data are consistent with the hypothesis that interglacial climates are forced by Northern Hemisphere summer solar insolation centered at 65 degreesN latitude, as predicted by Milankovitch theory.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; ETH Zentrum, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Michigan System; University of Michigan; Swiss Federal Institutes of Technology Domain; ETH Zurich; Australian National University	Stirling, CH (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.		McCulloch, Malcolm T/C-3651-2009; Lee, Der-Chuen/N-9225-2013	McCulloch, Malcolm T/0000-0003-1538-1558; Esat, Tezer/0000-0001-5331-6568; Lee, Der-Chuen/0000-0001-8855-9594; Esat, Sevilay/0000-0002-7257-4009				Bard E, 1996, GEOPHYS RES LETT, V23, P1473, DOI 10.1029/96GL01279; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BLAKE SG, 1995, BIOL J LINN SOC, V56, P43, DOI 10.1006/bijl.1995.0053; BROOKE M, 1992, PITCAIRN ISLAND EXPE; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; EDWARDS LR, 1986, EARTH PLANET SC LETT, V81, P175; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Galewsky J, 1996, GEOLOGY, V24, P819, DOI 10.1130/0091-7613(1996)024<0819:FTACPD>2.3.CO;2; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; GRUN R, 1994, QUATERNARY SCI REV, V13, P121, DOI 10.1016/0277-3791(94)90037-X; HAMELIN B, 1991, EARTH PLANET SC LETT, V106, P169, DOI 10.1016/0012-821X(91)90070-X; HENDERSON GM, 1993, EARTH PLANET SC LETT, V115, P65, DOI 10.1016/0012-821X(93)90213-S; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Imbrie J., 1979, ICE AGES SOLVING MYS; Karner DB, 2000, SCIENCE, V288, P2143, DOI 10.1126/science.288.5474.2143; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; Luo XZ, 1997, INT J MASS SPECTROM, V171, P105, DOI 10.1016/S0168-1176(97)00136-5; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Milankovitch M., 1941, CANON INSOLATION ICE; PANDOLFI JM, 1995, BIOL J LINN SOC, V56, P63, DOI 10.1006/bijl.1995.0054; PAULAY G, 1991, HENDERSON ISLAND BIO, P304; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; Stirling CH, 2000, GEOCHIM COSMOCHIM AC, V64, P3737, DOI 10.1016/S0016-7037(00)00457-9; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; SZABO BJ, 1994, SCIENCE, V266, P93, DOI 10.1126/science.266.5182.93; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255	29	100	105	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					290	293		10.1126/science.291.5502.290	http://dx.doi.org/10.1126/science.291.5502.290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209076				2022-12-01	WOS:000166352900041
J	Ferrand, E; Robert, R; Ingrand, P; Lemaire, F				Ferrand, E; Robert, R; Ingrand, P; Lemaire, F		French LATAREA Grp	Withholding and withdrawal of life support in intensive-care units in France: a prospective survey	LANCET			English	Article							SUSTAINING TREATMENT; DECISIONS; LIMIT	Background In France, there are no guidelines available on withholding and withdrawal of life-sustaining treatments, and information on the frequency of such decisions is scarce. Methods We undertook a prospective 2-month survey in 113, of a total of 220, intensive-care units (ICUs) in France to study the frequency of, and processes leading to, decisions to withhold and withdraw life-sustaining treatments. Findings Life-supporting therapies were withheld or withdrawn in 807 (11.0%) of 7309 patients (withholding in 336 [4.6%] and withdrawal in 471 [6.4%], preceded in 358 by withholding). Of 1175 deaths in ICU, 628 (53%) were preceded by a decision to limit life-supporting therapies. Futility and poor expected quality of life were the most frequently cited reasons. Decisions were strongly correlated with the simplified acute physiological score, but an independent centre effect persisted after adjustment for this score. Decisions were mostly taken by all the ICU medical staff, with (54%) or without (34%) the nursing staff; however, a single physician made decisions in 12% of cases. The patient's family was involved in the decision-making process in 44% of cases. The patient's willingness to limit his or her own care was known in only 8% of the cases; only 0.5% of the patients were involved in decisions. Interpretation Withholding and withdrawal of life-support therapies are widely practised in French ICUs, despite their prohibition by the French legislation. The lack of an official statement from French scientific bodies may explain several limitations on the various steps of the decision-making process.	Henri Mondor Univ Hosp, Surg Unit, Creteil, France; Henri Mondor Univ Hosp, Med Unit, Creteil, France; Henri Mondor Univ Hosp, Intens Care Unit, Creteil, France; Jean Bernard Univ Hosp, Dept Biostat, Poitiers, France; Jean Bernard Univ Hosp, Med Intens Care Unit, Poitiers, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Poitiers; CHU Poitiers	Ferrand, E (corresponding author), Hop Henri Mondor, Unite Reanimat Chirurg & Traumatol, Serv Anesthesie Reanimat, 51 Rue M de Lattre de Tassigny, F-94010 Creteil, France.	eferrand@club-internet.fr						[Anonymous], 1990, CRIT CARE MED, V18, P1435; [Anonymous], 1991, Am Rev Respir Dis, V144, P726; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; *APPL INT C, 1992, J MED ETHICS S, V18, P1; ASCH DA, 1995, AM J RESP CRIT CARE, V151, P288, DOI 10.1164/ajrccm.151.2.7842181; *CCNE, 1998, CAH COM CONS NAT ETH, P3; COHEN LM, 1993, ARCH INTERN MED, V153, P2481, DOI 10.1001/archinte.153.21.2481; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Danis M, 1997, CRIT CARE MED, V25, P887; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; FABERLANGENDOEN K, 1992, CRIT CARE MED, V20, P570, DOI 10.1097/00003246-199205000-00005; FAVEREAU E, 1998, LIBERATION      0312, P1; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Peillon D, 1997, ANN FR ANESTH, V16, P25, DOI 10.1016/S0750-7658(97)84274-8; PEILLON D, 1995, REAN URG, V4, P3; Portes L., 1954, RECHERCHE ETHIQUE ME; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; *PRES COMM STUD ET, 1983, DEC FOR LIF SUST TRE, P121; Robert R, 1996, REAN URG, V5, P611; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; SPRUNG CL, 1992, CRIT CARE MED, V20, P320; Turner JS, 1996, INTENS CARE MED, V22, P1020, DOI 10.1007/s001340050207; VINCENT JL, 1990, INTENS CARE MED, V16, P256, DOI 10.1007/BF01705162; WOOD GG, 1995, CAN J ANAESTH, V42, P186, DOI 10.1007/BF03010673	27	348	362	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2001	357	9249					9	14		10.1016/S0140-6736(00)03564-9	http://dx.doi.org/10.1016/S0140-6736(00)03564-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EQ	11197395				2022-12-01	WOS:000166341500008
J	Gillon, J; Yakir, D				Gillon, J; Yakir, D			Influence of carbonic anhydrase activity in terrestrial vegetation on the O-18 content of atmospheric CO2	SCIENCE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; ISOTOPIC COMPOSITION; C-4 PHOTOSYNTHESIS; DISCRIMINATION; DELTA-O-18; OXYGEN; PLANTS; LEAVES; WATER; (COO)-O-18-O-16	The oxygen-18 (O-18) content of atmospheric carbon dioxide (CO2) is an important indicator of CO2 uptake on land. It has generally been assumed that during photosynthesis, oxygen in CO2 reaches isotopic equilibrium with oxygen in O-18-enriched water in leaves. We show, however, large differences in the activity of carbonic anhydrase (which catalyzes CO2 hydration and O-18 exchange in leaves) among major plant groups that cause variations in the extent of O-18 equilibrium (theta (eq)). A clear distinction in theta (eq) between C-3 trees and shrubs, and C-4 grasses makes atmospheric (COO)-O-18 a potentially sensitive indicator to changes in C-3 and C-4 productivity. We estimate a global mean theta (eq) value of similar to0.8, which reasonably reconciles inconsistencies between O-18 budgets of atmospheric O-2 (Dole effect) and CO2.	Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yakir, D (corresponding author), Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel.		Yakir, Dan/K-1500-2012					BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; BENDER M, 1985, NATURE, V318, P349, DOI 10.1038/318349a0; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5873, DOI 10.1029/96JD02361; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P219, DOI 10.1007/BF01323191; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; FLANAGAN LB, 1994, AUST J PLANT PHYSIOL, V21, P221, DOI 10.1071/PP9940221; FORSTEL H, 1978, P 3 INT S ENV BIOG G, P811; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; GILLON J, UNPUB; Gillon JS, 2000, PLANT CELL ENVIRON, V23, P903, DOI 10.1046/j.1365-3040.2000.00597.x; Gillon JS, 2000, PLANT PHYSIOL, V123, P201, DOI 10.1104/pp.123.1.201; Harwood KG, 1998, PLANT CELL ENVIRON, V21, P269, DOI 10.1046/j.1365-3040.1998.00276.x; HATCH MD, 1990, PLANT PHYSIOL, V93, P825, DOI 10.1104/pp.93.2.825; HOFFMANN GW, UNPUB; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; MAKINO A, 1992, PLANT PHYSIOL, V100, P1737, DOI 10.1104/pp.100.4.1737; Mills GA, 1940, J AM CHEM SOC, V62, P1019, DOI 10.1021/ja01862a010; Peylin P, 1999, TELLUS B, V51, P642, DOI 10.1034/j.1600-0889.1999.t01-2-00006.x; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Tans PP, 1998, TELLUS B, V50, P163, DOI 10.1034/j.1600-0889.1998.t01-1-00004.x; Trolier M, 1996, J GEOPHYS RES-ATMOS, V101, P25897, DOI 10.1029/96JD02363; UTSONIYAMA E, 1993, PHYSIOL PLANTARUM, V88, P413; Wang XF, 1998, GLOBAL CHANGE BIOL, V4, P835, DOI 10.1046/j.1365-2486.1998.00197.x; Waring R. H., 1985, FOREST ECOSYSTEMS; Williams TG, 1996, PLANT PHYSIOL, V112, P319, DOI 10.1104/pp.112.1.319; YAKIR D, 1994, PLANT CELL ENVIRON, V17, P73, DOI 10.1111/j.1365-3040.1994.tb00267.x; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0	36	134	148	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2584	2587		10.1126/science.1056374	http://dx.doi.org/10.1126/science.1056374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283366				2022-12-01	WOS:000167861000036
J	Butler, D				Butler, D			The battle of Tugen Hills	NATURE			English	News Item																		FLEAUX R, 2001, SCI AVENIR, P18; Gitonga E, 2001, SCIENCE, V291, P986; Pickford M, 2001, SCIENCE, V291, P986; PICKFORD M, 1975, NATURE, V256, P279, DOI 10.1038/256279a0; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; 2000, SCIENCE, V290, P2065	6	3	3	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2001	410	6828					508	509		10.1038/35069232	http://dx.doi.org/10.1038/35069232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417WW	11279458				2022-12-01	WOS:000167859300013
J	Denton, M; Marshall, C				Denton, M; Marshall, C			Laws of form revisited	NATURE			English	Article									Univ Otago, Dept Biochem, Dunedin 9001, New Zealand	University of Otago	Denton, M (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9001, New Zealand.		Marshall, Craig J./C-6668-2009	Marshall, Craig J./0000-0003-4186-0368				CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; LINDGARD P, 1996, PROTEIN FOLDS, P98; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0	5	59	60	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2001	410	6827					417	417		10.1038/35068645	http://dx.doi.org/10.1038/35068645			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	412YX	11260691				2022-12-01	WOS:000167583800021
J	Newschaffer, CJ; Topham, A; Herzberg, T; Weiner, S; Weinberg, DS				Newschaffer, CJ; Topham, A; Herzberg, T; Weiner, S; Weinberg, DS			Risk of colorectal cancer after breast cancer	LANCET			English	Article							HORMONE REPLACEMENT THERAPY; ADJUVANT TAMOXIFEN THERAPY; WOMEN; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; ESTROGEN; PROGRAM	Background History of breast cancer has been reported as a risk factor for colorectal cancer in women. In view of the ambiguous nature of existing evidence and the growing interest in targeted colorectal cancer prevention, we sought to quantify this risk. Methods We used the Surveillance Epidemiology and End Results (SEER) database to estimate risk of colorectal cancer after breast-cancer diagnosis in women with first incident breast cancer between 1974 and 1995. Observed colon and rectal cancer risk was compared with that expected in the general population. We stratified comparisons by age at breast-cancer diagnosis. stage of cancer, ethnic origin of patient, and follow-up time. Findings Overall, women with previous breast cancer were 5% less likely (95% CI 1-9) to develop colon and 13% less likely (6-19) to develop rectal cancer than women in the general population. Stratified analyses suggested that the risk reductions observed for colon and rectal cancer were most pronounced for women with breast cancer diagnosed after age 65 years, in white women, women with local stage breast cancer, and women diagnosed in the later study years (1990-94). Interpretations Breast cancer does not increase subsequent colorectal cancel risk, and reduced risk was seen for certain subgroups of women. Because no biologically plausible endogenous protective factor has been identified. we suggest that reduced risk could stem from an accumulation of exposures that increase breast-cancer frequency but protect against colorectal cancer.	Johns Hopkins Sch Med & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Thomas Jefferson Univ, Jefferson Med Coll, Oncol Data Serv, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Gastroenterol & Hepatol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA	Johns Hopkins University; Jefferson University; Jefferson University; Jefferson University	Newschaffer, CJ (corresponding author), Johns Hopkins Sch Med & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cnewscha@jhsp.edu						Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 1999, J Epidemiol Biostat, V4, P191; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; BRESLOW N, 1986, NATL CANC I MONOGR, V67, P149; Burnand B, 1999, ENDOSCOPY, V31, P673; Curtis RE, 1996, J NATL CANCER I, V88, P832, DOI 10.1093/jnci/88.12.832; Donovan JM, 1998, J WOMENS HEALTH, V7, P45, DOI 10.1089/jwh.1998.7.45; EISEN GM, 1994, J CLIN GASTROENTEROL, V19, P57, DOI 10.1097/00004836-199407000-00015; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Foulkes WD, 1996, J MED GENET, V33, P534, DOI 10.1136/jmg.33.7.534; Goodman SN, 1998, AM J EPIDEMIOL, V147, P807, DOI 10.1093/oxfordjournals.aje.a009531; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Jednak MA, 1998, PRIMARY CARE, V25, P293, DOI 10.1016/S0095-4543(05)70065-8; Jordan V C, 1997, Oncology (Williston Park), V11, P7; Lin KM, 1999, DIS COLON RECTUM, V42, P1041, DOI 10.1007/BF02236700; McCullagh P, 2019, GEN LINEAR MODELS; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; NEUGUT AI, 1991, CANCER, V68, P2069, DOI 10.1002/1097-0142(19911101)68:9<2069::AID-CNCR2820680938>3.0.CO;2-M; NEWELL GR, 1974, J NATL CANCER I, V53, P369, DOI 10.1093/jnci/53.2.369; PEARCE N, 1987, AM J EPIDEMIOL, V125, P1085, DOI 10.1093/oxfordjournals.aje.a114624; Platz EA, 1997, CANCER CAUSE CONTROL, V8, P894, DOI 10.1023/A:1018420513815; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; RUTQVIST LE, 1995, J NATL CANCER I, V87, P645, DOI 10.1093/jnci/87.9.645; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SCHATZKIN A, 1998, CANCER, V62, P1451; SCHOEN RE, 1994, AM J GASTROENTEROL, V89, P835; Schottenfeld D, 1996, CANC EPIDEMIOLOGY PR, P813; Stoll BA, 1998, BRIT J SURG, V85, P1468; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; URY HK, 1985, AM J EPIDEMIOL, V122, P197, DOI 10.1093/oxfordjournals.aje.a114083; Whitlock EP, 1998, J WOMENS HEALTH, V7, P1017, DOI 10.1089/jwh.1998.7.1017	31	36	37	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2001	357	9259					837	840		10.1016/S0140-6736(00)04197-0	http://dx.doi.org/10.1016/S0140-6736(00)04197-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412ZW	11265952				2022-12-01	WOS:000167586300010
J	Munch, S; deKryger, L				Munch, S; deKryger, L			Moral wounds: Complicated complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; REISER SJ, 1980, ANN INTERN MED, V92, P837, DOI 10.7326/0003-4819-92-6-837	2	27	28	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1131	1132		10.1001/jama.285.9.1131	http://dx.doi.org/10.1001/jama.285.9.1131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231729				2022-12-01	WOS:000167194700001
J	Clayton, JD; Kyriacou, CP; Reppert, SM				Clayton, JD; Kyriacou, CP; Reppert, SM			Keeping time with the human genome	NATURE			English	Article							MOUSE	The cloning and characterization of 'clock gene' families has advanced our understanding of the molecular control of the mammalian circadian clock. We have analysed the human genome for additional relatives, and identified new candidate genes that may expand our knowledge of the molecular workings of the circadian clock. This knowledge could lead to the development of therapies for treating jet lag and sleep disorders, and add to our understanding of the genetic contribution of clock gene alterations to sleep and neuropsychiatric disorders. The human genome will also aid in the identification of output genes that ultimately control circadian behaviours.	Massachusetts Gen Hosp, MassGen Hosp Children, Lab Dev Chronobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Leicester	Reppert, SM (corresponding author), Massachusetts Gen Hosp, MassGen Hosp Children, Lab Dev Chronobiol, Boston, MA 02114 USA.	reppert@helix.mgh.harvard.edu						Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Reppert SM, 2000, J BIOL RHYTHM, V15, P357, DOI 10.1177/074873000129001459; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; TOH KL, 2001, SCIENCE         0111; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Young MW, 2000, SCIENCE, V288, P451, DOI 10.1126/science.288.5465.451	15	70	79	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					829	831		10.1038/35057006	http://dx.doi.org/10.1038/35057006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237000	Bronze			2022-12-01	WOS:000166938800047
J	McPherson, JD; Marra, M; Hillier, L; Waterston, RH; Chinwalla, A; Wallis, J; Sekhon, M; Wylie, K; Mardis, ER; Wilson, RK; Fulton, R; Kucaba, TA; Wagner-McPherson, C; Barbazuk, WB; Gregory, SG; Humphray, SJ; French, L; Evans, RS; Bethel, G; Whittaker, A; Holden, JL; McCann, OT; Dunham, A; Soderlund, C; Scott, CE; Bentley, DR; Schuler, G; Chen, HC; Jang, WH; Green, ED; Idol, JR; Maduro, VVB; Montgomery, KT; Lee, E; Miller, A; Emerling, S; Kucherlapati, R; Gibbs, R; Scherer, S; Gorrell, JH; Sodergren, E; Clerc-Blankenburg, K; Tabor, P; Naylor, S; Garcia, D; de Jong, PJ; Catanese, JJ; Nowak, N; Osoegawa, K; Qin, SZ; Rowen, L; Madan, A; Dors, M; Hood, L; Trask, B; Friedman, C; Massa, H; Cheung, VG; Kirsch, IR; Reid, T; Yonescu, R; Weissenbach, J; Bruls, T; Heilig, R; Branscomb, E; Olsen, A; Doggett, N; Cheng, JF; Hawkins, T; Myers, RM; Shang, J; Ramirez, L; Schmutz, J; Velasquez, O; Dixon, K; Stone, NE; Cox, DR; Haussler, D; Kent, WJ; Furey, T; Rogic, S; Kennedy, S; Jones, S; Rosenthal, A; Wen, GP; Schilhabel, M; Gloeckner, G; Nyakatura, G; Siebert, R; Schlegelberger, B; Korenburg, J; Chen, XN; Fujiyama, A; Hattori, M; Toyoda, A; Yada, T; Park, HS; Sakaki, Y; Shimizu, N; Asakawa, S; Kawasaki, K; Sasaki, T; Shintani, A; Shimizu, A; Shibuya, K; Kudoh, J; Minoshima, S; Ramser, J; Seranski, P; Hoff, C; Poustka, A; Reinhardt, R; Lehrach, H				McPherson, JD; Marra, M; Hillier, L; Waterston, RH; Chinwalla, A; Wallis, J; Sekhon, M; Wylie, K; Mardis, ER; Wilson, RK; Fulton, R; Kucaba, TA; Wagner-McPherson, C; Barbazuk, WB; Gregory, SG; Humphray, SJ; French, L; Evans, RS; Bethel, G; Whittaker, A; Holden, JL; McCann, OT; Dunham, A; Soderlund, C; Scott, CE; Bentley, DR; Schuler, G; Chen, HC; Jang, WH; Green, ED; Idol, JR; Maduro, VVB; Montgomery, KT; Lee, E; Miller, A; Emerling, S; Kucherlapati, R; Gibbs, R; Scherer, S; Gorrell, JH; Sodergren, E; Clerc-Blankenburg, K; Tabor, P; Naylor, S; Garcia, D; de Jong, PJ; Catanese, JJ; Nowak, N; Osoegawa, K; Qin, SZ; Rowen, L; Madan, A; Dors, M; Hood, L; Trask, B; Friedman, C; Massa, H; Cheung, VG; Kirsch, IR; Reid, T; Yonescu, R; Weissenbach, J; Bruls, T; Heilig, R; Branscomb, E; Olsen, A; Doggett, N; Cheng, JF; Hawkins, T; Myers, RM; Shang, J; Ramirez, L; Schmutz, J; Velasquez, O; Dixon, K; Stone, NE; Cox, DR; Haussler, D; Kent, WJ; Furey, T; Rogic, S; Kennedy, S; Jones, S; Rosenthal, A; Wen, GP; Schilhabel, M; Gloeckner, G; Nyakatura, G; Siebert, R; Schlegelberger, B; Korenburg, J; Chen, XN; Fujiyama, A; Hattori, M; Toyoda, A; Yada, T; Park, HS; Sakaki, Y; Shimizu, N; Asakawa, S; Kawasaki, K; Sasaki, T; Shintani, A; Shimizu, A; Shibuya, K; Kudoh, J; Minoshima, S; Ramser, J; Seranski, P; Hoff, C; Poustka, A; Reinhardt, R; Lehrach, H		Int Human Genome Mapping Consortiu	A physical map of the human genome	NATURE			English	Article							DROSOPHILA-MELANOGASTER; DNA-SEQUENCE; CHROMOSOME; HYBRIDIZATION; FRAGMENTS; SHOTGUN; CONTIGS; VECTOR; CLONES; GENES	The human genome is by far the largest genome to be sequenced, and its size and complexity present many challenges for sequence assembly. The International Human Genome Sequencing Consortium constructed a map of the whole genome to enable the selection of clones for sequencing and for the accurate assembly of the genome sequence. Here we report the construction of the whole-genome bacterial artificial chromosome (BAC) map and its integration with previous landmark maps and information from mapping efforts focused on specific chromosomal regions. We also describe the integration of sequence data with the map.	Washington Univ, Sch Med, Genome Sequencing Ctr, Dept Genet, St Louis, MO 63108 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Texas San Antonio, San Antonio, TX 78285 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Inst Syst Biol, Multimegabase Sequencing Ctr, Seattle, WA 98105 USA; Fred Hutchinson Canc Res Inst, Div Human Biol, Seattle, WA 98109 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; NCI, Dept Genet, Med Branch, Washington, DC USA; Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; US DOE, Joint Genome Inst, Walnut Creek, CA USA; Stanford Univ, Stanford Human Genome Ctr, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Math, Santa Cruz, CA 95064 USA; British Columbia Canc Res Ctr, Vancouver, BC V5Z 4E6, Canada; Inst Mol Biotechnol, Dept Genome Anal, D-07745 Jena, Germany; Univ Kiel, Inst Human Genet, D-24098 Kiel, Germany; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Deutsch Krebsforschungszentrum, Abt Mol Genomanal, D-69120 Heidelberg, Germany	Washington University (WUSTL); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas at San Antonio (UTSA); Roswell Park Cancer Institute; Institute for Systems Biology (ISB); Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CEA; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Stanford University; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; British Columbia Cancer Agency; University of Kiel; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RIKEN; Keio University; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ)	McPherson, JD (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Dept Genet, 4444 Forest Pk Blvd, St Louis, MO 63108 USA.	jmcphers@watson.wustl.edu	Siebert, Reiner/A-8049-2010; Sasaki, Takashi/AAD-1461-2019; Wilson, Richard K./AAF-4139-2019; Hattori, Masahira/AAD-3785-2019; Kucherlapati, Raju/ABC-8807-2021; Cheung, Vivian G./AAT-3115-2020; Glöckner, Gernot/A-7800-2010; Jones, Steven J/C-3621-2009; Schmutz, Jeremy/N-3173-2013; Marra, Marco A/B-5987-2008; Mardis, Elaine/W-2202-2019; McPherson, John D/D-2633-2017; Hattori, Masahira/C-6958-2016; Sekhon, Mandeep/L-4665-2018	Wilson, Richard K./0000-0002-1992-1358; Glöckner, Gernot/0000-0002-9061-1061; Jones, Steven J/0000-0003-3394-2208; Schmutz, Jeremy/0000-0001-8062-9172; Marra, Marco A/0000-0001-7146-7175; McPherson, John D/0000-0001-8049-9347; Hattori, Masahira/0000-0001-9467-0344; Sekhon, Mandeep/0000-0002-9993-6938; Minoshima, Satoshi/0000-0002-0043-3047; Barbazuk, William/0000-0002-0909-4563; Sasaki, Takashi/0000-0002-6275-046X; Furey, Terry/0000-0001-5546-9672; Gregory, Simon/0000-0002-7805-1743; Cheng, Jan-Fang/0000-0001-7315-7613; Chinwalla, Asif/0000-0001-7831-3996; Reinhardt, Richard/0000-0001-9376-2132				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bouck JB, 2000, NAT GENET, V25, P31, DOI 10.1038/75563; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Capecchi MR, 2000, NAT GENET, V26, P159, DOI 10.1038/82825; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOGGETT NA, 1995, NATURE, V377, P335; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eeckman FH, 1995, METHOD CELL BIOL, V48, P583; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Hoskins RA, 2000, SCIENCE, V288, P1751; *INT RAD HYBRD MAP, 2000, NEW GEN MAP HUM GEN; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LICHTER P, 1991, GENET ANAL-BIOMOL E, V8, P24, DOI 10.1016/1050-3862(91)90005-C; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; OSOEGAWA K, IN PRESS GENOME RES; Pennisi E, 2000, SCIENCE, V287, P1179, DOI 10.1126/science.287.5456.1179; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Roest Crollius H, 1996, GENOME RES, V6, P943, DOI 10.1101/gr.6.10.943; Ross NP, 1999, ENVIRON ECOL STAT, V6, P5, DOI 10.1023/A:1009627431759; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; *WHIT I BIOM RES, 2000, YAC STS CONT MAP HUM; WILSON REK, 1997, ANAL DNA, P398; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082	46	616	646	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					934	941		10.1038/35057157	http://dx.doi.org/10.1038/35057157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237014	Bronze			2022-12-01	WOS:000166938800061
J	Murphy, WJ; Eizirik, E; Johnson, WE; Zhang, YP; Ryder, OA; O'Brien, SJ				Murphy, WJ; Eizirik, E; Johnson, WE; Zhang, YP; Ryder, OA; O'Brien, SJ			Molecular phylogenetics and the origins of placental mammals	NATURE			English	Article							ENDEMIC AFRICAN MAMMALS; TREE TOPOLOGIES; EVOLUTION; ORDER; POSITION	The precise hierarchy of ancient divergence events that led to the present assemblage of modern placental mammals has been an area of controversy among morphologists, palaeontologists and molecular evolutionists. Here we address the potential weaknesses of limited character and taxon sampling in a comprehensive molecular phylogenetic analysis of 64 species sampled across all extant orders of placental mammals. We examined sequence variation in 18 homologous gene segments (including nearly 10,000 base pairs) that were selected for maximal phylogenetic informativeness in resolving the hierarchy of early mammalian divergence. Phylogenetic analyses identify four primary superordinal clades: (I) Afrotheria (elephants, manatees, hyraxes, tenrecs, aardvark and elephant shrews); (II) Xenarthra (sloths, anteaters and armadillos); (III) Glires (rodents and lagomorphs), as a sister taxon to primates, flying lemurs and tree shrews; and (IV) the remaining orders of placental mammals (cetaceans, artiodactyls, perissodactyls, carnivores, pangolins, bats and core insectivores). Our results provide new insight into the pattern of the early placental mammal radiation.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming, Peoples R China; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; Kunming Institute of Zoology; Zoological Society of San Diego; University System of Maryland; University of Maryland College Park	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@mail.ncifcrf.gov	Johnson, Warren/D-4149-2016; Eizirik, Eduardo/K-8034-2012; OBRIEN, STEPHEN/ABD-1346-2020	Johnson, Warren/0000-0002-5954-186X; Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757				EASTEAL S, 1990, GENETICS, V124, P165; Eisenberg J.F., 1981, MAMMALIAN RAD; EIZIRIK E, IN PRESS J HERED; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Gregory W. K., 1910, B AM MUS NAT HIST, V27, P1, DOI DOI 10.1007/S13364-013-0165-6; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Huchon D, 1999, MOL BIOL EVOL, V16, P577, DOI 10.1093/oxfordjournals.molbev.a026140; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Krettek A, 1995, J MOL EVOL, V41, P952; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; MADSEN O, IN PRESS NATURE; McKenna MC, 1975, PHYLOGENY PRIMATES, P2146, DOI [10.1007/978-1-4684-2166-8_2, DOI 10.1007/978-1-4684-2166-8_2]; McKenna MC, 1997, CLASSIFICATION MAMMA; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; PETTIGREW JD, 1986, SCIENCE, V231, P1304, DOI 10.1126/science.3945827; Reyes A, 2000, MOL BIOL EVOL, V17, P979, DOI 10.1093/oxfordjournals.molbev.a026379; ROSE KD, 1993, MAMMAL PHYLOGENY : PLACENTALS, P81; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stanhope MJ, 1998, MOL PHYLOGENET EVOL, V9, P501, DOI 10.1006/mpev.1998.0517; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1	30	1034	1106	6	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					614	618		10.1038/35054550	http://dx.doi.org/10.1038/35054550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214319				2022-12-01	WOS:000166692300043
J	Naveilhan, P; Hassani, H; Lucas, G; Blakeman, KH; Hao, JX; Xu, XJ; Wiesenfeld-Hallin, Z; Thoren, P; Ernfors, P				Naveilhan, P; Hassani, H; Lucas, G; Blakeman, KH; Hao, JX; Xu, XJ; Wiesenfeld-Hallin, Z; Thoren, P; Ernfors, P			Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor	NATURE			English	Article							STRESS-INDUCED ANALGESIA; SCIATIC-NERVE INJURY; SUBSTANCE-P; PERIPHERAL AXOTOMY; NEUROPATHIC PAIN; FEEDING-BEHAVIOR; SPINAL-CORD; RAT; NEURONS; COMPLEMENTARY	Neuropeptide Y (NPY) is believed to exert antinociceptive actions by inhibiting the release of substance P and other 'pain neurotransmitters' in the spinal cord dorsal horn(1-3). However, the physiological significance and potential therapeutic value of NPY remain obscure(4). It is also unclear which receptor subtype(s) are involved. To identify a possible physiological role for the NPY Y1 receptor in pain transmission, we generated NPY Y1 receptor null mutant (Y1(-/-)) mice by homologous recombination techniques. Here we show that Y1(-/-) mice develop hyperalgesia to acute thermal, cutaneous and visceral chemical pain, and exhibit mechanical hypersensitivity. Neuropathic pain is increased, and the mice show a complete absence of the pharmacological analgesic effects of NPY. In the periphery, Y1 receptor activation is sufficient and required for substance P release and the subsequent development of neurogenic inflammation and plasma leakage. We conclude that the Y1 receptor is required for central physiological and pharmacological NPY-induced analgesia and that its activation is both sufficient and required for the release of substance P and initiation of neurogenic inflammation.	Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Karolinska Inst, Huddinge Univ Hosp, Div Clin Neurophysiol, Dept Med Lab Sci & Technol, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden.		Lucas, Guilherme/N-8827-2014; Naveilhan, Philippe/K-2377-2015	Lucas, Guilherme/0000-0002-1656-9571; Naveilhan, Philippe/0000-0003-4093-4513; Hygge Blakeman, Karin/0000-0001-6925-7099; Ernfors, Patrik/0000-0002-1140-3986				Allen BJ, 1999, J NEUROPHYSIOL, V81, P1379, DOI 10.1152/jn.1999.81.3.1379; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; DUGGAN AW, 1991, NEUROSCIENCE, V44, P733, DOI 10.1016/0306-4522(91)90092-3; HUA XY, 1991, J PHARMACOL EXP THER, V258, P243; Hudspith MJ, 1999, EUR J PAIN, V3, P3, DOI 10.1016/S1090-3801(99)90213-6; Inoue H, 1997, EUR J PHARMACOL, V333, P231, DOI 10.1016/S0014-2999(97)01040-6; JANCSO N, 1968, BRIT J PHARMACOL, V33, P32, DOI 10.1111/j.1476-5381.1968.tb00471.x; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; MAREK P, 1992, BRAIN RES, V578, P197, DOI 10.1016/0006-8993(92)90248-8; Munglani R, 1996, DRUGS, V52, P371, DOI 10.2165/00003495-199652030-00004; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; Parker D, 1998, EUR J NEUROSCI, V10, P2856, DOI 10.1046/j.1460-9568.1998.00295.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Polgar E, 1999, J NEUROSCI, V19, P2637; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SEMOS ML, 1994, NEUROPHARMACOLOGY, V33, P1487, DOI 10.1016/0028-3908(94)90053-1; Shi TJ, 1998, REGUL PEPTIDES, V75-6, P161, DOI 10.1016/S0167-0115(98)00064-0; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; WALKER MW, 1988, J NEUROSCI, V8, P2438; WATKINS LR, 1986, ANN NY ACAD SCI, V467, P273, DOI 10.1111/j.1749-6632.1986.tb14635.x; WILCOX GL, 1991, EXCITATORY NEUROTRAN, P97; XU XJ, 1994, NEUROSCIENCE, V63, P817, DOI 10.1016/0306-4522(94)90526-6; ZHANG X, 1994, EUR J NEUROSCI, V6, P43, DOI 10.1111/j.1460-9568.1994.tb00246.x; ZHANG X, 1994, P NATL ACAD SCI USA, V91, P11738, DOI 10.1073/pnas.91.24.11738	30	149	153	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					513	517		10.1038/35054063	http://dx.doi.org/10.1038/35054063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206547				2022-12-01	WOS:000166570500048
J	Schwetz, BA				Schwetz, BA			Proposal for public disclosure about clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-01	WOS:000167194700008
J	Schwetz, BA				Schwetz, BA			New suppository for ulcerative proctitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-01	WOS:000167194700007
J	Bobrow, M; Thomas, S				Bobrow, M; Thomas, S			Patents in a genetic age - The present patent system risks becoming a barrier to medical progress.	NATURE			English	Editorial Material									Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XQ, England; Nuffield Council Bioeth, London WC1 3JS, England	Addenbrooke's Hospital; University of Cambridge	Bobrow, M (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 2XQ, England.							Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Meyers TC, 2000, NAT STRUCT BIOL, V7, P950, DOI 10.1038/80723; 5835382	4	21	22	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					763	764		10.1038/35057480	http://dx.doi.org/10.1038/35057480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236975				2022-12-01	WOS:000166938800013
